N-CSRS 1 d592380dncsrs.htm GMO TRUST GMO Trust

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM N-CSR

 

 

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number 811-04347

 

 

GMO Trust

(Exact name of the registrant as specified in charter)

 

 

 

40 Rowes Wharf, Boston, MA 02110
(Address of principal executive offices) (Zip Code)

 

 

Sheppard N. Burnett, Chief Executive Officer, 40 Rowes Wharf, Boston, MA 02110

(Name and address of agent for services)

 

 

Registrant’s telephone number, including area code: 617-346-7646

Date of fiscal year end: 02/28/19

Date of reporting period: 08/31/18

 

 

 


Item 1. Reports to Stockholders.

The semi-annual reports for each series of the registrant for the period ended August 31, 2018 are filed herewith.


GMO Trust

Semiannual Report

August 31, 2018

Asset Allocation Bond Fund

Core Plus Bond Fund

Emerging Country Debt Fund

High Yield Fund

Opportunistic Income Fund

U.S. Treasury Fund


 

 

 

 

For a free copy of the Funds’ proxy voting guidelines, shareholders may call 1-617-346-7646 (collect), visit GMO’s website at www.gmo.com or visit the Securities and Exchange Commission’s website at www.sec.gov. Information regarding how the Funds voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available on GMO’s website at

www.gmo.com or on the Securities and Exchange Commission’s website at www.sec.gov.

The Funds file their complete schedule of portfolio holdings with the Securities and Exchange Commission for the first and third quarter of each fiscal year on Form N-Q, which is available on the Commission’s website at www.sec.gov. The Funds’ Form N-Q may be reviewed and copied at the Commission’s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference Room may be obtained by calling 1-800-SEC-0330. The Funds have a policy with respect to disclosure of portfolio holdings under which they may also make a complete schedule of portfolio holdings available on GMO’s website at www.gmo.com.

This report is prepared for the general information of shareholders. It is authorized for distribution to prospective investors only when preceded or accompanied by a prospectus for the GMO Trust, which contains a complete discussion of the risks associated with an investment in these Funds and other important information. The GMO Trust prospectus can be obtained at www.gmo.com. The GMO Trust Statement of Additional Information includes additional information about the Trustees of GMO Trust and is available without charge, upon request, by calling 1-617-346-7646 (collect).

An investment in the Funds is subject to risk, including the possible loss of principal amount invested. There can be no assurance that the Funds will achieve their stated investment objectives. Please see the Funds’ prospectus regarding specific principal risks for each Fund. General risks may include: market risk-fixed income investments, management and operational risk, market risk-asset backed securities, credit risk and derivatives risk.

The Funds are distributed by Funds Distributor LLC. Funds Distributor LLC is not affiliated with GMO.


TABLE OF CONTENTS

 

Asset Allocation Bond Fund

  

Investment Concentration Summary

     1  

Schedule of Investments

     2  

Core Plus Bond Fund

  

Investment Concentration Summary

     5  

Schedule of Investments

     6  

Emerging Country Debt Fund

  

Investment Concentration Summary

     9  

Schedule of Investments

     10  

High Yield Fund

  

Investment Concentration Summary

     21  

Schedule of Investments

     22  

Opportunistic Income Fund

  

Investment Concentration Summary

     26  

Schedule of Investments

     27  

U.S. Treasury Fund

  

Investment Concentration Summary

     36  

Schedule of Investments

     37  

Portfolio, Counterparty and Currency Abbreviations

     38  

Fund Financial Statements:

  

Statements of Assets and Liabilities

     39  

Statements of Operations

     43  

Statements of Changes in Net Assets

     45  

Financial Highlights

     48  

Notes to Financial Statements

     54  

Board Review of Investment Management Agreements

     99  

Fund Expenses

     106  

 

   


GMO Asset Allocation Bond Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Debt Obligations

    94.0

Mutual Funds

    4.9  

Short-Term Investments

    3.9  

Swap Contracts

    0.1  

Forward Currency Contracts

    0.0

Other

    (2.9
 

 

 

 
    100.0 % 
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

^

Rounds to 0.0%.

 

1


GMO Asset Allocation Bond Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value† /
Shares
    Description   Value ($)  
    DEBT OBLIGATIONS — 94.0%  
    U.S. Government — 86.4%  
    36,951,627     U.S. Treasury Inflation Indexed Bond, 0.63%, due 04/15/23 (a)     36,729,527  
    23,549,384     U.S. Treasury Inflation Indexed Bond, 0.25%, due 01/15/25 (a)     22,816,921  
    66,923,303     U.S. Treasury Inflation Indexed Bond, 0.63%, due 01/15/26 (a)     66,229,364  
    54,644,884     U.S. Treasury Inflation Indexed Bond, 0.38%, due 01/15/27 (a)     52,830,504  
    29,743,889     U.S. Treasury Inflation Indexed Bond, 0.50%, due 01/15/28 (a)     28,915,088  
    61,063,430     U.S. Treasury Inflation Indexed Bond, 1.75%, due 01/15/28 (a)     66,209,028  
    60,941,392     U.S. Treasury Inflation Indexed Bond, 2.50%, due 01/15/29 (a)     70,995,721  
    1,500,000     U.S. Treasury Note, Variable Rate, USBM + 0.05%, 2.14%, due 10/31/19     1,500,926  
    17,500,000     U.S. Treasury Note, Variable Rate USBM + 0.00%, 2.09%, due 01/31/20     17,498,116  
    10,000,000     U.S. Treasury Note, Variable Rate USBM + 0.03%, 2.12%, due 04/30/20 (b)     10,001,461  
     

 

 

 
    Total U.S. Government     373,726,656  
     

 

 

 
    U.S. Government Agency — 7.6%  
    15,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.24%, 2.08%,
due 03/06/19
    15,000,862  
    18,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.21%, 2.13%,
due 02/10/20
    17,989,995  
     

 

 

 
    Total U.S. Government Agency     32,990,857  
     

 

 

 
    TOTAL DEBT OBLIGATIONS
(COST $410,707,887)
    406,717,513  
     

 

 

 
    MUTUAL FUNDS — 4.9%  
    United States — 4.9%  
          Affiliated Issuers — 4.9%      
    855,913     GMO U.S. Treasury Fund     21,380,716  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $21,380,716)
    21,380,716  
     

 

 

 
    SHORT-TERM INVESTMENTS — 3.9%

 

    Foreign Government Obligations — 3.5%

 

JPY

    1,682,000,000     Japan Treasury Discount Bill, Zero Coupon, due 10/09/18     15,139,938  
     

 

 

 
    
Shares
    Description   Value ($)  
    Money Market Funds — 0.4%  
    1,516,027     State Street Institutional Treasury Plus Money Market Fund-Premier Class, 1.88% (c)     1,516,027  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $16,748,995)
    16,655,965  
     

 

 

 
    TOTAL INVESTMENTS — 102.8%
(COST $448,837,598)
    444,754,194  
     

 

 

 
    Other Assets and Liabilities
(net) — (2.8%)
    (12,205,686
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $432,548,508  
     

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Forward Currency Contracts

 

Settlement
Date

 

Counter-
party

  Currency
Sold
    Currency
Purchased
   

Net
Unrealized
Appreciation
(Depreciation) ($)

 
10/05/2018   JPM     AUD       1,380,000       USD       1,020,103       28,062  
10/05/2018   MSCI     AUD       20,660,000       USD       15,168,572       316,717  
09/04/2018   GS     CAD       7,646,590       USD       5,848,127       (11,329
09/04/2018   JPM     CAD       2,353,942       USD       1,790,000       (13,787
10/12/2018   MSCI     CHF       20,209,652       USD       20,494,216       (423,494
09/19/2018   BCLY     EUR       610,000       USD       718,174       9,395  
09/19/2018   GS     EUR       1,400,000       USD       1,635,131       8,424  
09/19/2018   MSCI     EUR       2,800,000       USD       3,270,628       17,213  
09/14/2018   JPM     GBP       10,370,000       USD       13,925,189       476,452  
09/07/2018   GS     JPY       236,477,704       USD       2,140,000       11,416  
09/07/2018   JPM     JPY       57,645,843       USD       520,000       1,118  
09/07/2018   MSCI     JPY       313,660,277       USD       2,850,000       26,679  
10/09/2018   MSCI     JPY       1,682,000,000       USD       15,302,316       127,822  
10/05/2018   BCLY     NOK       14,870,681       USD       1,780,000       4,638  
09/05/2018   BCLY     NZD       6,640,000       USD       4,663,829       270,804  
09/05/2018   MSCI     NZD       690,000       USD       469,688       13,184  
12/05/2018   MSCI     NZD       5,490,000       USD       3,637,921       4,913  
11/05/2018   GS     SEK       35,468,263       USD       3,900,000       2,693  
09/04/2018   BCLY     USD       790,000       CAD       1,030,409       (415
09/04/2018   MSCI     USD       6,939,677       CAD       8,970,123       (66,020
09/05/2018   JPM     USD       1,220,642       NZD       1,840,000       (3,298
09/05/2018   MSCI     USD       3,637,152       NZD       5,490,000       (4,968
09/07/2018   GS     USD       1,990,000       JPY       222,857,623       15,988  
09/07/2018   JPM     USD       3,800,605       JPY       416,267,408       (53,696
09/07/2018   MSCI     USD       1,380,000       JPY       153,452,936       1,261  
09/14/2018   BCLY     USD       1,578,451       GBP       1,210,000       (9,216
09/14/2018   GS     USD       2,546,609       GBP       1,980,000       21,231  
09/14/2018   JPM     USD       1,115,790       GBP       860,000       (465
09/14/2018   MSCI     USD       5,338,867       GBP       4,010,000       (138,342
09/19/2018   GS     USD       2,790,096       EUR       2,430,000       33,404  
09/19/2018   JPM     USD       559,050       EUR       480,000       (1,322
10/05/2018   BCLY     USD       280,354       AUD       380,000       (7,183
10/05/2018   JPM     USD       3,702,127       AUD       5,120,000       (21,512
10/05/2018   JPM     USD       11,769,113       NOK       95,799,993       (331,865
10/12/2018   BOA     USD       400,000       CHF       394,646       8,472  
 

 

2   See accompanying notes to the financial statements.  


GMO Asset Allocation Bond Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Forward Currency Contracts — continued

 

Settlement
Date

 

Counter-
party

  Currency
Sold
    Currency
Purchased
   

Net
Unrealized
Appreciation
(Depreciation) ($)

 
10/12/2018   JPM     USD       4,530,000       CHF       4,366,729       (10,280
11/05/2018   BCLY     USD       17,583,213       SEK       155,508,409       (495,711
12/03/2018   GS     USD       3,683,279       CAD       4,801,338       2,004  
           

 

 

 
            $ (191,013
           

 

 

 
 

 

Reverse Repurchase Agreements(1)

 

Average balance outstanding

   $ (41,051,668

Average interest rate

     0.22

Maximum balance outstanding

   $ (41,051,668

Average balance outstanding was calculated based on daily face value balances outstanding during the period that the Fund had entered into reverse repurchase agreements. Average interest rate was calculated based on interest received and/or paid during the period that the Fund had entered into reverse repurchase agreements. The Fund had no reverse repurchase agreements outstanding at the end of the period.

Swap Contracts

Centrally Cleared Interest Rate Swaps

 

Fund Pays

  Fund Receives  

Notional

Amount

     Expiration
Date
     Periodic
Payment
Frequency
     Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

3 Month NZD Bank

Bill Rate

  2.37%   NZD      126,240,000        09/19/2023        Quarterly        1,459       184,958       183,499  

2.37%

  3 Month NZD Bank Bill Rate   NZD      31,178,500        09/19/2023        Semi-Annually              (46,653     (46,653

2.41%

  3 Month NZD Bank Bill Rate   NZD      31,178,500        09/19/2023        Semi-Annually              (82,147     (82,147

1.72%

  6 Month GBP LIBOR   GBP      16,041,000        06/21/2028        Semi-Annually        1,475       19,088       17,613  

2.85%

  6 Month AUD BBSW   AUD      3,336,000        09/19/2028        Semi-Annually              (34,042     (34,042

2.84%

  6 Month AUD BBSW   AUD      12,512,000        09/19/2028        Semi-Annually        768       (120,356     (121,124

2.88%

  6 Month AUD BBSW   AUD      8,129,000        09/19/2028        Semi-Annually              (98,813     (98,813

2.76%

  6 Month AUD BBSW   AUD      50,952,000        09/19/2028        Semi-Annually        (41,250     (225,023     (183,773

3 Month NZD Bank

Bill Rate

  3.16%   NZD      7,665,000        09/19/2028        Quarterly              146,041       146,041  

3 Month NZD Bank

Bill Rate

  3.02%   NZD      5,525,000        09/19/2028        Quarterly        (819     59,674       60,493  

3 Month NZD Bank

Bill Rate

  2.88%   NZD      13,266,500        09/19/2028        Quarterly              36,895       36,895  

3 Month NZD Bank

Bill Rate

  2.91%   NZD      13,266,500        09/19/2028        Quarterly              58,482       58,482  

3 Month NZD Bank

Bill Rate

  2.92%   NZD      15,344,000        09/19/2028        Quarterly        15,981       76,557       60,576  

2.90%

  3 Month NZD Bank Bill Rate   NZD      3,199,000        09/19/2028        Quarterly              (12,057     (12,057

3 Month CAD LIBOR

  2.71%   CAD      9,042,000        09/20/2028        Semi-Annually        4,687       52,518       47,831  

3 Month CAD LIBOR

  2.74%   CAD      8,105,000        09/20/2028        Semi-Annually              61,532       61,532  

3 Month CAD LIBOR

  2.77%   CAD      6,029,000        09/20/2028        Semi-Annually              59,007       59,007  

3 Month CAD LIBOR

  2.76%   CAD      11,427,000        09/20/2028        Semi-Annually              103,606       103,606  

3 Month CAD LIBOR

  2.70%   CAD      4,042,000        09/20/2028        Semi-Annually              21,258       21,258  

3 Month CAD LIBOR

  2.61%   CAD      11,242,000        09/20/2028        Semi-Annually              (11,828     (11,828

6 Month CHF LIBOR

  0.45%   CHF      7,982,000        09/20/2028        Semi-Annually              40,583       40,583  

6 Month CHF LIBOR

  0.44%   CHF      5,692,000        09/20/2028        Semi-Annually              22,439       22,439  

6 Month EURIBOR

  0.98%   EUR      3,497,000        09/20/2028        Semi-Annually              38,340       38,340  

6 Month EURIBOR

  1.00%   EUR      3,660,000        09/20/2028        Semi-Annually              51,172       51,172  

6 Month EURIBOR

  1.00%   EUR      8,181,000        09/20/2028        Semi-Annually        5,262       110,190       104,928  

6 Month EURIBOR

  0.97%   EUR      6,000,000        09/20/2028        Semi-Annually              63,049       63,049  

 

  See accompanying notes to the financial statements.   3


GMO Asset Allocation Bond Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Centrally Cleared Interest Rate Swaps — continued

 

Fund Pays

  Fund Receives  

Notional

Amount

     Expiration
Date
     Periodic
Payment
Frequency
     Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

1.09%

  6 Month EURIBOR   EUR      4,461,000        09/20/2028        Semi-Annually              (108,093     (108,093

0.93%

  6 Month EURIBOR   EUR      2,999,000        09/20/2028        Semi-Annually              (16,828     (16,828

0.94%

  6 Month EURIBOR   EUR      2,999,000        09/20/2028        Semi-Annually              (18,707     (18,707

1.01%

  6 Month EURIBOR   EUR      2,788,000        09/20/2028        Semi-Annually              (39,298     (39,298

1.61%

  6 Month GBP LIBOR   GBP      32,667,000        09/20/2028        Semi-Annually              (227,869     (227,869

1.58%

  6 Month GBP LIBOR   GBP      3,900,000        09/20/2028        Semi-Annually              (15,878     (15,878

3 Month USD LIBOR

  3.04%   USD      5,918,000        09/20/2028        Quarterly        (1,160     60,857       62,017  

3 Month USD LIBOR

  2.99%   USD      9,800,000        09/20/2028        Quarterly              58,245       58,245  

3 Month USD LIBOR

  2.98%   USD      557,000        09/20/2028        Quarterly              2,431       2,431  

3 Month USD LIBOR

  2.99%   USD      6,688,000        09/20/2028        Quarterly              20,686       20,686  

3 Month USD LIBOR

  2.96%   USD      9,587,000        09/20/2028        Quarterly              30,082       30,082  

2.92%

  3 Month USD LIBOR   USD      5,093,000        09/20/2028        Quarterly              1,657       1,657  

2.95%

  3 Month USD LIBOR   USD      5,284,000        09/20/2028        Quarterly              (9,168     (9,168

2.94%

  3 Month USD LIBOR   USD      4,757,000        09/20/2028        Quarterly              (6,585     (6,585

3.02%

  3 Month USD LIBOR   USD      2,195,000        09/20/2028        Quarterly              (17,761     (17,761

2.77%

  6 Month AUD BBSW   AUD      6,042,000        12/19/2028        Semi-Annually              (18,756     (18,756

2.83%

  6 Month AUD BBSW   AUD      6,300,000        12/19/2028        Semi-Annually              (43,394     (43,394

3 Month SEK STIBOR

  1.20%   SEK      22,165,000        12/19/2028        Quarterly              (503     (503

1.23%

  3 Month SEK STIBOR   SEK      38,222,000        12/19/2028        Quarterly              (9,141     (9,141

6 Month EURIBOR

  0.97%   EUR      3,642,000        12/20/2028        Semi-Annually              14,159       14,159  
               

 

 

   

 

 

   

 

 

 
   $ (13,597   $ 230,606     $ 244,203  
               

 

 

   

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

(a)

Indexed security in which price and/or coupon is linked to the price of a specific instrument or financial statistic (Note 2).

 

(b)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(c)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 38.

 

 

4   See accompanying notes to the financial statements.  


GMO Core Plus Bond Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary†   % of Total Net Assets  

Debt Obligations

    73.4

Short-Term Investments

    25.2  

Mutual Funds

    15.0  

Swap Contracts

    0.6  

Loan Participations

    0.1  

Forward Currency Contracts

    0.1  

Rights/Warrants

    0.0

Loan Assignments

    0.0

Purchased Options

    0.0

Written Options/Credit Linked Options

    0.0

Futures Contracts

    (0.0 )^ 

Reverse Repurchase Agreements

    (0.1

Other

    (14.3
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary‡   % of Investments  

United States

    96.1

New Zealand

    17.0  

Canada

    11.6  

Other Emerging

    4.8 ¥ 

Euro Region

    4.1 § 

Switzerland

    3.4  

Japan

    0.2  

Sweden

    (0.4

United Kingdom

    (17.4

Australia

    (19.4
 

 

 

 
    100.0 % 
 

 

 

 

 

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table is normalized to 100%, therefore the absolute exposure presented for each country may not be representative of the true exposure of the Fund. The table excludes short-term investments. The table includes exposure through the use of certain derivative financial instruments and excludes exposure through certain currency linked derivatives such as forward currency contracts and currency options. The table is based on duration adjusted net exposures (both investments and derivatives), taking into account the market value of securities and the notional amounts of swaps and other derivative financial instruments. For example, U.S. asset-backed securities may represent a relatively small percentage due to their short duration, even though they represent a large percentage of market value (direct and indirect). Duration is based on GMO’s models. The greater the duration of a bond, the greater its contribution to the concentration percentage. Credit default swap exposures are factored into the duration adjusted exposure using the reference security and applying the same methodology to that security.

 

¥

“Other Emerging” is associated with investments in GMO Emerging Country Debt Fund and is comprised of emerging countries that each represents between (1.0)% and 1.0% of Investments.

 

§

“Euro Region” is comprised of derivative financial instruments attributed to the Eurozone and not a particular country.

 

^

Rounds to 0.0%.

 

 

5


GMO Core Plus Bond Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value† /
Shares
    Description   Value ($)  
    DEBT OBLIGATIONS — 49.0%  
    United States — 49.0%  
          Asset-Backed Securities — 3.0%      
    322,361     Bear Stearns Commercial Mortgage Securities Trust, Series 05-PW10, Class AJ, Variable Rate, 5.78%, due 12/11/40     341,704  
    16,740,000     Commercial Mortgage Trust, Series 13-WWP, Class A2, 144A, 3.42%, due 03/10/31     16,876,058  
    5,000,000     Commercial Mortgage Trust, Series 13-WWP, Class D, 144A, 3.90%, due 03/10/31     5,134,519  
     

 

 

 
    Total Asset-Backed Securities     22,352,281  
     

 

 

 
    U.S. Government — 29.9%  
    9,307,000     U.S. Treasury Bond, 3.75%, due 11/15/43     10,500,550  
    45,764,000     U.S. Treasury Bond, 3.38%, due 05/15/44 (a)     48,638,551  
    30,399,000     U.S. Treasury Note, 2.00%, due 02/28/21     29,902,641  
    51,233,000     U.S. Treasury Note, 1.75%, due 11/30/21     49,702,014  
    4,745,000     U.S. Treasury Note, 2.00%, due 02/15/23     4,597,646  
    36,868,000     U.S. Treasury Note, 2.50%, due 05/15/24     36,319,301  
    27,877,000     U.S. Treasury Note, 2.00%, due 08/15/25     26,430,881  
    16,615,000     U.S. Treasury Note, 2.25%, due 02/15/27     15,869,272  
     

 

 

 
    Total U.S. Government     221,960,856  
     

 

 

 
    U.S. Government Agency — 16.1%  
    15,217,000     Federal Home Loan Mortgage Corp., TBA, 3.50%, due 02/15/48     15,126,620  
    36,871,000     Federal National Mortgage Association, TBA, 2.50%, due 05/25/32     35,850,702  
    8,706,000     Federal National Mortgage Association, TBA, 3.00%, due 06/25/47     8,418,207  
    28,967,000     Federal National Mortgage Association, TBA, 4.00%, due 04/25/48     29,487,925  
    30,389,000     Government National Mortgage Association, TBA, 3.50%, due 12/20/47     30,485,746  
     

 

 

 
    Total U.S. Government Agency     119,369,200  
     

 

 

 
    TOTAL DEBT OBLIGATIONS
(COST $369,308,299)
    363,682,337  
     

 

 

 
    MUTUAL FUNDS — 44.6%  
    United States — 44.6%  
          Affiliated Issuers — 29.6%      
    1,481,448     GMO Emerging Country Debt Fund, Class IV     39,776,871  
    6,095,739     GMO Opportunistic Income Fund, Class VI     162,817,183  
    683,317     GMO U.S. Treasury Fund     17,069,267  
     

 

 

 
    Total Affiliated Issuers     219,663,321  
     

 

 

 
Shares /
Par Value†
    Description   Value ($)  
    Exchange-Traded Funds — 15.0%  
    964,362     iShares iBoxx $ Investment Grade Corporate Bond ETF     111,325,949  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $334,127,572)
    330,989,270  
     

 

 

 
    SHORT-TERM INVESTMENTS — 20.6%

 

    Foreign Government Obligations — 20.2%

 

JPY

    3,300,000,000     Japan Treasury Discount Bill, Zero Coupon, due 09/18/18     29,701,544  

JPY

    5,600,000,000     Japan Treasury Discount Bill, Zero Coupon, due 09/25/18     50,403,881  

JPY

    1,611,500,000     Japan Treasury Discount Bill, Zero Coupon, due 10/22/18     14,506,082  

JPY

    2,850,000,000     Japan Treasury Discount Bill, Zero Coupon, due 11/05/18     25,656,053  

JPY

    3,300,000,000     Japan Treasury Discount Bill, Zero Coupon, due 11/19/18     29,708,821  
     

 

 

 
    Total Foreign Government Obligations     149,976,381  
     

 

 

 
    Money Market Funds — 0.4%  
    3,349,336     State Street Institutional Treasury Plus Money Market Fund-Premier Class, 1.88% (b)     3,349,336  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $154,033,241)     153,325,717  
     

 

 

 
    TOTAL INVESTMENTS — 114.2%
(Cost $857,469,112)
    847,997,324  
    Other Assets and Liabilities
(net) — (14.2%)
    (105,687,078
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $742,310,246  
     

 

 

 
 

 

6   See accompanying notes to the financial statements.  


GMO Core Plus Bond Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

 

Forward Currency Contracts

 

Settlement

Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
   

Net
Unrealized
Appreciation
(Depreciation) ($)

 
10/05/2018   JPM     AUD       2,680,000       USD       1,981,070       54,498  
10/05/2018   MSCI     AUD       43,640,000       USD       32,040,488       669,000  
09/04/2018   GS     CAD       16,026,779       USD       12,250,747       (30,308
09/04/2018   JPM     CAD       696,977       USD       530,000       (4,082
10/12/2018   MSCI     CHF       41,118,217       USD       41,701,541       (857,278
09/19/2018   BCLY     EUR       1,170,000       USD       1,377,482       18,019  
09/19/2018   GS     EUR       2,780,000       USD       3,246,904       16,727  
09/19/2018   MSCI     EUR       5,770,000       USD       6,739,831       35,472  
09/14/2018   JPM     GBP       15,860,000       USD       21,297,347       728,691  
09/07/2018   GS     JPY       486,215,840       USD       4,400,000       23,471  
09/07/2018   JPM     JPY       24,388,626       USD       220,000       473  
09/07/2018   MSCI     JPY       492,549,333       USD       4,470,000       36,462  
09/18/2018   JPM     JPY       3,300,000,000       USD       30,099,048       372,902  
09/25/2018   MSCI     JPY       5,600,000,000       USD       51,205,618       735,569  
10/22/2018   GS     JPY       1,611,500,000       USD       14,458,102       (94,149
11/05/2018   GS     JPY       2,850,000,000       USD       25,700,798       (61,728
11/19/2018   JPM     JPY       3,300,000,000       USD       30,085,854       226,584  
10/05/2018   BCLY     NOK       12,447,929       USD       1,490,000       3,882  
09/05/2018   BCLY     NZD       10,800,000       USD       7,585,589       440,307  
09/05/2018   JPM     NZD       1,280,000       USD       868,018       21,170  
09/05/2018   MSCI     NZD       2,820,000       USD       1,919,594       53,881  
12/05/2018   MSCI     NZD       13,710,000       USD       9,084,863       12,269  
11/05/2018   GS     SEK       16,369,968       USD       1,800,000       1,243  
09/04/2018   BCLY     USD       1,570,000       CAD       2,047,774       (825
09/04/2018   MSCI     USD       11,353,978       CAD       14,675,982       (108,015
09/05/2018   JPM     USD       789,437       NZD       1,190,000       (2,133
09/05/2018   MSCI     USD       9,082,944       NZD       13,710,000       (12,406
09/07/2018   GS     USD       4,000,000       JPY       447,954,744       32,133  
09/07/2018   JPM     USD       6,452,457       JPY       707,380,487       (85,179
09/07/2018   MSCI     USD       2,730,000       JPY       303,569,939       2,495  
09/14/2018   BCLY     USD       1,532,239       GBP       1,170,000       (14,880
09/14/2018   GS     USD       5,537,912       GBP       4,300,000       38,710  
09/14/2018   JPM     USD       2,400,246       GBP       1,850,000       (1,001
09/14/2018   MSCI     USD       3,593,523       GBP       2,700,000       (91,923
09/19/2018   GS     USD       5,749,926       EUR       5,010,000       71,363  
09/19/2018   JPM     USD       267,878       EUR       230,000       (633
10/05/2018   BCLY     USD       1,674,744       AUD       2,270,000       (42,910

 

Settlement

Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
   

Net
Unrealized
Appreciation
(Depreciation) ($)

 
10/05/2018   JPM     USD       2,451,213       AUD       3,390,000       (14,243
10/05/2018   JPM     USD       24,578,836       NOK       200,070,497       (693,073
10/12/2018   BOA     USD       1,850,000       CHF       1,825,236       39,184  
10/12/2018   JPM     USD       2,050,000       CHF       1,976,113       (4,652
11/05/2018   BCLY     USD       34,912,812       SEK       308,590,214       (1,004,445
12/03/2018   GS     USD       9,412,314       CAD       12,269,422       5,122  
           

 

 

 
            $ 515,764  
           

 

 

 

Futures Contracts

 

Number of
Contracts +

  Type   Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation) ($)
 
Buys        
72   U.S. Long
Bond (CBT)
  December 2018     10,383,750       (50,722
393   U.S. Treasury
Note 2 Yr.
(CBT)
  December 2018     83,064,235       (20,116
118   U.S. Treasury
Note 5 Yr.
(CBT)
  December 2018     13,381,016       (14,918
25   U.S. Treasury
Note 10 Yr.
(CBT)
  December 2018     3,006,640       (5,312
185   U.S. Treasury
Ultra 10 Yr.
(CBT)
  December 2018     23,688,672       (60,984
12   U.S. Ultra
Bond (CBT)
  December 2018     1,911,750       (12,574
     

 

 

   

 

 

 
      $ 135,436,063     $ (164,626
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

 

Sales - Fund is short the futures contract.

 

 

Swap Contracts

Centrally Cleared Interest Rate Swaps

 

Fund Pays

   Fund Receives  

Notional

Amount

     Expiration
Date
     Periodic
Payment
Frequency
     Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

2.85%

   6 Month AUD BBSW   AUD      1,656,000        09/19/2028        Semi-Annually              (16,899     (16,899

2.84%

   6 Month AUD BBSW   AUD      79,945,000        09/19/2028        Semi-Annually        4,905       (769,010     (773,915

2.88%

   6 Month AUD BBSW   AUD      16,756,000        09/19/2028        Semi-Annually              (203,680     (203,680

2.76%

   6 Month AUD BBSW   AUD      87,483,000        09/19/2028        Semi-Annually        (70,825     (386,358     (315,533

2.77%

   6 Month AUD BBSW   AUD      12,744,000        12/19/2028        Semi-Annually              (39,560     (39,560

2.83%

   6 Month AUD BBSW   AUD      13,183,000        12/19/2028        Semi-Annually              (90,804     (90,804

3 Month CAD LIBOR

   2.71%   CAD      41,705,000        09/20/2028        Semi-Annually        15,790       242,230       226,440  

3 Month CAD LIBOR

   2.74%   CAD      16,525,000        09/20/2028        Semi-Annually              125,455       125,455  

3 Month CAD LIBOR

   2.77%   CAD      10,885,000        09/20/2028        Semi-Annually              106,533       106,533  

3 Month CAD LIBOR

   2.76%   CAD      23,174,000        09/20/2028        Semi-Annually              210,114       210,114  

3 Month CAD LIBOR

   2.70%   CAD      6,033,000        09/20/2028        Semi-Annually              31,730       31,730  

 

  See accompanying notes to the financial statements.   7


GMO Core Plus Bond Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Centrally Cleared Interest Rate Swaps — continued

 

Fund Pays

   Fund Receives    

Notional

Amount

     Expiration
Date
     Periodic
Payment
Frequency
     Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

3 Month CAD LIBOR

     2.61%     CAD      22,873,000        09/20/2028        Semi-Annually              (24,065     (24,065

6 Month CHF LIBOR

     0.45%     CHF      13,773,000        09/20/2028        Annually              70,027       70,027  

6 Month CHF LIBOR

     0.44%     CHF      13,107,000        09/20/2028        Annually              51,671       51,671  

6 Month EURIBOR

     0.98%     EUR      10,552,000        09/20/2028        Annually              115,689       115,689  

6 Month EURIBOR

     1.00%     EUR      5,896,000        09/20/2028        Annually              82,435       82,435  

6 Month EURIBOR

     1.00%     EUR      12,482,000        09/20/2028        Annually        8,028       168,120       160,092  

6 Month EURIBOR

     0.97%     EUR      20,000,000        09/20/2028        Annually              210,163       210,163  

1.09%

     6 Month EURIBOR     EUR      7,278,000        09/20/2028        Annually              (176,350     (176,350

0.93%

     6 Month EURIBOR     EUR      7,086,000        09/20/2028        Annually              (39,762     (39,762

0.94%

     6 Month EURIBOR     EUR      7,085,000        09/20/2028        Annually              (44,194     (44,194

1.01%

     6 Month EURIBOR     EUR      5,806,000        09/20/2028        Annually              (81,838     (81,838

6 Month EURIBOR

     0.97%     EUR      6,896,000        12/20/2028        Annually              26,809       26,809  

1.72%

     6 Month GBP LIBOR     GBP      22,061,000        06/21/2028        Semi-Annually        2,028       26,251       24,223  

1.61%

     6 Month GBP LIBOR     GBP      59,218,000        09/20/2028        Semi-Annually              (413,076     (413,076

1.58%

     6 Month GBP LIBOR     GBP      39,100,000        09/20/2028        Semi-Annually              (159,186     (159,186

3 Month NZD Bank Bill Rate

     2.37%     NZD      192,324,000        09/19/2023        Semi-Annually        2,223       281,779       279,556  
     3 Month NZD Bank                    

2.37%

     Bill Rate     NZD      32,188,500        09/19/2023        Semi-Annually              (48,164     (48,164
     3 Month NZD Bank                    

2.41%

     Bill Rate     NZD      32,188,500        09/19/2023        Semi-Annually              (84,808     (84,808

3 Month NZD Bank Bill Rate

     3.16%     NZD      12,070,000        09/19/2028        Semi-Annually              229,969       229,969  

3 Month NZD Bank Bill Rate

     3.02%     NZD      53,265,000        09/19/2028        Semi-Annually        (7,893     575,304       583,197  

3 Month NZD Bank Bill Rate

     2.88%     NZD      13,696,000        09/19/2028        Semi-Annually              38,089       38,089  

3 Month NZD Bank Bill Rate

     2.91%     NZD      13,696,000        09/19/2028        Semi-Annually              60,375       60,375  

3 Month NZD Bank Bill Rate

     2.93%     NZD      35,924,000        09/19/2028        Semi-Annually        59,220       200,116       140,896  

3 Month NZD Bank Bill Rate

     2.92%     NZD      9,165,000        09/19/2028        Semi-Annually        9,545       45,728       36,183  

3 Month SEK STIBOR

     1.20%     SEK      44,195,000        12/19/2028        Annually              (1,004     (1,004

1.23%

     3 Month SEK STIBOR     SEK      76,148,000        12/19/2028        Annually              (18,211     (18,211

3 Month USD LIBOR

     3.04%     USD      14,243,000        09/20/2028        Semi-Annually        (2,792     146,464       149,256  

3 Month USD LIBOR

     2.99%     USD      25,200,000        09/20/2028        Semi-Annually              149,773       149,773  

3 Month USD LIBOR

     2.98%     USD      1,215,000        09/20/2028        Semi-Annually              5,304       5,304  

3 Month USD LIBOR

     2.99%     USD      14,592,000        09/20/2028        Semi-Annually              45,134       45,134  

3 Month USD LIBOR

     2.96%     USD      19,519,000        09/20/2028        Semi-Annually              61,247       61,247  

2.92%

     3 Month USD LIBOR     USD      11,126,000        09/20/2028        Semi-Annually              3,620       3,620  

2.95%

     3 Month USD LIBOR     USD      11,347,000        09/20/2028        Semi-Annually              (19,687     (19,687

2.94%

     3 Month USD LIBOR     USD      10,214,000        09/20/2028        Semi-Annually              (14,140     (14,140

3.02%

     3 Month USD LIBOR     USD      5,131,000        09/20/2028        Semi-Annually              (41,517     (41,517
                

 

 

   

 

 

   

 

 

 
                 $ 20,229     $ 637,816     $ 617,587  
                

 

 

   

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

(a)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(b)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 38.

 

 

8   See accompanying notes to the financial statements.  


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary†   % of Total Net Assets  

Debt Obligations

    89.2

Short-Term Investments

    7.5  

Loan Participations

    1.3  

Rights/Warrants

    0.8  

Swap Contracts

    0.3  

Loan Assignments

    0.2  

Forward Currency Contracts

    0.0

Purchased Options

    0.0

Futures Contracts

    0.0

Written Options/Credit Linked Options

    (0.1

Reverse Repurchase Agreements

    (1.0

Other

    1.8  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary‡   % of Investments  

Mexico

    13.5

Other Emerging

    13.3 • 

Russia

    5.8  

Turkey

    5.8  

Indonesia

    5.6  

Argentina

    5.2  

Brazil

    5.1  

Ukraine

    3.3  

Venezuela

    3.3  

Tunisia

    2.9  

China

    2.4  

Philippines

    2.4  

Pakistan

    2.1  

Colombia

    2.0  

Ecuador

    2.0  

Israel

    2.0  

Uruguay

    1.9  

Dominican Republic

    1.8  

Kazakhstan

    1.8  

South Africa

    1.8  

Costa Rica

    1.5  

Egypt

    1.5  

Chile

    1.5  

Croatia

    1.3  

Congo

    1.2  

Hungary

    1.2  

Ivory Coast

    1.2  

Bahrain

    1.1  

Saudi Arabia

    1.1  

Sri Lanka

    1.1  

Angola

    1.0  

Morocco

    0.9  

Peru

    0.9  

Other Developed

    0.5  
 

 

 

 
    100.0 % 
 

 

 

 
 

 

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments. The table includes exposure through the use of certain derivative financial instruments and excludes exposure through certain currency linked derivatives such as forward currency contracts and currency options. The table is based on duration adjusted net exposures (both investments and derivatives), taking into account the market value of securities and the notional amounts of swaps and other derivative financial instruments. For example, U.S. asset-backed securities may represent a relatively small percentage due to their short duration, even though they represent a large percentage of market value (direct and indirect). Duration is based on GMO’s models. The greater the duration of a bond, the greater its contribution to the concentration percentage. Credit default swap exposures are factored into the duration adjusted exposure using a reference security and applying the same methodology to that security.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

^

Rounds to 0.0%.

 

 

9


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value†

    Description   Value ($)  
    DEBT OBLIGATIONS — 88.8%

 

    Albania — 1.0%

 

          Foreign Government Obligations  
    49,649,849     Republic of Albania Par Bond, Zero Coupon, due 08/31/25 (a) (b)     37,147,660  
     

 

 

 
    Angola — 0.5%

 

          Foreign Government Obligations  
    18,100,000     Angolan Government International Bond, 144A, 9.38%, due 05/08/48     18,145,250  
     

 

 

 
    Argentina — 4.2%

 

          Foreign Government Obligations  

JPY

    407,485,276     Republic of Argentina, 4.33%,
due 12/31/33 (c)
    2,539,716  

EUR

    8,008,646     Republic of Argentina Discount Bond, 7.82%, due 12/31/33     7,762,189  
    40,308,593     Republic of Argentina Discount Bond, 8.28%, due 12/31/33     32,448,417  
    10,786,557     Republic of Argentina Discount Bond, 8.28%, due 12/31/33     9,006,775  

EUR

    59,150,000     Republic of Argentina Par Bond, Step Up, 2.26%, due 12/31/38     37,418,806  

EUR

    112,130,000     Republic of Argentina Par Bond, Step Up, 2.26%, due 12/31/38     68,331,317  
     

 

 

 
    Total Argentina        157,507,220  
     

 

 

 
    Armenia — 0.1%

 

          Foreign Government Obligations  
    2,195,000     Republic of Armenia, Reg S, 7.15%, due 03/26/25     2,310,238  
     

 

 

 
    Azerbaijan — 0.8%

 

          Foreign Government Agency — 0.6%  
    12,650,000     Southern Gas Corridor CJSC, Reg S, 6.88%, due 03/24/26     13,677,813  
    7,987,000     State Oil Company of the Azerbaijan Republic, Reg S, 6.95%, due 03/18/30     8,416,301  
     

 

 

 
        22,094,114  
     

 

 

 
    Foreign Government Obligations — 0.2%

 

    7,100,000     Republic of Azerbaijan International Bond, Reg S, 5.13%, due 09/01/29     6,789,375  
     

 

 

 
    Total Azerbaijan     28,883,489  
     

 

 

 
    Bahrain — 0.8%

 

          Foreign Government Obligations  
    35,150,000     Bahrain Government International Bond, Reg S, 7.50%, due 09/20/47     30,800,187  
     

 

 

 

Par Value†

    Description   Value ($)  
    Belarus — 0.1%

 

          Foreign Government Obligations  
    3,700,000     Republic of Belarus International Bond, Reg S, 6.20%, due 02/28/30     3,482,625  
     

 

 

 
    Belize — 0.5%

 

          Foreign Government Obligations  
    33,578,000     Republic of Belize, Reg S, Step Up, 4.94%, due 02/20/34     19,894,965  
     

 

 

 
    Brazil — 2.6%

 

          Foreign Government Agency — 1.9%  

GBP

    12,895,000     Petrobras Global Finance BV, 6.63%, due 01/16/34     16,383,371  
    65,739,000     Petrobras Global Finance BV, 6.85%, due 06/05/2115     53,741,632  
     

 

 

 
        70,125,003  
     

 

 

 
    Foreign Government Obligations — 0.7%

 

    16,897,000     Republic of Brazil, 7.13%, due 01/20/37     17,741,850  
    5,000,000     Republic of Brazil, 5.00%, due 01/27/45     3,875,000  
    6,340,000     Republic of Brazil, 5.63%, due 02/21/47     5,300,240  
     

 

 

 
        26,917,090  
     

 

 

 
    Total Brazil     97,042,093  
     

 

 

 
    Cameroon — 0.1%

 

          Foreign Government Obligations  
    4,500,000     Republic of Cameroon International Bond, Reg S, 9.50%, due 11/19/25     4,590,000  
     

 

 

 
    Chile — 1.0%

 

          Corporate Debt — 0.8%  
    20,411,000     Empresa Nacional de Electricidad SA, 8.13%, due 02/01/97 (c)     26,456,738  
    3,600,000     Empresa Nacional del Petroleo, Reg. S, 4.50%, due 09/14/47     3,231,000  
     

 

 

 
        29,687,738  
     

 

 

 
    Foreign Government Agency — 0.2%

 

    7,300,000     Corp Nacional del Cobre de Chile, Reg S, 4.50%, due 08/01/47     7,026,250  
     

 

 

 
    Total Chile     36,713,988  
     

 

 

 
    Colombia — 1.9%

 

          Foreign Government Agency — 1.3%  
    43,011,000     Ecopetrol SA, 7.38%, due 09/18/43     48,441,139  
     

 

 

 
    Foreign Government Obligations — 0.6%

 

    647,000     Colombia Government International Bond, 8.38%, due 02/15/27     724,721  
    15,200,000     Colombia Government International Bond, 5.63%, due 02/26/44     16,476,800  
 

 

10   See accompanying notes to the financial statements.  


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value†

    Description   Value ($)  
    Colombia — continued  
    Foreign Government Obligations — continued

 

    3,800,000     Republic of Colombia, 11.85%, due 03/09/28 (b)     5,349,582  
     

 

 

 
        22,551,103  
     

 

 

 
    Total Colombia     70,992,242  
     

 

 

 
    Congo Republic (Brazzaville) — 1.7%

 

          Foreign Government Obligations  
    79,089,609     Republic of Congo, Reg S, Step Up, 6.00%, due 06/30/29 (c)     64,133,764  
     

 

 

 
    Costa Rica — 1.1%

 

          Foreign Government Agency — 0.1%  
    5,500,000     Instituto Costarricense de Electricidad, Reg S, 6.38%, due 05/15/43     4,593,875  
     

 

 

 
    Foreign Government Obligations — 1.0%

 

    37,631,000     Costa Rica Government International Bond, Reg S, 7.16%, due 03/12/45     36,549,109  
     

 

 

 
    Total Costa Rica     41,142,984  
     

 

 

 
    Dominican Republic — 1.9%

 

          Asset-Backed Securities — 0.6%  
    20,728,927     Autopistas Del Nordeste Ltd., Reg S, 9.39%, due 04/15/24     21,894,929  
     

 

 

 
    Foreign Government Obligations — 1.3%

 

    17,687,000     Dominican Republic International Bond, Reg S, 8.63%, due 04/20/27     20,118,963  
    29,811,000     Dominican Republic International Bond, Reg S, 6.85%, due 01/27/45     30,034,582  
     

 

 

 
        50,153,545  
     

 

 

 
    Total Dominican Republic     72,048,474  
     

 

 

 
    Ecuador — 1.6%

 

          Foreign Government Obligations  
    16,700,000     Ecuador Government International Bond, Reg S, 9.63%, due 06/02/27     15,823,250  
    31,400,000     Ecuador Government International Bond, 8.88%, due 10/23/27     28,495,500  
    20,100,000     Ecuador Government International Bond, 7.88%, due 01/23/28     17,185,500  
     

 

 

 
    Total Ecuador     61,504,250  
     

 

 

 
    Egypt — 1.0%

 

          Foreign Government Obligations  
    1,400,000     Egypt Government International Bond, Reg S, 8.50%, due 01/31/47     1,366,750  
    39,000,000     Egypt Government International Bond, 7.90%, due 02/21/48     35,880,000  
     

 

 

 
    Total Egypt     37,246,750  
     

 

 

 

Par Value†

    Description   Value ($)  
    El Salvador — 0.6%

 

          Foreign Government Obligations  
    24,275,000     El Salvador Government International Bond, Reg S, 7.65%, due 06/15/35     23,668,125  
     

 

 

 
    Ethiopia — 0.1%

 

          Foreign Government Obligations  
    4,190,000     Federal Democratic Republic of Ethiopia, Reg S, 6.63%, due 12/11/24     4,085,250  
     

 

 

 
    Gabon — 0.4%

 

          Foreign Government Obligations  
    15,300,000     Gabonese Republic, Reg S, 6.38%, due 12/12/24     13,903,875  
     

 

 

 
    Ghana — 1.0%

 

          Foreign Government Agency — 0.4%  
    14,700,626     Saderea, Ltd., Reg S, 12.50%, due 11/30/26     15,564,288  
     

 

 

 
    Foreign Government Obligations — 0.6%

 

    17,482,000     Republic of Ghana, Reg S, 10.75%, due 10/14/30 (e)     21,262,483  
     

 

 

 
    Total Ghana     36,826,771  
     

 

 

 
    Greece — 0.2%

 

          Foreign Government Obligations  

EUR

    5,800,000     Hellenic Republic Government Bond, Reg S, Step Up, 3.00%, due 02/24/36     5,773,030  
     

 

 

 
    Grenada — 0.2%

 

          Foreign Government Obligations  
    7,628,287     Grenada Government International Bond, Reg S, Step Up, 7.00%, due 05/12/30     6,751,034  
     

 

 

 
    Guatemala — 0.5%

 

          Foreign Government Obligations  
    16,195,000     Republic of Guatemala, Reg S, 8.13%, due 10/06/34     20,243,750  
     

 

 

 
    Honduras — 0.3%

 

          Foreign Government Obligations  
    5,516,000     Honduras Government International Bond, Reg S, 7.50%, due 03/15/24     5,922,805  
    6,646,000     Honduras Government International Bond, Reg S, 6.25%, due 01/19/27     6,795,535  
     

 

 

 
    Total Honduras     12,718,340  
     

 

 

 
    Hungary — 0.4%

 

          Foreign Government Obligations  
    12,084,000     Hungary Government International Bond, 7.63%, due 03/29/41     16,962,915  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   11


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value†

    Description   Value ($)  
    Indonesia — 3.5%

 

          Foreign Government Agency — 0.6%  
    14,400,000     Pertamina Persero PT, Reg S, 6.50%, due 05/27/41     15,778,512  
    6,100,000     Perusahaan Listrik Negara PT, 144A, 6.15%, due 05/21/48     6,458,375  
     

 

 

 
        22,236,887  
     

 

 

 
    Foreign Government Obligations — 2.9%

 

    30,000,000     Indonesia Government International Bond, 4.35%, due 01/11/48     27,862,500  
    43,091,000     Indonesia Government International Bond, Reg S, 6.63%, due 02/17/37     51,246,299  
    28,780,000     Indonesia Government International Bond, Reg S, 5.25%, due 01/17/42     29,844,860  
     

 

 

 
        108,953,659  
     

 

 

 
    Total Indonesia     131,190,546  
     

 

 

 
    Iraq — 0.4%

 

          Foreign Government Obligations  
    15,000,000     Republic of Iraq, Reg S, 5.80%, due 01/15/28     13,687,500  
     

 

 

 
    Israel — 1.4%

 

          Foreign Government Agency  
    7,243,000     Israel Electric Corp., Ltd., Reg S, 7.88%, due 12/15/26     8,836,460  

JPY

    2,500,000,000     Israel Electric Corp., Ltd., 4.10%, due 01/14/32 (c)     26,053,011  
    12,798,000     Israel Electric Corp., Ltd., Reg S, 8.10%, due 12/15/96     16,701,390  
     

 

 

 
    Total Israel     51,590,861  
     

 

 

 
    Ivory Coast — 0.9%

 

          Foreign Government Obligations  
    15,075,650     Ivory Coast Government International Bond, Reg S, Step Up, 5.75%, due 12/31/32     13,568,085  

EUR

    19,500,000     Ivory Coast Government International Bond, Reg. S, 6.63%, due 03/22/48     20,484,335  
     

 

 

 
    Total Ivory Coast     34,052,420  
     

 

 

 
    Jamaica — 0.6%

 

          Foreign Government Agency — 0.1%  
    4,000,000     National Road Operating & Construction Co., Ltd., Reg S, 9.38%, due 11/10/24 (c)     4,843,600  
     

 

 

 
    Foreign Government Obligations — 0.5%

 

    16,875,000     Jamaica Government International Bond, 7.88%, due 07/28/45     19,342,969  
     

 

 

 
    Total Jamaica     24,186,569  
     

 

 

 

Par Value†

    Description   Value ($)  
    Jordan — 0.5%  
          Foreign Government Obligations      
    6,887,000     Jordan Government International Bond, Reg S, 5.75%, due 01/31/27     6,404,910  
    15,000,000     Jordan Government International Bond, Reg. S, 7.38%, due 10/10/47     13,762,500  
     

 

 

 
    Total Jordan     20,167,410  
     

 

 

 
    Kazakhstan — 1.3%

 

          Foreign Government Agency — 0.4%  
    14,700,000     KazMunayGas National Co JSC, 144A, 6.38%, due 10/24/48     15,269,625  
     

 

 

 
    Foreign Government Obligations — 0.9%

 

    28,499,000     Kazakhstan Government International Bond, Reg S, 6.50%, due 07/21/45     35,196,265  
     

 

 

 
    Total Kazakhstan     50,465,890  
     

 

 

 
    Kenya — 0.3%  
          Foreign Government Obligations      
    11,600,000     Kenya Government International Bond, Reg. S, 8.25%, due 02/28/48     10,759,000  
     

 

 

 
    Macedonia — 0.5%  
          Foreign Government Obligations      

EUR

    7,300,000     Macedonia Government International Bond, Reg S, 2.75%, due 01/18/25     8,399,332  

EUR

    8,039,000     Macedonia Government International Bond, Reg S, 5.63%, due 07/26/23     10,700,679  
     

 

 

 
    Total Macedonia     19,100,011  
     

 

 

 
    Mexico — 9.2%

 

          Foreign Government Agency — 3.8%  
    4,000,000     Petroleos Mexicanos, 6.38%, due 01/23/45     3,583,480  
    84,087,000     Petroleos Mexicanos, 6.75%, due 09/21/47     77,570,257  
    68,851,000     Petroleos Mexicanos, Reg. S, 6.35%, due 02/12/48     60,795,433  
     

 

 

 
        141,949,170  
     

 

 

 
    Foreign Government Obligations — 5.4%

 

    138,478,000     United Mexican States, 5.75%, due 10/12/2110     138,478,000  

GBP

    49,396,000     United Mexican States, 5.63%, due 03/19/2114     66,219,997  
     

 

 

 
        204,697,997  
     

 

 

 
    Total Mexico     346,647,167  
     

 

 

 
    Morocco — 0.6%

 

          Foreign Government Agency  
    20,800,000     Office Cherifien des Phosphates SA, Reg S, 6.88%, due 04/25/44     22,568,000  
     

 

 

 
 

 

12   See accompanying notes to the financial statements.  


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value†

    Description   Value ($)  
    Mozambique — 0.1%

 

          Foreign Government Obligations  
    4,744,000     Mozambique International Bond, Reg S, 10.50%, due 01/18/23 (d)     3,990,890  
     

 

 

 
    Nigeria — 0.4%

 

          Foreign Government Obligations  
    10,750,000     Nigeria Government International Bond, Reg S, 7.63%, due 11/28/47     9,742,187  
    7,200,000     Nigeria Government International Bond, Reg S, 7.70%, due 02/23/38     6,678,000  
     

 

 

 
    Total Nigeria     16,420,187  
     

 

 

 
    Oman — 0.5%

 

          Foreign Government Obligations  
    21,700,000     Oman Government International Bond, Reg S, 6.75%, due 01/17/48     20,289,500  
     

 

 

 
    Pakistan — 1.1%

 

          Foreign Government Obligations  
    39,562,000     Islamic Republic of Pakistan, Reg S, 7.88%, due 03/31/36     35,684,924  
    6,000,000     Pakistan Government International Bond, Reg S, 6.88%, due 12/05/27     5,422,500  
     

 

 

 
    Total Pakistan     41,107,424  
     

 

 

 
    Panama — 0.6%

 

          Foreign Government Agency — 0.2%  
    9,300,000     Aeropuerto Internacional de Tocumen SA, 144A, 6.00%, due 11/18/48     9,346,500  
     

 

 

 
    Foreign Government Obligations — 0.4%

 

    7,851,000     Panama Government International Bond, 8.13%, due 04/28/34     10,530,154  
    4,252,000     Panama Government International Bond, 4.30%, due 04/29/53     4,103,180  
     

 

 

 
        14,633,334  
     

 

 

 
    Total Panama     23,979,834  
     

 

 

 
    Paraguay — 0.2%  
          Foreign Government Obligations      
    8,000,000     Republic of Paraguay, Reg S, 6.10%, due 08/11/44     8,720,000  
     

 

 

 
    Peru — 1.1%

 

          Foreign Government Agency — 1.0%  
    14,304,000     Peru Enhanced Pass-Through Finance Ltd., Reg S, Zero Coupon, due 06/02/25 (c)     12,724,409  
    25,895,000     Petroleos del Peru SA, Reg S, 5.63%, due 06/19/47     25,927,369  
     

 

 

 
        38,651,778  
     

 

 

 

Par Value†

    Description   Value ($)  
    Foreign Government Obligations — 0.1%

 

    5,000,000     Peru Par Bond, Series 30 Yr., Step Up, 4.00%, due 03/07/27 (b)     4,950,000  
     

 

 

 
    Total Peru     43,601,778  
     

 

 

 
    Philippines — 2.8%

 

          Foreign Government Agency  
    9,000,000     Bangko Sentral ng Pilipinas Bond, 8.60%, due 06/15/97 (c)     16,187,778  
    23,300,000     Central Bank of Philippines, Series A, 8.60%, due 06/15/27     29,884,580  
    42,012,000     National Power Corp., Global Bond, 9.63%, due 05/15/28     59,289,435  
     

 

 

 
    Total Philippines     105,361,793  
     

 

 

 
    Qatar — 0.3%

 

          Foreign Government Obligations  
    11,000,000     Qatar Government International Bond, 144A, 5.10%, due 04/23/48      11,302,500  
     

 

 

 
    Romania — 0.2%

 

          Foreign Government Obligations  

EUR

    5,180,000     Romanian Government International Bond, Reg S, 3.88%, due 10/29/35     6,175,027  
     

 

 

 
    Russia — 4.4%

 

          Foreign Government Agency — 2.1%  
    13,575,000     Gazprom Neft OAO Via GPN Capital SA, Reg S, 4.38%, due 09/19/22     13,184,719  
    41,067,000     Gazprom OAO Via Gaz Capital SA, Reg S, 8.63%, due 04/28/34     50,307,075  
    15,700,000     Sberbank of Russia Via SB Capital SA, Reg S, 5.13%, due 10/29/22     15,386,000  
     

 

 

 
        78,877,794  
     

 

 

 
    Foreign Government Obligations — 2.3%

 

    26,000,000     Russian Foreign Bond, 144A, 5.25%, due 06/23/47     24,700,000  
    64,400,000     Russian Foreign Bond, Reg S, 5.25%, due 06/23/47     61,180,000  
     

 

 

 
        85,880,000  
     

 

 

 
    Total Russia     164,757,794  
     

 

 

 
    Rwanda — 0.1%  
          Foreign Government Obligations      
    5,487,000     Rwanda International Government Bond, Reg S, 6.63%, due 05/02/23     5,466,424  
     

 

 

 
    Saudi Arabia — 0.5%  
          Foreign Government Obligations      
    21,000,000     Saudi Government International Bond, 144A, 5.00%, due 04/17/49     20,763,750  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   13


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value†

    Description   Value ($)  
    Senegal — 0.2%  
          Foreign Government Obligations      
    7,300,000     Senegal Government International Bond, Reg S, 6.75%, due 03/13/48     6,232,375  
     

 

 

 
    South Africa — 1.3%

 

          Foreign Government Agency — 0.3%  
    3,500,000     Eskom Holdings SOC, Ltd., 144A, 8.45%, due 08/10/28     3,495,387  

ZAR

    163,000,000     Eskom Holdings SOC, Ltd., Zero Coupon, due 12/31/32     1,560,412  
    4,975,000     Eskom Holdings SOC, Ltd., Reg S, 7.13%, due 02/11/25     4,695,156  

ZAR

    27,300,000     Transnet, Ltd., 13.50%, due 04/18/28     2,083,755  
     

 

 

 
        11,834,710  
     

 

 

 
    Foreign Government Obligations — 1.0%

 

    21,700,000     Republic of South Africa Government International Bond, 5.65%, due 09/27/47     19,313,000  
    19,900,000     Republic of South Africa Government International Bond, 6.30%, due 06/22/48     18,805,500  
     

 

 

 
        38,118,500  
     

 

 

 
    Total South Africa     49,953,210  
     

 

 

 
    Sri Lanka — 0.9%

 

          Foreign Government Obligations  
    11,000,000     Sri Lanka Government International Bond, 144A, 6.75%, due 04/18/28     10,587,500  
    1,425,000     Sri Lanka Government International Bond, Reg S, 6.13%, due 06/03/25     1,362,656  
    14,280,000     Sri Lanka Government International Bond, Reg S, 6.83%, due 07/18/26     14,047,950  
    7,144,000     Sri Lanka Government International Bond, Reg S, 6.20%, due 05/11/27     6,706,430  
     

 

 

 
    Total Sri Lanka     32,704,536  
     

 

 

 
    Suriname — 0.4%

 

          Foreign Government Obligations  
    16,178,000     Republic of Suriname, Reg S, 9.25%, due 10/26/26 (e)     15,955,552  
     

 

 

 
    Trinidad And Tobago — 0.4%

 

          Foreign Government Agency  
    6,736,000     Petroleum Company of Trinidad and Tobago Ltd., Reg S, 9.75%, due 08/14/19     6,567,600  
    7,292,000     Trinidad Generation UnLtd, Reg S, 5.25%, due 11/04/27     7,142,514  
     

 

 

 
    Total Trinidad And Tobago     13,710,114  
     

 

 

 

Par Value†

    Description   Value ($)  
    Tunisia — 1.9%

 

          Foreign Government Agency  

JPY

    7,340,000,000     Banque Centrale de Tunisie SA, 4.30%, due 08/02/30 (c)     53,509,135  

JPY

    2,500,000,000     Banque Centrale de Tunisie SA, 4.20%, due 03/17/31 (c)     17,775,178  
     

 

 

 
    Total Tunisia     71,284,313  
     

 

 

 
    Turkey — 4.2%

 

          Foreign Government Agency — 0.4%  
    3,600,000     Export Credit Bank of Turkey, 144A, 6.13%, due 05/03/24     2,736,000  
    5,000,000     TC Ziraat Bankasi AS, Reg S, 5.13%, due 09/29/23     3,712,500  
    12,200,000     Turkiye Vakiflar Bankasi TAO, Reg s, 5.75%, due 01/30/23 (e)     8,723,000  
     

 

 

 
        15,171,500  
     

 

 

 
    Foreign Government Obligations — 3.8%

 

    30,744,000     Republic of Turkey, 6.75%, due 05/30/40     24,057,180  
    83,302,000     Republic of Turkey, 6.00%, due 01/14/41     59,977,440  
    3,600,000     Republic of Turkey, 6.63%, due 02/17/45     2,740,500  
    84,513,000     Republic of Turkey, 5.75%, due 05/11/47     58,947,817  
     

 

 

 
        145,722,937  
     

 

 

 
    Total Turkey     160,894,437  
     

 

 

 
    Ukraine — 2.2%

 

          Foreign Government Agency — 0.3%  
    8,189,000     Oschadbank Via SSB #1 Plc, Reg S, Step Up, 9.63%, due 03/20/25     8,137,819  
    3,700,000     Ukreximbank Via Biz Finance Plc, Reg S, 9.75%, due 01/22/25     3,672,250  
     

 

 

 
        11,810,069  
     

 

 

 
    Foreign Government Obligations — 1.9%

 

    6,019,000     Ukraine Government International Bond, Reg S, 7.75%, due 09/01/21     5,966,334  
    6,019,000     Ukraine Government International Bond, Reg S, 7.75%, due 09/01/22     5,913,667  
    6,585,000     Ukraine Government International Bond, Reg S, 7.75%, due 09/01/23     6,387,450  
    8,585,000     Ukraine Government International Bond, Reg S, 7.75%, due 09/01/24     8,241,600  
    6,585,000     Ukraine Government International Bond, Reg S, 7.75%, due 09/01/25     6,181,669  
    6,019,000     Ukraine Government International Bond, Reg S, 7.75%, due 09/01/26     5,537,480  
 

 

14   See accompanying notes to the financial statements.  


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value†

    Description   Value ($)  
    Ukraine — continued  
    Foreign Government Obligations — continued

 

    6,869,000     Ukraine Government International Bond, Reg S, 7.75%, due 09/01/27     6,250,790  
    33,100,000     Ukraine Government International Bond, Reg S, 7.38%, due 09/25/32     28,052,250  
     

 

 

 
        72,531,240  
     

 

 

 
    Total Ukraine     84,341,309  
     

 

 

 
    United States — 15.6%

 

          Asset-Backed Securities — 0.5%  
    3,916,051     Countrywide Home Equity Loan Trust, Series 05-F, Class 2A, AMBAC, Variable Rate, 1 mo. LIBOR + .24%, 2.30%, due 12/15/35 ◆     3,418,986  
    2,078,992     Countrywide Home Equity Loan Trust, Series 05-H, Class 2A, FGIC, Variable Rate, 1 mo. LIBOR + .24%, 2.30%, due 12/15/35 ◆     2,020,914  
    2,664,973     Countrywide Home Equity Loan Trust, Series 06-D, Class 2A, XLCA, Variable Rate, 1 mo. LIBOR + .20%, 2.26%, due 05/15/36 ◆     2,504,094  
    10,237,145     Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, Variable Rate, 1 mo. LIBOR + .15%, 2.21%, due 11/25/36 ◆     5,124,629  
    10,373,640     Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A4, Variable Rate, 1 mo. LIBOR + .22%, 2.28%, due 11/25/36 ◆     5,226,485  
    5,596,171     Wamu Asset-Backed Certificates, Series 07-HE2, Class 2A4, Variable Rate, 1 mo. LIBOR + .36%, 2.42%, due 04/25/37 ◆     3,042,590  
     

 

 

 
        21,337,698  
     

 

 

 
    Corporate Debt — 0.1%

 

    385,402     AMBAC Assurance Corp., 144A, 5.10%, due 06/07/20     522,220  
    1,755,213     AMBAC LSNI LLC, 144A 3 mo. LIBOR + 5.00%, 7.34%, due 02/12/23     1,777,153  
     

 

 

 
        2,299,373  
     

 

 

 
    U.S. Government — 15.0%

 

    77,930,300     U.S. Treasury Inflation Indexed Note, 0.13%, due 01/15/22 (f)     76,288,589  
    45,000,000     U.S. Treasury Note 3 mo. USD LIBOR + 0.05%, 1.25%, due 11/30/18 (g)     44,906,666  
    200,000,000     U.S. Treasury Note, 1.50%, due 12/31/18     199,563,206  
    68,000,000     U.S. Treasury Note, 1.25%, due 01/31/19     67,723,750  
    27,000,000     U.S. Treasury Note, 1.38%, due 02/28/19     26,881,875  
    51,500,000     U.S. Treasury Note, USBM + 0.03%, 2.12%, due 04/30/20     51,507,523  

Par Value†

    Description   Value ($)  
    United States — continued  
    U.S. Government — continued  
    100,000,000     U.S. Treasury Note, USBM + 0.00%, 2.09%, due 01/31/20     99,989,232  
     

 

 

 
        566,860,841  
     

 

 

 
    Total United States     590,497,912  
     

 

 

 
    Uruguay — 1.4%

 

          Foreign Government Obligations  
    52,218,000     Uruguay Government International Bond, 5.10%, due 06/18/50     53,197,087  
     

 

 

 
    Venezuela — 3.4%

 

          Foreign Government Agency — 1.4%  
    111,465,000     Electricidad de Caracas Finance BV, Reg S, 8.50%, due 04/10/18 (d)     11,146,500  
    176,000,000     Petroleos de Venezuela SA, Reg S, 6.00%, due 05/16/24 (d)     32,780,000  
    61,967,000     Petroleos de Venezuela SA, Reg S, 6.00%, due 11/15/26 (d)     11,154,060  
     

 

 

 
        55,080,560  
     

 

 

 
    Foreign Government Obligations — 2.0%

 

    7,000,000     Venezuela Government International Bond, 9.38%, due 01/13/34 (d)     1,877,181  
    19,028,000     Venezuela Government International Bond, Reg S, 7.75%, due 10/13/19 (d) (e)     4,780,785  
    55,350,000     Venezuela Government International Bond, Reg S, 6.00%, due 12/09/20 (d)     13,525,293  
    172,793,000     Venezuela Government International Bond, Reg S, 9.00%, due 05/07/23 (d)     42,007,067  
    51,500,000     Venezuela Government International Bond, Reg S, 11.95%, due 08/05/31 (d)     13,325,625  
     

 

 

 
        75,515,951  
     

 

 

 
    Total Venezuela     130,596,511  
     

 

 

 
    Vietnam — 0.6%

 

          Foreign Government Agency — 0.5%  
    25,105,000     Debt and Asset Trading Corp., Reg S, 1.00%, due 10/10/25     17,247,261  
     

 

 

 
    Foreign Government Obligations — 0.1%

 

    6,428,000     Socialist Republic of Vietnam, Series 30 Yr., Variable Rate, 6 Mo. LIBOR +0.81%, 3.13%, due 03/13/28 (c)     5,528,080  
     

 

 

 
    Total Vietnam     22,775,341  
     

 

 

 
    Zambia — 0.2%  
          Foreign Government Obligations      
    11,300,000     Zambia Government International Bond, Reg S, 8.97%, due 07/30/27 (e)     8,136,000  
     

 

 

 
    TOTAL DEBT OBLIGATIONS
(COST $3,600,965,233)
    3,361,150,241  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   15


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value†

    Description   Value ($)  
    LOAN ASSIGNMENTS — 0.2%  
    Indonesia — 0.0%  
    408,070     Republic of Indonesia Loan Agreement, dated September 14, 1994, 6 mo. LIBOR + 0.75%, 1.25%, due 12/16/19 (b)     378,036  

EUR

    540,685     Republic of Indonesia, Indonesia Paris Club Debt, 4.00%, due 06/01/21 (c)     566,620  
     

 

 

 
        944,656  
     

 

 

 
    Kenya — 0.2%  
    7,300,000     Republic of Kenya Loan Agreement, 9.17%, due 04/10/25 (c)     7,300,000  
     

 

 

 
    TOTAL LOAN ASSIGNMENTS (COST $8,339,796)     8,244,656  
     

 

 

 
    LOAN PARTICIPATIONS — 1.4%

 

    Angola — 0.8%

 

    19,112,500     Republic of Angola Loan Agreement (Participation with Development Bank of Southern Africa), 6 mo. LIBOR + 6.25%, 6.60%, due 12/13/23 (c)     17,392,375  
    13,714,938     Republic of Angola Loan Agreement (Participation with Development Bank of Southern Africa), 6 mo. LIBOR + 6.25%, 6.60%, due 12/20/23 (c)     12,480,593  
     

 

 

 
    Total Angola     29,872,968  
     

 

 

 
    Egypt — 0.0%

 

CHF

    65,516     Paris Club Loan Agreement (Participation with Standard Chartered Bank), Zero Coupon, due 01/03/24 (b)     60,406  
     

 

 

 
    Indonesia — 0.1%

 

    2,346,716     Republic of Indonesia Loan Agreement (Participation with Deutsche Bank), 6 mo. LIBOR + 0.88%, 3.33%, due 09/29/19 (c)     2,173,998  
    299,626     Republic of Indonesia Loan Agreement (Participation with Deutsche Bank), 6 mo. LIBOR + 0.88%, 2.41%, due 10/14/19 (c)     277,574  
     

 

 

 
    Total Indonesia     2,451,572  
     

 

 

 
    Iraq — 0.5%

 

EUR

    1,063,115     Republic of Iraq Paris Club Loan Agreement (Participation with Credit Suisse), 4.50%, due 12/30/27 (b)     884,541  

JPY

    152,901,473     Republic of Iraq Paris Club Loan Agreement (Participation with Deutsche Bank), 2.57%, due 01/01/28 (c)     826,048  
Par Value† /
Shares
    Description   Value ($)  
    Iraq — continued  

JPY

    2,753,142,613     Republic of Iraq Paris Club Loan Agreement (Participation with Deutsche Bank), 2.57%, due 01/01/28 (c)     14,806,902  

JPY

    359,728,676     Republic of Iraq Paris Club Loan Agreement (Participation with Deutsche Bank), 2.57%, due 01/01/28 (c)     1,934,691  
     

 

 

 
    Total Iraq     18,452,182  
     

 

 

 
    Russia — 0.0%

 

EUR

    76,893,500     Russian Foreign Trade Obligations (Participation with GML International Ltd.) (c) (d)     3  
     

 

 

 
    TOTAL LOAN PARTICIPATIONS (COST $73,207,865)     50,837,131  
     

 

 

 
    MUTUAL FUNDS — 2.6%

 

    United States — 2.6%

 

          Affiliated Issuers — 2.6%  
    568,012     GMO Opportunistic Income Fund, Class VI     15,171,593  
    3,251,005     GMO U.S. Treasury Fund     81,210,113  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $93,156,925)
    96,381,706  
     

 

 

 
    RIGHTS/WARRANTS — 0.8%

 

    Argentina — 0.5%

 

JPY

    740,189,000     Republic of Argentina GDP Linked, Expires 12/15/35 (c) (f)     403,968  

EUR

    335,089,675     Republic of Argentina GDP Linked, Expires 12/15/35 (f)     19,496,386  
     

 

 

 
    Total Argentina     19,900,354  
     

 

 

 
    Nigeria — 0.1%

 

    28,000     Central Bank of Nigeria Oil Warrants, Expires 11/15/20 (c) (f)     1,624,000  
     

 

 

 
    Ukraine — 0.2%

 

    14,446,000     Government of Ukraine GDP Linked, Expires 05/31/40 (f)     7,764,725  
     

 

 

 
    Uruguay — 0.0%

 

    4,000,000     Banco Central Del Uruguay Value Recovery Rights, VRRB, Expires 01/02/21 * (b) (f)      
     

 

 

 
    Venezuela — 0.0%

 

    1,080,062     Republic of Venezuela Oil Warrants, Expires 04/15/20 (c) (f)     1,620,093  
     

 

 

 
    TOTAL RIGHTS/WARRANTS
(COST $55,515,266)
    30,909,172  
     

 

 

 
 

 

16   See accompanying notes to the financial statements.  


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares /

Par Value†

    Description   Value ($)  
    SHORT-TERM INVESTMENTS — 5.2%

 

    Money Market Funds — 0.8%

 

    31,342,999     State Street Institutional Treasury Plus Money Market Fund-Premier Class, 1.88% (h)     31,342,999  
     

 

 

 
    U.S. Government — 4.4%

 

    47,000,000     U.S. Treasury Bill, 1.73%, due 10/04/18 (i)     46,924,212  
    53,000,000     U.S. Treasury Bill, 1.88%, due 10/25/18 (i)     52,850,584  
    35,500,000     U.S. Treasury Bill, 1.96%, due 11/08/18 (i)     35,369,242  
    23,000,000     U.S. Treasury Bill, 2.04%, due 12/06/18 (i)     22,875,968  
    10,000,000     U.S. Treasury Bill, 2.18%, due 01/31/19 (i)     9,909,565  
     

 

 

 
    Total U.S. Government     167,929,571  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $199,257,843)
    199,272,570  
     

 

 

 
    TOTAL INVESTMENTS — 99.0%
(Cost $4,030,442,928)
    3,746,795,476  
    Other Assets and Liabilities
(net) — 1.0%
    36,618,449  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $3,783,413,925  
     

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Forward Currency Contracts

 

Settlement
Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
    Net
Unrealized
Appreciation
(Depreciation) ($)
 
09/19/2018   MSCI     EUR       55,027,600       USD       64,276,727       338,289  
09/19/2018   JPM     GBP       12,000,000       USD       15,953,232       387,307  
09/18/2018   JPM     USD       13,682,449       JPY       1,500,000,000       (170,564
           

 

 

 
            $ 555,032  
           

 

 

 
 

Reverse Repurchase Agreements

 

Face Value

    

Description

   Value ($)  

USD

    8,699,070     

JP Morgan Securities, Inc., 1.65%, dated 07/03/18 (collateral: Republic of Ghana, Reg S, 10.75%, 10/14/30), to be repurchased on demand at face value plus accrued interest.

     (8,699,070
USD     11,796,571      JP Morgan Securities, Inc., 1.65%, dated 07/03/18 (collateral: Republic of Suriname, Reg S, 9.25%, 10/26/26), to be repurchased on demand at face value plus accrued interest.      (11,796,571
USD     7,113,084      JP Morgan Securities, Inc., 1.65%, dated 07/03/18 (collateral: Zambia Government International Bond, Reg S, 8.97%, 07/30/27), to be repurchased on demand at face value plus accrued interest.      (7,113,084
USD     6,948,507      JP Morgan Securities, Inc., 1.30%, dated 08/23/18 (collateral: Turkiye Vakiflar Bankasi TAO, Reg S, 5.75%, due 01/30/23), to be repurchased on demand at face value plus accrued interest.      (6,948,507
USD     2,375,834      JP Morgan Securities, Inc., 1.00%, dated 07/19/18 (collateral: Venezuela Government International Bond, Reg S, 7.75%, due 10/13/19), to be repurchased on demand at face value plus accrued interest.      (2,375,834
       

 

 

 
        $ (36,933,066
       

 

 

 
     Average balance outstanding    $ (22,440,014
     Average interest rate      (1.97 )% 
     Maximum balance outstanding    $ (70,329,039

Average balance outstanding was calculated based on daily face value balances outstanding during the period that the Fund had entered into reverse repurchase agreements. Average interest rate was calculated based on interest received and/or paid during the period that the Fund had entered into reverse repurchase agreements.

 

  See accompanying notes to the financial statements.   17


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Credit Linked Options

 

Principal /

Notional Amount

    Expiration
Date
 

Descriptions

  Premiums ($)     Value ($)  
Put Sold   USD     24,000,000     03/10/2020   Lebanon Gap Credit Linked Put Option, Fund receives premium of 0.50% (OTC) (CP-DB) (b)     (361,333     (305,746
Put Sold   USD     9,746,000     01/24/2024   Republic of Philippines Credit Linked Put Option, Fund receives premium of 0.25% (OTC) (CP-DB) (b)     (13,848     23,480  
Put Sold   USD     45,000,000     01/20/2021   Republic of Philippines Credit Linked Put Option, Fund receives premium of 0.25% (OTC) (CP-DB) (b)     (472,813     108,414  
Put Sold   USD     46,000,000     04/13/2021   Lebanon Gap Credit Linked Put Option, Fund receives premium of 0.50% (OTC) (CP-DB) (b)     (947,472     (1,067,938
Put Sold   USD     100,000,000     04/15/2024   Banco do Brasil Credit Linked Put Option, Fund receives premium of 0.44% (OTC) (CP-DB) (b)     (2,598,444     (1,596,442
Put Sold   USD     50,797,000     04/15/2024   Banco do Brasil Credit Linked Put Option, Fund receives premium of 0.30% (OTC) (CP-DB) (b)     (707,789     (230,655
         

 

 

   

 

 

 
          $ (5,101,699   $ (3,068,887
         

 

 

   

 

 

 

Swap Contracts

Centrally Cleared Credit Default Swaps

 

Reference Entity

 

Notional

Amount

  Annual
Premium
    Implied
Credit
Spread (1)
    Maximum
Potential
Amount of Future
Payments by the
Fund Under the

Contract (2)
    Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Buy Protection^:

                   

CDX-EMS29V1-5Y

  USD   282,000,000     1.00%       1.39%       N/A       06/20/2023       Quarterly     $ 7,670,400     $ 16,168,752     $ 8,498,352  
               

 

 

   

 

 

   

 

 

 

OTC Credit Default Swaps

 

Reference Entity

 

Counterparty

 

Notional

Amount

    Annual
Premium
    Implied
Credit
Spread (1)
    Maximum
Potential
Amount of Future
Payments by the
Fund Under the
Contract (2)
  Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Buy Protection^:

                       

CDX-EM21

  BCLY   USD     20,222,950       5.00%       5.00%       N/A         06/20/2019       Quarterly       (504,450     (495,462     8,988  

Republic of Brazil

  JPM   USD     50,000,000       1.00%       0.19%       N/A         06/20/2019       Quarterly       1,008,872       156,387       (852,485

Republic of Croatia

  JPM   USD     44,000,000       1.00%       0.84%       N/A         06/20/2019       Quarterly       3,659,820       (284,514     (3,944,334

Commonwealth of

Bahamas

  DB   EUR     51,746,000       1.00%       1.72%       N/A         12/20/2020       Quarterly       7,730,397       985,856       (6,744,541

Commonwealth of

Bahamas

  DB   EUR     66,982,145       1.00%       4.33%       N/A         06/20/2025       Quarterly       9,635,537       3,114,978       (6,520,559

United States of

Mexico

  GS   USD     20,000,000       1.00%       2.00%       N/A         09/20/2031       Quarterly       2,640,655       1,925,127       (715,528

Sell Protection^:

                       

Commonwealth of

Bahamas

  DB   USD     61,270,000       1.00%       1.92%       61,270,000     USD     12/20/2020       Quarterly       (7,515,364     (1,232,797     6,282,567  

Republic of Malaysia

  JPM   USD     10,000,000       1.00%       1.02%       10,000,000     USD     12/20/2022       Quarterly       (826,278     64,449       890,727  

Commonwealth of

Bahamas

  DB   USD     3,487,000       1.00%       2.05%       3,487,000     USD     06/20/2023       Quarterly       (641,463     (155,845     485,618  

Commonwealth of

Bahamas

  DB   USD     6,975,000       1.00%       2.05%       6,975,000     USD     06/20/2023       Quarterly       (1,263,915     (311,735     952,180  

Republic of Croatia

  JPM   USD     40,000,000       1.00%       1.07%       40,000,000     USD     06/20/2023       Quarterly       (6,395,816     (35,254     6,360,562  

 

18   See accompanying notes to the financial statements.  


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

OTC Credit Default Swaps — continued

 

Reference Entity

 

Counterparty

 

Notional

Amount

    Annual
Premium
    Implied
Credit
Spread (1)
    Maximum
Potential
Amount of Future
Payments by the
Fund Under the
Contract (2)
  Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Peoples Republic of

Malaysia

  JPM   USD     20,000,000       1.00%       3.24%       20,000,000     USD     03/20/2024       Quarterly       (932,016     (69,776     862,240  

Peoples Republic of

China

  JPM   USD     4,873,000       1.00%       3.85%       4,873,000     USD     06/20/2024       Quarterly       3,073       69,149       66,076  

Peoples Republic of

China

  JPM   USD     60,000,000       1.00%       0.73%       60,000,000     USD     06/20/2024       Quarterly       (2,413,417     851,408       3,264,825  

Republic of Brazil

  JPM   USD     27,250,000       1.00%       0.73%       27,250,000     USD     06/20/2024       Quarterly       (2,095,396     (2,986,537     (891,141

Peoples Republic of

China

  GS   USD     25,000,000       1.00%       0.81%       25,000,000     USD     03/20/2025       Quarterly       (744,727     279,261       1,023,988  

Commonwealth of

Bahamas

  DB   USD     89,694,857       1.00%       4.60%       89,694,857     USD     06/20/2025       Quarterly       (10,800,222     (3,875,726     6,924,496  

Indonesia

  GS   USD     36,208,000       1.00%       1.65%       36,208,000     USD     06/20/2025       Quarterly       (3,153,880     (1,385,130     1,768,750  

Indonesia

  GS   USD     10,000,000       1.00%       1.65%       10,000,000     USD     06/20/2025       Quarterly       (961,768     (382,548     579,220  

Peoples Republic of

China

  GS   USD     22,436,000       1.00%       0.83%       22,436,000     USD     06/20/2025       Quarterly       (590,310     227,557       817,867  

Republic of Brazil

  BOA   USD     4,873,000       1.00%       3.51%       4,873,000     USD     12/20/2025       Quarterly       (726,704     (711,759     14,945  

Russia

  GS   USD     2,436,000       1.00%       2.03%       2,436,000     USD     12/20/2025       Quarterly       (238,041     (154,901     83,140  

Russia

  GS   USD     8,487,000       1.00%       2.13%       8,487,000     USD     12/20/2026       Quarterly       (1,059,663     (653,385     406,278  

Republic of Brazil

  JPM   USD     40,000,000       1.00%       3.85%       40,000,000     USD     03/20/2030       Quarterly       (5,674,358     (8,875,031     (3,200,673
                   

 

 

   

 

 

   

 

 

 
                    $ (21,859,434   $ (13,936,228   $ 7,923,206  
                   

 

 

   

 

 

   

 

 

 

 

^

Buy Protection - Fund pays a premium and buys credit protection. If a credit event occurs the Fund will, depending on the terms of the particular swap contract, either (i) receive from the seller of protection an amount equal to notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.

    

Sell Protection - Fund receives a premium and sells credit protection. If a credit event occurs the Fund will, depending on the terms of the particular swap contract, either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.

(1)

As of August 31, 2018, implied credit spreads in absolute terms, calculated using a model, and utilized in determining the market value of credit default swap contracts on the reference security, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e., higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the contract.

(2)

The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap contract.

OTC Cross-Currency Basis Swaps

 

Fund Pays

  

Fund

Receives

  

Counterparty

  Notional
Amount
   Expiration
Date
     Periodic
Payment
Frequency
     Premiums
Paid/
(Received) ($)
     Value ($)      Net
Unrealized
Appreciation/
(Depreciation) ($)
 

3 Month USD LIBOR plus a spread of (0.35)%

   3 Month USD LIBOR    JPM     EUR      122,436,000      09/11/2020        Quarterly      $      $ 4,242,662      $ 4,242,662  
                   

 

 

    

 

 

    

 

 

 

 

  See accompanying notes to the financial statements.   19


GMO Emerging Country Debt Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

OTC Cross-Currency Interest Rate Swaps

 

Fund Pays

  

Fund

Receives

  

Counterparty

   Notional
Amount
     Expiration
Date
    

Periodic
Payment
Frequency

   Premiums
Paid/
(Received) ($)
     Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

(0.22)%

   3 Month USD LIBOR    GS      JPY       14,852,761,000        04/28/2025      Quarterly             (1,076,320     (1,076,320

1.17%

   3 Month USD LIBOR    JPM      GBP       53,411,000        03/10/2026      Quarterly             4,314,492       4,314,492  

1.26%

   3 Month USD LIBOR    JPM      EUR       1,462,000        09/04/2035      Annual             (33,671     (33,671
                   

 

 

    

 

 

   

 

 

 
                    $      $ 3,204,501     $ 3,204,501  
                   

 

 

    

 

 

   

 

 

 

Centrally Cleared Interest Rate Swaps

 

Fund Pays

   Fund
Receives
    

Notional

Amount

     Expiration
Date
    

Periodic
Payment
Frequency

   Premiums
Paid/
(Received) ($)
     Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

(1.53)%

     EUR EURIBOR      EUR      18,000,000        03/20/2048      Annual             (351,788     (351,788
                 

 

 

    

 

 

   

 

 

 
   $      $ (351,788   $ (351,788
  

 

 

    

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

*

Non-income producing security.

 

These securities are primarily backed by subprime mortgages.

 

(a)

Security is backed by U.S. Treasury Bonds.

 

(b)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

 

(c)

Investment valued using significant unobservable inputs (Note 2).

 

(d)

Security is in default.

 

(e)

All or a portion of this security has been pledged to cover collateral requirements on reverse repurchase agreements (Note 2).

 

(f)

Indexed security in which price and/or coupon is linked to the price of a specific instrument or financial statistic (Note 2).

(g)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(h)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(i)

The rate shown represents yield-to-maturity.

 

(j)

Reverse repurchase agreements have an open maturity date and can be closed by either party on demand.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 38.

 

 

20   See accompanying notes to the financial statements.  


GMO High Yield Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Debt Obligations

    75.5

Short-Term Investments

    21.4  

Mutual Funds

    0.6  

Swap Contracts

    0.4  

Forward Currency Contracts

    0.1  

Futures Contracts

    0.0

Other

    2.0  
 

 

 

 
    100.0 % 
 

 

 

 

 

Industry Group Summary(a)   % of Investments  

Communications

    20.2

Consumer Cyclical

    15.3  

Energy

    13.4  

Consumer Non-Cyclical

    12.4  

Technology

    8.6  

Capital Goods

    8.1  

Basic Industry

    6.9  

Finance Companies

    3.7  

Electric

    3.1  

Banking

    2.7  

Insurance

    2.7  

Transportation

    1.2  

Industrial Other

    0.6  

REITS

    0.5  

Financial Other

    0.3  

Cash/Cash Equivalents

    0.3  
 

 

 

 
    100.0
 

 

 

 
&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

(a) 

The table excludes short-term investments and mutual funds, if any. The table includes exposure through the use of certain derivative financial instruments and excludes exposures through certain currency linked derivatives such as forward currency contracts. The table takes in account the market values of securities and the notional amounts of swaps. The table is not normalized, thus the table may not total to 100%.

 

^

Rounds to 0.0%.

 

21


GMO High Yield Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    DEBT OBLIGATIONS — 75.5%

 

    Canada — 0.9%

 

          Corporate Debt — 0.9%  
    500,000    

Canbriam Energy Inc, 144A, 9.75%, due 11/15/19

    500,000  
    1,400,000    

Teck Resources Ltd, 6.13%, due 10/01/35

    1,484,000  
     

 

 

 
    Total Canada     1,984,000  
     

 

 

 
    France — 0.6%

 

          Corporate Debt — 0.6%  
    1,250,000     Credit Agricole SA, 144A, Variable Rate, 3 mo. USD LIBOR + 6.98%, 8.38%, due 10/29/49     1,303,887  
     

 

 

 
    Germany — 0.5%  
    Corporate Debt — 0.5%  
    1,208,000     Deutsche Bank AG, 4.50%, due 04/01/25     1,129,707  
     

 

 

 
    Hong Kong — 0.4%  
    Corporate Debt — 0.4%  
    750,000     Studio City Co Ltd, 144A, 5.88%, due 11/30/19     762,000  
     

 

 

 
    Ireland — 0.5%  
    Corporate Debt — 0.5%  
    1,130,000     Park Aerospace Holdings Ltd, 144A, 5.50%, due 02/15/24     1,161,075  
     

 

 

 
    Italy — 0.7%  
    Corporate Debt — 0.7%  
    500,000     Telecom Italia Capital SA, 7.20%, due 07/18/36     533,750  
    1,100,000     Intesa Sanpaolo SPA, 144A, 5.02%, due 06/26/24     994,756  
     

 

 

 
    Total Italy     1,528,506  
     

 

 

 
    United Kingdom — 1.5%  
    Corporate Debt — 1.5%  
    1,000,000     Avon Products Inc, 7.00%, due 03/15/23     857,500  
    500,000     Virgin Media Secured Finance Plc, 5.25%, due 01/15/21     511,875  
    2,000,000     Virgin Media Secured Finance Plc, 144A, 5.25%, due 01/15/26     1,945,400  
     

 

 

 
    Total United Kingdom     3,314,775  
     

 

 

 
    United States — 70.4%  
    Corporate Debt — 19.9%  
    900,000     Allegheny Technologies, Inc., 5.95%, due 01/15/21     913,500  
    500,000     Ally Financial, Inc., 8.00%, due 11/01/31     611,250  
    1,625,000     Antero Resources Corp., 5.63%, due 06/01/23     1,672,206  
    
Par Value†
    Description   Value ($)  
    United States — continued  
    Corporate Debt — continued  
    150,000     Arconic, Inc., 6.15%, due 08/15/20     156,000  
    750,000     Arconic, Inc., 6.75%, due 01/15/28     766,875  
    2,875,000     CCO Holdings LLC / CCO Holdings Capital Corp., 5.25%, due 09/30/22     2,894,766  
    900,000     CenturyLink, Inc., 5.80%, due 03/15/22     919,980  
    1,125,000     CF Industries, Inc., 4.95%, due 06/01/43     987,750  
    1,625,000     CommScope Technologies LLC, 144A, 5.00%, due 03/15/27     1,580,312  
    900,000     DCP Midstream Operating LP, 144A, 6.75%, due 09/15/37     969,750  
    500,000     Edgewell Personal Care Co., 4.70%, due 05/19/21     503,750  
    1,000,000     Embarq Corp., 8.00%, due 06/01/36     975,000  
    1,550,000     EMC Corp., 3.38%, due 06/01/23     1,462,386  
    1,625,000     Energy Transfer Equity LP, 5.50%, due 06/01/27     1,704,219  
    750,000     Ensco Plc, 5.75%, due 10/01/44     545,625  
    375,000     Equinix, Inc., REIT, 5.38%, due 01/01/22     386,175  
    1,250,000     Equinix, Inc., REIT, 5.75%, due 01/01/25     1,287,500  
    750,000     Freeport-McMoRan, Inc., 3.88%, due 03/15/23     721,875  
    1,250,000     Frontier Communications Corp., 8.50%, due 04/15/20     1,262,500  
    750,000     Genworth Holdings, Inc., 7.70%, due 06/15/20     780,000  
    1,125,000     Goodyear Tire & Rubber Co. (The), 5.00%, due 05/31/26     1,056,094  
    2,375,000     HCA, Inc., 4.50%, due 02/15/27     2,351,250  
    875,000     KB Home, 8.00%, due 03/15/20     925,312  
    1,000,000     L Brands, Inc., 6.75%, due 07/01/36     815,000  
    2,250,000     LifePoint Health, Inc., 5.88%, due 12/01/23     2,357,460  
    500,000     Mack-Cali Realty LP, REIT, 4.50%, due 04/18/22     488,073  
    250,000     Magellan Health, Inc., 4.40%, due 09/22/24     244,214  
    600,000     Murphy Oil Corp., 4.45%, due 12/01/22     598,597  
    750,000     Navient Corp., 5.50%, due 01/25/23     741,555  
    542,000     Nuance Communications, Inc., 144A, 5.38%, due 08/15/20     542,000  
    500,000     NuStar Logistics LP, 5.63%, due 04/28/27     498,125  
    500,000     Oceaneering International, Inc., 4.65%, due 11/15/24     475,431  
    625,000     Sirius XM Radio, Inc., 144A, 5.38%, due 07/15/26     623,438  
    500,000     Sprint Capital Corp., 8.75%, due 03/15/32     552,500  
    2,450,000     Standard Industries, Inc., 144A, 5.38%, due 11/15/24     2,462,250  
    1,125,000     Steel Dynamics, Inc., 5.25%, due 04/15/23     1,142,212  
    1,500,000     T-Mobile USA, Inc., 5.38%, due 04/15/27     1,507,800  
    250,000     Talen Energy Supply LLC, 4.60%, due 12/15/21     216,875  
 

 

22   See accompanying notes to the financial statements.  


GMO High Yield Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    United States — continued  
    Corporate Debt — continued  
    875,000     Targa Resources Partners LP / Targa Resources Partners Finance Corp., 6.75%, due 03/15/24     918,750  
    750,000     Transocean, Inc., 6.80%, due 03/15/38     617,813  
    500,000     USG Corp., 144A, 4.88%, due 06/01/27     506,105  
    625,000     VeriSign, Inc., 4.75%, due 07/15/27     602,344  
    750,000     Williams Cos., Inc. (The), 8.75%, due 03/15/32     1,005,000  
    500,000     Wyndham Destinations, Inc., 4.15%, due 04/01/24     494,000  
    900,000     Yum! Brands, Inc., 5.35%, due 11/01/43     776,250  
     

 

 

 
    Total Corporate Debt     43,619,867  
     

 

 

 
    U.S. Government — 16.5%  
    19,750,000     U.S. Treasury Note, Variable Rate, USBM + 0.03%, 2.12%, due 04/30/20 (a)     19,752,885  
    16,300,000     U.S. Treasury Note, Variable Rate, USBM + 0.04%, 2.13%, due 07/31/20     16,298,132  
     

 

 

 
    Total U.S. Government     36,051,017  
     

 

 

 
    U.S. Government Agency — 34.0%  
    54,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.22%, 2.12%, due 02/01/19     54,014,069  
    3,300,000     Federal Home Loan Banks, Variable Rate, 1 mo. USD LIBOR - 0.11%, 1.96%, due 05/28/19     3,299,509  
    17,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.14%, 2.20%, due 12/26/19     17,009,238  
     

 

 

 
    Total U.S. Government Agency     74,322,816  
     

 

 

 
    Total United States     153,993,700  
     

 

 

 
    TOTAL DEBT OBLIGATIONS
(COST $164,470,213)
    165,177,650  
     

 

 

 

Shares /
Par Value†

   

Description

 

Value ($)

 
    MUTUAL FUNDS — 0.6%  
    United States — 0.6%  
    Affiliated Issuers — 0.6%  
    52,717     GMO U.S. Treasury Fund     1,316,876  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $1,316,876)
    1,316,876  
     

 

 

 
    SHORT-TERM INVESTMENTS — 21.4%

 

    Foreign Government Obligations — 21.4%

 

JPY

    1,731,000,000     Japan Treasury Discount Bill, Zero Coupon, due 09/10/18     15,579,420  

JPY

    1,731,000,000     Japan Treasury Discount Bill, Zero Coupon, due 10/01/18     15,580,542  

JPY

    1,731,000,000     Japan Treasury Discount Bill, Zero Coupon, due 11/05/18     15,582,677  
     

 

 

 
        46,742,639  
     

 

 

 
    Money Market Funds — 0.0%  
    57,470     State Street Institutional Treasury Plus Money Market Fund-Premier Class, 1.88% (b)     57,470  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $46,896,434)
    46,800,109  
     

 

 

 
    TOTAL INVESTMENTS — 97.5%
(Cost $212,683,523)
    213,294,635  
    Other Assets and Liabilities (net) — 2.5%     5,422,213  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $218,716,848  
     

 

 

 
 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Forward Currency Contracts

 

Settlement
Date

 

Counter-
party

 

Currency

Sold

   

Currency
Purchased

   

Net
Unrealized
Appreciation
(Depreciation) ($)

 
09/10/2018   GS   JPY     1,731,000,000     USD     15,707,875       123,891  
10/01/2018  

BCLY

  JPY     1,731,000,000     USD     15,735,291       127,828  
11/05/2018  

GS

  JPY     1,731,000,000     USD     15,609,853       (37,492
           

 

 

 
            $ 214,227  
           

 

 

 

Futures Contracts

 

Number
of
Contracts+

 

Type

  Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation) ($)
 
Buys        
178   U.S. Treasury Note 10 Yr. (CBT)   December 2018     21,407,281       6,683  
77   U.S. Treasury Note 2 Yr. (CBT)   December 2018     16,274,672       3,736  
377   U.S. Treasury Note 5 Yr. (CBT)   December 2018     42,751,211       8,341  
     

 

 

   

 

 

 
      $ 80,433,164     $ 18,760  
     

 

 

   

 

 

 
Sales        
45   U.S. Long Bond (CBT)   December 2018   $ 6,489,844     $ 6,906  
     

 

 

   

 

 

 
+

Buys - Fund is long the futures contract.

    

Sales - Fund is short the futures contract.

 

 

  See accompanying notes to the financial statements.   23


GMO High Yield Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Swap Contracts

Centrally Cleared Credit Default Swaps

 

Reference Entity

 

Notional
Amount

  Annual
Premium
    Implied
Credit
Spread (1)
    Maximum
Potential
Amount of Future
Payments by the
Fund Under the
Contract (2)
    Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Sell Protection^:

                   

CDX.NA.HYS.30.V1-5Y

  USD   81,470,000     5.00%       3.30%       81,470,000 USD       06/20/2023       Quarterly     $ 5,080,795     $ 5,629,088     $ 548,293  
               

 

 

   

 

 

   

 

 

 

OTC Credit Default Swaps

 

Reference Entity

 

Counterparty

 

Notional
Amount

    Annual
Premium
    Implied
Credit
Spread (1)
    Maximum
Potential
Amount of Future
Payments by the
Fund Under the
Contract (2)
    Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Buy Protection^:

                     

Sears Roebuck Acceptance Corp.

  GS   USD     240,000       5.00%       23.52%       N/A       06/20/2022       Quarterly       57,204       66,225       9,021  

Sears Roebuck Acceptance Corp.

  GS   USD     360,000       5.00%       23.52%       N/A       06/20/2022       Quarterly       85,806       99,338       13,532  
                 

 

 

   

 

 

   

 

 

 
                  $ 143,010     $ 165,563     $ 22,553  
                 

 

 

   

 

 

   

 

 

 

 

^

Buy Protection - Fund pays a premium and buys credit protection. If a credit event occurs the Fund will, depending on the terms of the particular swap contract, either (i) receive from the seller of protection an amount equal to notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.

 

Sell Protection - Fund receives a premium and sells credit protection. If a credit event occurs the Fund will, depending on the terms of the particular swap contract, either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.

(1)

As of August 31, 2018, implied credit spreads in absolute terms, calculated using a model, and utilized in determining the market value of credit default swap contracts on the reference security, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e., higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the contract.

(2)

The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap contract.

OTC Total Return Swaps

 

Fund Pays

 

Fund Receives

 

Counterparty

  Notional
Amount
    Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

1 Month USD LIBOR

  Total Return on iBoxx High Yield Corp. ETF   BOA     USD       22,438,630       09/14/2018       At Maturity             98,263       98,263  

1 Month USD LIBOR

  Total Return on iBoxx High Yield Corp. ETF   CITI     USD       39,311,346       09/14/2018       At Maturity             167,237       167,237  

1 Month USD LIBOR

  Total Return on iBoxx High Yield Corp. ETF   CITI     USD       7,845,532       09/21/2018       At Maturity             20,747       20,747  

1 Month USD LIBOR

  Total Return on iBoxx High Yield Corp. ETF   CITI     USD       6,346,528       09/21/2018       At Maturity             8,765       8,765  
             

 

 

   

 

 

   

 

 

 
              $     $ 295,012     $ 295,012  
             

 

 

   

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

24   See accompanying notes to the financial statements.  


GMO High Yield Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

(a)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on securities sold short, OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

(b)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 38.

 

 

  See accompanying notes to the financial statements.   25


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Debt Obligations

    89.6

Mutual Funds

    4.5  

Short-Term Investments

    3.5  

Swap Contracts

    2.2  

Purchased Options

    0.0

Futures Contracts

    0.0

Written Options

    (0.0 )^ 

Other

    0.2  
 

 

 

 
    100.0 % 
 

 

 

 
 
Industry Sector Summary   % of Debt Obligations  

Student Loans – Private

    22.1

Small Balance Commercial Mortgages

    16.6  

Commercial Mortgage-Backed Securities

    14.1  

Collateralized Loan Obligations

    13.7  

Residential Mortgage-Backed Securities – Other

    11.0  

Student Loans – Federal Family Education Loan Program

    5.2  

Mutual Funds

    4.8  

Auto Retail Subprime

    2.5  

Residential Mortgage-Backed Securities – Prime

    2.1  

Residential Mortgage-Backed Securities – Alt-A

    2.1  

CMBS Collateralized Debt Obligations

    2.1  

U.S. Government Agency

    1.8  

Residential Mortgage-Backed Securities – Subprime

    1.4  

Time Share

    0.5  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

^

Rounds to 0.0%.

 

 

26


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    DEBT OBLIGATIONS — 89.6%

 

    Asset-Backed Securities — 87.9%

 

          Auto Retail Subprime — 2.3%  
    1,524,850     CarFinance Capital Auto Trust, Series 14-1A, Class D, 144A, 4.90%, due 04/15/20     1,525,980  
    1,073,840     CarFinance Capital Auto Trust, Series 13-2A, Class E, 144A, 7.86%, due 10/15/20     1,073,885  
    4,130,000     CFC LLC, Series 14-2A, Class E, 144A, 5.36%, due 11/15/21     4,156,202  
    6,265,989     CPS Auto Receivables Trust, Series 14-B, Class D, 144A, 4.62%, due 05/15/20     6,315,214  
    1,049,647     CPS Auto Receivables Trust, Series 15-C, Class D, 144A, 4.63%, due 08/16/21     1,066,382  
    2,250,000     Exeter Automobile Receivables Trust, Series 14-2A, Class D, 144A, 4.93%, due 12/15/20     2,261,868  
    2,159,341     Exeter Automobile Receivables Trust, Series 14-1A, Class D, 144A, 5.53%, due 02/16/21     2,161,360  
    5,377,425     Flagship Credit Auto Trust, Series 14-1, Class D, 144A, 4.83%, due 06/15/20     5,399,973  
    1,400,000     Flagship Credit Auto Trust, Series 14-1, Class E, 144A, 5.71%, due 08/16/21     1,407,024  
     

 

 

 
    Total Auto Retail Subprime         25,367,888  
     

 

 

 
    CMBS Collateralized Debt Obligations — 2.0%

 

    2,852,541     ARCap 2005-1 Resecuritization Trust, Series 05-1A, Class A, 144A, 5.45%, due 12/21/42     2,883,750  
    8,586,000     ARCap 2005-1 Resecuritization Trust, Series 05-1A, Class B, 144A, 5.55%, due 12/21/42     3,687,229  
    5,297,096     Capitalsource Real Estate Loan Trust, Series 06-1A, Class B, 144A, Variable Rate, 3 mo. LIBOR + .39%, 2.72%, due 01/20/37(a)     5,230,882  
    8,612,402     GS Mortgage Securities Corp., Series 06-CC1, Class A, 144A, Variable Rate, 5.50%, due 03/21/46     7,923,413  
    1,347,718     Sorin Real Estate CDO IV Ltd., Series 06-4A, Class C, 144A, Variable Rate, 3 mo. LIBOR + .53%, 2.87%, due 10/28/46     1,342,298  
     

 

 

 
    Total CMBS Collateralized Debt Obligations     21,067,572  
     

 

 

 
    Collateralized Loan Obligations — 12.9%

 

    18,135,165     ACIS CLO Ltd., Series 15-6A, Class A1, 144A, Variable Rate, 3 mo. LIBOR + 1.59%, 3.93%, due 05/01/27     18,157,816  
    37,489,650     Arrowpoint CLO Ltd., Series 15-4A, Class A, 144A, Variable Rate, 3 mo. LIBOR + 1.55%, 3.88%, due 04/18/27     37,583,112  
    1,705,200     Atrium VIII, Series 8A, Class CR, 144A, Variable Rate, 3 mo. LIBOR+ 2.50%, 4.85%, due 10/23/24     1,706,540  
    1,543,140     BFNS LLC, Series 17-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.98 %, 3.32%, due 01/25/29     1,543,174  
    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

          Collateralized Loan Obligations — continued  
    6,006,000     BlueMountain CLO Ltd., Series 14-3A, Class BR, 144A, Variable Rate, 3 mo. LIBOR + 2.10%, 4.44%, due 10/15/26     6,010,541  
    4,504,500     Carlyle Global Market Strategies CLO Ltd., Series 14-5A, Class BR, 144A, Variable Rate, 3 mo. LIBOR + 2.05%, 4.39%, due 10/16/25     4,504,491  
    8,573,000     CIFC Funding Ltd., Series 15-2A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 0.78%, 3.12%, due 04/15/27     8,538,159  
    3,001,600     CIFC Funding Ltd., Series 12-2RA, Class A1, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.15%, due 01/20/28     2,979,532  
    9,875,050     Crown Point CLO II Ltd., Series 13-2A, Class A3LR, 144A, Variable Rate, 3 mo. LIBOR + 1.75%, 4.09%, due 12/31/23     9,873,549  
    4,263,000     Halcyon Loan Advisors Funding Ltd., Series 12-1A, Class B, 144A, Variable Rate, 3 mo. LIBOR + 3.00%, 5.31%, due 08/15/23     4,269,586  
    1,444,096     JFIN Revolver CLO Ltd., Series 14-2A, Class C, 144A, Variable Rate 3 mo. LIBOR + 2.75%, 5.07%, due 02/20/22     1,446,487  
    1,465,400     Madison Park Funding XII Ltd, Series 14-12A, Class CR, 144A, Variable Rate, 3 mo. LIBOR + 2.35%, 4.70%, due 07/20/26     1,466,360  
    13,689,000     Saratoga Investment CLO Ltd., Series 13-1A, Class CR, 144A, Variable Rate, 3 mo. LIBOR + 3.36%, 5.71%, due 10/20/25     13,716,145  
    5,180,434     Symphony CLO II Ltd., Series 06-2A, Class C, 144A, Variable Rate, 3 mo. LIBOR + 1.50%, 3.81%, due 10/25/20     5,182,480  
    2,156,750     Symphony CLO VIII LP, Series 12-8A, Class CR, 144A, Variable Rate, 3 mo. LIBOR + 3.05%, 5.39%, due 01/09/23     2,160,755  
    2,944,550     Vibrant Clo III Ltd., Series 15-3A, Class BR, 144A, Variable Rate, 3 mo. LIBOR + 2.95%, 5.30%, due 04/20/26     2,948,664  
    1,568,784     Voya CLO Ltd., Series 14-3A, Class A2A, 144A, Variable Rate, 3 mo. LIBOR +1.90%, 4.24%, due 07/25/26     1,569,457  
    13,519,825     Zais CLO 1 Ltd., Series 14-1A, Class A1, 144A, Variable Rate, 3 mo. LIBOR + 1.4%, 3.74%, due 04/15/26     13,522,056  
    2,762,417     Zais CLO 1 Ltd., Series 14-1A, Class A2, 144A, Variable Rate, 3 mo. LIBOR + 1.85%, 4.19%, due 04/15/26     2,755,981  
     

 

 

 
    Total Collateralized Loan Obligations     139,934,885  
     

 

 

 
    Commercial Mortgage-Backed Securities — 13.2%

 

    3,144,747     Commercial Mortgage Trust, Series 05-C6, Class G, 144A, Variable Rate, 5.85%, due 06/10/44     2,356,889  
    4,175,780     Core Industrial Trust, Series 15-TEXW, Class C, 144A, 3.73%, due 02/10/34     4,186,033  
    1,454,200     Core Industrial Trust, Series 15-TEXW, Class D, 144A, Variable Rate, 3.98%, due 02/10/34     1,454,843  
 

 

  See accompanying notes to the financial statements.   27


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

          Commercial Mortgage-Backed Securitiess — continued  
    3,550,200     Core Industrial Trust, Series 15-TEXW, Class E, 144A, Variable Rate, 3.98%, due 02/10/34     3,511,504  
    5,151,600     Core Industrial Trust, Series 15-WEST, Class C, 144A, 3.49%, due 02/10/37     5,040,047  
    23,260,500     Core Industrial Trust, Series 15-WEST, Class E, 144A, Variable Rate, 4.37%, due 02/10/37     22,839,350  
    2,665,373     Credit Suisse First Boston Mortgage Securities Corp., Series 05-C2, Class AMFL, Variable Rate, 1 mo. LIBOR + .25%, 2.31%, due 04/15/37     2,546,156  
    1,223,732     Credit Suisse First Boston Mortgage Securities Corp., Series 05-C2, Class AMFX, 4.88%, due 04/15/37     1,208,757  
    10,742,760     GS Mortgage Securities Corp., Series 16-RENT, Class E, 144A, Variable Rate, 4.20%, due 02/10/29     10,582,975  
    10,459,601     GS Mortgage Securities Corp., Series 16-GS2, Class D, 144A, 2.75%, due 05/10/49     8,550,965  
    4,264,000     GS Mortgage Securities Trust, Series 11-GC3, Class F, 144A, Variable Rate, 5.00%, due 03/10/44     3,681,544  
    16,659,820     GS Mortgage Securities Trust, Series 11-GC3, Class D, 144A, Variable Rate, 5.83%, due 03/10/44     16,955,490  
    15,187,775     Hyatt Hotel Portfolio Trust, Series 17-HYT2, Class G, 144A, Variable Rate, 1 mo. LIBOR + 4.15%, 6.21%, due 08/09/32     15,273,285  
    2,432,859     JP Morgan Chase Commercial Mortgage Securities Trust, Series 04-CB9, Class F, 144A, Variable Rate, 5.47%, due 06/12/41     2,311,216  
    5,389,564     JP Morgan Chase Commercial Mortgage Securities Trust, Series 04-C3, Class H, 144A, Variable Rate, 6.01%, due 01/15/42     5,405,760  
    1,488,623     Morgan Stanley Dean Witter Capital I Trust, Series 01-TOP3, Class E, 144A, Variable Rate, 7.86%, due 07/15/33     1,572,598  
    8,543,000     Union Station District of Columbia, Series 2018-USDC, Class E, 144A, 4.49%, due 05/09/38     8,304,480  
    8,270,894     WaMu Commercial Mortgage Securities Trust, Series 07-SL3, Class G, 144A, Variable Rate, 3.80%, due 03/23/45     8,260,775  
    3,434,000     Wells Fargo Commercial Mortgage Trust, Series 13-BTC, Class D, 144A, Variable Rate, 3.67%, due 04/16/35     3,328,835  
    8,563,000     Wells Fargo Commercial Mortgage Trust, Series 13-BTC, Class F, 144A, Variable Rate, 3.67%, due 04/16/35     7,952,250  
    8,471,000     West Town Mall Trust, Series 17-KNOX, Class E, 144A, Variable Rate, 4.49%, due 07/05/30     8,066,434  
     

 

 

 
    Total Commercial Mortgage-Backed Securities     143,390,186  
     

 

 

 
    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

    Residential Mortgage-Backed Securities —Other — 10.3%

 

    1,329,214     ACE Securities Corp. Home Equity Loan Trust, Series 06-ASL1, Class A, Variable Rate, 1 mo. LIBOR + .28%, 2.34%, due 02/25/36     706,857  
    20,896,391     American Home Mortgage Investment Trust, Series 06-2, Class 4A, Variable Rate, 1 mo. LIBOR + .36%, 2.42%, due 02/25/36     3,703,342  
    5,860,949     BCMSC Trust, Series 99-A, Class M1, Variable Rate, 6.79%, due 03/15/29     5,425,681  
    8,834,023     BCMSC Trust, Series 99-B, Class A4, Variable Rate, 7.30%, due 12/15/29     3,321,509  
    2,928,137     BCMSC Trust, Series 00-A, Class A4, Variable Rate, 8.29%, due 06/15/30     1,194,581  
    754,330     Bear Stearns Mortgage Funding Trust, Series 07-SL2, Class 1A, Variable Rate, 1 mo. LIBOR + .32%, 2.38%, due 02/25/37     709,119  
    5,579,386     Conseco Finance Securitizations Corp., Series 01-3, Class M1, Variable Rate, 7.15%, due 05/01/33     5,267,650  
    7,708,818     Conseco Financial Corp., Series 97-6, Class M1, Variable Rate, 7.21%, due 01/15/29     7,704,215  
    3,097,697     Conseco Financial Corp., Series 98-6, Class M1, Variable Rate, 6.63%, due 06/01/30     2,875,439  
    2,262,212     Countrywide Home Equity Loan Trust, Series 07-E, Class A, FSA, Variable Rate, 1 mo. LIBOR + .15%, 2.21%, due 06/15/37     2,065,896  
    687,818     GMACM Home Equity Loan Trust, Series 04-HE3, Class A3, FSA, Variable Rate, 1 mo. LIBOR + .50%, 2.56%, due 10/25/34     643,827  
    9,112,807     GMACM Home Equity Loan Trust, Series 07-HE3, Class 2A1, Variable Rate, 7.00%, due 09/25/37     9,213,568  
    7,309,036     Home Equity Loan Trust, Series 05-HS1, Class AI4, Step Up, 5.61%, due 09/25/35     4,119,261  
    31,563,134     Home Equity Mortgage Loan Asset-Backed Trust, Series 06-A, Class A, Variable Rate, 1 mo. LIBOR + .26%, 2.32%, due 06/25/36     3,943,915  
    16,133,972     Home Loan Trust, Series 07-HI1, Class A4, Step Up, 5.93%, due 03/25/37     9,644,282  
    4,308,431     Master Second Lien Trust, Series 06-1, Class A, Variable Rate, 1 mo. LIBOR + .32%, 2.38%, due 03/25/36     866,925  
    732,284     Mellon Re-REMIC Pass-Through Trust, Series 04-TBC1, Class A, 144A, Variable Rate, 1 mo. LIBOR + .25%, 2.31%, due 02/26/34     692,299  
    14,421,908     New Century Home Equity Loan Trust, Series 06-S1, Class A2A, Variable Rate, 1 mo. LIBOR + .20%, 2.26%, due 03/25/36     1,223,221  
    8,226,552     New Century Home Equity Loan Trust, Series 06-S1, Class A1, Variable Rate, 1 mo. LIBOR + .34%, 2.40%, due 03/25/36     697,622  
    21,932,893     New Century Home Equity Loan Trust, Series 06-S1, Class A2B, Variable Rate, 1 mo. LIBOR + .40%, 2.46%, due 03/25/36     1,859,793  
 

 

28   See accompanying notes to the financial statements.  


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

          Residential Mortgage-Backed Securities —
Other — continued
 
    1,916,669     Nomura Asset Acceptance Corp. Alternative Loan Trust, Series 05-S3, Class M1, Variable Rate, 1 mo. LIBOR + .90%, 2.96%, due 08/25/35     2,161,726  
    8,613,755     Oakwood Mortgage Investors, Inc., Series 99-C, Class A2, 7.48%, due 08/15/27     8,427,485  
    1,592,175     Oakwood Mortgage Investors, Inc., Series 98-A, Class B1, Variable Rate, 7.50%, due 05/15/28     1,678,737  
    2,828,176     Oakwood Mortgage Investors, Inc., Series 98-D, Class M1, 144A, 7.42%, due 01/15/29     2,865,943  
    5,998,408     Oakwood Mortgage Investors, Inc., Series 99-E, Class A1, Variable Rate, 7.61%, due 03/15/30     5,512,756  
    11,023,673     Oakwood Mortgage Investors, Inc., Series 00-D, Class A4, Variable Rate, 7.40%, due 07/15/30     5,424,388  
    1,436,566     Oakwood Mortgage Investors, Inc., Series 01-D, Class A4, Variable Rate, 6.93%, due 09/15/31     1,248,100  
    1,951,412     PHH Mortgage Trust, Series 07-1SL, Class M2, 144A, Step Up, 7.00%, due 12/25/27     2,230,946  
    18,913,849     Residential Funding Mortgage Securities II, Series 06-HI4, Class A4, Step Up, 6.22%, due 09/25/36     14,928,071  
    1,503,492     SACO I Trust, Series 05-10, Class 2A1, Variable Rate, 1 mo. LIBOR + .52%, 2.58%, due 01/25/36     1,503,499  
     

 

 

 
    Total Residential Mortgage-Backed Securities — Other     111,860,653  
     

 

 

 
    Residential Mortgage-Backed Securities — Prime — 2.0%

 

    2,217,405     Bear Stearns ARM Trust, Series 05-6, Class 3A1, Variable Rate, 4.38%, due 08/25/35     2,178,775  
    2,122,321     Bear Stearns ARM Trust, Series 05-9, Class A1, Variable Rate, U.S. Treasury Yield 1 Year CMT + 2.30%, 4.73%, due 10/25/35     2,147,053  
    1,295,603     Citigroup Mortgage Loan Trust, Series 05-3, Class 2A2, Variable Rate, 4.35%, due 08/25/35     1,299,447  
    3,090,279     IndyMac INDA Mortgage Loan Trust, Series 06-AR3, Class 1A1, Variable Rate, 3.80%, due 12/25/36     2,961,610  
    2,319,796     IndyMac INDA Mortgage Loan Trust, Series 07-AR1, Class 1A1, Variable Rate, 3.75%, due 03/25/37     2,248,059  
    3,443,553     RFMSI Trust, Series 05-SA4, Class 2A2, Variable Rate, 4.57%, due 09/25/35     3,431,759  
    2,262,785     WaMu Mortgage Pass-Through Certificates, Series 05-AR10, Class 1A3, Variable Rate, 4.11%, due 09/25/35     2,301,515  
    1,968,499     WaMu Mortgage Pass-Through Certificates, Series 06-AR19, Class 2A, Variable Rate, COFI + 1.25, 2.18%, due 01/25/47     1,909,843  
    3,222,489     Washington Mutual Mortgage Pass-Through Certificates WMALT, Series 07-5, Class A6, 6.00%, due 06/25/37     3,224,386  
     

 

 

 
    Total Residential Mortgage-Backed Securities —Prime     21,702,447  
     

 

 

 
    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

    Residential Mortgage-Backed Securities — Subprime — 1.4%

 

    1,788,863     Asset Backed Funding Certificates, Step Up, 4.81%, due 06/25/35     1,831,877  
    2,578,393     BCAP LLC, Series 14-RR2, Class 11A3, 144A, Variable Rate, 2.36%, due 05/26/37     2,496,824  
    4,697,831     Bear Stearns Asset-Backed Securities, Inc., Series 07-AQ1, Class A1, Variable Rate, 1 mo. LIBOR + .11%, 2.17%, due 04/25/31     6,273,195  
    2,224,728     Credit Suisse First Boston Mortgage Securities Corp., Series 02-22, Class 2M2, Variable Rate, due 06/25/32     2,291,211  
    1,703,513     Meritage Mortgage Loan Trust, Series 05-2, Class M2, Variable Rate, 1 mo. LIBOR + .75%, 2.81%, due 11/25/35     1,727,462  
     

 

 

 
    Total Residential Mortgage-Backed Securities —Subprime     14,620,569  
     

 

 

 
    Residential Mortgage-Backed Securities — Alt-A — 2.0%

 

    2,061,073     Adjustable Rate Mortgage Trust, Series 05-1, Class 5M1, Variable Rate, 1 mo. LIBOR + 1.05%, 3.11%, due 05/25/35     2,067,117  
    2,522,050     Alternative Loan Trust, Series 06-7CB, Class 1A1, Variable Rate, 1 mo. LIBOR + .70%, 2.76%, due 05/25/36     1,576,293  
    2,532,862     Alternative Loan Trust, Series 06-28CB, Class A1, Variable Rate, 1 mo. LIBOR + .70%, 2.76%, due 10/25/36     1,695,007  
    5,166,936     Bear Stearns ARM Trust, Series 07-1, Class 2A1, Variable Rate, 3.87%, due 02/25/47     5,273,426  
    3,788,505     Bear Stearns Asset Backed Securities I Trust, Series 04-AC5, Class A1, Step Up, 5.75%, due 10/25/34     3,878,452  
    7,092,284     Citigroup Mortgage Loan Trust, Inc., Series 06-AR5, Class 2A2A, Variable Rate, 3.88%, due 07/25/36     5,277,865  
    1,807,477     JP Morgan Resecuritization Trust, Series 09-10, Class 7A1, 144A, Variable Rate, 6.05%, due 02/26/37     1,866,852  
     

 

 

 
    Total Residential Mortgage-Backed Securities — Alt-A     21,635,012  
     

 

 

 
    Small Balance Commercial Mortgages — 15.6%

 

    8,448,000     Barclays Commercial Mortgage Trust, Series 18-CHRS, Class E, 144A, Variable Rate, 4.41%, due 08/05/38     7,363,540  
    638,897     Bayview Commercial Asset Trust, Series 04-1, Class M1, 144A, Variable Rate, 1 mo. LIBOR + 0.56%, 2.90%, due 04/25/34     625,195  
    355,303     Bayview Commercial Asset Trust, Series 04-1, Class M2, 144A, Variable Rate, 1 mo. LIBOR + 1.20%, 3.86%, due 04/25/34     353,268  
    619,141     Bayview Commercial Asset Trust, Series 04-1, Class B, 144A, Variable Rate, 1 mo. LIBOR + 1.90%, 4.91%, due 04/25/34     621,140  
 

 

  See accompanying notes to the financial statements.   29


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

    Small Balance Commercial Mortgages — continued

 

    6,135,214     Bayview Commercial Asset Trust, Series 05-2A, Class A1, 144A, Variable Rate, 1 mo. LIBOR + .31%, 2.37%, due 08/25/35     5,831,218  
    3,296,700     Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, Variable Rate, 1 mo. LIBOR + .39%, 2.45%, due 01/25/36     3,095,320  
    1,880,236     Bayview Commercial Asset Trust, Series 06-1A, Class M1, 144A, Variable Rate, 1 mo. LIBOR + .38%, 2.44%, due 04/25/36     1,771,061  
    2,578,414     Bayview Commercial Asset Trust, Series 06-2A, Class A1, 144A, Variable Rate, 1 mo. LIBOR + .23%, 2.29%, due 07/25/36     2,491,660  
    5,274,178     Bayview Commercial Asset Trust, Series 06-2A, Class A2, 144A, Variable Rate, 1 mo. LIBOR + .28%, 2.34%, due 07/25/36     5,112,189  
    7,493,056     Bayview Commercial Asset Trust, Series 06-3A, Class A1, 144A, Variable Rate, 1 mo. LIBOR + .25%, 2.31%, due 10/25/36     7,140,938  
    895,763     Bayview Commercial Asset Trust, Series 06-3A, Class A2, 144A, Variable Rate, 1 mo. LIBOR + .30%, 2.36%, due 10/25/36     855,667  
    2,691,555     Bayview Commercial Asset Trust, Series 07-3, Class A1, 144A, Variable Rate, 1 mo. LIBOR + .24%, 2.30%, due 07/25/37     2,566,571  
    11,402,507     Bayview Commercial Asset Trust, Series 07-2A, Class A1, 144A, Variable Rate, 1 mo. LIBOR + .27%, 2.33%, due 07/25/37     10,973,774  
    6,071,136     Bayview Commercial Asset Trust, Series 07-2A, Class A2, 144A, Variable Rate, 1 mo. LIBOR + .32%, 2.38%, due 07/25/37     5,709,478  
    2,448,365     Bayview Commercial Asset Trust, Series 07-6A, Class A3B, 144A, Variable Rate, 1 mo. LIBOR + .85%, 2.91%, due 12/25/37     2,422,782  
    20,953,338     Bayview Commercial Asset Trust, Series 07-6A, Class A3A, 144A, Variable Rate, 1 mo. LIBOR + 1.25%, 3.31%, due 12/25/37     20,925,061  
    3,300,000     Core Industrial Trust, Series 15-WEST, Class D, 144A, Variable Rate, 4.37%, due 02/10/37     3,329,187  
    21,022,087     GE Business Loan Trust, Series 06-1X, Class A, Variable Rate, 1 mo. LIBOR + .20%, 2.26%, due 05/15/34     20,394,517  
    2,358,239     GE Business Loan Trust, Series 06-2A, Class A, 144A, Variable Rate, 1 mo. LIBOR + 0.18%, 2.24%, due 11/15/34     2,316,208  
    5,326,826     GE Business Loan Trust, Series 07-1A, Class A, 144A, Variable Rate, 1 mo. LIBOR + .17%, 2.23%, due 04/15/35     5,222,966  
    4,271,986     GE Business Loan Trust, Series 07-1A, Class D, 144A, Variable Rate, 1 mo. LIBOR + 1.00%, 3.06%, due 04/16/35     3,877,957  
    2,692,701     Lehman Brothers Small Balance Commercial, Series 06-1A, Class M1, 144A, Variable Rate, 1 mo. LIBOR + .31%, 2.37%, due 04/25/31     2,692,538  
    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

          Small Balance Commercial Mortgages — continued  
    7,540,867     Lehman Brothers Small Balance Commercial, Series 06-2A, Class M1, 144A, Variable Rate, 1 mo. LIBOR + .29%, 2.35%, due 09/25/36     7,500,100  
    2,585,627     Lehman Brothers Small Balance Commercial, Series 06-3A, Class 1A, 144A, Variable Rate, 1 mo. LIBOR + .20%, 2.26%, due 12/25/36     2,565,984  
    4,300,000     Lehman Brothers Small Balance Commercial, Series 07-2A, Class M1, 144A, Variable Rate, 1 mo. LIBOR + .40%, 2.46%, due 06/25/37     4,104,353  
    4,441,609     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 05-1A, Class A, 144A, Variable Rate, 1 mo. LIBOR + .25%, 2.31%, due 02/25/30     4,367,123  
    1,744,539     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 05-2A, Class M1, 144A, Variable Rate, 1 mo. LIBOR + .40%, 2.46%, due 09/25/30     1,733,895  
    2,002,843     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 05-2A, Class M2, 144A, Variable Rate, 1 mo. LIBOR + .52%, 2.58%, due 09/25/30     1,973,530  
    5,445,606     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 06-1A, Class M3, 144A, Variable Rate, 1 mo. LIBOR + .53%, 2.59%, due 04/25/31     5,238,332  
    2,022,599     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 06-1A, Class B, 144A, Variable Rate, 1 mo. LIBOR + 1.00%, 3.06%, due 04/25/31     1,923,102  
    2,554,500     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 06-2A, Class M2, 144A, Variable Rate, 1 mo. LIBOR + .39%, 2.45%, due 09/25/36     2,453,854  
    2,563,200     Morgan Stanley Capital I Trust, Series 12-STAR, Class C, 144A, 3.85%, due 08/05/34     2,567,046  
    854,400     Morgan Stanley Capital I Trust, Series 12-STAR, Class D, 144A, 4.06%, due 08/05/34     855,110  
    1,773,858     Velocity Commercial Capital Loan Trust, Series 16-2, Class AFL, Variable Rate, 1 mo. LIBOR + 1.80%, 3.86%, due 10/25/46     1,788,172  
    9,503,550     WaMu Commercial Mortgage Securities Trust, Series 07-SL2, Class C, 144A, Variable Rate, 3.37%, due 12/27/49     9,501,429  
    3,430,400     WaMu Commercial Mortgage Securities Trust, Series 07-SL2, Class D, 144A, Variable Rate, 3.74%, due 12/27/49     3,438,414  
    2,585,664     WaMu Commercial Mortgage Securities Trust, Series 07-SL2, Class E, 144A, Variable Rate, 3.90%, due 12/27/49     2,582,718  
     

 

 

 
    Total Small Balance Commercial Mortgages     168,285,397  
     

 

 

 
 

 

30   See accompanying notes to the financial statements.  


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

    Student Loans — Federal Family Education Loan Program — 4.9%

 

    8,238,923     AccessLex Institute, Series 04-2, Class A3, Variable Rate, 3 mo. LIBOR + .19%, 2.53%, due 10/25/24     8,139,661  
    18,185,119     AccessLex Institute, Series 04-2, Class B, Variable Rate, 3 mo. LIBOR + .70%, 3.04%, due 01/25/43     16,363,714  
    16,255,656     AccessLex Institute, Series 07-1, Class A4, Variable Rate 3 mo. LIBOR + 0.06%, 2.40%, due 01/25/23     15,961,541  
    5,357,926     Collegiate Funding Services Education Loan Trust, Series 05-B, Class B, Variable Rate, 3 mo. LIBOR + .32%, 2.66%, due 03/28/35(a)     5,036,451  
    6,648,426     KeyCorp Student Loan Trust, Series 04-A, Class 1A2, Variable Rate, 3 mo. LIBOR + 0.24%, 2.58%, due 10/27/42     6,514,498  
    1,255,232     South Carolina Student Loan Corp., Series 14-1, Class A1, Variable Rate, 1 mo. LIBOR + .75%, 2.83%, due 05/01/30     1,260,751  
     

 

 

 
    Total Student Loans — Federal Family Education Loan Program     53,276,616  
     

 

 

 
    Student Loans — Private — 20.8%

 

    6,408,127     Access Group, Inc., Series 05-A, Class B, Variable Rate, 3 mo. LIBOR + .80%, 3.14%, due 07/25/34     6,174,823  
    2,082,902     Access Group, Inc., Series 03-A, Class A2, Variable Rate, 3 mo. USBM +1.20%, 3.28%, due 07/01/38     2,083,319  
    6,063,317     KeyCorp Student Loan Trust, Series 05-A, Class 2B, Variable Rate, 3 mo. LIBOR + 0.73%, 3.07%, due 09/27/38     6,030,903  
    31,059,920     KeyCorp Student Loan Trust, Series 06-A, Class 2B, Variable Rate, 3 mo. LIBOR + .48%, 2.82%, due 12/27/41     30,561,064  
    3,123,725     KeyCorp Student Loan Trust, Series 04-A, Class 2C, Variable Rate, 3 mo. LIBOR + 0.80%, 3.14%, due 04/28/42     3,037,153  
    5,622,500     KeyCorp Student Loan Trust, Series 04-A, Class 2D, Variable Rate, 3 mo. LIBOR + 1.25%, 3.59%, due 07/28/42     4,702,163  
    2,407,810     L2L Education Loan Trust, Series 06-1A, Class B, 144A, Variable Rate, 1 mo. LIBOR + 0.50%, 2.56%, due 10/15/28     2,325,450  
    18,250,000     National Collegiate Commutation Trust, Series 07-3, Class A3R4, 144A, Variable Rate, 5.16%, due 03/31/38(a)     8,942,500  
    7,147,991     National Collegiate Commutation Trust, Series 07-3, Class A3L, 144A, Variable Rate 1 mo. LIBOR + .84%, 2.92%, due 03/31/38     2,793,583  
    5,300,541     National Collegiate Student Loan Trust, Variable 1 mo. LIBOR + .38%, 2.44%, due 10/25/33     5,117,217  
    870,416     National Collegiate Student Loan Trust, Series 06-2, Class A3, Variable Rate, 1 mo. LIBOR + .21%, 2.27%, due 11/25/27     868,284  
    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

          Student Loans — Private — continued  
    18,577     National Collegiate Student Loan Trust, Series 06-1, Class A4, Variable Rate 1 mo. LIBOR + 0.25%, 2.31%, due 03/27/28     18,573  
    1,371,631     National Collegiate Student Loan Trust, Series 06-3, Class A4, Variable Rate, 1 mo. LIBOR + .27%, 2.33%, due 03/26/29     1,354,224  
    3,050,355     National Collegiate Student Loan Trust, Series 05-2, Class A4, Variable Rate, 1 mo. LIBOR + .27%, 2.33%, due 09/25/29     3,026,762  
    16,597,764     National Collegiate Student Loan Trust, Series 07-1, Class A3, Variable Rate 1 mo. LIBOR + 0.24%, 2.30%, due 07/25/30     16,369,621  
    8,685,000     National Collegiate Student Loan Trust, Series 06-4, Class A4, Variable Rate, 1 mo. LIBOR + .31%, 2.37%, due 05/25/32     7,980,486  
    12,960,000     National Collegiate Student Loan Trust, Series 06-1, Class A5, Variable Rate, 1 mo. LIBOR + .35%, 2.41%, due 03/25/33     12,297,877  
    12,763,500     National Collegiate Student Loan Trust, Series 05-2, Class A51, Variable Rate, 1 mo. LIBOR + 0.37%, 2.43%, due 06/25/33     11,944,895  
    8,514,000     National Collegiate Student Loan Trust, Series 07-1, Class A4, Variable Rate, 1 mo. LIBOR + 0.31%, 2.37%, due 10/25/33     7,460,726  
    25,000     National Collegiate Student Loan Trust, Series 07-3, Class A3A4, Variable Rate, 5.16%, due 03/25/38 (a)     23,000  
    75,000     National Collegiate Student Loan Trust, Series 07-4, Class A3A7, Variable Rate, 5.50%, due 03/25/38 (a)     70,500  
    10,865,000     SLM Private Credit Student Loan Trust, Series 03-A, Class A3, Variable Rate, 4.28%, due 06/15/32 (a)     10,862,827  
    5,500,000     SLM Private Credit Student Loan Trust, Series 03-C, Class A3, Variable Rate, 4.34%, due 09/15/32 (a)     5,499,450  
    3,509,557     SLM Private Credit Student Loan Trust, Series 03-C, Class C, Variable Rate, 3 mo. LIBOR + 1.60%, 3.94%, due 09/15/32     1,199,540  
    9,000,000     SLM Private Credit Student Loan Trust, Series 04-B, Class A4, Variable Rate, 3 mo. LIBOR + .43%, 2.77%, due 09/15/33     8,651,794  
    4,881,794     SLM Private Credit Student Loan Trust, Series 05-A, Class B, Variable Rate, 3 mo. LIBOR + .28%, 2.62%, due 12/15/38     4,821,541  
    29,081,181     SLM Private Credit Student Loan Trust, Series 06-A, Class A5, Variable Rate, 3 mo. LIBOR + .29%, 2.63%, due 06/15/39     28,391,474  
    19,660,920     SLM Private Credit Student Loan Trust, Series 05-B, Class A4, Variable Rate, 3 mo. LIBOR + .33%, 2.67%, due 06/15/39     19,200,033  
    2,672,291     SLM Private Credit Student Loan Trust, Series 06-C, Class C, Variable Rate, 3 mo. LIBOR + .39%, 2.73%, due 12/15/39     2,100,851  
 

 

  See accompanying notes to the financial statements.   31


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    Asset-Backed Securities — continued

 

          Student Loans — Private — continued  
    11,296,810     South Carolina Student Loan Corp., Series 15-A, Class A, Variable Rate, 1 mo. LIBOR + 1.50%, 3.56%, due 01/25/36     11,403,409  
     

 

 

 
    Total Student Loans — Private     225,314,042  
     

 

 

 
    Time Share — 0.5%

 

    533,206     BXG Receivables Note Trust, Series 12-A, Class B, 144A, 3.99%, due 12/02/27     529,473  
    1,942,050     BXG Receivables Note Trust, Series 13-A, Class B, 144A, 4.00%, due 12/04/28     1,931,469  
    1,125,036     Marriott Vacation Club Owner Trust, Series 12-1A, Class B, 144A, Variable Rate, 3.50%, due 05/20/30     1,118,713  
    1,770,700     Westgate Resorts LLC, Series 17-1A, Class A, 144A, 3.05%, due 12/20/30     1,752,870  
     

 

 

 
    Total Time Share     5,332,525  
     

 

 

 
    Total Asset-Backed Securities     951,787,792  
     

 

 

 
    U.S. Government — 0.2%

 

    2,800,000     U.S. Treasury Note, Variable Rate, USBM + 0.03%, 2.12%, due 04/30/20 (b)     2,800,409  
     

 

 

 
    U.S. Government Agency — 1.5%

 

    95,586     Agency for International Development Floater (Support of Jamaica), Variable Rate, 3 mo. LIBOR + .30%, 2.33%, due 10/01/18 (c)     95,499  
    6,418,750     Agency for International Development Floater (Support of Morocco), Variable Rate, 6 mo. LIBOR – .02%, 2.52%, due 02/01/25 (c)     6,202,825  
    6,375,000     Agency for International Development Floater (Support of Morocco), Variable Rate, 6 mo. LIBOR + .15%, 2.69%, due 10/29/26 (c)     6,157,818  
    
Par Value†
    Description   Value ($)  
    U.S. Government Agency — continued

 

    3,525,000     Agency for International Development Floater (Support of Tunisia), Variable Rate, 6 mo. LIBOR, 2.54%, due 07/01/23(c)     3,435,320  
     

 

 

 
    Total U.S. Government Agency     15,891,462  
     

 

 

 
    TOTAL DEBT OBLIGATIONS (COST $953,762,170)     970,479,663  
     

 

 

 
    MUTUAL FUNDS — 4.5%

 

    United States — 4.5%

 

          Affiliated Issuers — 4.5%      
    1,952,608     GMO U.S. Treasury Fund     48,776,146  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $48,776,146)
    48,776,146  
     

 

 

 
    SHORT-TERM INVESTMENTS — 3.5%

 

    Money Market Funds — 0.7%

 

    7,129,966     State Street Institutional Treasury Plus Money Market Fund-Premier Class, 1.88% (d)     7,129,966  
     

 

 

 
    Repurchase Agreements — 2.8%

 

    29,978,268     Barclays Bank plc Repurchase Agreement, dated 8/31/18, maturing on 9/4/18 with a maturity value of $29,984,830 and an effective yield of 1.97%, collateralized by a U.S. Treasury Note with maturity date 05/15/25 and a market value of $30,581,994.     29,978,268  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $37,108,234)
  $ 37,108,234  
     

 

 

 
 

 

PURCHASED OPTIONS — 0.0%

 

Description   Counterparty   Exercise
Rate
    Expiration
Date
  Principal/
Notional
Amount
    Floating Rate
Index
  Pay/Receive
Floating Rate
  Value ($)
Options on Credit Default Swaps — Puts — 0.0%

CDX.NA.HYS.30.V1-5Y

  MSCS     106.00   09/19/18     USD 21,120,000     Fixed Spread   Pay   31,941

CDX.NA.HYS.30.V1-5Y

  BOA     106.50   09/19/18     USD 25,344,000     Fixed Spread   Pay   75,115

CDX.NA.HYS.30.V1-5Y

  BCLY     106.00   09/19/18     USD 21,115,000     Fixed Spread   Pay   31,934

CDX.NA.IGS.30.V1-5Y

  MSCS     62.50   09/19/18     USD 84,480,000     Fixed Spread   Pay   60,818

CDX.NA.IGS.30.V1-5Y

  GS     62.50   09/19/18     USD 84,460,000     Fixed Spread   Pay   60,804
             

 

   

Total Options on Credit Default Swaps – Puts

    260,612  
     

 

 

 
   

TOTAL PURCHASED OPTIONS (COST $314,869)

    260,612  
     

 

 

 
   

TOTAL INVESTMENTS — 97.6%
(Cost $1,039,961,419)

    1,056,624,655  
   

Other Assets and Liabilities (net) — 2.4%

    26,277,007  
     

 

 

 
   

TOTAL NET ASSETS — 100.0%

    $1,082,901,662  
     

 

 

 

 

32   See accompanying notes to the financial statements.  


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Futures Contracts

 

Number of
Contracts +
   

Type

     Expiration
Date
     Notional
Amount ($)
       Value/Net
Unrealized
Appreciation
(Depreciation) ($)
 
  Buys                   
  652     U.S. Treasury Note 2 Yr. (CBT)      December 2018        137,806,313          31,636  
  1,130     U.S. Treasury Note 5 Yr. (CBT)      December 2018        128,140,235          25,000  
  178     U.S. Treasury Ultra 10 Yr. (CBT)      December 2018        22,792,344          (4,442
           

 

 

      

 

 

 
            $ 288,738,892        $ 52,194  
           

 

 

      

 

 

 

 

+

Buys - Fund is long the futures contract.

  

Sales - Fund is short the futures contract.

Written Options

 

Description

 

Counterparty

  Exercise
Rate
    Expiration
Date
   

Principal/
Notional
Amount

    Floating
Rate Index
   

Pay/Receive
Floating Rate

 

Value ($)

Written Options on Credit Default Swaps — Puts

CDX-NA.HYS.30.V1-5Y

  BOA     101.00     09/19/18     USD     (21,027,500     Fixed Spread     Pay   (3,195)

CDX-NA.IGS.30.V1-5Y

  MSCS     85.00     09/19/18     USD     (84,130,000     Fixed Spread     Pay   (4,541)

CDX-NA.IGS.30.V1-5Y

  BOA     85.00     09/19/18     USD     (84,130,000     Fixed Spread     Pay   (4,541)

CDX-NA.HYS.30.V1-5Y

  MSCS     101.00     10/17/18     USD     (21,120,000     Fixed Spread     Pay   (15,585)

CDX-NA.IGS.30.V1-5Y

  MSCS     85.00     10/17/18     USD     (84,480,000     Fixed Spread     Pay   (24,548)
               

 

       
TOTAL WRITTEN OPTIONS ON CREDIT DEFAULT SWAPS — PUTS
(Premiums $163,443)
  (52,410)
   

 

Swap Contracts

Centrally Cleared Credit Default Swaps

 

Reference Entity

 

Notional
Amount

  Annual
Premium
    Implied
Credit
Spread (1)
    Maximum
Potential
Amount of
Future
Payments by
the Fund
Under the
Contract (2)
    Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Buy Protection^:

                   

CDX.NA.HYS.27.V1-5Y

  USD   25,022,200     5.00%       2.54%       N/A       12/20/2021       Quarterly       (1,825,591     (1,824,776     815  

Sell Protection^:

                   

CDX.NA.IGS.28.V1-5Y

  USD   17,200,000     1.00%       0.49%       17,200,000 USD       06/20/2022       Quarterly       300,982       316,721       15,739  
               

 

 

   

 

 

   

 

 

 
                $ (1,524,609   $ (1,508,055   $ 16,554  
               

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   33


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

OTC Credit Default Swaps

 

Reference Entity

 

Counterparty

 

Notional

Amount

    Annual
Premium
    Implied
Credit
Spread (1)
    Maximum
Potential
Amount of
Future
Payments by
the Fund
Under the
Contract (2)
    Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Buy Protection^:

                     

CDX.NA.HYS.25.V1-5Y

  BOA   USD     4,400,000       5.00%       0.50%       N/A       12/20/2020       Quarterly       369,771       (428,013     (797,784

CDX.NA.HYS.25.V1-5Y

  JPM   USD     4,343,000       5.00%       0.69%       N/A       12/20/2020       Quarterly       (26,058     (422,468     (396,410

CDX.NA.HYS.25.V1-5Y

  JPM   USD     8,543,000       5.00%       0.69%       N/A       12/20/2020       Quarterly       (847,893     (831,026     16,867  

CDX.NA.IGS.25.V1-5Y

  BOA   USD     4,400,000       1.00%       2.49%       N/A       12/20/2020       Quarterly       710,600       (29,153     (739,753

CDX.NA.IGS.25.V1-5Y

  CITI   USD     4,300,000       1.00%       0.71%       N/A       12/20/2020       Quarterly       547,891       (28,490     (576,381

CDX.NA.HYS.27.V2-5Y

  GS   USD     8,580,000       5.00%       1.78%       N/A       12/20/2021       Quarterly       21,450       (874,793     (896,243

CDX.NA.HYS.27.V2-5Y

  JPM   USD     4,300,000       5.00%       1.78%       N/A       12/20/2021       Quarterly       (11,825     (438,416     (426,591

D.R. HORTON INC

  BCLY   USD     17,200,000       1.00%       1.78%       N/A       06/20/2022       Quarterly       (165,250     (308,782     (143,532

CDX.NA.HYS.29.V1-5Y

  JPM   USD     6,425,250       5.00%       3.35%       N/A       12/20/2022       Quarterly       (282,711     (423,623     (140,912

CDX.NA.HYS.29.V1-5Y

  MSCS   USD     3,450,800       5.00%       3.35%       N/A       12/20/2022       Quarterly       (188,414     (227,515     (39,101

Navient Corp.

  BCLY   USD     2,576,400       5.00%       0.64%       N/A       12/20/2022       Quarterly       (208,665     (250,201     (41,536

Navient Corp.

  BCLY   USD     2,576,400       5.00%       2.49%       N/A       12/20/2022       Quarterly       (198,694     (250,201     (51,507

Navient Corp.

  BCLY   USD     3,435,200       5.00%       2.49%       N/A       12/20/2022       Quarterly       (264,646     (333,602     (68,956

CMBX.NA.AS.7

  BOA   USD     4,505,000       1.00%       0.71%       N/A       01/17/2047       Monthly       47,352       (81,474     (128,826

CMBX.NA.AS.7

  DB   USD     16,677,794       1.00%       0.62%       N/A       01/17/2047       Monthly       197,705       (301,620     (499,325

CMBX.NA.AS.7

  GS   USD     4,400,000       1.00%       0.62%       N/A       01/17/2047       Monthly       112,812       (79,575     (192,387

CMBX.NA.AS.7

  MSCS   USD     13,270,000       1.00%       0.62%       N/A       01/17/2047       Monthly       205,782       (239,990     (445,772

CMBX.NA.AA.8

  CSI   USD     8,892,000       1.50%       1.40%       N/A       10/17/2057       Monthly       247,717       (46,305     (294,022

CMBX.NA.AS.8

  MSCS   USD     3,384,000       1.00%       0.72%       N/A       10/17/2057       Monthly       140,432       (53,060     (193,492

CMBX.NA.AS.8

 

CGMI

  USD     8,892,000       1.00%       0.72%       N/A       10/17/2057       Monthly       73,095       (139,424     (212,519

CMBX.NA.BBB-.8

 

CGMI

  USD     4,223,000       3.00%       4.80%       N/A       10/17/2057       Monthly       392,728       376,128       (16,600

CMBX.NA.BBB-.8

  GS   USD     4,224,000       3.00%       4.80%       N/A       10/17/2057       Monthly       400,908       376,217       (24,691

CMBX.NA.BBB-.8

  GS   USD     8,650,000       3.00%       4.80%       N/A       10/17/2057       Monthly       1,299,082       770,425       (528,657

CMBX.NA.AAA.9

  DB   USD     4,292,500       0.50%       0.45%       N/A       09/17/2058       Monthly       (5,380     (15,081     (9,701

CMBX.NA.AAA.9

  DB   USD     21,462,500       0.50%       0.45%       N/A       09/17/2058       Monthly       (23,012     (75,403     (52,391

CMBX.NA.AAA.9

  GS   USD     874,200       0.50%       0.45%       N/A       09/17/2058       Monthly       48,015       (3,071     (51,086

CMBX.NA.BBB-.9

  DB   USD     4,400,000       3.00%       4.42%       N/A       09/17/2058       Monthly       950,085       352,982       (597,103

CMBX.NA.BBB-.9

  MSCS   USD     8,528,000       3.00%       4.42%       N/A       09/17/2058       Monthly       974,545       684,143       (290,402

CMBX.NA.BBB-.9

  DB   USD     4,263,000       3.00%       4.42%       N/A       09/17/2058       Monthly       517,160       341,991       (175,169

CMBX.NA.BBB-.9

  GS   USD     1,760,000       3.00%       4.42%       N/A       09/17/2058       Monthly       346,611       141,193       (205,418

CMBX.NA.BBB-.10

  GS   USD     2,551,200       3.00%       4.12%       N/A       11/17/2059       Monthly       236,632       179,718       (56,914

Sell Protection^:

                     

CDX-NA.HYS.27.V3-5Y

  JPM   USD     8,543,000       5.00%       0.64%       8,543,000 USD       12/20/2021       Quarterly       1,230,192       1,190,271       (39,921

CDX-NA.HYS.27.V3-5Y

  JPM   USD     12,672,000       5.00%       0.64%       12,672,000 USD       12/20/2021       Quarterly       1,795,622       1,765,553       (30,069

CDX.NA.HYS.27.V2-5Y

  GS   USD     12,870,000       5.00%       0.64%       12,870,000 USD       12/20/2021       Quarterly       1,657,013       1,793,140       136,127  

CDX.NA.HYS.27.V2-5Y

  JPM   USD     8,600,000       5.00%       0.64%       8,600,000 USD       12/20/2021       Quarterly       1,143,800       1,198,213       54,413  

CDX.NA.HYS.27.V3-5Y

  BOA   USD     8,545,000       5.00%       2.49%       8,545,000 USD       12/20/2021       Quarterly       1,369,764       1,190,550       (179,214

CDX.NA.HYS.29.V1-5Y

  BOA   USD     25,885,000       5.00%       2.49%       25,885,000 USD       12/20/2022       Quarterly       4,283,968       3,829,000       (454,968

CDX.NA.HYS.29.V1-5Y

  MSCS   USD     10,233,600       5.00%       1.35%       10,233,600 USD       12/20/2022       Quarterly       1,547,320       1,513,790       (33,530

CDX.NA.HYS.29.V1-5Y

  JPM   USD     42,835,000       5.00%       0.40%       42,835,000 USD       12/20/2022       Quarterly       9,136,706       7,832,831       (1,303,875

CDX.NA.HYS.29.V1-5Y

  BOA   USD     5,115,600       5.00%       1.37%       5,115,600 USD       12/20/2022       Quarterly       742,274       756,718       14,444  

CDX.NA.HYS.29.V1-5Y

  MSCS   USD     21,567,500       5.00%       0.40%       21,567,500 USD       12/20/2022       Quarterly       4,121,549       3,943,845       (177,704
                 

 

 

   

 

 

   

 

 

 
                  $ 32,646,033     $ 22,355,422     $ (10,290,611
                 

 

 

   

 

 

   

 

 

 

 

^

Buy Protection - Fund pays a premium and buys credit protection. If a credit event occurs the Fund will, depending on the terms of the particular swap contract, either (i) receive from the seller of protection an amount equal to notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.

    

Sell Protection - Fund receives a premium and sells credit protection. If a credit event occurs the Fund will, depending on the terms of the particular swap contract, either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.

 

34   See accompanying notes to the financial statements.  


GMO Opportunistic Income Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

(1)

As of August 31, 2018, implied credit spreads in absolute terms, calculated using a model, and utilized in determining the market value of credit default swap contracts on the reference security, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e., higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the contract.

(2)

The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap contract.

Centrally Cleared Interest Rate Swaps

 

Fund Pays

  

Fund Receives

  

Notional Amount

     Expiration
Date
    

Periodic
Payment
Frequency

   Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

1.27%

   3 Month USD LIBOR    USD      10,495,000        03/10/2021      Quarterly            403,154       403,154  

2.55%

   3 Month USD LIBOR    USD      21,181,000        03/16/2021      Quarterly      144,649       156,077       11,428  

2.10%

   3 Month USD LIBOR    USD      8,447,000        11/24/2021      Quarterly      149,033       201,071       52,038  

2.59%

   3 Month USD LIBOR    USD      3,584,000        02/09/2022      Quarterly      462       33,621       33,159  

2.90%

   3 Month USD LIBOR    USD      7,624,000        06/22/2022      Quarterly            (9,313     (9,313

2.06%

   3 Month USD LIBOR    USD      11,981,000        11/10/2022      Quarterly      163,222       384,135       220,913  

2.15%

   3 Month USD LIBOR    USD      8,477,000        10/13/2024      Quarterly      164,029       345,830       181,801  

2.00%

   3 Month USD LIBOR    USD      19,668,000        04/16/2025      Quarterly      (91,173     1,072,950       1,164,123  

1.65%

   3 Month USD LIBOR    USD      9,022,000        05/19/2026      Quarterly      252,588       794,875       542,287  

2.88%

   3 Month USD LIBOR    USD      7,356,000        06/04/2028      Quarterly            23,934       23,934  

3.00%

   3 Month USD LIBOR    USD      6,581,000        07/30/2028      Quarterly            (47,727     (47,727
                 

 

 

   

 

 

   

 

 

 
                  $ 782,810     $ 3,358,607     $ 2,575,797  
                 

 

 

   

 

 

   

 

 

 

OTC Total Return Swaps

 

Fund Pays

  Fund Receives    

Counterparty

  Notional
Amount
   

Expiration
Date

  Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Total Return on iBoxx USD Liquid Leverage Loans Index

    3 Month USD LIBOR     JPM     USD       40,000,000     12/20/2018     Quarterly             (218,064     (218,064

Total Return on iBoxx USD Liquid Leverage Loans Index

    3 Month USD LIBOR     MSCS     USD       25,000,000     12/20/2018     Quarterly             (143,837     (143,837
             

 

 

   

 

 

   

 

 

 
              $     $ (361,901   $ (361,901
             

 

 

   

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

(a)

Investment valued using significant unobservable inputs (Note 2).

 

(b)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(c)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

 

(d)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 38.

 

 

  See accompanying notes to the financial statements.   35


GMO U.S. Treasury Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary   % of Total Net Assets  

Short-Term Investments

    102.2

Other

    (2.2
 

 

 

 
    100.0 % 
 

 

 

 

 

36


GMO U.S. Treasury Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value† /
Shares
    Description   Value ($)  
    SHORT-TERM INVESTMENTS — 102.2%

 

    U.S. Government — 78.4%

 

    1,000,000     U.S. Treasury Bill, 0.64%, due 09/06/18 (a)     999,895  
    28,024,000     U.S. Treasury Bill, 1.65%, due 09/27/18 (a)     27,989,937  
    56,815,300     U.S. Treasury Bill, 1.73%, due 10/04/18 (a)     56,723,685  
    109,426,900     U.S. Treasury Bill, 1.80%, due 10/11/18 (a)     109,206,185  
    7,562,000     U.S. Treasury Bill, 2.18%, due 01/31/19 (a)     7,493,613  
    19,127,500     U.S. Treasury Bill, 2.18%, due 02/07/19 (a)     18,946,291  
    22,241,200     U.S. Treasury Note, 0.75%, due 10/31/18     22,196,719  
    44,482,500     U.S. Treasury Note, 1.00%, due 11/30/18     44,364,083  
    31,137,700     U.S. Treasury Note, 1.25%, due 11/30/18     31,073,117  
    22,241,200     U.S. Treasury Note, 1.50%, due 12/31/18     22,192,626  
    17,793,000     U.S. Treasury Note, 0.75%, due 02/15/19     17,674,148  
    22,241,200     U.S. Treasury Note, Variable Rate, USBM + 0.05%, 2.14%, due 10/31/19     22,254,924  
    101,108,700     U.S. Treasury Note, Variable Rate, USBM + 0.00%, 2.09%, due 01/31/20     101,097,813  
    145,902,600     U.S. Treasury Note, Variable Rate, USBM + 0.03%, 2.12%, due 04/30/20     145,923,913  
    22,241,200     U.S. Treasury Note, Variable Rate USBM + 0.04%, 2.13%, due 07/31/20     22,238,651  
     

 

 

 
    TOTAL U.S. GOVERNMENT
(COST $650,322,827)
    650,375,600  
     

 

 

 
    U.S. Government Agency — 18.0%

 

    22,240,000     Federal Home Loan Banks, 0.88%, due 10/01/18     22,218,227  
    11,120,000     Federal Home Loan Banks, Variable Rate, 1 mo. USD LIBOR – .09%, 1.98%, due 01/14/19     11,120,737  
    44,480,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR – .16%, 2.18%, due 01/28/19     44,503,203  
    11,120,000     Federal Home Loan Banks, Variable Rate, 1 mo. USD LIBOR – .08%, 1.99%, due 04/26/19     11,120,579  
    24,470,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR – .16%, 2.18%, due 02/07/20     24,473,942  
    35,590,000     Federal Home Loan Banks, Variable Rate 3 mo. USD LIBOR – .23%, 2.11%, due 05/04/20     35,569,854  
     

 

 

 
    TOTAL U.S. GOVERNMENT AGENCY (COST $149,010,286)     149,006,542  
     

 

 

 
    Money Market Funds — 0.1%

 

    1,277,616     State Street Institutional Treasury Plus Money Market Fund-Premier Class, 1.88% (b)     1,277,616  
     

 

 

 
    
Par Value†
    Description   Value ($)  
    Repurchase Agreements — 5.7%

 

    47,000,628     Barclays Bank plc Repurchase Agreement, dated 8/31/18, maturing on 9/4/18 with a maturity value of $47,010,916 and an effective yield of 1.97%, collateralized by a U.S. Treasury Note with maturity date 05/15/25 and a market value of $47,947,163.     47,000,628  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $847,611,357)
    847,660,386  
     

 

 

 
    TOTAL INVESTMENTS — 102.2%
(Cost $847,611,357)
    847,660,386  
    Other Assets and Liabilities (net) — (2.2%)     (18,477,042
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $829,183,344  
     

 

 

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

(a)

The rate shown represents yield-to-maturity.

 

(b)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 38.

 

 

  See accompanying notes to the financial statements.   37


GMO Trust Funds

 

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Portfolio Abbreviations:

144A - Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.

AMBAC - Insured as to the payment of principal and interest by AMBAC Assurance Corporation.

AUD BBSW - Bank Bill Swap Reference Rate denominated in Australian Dollars.

CAD LIBOR - London Interbank Offered Rate denominated in Canadian Dollars.

CDO - Collateralized Debt Obligation

CHF LIBOR - London Interbank Offered Rate denominated in Swiss Francs.

CJSC - Closed Joint-Stock Company

CLO - Collateralized Loan Obligation

CMBS - Commercial Mortgage Backed Security

CMT - Constant Maturity Treasury

COFI - Cost of Funds Index

CP - Counterparty

ETF - Exchange-Traded Fund

EURIBOR - Euro Interbank Offered Rate

FGIC - Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.

FSA - Insured as to the payment of principal and interest by Financial Security Assurance.

GBP LIBOR - London Interbank Offered Rate denominated in British Pounds.

GDP - Gross Domestic Product

JSC - Joint-Stock Company

LIBOR - London Interbank Offered Rate

NZD Bank Bill Rate - Bank Bill Rate denominated in New Zealand Dollars.

OTC - Over-the-Counter

Reg S - Security exempt from registration under Regulation S of the Securities Act of 1933, which exempts from registration securities offered and sold outside the United States. Security may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act of 1933.

REIT - Real Estate Investment Trust

SEK STIBOR - Stockholm Interbank Offered Rate denominated in Swedish Krona

TBA - To Be Announced-Delayed Delivery Security

USBM - U.S. Treasury 3 Month Bill Money Market Yield.

USD LIBOR - London Interbank Offered Rate denominated in United States Dollars.

VRRB - Variable Rate Reduction Bond

XLCA - Insured as to the payment of principal and interest by XL Capital Assurance Inc.

The rates shown on variable rate notes are the current interest rates at August 31, 2018, which are subject to change based on the terms of the security.

Counterparty Abbreviations:

 

BCLY - Barclays Bank plc

BOA - Bank of America, N.A.

CITI - Citibank N.A.

CGMI - Citigroup Global Markets Inc.

CSI - Credit Suisse International

DB - Deutsche Bank AG

GS - Goldman Sachs International

JPM - JPMorgan Chase Bank, N.A.

MSCI - Morgan Stanley & Co. International PLC

MSCS - Morgan Stanley Capital Services LLC

 

 

Currency Abbreviations:

 

AUD - Australian Dollar

CAD - Canadian Dollar

CHF - Swiss Franc

EUR - Euro

GBP - British Pound

JPY - Japanese Yen

NOK - Norwegian Krone

NZD - New Zealand Dollar

SEK - Swedish Krona

USD - United States Dollar

ZAR - South African Rand

 
 

 

38   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited)

 

 

     Asset Allocation
Bond Fund
     Core Plus
Bond Fund
     Emerging
Country Debt
Fund
 

Assets:

 

Investments in affiliated issuers, at value (Notes 2 and 10)(a)

   $ 21,380,716      $ 219,663,321      $ 96,381,706  

Investments in unaffiliated issuers, at value (Note 2)(b)

     423,373,478        628,334,003        3,650,413,770  

Foreign currency, at value (Note 2)(c)

            10         

Cash

            65        252  

Receivable for investments sold

     79,618,699        48,842,593         

Receivable for Fund shares sold

                   64,230,445  

Receivable for closed swap contracts (Note 4)

     418,197        200,654         

Dividends and interest receivable

     725,534        1,208,990        50,818,474  

Unrealized appreciation on open forward currency contracts (Note 4)

     1,401,890        3,639,627        725,596  

Receivable for variation margin on open futures contracts (Note 4)

            54,547         

Receivable for variation margin on open cleared swap contracts (Note 4)

     170,817               419,388  

Due from broker (Note 2)

     2,010,378        5,318,333        8,651,776  

Receivable for open OTC swap contracts (Note 4)

                   16,231,326  

Interest receivable for open OTC swap contracts (Note 4)

                   959,118  

Receivable for expenses reimbursed and/or waived by GMO (Note 5)

     21,137        103,084        5,857  

Receivable for options (Note 4)(d)

                   131,894  

Miscellaneous receivable

                   184,864  
  

 

 

    

 

 

    

 

 

 

Total assets

     529,120,846        907,365,227        3,889,154,466  
  

 

 

    

 

 

    

 

 

 

Liabilities:

 

Due to custodian

     180                

Payable for investments purchased

     47,325                

Payable for Fund shares repurchased

     94,261,936        42,053,036        40,000,000  

Payable for purchases of delayed delivery securities

            118,710,843         

Payable to affiliate for (Note 5):

 

Management fee

     112,390        167,310        1,129,777  

Shareholder service fee

     39,002        68,771        375,116  

Payable to agents unaffiliated with GMO

     191        168        727  

Payable for variation margin on open cleared swap contracts (Note 4)

            645,147         

Payable for closed swap contracts (Note 4)

     325,868        158,538         

Unrealized depreciation on open forward currency contracts (Note 4)

     1,592,903        3,123,863        170,564  

Interest payable for open OTC swap contracts (Note 4)

                   715,901  

Payable for open OTC swap contracts (Note 4)

                   22,720,391  

Payable for reverse repurchase agreements (Note 2)

                   36,933,066  

Payable for options (Note 4)(d)

                   3,200,781  

Payable to Trustees and related expenses

     5,041        2,587        11,079  

Accrued expenses

     187,502        124,718        483,139  
  

 

 

    

 

 

    

 

 

 

Total liabilities

     96,572,338        165,054,981        105,740,541  
  

 

 

    

 

 

    

 

 

 

Net assets

   $ 432,548,508      $ 742,310,246      $ 3,783,413,925  
  

 

 

    

 

 

    

 

 

 

(a)  Cost of investments – affiliated issuers:

   $ 21,380,716      $ 219,026,965      $ 93,156,925  

(b)  Cost of investments – unaffiliated issuers:

   $ 427,456,882      $ 638,442,147      $ 3,937,286,003  

(c)  Cost of foreign currency:

   $      $ 10      $  

(d)  Premiums on options:

   $      $      $ 5,101,699  

 

  See accompanying notes to the financial statements.   39


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

 

     Asset Allocation
Bond Fund
    Core Plus
Bond Fund
    Emerging
Country Debt
Fund
 

Net assets consist of:

 

Paid-in capital

   $ 489,954,073     $ 772,576,330     $ 4,170,084,165  

Accumulated undistributed (distributions in excess of) net investment income

     17,471,244       9,395,007       (27,272,676

Accumulated net realized gain (loss)

     (70,846,595     (31,158,028     (101,689,090

Net unrealized appreciation (depreciation)

     (4,030,214     (8,503,063     (257,708,474
  

 

 

   

 

 

   

 

 

 
   $ 432,548,508     $ 742,310,246     $ 3,783,413,925  
  

 

 

   

 

 

   

 

 

 

Net assets attributable to:

 

Class III

   $ 83,097,382     $ 43,441,899     $ 1,223,579,794  
  

 

 

   

 

 

   

 

 

 

Class IV

   $     $ 698,868,347     $ 2,559,834,131  
  

 

 

   

 

 

   

 

 

 

Class VI

   $ 349,451,126     $     $  
  

 

 

   

 

 

   

 

 

 

Shares outstanding:

 

Class III

     3,730,363       2,047,184       45,498,905  
  

 

 

   

 

 

   

 

 

 

Class IV

           32,843,694       95,321,929  
  

 

 

   

 

 

   

 

 

 

Class VI

     15,630,115              
  

 

 

   

 

 

   

 

 

 

Net asset value per share:

 

Class III

   $ 22.28     $ 21.22     $ 26.89  
  

 

 

   

 

 

   

 

 

 

Class IV

   $     $ 21.28     $ 26.85  
  

 

 

   

 

 

   

 

 

 

Class VI

   $ 22.36     $     $  
  

 

 

   

 

 

   

 

 

 

 

40   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     High Yield
Fund
     Opportunistic
Income Fund
     U.S. Treasury
Fund
 

Assets:

 

Investments in affiliated issuers, at value (Notes 2 and 10)(a)

   $ 1,316,876      $ 48,776,146      $  

Investments in unaffiliated issuers, at value (Note 2)(b)

     211,977,759        1,007,848,509        847,660,386  

Cash

            58,767        21  

Receivable for Fund shares sold

     60,462,236                

Receivable for closed swap contracts (Note 4)

            488,287         

Dividends and interest receivable

     1,186,569        3,442,622        1,140,911  

Unrealized appreciation on open forward currency contracts (Note 4)

     251,719                

Receivable for variation margin on open futures contracts (Note 4)

     64,977        189,782         

Receivable for variation margin on open cleared swap contracts (Note 4)

     120,859                

Due from broker (Note 2)

     3,626,822        1,824,000         

Receivable for open OTC swap contracts (Note 4)

     460,575        28,236,708         

Interest receivable for open OTC swap contracts (Note 4)

            1,591,458         

Receivable for expenses reimbursed and/or waived by GMO (Note 5)

     80,971        35,085        130,968  

Receivable for options (Note 4)(d)

                    

Miscellaneous receivable

                    
  

 

 

    

 

 

    

 

 

 

Total assets

     279,549,363        1,092,491,364        848,932,286  
  

 

 

    

 

 

    

 

 

 

Liabilities:

 

Payable for investments purchased

     11,244        49,638         

Payable for Fund shares repurchased

     60,589,214               19,087,500  

Payable to affiliate for (Note 5):

 

Management fee

     64,770        367,264        109,117  

Shareholder service fee

     10,178        50,500         

Payable to agents unaffiliated with GMO

     38        206        420  

Payable for variation margin on open cleared swap contracts (Note 4)

            125,002         

Payable for closed swap contracts (Note 4)

            1,920,702         

Dividend payable

                   406,682  

Unrealized depreciation on open forward currency contracts (Note 4)

     37,492                

Interest payable for open OTC swap contracts (Note 4)

     6,083        583,196         

Payable for open OTC swap contracts (Note 4)

            6,243,187         

Written options outstanding, at value (Note 4)(c)

            52,410         

Payable to Trustees and related expenses

     529        3,466        5,373  

Accrued expenses

     112,967        194,131        139,850  
  

 

 

    

 

 

    

 

 

 

Total liabilities

     60,832,515        9,589,702        19,748,942  
  

 

 

    

 

 

    

 

 

 

Net assets

   $ 218,716,848      $ 1,082,901,662      $ 829,183,344  
  

 

 

    

 

 

    

 

 

 

(a)  Cost of investments – affiliated issuers:

   $ 1,316,876      $ 48,776,146      $  

(b)  Cost of investments – unaffiliated issuers:

   $ 211,366,647      $ 991,185,273      $ 847,611,357  

(c)  Premiums on written options:

   $      $ 163,443      $  

 

  See accompanying notes to the financial statements.   41


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

 

     High Yield
Fund
     Opportunistic
Income Fund
    U.S. Treasury
Fund
 

Net assets consist of:

       

Paid-in capital

   $ 214,419,851      $ 1,148,417,155     $ 831,170,353  

Accumulated undistributed (distributions in excess of) net investment income

    
830,243
 
     19,474,044        

Accumulated net realized gain (loss)

     1,749,891        (93,755,839     (2,036,038

Net unrealized appreciation (depreciation)

     1,716,863        8,766,302       49,029  
  

 

 

    

 

 

   

 

 

 
   $ 218,716,848      $ 1,082,901,662     $ 829,183,344  
  

 

 

    

 

 

   

 

 

 

Net assets attributable to:

       

Core Class

   $      $     $ 829,183,344  
  

 

 

    

 

 

   

 

 

 

Class VI

   $ 218,716,848      $ 1,082,901,662     $  
  

 

 

    

 

 

   

 

 

 

Shares outstanding:

       

Core Class

                  33,197,421  
  

 

 

    

 

 

   

 

 

 

Class VI

     10,721,117        40,540,085        
  

 

 

    

 

 

   

 

 

 

Net asset value per share:

       

Core Class

   $      $     $ 24.98  
  

 

 

    

 

 

   

 

 

 

Class VI

   $ 20.40      $ 26.71     $  
  

 

 

    

 

 

   

 

 

 

 

42   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Operations — Six Months Ended August 31, 2018 (Unaudited)

 

 

     Asset Allocation
Bond Fund
    Core Plus
Bond Fund
    Emerging
Country Debt
Fund
 

Investment Income:

      

Interest

   $ 17,051,461     $ 3,623,403     $ 101,282,657  

Dividends from affiliated issuers (Note 10)

     237,627       2,153,754       906,174  

Dividends from unaffiliated issuers

     28,773       2,420,938       563,534  
  

 

 

   

 

 

   

 

 

 

Total investment income

     17,317,861       8,198,095       102,752,365  
  

 

 

   

 

 

   

 

 

 

Expenses:

 

Management fee (Note 5)

     1,101,678       1,105,922       7,021,258  

Shareholder service fee – Class III (Note 5)

     145,166       29,826       949,378  

Shareholder service fee – Class IV (Note 5)

           422,486       1,373,155  

Shareholder service fee – Class VI (Note 5)

     189,142              

Audit and tax fees

     44,001       45,147       79,903  

Custodian, fund accounting agent and transfer agent fees

     82,736       81,589       346,813  

Legal fees

     14,276       15,709       28,937  

Registration fees

     1,488       2,771       7,836  

Trustees’ fees and related expenses (Note 5)

     12,952       10,290       45,441  

Interest expense (Note 2)

           3,631       214,800  

Miscellaneous

     5,332       5,488       33,839  
  

 

 

   

 

 

   

 

 

 

Total expenses

     1,596,771       1,722,859       10,101,360  

Fees and expenses reimbursed and/or waived by GMO (Note 5)

     (138,208     (140,314      

Indirectly incurred management fees waived or borne by GMO (Note 5)

           (448,084     (30,452

Indirectly incurred shareholder service fees waived or borne by GMO (Note 5)

           (73,701     (4,187
  

 

 

   

 

 

   

 

 

 

Net expenses

     1,458,563       1,060,760       10,066,721  
  

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     15,859,298       7,137,335       92,685,644  
  

 

 

   

 

 

   

 

 

 

Realized and unrealized gain (loss):

      

Net realized gain (loss) on:

      

Investments in unaffiliated issuers

     (9,425,171     (2,910,536     5,388,334  

Investments in affiliated issuers

     (15,659     737,344        

Futures contracts

           1,264,909        

Options

                 70,000  

Swap contracts

     666,232       1,089,740       7,401,897  

Forward currency contracts

     1,184,981       1,719,992       7,902,011  

Foreign currency and foreign currency related transactions

     43,881       100,942       277,071  
  

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

     (7,545,736     2,002,391       21,039,313  
  

 

 

   

 

 

   

 

 

 

Change in net unrealized appreciation (depreciation) on:

      

Investments in unaffiliated issuers

     6,502,743       (3,601,084     (323,937,912

Investments in affiliated issuers

           (1,674,383     202,914  

Investments in securities sold short

                  

Futures contracts

           (435,317      

Written options

                 (3,210,846

Swap contracts

     1,505,460       2,913,646       19,526,095  

Forward currency contracts

     1,446,179       9,352,266       (1,402,074

Foreign currency and foreign currency related transactions

     14,352             (414,909
  

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

     9,468,734       6,555,128       (309,236,732
  

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

     1,922,998       8,557,519       (288,197,419
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

   $ 17,782,296     $ 15,694,854     $ (195,511,775
  

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   43


GMO Trust Funds

 

Statements of Operations — Six Months Ended August 31, 2018 (Unaudited) — (Continued)

 

 

     High Yield
Fund(a)
    Opportunistic
Income Fund
    U.S. Treasury
Fund
 

Investment Income:

      

Interest

   $ 1,033,664     $ 23,250,811     $ 19,492,631  

Dividends from affiliated issuers (Note 10)

     17,539       383,902        

Dividends from unaffiliated issuers

     2,357       54,595       6,579  
  

 

 

   

 

 

   

 

 

 

Total investment income

     1,053,560       23,689,308       19,499,210  
  

 

 

   

 

 

   

 

 

 

Expenses:

 

Management fee (Note 5)

     138,886       2,261,458       844,545  

Shareholder service fee – Class III (Note 5)

                  

Shareholder service fee – Class IV (Note 5)

                  

Shareholder service fee – Class VI (Note 5)

     21,825       310,950        

Organizational expenses

     138,574              

Audit and tax fees

     23,145       62,465       18,367  

Custodian, fund accounting agent and transfer agent fees

     12,059       108,546       111,444  

Legal fees

     1,811       71,666       13,759  

Registration fees

     4,588       1,028       704  

Trustees’ fees and related expenses (Note 5)

     942       13,131       24,781  

Interest expense (Note 2)

     20,638       18,889        

Miscellaneous

     5,026       19,635       7,919  
  

 

 

   

 

 

   

 

 

 

Total expenses

     367,494       2,867,768       1,021,519  

Fees and expenses reimbursed and/or waived by GMO (Note 5)

     (144,177     (198,590     (992,445
  

 

 

   

 

 

   

 

 

 

Net expenses

     223,317       2,669,178       29,074  
  

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     830,243       21,020,130       19,470,136  
  

 

 

   

 

 

   

 

 

 

Realized and unrealized gain (loss):

      

Net realized gain (loss) on:

      

Investments in unaffiliated issuers

     33,851       12,322,261       (709,175

Investments in affiliated issuers

           (40,186      

Investments in securities sold short

           333,555        

Futures contracts

     22,520       604,530        

Written options

           583,963        

Swap contracts

     1,509,108       499,477        

Forward currency contracts

     108,242       (5,155      

Foreign currency and foreign currency related transactions

     76,170       (6,443      
  

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

     1,749,891       14,292,002       (709,175 )* 
  

 

 

   

 

 

   

 

 

 

Change in net unrealized appreciation (depreciation) on:

      

Investments in unaffiliated issuers

     611,112       (9,879,427     1,256,117  

Investments in affiliated issuers

           23,383        

Investments in securities sold short

           (494,647      

Futures contracts

     25,666       17,161        

Written options

           (152,176      

Swap contracts

     865,858       (4,202,294      

Forward currency contracts

     214,227       17,898        

Foreign currency and foreign currency related transactions

           (34      
  

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

     1,716,863       (14,670,136     1,256,117  
  

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

     3,466,754       (378,134     546,942  
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

   $ 4,296,997     $ 20,641,996     $ 20,017,078  
  

 

 

   

 

 

   

 

 

 

(a)  Period from June 25, 2018 (commencement of operations) through August 31, 2018.

      

*   For the details related to in-kind redemption realized gain (loss) please refer to Note 6.

      

 

44   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Changes in Net Assets

 

 

     Asset Allocation Bond Fund     Core Plus Bond Fund  
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
    Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 

Increase (decrease) in net assets:

 

Operations:

 

Net investment income (loss)

   $ 15,859,298     $ 20,940,318     $ 7,137,335     $ 17,999,886  

Net realized gain (loss)

     (7,545,736     694,506       2,002,391       8,423,203  

Change in net unrealized appreciation (depreciation)

     9,468,734       (19,218,760     6,555,128       (17,657,057
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     17,782,296       2,416,064       15,694,854       8,766,032  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

        

Net investment income

        

Class III

     (1,443,569     (2,024,013     (174,777     (332,939

Class IV

                 (3,055,497     (23,549,157

Class VI

     (5,659,469     (10,978,139            
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (7,103,038     (13,002,152     (3,230,274     (23,882,096
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

        

Class III

     (126,632,696     (73,760,828     8,189,800       12,381,895  

Class IV

                 (233,621,573     369,406,029  

Class VI

     (677,641,164     (181,503,566            
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (804,273,860     (255,264,394     (225,431,773     381,787,924  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (793,594,602     (265,850,482     (212,967,193     366,671,860  
Net assets:

 

   

Beginning of period

     1,226,143,110       1,491,993,592       955,277,439       588,605,579  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 432,548,508     $ 1,226,143,110     $ 742,310,246     $ 955,277,439  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 17,471,244     $ 8,714,984     $ 9,395,007     $ 5,487,946  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   45


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     Emerging Country Debt Fund     High Yield Fund  
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
    Period from
June 25, 2018
(commencement
of operations)
through
August 31, 2018
(Unaudited)
 

Increase (decrease) in net assets:

 

Operations:

 

Net investment income (loss)

   $ 92,685,644     $ 190,864,386     $ 830,243  

Net realized gain (loss)

     21,039,313       86,872,155       1,749,891  

Change in net unrealized appreciation (depreciation)

     (309,236,732     (51,980,538     1,716,863  
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     (195,511,775     225,756,003       4,296,997  
  

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

      

Net investment income

      

Class III

     (17,088,236     (72,600,877      

Class IV

     (35,795,942     (207,887,262      
  

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (52,884,178     (280,488,139      
  

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

      

Class III

     27,875,371       220,374,650        

Class IV

     (134,223,114     (118,629,623      

Class VI

                 214,419,851  
  

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (106,347,743     101,745,027       214,419,851  
  

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

      

Class III

     637,514       1,028,334        

Class IV

     1,354,875       2,878,920        
  

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

     1,992,389       3,907,254        
  

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

     (104,355,354     105,652,281       214,419,851  
  

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (352,751,307     50,920,145       218,716,848  

Net assets:

 

Beginning of period

     4,136,165,232       4,085,245,087        
  

 

 

   

 

 

   

 

 

 

End of period

   $ 3,783,413,925     $ 4,136,165,232     $ 218,716,848  
  

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ (27,272,676   $ (67,074,142   $ 830,243  
  

 

 

   

 

 

   

 

 

 

 

46   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     Opportunistic Income Fund     U.S. Treasury Fund  
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
    Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 

Increase (decrease) in net assets:

        

Operations:

        

Net investment income (loss)

   $ 21,020,130     $ 55,173,815     $ 19,470,136     $ 24,320,611  

Net realized gain (loss)

     14,292,002       (3,342,915     (709,175     (1,278,414

Change in net unrealized appreciation (depreciation)

     (14,670,136     10,426,708       1,256,117       (1,139,646
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     20,641,996       62,257,608       20,017,078       21,902,551  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

        

Net investment income

        

Core Class

                 (19,470,136     (24,320,611

Class VI

     (8,575,128     (32,473,748            
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (8,575,128     (32,473,748     (19,470,136     (24,320,611
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

        

Core Class

                 (1,496,069,163     (339,573,514

Class VI

     (136,292,026     (336,644,785            
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (136,292,026     (336,644,785     (1,496,069,163     (339,573,514
  

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

        

Class VI

     1,172,551       1,921,360              
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

     1,172,551       1,921,360              
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

     (135,119,475     (334,723,425     (1,496,069,163     (339,573,514
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (123,052,607     (304,939,565     (1,495,522,221     (341,991,574
Net assets:

 

   

Beginning of period

     1,205,954,269       1,510,893,834       2,324,705,565       2,666,697,139  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 1,082,901,662     $ 1,205,954,269     $ 829,183,344     $ 2,324,705,565  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 19,474,044     $ 7,029,042     $     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   47


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

ASSET ALLOCATION BOND FUND

 

    Class III Shares   Class VI Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014   2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 21.95     $ 22.15     $ 22.16     $ 26.36     $ 24.57     $ 24.43     $ 22.02     $ 22.23     $ 22.21     $ 26.40     $ 24.60     $ 24.46
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(a)

      0.39       0.33       0.18       0.01       0.38       0.00 (b)        0.40       0.36       0.21       0.06       0.22       0.03

Net realized and unrealized gain (loss)

      0.12       (0.31 )       (0.19 )       (2.58 )       2.48       0.17       0.12       (0.33 )       (0.19 )       (2.61 )       2.68       0.16
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      0.51       0.02       (0.01 )       (2.57 )       2.86       0.17       0.52       0.03       0.02       (2.55 )       2.90       0.19
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.18 )       (0.22 )             (1.63 )       (0.67 )       (0.03 )       (0.18 )       (0.24 )             (1.64 )       (0.70 )       (0.05 )

From net realized gains

                              (0.40 )                                     (0.40 )      
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.18 )       (0.22 )             (1.63 )       (1.07 )       (0.03 )       (0.18 )       (0.24 )             (1.64 )       (1.10 )       (0.05 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 22.28     $ 21.95     $ 22.15     $ 22.16     $ 26.36     $ 24.57     $ 22.36     $ 22.02     $ 22.23     $ 22.21     $ 26.40     $ 24.60
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      2.33 %**       0.07 %       (0.05 )%       (9.88 )%       11.92 %       0.72 %       2.38 %**       0.12 %       0.09 %       (9.79 )%       12.05 %       0.79 %

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 83,097     $ 207,008     $ 282,272     $ 352,828     $ 421,910     $ 260,775     $ 349,451     $ 1,019,135     $ 1,209,721     $ 1,888,505     $ 4,652,197     $ 2,849,433

Net operating expenses to average daily net assets

      0.41 %*(e)       0.41 %       0.41 %(e)       0.40 %(e)       0.40 %(e)       0.40 %(d)(e)       0.31 %*(e)       0.31 %       0.31 %(e)       0.31 %(e)       0.31 %(e)       0.31 %(d)(e)

Interest and/or dividend expenses to average daily net assets

            0.00 %(f)(g)       0.00 %(f)(g)       0.02 %(f)       0.01 %(f)       0.00 %(f)(g)             0.00 %(f)(g)       0.00 %(f)(g)       0.02 %(f)       0.01 %(f)       0.00 %(f)(g)

Total net expenses to average daily net assets

      0.41 %*(e)       0.41 %       0.41 %(e)       0.42 %(e)       0.41 %(e)       0.40 %(e)       0.31 %*(e)       0.31 %       0.31 %(e)       0.33 %(e)       0.32 %(e)       0.31 %(e)

Net investment income (loss) to average daily net assets(a)

      3.47 %*       1.50 %       0.81 %       0.03 %       1.49 %       0.01 %       3.63 %*       1.59 %       0.94 %       0.27 %       0.84 %       0.13 %

Portfolio turnover rate

      42 %**(h)       89 %       130 %(h)       177 %       177 %       32 %       42 %**(h)       89 %       130 %(h)       177 %       177 %       32 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.03 %*       0.02 %       0.02 %       0.03 %       0.02 %       0.02 %       0.03 %*       0.02 %       0.02 %       0.03 %       0.02 %       0.02 %

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

Net investment income (loss) was less than $0.01 per share.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(e) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(f) 

Interest expense incurred as a result of entering into reverse repurchase agreements and/or margin on cleared swap contracts, if any, is included in the Fund’s net expenses. Income earned on investing proceeds from reverse repurchase agreements, if any, is included in interest income.

(g) 

Ratio is less than 0.01%.

(h) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the year ended February 28, 2017, including transactions in USTF, was 57% and 126%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

48   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

CORE PLUS BOND FUND

 

    Class III Shares   Class IV Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017(a)   2016(a)   2015(a)   2014(a)   2018   2017(a)   2016(a)   2015(a)   2014(a)

Net asset value, beginning of period

    $ 20.93     $ 21.10     $ 21.39     $ 23.43     $ 22.35     $ 22.23     $ 20.98     $ 21.15     $ 21.45     $ 23.49     $ 22.41     $ 22.29
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(b)

      0.17       0.41       0.26       0.24       0.21       0.21       0.17       0.46       0.24       0.27       0.21       0.21

Net realized and unrealized gain (loss)

      0.21       (0.06 )       0.25       (1.14 )       1.83       0.24       0.21       (0.10 )       0.29       (1.17 )       1.83       0.27
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      0.38       0.35       0.51       (0.90 )       2.04       0.45       0.38       0.36       0.53       (0.90 )       2.04       0.48
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.09 )       (0.52 )       (0.80 )       (1.14 )       (0.96 )       (0.33 )       (0.08 )       (0.53 )       (0.83 )       (1.14 )       (0.96 )       (0.36 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.09 )       (0.52 )       (0.80 )       (1.14 )       (0.96 )       (0.33 )       (0.08 )       (0.53 )       (0.83 )       (1.14 )       (0.96 )       (0.36 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 21.22     $ 20.93     $ 21.10     $ 21.39     $ 23.43     $ 22.35     $ 21.28     $ 20.98     $ 21.15     $ 21.45     $ 23.49     $ 22.41
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      1.80 %**       1.61 %       2.44 %       (3.93 )%       9.25 %       2.15 %       1.84 %**       1.68 %       2.55 %       (3.91 )%       9.32 %       2.15 %

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 43,442     $ 34,641     $ 22,172     $ 52,187     $ 51,045     $ 48,632     $ 698,868     $ 920,637     $ 566,433     $ 215,060     $ 191,054     $ 191,571

Net operating expenses to average daily net assets(d)

      0.29 %*       0.29 %       0.35 %       0.35 %       0.37 %       0.38 %       0.24 %*       0.24 %       0.30 %       0.30 %       0.32 %       0.33 %

Interest and/or dividend expenses to average daily net assets(e)

      0.00 %(f)*       0.00 %(f)       0.00 %(f)       0.01 %       0.00 %(f)       0.00 %(f)       0.00 %(f)*       0.00 %(f)       0.00 %(f)       0.01 %       0.00 %(f)       0.00 %(f)

Total net expenses to average daily net assets(d)

      0.29 %*       0.29 %       0.35 %       0.36 %       0.37 %       0.38 %       0.24 %*       0.24 %       0.30 %       0.31 %       0.32 %       0.33 %

Net investment income (loss) to average daily net assets(b)

      1.63 %*       1.91 %       1.21 %       1.14 %       0.89 %       0.95 %       1.61 %*       2.14 %       1.10 %       1.17 %       0.94 %       0.99 %

Portfolio turnover rate

      100 %(g)**       198 %(g)       216 %(g)       21 %       128 %       87 %       100 %(g)**       198 %(g)       216 %(g)       21 %       128 %       87 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:(h)

      0.15 %*       0.14 %       0.30 %       0.21 %       0.15 %       0.12 %       0.15 %*       0.14 %       0.26 %       0.21 %       0.15 %       0.12 %

 

(a) 

Per share amounts were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

Interest expense incurred as a result of entering into reverse repurchase agreements and/or margin on cleared swap contracts, if any, is included in the Fund’s net expenses. Income earned on investing proceeds from reverse repurchase agreements, if any, is included in interest income.

(f) 

Ratio is less than 0.01%.

(g) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 118%, 221% and 325%, respectively, of the average value of its portfolio.

(h) 

Ratios include indirect fees waived or borne by GMO.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   49


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

EMERGING COUNTRY DEBT FUND

 

    Class III Shares   Class IV Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017(a)   2016(a)   2015(a)   2014(a)   2018   2017(a)   2016(a)   2015(a)   2014(a)

Net asset value, beginning of period

    $ 28.62     $ 28.99     $ 26.01     $ 28.47     $ 29.31     $ 31.02     $ 28.57     $ 28.95     $ 25.98     $ 28.44     $ 29.28     $ 30.99
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(b)

      0.65       1.36       1.94       1.53       1.77 (c)        1.80       0.65       1.39       1.95       1.53       1.80 (c)        1.80

Net realized and unrealized gain (loss)

      (2.00 )       0.32       3.01 (d)        (2.04 )       (0.03 )       (1.77 )       (1.99 )       0.29       3.01 (d)        (2.01 )       (0.06 )       (1.74 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (1.35 )       1.68       4.95       (0.51 )       1.74       0.03       (1.34 )       1.68       4.96       (0.48 )       1.74       0.06
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.38 )       (2.05 )       (1.97 )       (1.95 )       (2.58 )       (1.74 )       (0.38 )       (2.06 )       (1.99 )       (1.98 )       (2.58 )       (1.77 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.38 )       (2.05 )       (1.97 )       (1.95 )       (2.58 )       (1.74 )       (0.38 )       (2.06 )       (1.99 )       (1.98 )       (2.58 )       (1.77 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 26.89     $ 28.62     $ 28.99     $ 26.01     $ 28.47     $ 29.31     $ 26.85     $ 28.57     $ 28.95     $ 25.98     $ 28.44     $ 29.28
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

      (4.75 )%**       5.81 %       19.47 %       (1.77 )%       6.03 %       0.27 %       (4.71 )%**       5.83 %       19.50 %       (1.73 )%       6.07 %       0.33 %

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 1,223,580     $ 1,273,188     $ 1,067,086     $ 827,667     $ 746,182     $ 582,639     $ 2,559,834     $ 2,862,977     $ 3,018,159     $ 3,099,809     $ 3,262,104     $ 2,465,331

Net operating expenses to average daily net assets(f)

      0.53 %*       0.53 %       0.54 %       0.54 %       0.56 %       0.56 %(g)       0.48 %*       0.48 %       0.49 %       0.49 %       0.51 %       0.51 %(g)

Interest and/or dividend expenses to average daily net assets(h)

      0.01 %       0.00 %(i)             0.00 %(i)                   0.01 %       0.00 %(i)             0.00 %(i)            

Total net expenses to average daily net assets(f)

      0.54 %*       0.53 %       0.54 %       0.54 %       0.56 %       0.56 %(g)       0.49 %*       0.48 %       0.49 %       0.49 %       0.51 %       0.51 %(g)

Net investment income (loss) to average daily net assets(b)

      4.59 %*       4.57 %       6.76 %       5.58 %       5.86 %(j)       5.99 %       4.63 %*       4.67 %       6.81 %       5.60 %       5.93 %(j)       6.02 %

Portfolio turnover rate

      9 %(k)**       34 %(k)       21 %(k)       20 %       18 %       27 %       9 %(k)**       34 %(k)       21 %(k)       20 %       18 %       27 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:(l)

      0.00 %*(i)       0.00 %(i)       0.00 %(i)       0.00 %(i)       0.00 %(i)             0.00 %*(i)       0.00 %(i)       0.00 %(i)       0.00 %(i)       0.00 %(i)      

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.01     $ 0.03     $ 0.04 (a)      $ 0.04 (a)      $ 0.06 (a)      $ 0.05 (a)      $ 0.01     $ 0.03     $ 0.04 (a)      $ 0.04 (a)      $ 0.06 (a)      $ 0.05 (a) 

 

(a) 

Per share amounts were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

Includes income per share of $0.06 and $0.09, respectively, as a result of litigation on certain sovereign debt. Excluding this income, the Fund’s net investment income per share would have been $1.71 and $1.71, respectively. These per share amounts have been adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(d) 

Includes realized gain per share of $0.23 and $0.23, respectively, as a result of litigation on Argentinian sovereign debt. Excluding this income, the Fund’s realized gain per share would have been $2.78 and $2.78, respectively.

(e) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(f) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(g) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(h) 

Interest expense incurred as a result of entering into reverse repurchase agreements and/or margin on cleared swap contracts, if any, is included in the Fund’s net expenses. Income earned on investing proceeds from reverse repurchase agreements, if any, is included in interest income.

(i) 

Ratio is less than 0.01%.

(j) 

Includes income of $0.24 and $0.24, respectively, of average daily net assets as a result of litigation on certain sovereign debt. Excluding this income, the Fund’s net investment income to average daily net assets would have been 5.62% and 5.69%, respectively.

(k) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 9%, 33% and 23%, respectively, of the average value of its portfolio.

(l) 

Ratios include indirect fees waived or borne by GMO.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

50   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout the period)

 

 

HIGH YIELD FUND

 

     Class VI Shares
     Period from
June 25, 2018
(commencement
of operations)
through
August 31, 2018
(Unaudited)

Net asset value, beginning of period

     $ 20.00
    

 

 

 

Income (loss) from investment operations:

    

Net investment income (loss)(a)

       0.08

Net realized and unrealized gain (loss)

       0.32
    

 

 

 

Total from investment operations

       0.40
    

 

 

 

Net asset value, end of period

     $ 20.40
    

 

 

 

Total Return(b)

       2.00 %**

Ratios/Supplemental Data:

    

Net assets, end of period (000’s)

     $ 218,717

Net operating expenses to average daily net assets(c)

       0.51 %*

Interest and/or dividend expenses to average daily net assets(d)

       0.05 %*

Total net expenses to average daily net assets(c)

       0.56 %*

Net investment income (loss) to average daily net assets(a)

       2.09 %*

Portfolio turnover rate(e)

       17 %**

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.36 %*
(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

Interest expense incurred as a result of entering into reverse repurchase agreements and/or margin on cleared swap contracts, if any, is included in the Fund’s net expenses. Income earned on investing proceeds from reverse repurchase agreements, if any, is included in interest income.

(e) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018, including transactions in USTF, was 32% of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

 

  See accompanying notes to the financial statements.   51


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

OPPORTUNISTIC INCOME FUND

 

     Class VI Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015(a)   2014(a)(b)

Net asset value, beginning of period

     $ 26.41     $ 25.78     $ 24.57     $ 24.80     $ 24.22     $ 24.22
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(c)

       0.50       1.15       0.96       0.53       0.54       0.84

Net realized and unrealized gain (loss)

       0.03       0.18       0.89       (0.34 )       0.42       0.14
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       0.53       1.33       1.85       0.19       0.96       0.98
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.23 )       (0.70 )       (0.64 )       (0.42 )       (0.38 )       (0.56 )

From net realized gains

                                     (0.42 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.23 )       (0.70 )       (0.64 )       (0.42 )       (0.38 )       (0.98 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 26.71     $ 26.41     $ 25.78     $ 24.57 (d)      $ 24.80     $ 24.22
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(e)

       2.00 %**       5.18 %       7.62 %       0.77 %       3.98 %       4.27 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 1,082,902     $ 1,205,954     $ 1,510,894     $ 1,648,019     $ 1,790,805     $ 2,111,080

Net operating expenses to average daily net assets(f)

       0.47 %*       0.47 %       0.33 %       0.31 %       0.31 %       0.31 %(g)

Interest and/or dividend expenses to average daily net assets(i)

       0.00 %*(h)       0.00 %(h)       0.00 %(h)       0.00 %(h)       0.00 %(h)      

Total net expenses to average daily net assets(f)

       0.47 %*       0.47 %       0.33 %       0.31 %       0.31 %       0.31 %(g)

Net investment income (loss) to average daily net assets(c)

       3.72 %*       4.39 %       3.82 %       2.13 %       2.18 %       3.51 %

Portfolio turnover rate

       48 %**(j)       152 %(j)       66 %(j)       66 %       37 %       30 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.04 %       0.03 %       0.04 %       0.03 %       0.03 %       0.02 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):

     $ 0.03     $ 0.04     $ 0.03     $ 0.04     $ 0.03     $ 0.05

 

(a) 

Per share amounts were adjusted to reflect a 1:7 reverse stock split effective May 15, 2014.

(b) 

Effective February 12, 2014, GMO Debt Opportunities Fund (the “Acquired Fund”) merged into GMO Short-Duration Collateral Fund (the “Acquiring Fund”) and the surviving entity was renamed GMO Debt Opportunities Fund. For accounting and financial reporting purposes, the Acquired Fund is the surviving entity, meaning the combined entity adopted the historical financial reporting history of the Acquired Fund. Share and per share information have been adjusted to reflect the effects of the merger.

(c) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(d) 

Beginning December 21, 2015 the pricing source for certain fixed income assets of the Fund changed, which resulted in an increase in the December 21, 2015 net asset value of the Fund by $0.04 per share.

(e) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(f) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(g) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(h) 

Ratio is less than 0.01%.

(i) 

Interest expense incurred as a result of entering into reverse repurchase agreements and/or margin on cleared swap contracts, if any, is included in the Fund’s net expenses. Income earned on investing proceeds from reverse repurchase agreements, if any, is included in interest income.

(j) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 57%, 175% and 75%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

52   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

U.S. TREASURY FUND

 

     Core Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

     $ 24.97     $ 25.00     $ 25.00     $ 25.00     $ 25.00     $ 25.00
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)

       0.23       0.26       0.12       0.04       0.01       0.02

Net realized and unrealized gain (loss)

       0.01       (0.03 )       0.01       0.00       0.00 (a)        0.01
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       0.24       0.23       0.13       0.04       0.01       0.03
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.23 )       (0.26 )       (0.12 )       (0.03 )       (0.01 )       (0.02 )

From net realized gains

                   (0.01 )       (0.01 )       (0.00 )(b)       (0.01 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.23 )       (0.26 )       (0.13 )       (0.04 )       (0.01 )       (0.03 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 24.98     $ 24.97     $ 25.00     $ 25.00     $ 25.00     $ 25.00
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

       1.00 %**       0.96 %       0.54 %       0.19 %       0.06 %       0.11 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 829,183     $ 2,324,706     $ 2,666,697     $ 4,033,504     $ 2,243,931     $ 1,909,864

Net expenses to average daily net assets

       0.00 %(d)*       0.00 %(d)       0.00 %(d)       0.00 %(d)       0.00 %(d)       0.00 %(d)(e)

Net investment income (loss) to average daily net assets

       1.85 %*       1.06 %       0.47 %       0.16 %       0.05 %       0.08 %

Portfolio turnover rate(f)

       0 %**       0 %       0 %       0 %       0 %       0 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.09 %*       0.09 %       0.10 %       0.10 %       0.10 %       0.10 %

 

(a) 

Net realized and unrealized gain (loss) was less than $0.01 per share.

(b) 

Distributions from net realized gains were less than $0.01 per share.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Ratio is less than 0.01%.

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f) 

Portfolio turnover rate calculation excludes short-term investments.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   53


GMO Trust Funds

 

Notes to Financial Statements

August 31, 2018 (Unaudited)

 

 

1.

Organization

Each of Asset Allocation Bond Fund, Core Plus Bond Fund, Emerging Country Debt Fund, High Yield Fund (commenced operations on June 25, 2018), Opportunistic Income Fund and U.S. Treasury Fund (each a “Fund” and collectively the “Funds”) is a series of GMO Trust (the “Trust”). The Trust is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust was established as a Massachusetts business trust under the laws of The Commonwealth of Massachusetts on June 24, 1985. The Declaration of Trust permits the Trustees of the Trust (“Trustees”) to create an unlimited number of series of shares (Funds) and to subdivide Funds into classes. The Funds are advised and managed by Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”).

The Funds may invest in GMO U.S. Treasury Fund and in money market funds unaffiliated with GMO.

Many of the Funds may invest without limitation in other GMO Funds (“underlying funds”). In particular, pursuant to an exemptive order granted by the Securities and Exchange Commission (“SEC”), some of the Funds may invest in Emerging Country Debt Fund, Opportunistic Income Fund and U.S. Treasury Fund. The financial statements of the underlying funds should be read in conjunction with the Funds’ financial statements. The financial statements are available without charge on the SEC’s website at www.sec.gov or on GMO’s website at www.gmo.com.

The following table provides information about the Funds’ principal investment objectives and benchmarks (if any):

 

     
Fund Name   Benchmark   Investment Objective
Asset Allocation Bond Fund   FTSE 3-Month Treasury Bill Index   Total return in excess of benchmark
Core Plus Bond Fund   Bloomberg Barclays U.S. Aggregate Index   Total return in excess of benchmark
Emerging Country Debt Fund   J.P. Morgan EMBI Global   Total return in excess of benchmark
High Yield Fund   Markit iBoxx USD Liquid High Yield Index   Total return in excess of benchmark
Opportunistic Income Fund   Not Applicable   Capital appreciation and current income
U.S. Treasury Fund   Not Applicable   Liquidity and safety of principal with current income as a secondary objective

Asset Allocation Bond Fund and U.S. Treasury Fund currently limit subscriptions.

Emerging Country Debt Fund is currently distributed in Switzerland. The distribution of shares in Switzerland will be exclusively made to, and directed at, qualified investors as defined in the Swiss Collective Investment Schemes Act of 23 June 2006, as amended, and its implementing ordinance.

 

2.

Significant accounting policies

The following is a summary of significant accounting policies followed by each Fund in the preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and have been consistently followed by the Funds in preparing these financial statements. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates. The accounting records of the Funds are maintained in U.S. dollars.

Portfolio valuation

Typically, the Funds and the underlying funds value fixed income securities at the most recent price supplied by a pricing source determined by GMO. GMO evaluates pricing sources on an ongoing basis and may change a pricing source at any time. GMO monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another source) when it believes that the price supplied is not reliable. Alternative pricing sources are often but not always available for securities held by the Funds and the underlying funds. See the table below for information about securities for which no alternative pricing source was available.

 

54


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Exchange-traded securities (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price or (iii) most recent quoted price published by the exchange (if no reported last sale or official closing price) or (iv) the quoted price provided by a pricing source (in the event GMO deems the private market to be a more reliable indicator of market value than the exchange). Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within that range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. Cleared derivatives are valued using the price quoted (which may be based on a model) by the relevant clearing house. If an updated quote for a cleared derivative is not available when a Fund calculates its net asset value, the derivative will generally be valued using an industry standard model, which may differ from the model used by the relevant clearing house. Over-the-counter (“OTC”) derivatives are generally valued at the price determined by an industry standard model. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Shares of the underlying funds and other open-end registered investment companies are valued at their most recent net asset value. If quotations are not readily available or circumstances make an existing valuation methodology or procedure unreliable, derivatives and other securities are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Because of the uncertainty inherent in pricing, and in particular fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See the table below for information about securities and derivatives, if any, that were fair valued using methods determined in good faith by or at the direction of the Trustees. The Funds and/or the underlying funds classify such securities as Level 3 (levels defined below). For the period ended August 31, 2018, the Funds did not reduce the value of any of their OTC derivatives contracts, if any, based on the creditworthiness of their counterparties. See Note 4 “Derivative financial instruments” for a further discussion on valuation of derivatives.

The foregoing valuation methodologies are modified for equities that trade in non-U.S. securities markets that close before the close of the New York Stock Exchange (“NYSE”) due to time zone differences, including the value of equities that underlie futures, options and other derivatives (to the extent the market for those derivatives closes prior to the close of the NYSE). In those cases, the price will generally be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees that are intended to reflect valuation changes through the NYSE close. The table below shows the percentage of the net assets of the Funds, held either directly or through investments in the underlying funds, if any, that were valued using fair value inputs obtained from that independent pricing service as of August 31, 2018. These securities listed on foreign exchanges (including the value of equity securities that underlie futures, options and other derivatives (to the extent the market for such instruments closes prior to the close of the NYSE)) are classified as Level 2 (levels defined below) in the table below.

“Quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If a market quotation for a security does not involve a bid or an ask, the “quoted price” may be the price provided by a market participant or other third-party pricing source in accordance with the market practice for that security. If an updated quoted price for a security is not available when a Fund calculates its net asset value, the Fund will generally use the last quoted price so long as GMO believes that the last quoted price continues to represent that security’s fair value.

In the case of derivatives, prices determined by a model may reflect an estimate of the average of bid and ask prices, regardless of whether a Fund has a long position or a short position.

As discussed above, certain of the Funds and underlying funds invest in securities and/or derivatives which may have been fair valued using methods determined in good faith by or at the direction of the Trustees or valued using prices for which no alternative pricing source was available. The table below presents securities and/or derivatives on a net basis, based on market values or unrealized

 

55


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

appreciation/(depreciation), which will tend to understate the Funds’ exposure. The net aggregate direct and indirect exposure to these valuation methodologies (based on each Fund’s net assets) as of August 31, 2018 is as follows:

Securities and derivatives

 

     
Fund Name   Fair valued using
methods determined in
good faith by or at the
direction of the Trustees
    Single source; No
alternative pricing
source was available
 

Asset Allocation Bond Fund

           

Core Plus Bond Fund

    < 1%       3%  

Emerging Country Debt Fund

    1% †      3%  

Opportunistic Income Fund

    1% ‡      11%  

High Yield Fund

           

U.S. Treasury Fund

           

 

 

Includes the Republic of Albania Par Bond, due 08/31/25 which represents 1.0% of the Fund’s total net assets and is valued by applying a 140 basis point spread to the yield of the U.S. Treasury Strip Principal, due 08/15/25.

 

Consists of four U.S. Agency for International Development Floater Bonds which were valued using current LIBOR yield and adjusted by 125 basis points for liquidity considerations.

U.S. GAAP requires the Funds to disclose the fair value of their investments in a three-level hierarchy (Levels 1, 2 and 3). The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Funds’ investments. The inputs or methodologies used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers into or out of an investment’s assigned level within the fair value hierarchy. In addition, in periods of market dislocation, the observability of prices and inputs may be reduced for many instruments. This condition, as well as changes related to the liquidity of investments, could cause a security to be reclassified between levels.

U.S. GAAP requires additional disclosures about fair value measurements for material Level 3 securities and derivatives, if any (determined by each category of asset or liability as compared to a Fund’s total net assets separately identified in the table below). Other than Funds with investments valued using unadjusted prices supplied by a third-party pricing source (e.g., broker quotes, vendor) or as described in the footnotes to the Securities and derivatives table above, there were no other Funds with classes of investments or derivatives with direct material Level 3 holdings at August 31, 2018.

The three levels are defined as follows:

Level 1 – Valuations based on quoted prices for identical securities in active markets.

The types of assets and liabilities categorized in Level 1 generally include actively traded domestic and certain foreign equity securities; certain U.S. government obligations; derivatives actively traded on a national securities exchange (such as some futures and options); and shares of open-end mutual funds (even if their investments are valued using Level 2 or Level 3 inputs).

Level 2 – Valuations determined using other significant direct or indirect observable inputs.

The types of assets and liabilities categorized in Level 2 generally include certain U.S. government agency securities, mortgage-backed securities, asset-backed securities, certain sovereign debt obligations, and corporate bonds valued using vendor prices or broker quotes; cleared derivatives and certain OTC derivatives such as swaps, options, swaptions, and forward currency contracts valued using industry standard models; certain restricted securities valued at the most recent available market or quoted price; certain debt obligations, such as collateralized loan obligations, that have yet to begin trading that are valued at cost; and certain foreign equity securities that are adjusted based on inputs from an independent pricing service approved by the Trustees, including the value of equity securities that underlie futures, options and other derivatives (to the extent the market for such instruments closes prior to the close of the NYSE) to reflect estimated valuation changes through the NYSE close.

 

56


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Level 3 – Valuations based primarily on inputs that are unobservable and significant.

The types of assets and liabilities categorized in Level 3 generally include, but are not limited to, certain debt securities (such as asset-backed, mortgage-backed, loans and sovereign debt) and derivatives even though they are valued using broker quotes; certain debt securities and derivatives adjusted by a specified discount for liquidity or other considerations; certain sovereign debt securities valued using comparable securities issued by the sovereign adjusted by a specified spread; securities whose trading has been suspended or that have been de-listed from their current primary trading exchange valued at the most recent available market or quoted price; securities in default or bankruptcy proceedings for which there is no current market quotation valued at the most recent available market or quoted price; potential litigation recoveries and interests related to bankruptcy proceedings; and third-party investment funds where valuations are provided by fund sponsors and which are adjusted for liquidity considerations as well as the timing of the receipt of information.

The following is a summary of the respective levels assigned to the Funds’ direct securities and derivatives, if any, as of August 31, 2018:

 

         
Description   Level 1     Level 2     Level 3     Total  

Asset Allocation Bond Fund

         

Asset Valuation Inputs

         

Debt Obligations

         

U.S. Government

  $ 29,000,503     $ 344,726,153     $     $ 373,726,656  

U.S. Government Agency

    32,990,857                   32,990,857  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

    61,991,360       344,726,153             406,717,513  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

    21,380,716                   21,380,716  

Short-Term Investments

    1,516,027       15,139,938             16,655,965  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    84,888,103       359,866,091             444,754,194  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          1,401,890             1,401,890  

Swap Contracts

         

Interest Rate Risk

          1,393,506             1,393,506  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 84,888,103     $ 362,661,487     $     $ 447,549,590  
   

 

 

   

 

 

   

 

 

   

 

 

 
           

Liability Valuation Inputs

         

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

  $     $ (1,592,903   $     $ (1,592,903

Swap Contracts

         

Interest Rate Risk

          (1,162,900           (1,162,900
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (2,755,803   $     $ (2,755,803
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Core Plus Bond Fund

         

Asset Valuation Inputs

         

Debt Obligations

         

Asset-Backed Securities

  $     $ 22,352,281     $     $ 22,352,281  

U.S. Government

    221,960,856                   221,960,856  

U.S. Government Agency

          119,369,200             119,369,200  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

    221,960,856       141,721,481             363,682,337  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

    330,989,270                   330,989,270  

Short-Term Investments

    3,349,336       149,976,381             153,325,717  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    556,299,462       291,697,862             847,997,324  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

57


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Core Plus Bond Fund (continued)

 

Asset Valuation Inputs (continued)

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

  $     $ 3,639,627     $     $ 3,639,627  

Swap Contracts

         

Interest Rate Risk

          3,310,129             3,310,129  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 556,299,462     $ 298,647,618     $     $ 854,947,080  
   

 

 

   

 

 

   

 

 

   

 

 

 
           

Liability Valuation Inputs

         

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

  $     $ (3,123,863   $     $ (3,123,863

Futures Contracts

         

Interest Rate Risk

    (164,626                 (164,626

Swap Contracts

         

Interest Rate Risk

          (2,672,313           (2,672,313
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (164,626   $ (5,796,176   $     $ (5,960,802
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Emerging Country Debt Fund

         

Asset Valuation Inputs

         

Debt Obligations

         

Asset-Backed Securities

  $     $ 43,232,627     $     $ 43,232,627  

Corporate Debt

          5,530,373       26,456,738       31,987,111  

Foreign Government Agency

          723,586,093       131,093,111       854,679,204  

Foreign Government Obligations

          1,744,741,656       119,648,802       1,864,390,458  

U.S. Government

    490,572,252       76,288,589             566,860,841  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

    490,572,252       2,593,379,338       277,198,651       3,361,150,241  
   

 

 

   

 

 

   

 

 

   

 

 

 

Loan Assignments

                8,244,656       8,244,656  

Loan Participations

                50,837,131       50,837,131  

Mutual Funds

    96,381,706                   96,381,706  

Rights/Warrants

          27,261,111       3,648,061       30,909,172  

Short-Term Investments

    199,272,570                   199,272,570  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    786,226,528       2,620,640,449       339,928,499       3,746,795,476  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          725,596             725,596  

Options

         

Credit Risk

                131,894       131,894  

Swap Contracts

         

Credit Risk

          23,842,924             23,842,924  

Interest Rate Risk

          8,557,154             8,557,154  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 786,226,528     $ 2,653,766,123     $ 340,060,393     $ 3,780,053,044  
   

 

 

   

 

 

   

 

 

   

 

 

 
           

Liability Valuation Inputs

         

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

  $     $ (170,564   $     $ (170,564

Options

         

Credit Risk

                (3,200,781     (3,200,781

Swap Contracts

         

Credit Risk

          (21,610,400           (21,610,400

Interest Rate Risk

          (1,461,779           (1,461,779
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (23,242,743   $ (3,200,781   $ (26,443,524
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

58


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

High Yield Fund

         

Asset Valuation Inputs

         

Debt Obligations

         

Corporate Debt

  $     $ 54,803,817     $     $ 54,803,817  

U.S. Government

    36,051,017                   36,051,017  

U.S. Government Agency

    74,322,816                   74,322,816  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

    110,373,833       54,803,817             165,177,650  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

    1,316,876                   1,316,876  

Short-Term Investments

    57,470       46,742,639             46,800,109  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    111,748,179       101,546,456             213,294,635  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          251,719             251,719  

Futures Contracts

         

Interest Rate Risk

    25,666                   25,666  

Swap Contracts

         

Credit Risk

          5,794,651             5,794,651  

Interest Rate Risk

          295,012             295,012  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 111,773,845     $ 107,887,838     $     $ 219,661,683  
   

 

 

   

 

 

   

 

 

   

 

 

 
           

Liability Valuation Inputs

         

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

  $     $ (37,492   $     $ (37,492
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (37,492   $     $ (37,492
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Opportunistic Income Fund

         

Asset Valuation Inputs

         

Debt Obligations

         

Asset-Backed Securities

  $     $ 916,122,182     $ 35,665,610     $ 951,787,792  

U.S. Government

    2,800,409                   2,800,409  

U.S. Government Agency

                15,891,462       15,891,462  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

    2,800,409       916,122,182       51,557,072       970,479,663  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

    48,776,146                   48,776,146  

Short-Term Investments

    7,129,966       29,978,268             37,108,234  

Purchased Options

          260,612             260,612  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    58,706,521       946,361,062       51,557,072       1,056,624,655  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Futures Contracts

         

Interest Rate Risk

    56,636                   56,636  

Swap Contracts

         

Credit Risk

          28,553,429             28,553,429  

Interest Rate Risk

          3,415,647             3,415,647  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 58,763,157     $ 978,330,138     $ 51,557,072     $ 1,088,650,367  
   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Valuation Inputs

         

Derivatives^

         

Futures Contracts

         

Interest Rate Risk

  $ (4,442   $     $     $ (4,442

Written Options

         

Credit Risk

          (52,410           (52,410

Swap Contracts

         

Credit Risk

          (7,706,062           (7,706,062

Interest Rate Risk

          (418,941           (418,941
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (4,442   $ (8,177,413   $     $ (8,181,855
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

59


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

U.S. Treasury Fund

         

Asset Valuation Inputs

         

Short-Term Investments

  $ 800,659,758     $ 47,000,628     $     $ 847,660,386  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    800,659,758       47,000,628             847,660,386  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 800,659,758     $ 47,000,628     $     $ 847,660,386  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

The risks referenced in the tables above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.

 

  ^

The tables above are based on market values or unrealized appreciation/(depreciation), in the case of forward currency contracts, rather than the notional amounts of derivatives. The uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Funds’ net asset values than the uncertainties surrounding inputs for a non-derivative security with the same market value. Excludes purchased options and rights/warrants, if any, which are included in investments.

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs of the underlying funds, please refer to the underlying funds’ summary of levels above.

For all Funds for the period ended August 31, 2018, there were no significant transfers between Level 1 and Level 2.

The following is a reconciliation of securities and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 

                     
     Balances
as of
February 28,
2018
    Purchases     Sales    

Accrued

Discounts/

Premiums

   

Total
Realized

Gain/
(Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Transfer

into

Level 3†

    Transfer
out of
Level 3†
    Balances
as of
August 31,
2018
   

Net Change in
Unrealized
Appreciation
(Depreciation)
from

Investments
Still Held as

of August 31,
2018

 
Emerging Country Debt Fund                                                            
Debt Obligations                      

Corporate Debt

  $ 26,126,080     $     $     $ (711 )   $     $ 331,369     $     $     $ 26,456,738     $ 331,369  

Foreign Government Agency

    134,381,263                   788,504             (4,076,656                 131,093,111       (4,076,656

Foreign Government Obligations

    123,199,974             (3,206,336     2,257,459             (2,602,295                 119,648,802       (2,602,295
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Debt Obligations

    283,707,317             (3,206,336     3,045,252             (6,347,582                 277,198,651       (6,347,582
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loan Assignments

    1,110,398       7,300,000       (224,630     7,443             51,445                   8,244,656       51,445  

Loan Participations

    59,670,207             (5,496,530     1,061,483             (4,398,029                 50,837,131       (4,398,029

Rights/Warrants

    6,474,227                               (2,826,166                 3,648,061       (2,826,166
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    350,962,149       7,300,000       (8,927,496     4,114,178             (13,520,332                 339,928,499       (13,520,332
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
Derivatives                      

Options

    (912,233           (70,000           1,124,194       (3,210,848                 (3,068,887     (1,751,774
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 350,049,916     $ 7,300,000     $ (8,997,496 )#    $ 4,114,178     $ 1,124,194   $ (16,731,180 )   $     $     $ 336,859,612     $ (15,272,106
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 

 

60


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

                     
     Balances
as of
February 28,
2018
    Purchases     Sales    

Accrued

Discounts/

Premiums

   

Total
Realized

Gain/
(Loss)

   

Change in

Unrealized

Appreciation

(Depreciation)

   

Transfer

into

Level 3†

    Transfer
out of
Level 3†
    Balances
as of
August 31,
2018
   

Net Change in
Unrealized
Appreciation
(Depreciation)
from

Investments
Still Held as

of August 31,
2018

 
Opportunistic Income Fund                                                            
Debt Obligations                      

Asset-Backed Securities

  $ 37,555,550     $     $ (2,019,705   $ 91,828     $     $ 37,937     $     $     $ 35,665,610     $ 37,937  

U.S. Government Agency

    17,123,540             (1,318,639     16,997             69,564                   15,891,462       69,564  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 54,679,090     $     $ (3,338,344 )##    $ 108,825     $     $ 107,501     $     $     $ 51,557,072     $ 107,501  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 

 

 

The Funds account for securities and derivatives, if any, transferred into and out of Level 3 at the value at the end of the period.

  #

Includes $8,927,495 of proceeds received from principal paydowns.

  ##

Includes $3,338,344 of proceeds received from principal paydowns.

The net aggregate direct and indirect exposure to investments in securities and/or derivatives using Level 3 inputs and presented on a net basis, which will tend to understate the Funds’ exposure, (based on each Fund’s net assets) as of August 31, 2018 were as follows:

 

   
Fund Name   Level 3 securities
and derivatives
 

Asset Allocation Bond Fund

     

Core Plus Bond Fund

    2%  

Emerging Country Debt Fund

    9%  

High Yield Fund

     

Opportunistic Income Fund

    5%  

U.S. Treasury Fund

     

Cash

Cash and foreign currency, if any, in the Statements of Assets and Liabilities consist of cash balances held with the custodian.

Due to/from broker

Due to/from broker in the Statements of Assets and Liabilities includes collateral on swap contracts, futures contracts, option contracts and forward currency contracts, if any, and may include marked-to-market amounts related to foreign currency or cash owed.

Foreign currency translation

The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm Eastern time. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated in the Statements of Operations from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.

Indexed investments

Each Fund may invest in various transactions and instruments that are designed to track the performance of an index (including, but not limited to, securities indices and credit default indices). Indexed securities are securities the redemption values and/or coupons of

 

61


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

which are indexed to a specific instrument, group of instruments, index, or other statistic. Indexed securities typically, but not always, are debt securities or deposits whose value at maturity or coupon rate is determined by reference to other securities, securities or inflation indices, currencies, precious metals or other commodities, or other financial indicators. For example, the maturity value of gold-indexed securities depends on the price of gold and, therefore, their price tends to rise and fall with gold prices.

Loan assignments and participations

The Funds (except U.S. Treasury Fund) may invest in direct debt instruments, which are interests in amounts owed to lenders or lending syndicates, to suppliers of goods or services, or to other parties by corporate, governmental or other borrower. Such “loans” may include bank loans, promissory notes, and loan participations, or in the case of suppliers of goods or services, trade claims or other receivables. A loan is often administered by a bank or other financial institution that acts as agent for all holders. The agent administers the terms of the loan, as specified in the loan agreement. Unless, under the terms of the loan or other indebtedness a Fund has direct recourse against the borrower, it may have to rely on the agent to enforce its rights against the borrower. When investing in a loan participation, (i) a Fund has the right to receive payments of principal, interest and any fees to which it is entitled only from the party from whom the Fund has purchased the participation and only upon receipt by that party of payments from the borrower and (ii) a Fund generally has no right to enforce compliance by the borrower with the terms of the loan agreement or to vote on matters arising under the loan agreement. Thus, a Fund may be subject to credit risk both of the party from whom it purchased the loan participation and the borrower and that Fund may have minimal control over the terms of any loan modification. Loan assignments and participations outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Repurchase agreements

The Funds may enter into repurchase agreements with banks and brokers. Under a repurchase agreement a Fund acquires a security for a relatively short period for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired may be less than the amount owed to the Fund by the seller. If the seller in a repurchase agreement transaction defaults or enters into insolvency proceedings and the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and, even if the Fund is able to dispose of the securities, the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. As of August 31, 2018, the Funds listed below had entered into repurchase agreements. The value of related collateral for each broker listed below exceeds the value of the repurchase agreements at period end. Repurchase agreements outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

 

         
Fund Name   Counterparty     Gross Value     Net Value (with
related collateral)
    Weighted Average
Maturity (days)
 

Opportunistic Income Fund

    Barclays Bank plc       $29,978,268       $30,581,994       4.0  

U.S. Treasury Fund

    Barclays Bank plc       $47,000,628       $47,947,163       4.0  

Reverse repurchase agreements

The Funds may enter into reverse repurchase agreements with banks and brokers to enhance return. Under a reverse repurchase agreement a Fund sells portfolio assets subject to an agreement by that Fund to repurchase the same assets at an agreed upon price and date. A Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result may realize a loss on the transaction if the securities it sold are worth more than the purchase price it originally received from the buyer. As of August 31, 2018, the Funds listed below had entered into reverse repurchase agreements.

 

     
Fund Name   Received from
reverse repurchase
agreements ($)
    Market value of
securities plus
accrued interest ($)
 

Emerging Country Debt Fund

    $36,933,066       $35,548,608  

As of August 31, 2018, Emerging Country Debt Fund had investments in reverse repurchase agreements with JP Morgan Securities, Inc. with a gross value of $36,933,066. The value of related collateral on reverse repurchase agreements exceeded the value at period end. As of August 31, 2018, the reverse repurchase agreements held by Emerging Country Debt Fund had open maturity dates.

 

62


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Reverse repurchase agreements outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

The following is a summary of the gross value of reverse repurchase agreements categorized by class of collateral pledged and maturity date:

 

     
           August 31, 2018  
   
           Remaining Contractual Maturity of the Agreements  
   
     Overnight and
Continuous
   

Up to

30 days

    Between
30-90 days
    Greater Than
90 days
    Demand     Total  

Emerging Country Debt Fund

             

Reverse Repurchase Agreements

             

Non-U.S. Government Debt Obligations

  $     $     $     $     $ 36,933,066     $ 36,933,066  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total borrowings

  $     $     $     $     $ 36,933,066     $ 36,933,066  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

Inflation-indexed bonds

The Funds may invest in inflation-indexed bonds. Inflation-indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation/deflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that accrues inflation/deflation into the principal value of the bond. Many other issuers adjust the coupon accruals for inflation related changes. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.

The market price of inflation-indexed bonds normally changes when real interest rates change. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e., nominal interest rate minus inflation) might decline, leading to an increase in value of inflation-indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation-indexed bonds. Coupon payments received by a Fund from inflation-indexed bonds are generally included in the Fund’s gross income for the period in which they accrue. In addition, any increase/decrease in the principal amount of an inflation-indexed bond is generally included in the Fund’s gross income even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Delayed delivery commitments and when-issued securities

The Funds (except U.S. Treasury Fund) may purchase or sell securities on a when-issued or forward commitment basis. Payment and delivery may take place a month or more after the date of the transaction. The price of the underlying securities and the date when the securities will be delivered and paid for are fixed at the time the transaction is negotiated. The purchase of when-issued or delayed delivery securities can cause a Fund’s portfolio to be leveraged. Investments in when-issued securities also present the risk that the security will not be issued or delivered. Delayed delivery commitments outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Short sales

Certain Funds may enter into short sales transactions. A short sale is a transaction in which a Fund sells securities it may not own in anticipation of a decline in the fair market value of the securities. Securities sold in short sale transactions and the interest payable on such securities, if any, are reflected as a liability in the Statements of Assets and Liabilities. A Fund is obligated to deliver securities at the trade price at the time the short position is closed. Possible losses from short sales may be unlimited, whereas losses from purchases cannot exceed the total amount invested. Short sales outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Taxes and distributions

Each Fund has elected to be treated or intends to elect to be treated and intends to qualify each tax year as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). Each Fund intends to distribute its net investment income, if any, and its net realized short-term and long-term capital gains, if any, after giving effect to any available

 

63


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

capital loss carryforwards for U.S. federal income tax purposes. Therefore, each Fund makes no provision for U.S. federal income or excise taxes.

With the exception of U.S. Treasury Fund, the policy of each Fund is to declare and pay dividends of its net investment income, if any, at least annually, although the Funds are permitted to, and will from time to time, declare and pay dividends of net investment income, if any, more frequently. The policy of U.S. Treasury Fund is to declare dividends daily, to the extent net investment income is available. U.S. Treasury Fund will generally pay dividends on the first business day following the end of each month in which dividends were declared. Accrued dividends in respect of a shareholder’s partial redemption of U.S. Treasury Fund shares redeemed between monthly payment dates will be paid on the first business day following the end of the month in which redemptions are made. Accrued dividends in respect of a shareholder’s complete redemption of U.S. Treasury Fund shares between monthly payment dates will be paid with the redemption proceeds. Each Fund also intends to distribute net realized short-term and long-term capital gains, if any, at least annually. In addition, each Fund may, from time to time at their discretion, make unscheduled distributions in advance of large redemptions by shareholders or as otherwise deemed appropriate by a Fund. Typically, all distributions are reinvested in additional shares of each Fund, at net asset value, unless GMO or its agents receive and process a shareholder election to receive cash distributions. Distributions to shareholders are recorded by each Fund on the ex-dividend date.

Taxes on foreign interest and dividend income are generally withheld in accordance with the applicable country’s tax treaty with the United States. The foreign withholding rates applicable to a Fund’s investments in certain jurisdictions may be higher if a significant portion of the Fund is held by non-U.S. shareholders. Each Fund may be subject to taxation on realized capital gains, repatriation proceeds and other transaction-based charges imposed by certain countries in which it invests. Transaction-based charges are generally calculated as a percentage of the transaction amount. Taxes related to capital gains realized during the period ended August 31, 2018, if any, are reflected as part of Net realized gain (loss) in the Statements of Operations. Changes in tax liabilities related to capital gain taxes on unrealized investment gains, if any, are reflected as part of Change in net unrealized appreciation (depreciation) in the Statements of Operations.

Income and capital gain distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP. Certain capital accounts in the financial statements are periodically adjusted for permanent differences in order to reflect their tax character. These adjustments have no impact on net assets or net asset value per share. Temporary differences that arise from recognizing certain items of income, expense, gain or loss in different periods for financial statement and tax purposes will likely reverse at some time in the future. Distributions in excess of net investment income or net realized gains are temporary over-distributions for financial statement purposes resulting from differences in the recognition or classification of income or distributions for financial statement and tax purposes.

Distributions in excess of a Fund’s tax basis earnings and profits, if significant, are reported in the Funds’ financial statements as a return of capital.

As of February 28, 2018, certain Funds elected to defer to March 1, 2018 post-October capital losses. The Funds’ loss deferrals are as follows:

 

   
Fund Name   Post-October
Capital Losses ($)
 
Asset Allocation Bond Fund     (1,850,864)  
Core Plus Bond Fund     (5,029,797)  
Emerging Country Debt Fund     (980,792)  
High Yield Fund     N/A  
Opportunistic Income Fund     (1,668,698)  
U.S. Treasury Fund     (586,886)  

As of February 28, 2018, certain Funds had capital loss carryforwards available to offset future realized gains, if any, to the extent permitted by the Code. Net capital losses recognized in taxable years beginning on or after March 1, 2011 are carried forward without expiration and generally retain their short-term and/or long-term tax character, as applicable. In addition, such losses should be utilized prior to losses scheduled to expire on or before February 28, 2019. As a result of this ordering rule, losses that are subject to

 

64


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

expiration may expire unused. Utilization of the capital loss carryforwards, post-October capital losses, late-year ordinary losses, and losses realized subsequent to February 28, 2018, if any, could be subject to further limitations imposed by the Code related to share ownership activity. The Funds’ capital loss carryforwards are as follows:

 

       
     Short-Term ($)           Long-Term ($)  
         
Fund Name   Expiration
Date
2/28/2019
    No
Expiration
Date
    Total
Short-
Term ($)
    No
Expiration
Date
 
Asset Allocation Bond Fund           (24,215,916)       (24,215,916)       (36,964,291)  
Core Plus Bond Fund           (291,118)       (291,118)       (27,549,806)  
Emerging Country Debt Fund     (66,474,254)       (47,525,714)       (113,999,968)        
High Yield Fund                        
Opportunistic Income Fund                       (101,703,005)  
U.S. Treasury Fund           (739,977)       (739,977)        

As of August 31, 2018, the approximate total cost, aggregate investment-level gross/net unrealized appreciation (depreciation) in the value of total investments (including total securities sold short, if any), and the net unrealized appreciation (depreciation) of outstanding financial instruments for U.S. federal income tax purposes were as follows:

 

     
     Total Investments     Outstanding
Financial
Instruments
 
           
Fund Name   Aggregate
Cost ($)
    Gross Unrealized
Appreciation ($)
    Gross Unrealized
(Depreciation) ($)
    Net Unrealized
Appreciation
(Depreciation) ($)
    Net Unrealized
Appreciation
(Depreciation) ($)
 
Asset Allocation Bond Fund     449,115,206       254,523       (4,615,535)       (4,361,012)       53,190  
Core Plus Bond Fund     857,481,228       4,827,620       (14,311,524)       (9,483,904)       968,725  
Emerging Country Debt Fund     4,119,824,523       215,171,756       (588,200,803)       (373,029,047)       (22,693,045)  
High Yield Fund     212,669,038       921,606       (296,009)       625,597       823,391  
Opportunistic Income Fund     1,044,637,825       29,885,632       (17,898,802)       11,986,830       (7,896,934)  
U.S. Treasury Fund     847,611,357       115,526       (66,497)       49,029        

The Funds are subject to authoritative guidance related to the accounting and disclosure of uncertain tax positions under U.S. GAAP. This guidance sets forth a minimum threshold for the financial statement recognition of tax positions taken based on the technical merits of such positions. United States and non-U.S. tax rules (including the interpretation and application of tax laws) are subject to change. The Funds file tax returns and/or adopt certain tax positions in various jurisdictions. Non-U.S. taxes are provided for based on the Funds’ understanding of the prevailing tax rules of the non-U.S. markets in which they invest. Recently enacted tax rules, including interpretations of tax laws and tax legislation/initiatives currently under consideration in various jurisdictions, including the U.S., might affect the way the Funds and their investors are taxed prospectively and/or retroactively. Prior to the expiration of the relevant statutes of limitations, if any, the Funds are subject to examination by U.S. federal, state, local and non-U.S. jurisdictions with respect to the tax returns they have filed and the tax positions they have adopted. The Funds’ U.S. federal income tax returns are generally subject to examination by the Internal Revenue Service for a period of three years after they are filed. State, local and/or non-U.S. tax returns and/or other filings may be subject to examination for different periods, depending upon the tax rules of each applicable jurisdiction.

Security transactions and related investment income

Security transactions are accounted for in the financial statements on trade date. For purposes of daily net asset value calculations, the Funds’ policy is that security transactions are generally accounted for on the following business day. GMO may override that policy and a Fund may account for security transactions on trade date if it experiences significant purchases or redemptions or engages in significant portfolio transactions. Dividend income, net of applicable foreign withholding taxes, if any, is recorded on the ex-dividend

 

65


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

date or, if later, when a Fund is informed of the ex-dividend date. Income dividends and capital gain distributions from the underlying funds are recorded on the ex-dividend date. Interest income is recorded on the accrual basis and is adjusted for the amortization of premiums and accretion of discounts. Principal on inflation-indexed securities is adjusted for inflation and any increase or decrease is recorded as interest income or investment loss. Coupon income is not recognized on securities for which collection is not expected. Paydown gains and losses on mortgage-related and other asset-backed securities, if any, are recorded as components of interest income in the Statements of Operations. Non-cash dividends, if any, are recorded at the fair market value of the asset received. In determining the net gain or loss on securities sold, the Funds use the identified cost basis.

Expenses and class allocations

Most of the expenses of the Trust are directly attributable to an individual Fund. Generally, common expenses are allocated among the Funds based on, among other things, the nature and type of expense and the relative size of the Funds. Investment income, common expenses, purchase premiums and redemption fees, if any, and realized and unrealized gains and losses are allocated among the classes of shares of the Funds, if applicable, based on the relative net assets of each class. Shareholder service fees, if any, which are directly attributable to a class of shares, are charged to that class’s operations. In addition, the Funds may incur fees and expenses indirectly as a shareholder in the underlying funds. Because the underlying funds have different expense and fee levels and the Funds may own different proportions of the underlying funds at different times, the amount of fees and expenses indirectly incurred by a Fund will vary (see Note 5).

State Street Bank and Trust Company (“State Street”) serves as the Funds’ custodian, fund accounting agent and transfer agent. Prior to December 31, 2013, State Street’s transfer agent fees may have been reduced by an earnings allowance calculated on the average daily cash balances each Fund maintained in a State Street transfer agent account. Earnings allowances were reported as a reduction of expenses in the Statements of Operations. Effective January 1, 2014, any cash balances maintained at the transfer agent are held in a Demand Deposit Account and interest income earned, if any, is shown as interest income in the Statements of Operations. Any cash balances maintained at the custodian are held in a Demand Deposit Account and interest income earned, if any, is shown as interest income in the Statements of Operations.

Purchases and redemptions of Fund shares

Purchase premiums and redemption fees (if applicable) are paid to and retained by a Fund to help offset estimated portfolio transaction costs and other related costs (e.g., bid to ask spreads, stamp duties, and transfer fees) incurred by the Fund (directly or indirectly through investments in underlying funds) as a result of an investor’s purchase or redemption by allocating estimated transaction costs to the purchasing or redeeming shareholder. Such fees are recorded as a component of the Funds’ net share transactions. A Fund may impose a new purchase premium and redemption fee or modify an existing fee at any time.

Purchase premiums are not charged on reinvestments of dividends or other distributions. Redemption fees apply to all shares of a Fund regardless of how the shares were acquired (e.g., by direct purchase or by reinvestment of dividends or other distributions).

If GMO determines that any portion of a cash purchase or redemption, as applicable, is offset by a corresponding cash redemption or purchase occurring on the same day, it ordinarily will waive or reduce the purchase premium or redemption fee with respect to that portion.

GMO also may waive or reduce the purchase premium or redemption fee for a cash purchase or redemption of a Fund’s shares if the Fund will not incur transaction costs or will incur reduced transaction costs.

GMO also may reduce the purchase premium to the extent that securities are used to purchase a Fund’s shares (taking into account transaction costs, stamp duties or transfer fees). GMO may reduce redemption fees to the extent a Fund uses portfolio securities to redeem its shares (taking into account transaction costs, stamp duties or transfer fees).

 

66


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

As of August 31, 2018, the premium on cash purchases and the fee on cash redemptions were as follows:

 

             
     Asset Allocation Bond Fund   Core Plus Bond Fund   Emerging Country Debt Fund(1)   High Yield Fund   Opportunistic Income Fund   U.S. Treasury Fund
Purchase Premium       0.75%     0.40%  
Redemption Fee       0.75%     0.40%  

 

  (1) 

Prior to February 1, 2016, the premiums on purchases and the fee on redemptions were each 0.50% of the amount invested or redeemed.

Recently-issued accounting guidance

In March 2017, the Financial Accounting Standards Board (“FASB”) issued an amendment to U.S. GAAP, which amends the required amortization period for purchased callable debt securities that have been purchased at a premium. The scope of the amendment is limited to debt securities that have an explicit non-contingent call feature at a fixed price on a preset date or dates. The amendment requires that the aforementioned premium on such debt securities shall be amortized through the next call date, whereas current U.S. GAAP requires amortization through the maturity date of the security. This amendment does not apply to debt securities purchased at a discount and is effective for fiscal years beginning after December 15, 2018. GMO is currently evaluating the impact, if any, of this guidance on the Fund’s financial statements and disclosures.

 

3.

Investment and other risks

The following chart identifies selected risks associated with each Fund. Risks not marked for a particular Fund may, however, still apply to some extent to that Fund at various times.

 

             
     Asset Allocation Bond Fund   Core Plus Bond Fund   Emerging Country Debt Fund   High Yield Fund   Opportunistic Income Fund   U.S. Treasury Fund
Commodities Risk   X                    
Counterparty Risk   X   X   X   X   X   X
Credit Risk   X   X   X   X   X   X
Currency Risk   X   X   X   X   X    
Derivatives and Short Sales Risk   X   X   X   X   X    
Focused Investment Risk   X   X   X   X   X    
Fund of Funds Risk   X   X   X   X   X    
Futures Contracts Risk       X       X   X    
Illiquidity Risk   X   X   X   X   X    
Large Shareholder Risk   X   X   X   X   X   X
Leveraging Risk   X   X   X   X   X    

 

67


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

             
     Asset Allocation Bond Fund   Core Plus Bond Fund   Emerging Country Debt Fund   High Yield Fund   Opportunistic Income Fund   U.S. Treasury Fund
Management and Operational Risk   X   X   X   X   X   X
Market Disruption and Geopolitical Risk   X   X   X   X   X   X
Market Risk – Asset-Backed Securities   X   X   X       X    
Market Risk – Equities   X               X    
Market Risk – Fixed Income   X   X   X   X   X   X
Non-Diversified Funds   X   X   X   X   X    
Non-U.S. Investment Risk   X   X   X   X   X    
Small Company Risk   X   X           X    

Investing in mutual funds involves many risks. The risks of investing in a particular Fund depend on the types of investments in its portfolio and the investment strategies GMO employs on its behalf. This section does not describe every potential risk of investing in the Funds. Funds could be subject to additional risks because of the types of investments they make and market conditions, which may change over time.

Each Fund that invests in other GMO Funds or other investment companies (collectively, “Underlying Funds”) is exposed to the risks to which the Underlying Funds in which it invests are exposed, as well as the risk that the Underlying Funds will not perform as expected. Therefore, unless otherwise noted, the selected risks summarized below include both direct and indirect risks, and references in this section to investments made by a Fund include those made both directly by the Fund and indirectly by the Fund through Underlying Funds.

An investment in a Fund is not a bank deposit and, therefore, is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.

 COMMODITIES RISK. Commodity prices can be extremely volatile and are affected by many factors. Exposure to commodities can cause the value of a Fund’s shares to decline or fluctuate in a rapid and unpredictable manner. The value of commodity-related derivatives or indirect investments in commodities may fluctuate more than the commodity, commodities or commodity index to which they relate. See “Derivatives and Short Sales Risk” for a discussion of specific risks of a Fund’s derivatives investments, including commodity-related derivatives.

 COUNTERPARTY RISK. Funds that enter into contracts with counterparties, such as repurchase or reverse repurchase agreements or OTC derivatives contracts, or that lend their securities run the risk that the counterparty will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. If a counterparty fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, the Fund could miss investment opportunities or otherwise be forced to hold investments it would prefer to sell, resulting in losses for the Fund. In addition, a Fund may suffer losses if a counterparty fails to comply with applicable laws, regulations or other requirements. The Funds are not subject to any limit on their exposure to any one counterparty nor to a requirement that counterparties with whom they enter into contracts maintain a specific rating by a nationally recognized rating organization. Counterparty risk is pronounced during unusually adverse market conditions and is particularly acute in environments in which financial services firms are exposed (as they were in 2008) to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions.

Participants in OTC derivatives markets typically are not subject to the same level of credit evaluation and regulatory oversight as are members of exchange-based markets, and, therefore, OTC derivatives generally expose a Fund to greater counterparty risk than exchange-traded derivatives. A Fund is subject to the risk that a counterparty will not settle a derivative in accordance with its terms

 

68


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem. If a counterparty’s obligation to a Fund is not collateralized, then the Fund is essentially an unsecured creditor of the counterparty. If a counterparty defaults, the Fund will have contractual remedies (whether or not the obligation is collateralized), but the Fund may be unable to enforce them, thus causing the Fund to suffer a loss. Counterparty risk is greater for derivatives with longer maturities because of the longer time during which events may occur that prevent settlement. Counterparty risk also is greater when a Fund has entered into derivatives contracts with a single or small group of counterparties as it sometimes does as a result of its use of swaps and other OTC derivatives. Funds that use swap contracts are subject, in particular, to the creditworthiness of the counterparties because some types of swap contracts have terms longer than six months (and, in some cases, decades). The creditworthiness of a counterparty may be adversely affected by greater than average volatility in the markets, even if the counterparty’s net market exposure is small relative to its capital. Counterparty risk still exists even if a counterparty’s obligations are secured by collateral because the Fund’s interest in the collateral may not be perfected or additional collateral may not be posted promptly as required. GMO’s view with respect to a particular counterparty is subject to change. The fact, however, that it changes adversely (whether due to external events or otherwise) does not mean that a Fund’s existing transactions with that counterparty will necessarily be terminated or modified. In addition, a Fund may enter into new transactions with a counterparty that GMO no longer considers a desirable counterparty (for example, re-establishing the transaction with a lower notional amount or entering into a countervailing trade with the same counterparty). Counterparty risk also will be greater if a counterparty’s obligations exceed the value of the collateral held by the Fund (if any).

The Funds also are subject to counterparty risk because they execute their securities transactions through brokers and dealers. If a broker or dealer fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, the Funds could miss investment opportunities or be unable to dispose of investments they would prefer to sell, resulting in losses for the Funds. Counterparty risk with respect to derivatives has been and will continue to be affected by new rules and regulations relating to the derivatives market. As described under “Derivatives and Short Sales Risk,” some derivatives transactions are required to be centrally cleared, and a party to a cleared derivatives transaction is subject to the credit risk of the clearing house and the clearing member through which it holds its cleared position. Credit risk of market participants with respect to derivatives that are centrally cleared is concentrated in a few clearing houses, and it is not clear how an insolvency proceeding of a clearing house would be conducted and what impact an insolvency of a clearing house would have on the financial system. Also, in the event of a counterparty’s (or its affiliate’s) insolvency, the possibility exists that the Funds’ ability to exercise remedies, such as the termination of transactions, netting of obligations or realization on collateral, could be stayed or eliminated under new special resolution regimes adopted in the United States, the European Union and various other jurisdictions. Such regimes provide governmental authorities with broad authority to intervene when a financial institution is experiencing financial difficulty. In particular, in the European Union, governmental authorities could reduce, eliminate, or convert to equity the liabilities to the Funds of a counterparty experiencing financial difficulties (sometimes referred to as a “bail in”).

 CREDIT RISK. This is the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner. The market price of a fixed income investment will normally decline as a result (and/or in anticipation) of the issuer’s, guarantor’s, or obligor’s failure to meet its payment obligations, or a downgrading of the credit rating of the investment. This risk is particularly acute in environments in which financial services firms are exposed (as they were in 2008) to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. Fixed income investments also are subject to illiquidity risk. See “Illiquidity Risk.”

All fixed income investments are subject to credit risk. Financial strength and solvency of an issuer are the primary factors influencing credit risk. The risk varies depending upon whether the issuer is a corporation, a government or government entity, whether the particular security has a priority over other obligations of the issuer in payment of principal and interest and whether it has any collateral backing or credit enhancement. Credit risk may change over the term of a fixed income investment. U.S. government securities are subject to varying degrees of credit risk depending upon whether the securities are supported by the full faith and credit of the United States, supported by the ability to borrow from the U.S. Treasury, supported only by the credit of the issuing U.S. government agency, instrumentality, or corporation, or otherwise supported by the United States. For example, issuers of many types of U.S. government securities (e.g., the Federal Home Loan Mortgage Corporation (“Freddie Mac”), Federal National Mortgage Association (“Fannie Mae”), and Federal Home Loan Banks), although chartered or sponsored by Congress, are not funded by Congressional appropriations and their fixed income securities, including mortgage-backed and other asset-backed securities, are neither guaranteed nor insured by the U.S. government. These securities are subject to more credit risk than U.S. government

 

69


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

securities that are supported by the full faith and credit of the United States (e.g., U.S. Treasury bonds). Investments in sovereign or quasi-sovereign debt involve the risk that the governmental entities responsible for repayment may be unable or unwilling to pay interest and repay principal when due. A governmental entity’s ability and willingness to pay interest and repay principal in a timely manner may be affected by a variety of factors, including its cash flow, the size of its reserves, its access to foreign exchange, the relative size of its debt service burden to its economy as a whole, and political constraints. Investments in quasi-sovereign issuers are subject to the additional risk that the issuer may default independently of its sovereign. Sovereign debt risk is greater for fixed income securities issued or guaranteed by emerging countries.

In many cases, the credit risk and market price of a fixed income investment are reflected in its credit ratings, and a Fund holding a rated investment is subject to the risk that the investment’s rating will be downgraded, resulting in a decrease in the market price of the fixed income investment.

Securities issued by the U.S. government historically have presented minimal credit risk. However, events in 2011 led several major rating agencies to downgrade the long-term credit rating of U.S. bonds and introduced greater uncertainty about the repayment by the United States of its obligations. A further credit rating downgrade could decrease, and a default in the payment of principal or interest on U.S. government securities would decrease, the market price of a Fund’s investments and increase the volatility of a Fund’s portfolio.

As described under “Market Risk — Asset-Backed Securities,” asset-backed securities may be backed by many types of assets and their payment of interest and repayment of principal largely depend on the cash flows generated by the assets backing them. The credit risk of a particular asset-backed security depends on many factors, as described under “Market Risk — Asset-Backed Securities.” The obligations of issuers also may be subject to bankruptcy, insolvency and other laws affecting the rights and remedies of creditors.

A Fund also is exposed to credit risk on a reference security to the extent it writes protection under credit default swaps. See “Derivatives and Short Sales Risk” for more information regarding risks associated with the use of credit default swaps.

The extent to which the market price of a fixed income investment changes in response to a credit event depends on many factors and can be difficult to predict. For example, even though the effective duration of a long-term floating rate security is very short, an adverse credit event or change in the perceived creditworthiness of its issuer could cause its market price to decline much more than its effective duration would suggest.

Credit risk is particularly pronounced for below investment grade investments (commonly referred to as “junk bonds”). The sovereign debt of many non-U.S. governments, including their sub-divisions and instrumentalities, is below investment grade. Many asset-backed securities also are below investment grade. Below investment grade investments have speculative characteristics, often are less liquid than higher quality investments, present a greater risk of default and are more susceptible to real or perceived adverse industry conditions. Investments in distressed or defaulted or other low quality debt investments generally are considered speculative and may involve substantial risks not normally associated with investments in higher quality investments, including adverse business, financial or economic conditions that lead to payment defaults and insolvency proceedings on the part of their issuers. In particular, distressed or defaulted obligations might be repaid, if at all, only after lengthy workout or bankruptcy proceedings, during which the issuer does not make any interest or other payments and a Fund incurs additional expenses in seeking recovery. If GMO’s assessment of the eventual recovery value of a distressed or defaulted debt investment proves incorrect, a Fund may lose a substantial portion or all of its investment or may be required to accept cash or instruments worth less than its original investment. In the event of a default of sovereign debt, the Funds may be unable to pursue legal action against the issuer.

 CURRENCY RISK. Currency risk is the risk that fluctuations in exchange rates will adversely affect the market value of a Fund’s investments. Currency risk includes the risk that the currencies in which a Fund’s investments are traded, in which a Fund receives income, or in which a Fund has taken a position will decline in value. Currency risk also includes the risk that the currency to which the Fund has obtained exposure through hedging declines in value relative to the currency being hedged, in which event the Fund may realize a loss on both the hedging instrument and the currency being hedged. Currency exchange rates can fluctuate significantly for many reasons. See “Market Disruption and Geopolitical Risk.”

Many of the Funds use derivatives to take currency positions that are under- or over-weighted (in some cases significantly) relative to the currency exposure of their portfolios and their benchmarks. If the exchange rates of the currencies involved do not move as

 

70


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

expected, a Fund could lose money on both its holdings of a particular currency and the derivative. See also “Non-U.S. Investment Risk.”

Some currencies are illiquid (e.g., some emerging country currencies), and a Fund may not be able to convert them into U.S. dollars or may only be able to do so at an unfavorable exchange rate. Exchange rates for many currencies are affected by exchange control regulations.

Derivative transactions in foreign currencies (such as futures, forwards, options and swaps) may involve leveraging risk in addition to currency risk, as described under “Leveraging Risk.” In addition, the obligations of counterparties in currency derivative transactions are often not secured by collateral, which increases counterparty risk (see “Counterparty Risk”).

 DERIVATIVES AND SHORT SALES RISK. All of the Funds may invest in derivatives, which are financial contracts whose value depends on, or is derived from, the value of underlying assets, such as securities, commodities or currencies, reference rates, such as interest rates, currency exchange rates, inflation rates, or indices. Derivatives involve the risk that their value may not change as expected relative to changes in the value of the assets, rates, or indices they are designed to track. Derivatives include, but are not limited to, futures contracts, forward contracts, foreign currency contracts, swap contracts, contracts for differences, options on securities and indices, options on futures contracts, options on swap contracts, interest rate caps, floors and collars, reverse repurchase agreements, and other OTC contracts.

The use of derivatives involves risks that are potentially greater than, the risks of investing directly in securities. In particular, a Fund’s use of OTC derivatives exposes it to the risk that the counterparties will be unable or unwilling to make timely settlement payments or otherwise honor their obligations. An OTC derivatives contract typically can be closed, or the position transferred, only with the consent of the other party to the contract. If the counterparty defaults, the Fund will still have contractual remedies but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund, and if it does, the Fund may decide not to pursue its claims against the counterparty to avoid the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments GMO believes are owed to the Fund under an OTC derivatives contract, or those payments may be delayed or made only after the Fund has incurred the cost of litigation.

A Fund may invest in derivatives that (i) do not require the counterparty to post collateral (e.g., foreign currency forwards), (ii) require collateral but that do not provide for the Fund’s security interest in it to be perfected, (iii) require a significant upfront deposit by the Fund unrelated to the derivative’s fundamental fair (or intrinsic) value, or (iv) do not require that collateral be regularly marked-to-market. When a counterparty’s obligations are not fully secured by collateral, a Fund runs a greater risk of not being able to recover what it is owed if the counterparty defaults. Derivatives also present other risks described in this section, including market risk, illiquidity risk, currency risk, credit risk, and counterparty risk.

Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used may not produce valuations that are consistent with the values a Fund realizes when it closes or sells an OTC derivative. Valuation risk is more pronounced when a Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, inaccurate valuations may result in increased cash payments to counterparties, under-collateralization and/or errors in the calculation of a Fund’s net asset value.

A Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the cost of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of a Fund, the Funds will not be permitted to trade with that counterparty.

Swap contracts and other OTC derivatives are highly susceptible to illiquidity risk (see “Illiquidity Risk”) and counterparty risk (see “Counterparty Risk”). These derivatives also are subject to documentation risk, which is the risk that ambiguities, inconsistencies or errors in the documentation relating to a derivative transaction may lead to a dispute with the counterparty or unintended investment results. In addition, see “Commodities Risk” for a discussion of risks specific to commodity-related derivatives. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. See “Leveraging Risk.”

 

71


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

A Fund’s use of derivatives may be subject to special tax rules and could generate additional taxable income for shareholders. In addition, the tax treatment of a Fund’s use of derivatives will sometimes be unclear.

The SEC has proposed a rule under the 1940 Act, regulating the use by registered investment companies of derivatives and many related instruments. That rule, if adopted as proposed, would, among other things, restrict a Fund’s ability to engage in derivatives transactions or so increase the cost of derivatives transactions that a Fund would be unable to implement its investment strategy.

Derivatives Regulation. The U.S. government has enacted legislation that provides for new regulation of the derivatives market, including clearing, margin, reporting, and registration requirements. The European Union (and some other countries) have adopted similar requirements, which affect a Fund when it enters into a derivatives transaction with a counterparty subject to those requirements. Because these U.S. and European Union requirements are new and evolving (and some of the rules are not yet final), their impact on the Funds remains unclear.

Transactions in some types of swaps (including interest rate swaps and credit default swaps on North American and European indices) are required to be centrally cleared. In a transaction involving those swaps (“cleared derivatives”), a Fund’s counterparty is a clearing house rather than a bank or broker. Since the Funds are not members of clearing houses and only members of a clearing house (“clearing members”) can participate directly in the clearing house, the Funds hold cleared derivatives through accounts at clearing members. In cleared derivatives positions, the Funds make payments (including margin payments) to and receive payments from a clearing house through their accounts at clearing members. Clearing members guarantee performance of their clients’ obligations to the clearing house.

In some ways, cleared derivative arrangements are less favorable to mutual funds than bilateral arrangements, for example, by requiring that funds provide more margin for their cleared derivatives positions. Also, as a general matter, in contrast to a bilateral derivatives position, following a period of notice to a Fund, a clearing member at any time can require termination of an existing cleared derivatives position or an increase in the margin required at the outset of a transaction. Clearing houses also have broad rights to increase the margin required for existing positions or to terminate those positions at any time. Any increase in margin requirements or termination of existing cleared derivatives positions by the clearing member or the clearing house could interfere with the ability of a Fund to pursue its investment strategy. Further, any increase in margin requirements by a clearing member could expose a Fund to greater credit risk to its clearing member because margin for cleared derivatives positions in excess of a clearing house’s margin requirements typically is held by the clearing member (see “Counterparty Risk”). Also, a Fund is subject to risk if it enters into a derivatives transaction that is required to be cleared (or that GMO expects to be cleared), and no clearing member is willing or able to clear the transaction on the Fund’s behalf. While the documentation in place between the Funds and their clearing members generally provides that the clearing members will accept for clearing all cleared derivatives transactions that are within credit limits (specified in advance) for each Fund, the Funds are still subject to the risk that no clearing member will be willing or able to clear a transaction. In those cases, the position might have to be terminated, and the Fund could lose some or all of the benefit of the position, including loss of an increase in the value of the position and loss of hedging protection. In addition, the documentation governing the relationship between the Funds and clearing members is drafted by the clearing members and generally is less favorable to the Funds than the documentation for typical bilateral derivatives. For example, documentation relating to cleared derivatives generally includes a one-way indemnity by the Funds in favor of the clearing member for losses the clearing member incurs as the Funds’ clearing member. Also, such documentation typically does not provide the Funds any remedies if the clearing member defaults or becomes insolvent. While futures contracts entail similar risks, the risks may be more pronounced for cleared derivatives due to their more limited liquidity and market history.

Some types of cleared derivatives are required to be executed on an exchange or on a swap execution facility. A swap execution facility is a trading platform where multiple market participants can execute derivatives by accepting bids and offers made by multiple other participants in the platform. While this execution requirement is designed to increase transparency and liquidity in the cleared derivatives market, trading on a swap execution facility can create additional costs and risks for the Funds. For example, swap execution facilities typically charge fees, and if a Fund executes derivatives on a swap execution facility through a broker intermediary, the intermediary may impose fees as well. Also, a Fund may be required to indemnify a swap execution facility, or a broker intermediary who executes cleared derivatives on a swap execution facility on the Fund’s behalf, against any losses or costs that may be incurred as a result of the Fund’s transactions on the swap execution facility.

If a Fund wishes to execute a package of transactions that include a swap that is required to be executed on a swap execution facility as well as other transactions (for example, a transaction that includes both a security and an interest rate swap that hedges interest rate

 

72


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

exposure with respect to such security), the Fund may be unable to execute all components of the package on the swap execution facility. In that case, the Fund would need to trade some components of the package on the swap execution facility and other components in another manner, which could subject the Fund to the risk that some components would be executed successfully and others would not, or that the components would be executed at different times, leaving the Fund with an unhedged position for a period of time.

The U.S. government and the European Union have adopted mandatory minimum margin requirements for bilateral derivatives. New variation margin requirements became effective in March 2017 and new initial margin requirements will become effective in 2020. Such requirements could increase the amount of margin a Fund needs to provide in connection with its derivatives transactions and, therefore, make derivatives transactions more expensive.

These and other new rules and regulations could, among other things, further restrict a Fund’s ability to engage in, or increase the cost to the Fund of, derivatives transactions, for example, by making some types of derivatives no longer available to the Fund or otherwise limiting liquidity. The implementation of the clearing requirement has increased the cost of derivatives transactions for the Funds, since the Funds have to pay fees to their clearing members and are typically required to post more margin for cleared derivatives than they historically posted for bilateral derivatives. The cost of derivatives transactions is expected to increase further as clearing members raise their fees to cover the cost of additional capital requirements and other regulatory changes applicable to the clearing members. These rules and regulations are new and evolving, and, therefore, their potential impact on the Funds and the financial system are not yet known. While the new rules and regulations and central clearing of some derivatives transactions are designed to reduce systemic risk (i.e., the risk that the interdependence of large derivatives dealers could cause them to suffer liquidity, solvency or other challenges simultaneously), there is no assurance that they will achieve that result, and in the meantime, as noted above, central clearing and related requirements expose the Funds to new kinds of costs and risks.

Options. Some Funds are permitted to write options. The market price of an option is affected by many factors, including changes in the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant stock market and underlying securities. The market price of an option also may be adversely affected if the market for the option becomes less liquid. In addition, since an American-style option allows the holder to exercise its rights any time before the option’s expiration, the writer of an American-style option has no control over when it will be required to fulfill its obligations as a writer of the option. (The writer of a European-style option is not subject to this risk because the holder may only exercise the option on its expiration date.) If a Fund writes a call option and does not hold the underlying security or instrument, the Fund’s potential loss is theoretically unlimited.

National securities exchanges generally have established limits on the maximum number of options an investor or group of investors acting in concert may write. A Fund, GMO, and other funds advised by GMO likely constitute such a group. When applicable, these limits restrict a Fund’s ability to purchase or write options on a particular security.

Unlike exchange-traded options, which are standardized with respect to the underlying instrument, expiration date, contract size, and strike price, the terms of OTC options (i.e., options not traded on exchanges) generally are established through negotiation with the other party to the option contract. While a Fund has greater flexibility to tailor an OTC option, OTC options generally expose a Fund to greater credit risk than exchange-traded options, which are guaranteed by the clearing organization of the exchanges where they are traded. Purchasing and writing put and call options are highly specialized activities and entail greater than ordinary market risks.

Special tax rules apply to a Fund’s transactions in options, which could increase the taxes payable by shareholders subject to U.S. income taxation. In particular, a Fund’s options transactions potentially could cause a substantial portion of the Fund’s distributions to be taxable at ordinary income tax rates. See the Funds’ Prospectus and Statement of Additional Information for more information.

Short Investment Exposure. Some Funds may sell securities or currencies short as part of their investment programs in an attempt to increase their returns or for hedging purposes. Short sales expose a Fund to the risk that it will be required to acquire, convert, or exchange a security or currency to replace the borrowed security or currency when the security or currency sold short has appreciated in value, thus resulting in a loss to the Fund. Purchasing a security or currency to close out a short position can itself cause the price of the security or currency to rise further, thereby exacerbating any losses. A Fund that sells short a security or currency it does not own typically pays borrowing fees to a broker and is required to pay the broker any dividends or interest it receives on a borrowed security.

 

73


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

A Fund also may create short investment exposure by taking a derivative position in which the value of the derivative moves in the opposite direction from the price of an underlying asset, pool of assets, rate, currency or index.

Short sales of securities or currencies a Fund does not own and “short” derivative positions involve forms of investment leverage, and the amount of the Fund’s potential loss is theoretically unlimited. A Fund is subject to increased leveraging risk and other investment risks described in this “Investment and other risks” section to the extent it sells short securities or currencies it does not own or takes “short” derivative positions.

 FOCUSED INVESTMENT RISK. Funds with investments that are focused in a limited number of asset classes, sectors, industries, issuers, currencies, countries, or regions (or in sectors within a country or region) that are subject to the same or similar risk factors and funds with investments whose prices are closely correlated are subject to greater overall risk than funds with investments that are more diversified or whose prices are not as closely correlated.

A Fund that invests in the securities of a small number of issuers has greater exposure to adverse developments affecting those issuers and to a decline in the market price of those issuers’ securities than Funds investing in the securities of a larger number of issuers. Securities, sectors, or companies that share common characteristics are often subject to similar business risks and regulatory burdens, and often react similarly to specific economic, market, political or other developments.

Similarly, Funds having a significant portion of their assets in investments tied economically (or related) to a particular geographic region, country or market (e.g., emerging markets), or to sectors within a region, country, or market (e.g., Russian oil) have more exposure to regional and country economic risks than funds making investments throughout the world. The political and economic prospects of one country or group of countries within the same geographic region may affect other countries in that region, and a recession, debt crisis or decline in the value of the currency of one country can spread to other countries. Furthermore, companies in a particular geographic region or country are vulnerable to events affecting other companies in that region or country because they often share common characteristics, are exposed to similar business risks and regulatory burdens, and react similarly to specific economic, market, political or other developments. See also “Non-U.S. Investment Risk.”

 FUND OF FUNDS RISK. Funds that invest in Underlying Funds (including underlying GMO Funds) are exposed to the risk that the Underlying Funds will not perform as expected. The Funds also are indirectly exposed to all of the risks to which the Underlying Funds are exposed.

Absent reimbursement, a Fund bears the fees and expenses of an Underlying Fund (including purchase premiums and redemption fees, if any) in which it invests, and may incur additional expenses when investing in an Underlying Fund. In addition, total Fund expenses will increase if a Fund makes a new or further investment in Underlying Funds with higher fees or expenses than the average fees and expenses of the Underlying Funds then in the Fund’s portfolio.

In addition, to the extent a Fund invests in shares of underlying GMO Funds, it is indirectly subject to Large Shareholder Risk when an underlying GMO Fund has large shareholders (e.g., other GMO Funds). See “Large Shareholder Risk.”

At any particular time, one Underlying Fund may be purchasing securities of an issuer whose securities are being sold by another Underlying Fund, resulting in a Fund that holds each Underlying Fund indirectly incurring the costs associated with the two transactions without changing its exposure to those securities.

Investments in exchange-traded funds (“ETFs”) involve the risk that an ETF’s performance may not track the performance of the index it is designed to track. In addition, ETFs often use derivatives to track the performance of an index, and, therefore, investments in those ETFs are subject to the same derivatives risks discussed in “Derivatives and Short Sales Risk.” ETFs are investment companies that typically hold a portfolio of securities designed to track the price, performance, and dividend yield of a particular securities market index (or sector of an index). As investment companies, ETFs incur their own management and other fees and expenses, such as trustee fees, operating expenses, registration fees, and marketing expenses, and a Fund that invests in ETFs will bear a proportionate share of such fees and expenses. As a result, an investment by a Fund in an ETF could lead to higher operating expenses and lower returns than if the Fund were to invest directly in the securities underlying the ETF.

A Fund’s investments in one or more Underlying Funds could affect the amount, timing and character of its distributions and could cause the Fund to recognize taxable income in excess of the cash generated by such investments, requiring the Fund in turn to liquidate investments at disadvantageous times to generate cash needed to make required distributions.

 

74


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 FUTURES CONTRACTS RISK. The risk of loss to a Fund resulting from its use of futures contracts (or “futures”) is potentially unlimited. Futures markets are highly volatile, and the use of futures contracts may increase the volatility of the Fund’s net asset value. A Fund’s ability to establish and close out positions in futures contracts is subject to the development and maintenance of a liquid secondary market. A liquid secondary market may not exist for any particular futures contract at any particular time, and a Fund might be unable to effect closing transactions to terminate its exposure to the contract. In using futures contracts, a Fund relies on GMO’s ability to predict market and price movements correctly. The skills needed to use futures contracts successfully are different from those needed for traditional portfolio management. If a Fund uses futures contracts for hedging purposes, it runs the risk that changes in the prices of the contracts will not correlate perfectly with changes in the securities, index, or other asset underlying the contracts or movements in the prices of the Fund’s investments that are the subject of the hedge.

A Fund typically will be required to post margin with its futures commission merchant in connection with its positions in futures contracts. If the Fund has insufficient cash to meet margin requirements, the Fund may have to sell other investments at disadvantageous times. A Fund may be unable to reenter or may be delayed in recovering margin or other amounts deposited with a futures commission merchant or futures clearinghouse. For example, should the futures commission merchant become insolvent, a Fund may be unable to recover all (or any) of the margin it has deposited or realize the value of any increase in the price of its positions.

The Commodity Futures Trading Commission (the “CFTC”) and the various exchanges have established limits (referred to as “speculative position limits”) on the maximum net long or net short positions that any person and certain of its affiliated entities may hold or control in a particular futures contract. In addition, an exchange may impose trading limits on the number of contracts a person may trade on a particular day. An exchange may order the liquidation of positions found to be in violation of these limits, and it may impose sanctions or restrictions. In addition, the Dodd-Frank Wall Street Reform and Consumer Protection Act requires the CFTC to establish speculative position limits on listed futures and economically equivalent OTC derivatives, and those limits may adversely affect the market liquidity of those futures and derivatives. As a result of such limits, positions held by other GMO clients or by GMO or its affiliates may prevent GMO from taking positions on behalf of a Fund in a particular futures contract or OTC derivative.

Futures contracts traded on markets outside the United States generally are not subject to regulation by the CFTC or other U.S. regulators. U.S. regulators neither regulate the activities of a foreign exchange nor have the power to compel enforcement of the rules of a foreign exchange or the laws of the country where the exchange is located. Margin and other payments made by a Fund in foreign countries may not have the same protections as payments in the United States. In addition, foreign futures contracts may be less liquid and more volatile than U.S. contracts.

• ILLIQUIDITY RISK. Illiquidity risk is the risk that low trading volume, lack of a market maker, large position size, or legal restrictions (including daily price fluctuation limits or “circuit breakers”) limits, delays or prevents a Fund from selling particular securities or closing derivative positions at desirable prices. In addition to these risks, a Fund is exposed to illiquidity risk when it has an obligation to purchase particular securities (e.g., as a result of entering into reverse repurchase agreements, writing a put, or closing a short position). To the extent a Fund’s investments include asset-backed securities, distressed, defaulted or other low quality debt securities, emerging country debt or equity securities, securities of companies with smaller market capitalizations or smaller total float adjusted market capitalizations, or emerging market securities, it is subject to increased illiquidity risk. These types of investments can be difficult to value, exposing a Fund to the risk that the price at which it sells them will be less than the price at which they were valued when held by the Fund. Illiquidity risk also may be greater in times of financial stress. For example, Inflation-Protected Securities issued by the U.S. Treasury (“TIPS”) have experienced periods of greatly reduced liquidity during disruptions in fixed income markets, such as the events surrounding the bankruptcy of Lehman Brothers in 2008. Less liquid securities are more susceptible than other securities to price declines when market prices decline generally.

A Fund may buy securities or other investments that are less liquid than those in its benchmark. The more illiquid investments a Fund has, the greater the likelihood of its paying redemption proceeds in-kind.

Historically, the credit markets have experienced periods characterized by a significant lack of liquidity, and they may experience similar periods in the future. A lack of liquidity could require a Fund to sell securities to satisfy collateral posting requirements and meet redemptions, which could, in turn, create downward price pressure on the securities being sold.

A Fund’s ability to use options as part of its investment program depends on the liquidity of the options market. That market may not be liquid when a Fund seeks to close out an option position, and the hours of trading for options on an exchange may not conform to the hours during which the underlying securities are traded. To the extent that the options markets close before the markets for the

 

75


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

underlying securities, significant price and rate movements can take place in the markets for those securities that are not immediately reflected in the options markets. If a Fund receives a redemption request and is unable to close out an option it has sold, the Fund may temporarily be leveraged in relation to its assets.

 LARGE SHAREHOLDER RISK. To the extent a large number of shares of a Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy (e.g., GMO asset allocation accounts), the Fund is subject to the risk that a redemption by those shareholders of all or a large portion of their Fund shares will adversely affect the Fund’s performance by forcing the Fund to sell portfolio securities, potentially at disadvantageous prices, to raise the cash needed to satisfy the redemption request. In addition, the Funds and other accounts over which GMO has investment discretion that invest in the Funds are not limited in how often they may sell Fund shares. The Asset Allocation Funds and separate accounts managed by GMO for its clients hold substantial percentages of the outstanding shares of many Funds, and asset allocation decisions by GMO may result in substantial redemptions from (or investments in) those Funds. These transactions may adversely affect the Fund’s performance to the extent that the Fund is required to sell investments when it would not have otherwise done so. Redemptions of a large number of shares also may increase transaction costs or, by necessitating a sale of portfolio securities, have adverse tax consequences for Fund shareholders. Further, from time to time a Fund may trade in anticipation of a purchase or redemption order that ultimately is not received or differs in size from the actual order, leading to temporary underexposure or overexposure to the Fund’s intended investment program. In addition, redemptions and purchases of shares by a large shareholder or group of shareholders could limit the use of any capital loss carryforwards to offset future realized capital gains (if any) and other losses that would otherwise reduce distributable net investment income. In addition, large shareholders may limit or prevent a Fund’s use of equalization for U.S. federal tax purposes.

To the extent a Fund invests in other GMO Funds subject to large shareholder risk, the Fund is indirectly subject to this risk.

 LEVERAGING RISK. The use of traditional borrowing (including to meet redemption requests), reverse repurchase agreements and other derivatives and securities lending creates leverage (i.e., a Fund’s investment exposures exceed its net asset value). Leverage increases a Fund’s losses when the value of its investments (including derivatives) declines. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In the case of swaps, the risk of loss generally is related to a notional principal amount, even if the parties have not made any initial investment. Some derivatives, similar to short sales, have the potential for unlimited loss, regardless of the size of the initial investment. Similarly, a Fund’s portfolio will be leveraged and can incur losses if the value of the Fund’s assets declines between the time a redemption request is received or deemed to be received by a Fund (which in some cases may be the business day prior to actual receipt of the transaction activity by the Fund) and the time at which the Fund liquidates assets to meet redemption requests. Such a decline in the value of a Fund’s assets is more likely in the case of Funds managed from GMO’s non-U.S. offices for which the time period between the NAV determination and corresponding liquidation of assets could be longer due to time zone differences and market schedules. In the case of redemptions representing a significant portion of a Fund’s portfolio, the leverage effects described above can be significant and could expose a Fund and non-redeeming shareholders to material losses.

A Fund may manage some of its derivative positions by offsetting derivative positions against one another or against other assets. To the extent offsetting positions do not behave in relation to one another as expected, a Fund may perform as if it were leveraged.

Some Funds are permitted to purchase securities on margin or to sell securities short, either of which creates leverage. To the extent the market prices of securities pledged to counterparties to secure a Fund’s margin account or short sale decline, the Fund may be required to deposit additional funds with the counterparty to avoid having the pledged securities liquidated to compensate for the decline.

 MANAGEMENT AND OPERATIONAL RISK. Each Fund is subject to management risk because it relies on GMO to achieve its investment objective. Each Fund runs the risk that GMO’s investment techniques will fail to produce desired results and may cause the Fund to incur significant losses. GMO also may fail to use derivatives effectively, choosing to hedge or not to hedge positions at disadvantageous times.

For many Funds, GMO uses quantitative models as part of its investment process. GMO’s models may not accurately predict future market movements, or characteristics. In addition, they are based on assumptions that can limit their effectiveness, and they rely on data that is subject to limitations (e.g., inaccuracies, staleness) that could adversely affect their predictive value. The Funds also run the risk that GMO’s assessment of an investment (including a security’s fundamental fair (or intrinsic) value) is wrong.

 

76


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

GMO relies on quantitative models in making investment decisions. The usefulness of GMO’s models may be diminished by the faulty incorporation of mathematical models into computer code, by reliance on proprietary and third-party technology that includes errors, omissions, bugs, or viruses, and by the retrieval of limited or imperfect data for processing by the model. These risks are present in the ordinary course of business and are more likely to occur when GMO is making changes to its models. Any of these risks could adversely affect a Fund’s performance.

There can be no assurance that key GMO personnel will continue to be employed by GMO. The loss of their services could have an adverse impact on GMO’s ability to achieve the Funds’ investment objectives.

The Funds also are subject to a risk of loss resulting from other services provided by GMO and other service providers, including pricing, administrative, accounting, tax, legal, custody, transfer agency, and other services. Operational risk includes the possibility of loss caused by inadequate procedures and controls, human error, and system failures by a service provider. For example, trading delays or errors could prevent a Fund from benefiting from investment gains or avoiding losses. In addition, a service provider may be unable to provide a net asset value (“NAV”) for a Fund or share class on a timely basis. GMO is not contractually liable to the Funds for losses associated with operational risk absent its willful misfeasance, bad faith, gross negligence, or reckless disregard of its contractual obligations to provide services to the Funds. Other Fund service providers also have contractual limitations on their liability to the Funds for losses resulting from their errors.

The Funds and their service providers (including GMO) are susceptible to cyber-attacks and to technological malfunctions that may have effects similar to those of a cyber-attack. Cyber-attacks include, among others, stealing or corrupting data maintained online or digitally, preventing legitimate users from accessing information or services on a website, releasing confidential information without authorization, and disrupting operations. Successful cyber-attacks against, or security breakdowns of, a Fund, GMO, a sub-adviser, or a custodian, transfer agent, or other service provider may adversely affect the Fund or its shareholders. For instance, cyber-attacks may interfere with the processing of shareholder transactions, affect a Fund’s ability to calculate its net asset value, cause the release or misappropriation of private shareholder information or confidential Fund information, impede trading, cause reputational damage, and subject the Fund to regulatory fines, penalties or financial losses, and additional compliance costs. The Funds’ service providers regularly experience cyber-attacks and expect they will continue to do so. While GMO has established business continuity plans and systems designed to prevent, detect and respond to cyber-attacks, those plans and systems have inherent limitations. Similar types of cyber security risks also are present for issuers of securities in which the Funds invest, which could have material adverse consequences for those issuers and result in a decline in the market price of their securities. Furthermore, as a result of cyber-attacks, technological disruptions, malfunctions, or failures, an exchange or market may close or suspend trading in specific securities or the entire market, which could prevent the Funds from, among other things, buying or selling securities or accurately pricing their investments. The Funds cannot directly control cyber security plans and systems of their service providers, the Funds’ counterparties, issuers of securities in which the Funds invest, or securities markets and exchanges.

 MARKET DISRUPTION AND GEOPOLITICAL RISK. The Funds are subject to the risk that geopolitical and other events (e.g., wars and terrorism) will disrupt securities markets and adversely affect global economies and markets, thereby reducing the value of the Funds’ investments. Sudden or significant changes in the supply or prices of commodities or in other economic inputs (e.g., the marked decline in oil prices that began in late 2014) may have material and unexpected effects on both global securities markets and individual countries, regions, sectors, companies, or industries. Terrorism in the United States and around the world has increased geopolitical risk. The terrorist attacks on September 11, 2001 resulted in the closure of some U.S. securities markets for four days, and similar attacks are possible in the future. Securities markets may be susceptible to market manipulation or other fraudulent trading practices, which could disrupt their orderly functioning or reduce the prices of securities traded on them, including securities held by the Funds. Fraud and other deceptive practices committed by an issuer of securities held by a Fund undermine GMO’s due diligence efforts and, when discovered, will likely cause a steep decline in the market price of those securities and thus negatively affect the value of the Fund’s investments. In addition, when discovered, financial fraud may contribute to overall market volatility, which can negatively affect a Fund’s investment program as well as the rates or indices underlying a Fund’s investments.

While the U.S. government has always honored its credit obligations, a default by the U.S. government (as has been threatened in recent years) would be highly disruptive to the U.S. and global securities markets and could significantly reduce the value of the Funds’ investments. Similarly, political events within the United States have resulted, and may in the future result, in a shutdown of government services, which could adversely affect the U.S. economy, reduce the value of many Fund investments, and impair the operation of the U.S. or other securities markets. Uncertainty over the sovereign debt of several European Union countries, as well as uncertainty over the continued existence of the European Union itself, has disrupted and may continue to disrupt markets in the

 

77


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

United States and around the world. If a country changes its currency or if the European Union dissolves, the world’s securities markets likely will be significantly disrupted. In June 2016, the United Kingdom approved a referendum to leave the European Union (commonly known as “Brexit”) and in March 2017, the United Kingdom commenced the formal process of withdrawing from the European Union. Brexit has resulted in volatility in European and global markets and could have negative long-term impacts on financial markets in the United Kingdom and throughout Europe. Considerable uncertainty exists over the potential consequences and precise timeframe for Brexit, how it will be conducted, how negotiations of trade agreements will proceed, and how the financial markets will react, and as this process unfolds markets may be further disrupted. The consequences of the United Kingdom’s or another country’s exit from the European Union also could threaten the stability of the euro for remaining countries and could negatively affect the financial markets of other countries in the European region and beyond. War, terrorism, economic uncertainty, and related geopolitical events, such as sanctions, tariffs, the imposition of exchange controls or other cross-border trade barriers, have led, and in the future may lead, to increased short-term market volatility and may have adverse long-term effects on U.S. and world economies and markets generally. Likewise, natural and environmental disasters, such as the earthquake and tsunami in Japan in early 2011, and systemic market dislocations of the kind surrounding the insolvency of Lehman Brothers in 2008, if repeated, would be highly disruptive to economies and markets, adversely affecting individual companies and industries, securities markets, interest rates, credit ratings, inflation, investor sentiment, and other factors affecting the market price of the Funds’ investments. During such market disruptions, the Funds’ exposure to the risks described elsewhere in this “Investment and other risks” section will likely increase. Market disruptions, including sudden government interventions, can also prevent the Funds from implementing their investment programs and achieving their investment objectives. For example, a market disruption may adversely affect the orderly functioning of the securities markets and may cause the Funds’ derivatives counterparties to discontinue offering derivatives on some underlying commodities, securities, reference rates, or indices, or to offer them on a more limited basis. To the extent a Fund has focused its investments in the stock index of a particular region, adverse geopolitical and other events in that region could have a disproportionate impact on the Fund.

 MARKET RISK. All of the Funds are subject to market risk, which is the risk that the market price of their holdings will decline. Market risks include:

Asset-Backed Securities — Investments in asset-backed securities not only are subject to all of the market risks described under “Market Risk — Fixed Income,” but to other market risks as well.

Asset-backed securities are often exposed to greater risk of severe credit downgrades, illiquidity, and defaults than many other types of fixed income investments. These risks become particularly acute during periods of adverse market conditions, such as those that occurred in 2008.

As described under “Market Risk — Fixed Income” the market price of asset-backed securities, like that of other fixed income investments with complex structures, can decline for a variety of reasons, including market uncertainty about their credit quality and the reliability of their payment streams. Payment of interest on asset-backed securities and repayment of principal largely depend on the cash flow generated by the assets backing the securities, as well as the deal structure (e.g., the amount of underlying assets or other support available to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets, the level of credit support and the credit quality of the credit-support provider, if any, and the performance of other service providers with access to the payment stream. A problem in any of these factors can lead to a reduction in the payment stream GMO expected a Fund to receive when the Fund purchased the asset-backed security. Principal repayments of asset-backed securities are at risk if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities have. Asset-backed securities backed by sub-prime mortgage loans, in particular, expose a Fund to potentially greater declines in value due to defaults because sub-prime mortgage loans are typically made to less creditworthy borrowers and thus have a higher risk of default than conventional mortgage loans. The issuance of asset-backed securities) also are subject to bankruptcy, insolvency and other laws affecting the rights and remedies of creditors. As of the date of this report, many asset-backed securities owned by the Funds that were once rated investment grade are now rated below investment grade. See “Credit Risk” for more information about credit risk.

When worldwide economic and liquidity conditions deteriorated in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many asset-backed (as well as others) fixed income securities. These events reduced liquidity and contributed to

 

78


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

substantial declines in the market prices of asset-backed (and other) fixed income securities and may occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.

The market price of an asset-backed security depends in part on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of documentation for underlying assets also can affect the rights of holders of those underlying assets. The insolvency of a servicer is likely to result in a decline in the market price of the securities it is servicing, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as was provided by the asset-backed security. When interest rates rise, the obligations underlying asset-backed securities may be repaid more slowly than anticipated, and the market price of those securities may decrease.

The existence of insurance on an asset-backed security does not guarantee that the principal and interest will be paid because the insurer could default on its obligations.

The risk of investing in asset-backed securities has increased since 2008 because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated. See “Focused Investment Risk” for more information about risks of investing in correlated sectors. A single financial institution may serve as a servicer for many asset-backed securities. As a result, a disruption in that institution’s business may have a material impact on the many asset-backed securities it services. The risks associated with asset-backed securities are particularly pronounced for Opportunistic Income Fund, which has invested a substantial portion of its assets in asset-backed securities, and for the Funds that have invested a substantial portion of their assets in Opportunistic Income Fund.

Equities — Funds that invest in equities run the risk that the market price of an equity will decline. That decline may be attributable to factors affecting the issuer, such as poor performance by the issuer’s management or reduced demand for its goods or services, or to factors affecting a particular industry, such as a decline in demand, labor or raw material shortages, or increased production costs. A decline also may result from general market conditions not specifically related to a company or industry, such as real or perceived adverse economic conditions, changes in the general outlook for corporate earnings, changes in interest or currency rates, or adverse investor sentiment generally. The market prices of equities are volatile and can decline in a rapid or unpredictable manner. If a Fund purchases an equity for what GMO believes is less than its fundamental fair (or intrinsic) value, the Fund runs the risk that the market price of the equity will not appreciate or will decline due to GMO’s incorrect assessment. The market prices of equities trading at high multiples of current earnings often are more sensitive to changes in future earnings expectations than the market prices of equities trading at lower multiples.

Fixed Income — Funds that invest in fixed income investments (including bonds, notes, bills, synthetic debt instruments, and asset-backed securities) are subject to various market risks. The market price of a fixed income investment can decline due to market-related factors, including rising interest rates and widening credit spreads, or decreased liquidity due to market uncertainty about the value of a fixed income investment (or class of fixed income investments). In addition, the market price of fixed income investments with complex structures, such as asset-backed securities and sovereign and quasi-sovereign debt instruments, can decline due to uncertainty about their credit quality and the reliability of their payment streams. Some fixed income investments also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as was provided by the fixed income investment. When interest rates rise, fixed income investments also may be repaid more slowly than anticipated, causing a decrease in their market price. During periods of economic uncertainty and change, the market price of a Fund’s investments in below investment grade investments (commonly referred to as “junk bonds”) may be particularly volatile. Often below investment grade investments are subject to greater sensitivity to interest rate and economic changes than higher rated investments and can be more difficult to value, exposing a Fund to the risk that the price at which it sells them will be less than the price at which they were valued when held by the Fund. See “Credit Risk” and “Illiquidity Risk” for more information about these risks.

A risk run by each Fund with significant investment in fixed income investments is that an increase in prevailing interest rates will cause the market price of those securities to decline. The risk associated with increases in interest rates (also called “interest rate risk”) is generally greater for Funds investing in fixed income investments with longer durations. In addition, in managing some Funds, GMO may seek to evaluate potential investments in part by considering the volatility of interest rates. The value of a Fund’s investments may be significantly reduced if GMO’s assessment proves incorrect.

 

79


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The extent to which the market price of a fixed income investment changes with changes in interest rates is referred to as interest rate duration, which can be measured mathematically or empirically. A longer-maturity investment generally has longer interest rate duration because its fixed rate is locked in for a longer period of time. Floating-rate or adjustable-rate investments generally have shorter interest rate durations because their interest rates are not fixed but rather float up and down as interest rates change. Conversely, inverse floating-rate investments have durations that move in the opposite direction from short-term interest rates and thus tend to underperform fixed rate investments when interest rates rise but outperform them when interest rates decline. Fixed income investments paying no interest, such as zero coupon and principal-only securities, are subject to additional interest rate risk.

The market price of inflation-indexed bonds (including TIPS) typically declines during periods of rising real interest rates (i.e., nominal interest rate minus inflation) and increases during periods of declining real interest rates. In some interest rate environments, such as when real interest rates are rising faster than nominal interest rates, the market price of inflation-indexed bonds may decline more than the price of non-inflation-indexed (or nominal) fixed income bonds with similar maturities.

Generally, when interest rates on short term U.S. Treasury obligations equal or approach zero, a Fund that invests a substantial portion of its assets in U.S. Treasury obligations, such as U.S. Treasury Fund, will have a negative return unless GMO waives or reduces its management fees.

Fixed income securities denominated in foreign currencies also are subject to currency risk. See “Currency Risk.”

In response to government intervention, economic or market developments, or other factors, markets for fixed income investments may experience periods of high volatility, reduced liquidity or both. During those periods, a Fund could have unusually high shareholder redemptions, requiring it to generate cash by selling portfolio assets when it would otherwise not do so, including at unfavorable prices. Fixed income investments may be difficult to value during such periods. In recent years, central banks and governmental financial regulators, including the U.S. Federal Reserve, have kept interest rates historically low by purchasing bonds. However, the U.S. Federal Reserve recently has increased interest rates and continued economic recovery and the Federal Reserve’s conclusion of its quantitative easing program increase the likelihood that interest rates will increase in the United States and throughout the financial system. A substantial increase in interest rates could have an adverse effect on prices for fixed income investments and on the performance of the Funds. Other actions by central banks or regulators (such as intervention in foreign currency markets or currency controls) also could have a material adverse effect on the Funds.

 NON-DIVERSIFIED FUNDS. All of the Funds (except U.S. Treasury Fund) are not “diversified” investment companies within the meaning of the 1940 Act. This means they are allowed to invest in the securities of relatively few issuers. As a result, they may be subject to greater credit, market and other risks than if their investments were more diversified, and poor performance by a single investment may have a greater impact on their performance.

In addition, each of the Funds (other than U.S. Treasury Fund) may invest in shares of one or more other GMO Funds that are not diversified investment companies within the meaning of the 1940 Act.

 NON-U.S. INVESTMENT RISK. Funds that invest in non-U.S. securities are subject to more risks than Funds that invest only in U.S. securities. Many non-U.S. securities markets include securities of only a small number of companies in a small number of industries. As a result, the market prices of securities traded on those markets often fluctuate more than those of U.S. securities. In addition, issuers of non-U.S. securities often are not subject to as much regulation as U.S. issuers, and the reporting, accounting, custody, and auditing standards to which those issuers are subject often are not as rigorous as U.S. standards. Transactions in non-U.S. securities generally involve higher commission rates, transfer taxes, and custodial costs. In addition, some countries limit a Fund’s ability to profit from short-term trading (as defined in that country).

A Fund may be subject to non-U.S. taxation, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments; (ii) transactions in those investments; and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. A Fund may seek a refund of taxes paid, but its efforts may not be successful, in which case the Fund will have incurred additional expenses for no benefit. In addition, a Fund’s pursuit of a tax refund may subject it to administrative and judicial proceedings in the country where it is seeking the refund. A Fund’s decision to seek a refund is in its sole discretion, and, particularly in light of the cost involved, it may decide not to seek a refund, even if it is entitled to one. The outcome of a Fund’s efforts to obtain a refund is inherently unpredictable. Accordingly, a refund is not typically reflected in a Fund’s net asset value until it is received or until GMO is confident that it will be received. In

 

80


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

some cases, the amount of a refund could be material to a Fund’s net asset value. Generally, absent a determination that a refund is collectible and free from significant contingencies, a refund is not reflected in a Fund’s net asset value. See “Taxes, Non-U.S. Taxes” in the GMO Trust Statement of Additional Information for additional information.

Investing in non-U.S. securities also exposes a Fund to the risk of nationalization, expropriation, or confiscatory taxation of assets of their issuers, government involvement in every country, including the U.S., or in the affairs of specific companies or industries (including wholly or partially state-owned enterprises), adverse changes in investment regulations, capital requirements or exchange controls (which may include suspension of the ability to transfer currency from a country), and adverse political and diplomatic developments, including the imposition of economic sanctions.

In some non-U.S. securities markets, custody arrangements for securities provide significantly less protection than custody arrangements in U.S. securities markets, and prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose a Fund to credit and other risks it does not have in the United States. Fluctuations in currency exchange rates also affect the market prices of a Fund’s non-U.S. securities (see “Currency Risk”).

The Funds need a license to invest directly in securities traded in many non-U.S. securities markets. These licenses are often subject to limitations, including maximum investment amounts. Once a license is obtained, a Fund’s ability to continue to invest directly is subject to the risk that the license will be terminated or suspended. If a license to invest in a particular market is terminated or suspended, to obtain exposure to that market the Fund will be required to purchase American Depositary Receipts, Global Depositary Receipts, shares of other funds that are licensed to invest directly, or derivative instruments. The receipt of a non-U.S. license by one of GMO’s clients may preclude a Fund from obtaining a similar license. In addition, the activities of a GMO client could cause the suspension or revocation of a Fund’s license.

Funds that invest a significant portion of their assets in securities of issuers tied economically to emerging countries (or investments related to emerging markets) are subject to greater non-U.S. investment risk than Funds investing primarily in more developed non-U.S. countries (or markets). The risks of investing in those securities include: greater fluctuations in currency exchange rates; increased risk of default (by both government and private issuers); greater social, economic, and political uncertainty and instability (including the risk of war or natural disaster); increased risk of nationalization, expropriation, or other confiscation of issuer assets; greater governmental involvement in the economy or in the affairs of specific companies or industries (including wholly or partially state-owned enterprises); less governmental supervision and regulation of securities markets and participants in those markets; controls on investment, capital controls and limitations on repatriation of invested capital, dividends, interest and other income and on a Fund’s ability to exchange local currencies for U.S. dollars; inability to purchase and sell investments or otherwise settle security or derivative transactions (i.e., a market freeze); unavailability of currency hedging techniques; less rigorous auditing and financial reporting standards and resulting unavailability of material information about issuers; slower clearance and settlement; difficulties in obtaining and enforcing legal judgments; and significantly smaller market capitalizations of issuers. In addition, the economies of emerging countries may depend predominantly on only a few industries or revenues from particular commodities and often are more volatile than the economies of developed countries.

SMALL COMPANY RISK. Companies with smaller market capitalizations tend to have limited product lines, markets, or financial resources, lack the competitive strength of larger companies, have less experienced managers and depend on fewer key employees than larger companies. In addition, their securities often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations. Market risk and illiquidity risk are particularly pronounced for the securities of these companies.

Temporary Defensive Positions. Temporary defensive positions are positions that are inconsistent with a Fund’s principal investment strategies and are taken in response to adverse market, economic, political or other conditions.

The Funds (other than Emerging Country Debt Fund and U.S. Treasury Fund) may take temporary defensive positions if deemed prudent by GMO. Many of the Funds have previously taken temporary defensive positions.

To the extent a Fund takes a temporary defensive position, or otherwise holds cash, cash equivalents, or high quality debt investments on a temporary basis, the Fund may not achieve its investment objective.

 

81


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

4.

Derivative financial instruments

Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices that are used to increase, decrease or adjust elements of the investment exposures of a Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.

The Funds may use derivatives to gain long investment exposure to securities or other assets. In particular, the Funds may use swaps, options, or other derivatives on an index, an ETF, a single security, or a basket of securities to gain investment exposures (e.g., by selling protection under a credit default swap). The Funds also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.

The Funds may use derivatives in an attempt to reduce their investment exposures (which may result in a reduction below zero). For example, a Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer or may use a bond futures contract to short the bond market of a particular country. A Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that GMO believes is highly correlated with the relevant currency. The Funds may use derivatives in an attempt to adjust elements of their investment exposures to various securities, sectors, markets, indices, ETFs, and currencies without actually having to sell existing investments or make new direct investments. For instance, GMO may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposures, a Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio investments.

Each of the Funds is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of their derivative positions, the Funds will typically have (or may have, in the case of Opportunistic Income Fund and U.S. Treasury Fund) gross investment exposures in excess of their net assets (i.e., the Funds will be (or may be, in the case of U.S. Treasury Fund) leveraged) and therefore are subject to heightened risk of loss. Each Fund’s (other than U.S. Treasury Fund) performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.

Certain derivatives transactions that may be used by the Funds, including certain interest rate swaps and certain credit default index swaps, are required to be transacted through a central clearing organization. The Funds hold cleared derivatives transactions, if any, through clearing members, who are members of derivatives clearing houses. Certain other derivatives, including futures and certain options, are transacted on exchanges. The Funds hold exchange-traded derivatives through clearing brokers that are typically members of the exchanges. In contrast to bilateral derivatives transactions, following a period of advance notice to the Fund, clearing brokers generally can require termination of existing cleared or exchange-traded derivatives transactions at any time and increases in margin above the margin that it required at the beginning of a transaction. Clearing houses and exchanges also have broad rights to increase margin requirements for existing transactions and to terminate transactions. Any such increase or termination could interfere with the ability of a Fund to pursue its investment strategy. Also, a Fund is subject to execution risk if it enters into a derivatives transaction that is required to be cleared (or that GMO expects to be cleared), and no clearing member is willing or able to clear the transaction on the Fund’s behalf. In that case, the transaction might have to be terminated, and the Fund could lose some or all of the benefit of any increase in the value of the transaction after the time of the transaction.

The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. See “Investment and other risks” above for further information.

 

82


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

For Funds that held derivatives during the period ended August 31, 2018, the following table shows how the Fund used these derivatives (marked with an X):

 

           

 

Type of Derivative and Objective for Use

  Asset Allocation Bond Fund   Core Plus Bond Fund   Emerging Country Debt Fund   High Yield Fund   Opportunistic Income Fund
Forward currency contracts                    

Adjust currency exchange rate risk

  X   X   X        

Adjust exposure to foreign currencies

  X   X   X   X   X
Futures contracts                    

Adjust exposure to certain markets

                   

Adjust interest rate exposure

      X       X   X

Maintain the diversity and liquidity of the portfolio

      X       X   X
Options (Purchased)                    

Adjust currency exchange rate risk

                   

Adjust exposure to foreign currencies

                   

Adjust interest rate exposure

                  X

Achieve exposure to a reference entity’s credit

                  X

Adjust exposure to equity markets

                   

Provide a measure of protection against default loss

                  X
Options (Written)                    

Achieve exposure to a reference entity’s credit

                  X

Adjust currency exchange rate risk

                   

Adjust exposure to foreign currencies

                   

Adjust interest rate exposure

                  X

Maintain the diversity and liquidity of the portfolio

                   

Provide a measure of protection against default loss

                  X
Options (Credit linked)                    

Achieve exposure to a reference entity’s credit

          X        
Swap contracts                    

Achieve exposure to a reference entity’s credit

          X   X   X

Adjust exposure to certain markets

              X   X

Adjust interest rate exposure

  X   X   X       X

Provide a measure of protection against default loss

          X   X   X

Provide exposure to the Fund’s benchmark

      X            

Adjust exposure to foreign currencies

          X        
Rights and/or warrants                    

Achieve exposure to a reference commodity/economic statistic

          X        

 

83


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Forward currency contracts

The Funds (except U.S. Treasury Fund) may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market price of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked-to-market daily using rates supplied by a quotation service and changes in value are recorded by each Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was settled.

These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose a Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. Forward currency contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Futures contracts

The Funds may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, a Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (and if the futures are traded outside the U.S. and the market for such futures is closed prior to the close of the NYSE due to time zone differences, the values will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees to reflect estimated valuation changes through the NYSE close). The value of each of the Fund’s futures contracts is marked-to-market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by each Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin as recorded in the Statements of Assets and Liabilities. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Funds to the risk that they may not be able to enter into a closing transaction due to an illiquid market. Futures contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Options

The Funds may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. “Quanto” options are cash-settled options in which the underlying asset (often an index) is denominated in a currency other than the currency in which the option is settled. By purchasing options a Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. A Fund pays a premium for a purchased option. That premium, if any, which is disclosed in the Schedule of Investments, is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. Purchased option contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

The Funds may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies they own or in which they may invest. Writing options alters a Fund’s exposure to the underlying asset by, in the case of a call option, obligating that Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating that Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When a Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, a Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that a Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose a Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid

 

84


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

market. Written option contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

When an option contract is closed, that Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed in the Statements of Operations.

In a credit linked option contract, one party makes payments to another party in exchange for the option to exercise a contract where the buyer has the right to receive a specified return if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities and a specified decrease in the value of the related collateral occurs. A writer of a credit linked option receives periodic payments in return for its obligation to pay an agreed-upon value to the other party if they exercise their option in the case of a credit event. If no credit event occurs, the seller has no payment obligation and will keep the premiums received.

Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. The Funds value OTC options using industry models and inputs provided by primary pricing sources.

Swap contracts

The Funds may directly or indirectly use various swap contracts, including, without limitation, swaps on securities and securities indices, total return swaps, interest rate swaps, basis swaps, currency swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps, municipal swaps, dividend swaps, volatility swaps, correlation swaps and other types of available swaps. A swap contract is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap contract and during the term of the transaction, a Fund and/or the swap counterparty may post or receive cash or securities as collateral.

Initial upfront payments received or made upon entering into a swap contract are included in the fair market value of the swap. The Funds do not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap contract and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses in the Statements of Operations. A liquidation payment received or made at the termination of the swap contract is recorded as realized gain or loss in the Statements of Operations. The periodic frequency of payments received may differ from periodic payment frequencies made and their frequencies could be monthly, quarterly, semiannually, annually or at maturity.

Interest rate swap contracts involve an exchange by the parties of their respective commitments to pay or rights to receive interest (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal). Basis swaps are interest rate swaps that involve the exchange of two floating interest rate payments and may involve the exchange of two different currencies.

Inflation swaps involve the exchange of a floating rate linked to an index for a fixed rate interest payment with respect to a notional amount or principal.

Total return swap contracts involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or futures contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.

In a credit default swap contract, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.

 

85


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

For credit default swap contracts on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap contracts on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.

Correlation swaps involve receiving a stream of payments based on the actual average correlation between or among the price movements of two or more underlying variables over a period of time, in exchange for making a regular stream of payments based on a fixed “strike” correlation level (or vice versa), where both payment streams are based on a notional amount. The underlying variables may include, without limitation, commodity prices, exchange rates, interest rates and stock indices.

Variance swap contracts involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.

Generally, the Funds price their OTC swap contracts daily using industry standard models that may incorporate quotations from market makers or pricing vendors and record the change in value, if any, as unrealized gain or loss in the Statements of Operations. Gains or losses are realized upon the termination of the swap contracts or reset dates, as appropriate. Cleared swap contracts are valued using the quote (which may be based on a model) published by the relevant clearing house. If an updated quote for a cleared swap contract is not available by the time that a Fund calculates its net asset value on any business day, then that swap contract will generally be valued using an industry standard model, which may differ from the model used by the relevant clearing house.

The values assigned to swap contracts may differ significantly from the values realized upon termination, and the differences could be material. Entering into swap contracts involves counterparty credit, legal, and documentation risk that is generally not reflected in the value assigned to the swap contract. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that a Fund has amounts on deposit in excess of amounts owed by that Fund, or that any collateral the other party posts is insufficient or not timely received by a Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. Swap contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Rights and warrants

The Funds may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in the section entitled “Options” above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit a Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. Rights and/or warrants outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

As provided by U.S. GAAP, the table below is based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Funds (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.

 

86


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The following is a summary of the valuations of derivative instruments categorized by risk exposure.

The Effect of Derivative Instruments on the Statements of Assets and Liabilities as of August 31, 2018 and the Statements of Operations for the period ended August 31, 2018^:

The risks referenced in the tables below are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Portfolio valuation” sections for a further discussion of risks.

 

             
     Credit
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Asset Allocation Bond Fund

             

Asset Derivatives

             

Unrealized Appreciation on Forward Currency Contracts

  $         —     $         —     $ 1,401,890     $     $         —     $ 1,401,890  

Swap Contracts, at value¤

                      1,393,506             1,393,506  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $       $       $ 1,401,890     $ 1,393,506     $       $ 2,795,396  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ 1,401,890     $ 1,393,506     $     $ 2,795,396  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Derivatives

             

Unrealized Depreciation on Forward Currency Contracts

  $     $     $ (1,592,903   $     $     $ (1,592,903

Swap Contracts, at value¤

                      (1,162,900           (1,162,900
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (1,592,903   $ (1,162,900   $     $ (2,755,803
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ (1,592,903   $ (1,162,900   $     $ (2,755,803
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Forward Currency Contracts

  $     $     $ 1,184,981     $     $     $ 1,184,981  

Swap Contracts

                      666,232             666,232  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 1,184,981     $ 666,232     $     $ 1,851,213  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Forward Currency Contracts

  $     $     $ 1,446,179     $     $     $ 1,446,179  

Swap Contracts

                      1,505,460             1,505,460  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 1,446,179     $ 1,505,460     $     $ 2,951,639  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

Core Plus Bond Fund

             

Asset Derivatives

             

Unrealized Appreciation on Forward Currency Contracts

  $     $     $ 3,639,627     $     $         —     $ 3,639,627  

Swap Contracts, at value¤

                      3,310,129             3,310,129  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 3,639,627     $ 3,310,129     $     $ 6,949,756  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ 3,639,627     $ 3,310,129     $     $ 6,949,756  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Derivatives

             

Unrealized Depreciation on Forward Currency Contracts

  $     $     $ (3,123,863   $     $     $ (3,123,863

Unrealized Depreciation on Futures Contracts¤

                      (164,626           (164,626

Swap Contracts, at value¤

                      (2,672,313           (2,672,313
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (3,123,863   $ (2,836,939   $     $ (5,960,802
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ (3,123,863   $ (2,836,939   $     $ (5,960,802
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Forward Currency Contracts

  $     $     $ 1,719,992     $     $     $ 1,719,992  

Futures Contracts

                      1,264,909             1,264,909  

Swap Contracts

                      1,089,740             1,089,740  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 1,719,992     $ 2,354,649     $     $ 4,074,641  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

 

87


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

             
     Credit
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Core Plus Bond Fund (Continued)

             

Change in Net Appreciation (Depreciation) on

             

Forward Currency Contracts

  $     $     $ 9,352,266     $     $     $ 9,352,266  

Futures Contracts

                      (435,317           (435,317

Swap Contracts

                      2,913,646             2,913,646  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 9,352,266     $ 2,478,329     $     $ 11,830,595  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

Emerging Country Debt Fund

             

Asset Derivatives

             

Investments, at value (rights and/or warrants)

  $     $     $     $     $ 30,909,172     $ 30,909,172  

Unrealized Appreciation on Forward Currency Contracts

                725,596                   725,596  

Options, at value

    131,894                               131,894  

Swap Contracts, at value¤

    23,842,924                   8,557,154             32,400,078  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 23,974,818     $     $ 725,596     $ 8,557,154     $ 30,909,172     $ 64,166,740  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $ 30,909,172     $ 30,909,172  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $ 23,974,818     $     $ 725,596     $ 8,557,154     $     $ 33,257,568  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Derivatives

             

Unrealized Depreciation on Forward Currency Contracts

  $     $     $ (170,564   $     $     $ (170,564

Options, at value

    (3,200,781                             (3,200,781

Swap Contracts, at value¤

    (21,610,400                 (1,461,779           (23,072,179
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (24,811,181   $     $ (170,564   $ (1,461,779   $     $ (26,443,524
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $ (24,811,181   $     $ (170,564   $ (1,461,779   $     $ (26,443,524
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Forward Currency Contracts

  $     $     $ 7,902,011     $     $     $ 7,902,011  

Options

    70,000                               70,000  

Swap Contracts

    3,515,410                   3,886,487             7,401,897  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 3,585,410     $     $ 7,902,011     $ 3,886,487     $     $ 15,373,908  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Investments (rights and/or warrants)

  $     $ (20,972,817   $     $     $     $ (20,972,817

Forward Currency Contracts

                (1,402,074                 (1,402,074

Options

    (3,210,846                             (3,210,846

Swap Contracts

    1,238,904                   18,287,191             19,526,095  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (1,971,942   $ (20,972,817   $ (1,402,074   $ 18,287,191     $     $ (6,059,642
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

High Yield Fund

             

Asset Derivatives

             

Unrealized Appreciation on Forward Currency Contracts

  $     $     $ 251,719     $     $     $ 251,719  

Unrealized Appreciation on Futures Contracts¤

                      25,666             25,666  

Swap Contracts, at value¤

    5,794,651                   295,012             6,089,663  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 5,794,651     $     $ 251,719     $ 320,678     $     $ 6,367,048  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $ 5,794,651     $     $ 251,719     $ 320,678     $     $ 6,367,048  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Derivatives

             

Unrealized Depreciation on Forward Currency Contracts

  $     $     $ (37,492   $     $     $ (37,492
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (37,492   $     $     $ (37,492
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ (37,492   $     $     $ (37,492
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

 

88


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

             
     Credit
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

High Yield Fund (Continued)

             

Net Realized Gain (Loss) on

             

Forward Currency Contracts

  $     $     $ 108,242     $     $     $ 108,242  

Futures Contracts

                      22,520             22,520  

Swap Contracts

    759,732                   749,376             1,509,108  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 759,732     $     $ 108,242     $ 771,896     $     $ 1,639,870  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Forward Currency Contracts

  $     $     $ 214,227     $     $     $ 214,227  

Futures Contracts

                      25,666             25,666  

Swap Contracts

    570,846                   295,012             865,858  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 570,846     $     $ 214,227     $ 320,678     $     $ 1,105,751  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

Opportunistic Income Fund

             

Asset Derivatives

             

Investments, at value (purchased options)

  $ 260,612     $     $     $     $     $ 260,612  

Unrealized Appreciation on Futures Contracts¤

                      56,636             56,636  

Swap Contracts, at value¤

    28,553,429                   3,415,647             31,969,076  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $ 28,814,041     $     $     $ 3,472,283     $     $ 32,286,324  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Derivatives

             

Unrealized Depreciation on Futures Contracts¤

  $     $     $     $ (4,442   $     $ (4,442

Written Options, at value

    (52,410                             (52,410

Swap Contracts, at value¤

    (7,706,062                 (418,941           (8,125,003
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (7,758,472   $     $     $ (423,383   $       $ (8,181,855
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $ (7,758,472   $     $     $ (423,383   $     $ (8,181,855
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Investments (purchased options)

  $ (876,784   $     $     $     $     $ (876,784

Forward Currency Contracts

                (5,155                 (5,155

Futures Contracts

                      604,530             604,530  

Written Options

    583,963                               583,963  

Swap Contracts

    (361,054                 860,531             499,477  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (653,875   $     $ (5,155   $ 1,465,061     $     $ 806,031  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Investments (purchased options)

  $ 226,941     $     $     $     $     $ 226,941  

Forward Currency Contracts

                17,898                   17,898  

Futures Contracts

                      17,161             17,161  

Written Options

    (152,176                             (152,176

Swap Contracts

    (3,338,493                 (863,801           (4,202,294
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (3,263,728   $     $ 17,898     $ (846,640   $     $ (4,092,470
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

 

  ^

Because the Funds recognize changes in value through the Statements of Operations, they do not qualify for hedge accounting under authoritative guidance for derivative instruments. The Funds’ investments in derivatives may represent an economic hedge; however, they are considered to be non-hedge transactions for the purpose of these tables.

  ¤

The table includes cumulative unrealized appreciation/depreciation of futures and value of cleared swap contracts, if any, as reported in the Schedule of Investments. Period end variation margin on open futures and cleared swap contracts, if any, is reported within the Statements of Assets and Liabilities.

 

89


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Certain Funds are party to International Swaps and Derivatives Association, Inc. Master Agreements, Global Master Repurchase Agreements or other similar types of agreements (collectively, “Master Agreements”) that generally govern the terms of OTC derivative transactions, repurchase agreements and reverse repurchase agreements. The Master Agreements may include collateral posting terms and set-off provisions that apply in the event of a default and/or termination event. Upon the occurrence of such an event, including the bankruptcy or insolvency of the counterparty, the Master Agreements may permit the non-defaulting party to calculate a single net payment to close out applicable transactions. However, there is no guarantee that the terms of a Master Agreement will be enforceable; for example, when bankruptcy or insolvency laws impose restrictions on or prohibitions against the right of offset. Additionally, the set-off and netting provisions of a Master Agreement may not extend to the obligations of the counterparty’s affiliates or across varying types of transactions. Because no such event has occurred, the Funds do not presently have a legally enforceable right of set-off and these amounts have not been offset in the Statements of Assets and Liabilities, but have been presented separately in the table below. Termination events may also include a decline in the net assets of a Fund below a certain level over a specified period of time and may entitle a counterparty to elect an early termination of all the transactions under the Master Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse impact on a Fund’s operations. An estimate of the aggregate net payment, if any, that may need to be paid by a Fund (or may be received by a Fund) in such an event is represented by the Net Amounts in the tables below. For more information about other uncertainties and risks, see “Investments and other risks” above.

For financial reporting purposes, in the Statements of Assets and Liabilities any cash collateral that has been pledged to cover obligations of the Funds is reported as Due from Broker and any cash collateral received from the counterparty is reported as Due to Broker. Any non-cash collateral pledged by the Funds is noted in the Schedules of Investments. The tables below show the potential effect of netting arrangements made available by the Master Agreements on the financial position of the Funds. For financial reporting purposes, the Funds’ Statements of Assets and Liabilities generally show derivative assets and derivative liabilities (regardless of whether they are subject to netting arrangements) on a gross basis, which reflects the full risks and exposures of the Fund prior to netting. See Note 2 for information on repurchase agreements and reverse repurchase agreements held by the Funds at August 31, 2018, if any.

The tables above present the Funds’ derivative assets and liabilities by type of financial instrument. The following tables present the Funds’ OTC and/or exchange-traded derivative assets and liabilities by counterparty net of amounts that may be available for offset under the Master Agreements by the terms of the agreement and net of the related collateral received or pledged by the Funds as of August 31, 2018:

Asset Allocation Bond Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Bank of America, N.A.

  $ 8,472     $     $     $ 8,472  

Barclays Bank plc

    284,837             284,837        

Goldman Sachs International

    95,160       (44,316     (11,329     39,515  

JPMorgan Chase Bank, N.A.

    505,632       (69,407     (436,225    

Morgan Stanley & Co. International PLC

    507,789             507,789        
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,401,890     $ (113,723   $ 345,072     $ 47,987  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Barclays Bank plc

  $ 512,525     $ (227,688   $ (284,837   $

Goldman Sachs International

    11,329             11,329        

JPMorgan Chase Bank, N.A.

    436,225             436,225        

Morgan Stanley & Co. International PLC

    632,824       (125,035     (507,789    
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,592,903     $ (352,723   $ (345,072   $  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

90


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Core Plus Bond Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Bank of America, N.A.

  $ 39,184     $     $     $ 39,184  

Barclays Bank plc

    462,208             462,208        

Goldman Sachs International

    188,769             (186,185     2,584  

JPMorgan Chase Bank, N.A.

    1,404,318       (599,322     (804,996    

Morgan Stanley & Co. International PLC

    1,545,148       (475,526     (1,069,622    
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 3,639,627     $ (1,074,848   $ (1,598,595   $ 41,768  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Barclays Bank plc

  $ 1,063,060     $ (600,852   $ (462,208   $

Goldman Sachs International

    186,185             186,185        

JPMorgan Chase Bank, N.A.

    804,996             804,996        

Morgan Stanley & Co. International PLC

    1,069,622             1,069,622        
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 3,123,863     $ (600,852   $ 1,598,595     $  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Emerging Country Debt Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Deutsche Bank AG

  $ 4,232,728     $     $ 4,232,728     $  

Goldman Sachs International

    2,431,945             2,431,945        

JPMorgan Chase Bank, N.A.

    10,085,854             10,085,854        

Morgan Stanley & Co. International PLC

    338,289       (35,000           303,289  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 17,088,816     $ (35,000   $ 16,750,527     $ 303,289  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject
to Master
Agreements
    Collateral
Pledged
    Derivative (Assets)/
Liabilities Available
for Offset
    Net Amount
of Derivative
Liabilities
 

Bank of America, N.A.

  $ 711,759     $ (698,482   $     $ 13,277  

Barclays Bank plc

    495,462       (495,462          

Deutsche Bank AG

    8,776,884       (3,365,686     (4,232,728     1,178,470  

Goldman Sachs International

    3,652,284       (567,766     (2,431,945     652,573  

JPMorgan Chase Bank, N.A.

    12,455,347       (2,369,493     (10,085,854    
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 26,091,736     $ (7,496,889   $ (16,750,527   $ 1,844,320  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

91


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

High Yield Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Bank of America, N.A.

  $ 98,263     $     $     $ 98,263  

Barclays Bank plc

    127,828       (127,828          

Citibank N.A.

    196,749       (30,000           166,749  

Goldman Sachs International

    289,454       (251,962     (37,492    
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 712,294     $ (409,790   $ (37,492   $ 265,012  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Goldman Sachs International

  $ 37,492     $     $ 37,492     $  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 37,492     $     $ 37,492     $  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Opportunistic Income Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Bank of America, N.A.

  $ 5,851,383     $ (5,305,007   $ (546,376   $

Barclays Bank plc

    31,934             31,934        

Citigroup Global Markets Inc.

    376,128       (236,704     (139,424    

Deutsche Bank AG

    694,973       (302,869     (392,104    

Goldman Sachs International

    3,321,497       (2,364,058     (957,439    

JPMorgan Chase Bank, N.A.

    11,986,868       (8,715,853     (2,333,597     937,418  

Morgan Stanley Capital Services LLC

    6,234,537       (5,525,461     (709,076    
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 28,497,320     $ (22,449,952   $ (5,046,082   $ 937,418  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Bank of America, N.A.

  $ 546,376     $     $ 546,376     $  

Barclays Bank plc

    1,142,786       (1,110,852     (31,934    

Citibank N.A.

    28,490       (28,490          

Citigroup Global Markets Inc.

    139,424             139,424        

Credit Suisse International

    46,305                   46,305  

Deutsche Bank AG

    392,104             392,104        

Goldman Sachs International

    957,439             957,439        

JPMorgan Chase Bank, N.A.

    2,333,597             2,333,597        

Morgan Stanley Capital Services LLC

    709,076             709,076        
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 6,295,597     $ (1,139,342   $ 5,046,082     $ 46,305  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

  *

The actual collateral received and/or pledged is more than the amount shown.

 

92


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The average derivative activity of notional amounts (forward currency contracts, futures contracts and swap contracts), market values (rights and/or warrants), and principal amounts or number of contracts (options) outstanding, based on absolute values, at each month-end, was as follows for the period ended August 31, 2018:

 

           
Fund Name   Forward
Currency
Contracts ($)
    Futures
Contracts ($)
   

Swap

Contracts ($)

    Options
(Principal)
    Rights and/or
Warrants ($)
 

Asset Allocation Bond Fund

    181,145,907             522,706,349              

Core Plus Bond Fund

    425,475,109       126,921,917       910,759,689              

Emerging Country Debt Fund

    110,302,663             1,447,933,900       287,209,667       39,754,209  

High Yield Fund

    46,833,328       90,022,935       146,103,578              

Opportunistic Income Fund

    752,892       289,304,906       536,426,727       494,741,187        

 

5.

Fees and other transactions with affiliates

GMO receives a management fee for the services it provides to each Fund. Management fees are paid monthly at the annual rate equal to the percentage of each Fund’s average daily net assets set forth in the table below:

 

             
     Asset Allocation Bond Fund   Core Plus Bond Fund   Emerging Country Debt Fund   High Yield Fund   Opportunistic Income Fund   U.S. Treasury Fund
Management Fee   0.25%   0.25%   0.35%   0.35%   0.40%(a)   0.08%(b)

 

  (a) 

Prior to January 1, 2017, the management fee was 0.25%.

  (b) 

GMO has voluntarily waived the Fund’s entire management fee.

In addition, each class of shares of certain Funds pays GMO a shareholder service fee for providing client services and reporting, such as performance information, client account information, personal and electronic access to Fund information, access to analysis and explanations of Fund reports, and assistance in maintaining and correcting client-related information. Shareholder service fees are paid monthly at the annual rate equal to the percentage of each applicable Class’s average daily net assets set forth in the table below:

 

         
Fund Name   Class III     Class IV     Class V     Class VI  

Asset Allocation Bond Fund

    0.15%                       0.055%  

Core Plus Bond Fund

    0.15%       0.10%                  

Emerging Country Debt Fund

    0.15%       0.10%                  

High Yield Fund

    0.15%     0.10%     0.085%*       0.055%  

Opportunistic Income Fund

    0.15%                     0.055%  

 

  *

Class is offered but has no shareholders as of August 31, 2018.

For each Fund, other than Emerging Country Debt Fund and High Yield Fund, GMO has contractually agreed to reimburse each Fund for its “Specified Operating Expenses” (as defined below). Any such reimbursements are paid to a Fund concurrently with the Fund’s payment of management fees to GMO. GMO has contractually agreed to reimburse High Yield Fund for the portion of its “Specified Operating Expenses” that exceeds 0.10% of the Fund’s average net assets (“Expense Threshold Amount”).

 

93


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

“Specified Operating Expenses” means: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses, expenses of non-investment related legal services provided to the Funds by or at the direction of GMO, organizational and start-up expenses, federal securities law filing expenses, printing expenses, state and federal registration fees and custody expenses.

For High Yield Fund, GMO is permitted to recover from the Fund, on a class-by-class basis, as applicable, the “Specified Operating Expenses” GMO has borne or reimbursed (whether through reduction of its fees or otherwise) to the extent that the Funds’ “Specified Operating Expenses” later fall below the Expense Threshold Amount or the lower expense limit in effect when GMO seeks to recover the expenses. A Fund, however, is not obligated to pay any such amount more than three years after GMO bore or reimbursed an expense. The amount GMO is entitled to recover may not cause a Fund to exceed the Expense Threshold Amount or the lower expense limit in effect when GMO seeks recovery.

For the period ended August 31, 2018, GMO did not recoup any previously recorded waivers and/or reimbursements from High Yield Fund.

On August 31, 2018, the waivers and/or reimbursements subject to possible future recoupment are as follows:

 

       
     Expiring the
year ending
February 28,
2019
    Expiring the
year ending
February 29,
2020
    Expiring the
year ending
February 28,
2021
 
High Yield Fund, Class VI     $—       $—       $144,175  

For each Fund that pays GMO a management fee, GMO has contractually agreed to waive or reduce that fee, but not below zero, to the extent necessary to offset the management fees paid to GMO that are directly or indirectly borne by the Fund as a result of the Fund’s direct or indirect investments in other GMO Funds.

For each Fund that charges a shareholder service fee, GMO has contractually agreed to waive or reduce the shareholder service fee charged to holders of each class of shares of the Fund, but not below zero, to the extent necessary to offset the shareholder service fees directly or indirectly borne by the class of shares of the Fund as a result of the Fund’s direct or indirect investments in other GMO Funds.

These contractual waivers and reimbursements will continue through at least June 30, 2019 for each Fund unless the Funds’ Board of Trustees authorizes their modification or termination or reduces the fee rates paid to GMO under the Fund’s management contract or servicing and supplemental support agreement.

In addition to the contractual waivers and reimbursements described above, GMO has voluntarily agreed to waive U.S. Treasury Fund’s entire management fee. GMO may change or terminate this waiver at any time.

The Funds’ portion of the gross fees paid by the Trust to the Trust’s independent Trustees and their legal counsel and any agents unaffiliated with GMO during the period ended August 31, 2018 is shown in the table below and is included in the Statements of Operations.

 

     
Fund Name   Independent Trustees and
their legal counsel ($)
    Agent
unaffiliated
with GMO ($)
 

Asset Allocation Bond Fund

    12,952       1,246  

Core Plus Bond Fund

    10,290       940  

Emerging Country Debt Fund

    45,441       4,255  

High Yield Fund

    942       82  

Opportunistic Income Fund

    13,131       1,270  

U.S. Treasury Fund

    24,781       2,148  

 

94


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Certain Funds incur fees and expenses indirectly as a shareholder in the underlying funds. For the period ended August 31, 2018 these indirect fees and expenses expressed as an annualized percentage of each Fund’s average daily net assets were as follows:

 

         
Fund Name   Indirect Net Expenses
(excluding shareholder
service fees)
    Indirect Shareholder
Service Fees
    Indirect Interest
Expense
    Total Indirect
Expenses
 

Asset Allocation Bond Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

Core Plus Bond Fund

    0.106%       0.017%       0.001%       0.124%  

Emerging Country Debt Fund

    0.002%       0.000%       0.000%       0.002%  

High Yield Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

Opportunistic Income Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

U.S. Treasury Fund

    0.000%       0.000%       0.000%       0.000%  

The Funds are permitted to purchase or sell securities from or to certain other GMO funds under specified conditions outlined in procedures adopted by the Trustees. The procedures have been designed to ensure that any purchase or sale of securities by a Fund from another fund or portfolio that is or could be considered an affiliate by virtue of having a common investment adviser (or affiliated investment advisers), common Trustees and/or common officers complies with Rule 17a-7 of the 1940 Act. Further, as defined under the procedures, each transaction is effectuated at the current market price. During the period ended August 31, 2018, the Funds did not engage in these transactions.

 

6.

Purchases and sales of securities

Cost of purchases and proceeds from sales of securities, excluding short-term investments and including GMO U.S. Treasury Fund, if applicable, for the period ended August 31, 2018 are noted in the table below:

 

         
Fund Name   Purchases ($)     Purchases ($)     Sales ($)     Sales ($)  
  U.S. Government
Securities
    Investments (Non-U.S.
Government Securities)
    U.S. Government
Securities
    Investments (Non-U.S.
Government Securities)
 

Asset Allocation Bond Fund

    320,530,271       127,296,375       971,393,623       105,900,000  

Core Plus Bond Fund

    804,037,153       192,709,480       969,211,118       254,044,756  

Emerging Country Debt Fund

    58,803,335       241,068,495       78,595,445       225,169,825  

High Yield Fund

    109,487,380       105,884,483             49,710,304  

Opportunistic Income Fund

    292,361,719       325,258,262       331,674,043       441,444,035  

U.S. Treasury Fund

                       

Included in the table above are cost of purchases and proceeds from sales of securities for in-kind transactions, in accordance with U.S. GAAP for the period ended August 31, 2018. In-kind transactions are noted in the table below:

 

     
Fund Name   Purchases ($)     Sales ($)  

High Yield Fund

    210,796,589*        

U.S. Treasury Fund

          1,017,970,052**  

 

  *

Amount represents contribution of assets by sole shareholder to launch High Yield Fund on June 25, 2018.

  **

The redemption in-kind was redeemed by an affiliate.

For the period ended August 31, 2018, the Funds had the following net realized gains/(losses) attributed to redemption in-kind transactions:

 

   
Fund Name   Net realized gains/(losses)
attributed to redemption
in-kind transactions ($)
 

U.S. Treasury Fund

    $(67,064)  

 

95


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

7.

Guarantees

In the normal course of business the Funds enter into contracts with third-party service providers that contain a variety of representations and warranties and that provide general indemnifications. The Funds’ maximum exposure under these arrangements is unknown, as it involves possible future claims that may or may not be made against the Funds. Based on experience, GMO is of the view that the risk of loss to the Funds in connection with the Funds’ indemnification obligations is remote; however, there can be no assurance that such obligations will not result in material liabilities that adversely affect the Funds.

 

8.

Principal shareholders and related parties as of August 31, 2018

 

         
Fund Name   Number of
shareholders that held
more than 10% of the
outstanding shares of
the Fund
    Percentage of
outstanding shares of
the Fund held by those
shareholders owning
greater than 10% of the
outstanding shares of
the Fund
    Percentage of the
shares of the Fund held
by senior management
of GMO and GMO
Trust officers
    Percentage of the
Fund’s shares held by
accounts for which
GMO has
investment discretion
 

Asset Allocation Bond Fund

    2 ‡      72.74     < 0.01     99.98%  

Core Plus Bond Fund

    3     70.33     < 0.01     98.03%  

Emerging Country Debt Fund

                0.16     17.93%  

High Yield Fund

    2 ‡      96.46           100.00%  

Opportunistic Income Fund

    3 §      85.34     0.63     98.97%  

U.S. Treasury Fund

    2     26.56     0.42     92.00%  

 

 

One of the shareholders is another fund of the Trust.

  #

Two of the shareholders are other funds of the Trust.

  §

Three of the shareholders are other funds of the Trust.

 

9.

Share transactions

The Declaration of Trust permits each Fund to issue an unlimited number of shares of beneficial interest (without par value). Transactions in the Funds’ shares were as follows:

 

     
     Six Months Ended
August 31, 2018 (Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Asset Allocation Bond Fund

         

Class III:

         

Shares sold

    254,508     $ 5,606,697       1,573,475     $ 34,917,836  

Shares issued to shareholders in reinvestment of distributions

    65,557       1,443,569       91,336       2,024,013  

Shares repurchased

    (6,021,941     (133,682,962     (4,973,988     (110,702,677
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (5,701,876   $ (126,632,696     (3,309,177   $ (73,760,828
   

 

 

   

 

 

   

 

 

   

 

 

 

Class VI:

         

Shares sold

    196,736     $ 4,365,538       2,580,795     $ 57,553,648  

Shares issued to shareholders in reinvestment of distributions

    243,367       5,375,974       470,101       10,450,335  

Shares repurchased

    (31,096,021     (687,382,676     (11,188,462     (249,507,549
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (30,655,918   $ (677,641,164     (8,137,566   $ (181,503,566
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

96


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     
     Six Months Ended
August 31, 2018 (Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Core Plus Bond Fund

         

Class III:#

         

Shares sold

    446,727     $ 9,349,844       1,511,400     $ 31,905,214  

Shares issued to shareholders in reinvestment of distributions

    8,268       174,777       15,651       332,939  

Shares repurchased

    (63,078     (1,334,821     (922,673     (19,856,258
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    391,917     $ 8,189,800       604,378     $ 12,381,895  
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:#

         

Shares sold

    9,197,186     $ 192,901,009       23,678,705     $ 510,328,333  

Shares issued to shareholders in reinvestment of distributions

    139,474       2,955,446       1,076,119       22,940,052  

Shares repurchased

    (20,381,554     (429,478,028     (7,650,117     (163,862,356
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (11,044,894   $ (233,621,573     17,104,707     $ 369,406,029  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Emerging Country Debt Fund

         

Class III:

         

Shares sold

    1,435,583     $ 39,827,655       11,880,407 (a)     $ 347,049,633 (a)  

Shares issued to shareholders in reinvestment of distributions

    543,203       14,905,500       2,305,305       66,786,479  

Shares repurchased

    (973,147     (26,857,784     (6,501,002     (193,461,462

Purchase premiums

          135,321             245,786  

Redemption fees

          502,193             782,548  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    1,005,639     $ 28,512,885       7,684,710     $ 221,402,984  
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

         

Shares sold

    3,700,771     $ 100,955,303       22,750,109 (b)     $ 673,666,225 (b)  

Shares issued to shareholders in reinvestment of distributions

    1,153,964       31,618,617       6,058,977       175,314,884  

Shares repurchased

    (9,733,306     (266,797,034     (32,863,719     (967,610,732

Purchase premiums

          289,457             638,653  

Redemption fees

          1,065,418             2,240,267  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (4,878,571   $ (132,868,239     (4,054,633   $ (115,750,703
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

High Yield Fund

         

Class VI:*

         

Shares sold

    24,418,519 (c)     $ 489,555,915 (c)        

Shares repurchased

    (13,697,402     (275,136,064      
   

 

 

   

 

 

       

Net increase (decrease)

    10,721,117     $ 214,419,851        
   

 

 

   

 

 

       
                                 

Opportunistic Income Fund

         

Class VI:

         

Shares sold

    3,162,405     $ 84,106,425       5,326,894     $ 139,877,903  

Shares issued to shareholders in reinvestment of distributions

    259,216       6,879,585       1,013,058       26,556,559  

Shares repurchased

    (8,540,372     (227,278,036     (19,292,435     (503,079,247

Purchase premiums

          300,590             234,774  

Redemption fees

          871,961             1,686,586  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (5,118,751   $ (135,119,475     (12,952,483   $ (334,723,425
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

97


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     
     Six Months Ended
August 31, 2018 (Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

U.S. Treasury Fund

         

Core Class:

         

Shares sold

    135,653,776     $ 3,388,126,231       328,805,953     $ 8,215,411,179  

Shares issued to shareholders in reinvestment of distributions

    596,748       14,905,641       793,804       19,832,371  

Shares repurchased

    (196,143,011 )(d)      (4,899,101,035 )(d)      (343,182,979     (8,574,817,064
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (59,892,487   $ (1,496,069,163     (13,583,222   $ (339,573,514
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

  *

The period under the heading “Six Months Ended August 31, 2018 (Unaudited)” represents the period from June 25, 2018 (commencement of operations) through August 31, 2018.

  #

Shares were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

  (a) 

856,877 shares and $24,671,277 were purchased in-kind.

  (b)

4,131,686 shares and $118,797,723 were purchased in-kind. $15,552,985 of the purchases in-kind were contributed by affiliates.

  (c) 

10,546,955 shares and $210,939,097 were a contribution of assets by sole shareholder to launch High Yield Fund on June 25, 2018.

  (d) 

40,751,403 shares and $1,017,970,052 were redeemed in-kind by an affiliate.

 

10.

Investments in affiliated companies and other Funds of the Trust

An affiliated company for the purposes of this disclosure is a company in which a Fund has or had direct ownership of at least 5% of the issuer’s voting securities or an investment in other funds of GMO Trust. A summary of the Funds’ transactions involving companies that are or were affiliates during the period ended August 31, 2018 is set forth below:

 

               
Affiliate   Value,
beginning of
period
    Purchases     Sales
Proceeds
    Dividend
Income*
    Net Realized
Gain (Loss)
    Net Increase/
Decrease in
Unrealized
Appreciation/
Depreciation
    Value, end of
period
 

Asset Allocation Bond Fund

               

GMO U.S. Treasury Fund

  $     $ 127,296,375     $ 105,900,000     $ 237,627       $ (15,659   $     $ 21,380,716  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Core Plus Bond Fund

               

GMO Emerging Country Debt Fund, Class IV

  $ 50,741,626     $     $ 8,000,000     $ 566,358     $ (261,785   $ (2,702,970   $ 39,776,871  

GMO Opportunistic Income Fund, Class VI

    193,785,692             33,000,000       1,389,828       1,010,318       1,021,173       162,817,183  

GMO U.S. Treasury Fund

    18,513,042       176,550,000       177,990,000       197,568       (11,189     7,414       17,069,267  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 263,040,360     $ 176,550,000     $ 218,990,000     $ 2,153,754     $ 737,344     $ (1,674,383   $ 219,663,321  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Emerging Country Debt Fund

               

GMO Opportunistic Income Fund, Class VI

  $ 15,001,189     $     $     $ 129,507     $     $ 170,404     $ 15,171,593  

GMO U.S. Treasury Fund

    81,177,603                   776,667             32,510       81,210,113  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 96,178,792     $     $     $ 906,174     $     $ 202,914     $ 96,381,706  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

High Yield Fund

               

GMO U.S. Treasury Fund

  $     $ 24,516,876     $ 23,200,000     $ 17,539     $     $     $ 1,316,876  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Opportunistic Income Fund

               

GMO U.S. Treasury Fund

  $ 58,387,949     $ 111,870,000     $ 121,465,000     $ 383,902     $ (40,186   $ 23,383     $ 48,776,146  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

 

  *

The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2018 through August 31, 2018. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 28, 2019.

 

98


GMO Trust Funds

 

Board Review of Investment Management Agreements

August 31, 2018 (Unaudited)

 

 

GMO Asset Allocation Bond Fund

Approval of renewal of management agreement for GMO Asset Allocation Bond Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. The Trustees noted that the Fund is not currently offered as a standalone investment and the investment strategies it pursues are intended to complement the strategies used by the Manager in managing other GMO funds or accounts. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds. The Trustees noted in particular that, while the Fund may invest in other GMO funds (“underlying GMO funds”) that charge advisory fees, the Manager offsets against the fees the Fund pays to the Manager the management fees, shareholder servicing fees and most other expenses of those underlying GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

 

99


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Core Plus Bond Fund

Approval of renewal of management agreement for GMO Core Plus Bond Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

 

100


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds. The Trustees noted in particular that, while the Fund may invest in other GMO funds (“underlying GMO funds”) that charge advisory fees, the Manager offsets against the fees the Fund pays to the Manager the management fees, shareholder servicing fees and most other expenses of those underlying GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Emerging Country Debt Fund

Approval of renewal of management agreement for GMO Emerging Country Debt Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics.

 

101


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds. The Trustees noted in particular that, while the Fund may invest in other GMO funds (“underlying GMO funds”) that charge advisory fees, the Manager offsets against the fees the Fund pays to the Manager the management fees, shareholder servicing fees and most other expenses of those underlying GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO High Yield Fund

Approval of initial management agreement for GMO High Yield Fund (the “Fund”). At a meeting on March 8, 2018, the Trustees of GMO Trust (the “Trust”) approved the management agreement between the Trust, on behalf of the Fund, and Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) for an initial two-year term commencing April 13, 2018. In approving the initial management agreement, the Trustees considered information they believed, in light of the legal advice furnished to them, to be relevant, including information relating specifically to the Fund as well as to the Trust generally and the other series of the Trust (collectively, the “GMO funds”).

At meetings on November 30, 2017 and March 8, 2018, the Trustees discussed materials provided by the Manager for purposes of considering the Manager’s proposal to establish the Fund as a new series of the Trust and a proposed management agreement between the Trust, on behalf of the Fund, and the Manager. During these meetings, the Trustees met with members of the investment division of the Manager that was expected to be primarily responsible for the investment management of the Fund, as well as a member of the Manager’s Asset Allocation Team, the investment division primarily responsible for the investment management of GMO funds that might in the future invest in the Fund.

 

102


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

Since the Fund had not yet commenced operations, the Trustees were unable to consider its investment performance. The Trustees did, however, consider the performance of an investment sleeve within GMO Benchmark-Free Allocation Fund that used an investment strategy substantially similar to the strategy the Manager intended to pursue for the Fund.

The Trustees considered the Fund’s estimated total expense ratio (i.e., total annual operating expenses per share as a percentage of net asset value per share) as compared to the total expense ratios of other GMO funds and funds managed by other managers determined by the Manager to have similar investment characteristics. In considering the Fund’s total expense ratio, the Trustees took into account the Manager’s undertaking to reimburse specified operating expenses of the Fund.

The Trustees also reviewed the fees to be paid to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees considered a comparison furnished to them by the Manager of the management fees to be paid by the Fund as compared to the management fees of other GMO funds and of funds managed by other managers determined by the Manager to have similar investment characteristics. The Trustees also considered the shareholder servicing fees to be charged by the Manager to different share classes of the Fund in light of the services to be provided by the Manager and the comparable fees charged by other GMO fixed-income funds.

The Trustees also noted that the non-portfolio management-related services to be provided by the Manager to the Fund including, but not limited to valuation, legal and compliance, board governance, accounting and operational services, were the same as the services provided by the Manager under its current management contracts with other GMO funds.

Since the Fund had not yet commenced operations, the Trustees were unable to review information regarding the Manager’s profitability with respect to the Fund. The Trustees did, however, consider how the proposed fees compared to fees paid by other GMO funds and took note of various “fallout benefits” to the Manager that would result from its management of the Fund. As the Fund had not yet commenced operations, the Trustees did not consider possible economies of scale to the Manager associated with managing the Fund.

The Trustees considered the fact that Fund shares are expected to be principally owned by institutional and other sophisticated investors. The Trustees also considered the experience and sophistication of the Manager (including management and investment management personnel, as well as members of the Manager’s other departments, such as legal and compliance) and the resources the Manager would employ in managing the Fund. In addition, the Trustees considered the depth of the Manager’s personnel resources and other matters concerning the Manager’s business and organization and the nature and quality of its services to be provided to the Fund.

After reviewing these and other factors, the Trustees concluded, in the context of their overall review of the Fund’s initial management agreement, that the fees to be paid by the Fund to the Manager were reasonable.

In their deliberations, the Trustees considered all factors they deemed relevant, with each Trustee weighting individual factors as he thought appropriate. Following their deliberations, the Trustees who are not “interested persons” of the Trust voting separately, and then all Trustees voting together, approved the Fund’s initial management agreement.

GMO Opportunistic Income Fund

Approval of renewal of management agreement for GMO Opportunistic Income Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request.

 

103


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds. The Trustees noted in particular that, while the Fund may invest in other GMO funds (“underlying GMO funds”) that charge advisory fees, the Manager offsets against the fees the Fund pays to the Manager the management fees, shareholder servicing fees and most other expenses of those underlying GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO U.S. Treasury Fund

Approval of renewal of management agreement for GMO U.S. Treasury Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the

 

104


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management agreement. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds. 

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

 

105


GMO Trust Funds

(A Series of GMO Trust)

 

Fund Expenses

August 31, 2018 (Unaudited)

 

 

Expense Examples: The following information is in relation to expenses for the six month period ended August 31, 2018.

As a shareholder of the Funds, you may incur two types of costs: (1) transaction costs, including purchase premium and redemption fees, if applicable; and (2) ongoing costs, including direct and/or indirect management fees, direct and/or indirect shareholder services fees, and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Funds and to compare these costs with the ongoing costs of investing in other mutual funds.

These examples are based on an investment of $1,000 invested at the beginning of the period and held for the entire period, March 1, 2018 through August 31, 2018.

Actual Expenses

This section of the table for each class below provides information about actual account values and actual expenses. You may use the information in this section, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, a $10,000,000 account value divided by $1,000 = 10,000), then multiply the result by the number under the heading entitled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes

This section of the table for each class below provides information about hypothetical account values and hypothetical expenses based on the Funds’ actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Funds’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Funds with other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as purchase premium and redemption fees. Therefore, this section of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

 

    Actual     Hypothetical    

 

 
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Annualized
Expense Ratio
 

Asset Allocation Bond Fund

 

       

Class III

    $1,000.00       $1,023.30       $2.09       $1,000.00       $1,023.14       $2.09       0.41%  

Class VI

    $1,000.00       $1,023.80       $1.58       $1,000.00       $1,023.64       $1.58       0.31%  

Core Plus Bond Fund

 

       

Class III

    $1,000.00       $1,018.00       $2.09       $1,000.00       $1,023.14       $2.09       0.41%  

Class IV

    $1,000.00       $1,018.40       $1.83       $1,000.00       $1,023.39       $1.84       0.36%  

Emerging Country Debt Fund

 

       

Class III

    $1,000.00       $   952.50       $2.66       $1,000.00       $1,022.48       $2.75       0.54%  

Class IV

    $1,000.00       $   952.90       $2.41       $1,000.00       $1,022.74       $2.50       0.49%  

High Yield Fund**

 

       

Class VI

    $1,000.00       $1,020.00       $1.04       $1,000.00       $1,022.38       $2.85       0.56%  

Opportunistic Income Fund

 

       

Class VI

    $1,000.00       $1,020.00       $2.39       $1,000.00       $1,022.84       $2.40       0.47%  

U.S. Treasury Fund

 

       

Core

    $1,000.00       $1,010.00       $0.00       $1,000.00       $1,025.21       $0.00       0.00%  

 

  *

Expenses are calculated using each class’s annualized net expense ratio (including indirect expenses incurred) for the six months ended August 31, 2018, multiplied by the average account value over the period, multiplied by 184 days in the period, divided by 365 days in the year.

  **

For the period June 25, 2018 (commencement of operations) through August 31, 2018, expenses were calculated using the class’s annualized net expense ratio (including indirect expenses incurred) for the period ended August 31, 2018, multiplied by the average account value over the period, multiplied by 67 days in the period, divided by 365 days in the year.

 

106


GMO Trust

Semiannual Report

August 31, 2018

Climate Change Fund

Emerging Domestic Opportunities Fund

Emerging Markets Fund

Foreign Small Companies Fund

International Equity Fund

International Large/Mid Cap Equity Fund

Quality Fund

Resources Fund

Risk Premium Fund

Tax-Managed International Equities Fund

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)


 

 

 

 

For a free copy of the Funds’ proxy voting guidelines, shareholders may call 1-617-346-7646 (collect) or visit the Securities and Exchange Commission’s website at www.sec.gov. Information regarding how the Funds voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available on GMO’s website at www.gmo.com or on the Securities and Exchange Commission’s website at www.sec.gov.

The Funds file their complete schedule of portfolio holdings with the Securities and Exchange Commission for the first and third quarter of each fiscal year on Form N-Q, which is available on the Commission’s website at www.sec.gov. The Funds’ Form N-Q may be reviewed and copied at the Commission’s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference Room may be obtained by calling 1-800-SEC-0330. The Funds have a policy with respect to disclosure of portfolio holdings under which they may also make a complete schedule of portfolio holdings available on GMO’s website at www.gmo.com.

This report is prepared for the general information of shareholders. It is authorized for distribution to prospective investors only when preceded or accompanied by a prospectus for the GMO Trust, which contains a complete discussion of the risks associated with an investment in these Funds and other important information. The GMO Trust prospectus can be obtained at www.gmo.com. The GMO Trust Statement of Additional Information includes additional information about the Trustees of GMO Trust and is available without charge, upon request, by calling 1-617-346-7646 (collect).

An investment in the Funds is subject to risk, including the possible loss of principal amount invested. There can be no assurance that the Funds will achieve their stated investment objectives. Please see the Funds’ prospectus regarding specific principal risks for each Fund. General risks may include: market risk-equities, management and operational risk, non-U.S. investment risk, small company risk and derivatives risk.

The Funds are distributed by Funds Distributor LLC. Funds Distributor LLC is not affiliated with GMO.


TABLE OF CONTENTS

 

Climate Change Fund

  

Investment Concentration Summary

     1  

Schedule of Investments

     2  

Emerging Domestic Opportunities Fund

  

Investment Concentration Summary

     5  

Schedule of Investments

     6  

Emerging Markets Fund

  

Investment Concentration Summary

     9  

Schedule of Investments

     10  

Foreign Small Companies Fund

  

Investment Concentration Summary

     18  

Schedule of Investments

     19  

International Equity Fund

  

Investment Concentration Summary

     23  

Schedule of Investments

     24  

International Large/Mid Cap Equity Fund

  

Investment Concentration Summary

     29  

Schedule of Investments

     30  

Quality Fund

  

Investment Concentration Summary

     33  

Schedule of Investments

     34  

Resources Fund

  

Investment Concentration Summary

     36  

Schedule of Investments

     37  

Risk Premium Fund

  

Investment Concentration Summary

     40  

Schedule of Investments

     41  

Tax-Managed International Equities Fund

  

Investment Concentration Summary

     43  

Schedule of Investments

     44  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

  

Investment Concentration Summary

     50  

Schedule of Investments

     51  

Portfolio, Counterparty and Currency Abbreviations

     55  

Fund Financial Statements:

  

Statements of Assets and Liabilities

     56  

Statements of Operations

     62  

Statements of Changes in Net Assets

     65  

Financial Highlights

     71  

Notes to Financial Statements

     88  

Board Review of Investment Management Agreements

     144  

Fund Expenses

     158  

 

   


GMO Climate Change Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    94.2

Preferred Stocks

    3.6  

Mutual Funds

    1.9  

Short-Term Investments

    0.3  

Other

    0.0
 

 

 

 
    100.0 % 
 

 

 

 
 
Country Summary¤   % of Investments  

United States

    28.8

Japan

    9.2  

France

    7.5  

Norway

    6.2  

China

    5.3  

Russia

    4.9  

Germany

    4.6  

Denmark

    4.5  

Chile

    3.6  

Spain

    3.0  

United Kingdom

    2.8  

Italy

    2.4  

Poland

    2.0  

Australia

    1.7  

Netherlands

    1.7  

Other Developed

    1.6 ‡ 

Canada

    1.6  

Israel

    1.6  

Brazil

    1.5  

South Korea

    1.5  

Other Emerging

    1.4 † 

Sweden

    1.0  

Pakistan

    0.9  

Ukraine

    0.7  
 

 

 

 
    100.0 % 
 

 

 

 
 
Industry Group Summary   % of Equity Investments#  

Clean Energy

    41.5

Agriculture

    20.9  

Energy Efficiency

    16.0  

Copper

    9.0  

Smart Grid

    6.6  

Water

    6.0  
 

 

 

 
    100.0 % 
 

 

 

 
&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above shows country exposure in the Fund. The table excludes short-term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap contracts and other derivative financial instruments, if any.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

1


GMO Climate Change Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    COMMON STOCKS — 94.2%

 

    Argentina — 1.0%

 

    107,853     Adecoagro SA *     863,903  
     

 

 

 
    Australia — 1.7%

 

    392,362     Neometals Ltd     83,273  
    83,606     OZ Minerals Ltd     543,593  
    53,371     Quintis Ltd * (a)      
    144,469     Sandfire Resources NL     736,668  
    54,840     Tassal Group Ltd     175,311  
     

 

 

 
    Total Australia     1,538,845  
     

 

 

 
    Austria — 0.2%

 

    21,804     Zumtobel Group AG *     175,196  
     

 

 

 
    Brazil — 1.5%

 

    69,300     Cosan SA     592,090  
    56,100     Duratex SA     133,050  
    91,000     Sao Martinho SA     423,375  
    13,300     SLC Agricola SA     215,511  
     

 

 

 
    Total Brazil     1,364,026  
     

 

 

 
    Canada — 1.6%

 

    20,763     Canadian Solar Inc *     298,157  
    289,871     Capstone Mining Corp *     184,362  
    17,062     Nutrien Ltd     958,871  
     

 

 

 
    Total Canada     1,441,390  
     

 

 

 
    China — 5.3%

 

    3,875,000     Century Sunshine Group Holdings Ltd *     113,621  
    509,000     Chaowei Power Holdings Ltd     245,713  
    726,000     China Datang Corp Renewable Power Co Ltd – Class H     110,277  
    658,000     China High Speed Transmission Equipment Group Co Ltd     731,964  
    1,645,000     China Singyes Solar Technologies Holdings Ltd     520,035  
    780,000     China Suntien Green Energy Corp Ltd – Class H     236,892  
    1,052,000     Huaneng Renewables Corp Ltd – Class H     336,698  
    350,000     Tianneng Power International Ltd     435,040  
    376,000     Wasion Holdings Ltd     189,762  
    734,000     Xinjiang Goldwind Science & Technology Co Ltd – Class H     786,546  
    2,246,000     Xinyi Solar Holdings Ltd     669,909  
    140,914     Zhengzhou Yutong Bus Co Ltd – Class A     312,869  
     

 

 

 
    Total China     4,689,326  
     

 

 

 
    Denmark — 4.5%

 

    57,328     Vestas Wind Systems A/S     4,020,894  
     

 

 

 
    Finland — 0.2%

 

    15,815     Kemira Oyj     209,687  
     

 

 

 
Shares     Description   Value ($)  
    France — 7.5%

 

    15,537     Albioma SA     346,873  
    67,911     Electricite de France SA     1,111,608  
    7,226     Nexans SA     230,724  
    11,680     Schneider Electric SE     949,174  
    76,375     Suez     1,105,376  
    23,305     Valeo SA     1,057,733  
    65,766     Veolia Environnement SA     1,385,371  
    6,838     Vilmorin & Cie SA     474,395  
     

 

 

 
    Total France     6,661,254  
     

 

 

 
    Germany — 4.6%

 

    11,326     CENTROTEC Sustainable AG     168,552  
    29,193     CropEnergies AG     156,360  
    46,048     E.ON SE     491,590  
    13,378     K+S AG (Registered)     304,326  
    35,979     Nordex SE *     372,622  
    2,066     OSRAM Licht AG     92,731  
    100,454     PNE AG     330,542  
    38,933     Senvion SA *     317,452  
    14,245     Siemens AG (Registered)     1,849,056  
     

 

 

 
    Total Germany     4,083,231  
     

 

 

 
    Israel — 1.6%

 

    236,049     Israel Chemicals Ltd     1,379,270  
     

 

 

 
    Italy — 2.4%

 

    9,748     CNH Industrial NV     116,637  
    209,636     Enel SPA     1,036,428  
    21,087     Prysmian SPA     543,798  
    77,920     Terna Rete Elettrica Nazionale SPA     409,330  
     

 

 

 
    Total Italy     2,106,193  
     

 

 

 
    Japan — 9.2%

 

    4,100     Central Japan Railway Co     823,186  
    6,000     East Japan Railway Co     542,535  
    23,300     Ebara Corp     796,282  
    132,000     GS Yuasa Corp     650,729  
    116,700     Hitachi Zosen Corp     501,813  
    41,000     Kubota Corp     640,858  
    10,500     Kurita Water Industries Ltd     311,669  
    4,700     Odelic Co Ltd     183,718  
    6,300     Organo Corp     177,569  
    39,400     Osaki Electric Co Ltd     289,418  
    87,800     Panasonic Corp     1,045,920  
    38,500     Sumitomo Forestry Co Ltd     621,874  
    37,400     Takuma Co Ltd     460,762  
    8,300     West Japan Railway Co     556,543  
    27,400     Yokogawa Electric Corp     561,795  
     

 

 

 
    Total Japan     8,164,671  
     

 

 

 
 

 

2   See accompanying notes to the financial statements.  


GMO Climate Change Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Netherlands — 1.7%

 

    28,777     Arcadis NV     510,891  
    23,539     SIF Holding NV     463,480  
    18,100     Signify NV     510,213  
     

 

 

 
    Total Netherlands     1,484,584  
     

 

 

 
    Norway — 6.1%

 

    120,938     Austevoll Seafood ASA     1,591,354  
    11,322     Bakkafrost P/F     645,914  
    25,320     Grieg Seafood ASA     291,297  
    28,011     Marine Harvest ASA     604,973  
    19,829     Salmar ASA     954,691  
    29,843     Yara International ASA     1,373,175  
     

 

 

 
    Total Norway     5,461,404  
     

 

 

 
    Pakistan — 0.9%

 

    534,500     Engro Fertilizers Ltd     340,099  
    327,000     Fauji Fertilizer Co Ltd     257,718  
    19,140     Millat Tractors Ltd     193,402  
     

 

 

 
    Total Pakistan     791,219  
     

 

 

 
    Poland — 1.9%

 

    70,581     KGHM Polska Miedz SA *     1,726,781  
     

 

 

 
    Portugal — 1.0%

 

    221,429     EDP – Energias de Portugal SA     864,622  
     

 

 

 
    Russia — 4.8%

 

    129,260     MMC Norilsk Nickel PJSC ADR     2,145,115  
    66,867     PhosAgro PJSC GDR (Registered)     886,033  
    124,517     Ros Agro Plc GDR (Registered)     1,274,483  
     

 

 

 
    Total Russia     4,305,631  
     

 

 

 
    South Africa — 0.1%

 

    13,387     Tongaat Hulett Ltd     72,025  
     

 

 

 
    South Korea — 1.5%

 

    3,922     LG Chem Ltd     1,288,376  
     

 

 

 
    Spain — 3.0%

 

    6,318     Acciona SA     555,757  
    34,007     Endesa SA     760,850  
    15,951     Fomento de Construcciones y Contratas SA *     222,909  
    151,511     Iberdrola SA     1,125,792  
     

 

 

 
    Total Spain     2,665,308  
     

 

 

 
    Sweden — 1.0%

 

    11,941     Holmen AB     307,378  
    53,268     Svenska Cellulosa AB SCA – Class B     620,104  
     

 

 

 
    Total Sweden     927,482  
     

 

 

 
Shares     Description   Value ($)  
    Switzerland — 0.2%

 

    239     Gurit Holding AG     203,781  
     

 

 

 
    Taiwan — 0.2%

 

    45,000     Delta Electronics Inc     180,441  
     

 

 

 
    Thailand — 0.1%

 

    177,500     SPCG PCL     112,820  
     

 

 

 
    Ukraine — 0.7%

 

    43,428     Kernel Holding SA     579,102  
     

 

 

 
    United Kingdom — 2.8%

 

    47,381     Antofagasta Plc     496,317  
    21,298     Go-Ahead Group Plc     463,606  
    64,822     National Grid Plc     681,542  
    74,108     Polypipe Group Plc     356,091  
    227,686     Stagecoach Group Plc     480,759  
     

 

 

 
    Total United Kingdom     2,478,315  
     

 

 

 
    United States — 26.9%

 

    4,500     AGCO Corp.     268,470  
    22,600     Albemarle Corp.     2,158,752  
    25,200     BorgWarner, Inc.     1,103,004  
    23,400     Darling Ingredients, Inc. *     462,852  
    3,600     Deere & Co.     517,680  
    10,500     Delphi Technologies Plc     369,915  
    15,400     Eaton Corp Plc     1,280,356  
    1,900     Emerson Electric Co.     145,787  
    8,800     EnerSys     730,312  
    25,600     Exelon Corp.     1,118,976  
    49,600     First Solar, Inc. *     2,583,168  
    292,951     Freeport-McMoRan, Inc.     4,115,962  
    5,000     Mosaic Co. (The)     156,350  
    8,600     Owens Corning     486,932  
    40,300     PG&E Corp. *     1,861,054  
    1,900     PotlatchDeltic Corp. (REIT)     91,770  
    2,800     Rayonier, Inc. (REIT)     97,524  
    26,100     Renewable Energy Group, Inc. *     703,395  
    7,400     Rexnord Corp. *     214,822  
    22,300     Shiloh Industries, Inc. *     200,254  
    99,500     SolarEdge Technologies, Inc. *     4,771,025  
    4,600     TE Connectivity Ltd.     421,728  
     

 

 

 
    Total United States     23,860,088  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $86,142,258)
    83,699,865  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   3


GMO Climate Change Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    PREFERRED STOCKS (b) — 3.6%

 

    Chile — 3.6%

 

    75,800     Sociedad Quimica y Minera de Chile SA Sponsored ADR     3,229,838  
     

 

 

 
    TOTAL PREFERRED STOCKS
(COST $3,792,984)
    3,229,838  
     

 

 

 
    MUTUAL FUNDS — 1.9%

 

    United States — 1.9%

 

          Affiliated Issuers — 1.9%      
    66,660     GMO U.S. Treasury Fund     1,665,159  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $1,665,159)
    1,665,159  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.3%

 

    Money Market Fund — 0.3%

 

    253,712     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (c)     253,712  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $253,712)     253,712  
     

 

 

 
   

TOTAL INVESTMENTS — 100.0%

(Cost $91,854,113)

    88,848,574  
    Other Assets and Liabilities (net) — 0.0%     28,514  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $88,877,088  
     

 

 

 

Notes to Schedule of Investments:

 

*

Non-income producing security.

 

(a)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

 

(b)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(c)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

4   See accompanying notes to the financial statements.  


GMO Emerging Domestic Opportunities Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    70.9

Investment Funds

    18.4  

Mutual Funds

    3.5  

Short-Term Investments

    3.3  

Preferred Stocks

    2.4  

Debt Obligations

    1.1  

Forward Currency Contracts

    0.0

Futures Contracts

    0.0

Swap Contracts

    (0.1

Other

    0.5  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country Summary¤   % of Investments  

China

    18.6

India

    17.5  

Taiwan

    14.5  

United States

    11.7

Thailand

    6.9  

United Kingdom

    6.5

Brazil

    5.3  

Hong Kong

    4.4  

Philippines

    3.2  

Switzerland

    2.6  

Mexico

    2.1  

France

    2.0  

Indonesia

    1.1  

Russia

    1.1  

Peru

    0.7  

Belgium

    0.6  

South Korea

    0.6  

South Africa

    0.6  
 

 

 

 
    100.0 % 
 

 

 

 
 
Industry Group Summary   % of Equity Investments#  

Banks

    30.0

Software & Services

    13.5  

Household & Personal Products

    13.5  

Insurance

    9.8  

Food, Beverage & Tobacco

    9.0  

Diversified Financials

    5.2  

Capital Goods

    4.6  

Consumer Durables & Apparel

    3.5  

Real Estate

    2.5  

Materials

    1.9  

Food & Staples Retailing

    1.8  

Transportation

    1.7  

Media

    0.9  

Consumer Services

    0.8  

Telecommunication Services

    0.5  

Energy

    0.4  

Automobiles & Components

    0.4  
 

 

 

 
    100.0 % 
 

 

 

 
&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above shows country exposure in the Fund. The table excludes short-term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap contracts and other derivative financial instruments, if any.

 

*

Includes companies that derive more than 50% of their revenues or profits from emerging markets.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

5


GMO Emerging Domestic Opportunities Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

         
Shares
    Description   Value ($)  
    COMMON STOCKS — 70.9%

 

    Belgium — 0.6%

 

    99,400     Anheuser-Busch InBev SA Sponsored ADR     9,267,062  
     

 

 

 
    Brazil — 2.0%

 

    2,734,239     Banco BTG Pactual SA     13,761,484  
    1,135,000     Localiza Rent a Car SA     5,999,496  
    1,633,158     LPS Brasil Consultoria de Imoveis SA *     1,178,828  
    3,265,100     Rumo SA *     11,407,128  
     

 

 

 
    Total Brazil     32,346,936  
     

 

 

 
    China — 15.6%

 

    457,776     Alibaba Group Holding Ltd Sponsored ADR *     80,115,378  
    1,028,379     Anhui Conch Cement Co Ltd – Class H     6,273,552  
    36,886,004     China Construction Bank Corp – Class H     32,486,838  
    5,232,766     China International Capital Corp Ltd – Class H     9,591,666  
    1,290,098     Haitian International Holdings Ltd     2,589,018  
    711,819     Huayu Automotive Systems Co Ltd – Class A     2,133,391  
    97,994     Kweichow Moutai Co Ltd – Class A     9,462,244  
    556,738     Midea Group Co Ltd – Class A     3,393,457  
    621,410     Minth Group Ltd     2,548,282  
    66,120     New Oriental Education & Technology Group Inc Sponsored ADR     5,197,032  
    1,051,905     Ping An Insurance Group Co of China Ltd – Class H     10,146,510  
    136,668     TAL Education Group ADR *     4,045,373  
    1,841,884     Tencent Holdings Ltd     79,177,313  
    3,620,274     Weichai Power Co Ltd – Class H     3,839,528  
     

 

 

 
    Total China     250,999,582  
     

 

 

 
    France — 1.9%

 

    130,717     L’Oreal SA     31,294,420  
     

 

 

 
    Hong Kong — 4.2%

 

    7,847,241     AIA Group Ltd     67,755,077  
     

 

 

 
    India — 16.8%

 

    1,335,735     Action Construction Equipment Ltd     2,558,207  
    499,595     Amber Enterprises India Ltd * (a) (b)     6,920,854  
    482,227     Asian Granito India Ltd     1,596,392  
    355,440     Asian Paints Ltd     6,888,526  
    546,076     Axis Bank Ltd *     5,006,555  
    60,971     Bajaj Finserv Ltd     5,816,343  
    551,221     Bombay Burmah Trading Co     14,500,031  
    44,027     Britannia Industries Ltd     4,191,838  
    333,007     CCL Products India Ltd     1,365,830  
    1,201,247     CMI Ltd (b)     3,030,642  
    632,608     Dabur India Ltd     4,269,528  
    339,751     Dixon Technologies India Ltd (a) (b)     14,389,774  
    10,683,040     Gayatri Highways Ltd *     316,306  
         
Shares
    Description   Value ($)  
    India — continued  
    11,052,457     Gayatri Projects Ltd * (c)     32,473,377  
    1,487,940     HDFC Bank Ltd     43,451,185  
    580,572     Hindustan Unilever Ltd     14,551,214  
    1,977,361     ICICI Bank Ltd     9,537,219  
    862,961     IndusInd Bank Ltd     23,248,354  
    1,382,793     Kotak Mahindra Bank Ltd     25,116,964  
    1,608,076     Mahindra & Mahindra Financial Services Ltd     11,104,961  
    976,854     Marico Ltd     5,108,317  
    3,821,923     MEP Infrastructure Developers Ltd     2,749,440  
    1,503,690     Sangam India Ltd     1,762,788  
    1,040,279     Srikalahasthi Pipes Ltd     3,255,776  
    611,689     Sun TV Network Ltd     6,632,667  
    474,860     TCNS Clothing Co Ltd *     4,539,294  
    784,579     Titan Co Ltd     9,895,276  
    86,624     UltraTech Cement Ltd     5,458,011  
     

 

 

 
    Total India     269,735,669  
     

 

 

 
    Indonesia — 1.1%

 

    6,386,264     Bank Central Asia Tbk PT     10,756,280  
    27,141,400     Telekomunikasi Indonesia Persero Tbk PT     6,446,708  
     

 

 

 
    Total Indonesia     17,202,988  
     

 

 

 
    Mexico — 1.0%

 

    2,281,107     Grupo Financiero Banorte SAB de CV – Class O     15,558,606  
     

 

 

 
    Peru — 0.7%

 

    49,682     Credicorp Ltd     10,831,670  
     

 

 

 
    Philippines — 3.1%

 

    5,488,982     Bank of the Philippine Islands     9,627,409  
    5,213,872     BDO Unibank Inc     12,693,926  
    9,025,466     Concepcion Industrial Corp     7,762,009  
    823,089     Philippine Seven Corp     1,690,067  
    14,830,140     Puregold Price Club Inc     12,759,864  
    9,819,848     Semirara Mining & Power Corp     5,326,392  
     

 

 

 
    Total Philippines     49,859,667  
     

 

 

 
    Russia — 1.1%

 

    1,567,987     Sberbank of Russia Sponsored ADR     17,075,814  
     

 

 

 
    South Africa — 0.5%

 

    1,784,767     FirstRand Ltd     8,586,130  
     

 

 

 
    South Korea — 0.5%

 

    227,431     Shinhan Financial Group Co Ltd     8,932,802  
     

 

 

 
    Switzerland — 2.5%

 

    483,538     Nestle SA (Registered)     40,533,572  
     

 

 

 
 

 

6   See accompanying notes to the financial statements.  


GMO Emerging Domestic Opportunities Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

         
Shares
    Description   Value ($)  
    Taiwan — 7.9%

 

    18,730,000     Cathay Financial Holding Co Ltd     32,103,405  
    55,885,000     CTBC Financial Holding Co Ltd     39,300,812  
    27,832,245     E.Sun Financial Holding Co Ltd     20,484,203  
    10,991,000     Fubon Financial Holding Co Ltd     18,222,542  
    6,767,366     Uni-President Enterprises Corp     17,124,069  
     

 

 

 
    Total Taiwan     127,235,031  
     

 

 

 
    Thailand — 4.3%

 

    3,265,000     Bangkok Bank Pcl NVDR     20,449,975  
    3,392,578     CP ALL Pcl (Foreign Registered)     6,997,626  
    51,064,124     Land & Houses Pcl (Foreign Registered)     17,634,367  
    100,911,662     Quality Houses Pcl (Foreign Registered)     10,669,027  
    3,924,812     Tisco Financial Group Pcl (Foreign Registered)     9,836,157  
    2,968,323     Workpoint Entertainment Pcl (Foreign Registered)     3,650,439  
     

 

 

 
    Total Thailand     69,237,591  
     

 

 

 
    United Kingdom — 6.2%

 

    212,793     British American Tobacco Plc     10,290,085  
    1,573,687     Unilever Plc     89,676,133  
     

 

 

 
    Total United Kingdom     99,966,218  
     

 

 

 
    United States — 0.9%

 

    215,966     Colgate-Palmolive Co.     14,342,302  
     

 

 

 
    TOTAL COMMON STOCKS (COST $1,204,065,217)     1,140,761,137  
     

 

 

 
    PREFERRED STOCKS (d) — 2.4%

 

    Brazil — 2.4%

 

    1,132,200     Banco Bradesco SA     7,888,791  
    3,005,100     Itau Unibanco Holding SA     31,186,462  
     

 

 

 
    Total Brazil     39,075,253  
     

 

 

 
    TOTAL PREFERRED STOCKS (COST $54,811,297)     39,075,253  
     

 

 

 
    INVESTMENT FUNDS — 18.4%

 

    Brazil — 0.7%

 

    319,508     iShares MSCI Brazil Capped ETF     10,368,035  
     

 

 

 
    China — 2.1%

 

    689,600     Hang Seng Investment Index Funds Series – Hang Seng CEI ETF     9,846,832  
    576,200     iShares China Large-Cap ETF     24,425,118  
     

 

 

 
    Total China     34,271,950  
     

 

 

 
    Mexico — 1.0%

 

    321,800     iShares MSCI Mexico Capped ETF     16,199,412  
     

 

 

 
     Shares/
Par Value†
    Description   Value ($)  
    Taiwan — 6.0%

 

    2,531,993     iShares MSCI Taiwan Capped ETF     96,038,494  
     

 

 

 
    Thailand — 2.3%

 

    80,389,901     Digital Telecommunication Infrastructure Fund     36,827,694  
     

 

 

 
    United States — 6.3%

 

    2,362,669     iShares MSCI Emerging Markets ETF     101,996,421  
     

 

 

 
    TOTAL INVESTMENT FUNDS (COST $298,554,355)     295,702,006  
     

 

 

 
    DEBT OBLIGATIONS — 1.1%

 

    Brazil — 1.1%

 

    17,632,000     Itau Unibanco Holding SA, Reg. S, 5.65%, due 03/19/22     17,630,237  
     

 

 

 
    TOTAL DEBT OBLIGATIONS (COST $17,885,634)     17,630,237  
     

 

 

 
    MUTUAL FUNDS — 3.5%

 

    United States — 3.5%

 

    Affiliated Issuers — 3.5%

 

    2,236,018     GMO U.S. Treasury Fund     55,855,727  
     

 

 

 
    TOTAL MUTUAL FUNDS (COST $55,855,727)     55,855,727  
     

 

 

 
    SHORT-TERM INVESTMENTS — 3.3%

 

    Money Market Fund — 3.1%

 

    49,960,540     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (e)     49,960,540  
     

 

 

 
    U.S. Government — 0.2%

 

    4,000,000     U.S. Treasury Bill, 2.10%, due 01/03/19 (f) (g)     3,971,464  
     

 

 

 
   

TOTAL SHORT-TERM INVESTMENTS

(COST $53,935,197)

    53,932,004  
     

 

 

 
    TOTAL INVESTMENTS — 99.6%
(Cost $1,685,107,427)
    1,602,956,364  
    Other Assets and Liabilities (net) — 0.4%     6,193,345  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $1,609,149,709  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   7


GMO Emerging Domestic Opportunities Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Additional information on each restricted security is as follows:

 

Issuer Description

   Acquisition Date    Acquisition
Cost
     Value as a
Percentage
of Fund’s
Net Assets
  Value as of
August 31, 2018
 
Amber Enterprises India Ltd    12/11/2017    $ 6,214,810      0.43%   $ 6,920,854  
Dixon Technologies India Ltd    8/04/2017      9,417,811      0.89%     14,389,774  
          

 

 

 
           $ 21,310,628  
          

 

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Forward Currency Contracts

 

Settlement
Date

 

Counter-
party

 

Currency
Sold

   

Currency
Purchased

   

Net
Unrealized
Appre-
ciation
(Depre-
ciation)
($)

 
01/24/2019   MSCI   PHP     1,999,356,086     USD     38,279,841       1,371,680  
02/20/2019  

MSCI

  PHP     1,020,320,426     USD     19,069,628       269,367  
01/22/2019  

MSCI

  THB     2,788,249,378     USD     83,847,242       (1,714,274
01/24/2019  

MSCI

  USD     31,122,291     PHP     1,664,115,700       (402,676
           

 

 

 
            $ (475,903
           

 

 

 

 

Futures Contracts

 

Number
of
Contracts +

 

Type

  Expiration
Date
  Notional
Amount
($)
    Value/Net
Unrealized
Appreciation
(Depreciation)
($)
 
Buys        
139   Mini MSCI Emerging Markets   September 2018   $ 7,331,555     $ (512,178
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

    

Sales - Fund is short the futures contract.

 

 

Swap Contracts

OTC Total Return Swaps

 

Fund Pays

 

Fund Receives

 

Counterparty

  Notional
Amount
    Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net Unrealized
Appreciation/
(Depreciation) ($)
 

Total return on MSCI Daily TR Gross Emerging Markets Philippines USD

  1 Month LIBOR plus 0.50%   GS     USD       9,465,489       04/12/2019       Monthly             (331,768     (331,768

Total return on MSCI Daily TR Gross Emerging Markets Philippines USD

  1 Month LIBOR   GS     USD       10,909,506       06/20/2019       Monthly             (583,583     (583,583
             

 

 

   

 

 

   

 

 

 
  $     $ (915,351   $ (915,351
             

 

 

   

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

*

Non-income producing security.

 

(a)

The security is restricted as to resale.

 

(b)

Investment valued using significant unobservable inputs (Note 2).

 

(c)

Affiliated company (Note 10).

 

(d)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(e)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(f)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(g)

The rate shown represents yield-to-maturity.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

8   See accompanying notes to the financial statements.  


GMO Emerging Markets Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    92.5

Preferred Stocks

    2.4  

Mutual Funds

    2.3  

Investment Funds

    2.1  

Short-Term Investments

    0.1  

Swap Contracts

    0.0

Futures Contracts

    (0.5

Other

    1.1  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country Summary¤   % of Investments  

Taiwan

    19.5

China

    18.3  

Russia

    13.5  

United States

    10.8

South Korea

    6.7  

Thailand

    5.4  

South Africa

    4.4  

Turkey

    4.1  

India

    3.5  

Mexico

    2.8  

Indonesia

    2.5  

Poland

    2.2  

Brazil

    2.1  

Qatar

    1.2  

Philippines

    1.0  

United Arab Emirates

    0.7  

United Kingdom

    0.6  

Colombia

    0.2  

Czech Republic

    0.1  

Pakistan

    0.1  

Malaysia

    0.1  

Chile

    0.1  

Peru

    0.1  

Sri Lanka

    0.0

Egypt

    0.0
 

 

 

 
    100.0 % 
 

 

 

 
Industry Group Summary   % of Equity Investments#  

Banks

    17.1

Energy

    14.2  

Materials

    7.8  

Technology Hardware & Equipment

    7.5  

Real Estate

    6.1  

Semiconductors & Semiconductor Equipment

    6.1  

Telecommunication Services

    5.6  

Diversified Financials

    5.0  

Software & Services

    3.9  

Insurance

    3.9  

Capital Goods

    3.8  

Food, Beverage & Tobacco

    3.3  

Utilities

    2.7  

Consumer Durables & Apparel

    2.2  

Food & Staples Retailing

    1.9  

Transportation

    1.9  

Retailing

    1.7  

Consumer Services

    1.4  

Automobiles & Components

    1.2  

Household & Personal Products

    0.9  

Health Care Equipment & Services

    0.7  

Pharmaceuticals, Biotechnology & Life Sciences

    0.7  

Media

    0.3  

Commercial & Professional Services

    0.1  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above shows country exposure in the Fund. The table excludes short-term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap contracts and other derivative financial instruments, if any.

 

*

Includes companies that derive more than 50% of their revenues or profits from emerging markets.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

9


GMO Emerging Markets Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    COMMON STOCKS — 92.5%

 

    Brazil — 1.8%

 

    3,181,000     Ambev SA ADR     14,791,650  
    868,046     Banco BTG Pactual SA     4,368,894  
    421,800     BB Seguridade Participacoes SA     2,535,087  
    389,000     Cia de Saneamento Basico do Estado de Sao Paulo     2,330,313  
    455,600     Cia de Saneamento Basico do Estado de Sao Paulo ADR     2,738,156  
    1,538,500     Cielo SA     5,703,604  
    208,200     Cosan SA     1,778,832  
    236,700     Equatorial Energia SA     3,312,440  
    417,900     Estacio Participacoes SA     2,312,604  
    1,173,400     Kroton Educacional SA     2,944,231  
    338,200     Localiza Rent a Car SA     1,787,691  
    1,628,205     LPS Brasil Consultoria de Imoveis SA *     1,175,253  
    488,300     Petrobras Distribuidora SA     2,371,308  
    173,300     QGEP Participacoes SA     519,079  
    66,700     Qualicorp Consultoria e Corretora de Seguros SA     258,082  
    938,735     Rumo SA *     3,279,615  
    175,400     Smiles Fidelidade SA     2,235,401  
    1,352,751     Transmissora Alianca de Energia Eletrica SA     6,675,578  
    538,500     Ultrapar Participacoes SA     5,443,040  
    228,600     Ultrapar Participacoes SA Sponsored ADR     2,336,292  
     

 

 

 
    Total Brazil     68,897,150  
     

 

 

 
    Chile — 0.1%

 

    1,769,109     AES Gener SA     444,320  
    150,418     Inversiones La Construccion SA     2,452,539  
     

 

 

 
    Total Chile     2,896,859  
     

 

 

 
    China — 19.7%

 

    4,426,000     361 Degrees International Ltd     1,270,283  
    75,286,290     Agricultural Bank of China Ltd – Class H     36,481,940  
    5,163,946     Aier Eye Hospital Group Co Ltd – Class A     23,724,823  
    658,759     Aisino Corp – Class A     2,740,811  
    118,526     Alibaba Group Holding Ltd Sponsored ADR *     20,743,235  
    1,031,400     Anhui Conch Cement Co Ltd – Class H     6,291,981  
    774,000     Anhui Expressway Co Ltd – Class H     448,942  
    80,864,682     Bank of China Ltd – Class H     36,337,134  
    1,896,000     Baoye Group Co Ltd – Class H *     1,119,397  
    1,572,819     Cangzhou Mingzhu Plastic Co Ltd – Class A     1,077,482  
    576,300     Changyou.com Ltd ADR     7,774,287  
    6,994,560     China Communications Services Corp Ltd – Class H     5,794,930  
    118,430,606     China Construction Bank Corp – Class H     104,306,118  
    1,167,300     China International Capital Corp Ltd – Class H     2,139,662  
    2,127,368     China International Travel Service Corp Ltd – Class A     19,745,371  
    21,803,000     China Machinery Engineering Corp – Class H     10,617,349  
    3,064,837     China Mobile Ltd     28,826,375  
     Shares     Description   Value ($)  
    China — continued

 

    148,200     China Mobile Ltd Sponsored ADR     7,112,118  
    4,942,000     China Overseas Land & Investment Ltd     15,663,795  
    29,000     China Petroleum & Chemical Corp ADR     2,879,990  
    9,138,536     China Petroleum & Chemical Corp – Class A     9,166,134  
    24,350,000     China Petroleum & Chemical Corp – Class H     24,500,640  
    4,166,000     China Resources Land Ltd     14,532,057  
    1,228,544     China Shenhua Energy Co Ltd – Class A     3,334,599  
    7,278,000     China Shenhua Energy Co Ltd – Class H     16,255,417  
    885,100     China Vanke Co Ltd – Class H     3,070,767  
    3,508,310     China Yangtze Power Co Ltd – Class A     8,136,707  
    1,199,406     Chongqing Department Store Co Ltd – Class A     5,045,128  
    2,881,000     Country Garden Holdings Co Ltd     4,294,987  
    430,114     Country Garden Services Holdings Co Ltd *     726,652  
    6,984,766     Daqin Railway Co Ltd – Class A     8,830,968  
    633,269     Dashang Co Ltd – Class A     2,657,660  
    3,056,981     Fangda Special Steel Technology Co Ltd – Class A     4,971,359  
    1,919,256     Gree Electric Appliances Inc of Zhuhai – Class A *     10,965,814  
    9,584,000     Guangdong Investment Ltd     17,014,279  
    292,300     Haitian International Holdings Ltd     586,599  
    557,922     Hangzhou Robam Appliances Co Ltd – Class A     1,800,464  
    3,599,534     Heilan Home Co Ltd – Class A     5,260,227  
    1,534,836     Henan Shuanghui Investment & Development Co Ltd – Class A     5,228,794  
    10,248,000     Hua Han Health Industry Holdings Ltd * (a)     678,957  
    10,213,000     Huabao International Holdings Ltd     6,018,104  
    187,212     Huayu Automotive Systems Co Ltd – Class A     561,093  
    1,194,074     Huolinhe Opencut Coal Industry Corp Ltd of Inner Mongolia – Class A     1,491,992  
    84,359,947     Industrial & Commercial Bank of China Ltd – Class H     62,308,055  
    23,531     Kweichow Moutai Co Ltd – Class A     2,272,140  
    137,228     Kweichow Moutai Co Ltd – Class A     13,250,657  
    2,322,000     Logan Property Holdings Co Ltd     2,905,268  
    773,500     Longfor Properties Co Ltd     2,151,510  
    144,957     Midea Group Co Ltd – Class A     883,549  
    1,168,555     Midea Group Co Ltd – Class A     7,122,635  
    162,090     Minth Group Ltd     664,700  
    19,600     New Oriental Education & Technology Group Inc Sponsored ADR     1,540,560  
    12,369,000     PICC Property & Casualty Co Ltd – Class H     13,946,858  
    267,000     Ping An Insurance Group Co of China Ltd – Class H     2,575,440  
    5,152,400     Qingling Motors Co Ltd – Class H     1,405,415  
    2,227,600     SAIC Motor Corp Ltd – Class A     9,522,766  
    6,529,720     Shanghai Smi Holding Co Ltd – Class A     5,481,968  
    3,344,000     Shenzhen Investment Ltd     1,095,728  
    871,500     Shimao Property Holdings Ltd     2,602,623  
    11,025,850     Suning Universal Co Ltd – Class A     5,459,602  
    40,400     TAL Education Group ADR *     1,195,840  
    1,757,865     Tencent Holdings Ltd     75,565,576  
 

 

10   See accompanying notes to the financial statements.  


GMO Emerging Markets Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    China — continued

 

    300,800     Tencent Holdings Ltd ADR     12,976,512  
    923,000     Weichai Power Co Ltd – Class H     978,900  
    6,669,900     Yangzijiang Shipbuilding Holdings Ltd     5,201,103  
    10,352,000     Zhejiang Expressway Co Ltd – Class H *     8,219,034  
    500,573     Zhejiang Supor Cookware Co Ltd – Class A     3,674,824  
    2,088,421     Zhejiang Weixing New Building Materials Co Ltd – Class A     5,181,388  
     

 

 

 
    Total China     738,408,072  
     

 

 

 
    Colombia — 0.2%

 

    2,802,331     Ecopetrol SA     3,146,257  
    135,300     Ecopetrol SA Sponsored ADR     3,057,780  
     

 

 

 
    Total Colombia     6,204,037  
     

 

 

 
    Czech Republic — 0.2%

 

    483,861     Moneta Money Bank AS     1,691,269  
    6,261     Philip Morris CR AS     4,197,115  
     

 

 

 
    Total Czech Republic     5,888,384  
     

 

 

 
    Egypt — 0.0%

 

    1,581,356     Global Telecom Holding SAE *     376,942  
     

 

 

 
    India — 3.8%

 

    23,510     ACC Ltd     545,456  
    317,300     Action Construction Equipment Ltd     607,695  
    125,042     Asian Granito India Ltd     413,946  
    91,677     Asian Paints Ltd     1,776,726  
    1,070,235     Aurobindo Pharma Ltd     10,770,002  
    140,821     Axis Bank Ltd *     1,291,080  
    14,189     Bajaj Finserv Ltd     1,353,563  
    122,465     Bombay Burmah Trading Co     3,221,478  
    11,222     Britannia Industries Ltd     1,068,454  
    74,792     CCL Products India Ltd     306,760  
    293,346     CMI Ltd     740,086  
    161,246     Dabur India Ltd     1,088,264  
    574,247     Divi’s Laboratories Ltd     10,611,165  
    38,430     Dixon Technologies India Ltd     1,627,660  
    16,772,852     Gayatri Highways Ltd * (b)     496,614  
    16,772,852     Gayatri Projects Ltd * (b)     49,280,549  
    385,897     HDFC Bank Ltd     11,269,058  
    146,940     Hindustan Unilever Ltd     3,682,843  
    518,191     ICICI Bank Ltd     2,499,342  
    753,918     IDFC Bank Ltd     507,571  
    219,342     IndusInd Bank Ltd     5,909,121  
    3,013,682     Jai Balaji Industries Ltd *     396,241  
    1,322,083     Kiri Industries Ltd *     10,557,537  
    349,068     Kotak Mahindra Bank Ltd     6,340,449  
    432,592     Mahindra & Mahindra Financial Services Ltd     2,987,370  
    250,395     Marico Ltd     1,309,404  
    917,800     MEP Infrastructure Developers Ltd     660,253  
    765,633     Power Finance Corp Ltd     912,840  
     Shares     Description   Value ($)  
    India — continued

 

    528,333     Sangam India Ltd     619,369  
    253,494     Srikalahasthi Pipes Ltd     793,364  
    176,187     Sun TV Network Ltd     1,910,431  
    180,790     Tata Motors Ltd – Class A *     362,901  
    239,116     Titan Co Ltd     3,015,781  
    21,600     UltraTech Cement Ltd     1,360,974  
    1,706,236     Vakrangee Ltd     927,922  
     

 

 

 
    Total India     141,222,269  
     

 

 

 
    Indonesia — 2.7%

 

    45,024,200     Adaro Energy Tbk PT     5,708,652  
    8,877,300     Astra International Tbk PT     4,372,209  
    6,089,500     Bank Central Asia Tbk PT     10,256,445  
    14,906,200     Bank Mandiri Persero Tbk PT     6,945,349  
    7,593,200     Bank Negara Indonesia Persero Tbk PT     4,022,190  
    92,101,000     Bank Pembangunan Daerah Jawa Timur Tbk PT     4,188,941  
    127,885,600     Bank Rakyat Indonesia Persero Tbk PT     27,631,785  
    14,648,000     Bukit Asam Tbk PT     4,028,392  
    5,280,100     Bumi Serpong Damai Tbk PT *     430,680  
    610,800     Delta Dunia Makmur Tbk PT *     28,637  
    6,293,991     Indo Tambangraya Megah Tbk PT     12,094,308  
    1,797,200     Link Net Tbk PT     524,838  
    810,200     Matahari Department Store Tbk PT     412,712  
    359,900     Medco Energi Internasional Tbk PT *     21,261  
    83,219,300     Modernland Realty Tbk PT     1,436,603  
    168,492,900     Panin Financial Tbk PT *     2,335,448  
    3,611,400     PP Persero Tbk PT     466,289  
    5,468,700     Ramayana Lestari Sentosa Tbk PT     471,601  
    41,760,900     Surya Semesta Internusa Tbk PT     1,378,351  
    33,315,700     Telekomunikasi Indonesia Persero Tbk PT     7,913,247  
    40,972     Telekomunikasi Indonesia Persero Tbk PT Sponsored ADR     969,807  
    1,764,700     United Tractors Tbk PT     4,122,620  
    20,147,800     Waskita Beton Precast Tbk PT     533,892  
    2,807,800     XL Axiata Tbk PT *     606,014  
     

 

 

 
    Total Indonesia     100,900,271  
     

 

 

 
    Malaysia — 0.1%

 

    4,911,988     KSL Holdings Berhad *     1,015,019  
    21,400     Petron Malaysia Refining & Marketing Bhd     44,180  
    2,890,200     Sapura Energy Berhad *     237,304  
    3,472,967     UOA Development Berhad     2,051,141  
    2,230,100     YTL Power International Berhad     618,214  
     

 

 

 
    Total Malaysia     3,965,858  
     

 

 

 
    Mexico — 3.0%

 

    731,930     Banco Santander Mexico SA Institucion de Banca Multiple Grupo Financiero Santand – Class B     1,159,656  
    4,217,100     Cemex SAB de CV CPO *     2,988,683  
    1,085,600     Cemex SAB de CV Sponsored ADR *     7,696,904  
 

 

  See accompanying notes to the financial statements.   11


GMO Emerging Markets Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    Mexico — continued

 

    20,700     Concentradora Fibra Danhos SA de CV (REIT)     34,303  
    2,553,000     Corp Inmobiliaria Vesta SAB de CV     3,614,642  
    519,000     Credito Real SAB de CV SOFOM ER     671,255  
    1,466,000     Fibra Uno Administracion SA de CV (REIT)     1,918,321  
    662,900     Fomento Economico Mexicano SAB de CV     6,349,600  
    121,200     Fomento Economico Mexicano SAB de CV Sponsored ADR     11,620,656  
    2,763,100     Gentera SAB de CV     2,804,282  
    917,800     Grupo Aeroportuario del Centro Norte SAB de CV     6,033,237  
    11,300     Grupo Aeroportuario del Centro Norte SAB de CV ADR     595,623  
    20,900     Grupo Aeroportuario del Pacifico SAB de CV ADR     2,159,179  
    218,700     Grupo Aeroportuario del Pacifico SAB de CV – Class B     2,259,775  
    9,600     Grupo Aeroportuario del Sureste SAB de CV ADR     1,800,864  
    73,750     Grupo Aeroportuario del Sureste SAB de CV – Class B     1,382,992  
    2,079,600     Grupo Financiero Banorte SAB de CV – Class O     14,184,199  
    153,900     Grupo Financiero Inbursa SAB de CV – Class O     244,883  
    779,000     Grupo Lala SAB de CV     828,938  
    1,728,400     Grupo Mexico SAB de CV – Series B     5,058,026  
    27,200     Industrias Bachoco SAB de CV – Series B     132,133  
    1,252,000     Kimberly-Clark de Mexico SAB de CV – Class A     2,203,832  
    13,000     Megacable Holdings SAB de CV CPO     61,274  
    688,900     Mexichem SAB de CV     2,324,669  
    315,670     Promotora y Operadora de Infraestructura SAB de CV     3,354,931  
    9,900     Rassini SAB de CV     37,273  
    543,500     Unifin Financiera SAB de CV SOFOM ENR     1,386,540  
    11,278,300     Wal-Mart de Mexico SAB de CV     31,228,174  
     

 

 

 
    Total Mexico     114,134,844  
     

 

 

 
    Pakistan — 0.1%

 

    504,200     Engro Corp Ltd     1,336,144  
    1,725,000     Engro Fertilizers Ltd     1,097,605  
    1,221,700     Oil & Gas Development Co Ltd     1,496,036  
    285,250     Pakistan Oilfields Ltd     1,478,031  
     

 

 

 
    Total Pakistan     5,407,816  
     

 

 

 
    Peru — 0.1%

 

    13,000     Credicorp Ltd     2,834,260  
     

 

 

 
    Philippines — 1.0%

 

    1,379,433     Bank of the Philippine Islands     2,419,459  
    1,211,034     BDO Unibank Inc     2,948,438  
    8,932,000     Belle Corp     514,553  
    1,523,810     Concepcion Industrial Corp     1,310,495  
     Shares     Description   Value ($)  
    Philippines — continued

 

    2,524,800     DMCI Holdings Inc     604,712  
    1,587,500     Eagle Cement Corp     482,141  
    2,748,677     First Gen Corp     874,217  
    60,760     GT Capital Holdings Inc     995,849  
    8,672,100     LT Group Inc     2,789,242  
    1,229,850     Manila Electric Co     8,587,152  
    7,115,000     Manila Water Co Inc     3,247,625  
    20,677,000     Megaworld Corp     1,775,728  
    12,133,000     Metro Pacific Investments Corp     1,237,768  
    18,042,966     Nickel Asia Corp     1,833,309  
    4,380,775     Petron Corp     742,403  
    1,326,965     Pilipinas Shell Petroleum Corp     1,426,989  
    3,996,538     Puregold Price Club Inc     3,438,624  
    6,630,000     Semirara Mining & Power Corp     3,596,184  
     

 

 

 
    Total Philippines     38,824,888  
     

 

 

 
    Poland — 2.4%

 

    232,159     Bank Millennium SA *     563,458  
    359,019     Bank Polska Kasa Opieki SA     11,312,145  
    9,417     Bank Zachodni WBK SA     957,323  
    78,078     Budimex SA     2,399,358  
    100,668     CD Projekt SA *     5,608,497  
    1,755     Dino Polska SA *     43,128  
    28,308     Grupa Lotos SA     532,204  
    68,297     KRUK SA     3,811,414  
    1,192     LPP SA     2,969,251  
    671,083     Polski Koncern Naftowy ORLEN SA     17,790,613  
    7,809,765     Polskie Gornictwo Naftowe i Gazownictwo SA *     12,234,607  
    828,549     Powszechna Kasa Oszczednosci Bank Polski SA     9,441,421  
    1,521,722     Powszechny Zaklad Ubezpieczen SA     18,325,687  
    21,869     Stalprodukt SA     2,734,130  
    51,809     Warsaw Stock Exchange     578,611  
     

 

 

 
    Total Poland     89,301,847  
     

 

 

 
    Qatar — 1.3%

 

    909,394     Barwa Real Estate Co     8,992,361  
    251,370     Doha Bank QPSC     1,773,979  
    156,718     Masraf Al Rayan QSC     1,623,163  
    36,401     Ooredoo QPSC     731,379  
    35,383     Qatar Electricity & Water Co QSC     1,858,593  
    288,376     Qatar Gas Transport Co Ltd Nakilat     1,385,264  
    210,512     Qatar Insurance Co SAQ     2,128,772  
    63,708     Qatar International Islamic Bank QSC     980,409  
    43,481     Qatar Islamic Bank SAQ     1,672,124  
    564,866     Qatar National Bank QPSC     27,620,808  
    27,944     Qatar National Cement Co QSC     440,477  
    237,288     United Development Co QSC     905,571  
     

 

 

 
    Total Qatar     50,112,900  
     

 

 

 
 

 

12   See accompanying notes to the financial statements.  


GMO Emerging Markets Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    Russia — 14.1%

 

    5,660,800     Aeroflot PJSC     9,696,435  
    16,802,000     Alrosa PJSC     25,273,099  
    13,861     Etalon Group Plc GDR     32,292  
    523,850     Gazprom Neft PJSC     2,608,576  
    4,516     Gazprom Neft PJSC Sponsored ADR     111,320  
    16,978,392     Gazprom PJSC Sponsored ADR     74,889,819  
    785,069     Globaltrans Investment Plc Sponsored GDR (Registered)     8,641,605  
    118,764,000     Inter RAO UES PJSC     7,118,251  
    1,047,683     LUKOIL PJSC Sponsored ADR     72,397,622  
    717,027     M.Video PJSC *     4,605,735  
    2,932,900     Magnitogorsk Iron & Steel OJSC     2,111,442  
    5,587     Magnitogorsk Iron & Steel Works PJSC Sponsored GDR (Registered)     53,349  
    1,977,307     MMC Norilsk Nickel PJSC ADR     32,814,112  
    4,191,715     Mobile TeleSystems PJSC Sponsored ADR     32,485,791  
    12,195,717     Moscow Exchange MICEX-RTS PJSC     17,714,126  
    323,250     Novatek PJSC     5,195,810  
    334,258     Novatek PJSC Sponsered GDR (Registered)     55,896,612  
    1,584,950     Novolipetsk Steel PJSC     3,888,993  
    908,781     Novolipetsk Steel PJSC GDR     22,070,860  
    50,881     Polyus PJSC     3,301,678  
    176,056     Polyus PJSC GDR (Registered)     5,706,464  
    570,715     QIWI Plc Sponsored ADR *     8,104,153  
    21,440     Raspadskaya OJSC *     31,651  
    8,118,075     Rostelecom PJSC     8,137,262  
    33,228     Rostelecom PJSC Sponsored ADR     199,762  
    16,500     Safmar Financial Investment     196,195  
    3,294,690     Sberbank of Russia PJSC     8,856,049  
    4,681,680     Sberbank of Russia Sponsored ADR     50,984,797  
    49,860     Severstal PJSC     803,362  
    788,544     Severstal PJSC GDR (Registered)     12,688,626  
    2,878,707     Surgutneftegas OJSC Sponsored ADR     11,981,803  
    827,420     Tatneft PJSC     9,617,477  
    373,731     Tatneft PJSC Sponsored ADR     25,912,896  
    226,235     TCS Group Holding Plc GDR (Registered)     4,164,689  
    7,524     TMK PJSC GDR (Registered)     31,686  
    16,747,000     Unipro PJSC     662,467  
     

 

 

 
    Total Russia     528,986,866  
     

 

 

 
    South Africa — 4.7%

 

    271,282     Absa Group Ltd     3,000,416  
    6,075     AECI Ltd     43,019  
    510,548     Alviva Holdings Ltd     632,241  
    40,145     Astral Foods Ltd     707,018  
    1,012,841     AVI Ltd     7,992,009  
    217,873     Barloworld Ltd     1,853,016  
    140,940     BID Corp Ltd     3,007,223  
    285,827     Brait SE *     725,964  
    38,782     Capitec Bank Holdings Ltd     2,648,594  
    611,067     Clicks Group Ltd     8,439,449  
     Shares     Description   Value ($)  
    South Africa — continued

 

    418,056     Coronation Fund Managers Ltd     1,637,715  
    229,912     Discovery Ltd     2,739,562  
    63,541     Distell Group Holdings Ltd *     527,412  
    867,972     Exxaro Resources Ltd     8,797,818  
    2,490,384     FirstRand Ltd     11,980,702  
    259,689     Foschini Group Ltd (The)     3,085,219  
    5,176,049     Growthpoint Properties Ltd (REIT)     8,960,486  
    29,881     Hyprop Investments Ltd (REIT)     207,418  
    216,059     Imperial Holdings Ltd     3,027,420  
    128,946     JSE Ltd     1,420,893  
    329,630     Kumba Iron Ore Ltd     5,942,265  
    1,013,121     Lewis Group Ltd     1,951,400  
    340,553     Liberty Holdings Ltd     2,694,328  
    555,094     Metair Investments Ltd     660,010  
    121,935     Mondi Ltd     3,402,244  
    1,074,651     Mr Price Group Ltd     16,474,438  
    290,782     MTN Group Ltd     1,760,610  
    91,724     Nedbank Group Ltd     1,735,030  
    3,721,399     Old Mutual Ltd *     7,698,573  
    402,894     Rand Merchant Investment Holdings Ltd     1,119,956  
    205,378     Reinet Investments SCA     3,976,735  
    1,948,183     RMB Holdings Ltd     11,181,153  
    1,137,457     Sanlam Ltd     6,139,026  
    279,307     Sappi Ltd     1,907,729  
    125,094     Sasol Ltd     4,899,848  
    18,500     Sasol Ltd Sponsored ADR     726,310  
    304,621     Shoprite Holdings Ltd     4,228,760  
    742,409     Sibanye Gold Ltd *     429,497  
    197,091     SPAR Group Ltd (The)     2,749,582  
    220,444     Standard Bank Group Ltd     2,794,010  
    8,794,688     Steinhoff International Holdings NV *     1,676,281  
    222,227     Tiger Brands Ltd     4,326,345  
    2,249,108     Truworths International Ltd     13,163,273  
    201,908     Wilson Bayly Holmes-Ovcon Ltd     2,059,064  
     

 

 

 
    Total South Africa     175,130,061  
     

 

 

 
    South Korea — 5.5%  
    2,217,118     BNK Financial Group Inc     16,618,449  
    8,626     Celltrion Pharm Inc *     621,042  
    6,777     Cuckoo Holdings Co Ltd     1,071,508  
    170,225     Daou Data Corp     1,773,610  
    338,594     Daou Technology Inc     6,902,202  
    412,451     DB Insurance Co Ltd     23,713,426  
    13,124     Dong Ah Tire & Rubber Co Ltd     418,047  
    1,626,839     Dongwon Development Co Ltd     6,113,801  
    234,189     Grand Korea Leisure Co Ltd     5,079,611  
    13,804     GS Home Shopping Inc     2,571,534  
    2,765     Hankook Shell Oil Co Ltd     841,774  
    698,815     Hankook Tire Worldwide Co Ltd     11,425,818  
    14,845     Hanwha Aerospace Co Ltd *     333,341  
    5,862     HLB Inc *     547,330  
 

 

  See accompanying notes to the financial statements.   13


GMO Emerging Markets Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    South Korea — continued

 

    45,819     Hyundai Home Shopping Network Corp     4,670,880  
    486,003     Hyundai Hy Communications & Network Co Ltd     1,786,025  
    473,650     Hyundai Marine & Fire Insurance Co Ltd     15,823,833  
    53,484     Hyundai Mobis Co Ltd     10,762,819  
    9,577     Hyundai Wia Corp     366,836  
    67,809     iMarketKorea Inc     426,282  
    561,278     Kangwon Land Inc     14,600,275  
    693,792     Korea Asset In Trust Co Ltd 9 (REIT)     3,371,957  
    23,836     Korea Zinc Co Ltd     8,678,118  
    273,001     KT Skylife Co Ltd     3,261,598  
    269,151     KT&G Corp     24,414,102  
    210,245     Kyobo Securities Co Ltd     1,851,064  
    132,605     LF Corp     3,163,258  
    48,514     Maeil Holdings Co Ltd     620,876  
    152,407     Meritz Financial Group Inc     1,683,334  
    35,592     Meritz Fire & Marine Insurance Co Ltd     583,490  
    39,220     Samsung Card Co Ltd     1,241,689  
    14,427     Samsung Electronics Co Ltd GDR     15,405,802  
    42,753     Samsung Engineering Co Ltd *     646,682  
    15,647     Samsung Fire & Marine Insurance Co Ltd     3,724,717  
    58,643     Shinhan Financial Group Co Ltd     2,303,320  
    45,363     Sindoh Co Ltd     2,090,747  
    31,520     SK Innovation Co Ltd     5,464,384  
    98,870     SK Networks Co Ltd     397,768  
    3,551     ViroMed Co Ltd *     756,624  
     

 

 

 
    Total South Korea     206,127,973  
     

 

 

 
    Sri Lanka — 0.0%

 

    103,983,101     Anilana Hotels & Properties Ltd * (b)     834,693  
     

 

 

 
    Taiwan — 20.3%

 

    11,453,000     AcBel Polytech Inc     7,550,784  
    1,252,000     Actron Technology Corp     4,079,641  
    1,505,532     Advantech Co Ltd     10,251,471  
    11,408,740     AmTRAN Technology Co Ltd *     4,791,895  
    1,605,000     Asia Pacific Telecom Co Ltd *     382,627  
    3,277,620     Asustek Computer Inc     27,930,807  
    175,200     Aurora Corp     621,660  
    3,663,000     Catcher Technology Co Ltd     44,888,353  
    18,768,000     Cathay Financial Holding Co Ltd     32,168,538  
    8,248,740     Chailease Holding Co Ltd     28,062,815  
    119,000     Chaun-Choung Technology Corp     371,629  
    281,254     Chicony Electronics Co Ltd     591,937  
    259,089     Chicony Power Technology Co Ltd     372,883  
    3,469,100     Chin-Poon Industrial Co Ltd     4,288,716  
    799,000     China Motor Corp     670,834  
    9,984,259     Chunghwa Telecom Co Ltd     35,288,236  
    138,121     Chunghwa Telecom Co Ltd Sponsored ADR     4,860,478  
    317,000     Cleanaway Co Ltd     1,873,140  
    4,786,400     Coretronic Corp     9,004,834  
     Shares     Description   Value ($)  
    Taiwan — continued

 

    66,579,720     CTBC Financial Holding Co Ltd     46,821,814  
    2,587,000     CTCI Corp     3,963,219  
    1,870,000     Dynapack International Technology Corp     2,441,663  
    13,129,189     E.Sun Financial Holding Co Ltd     9,662,927  
    159,500     Elite Advanced Laser Corp     385,684  
    469,000     Everlight Electronics Co Ltd     485,376  
    7,911,084     Far EasTone Telecommunications Co Ltd     18,870,176  
    3,564,000     Farglory Land Development Co Ltd     3,655,328  
    699,000     FLEXium Interconnect Inc     2,249,858  
    1,581,000     Formosa Chemicals & Fibre Corp     6,335,752  
    2,154,000     Formosa Petrochemical Corp     8,844,969  
    3,442,000     Formosa Plastics Corp     12,617,963  
    3,162,303     Formosan Rubber Group Inc     1,467,689  
    11,024,075     Foxconn Technology Co Ltd     28,028,406  
    24,804,200     Fubon Financial Holding Co Ltd     41,124,155  
    5,839,200     Gigabyte Technology Co Ltd     9,963,299  
    357,000     Greatek Electronics Inc     607,731  
    1,599,700     Green Seal Holding Ltd     1,809,701  
    7,642,754     Highwealth Construction Corp     12,416,458  
    1,500,000     Holtek Semiconductor Inc     4,138,295  
    2,351,000     Huaku Development Co Ltd     4,987,740  
    3,248,900     IEI Integration Corp     4,020,879  
    3,668,700     Inventec Corp     3,292,821  
    235,000     King’s Town Bank Co Ltd     236,412  
    195,000     Kung Long Batteries Industrial Co Ltd     917,892  
    539,785     Makalot Industrial Co Ltd     2,798,740  
    523,000     Mercuries Life Insurance Co Ltd     271,608  
    176,000     Merida Industry Co Ltd     845,313  
    4,938,810     Novatek Microelectronics Corp     24,216,425  
    263,853     OptoTech Corp     196,111  
    5,220,000     Pou Chen Corp     5,755,570  
    1,211,000     Quanta Storage Inc     1,021,053  
    11,076,870     Radiant Opto-Electronics Corp     24,330,494  
    4,884,720     Realtek Semiconductor Corp     23,707,253  
    947,000     Rechi Precision Co Ltd     925,867  
    2,025,151     Ruentex Development Co Ltd     2,280,539  
    7,368,000     Ruentex Industries Ltd     15,115,457  
    811,000     Sercomm Corp     1,425,691  
    1,947,068     Simplo Technology Co Ltd     14,269,392  
    303,000     Sinbon Electronics Co Ltd     860,104  
    2,184,200     Sitronix Technology Corp     6,889,594  
    2,951,000     Syncmold Enterprise Corp     5,635,868  
    580,000     Taiwan Mobile Co Ltd     2,020,933  
    476,000     Taiwan PCB Techvest Co Ltd     448,234  
    8,122,000     Taiwan Semiconductor Manufacturing Co Ltd     68,051,710  
    1,340,010     Taiwan Semiconductor Manufacturing Co Ltd Sponsored ADR     58,424,436  
    3,357,269     Taiwan Surface Mounting Technology Corp     3,611,238  
    379,000     Test Research Inc     665,287  
    326,000     Tong Hsing Electronic Industries Ltd     897,720  
    424,981     Topco Scientific Co Ltd     1,079,676  
 

 

14   See accompanying notes to the financial statements.  


GMO Emerging Markets Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    Taiwan — continued

 

    1,149,000     Transcend Information Inc     2,779,994  
    1,716,160     Tripod Technology Corp     5,297,601  
    1,905,000     TXC Corp     2,212,079  
    5,658,812     Uni-President Enterprises Corp     14,318,996  
    5,201,000     United Integrated Services Co Ltd     10,497,479  
    3,216,000     Waterland Financial Holdings Co Ltd     1,110,129  
    284,214     Wistron NeWeb Corp     634,846  
    5,939,000     Yuanta Financial Holding Co Ltd     3,009,199  
    167,000     Yulon Finance Corp     560,265  
    3,873,670     Yungtay Engineering Co Ltd     5,907,450  
    275,000     Zeng Hsing Industrial Co Ltd     1,280,040  
     

 

 

 
    Total Taiwan     760,749,876  
     

 

 

 
    Thailand — 5.6%

 

    2,312,500     Advanced Info Service Pcl (Foreign Registered)     14,274,632  
    5,220,200     Amata Corp Pcl (Foreign Registered)     3,398,972  
    2,245,200     AP Thailand Pcl (Foreign Registered)     645,003  
    590,700     Bangkok Bank Pcl (Foreign Registered) (c)     3,753,932  
    1,618,700     Bangkok Bank Pcl NVDR     10,138,553  
    8,027,500     Central Pattana Pcl (Foreign Registered)     20,232,877  
    872,700     CP ALL Pcl (Foreign Registered)     1,800,055  
    1,077,000     Delta Electronics Thailand Pcl (Foreign Registered)     2,295,379  
    3,790,701     Glow Energy Pcl (Foreign Registered)     10,886,357  
    2,744,200     Hana Microelectronics Pcl (Foreign Registered)     3,231,754  
    5,672,900     Intouch Holdings Pcl (Foreign Registered) (c)     9,838,457  
    5,201,400     Intouch Holdings Pcl NVDR (c)     8,822,036  
    840,900     KCE Electronics Pcl     1,164,446  
    48,236,700     Land & Houses Pcl (Foreign Registered)     16,657,951  
    15,769,750     LPN Development Pcl (Foreign Registered)     4,771,866  
    3,025,300     MC Group Pcl (Foreign Registered)     1,210,924  
    2,484,500     Platinum Group Pcl (The)     596,130  
    4,105,800     Pruksa Holding Pcl (Foreign Registered)     2,533,744  
    1,021,400     PTT Exploration & Production Pcl (Foreign Registered)     4,450,266  
    5,950,200     PTT Global Chemical Pcl (Foreign Registered)     14,871,529  
    10,393,000     PTT Pcl (Foreign Registered)     16,686,397  
    52,431,592     Quality Houses Pcl (Foreign Registered)     5,543,403  
    5,095,202     Ratchaburi Electricity Generating Holding Pcl (Foreign Registered)     8,134,124  
    30,340,823     Sansiri Pcl (Foreign Registered)     1,493,282  
    8,279,800     Siamgas & Petrochemicals Pcl (Foreign Registered)     3,037,177  
    24,922,100     Star Petroleum Refining Pcl (Foreign Registered)     11,348,442  
    2,275,600     STP & I Pcl (Foreign Registered) *     321,384  
    5,390,175     Supalai Pcl (Foreign Registered)     3,985,590  
    3,476,800     Thai Oil Pcl (Foreign Registered)     8,952,802  
    142,900     Thai Vegetable Oil Pcl (Foreign Registered)     128,819  
    870,500     Tisco Financial Group Pcl (Foreign Registered)     2,181,601  
     Shares     Description   Value ($)  
    Thailand — continued

 

    28,005,650     TTW Pcl (Foreign Registered)     10,608,660  
    669,700     Workpoint Entertainment Pcl (Foreign Registered)     823,596  
     

 

 

 
    Total Thailand     208,820,140  
     

 

 

 
    Turkey — 4.4%

 

    1,831,223     Adana Cimento Sanayii TAS – Class C     394,434  
    1,181,263     Akbank Turk AS     1,039,220  
    325,642     Aksa Akrilik Kimya Sanayii AS     554,567  
    556,662     Alarko Holding AS     405,792  
    3,591,836     Albaraka Turk Katilim Bankas AS     689,996  
    634,355     Aselsan Elektronik Sanayi Ve Ticaret AS     2,503,184  
    356,823     Aygaz AS     651,563  
    1,194,507     BIM Birlesik Magazalar AS     13,306,328  
    4,119,907     EIS Eczacibasi Ilac ve Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS     2,327,999  
    63,672,567     Emlak Konut Gayrimenkul Yatirim Ortakligi AS (REIT)     17,831,606  
    105,143     Enerjisa Enerji AS     83,213  
    4,898,523     Enka Insaat ve Sanayi AS     3,831,993  
    14,015,132     Eregli Demir ve Celik Fabrikalari TAS     25,306,491  
    228,649     Ford Otomotiv Sanayi AS     2,332,073  
    5,194,966     Haci Omer Sabanci Holding AS     5,644,797  
    8,213,630     Ipek Dogal Enerji Kaynaklari Arastirma Ve Uretim AS *     6,110,557  
    3,402,129     Is Gayrimenkul Yatirim Ortakligi AS (REIT)     482,392  
    65,006     Mavi Giyim Sanayi Ve Ticaret AS – Class B     250,770  
    173,402     Otokar Otomotiv Ve Savunma Sanayi AS     1,884,900  
    17,775,348     Soda Sanayii AS     21,943,546  
    847,137     TAV Havalimanlari Holding AS     4,262,244  
    1,812,109     Tekfen Holding AS     5,661,282  
    407,420     Tofas Turk Otomobil Fabrikasi AS     1,424,579  
    1,469,612     Trakya Cam Sanayii AS     969,945  
    956,882     Tupras Turkiye Petrol Rafineriler AS     17,204,570  
    644,466     Turk Telekomunikasyon AS *     359,080  
    76,596     Turk Traktor ve Ziraat Makineleri AS     531,367  
    2,898,100     Turkcell Iletisim Hizmetleri AS     4,664,177  
    12,122,795     Turkiye Garanti Bankasi AS     11,015,722  
    7,594,630     Turkiye Halk Bankasi AS     7,107,094  
    2,720,379     Turkiye Is Bankasi – Class C     1,656,487  
    21,659,210     Turkiye Sinai Kalkinma Bankasi AS     2,512,167  
    1,812,649     Turkiye Vakiflar Bankasi TAO – Class D     958,098  
     

 

 

 
    Total Turkey     165,902,233  
     

 

 

 
    United Arab Emirates — 0.8%

 

    284,027     Abu Dhabi Commercial Bank PJSC     548,935  
    6,550,402     Air Arabia PJSC     1,801,016  
    3,500,178     Aldar Properties PJSC     1,837,639  
    12,945,725     DAMAC Properties Dubai Co PJSC     7,397,484  
    3,717,796     Dana Gas PJSC     1,122,272  
    80,966     DP World Ltd     1,731,735  
 

 

  See accompanying notes to the financial statements.   15


GMO Emerging Markets Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    United Arab Emirates — continued

 

    1,357,672     Dubai Investments PJSC     735,147  
    794,823     Dubai Islamic Bank PJSC     1,107,555  
    4,024,325     DXB Entertainments PJSC *     378,936  
    497,984     Emaar Development PJSC *     716,855  
    2,503,796     Emaar Properties PJSC     3,412,171  
    939,591     Emirates Telecommunications Group Co PJSC     4,332,971  
    288,555     First Abu Dhabi Bank PJSC     1,162,651  
    14,291,786     RAK Properties PJSC     2,412,778  
     

 

 

 
    Total United Arab Emirates     28,698,145  
     

 

 

 
    United Kingdom — 0.6%

 

    409,901     Unilever Plc     23,358,099  
     

 

 

 
    TOTAL COMMON STOCKS (COST $3,471,742,515)     3,467,984,483  
     

 

 

 
    PREFERRED STOCKS (d) — 2.4%

 

    Brazil — 0.4%

 

    336,900     Banco Bradesco SA     2,347,406  
    1,477,600     Companhia Energetica de Minas Gerais     2,706,267  
    903,640     Itau Unibanco Holding SA     9,377,836  
     

 

 

 
    Total Brazil     14,431,509  
     

 

 

 
    Colombia — 0.0%

 

    584,788     Grupo Aval Acciones y Valores SA     230,371  
     

 

 

 
    Russia — 0.3%

 

    195,603     Bashneft PJSC     4,903,223  
    3,944     Transneft PJSC     8,336,436  
     

 

 

 
    Total Russia     13,239,659  
     

 

 

 
    South Korea — 1.7%

 

    1,747,590     Samsung Electronics Co Ltd     62,268,870  
     

 

 

 
    Taiwan — 0.0%

 

    605,412     CTBC Financial Holding Co Ltd     1,224,107  
     

 

 

 
    TOTAL PREFERRED STOCKS (COST $79,520,833)     91,394,516  
     

 

 

 
     Shares     Description   Value ($)  
    INVESTMENT FUNDS — 2.1%

 

    Russia — 0.0%

 

    3,214,692     NCH Eagle Fund LP * (e) (f)     99,022  
     

 

 

 
    Thailand — 0.2%

 

    20,378,500     Digital Telecommunication Infrastructure Fund     9,335,665  
     

 

 

 
    United States — 1.9%

 

    1,627,307     iShares MSCI Emerging Markets ETF     70,250,843  
     

 

 

 
    TOTAL INVESTMENT FUNDS
(COST $82,620,125)
    79,685,530  
     

 

 

 
    MUTUAL FUNDS — 2.3%

 

    United States — 2.3%

 

          Affiliated Issuers — 2.3%      
    3,383,053     GMO U.S. Treasury Fund     84,508,659  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $84,508,659)
    84,508,659  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.1%

 

    Money Market Fund — 0.1%

 

    5,016,432     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (g)     5,016,432  
     

 

 

 
    Total Money Market Funds     5,016,432  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $5,016,432)     5,016,432  
     

 

 

 
    TOTAL INVESTMENTS — 99.4% (Cost $3,723,408,564)     3,728,589,620  
    Other Assets and Liabilities (net) — 0.6%     21,178,396  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $3,749,768,016  
     

 

 

 
 

 

Additional information on each restricted security is as follows:

 

Issuer Description

   Acquisition Date    Acquisition
Cost
     Value as a
Percentage
of Fund’s
Net Assets
  Value as of
August 31, 2018
 
NCH Eagle Fund LP    4/6/09    $ 5,452,004      0.00%   $ 99,022  
          

 

 

 

 

16   See accompanying notes to the financial statements.  


GMO Emerging Markets Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Futures Contracts

 

Number
of
Contracts +

 

Type

  Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation)
($)
 
Buys        
5,320   Mini MSCI Emerging Markets   September 2018   $ 280,603,400     $ (20,827,310
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

  Sales

- Fund is short the futures contract.

 
 

 

Swap Contracts

OTC Total Return Swaps

 

Fund Pays

 

Fund Receives

 

Counterparty

 

Notional
Amount

    Expiration
Date
   

Periodic
Payment
Frequency

  Premiums
Paid/
(Received)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation)
 

Depreciation of Total Return on Asustek Computer Inc + ( Daily Fed Funds Rate minus 0.25%)

  Appreciation of Total Return on Asustek Computer Inc   MSCI   USD     21,860,777       09/27/2018     At Maturity   $     $ 770,262     $ 770,262  
             

 

 

   

 

 

   

 

 

 
  $     $ 770,262     $ 770,262  
             

 

 

   

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

Notes to Schedule of Investments:

 

*

Non-income producing security.

 

(a)

Investment valued using significant unobservable inputs (Note 2).

 

(b)

Affiliated company (Note 10).

 

(c)

Security valued at the local price and adjusted by applying a premium or discount since holding exceeds foreign ownership limits.

 

(d)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(e)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

 

(f)

Private placement security; restricted as to resale.

 

(g)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

  See accompanying notes to the financial statements.   17


GMO Foreign Small Companies Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    96.2

Mutual Funds

    3.1  

Short-Term Investments

    0.2  

Preferred Stocks

    0.2  

Futures Contracts

    0.0

Other

    0.3  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country Summary¤   % of Investments  

Japan

    23.8

United Kingdom

    13.9  

South Korea

    6.8  

Germany

    5.8  

Canada

    5.6  

Switzerland

    5.2  

France

    5.1  

Australia

    3.1  

United States

    3.0  

Taiwan

    2.6  

Sweden

    2.6  

Italy

    2.6  

India

    2.1  

Singapore

    2.1  

China

    2.1  

Spain

    2.1  

European Union

    1.9  

Hong Kong

    1.8  

Malaysia

    1.6  

Austria

    1.2  

Belgium

    1.1  

Finland

    1.1  

Other Emerging

    1.1 † 

Norway

    1.0  

Other Developed

    0.7 ‡ 
 

 

 

 
    100.0 % 
 

 

 

 
Industry Group Summary   % of Equity Investments#  

Capital Goods

    17.1

Materials

    11.7  

Consumer Durables & Apparel

    7.3  

Technology Hardware & Equipment

    7.1  

Transportation

    5.8  

Pharmaceuticals, Biotechnology & Life Sciences

    5.7  

Software & Services

    5.5  

Real Estate

    5.5  

Automobiles & Components

    5.2  

Food, Beverage & Tobacco

    5.1  

Diversified Financials

    4.9  

Retailing

    3.5  

Energy

    2.9  

Household & Personal Products

    2.5  

Media

    2.1  

Health Care Equipment & Services

    1.9  

Insurance

    1.8  

Commercial & Professional Services

    1.5  

Semiconductors & Semiconductor Equipment

    1.3  

Utilities

    0.8  

Consumer Services

    0.5  

Food & Staples Retailing

    0.3  

Banks

    0.0
 

 

 

 
    100.0 % 
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above shows country exposure in the Fund. The table excludes short-term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap contracts and other derivative financial instruments, if any.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

18


GMO Foreign Small Companies Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    COMMON STOCKS — 96.2%

 

    Australia — 3.2%

 

    14,433     Australian Pharmaceutical Industries Ltd     19,152  
    3,653     Brickworks Ltd     45,970  
    35,442     Codan Ltd     79,392  
    1,941     Costa Group Holdings Ltd     10,104  
    5,140     Folkestone Education Trust (REIT)     10,190  
    164,024     GDI Property Group (REIT)     149,676  
    3,404     IDP Education Ltd     26,630  
    14,469     Mineral Resources Ltd     157,609  
    15,087     Nine Entertainment Co Holdings Ltd     26,214  
    25,546     Sandfire Resources NL     130,263  
     

 

 

 
    Total Australia     655,200  
     

 

 

 
    Austria — 1.3%

 

    9,238     FACC AG     233,170  
    1,476     S IMMO AG     31,014  
     

 

 

 
    Total Austria     264,184  
     

 

 

 
    Belgium — 1.1%

 

    51,060     AGFA-Gevaert NV *     224,223  
    97     Barco NV     13,348  
     

 

 

 
    Total Belgium     237,571  
     

 

 

 
    Brazil — 0.3%

 

    3,100     Estacio Participacoes SA     17,155  
    1,800     Mahle-Metal Leve SA     11,150  
    7,900     Via Varejo SA     32,778  
     

 

 

 
    Total Brazil     61,083  
     

 

 

 
    Canada — 5.7%

 

    10,590     BRP Inc Sub Voting     552,790  
    1,800     Canaccord Genuity Group Inc     9,724  
    14,000     Canfor Corp *     322,805  
    3,400     Canfor Pulp Products Inc     71,309  
    2,800     Cogeco Inc     133,177  
    8,200     Martinrea International Inc     88,723  
    300     Wajax Corp     6,365  
     

 

 

 
    Total Canada     1,184,893  
     

 

 

 
    China — 2.1%

 

    16,000     Central China Real Estate Ltd     6,691  
    577,000     Powerlong Real Estate Holdings Ltd     295,101  
    77,000     Road King Infrastructure Ltd     130,826  
    4,000     Tianneng Power International Ltd     4,972  
     

 

 

 
    Total China     437,590  
     

 

 

 
    Finland — 1.1%

 

    27,172     Finnair Oyj     237,031  
     

 

 

 
Shares     Description   Value ($)  
    France — 5.2%

 

    997     Alten SA     103,237  
    235     Aubay     11,302  
    14,525     Coface SA     136,275  
    6,624     Gaztransport Et Technigaz SA     453,202  
    1,474     Kaufman & Broad SA     77,622  
    13,335     Metropole Television SA     264,018  
    163     Trigano SA     23,891  
    299     Worldline SA *     18,250  
     

 

 

 
    Total France     1,087,797  
     

 

 

 
    Germany — 5.7%

 

    60     Amadeus Fire AG     6,917  
    4,696     Bauer AG     87,450  
    13,683     Deutsche Lufthansa AG (Registered)     357,503  
    5,335     Elmos Semiconductor AG     137,809  
    13,607     Wacker Neuson SE     376,191  
    9,512     Wuestenrot & Wuerttembergische AG     219,725  
     

 

 

 
    Total Germany     1,185,595  
     

 

 

 
    Hong Kong — 1.8%

 

    116,000     Johnson Electric Holdings Ltd     340,133  
    250,000     Singamas Container Holdings Ltd     32,202  
     

 

 

 
    Total Hong Kong     372,335  
     

 

 

 
    India — 2.1%

 

    6,591     Larsen & Toubro Infotech Ltd     166,160  
    1,682     Mindtree Ltd     26,499  
    2,998     Mphasis Ltd     53,516  
    4,641     NIIT Technologies Ltd     92,223  
    85,932     PTC India Ltd     101,603  
    948     Sonata Software Ltd     4,714  
     

 

 

 
    Total India     444,715  
     

 

 

 
    Indonesia — 0.1%

 

    10,300     Indo Tambangraya Megah Tbk PT     19,792  
     

 

 

 
    Italy — 2.6%

 

    14,541     ASTM SPA     296,782  
    5,377     La Doria SPA     61,701  
    400     Massimo Zanetti Beverage Group SPA     3,139  
    242     SAES Getters SPA     5,816  
    12,535     Societa Iniziative Autostradali e Servizi SPA     174,747  
     

 

 

 
    Total Italy     542,185  
     

 

 

 
    Japan — 24.1%

 

    7,900     Arakawa Chemical Industries Ltd     120,202  
    3,800     Arisawa Manufacturing Co Ltd     36,067  
    100     Azbil Corp     4,358  
    1,000     Dai-ichi Seiko Co Ltd     15,024  
    200     Daito Pharmaceutical Co Ltd     5,731  
 

 

  See accompanying notes to the financial statements.   19


GMO Foreign Small Companies Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Japan — continued

 

    500     Daitron Co Ltd     8,896  
    1,200     Daiwabo Holdings Co Ltd     71,561  
    9,400     Denka Co Ltd     321,659  
    1,000     DKS Co Ltd     6,620  
    1,200     DTS Corp     49,181  
    1,200     ESPEC Corp     24,565  
    9,400     Fancl Corp     482,873  
    200     Fujibo Holdings Inc     5,615  
    5,700     Fujitsu Frontech Ltd     62,994  
    5,200     Fuyo General Lease Co Ltd     312,142  
    200     Hagiwara Electric Holdings Co Ltd     5,985  
    300     Hakuto Co Ltd     4,397  
    200     Hamakyorex Co Ltd     6,720  
    2,000     Haseko Corp     25,910  
    600     Horiba Ltd     37,155  
    11,700     House Foods Group Inc     346,875  
    700     Innotech Corp     8,657  
    15,700     Ishihara Sangyo Kaisha Ltd *     233,684  
    200     Kaga Electronics Co Ltd     3,873  
    1,300     Kanematsu Corp     19,279  
    200     Kato Sangyo Co Ltd     6,495  
    5,500     Keihin Corp     115,579  
    19,200     Kyosan Electric Manufacturing Co Ltd     112,381  
    1,300     Marubun Corp     10,165  
    200     Maruwa Co Ltd     14,934  
    200     Mitsui Sugar Co Ltd     5,451  
    1,800     Nippon Systemware Co Ltd     33,378  
    8,100     Nisshinbo Holdings Inc     90,823  
    200     NuFlare Technology Inc     11,117  
    53,000     Prima Meat Packers Ltd     263,098  
    4,200     Rion Co Ltd     88,881  
    14,400     Rohto Pharmaceutical Co Ltd     460,020  
    300     Sanyo Denki Co Ltd     15,998  
    300     Shindengen Electric Manufacturing Co Ltd     15,085  
    24,000     Showa Corp     382,300  
    41,300     Sojitz Corp     143,718  
    3,600     T-Gaia Corp     94,738  
    1,000     Takasago Thermal Engineering Co Ltd     17,672  
    1,100     Tamura Corp     7,960  
    19,200     Tatsuta Electric Wire and Cable Co Ltd     104,810  
    1,200     Tokyo Seimitsu Co Ltd     37,289  
    4,500     Tokyu Construction Co Ltd     41,346  
    10,500     TS Tech Co Ltd     396,175  
    12,200     Ube Industries Ltd     310,422  
    200     Wacoal Holdings Corp     5,918  
    600     Yokowo Co Ltd     8,274  
    200     Zeon Corp     2,144  
     

 

 

 
    Total Japan     5,016,194  
     

 

 

 
    Malaysia — 1.6%

 

    188,600     Padini Holdings Berhad     274,468  
Shares     Description   Value ($)  
    Malaysia — continued

 

    66,600     Supermax Corp Berhad     54,353  
     

 

 

 
    Total Malaysia     328,821  
     

 

 

 
    Norway — 1.0%

 

    6,122     Austevoll Seafood ASA     80,556  
    187     Entra ASA     2,711  
    1,214     Grieg Seafood ASA     13,967  
    3,813     Kongsberg Automotive ASA *     4,436  
    61,366     Kvaerner ASA *     113,459  
     

 

 

 
    Total Norway     215,129  
     

 

 

 
    Poland — 0.2%

 

    2,659     Asseco Poland SA     32,942  
     

 

 

 
    Portugal — 0.8%

 

    10,394     Navigator Co SA (The)     51,937  
    2,540     Semapa-Sociedade de Investimento e Gestao     52,525  
    51,764     Sonae SGPS SA     55,069  
     

 

 

 
    Total Portugal     159,531  
     

 

 

 
    Singapore — 2.1%

 

    7,700     China Sunsine Chemical Holdings Ltd     6,681  
    112,800     UMS Holdings Ltd     61,356  
    336,600     Yanlord Land Group Ltd     372,984  
     

 

 

 
    Total Singapore     441,021  
     

 

 

 
    South Africa — 0.5%

 

    2,009     Astral Foods Ltd     35,382  
    20,150     Blue Label Telecoms Ltd     9,816  
    12,490     Metair Investments Ltd     14,851  
    3,022     Reunert Ltd     15,654  
    3,235     Wilson Bayly Holmes-Ovcon Ltd     32,991  
     

 

 

 
    Total South Africa     108,694  
     

 

 

 
    South Korea — 6.9%

 

    874     Chong Kun Dang Pharmaceutical Corp     85,159  
    156     Cuckoo Holdings Co Ltd     24,665  
    1,899     Daihan Pharmaceutical Co Ltd     81,359  
    2,360     DongKook Pharmaceutical Co Ltd     146,971  
    1,418     Dongwha Pharm Co Ltd     14,765  
    12,914     Dongwon Development Co Ltd     48,532  
    580     Green Cross Holdings Corp     15,961  
    133     GS Home Shopping Inc     24,776  
    343     HwaSung Industrial Co Ltd     4,450  
    4,040     Hyundai Corp     103,970  
    319     KC Co Ltd     6,247  
    968     Korea United Pharm Inc     24,854  
    1,310     Korean Reinsurance Co     12,244  
    15,927     Kwang Dong Pharmaceutical Co Ltd     107,586  
    528     Kwangju Bank Co Ltd     5,359  
 

 

20   See accompanying notes to the financial statements.  


GMO Foreign Small Companies Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    South Korea — continued

 

    9,331     Kyungdong Pharm Co Ltd     108,585  
    7,498     LF Corp     178,863  
    4,315     LOTTE Himart Co Ltd     277,403  
    391     Nice Information & Telecommunication Inc     8,096  
    1,752     Samjin Pharmaceutical Co Ltd     86,724  
    19,728     Seohan Co Ltd     37,899  
    3,347     Seoyon E-Hwa Co Ltd     18,250  
    391     SL Corp     7,060  
    194     Spigen Korea Co Ltd     9,063  
     

 

 

 
    Total South Korea     1,438,841  
     

 

 

 
    Spain — 2.1%

 

    45,066     Ence Energia y Celulosa SA     422,677  
    652     Papeles y Cartones de Europa SA     12,623  
     

 

 

 
    Total Spain     435,300  
     

 

 

 
    Sweden — 2.6%

 

    1,826     Fabege AB     24,400  
    6,871     Granges AB     80,486  
    3,459     Kindred Group Plc SDR     42,538  
    13,352     Klovern AB – B Shares     18,297  
    1,421     KNOW IT AB     28,378  
    1,235     Mr. Green & Co AB *     5,724  
    7,091     Nobina AB     52,289  
    3,300     Nolato AB – B Shares     233,136  
    850     Oriflame Holding AG     24,732  
    4,850     Resurs Holding AB     35,435  
     

 

 

 
    Total Sweden     545,415  
     

 

 

 
    Switzerland — 5.3%

 

    2,728     ALSO Holding AG (Registered) *     324,646  
    768     BKW AG     54,477  
    3,231     Bobst Group SA (Registered)     276,816  
    324     Georg Fischer AG (Registered)     424,084  
    11     LEM Holding SA (Registered)     13,988  
    119     Zehnder Group AG – Class RG     5,633  
     

 

 

 
    Total Switzerland     1,099,644  
     

 

 

 
    Taiwan — 2.6%

 

    207,000     Coretronic Corp     389,437  
    14,000     Gigabyte Technology Co Ltd     23,888  
    76,000     Wah Lee Industrial Corp     137,156  
     

 

 

 
    Total Taiwan     550,481  
     

 

 

 
    Turkey — 0.0%

 

    7,850     Selcuk Ecza Deposu Ticaret ve Sanayi AS     3,730  
     

 

 

 
    United Kingdom — 14.1%

 

    23,791     Computacenter Plc     418,323  
    12,213     Games Workshop Group Plc     564,439  
Shares     Description   Value ($)  
    United Kingdom — continued

 

    20,001     IG Group Holdings Plc     234,865  
    20,121     Morgan Sindall Group Plc     383,457  
    19,241     Plus500 Ltd     384,398  
    2,289     Safestore Holdings Plc (REIT)     15,782  
    5,845     Softcat Plc     64,420  
    60,647     SThree Plc     277,419  
    78,268     Stock Spirits Group Plc     195,983  
    48,305     Vesuvius Plc     389,156  
     

 

 

 
    Total United Kingdom     2,928,242  
     

 

 

 
   

TOTAL COMMON STOCKS

(COST $20,394,677)

    20,033,956  
     

 

 

 
    PREFERRED STOCKS (a) — 0.2%

 

    Germany — 0.2%

 

    447     Sixt SE     37,353  
     

 

 

 
   

TOTAL PREFERRED STOCKS

(COST $35,748)

    37,353  
     

 

 

 
    MUTUAL FUNDS — 3.1%

 

    United States — 3.1%

 

          Affiliated Issuers — 3.1%      
    25,594     GMO U.S. Treasury Fund     639,328  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $639,328)
    639,328  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.2%

 

    Money Market Fund — 0.2%

 

    45,712     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (b)     45,712  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $45,712)     45,712  
     

 

 

 
    TOTAL INVESTMENTS — 99.7%
(Cost $21,115,465)
    20,756,349  
    Other Assets and Liabilities (net) — 0.3%     62,025  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $20,818,374  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   21


GMO Foreign Small Companies Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Futures Contracts

 

Number
of
Contracts +

 

Type

  Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation)
($)
 
Buys        
4   Mini MSCI EAFE   September 2018   $ 391,760     $ (4,801
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

  

Sales - Fund is short the futures contract.

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

Notes to Schedule of Investments:

 

*

Non-income producing security.

 

(a)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(b)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

22   See accompanying notes to the financial statements.  


GMO International Equity Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    98.3

Preferred Stocks

    0.6  

Mutual Funds

    0.6  

Short-Term Investments

    0.2  

Futures Contracts

    0.0

Other

    0.3  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country Summary¤   % of Investments  

Japan

    27.9

United Kingdom

    15.6  

Germany

    12.4  

France

    8.0  

Sweden

    5.8  

Switzerland

    5.2  

Australia

    4.9  

Italy

    4.7  

Other Developed

    3.8 ‡ 

Norway

    3.8  

Hong Kong

    3.4  

Netherlands

    2.8  

Denmark

    1.7  
 

 

 

 
    100.0 % 
 

 

 

 
 
Industry Group Summary   % of Equity Investments#  

Capital Goods

    14.0

Pharmaceuticals, Biotechnology & Life Sciences

    12.6  

Materials

    11.5  

Automobiles & Components

    8.2  

Banks

    7.6  

Food, Beverage & Tobacco

    6.5  

Technology Hardware & Equipment

    5.1  

Consumer Durables & Apparel

    5.0  

Insurance

    4.7  

Diversified Financials

    4.3  

Energy

    2.9  

Semiconductors & Semiconductor
Equipment

    2.8  

Transportation

    2.7  

Household & Personal Products

    2.5  

Telecommunication Services

    2.4  

Software & Services

    1.8  

Utilities

    1.2  

Real Estate

    1.2  

Retailing

    1.1  

Commercial & Professional Services

    0.7  

Consumer Services

    0.5  

Media

    0.3  

Food & Staples Retailing

    0.2  

Health Care Equipment & Services

    0.2  
 

 

 

 
    100.0 % 
 

 

 

 
&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above shows country exposure in the Fund. The table excludes short-term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap contracts and other derivative financial instruments, if any.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

23


GMO International Equity Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    COMMON STOCKS — 98.3%

 

    Australia — 4.9%

 

    281,212     Abacus Property Group (REIT)     705,255  
    53,956     Altium Ltd     1,089,978  
    184,450     Appen Ltd     2,037,961  
    564,515     Caltex Australia Ltd     12,267,071  
    1,938,303     Costa Group Holdings Ltd     10,090,190  
    112,623     Credit Corp Group Ltd     1,869,487  
    160,897     Crown Resorts Ltd     1,645,395  
    245,236     CSL Ltd     40,203,110  
    2,493,489     CSR Ltd     7,730,346  
    4,338,670     Downer EDI Ltd     24,137,201  
    110,271     Elders Ltd     528,927  
    543,852     Macquarie Group Ltd     50,868,224  
    740,772     Metcash Ltd     1,474,991  
    1,547,774     Mineral Resources Ltd     16,859,728  
    2,676     Monadelphous Group Ltd     27,666  
    3,016,700     Nine Entertainment Co Holdings Ltd     5,241,595  
    1,713,099     OZ Minerals Ltd     11,138,295  
    509,074     Pact Group Holdings Ltd     1,507,768  
    162,922     Qantas Airways Ltd     754,224  
    557,202     Sandfire Resources NL     2,841,252  
    1,030,174     Shopping Centres Australasia Property Group (REIT)     1,788,211  
    345,301     Sigma Healthcare Ltd     141,635  
    252,701     Southern Cross Media Group Ltd     251,607  
    319,432     Tassal Group Ltd     1,021,151  
    17,335     Virtus Health Ltd     72,547  
     

 

 

 
    Total Australia     196,293,815  
     

 

 

 
    Austria — 0.8%

 

    69,286     Oesterreichische Post AG     3,061,649  
    393,728     OMV AG     20,874,269  
    183,920     voestalpine AG     8,266,892  
     

 

 

 
    Total Austria     32,202,810  
     

 

 

 
    Belgium — 0.5%

 

    538,793     AGFA-Gevaert NV *     2,366,041  
    1,001     Barco NV     137,743  
    40,732     D’ieteren SA/NV     1,806,172  
    6,577     Elia System Operator SA/NV     410,780  
    129,378     KBC Group NV     9,198,746  
    79,421     Orange Belgium SA     1,200,501  
    60,701     UCB SA     5,556,529  
     

 

 

 
    Total Belgium     20,676,512  
     

 

 

 
    Denmark — 1.7%

 

    417,927     Novo Nordisk A/S Sponsored ADR     20,549,471  
    753,240     Novo Nordisk A/S – Class B     37,079,113  
    11,091     Per Aarsleff Holding A/S     442,295  
    3,090     Rockwool International A/S – Class B     1,342,707  
Shares     Description   Value ($)  
    Denmark — continued  
    74,784     Royal Unibrew A/S     6,444,633  
    7,566     Schouw & Co AB     598,218  
    9,210     SimCorp A/S     872,361  
     

 

 

 
    Total Denmark     67,328,798  
     

 

 

 
    Finland — 0.2%

 

    40,363     DNA Oyj     858,825  
    9,776     Neste Oyj     848,778  
    23,933     Tieto Oyj     776,817  
    152,223     UPM-Kymmene Oyj     5,871,922  
     

 

 

 
    Total Finland     8,356,342  
     

 

 

 
    France — 7.9%

 

    18,695     AXA SA     471,129  
    822,598     BNP Paribas SA     48,428,770  
    114,196     Christian Dior SE     49,270,394  
    618,691     CNP Assurances     14,299,660  
    15,143     IPSOS     480,012  
    237,634     L’Oreal SA     56,890,979  
    208,823     Metropole Television SA     4,134,466  
    195,296     Sanofi     16,770,723  
    233,828     Sanofi ADR     10,019,530  
    74,811     SCOR SE     3,024,251  
    777,512     Societe Generale SA     31,837,007  
    1,788,022     STMicroelectronics NV – NY Shares     36,994,175  
    2,093,439     STMicroelectronics NV     43,193,054  
     

 

 

 
    Total France     315,814,150  
     

 

 

 
    Germany — 11.7%

 

    114,812     ADVA Optical Networking SE *     919,255  
    494,023     Allianz SE (Registered)     105,296,944  
    131,681     BASF SE     12,168,053  
    114,966     Bayer AG (Registered)     10,729,123  
    946,197     Bayerische Motoren Werke AG     91,598,235  
    71,737     Bechtle AG     7,471,236  
    5,166     Cewe Stiftung & Co KGAA     474,955  
    317,337     Covestro AG     27,018,522  
    1,331,483     Daimler AG (Registered Shares)     86,107,435  
    2,490,576     Deutsche Lufthansa AG (Registered)     65,072,672  
    402,663     Deutsche Pfandbriefbank AG     5,894,704  
    8,615     Diebold Nixdorf AG     571,328  
    43,776     Henkel AG & Co KGaA     4,884,780  
    6,074     Indus Holding AG     391,304  
    50,576     Jenoptik AG     1,989,746  
    1,899     Koenig & Bauer AG     131,717  
    49,705     Leoni AG     2,144,444  
    188,953     RHOEN-KLINIKUM AG     4,961,950  
    19,485     Siltronic AG     2,824,742  
    105,206     Software AG     5,188,042  
    45,692     Talanx AG     1,725,387  
 

 

24   See accompanying notes to the financial statements.  


GMO International Equity Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Germany — continued  
    173,865     Volkswagen AG     27,986,842  
     

 

 

 
    Total Germany     465,551,416  
     

 

 

 
    Hong Kong — 3.4%

 

    6,161,073     BOC Hong Kong Holdings Ltd     30,089,408  
    2,523,640     Champion (REIT)     1,856,177  
    2,067,814     Dah Sing Banking Group Ltd     4,265,078  
    411,515     Dah Sing Financial Holdings Ltd     2,559,506  
    4,603,096     Esprit Holdings Ltd *     1,091,418  
    291,645     Fortune Real Estate Investment Trust     349,349  
    3,809,645     Global Brands Group Holding Ltd *     184,657  
    2,171,001     Hysan Development Co Ltd     11,140,074  
    4,988,469     I-CABLE Communications Ltd *     56,583  
    2,395,913     Kerry Properties Ltd     9,086,076  
    803,257     Luk Fook Holdings International Ltd     2,795,100  
    1,419,647     Pacific Textiles Holdings Ltd     1,076,457  
    9,434,916     SJM Holdings Ltd     10,682,322  
    1,336,673     SmarTone Telecommunications Holdings Ltd     1,352,501  
    381,680     Television Broadcasts Ltd     1,133,618  
    47,968,920     WH Group Ltd     36,227,540  
    2,404,477     Wharf Holdings Ltd (The)     6,866,592  
    599,310     Wharf Real Estate Investment Co Ltd     3,976,329  
    1,137,045     Wheelock & Co Ltd     7,139,606  
    740,122     Xinyi Automobile Glass Hong Kong Enterprises Ltd *     180,155  
    1,776,297     Yue Yuen Industrial Holdings Ltd     4,924,320  
     

 

 

 
    Total Hong Kong     137,032,866  
     

 

 

 
    Ireland — 0.2%

 

    52,811     ICON Plc *     7,869,895  
     

 

 

 
    Israel — 0.2%

 

    707,790     Bank Leumi Le-Israel BM     4,754,463  
    1,390,486     Israel Discount Bank Ltd – Class A     4,859,562  
     

 

 

 
    Total Israel     9,614,025  
     

 

 

 
    Italy — 4.7%

 

    68,883     De’ Longhi SPA     2,252,115  
    6,475,585     Enel SPA     32,014,899  
    99,551     ERG SPA     2,062,043  
    669,237     EXOR NV     43,546,650  
    4,553,824     Fiat Chrysler Automobiles NV *     77,915,929  
    16,211     Fiat Chrysler Automobiles NV *     274,449  
    860,308     Hera SPA     2,699,001  
    1,952,528     Iren SPA     4,579,424  
    45,129     La Doria SPA     517,855  
    259,151     Mediobanca Banca di Credito Finanziario SPA     2,413,117  
    206,405     Poste Italiane SPA     1,589,992  
    153,652     Recordati SPA     5,382,728  
    8,580     Reply SPA     567,627  
Shares     Description   Value ($)  
    Italy — continued  
    1,457,711     Societa Cattolica di Assicurazioni SC     11,830,479  
     

 

 

 
    Total Italy     187,646,308  
     

 

 

 
    Japan — 27.8%

 

    17,213     ADEKA Corp     284,635  
    123,314     Alpine Electronics Inc     2,738,003  
    73,353     AOKI Holdings Inc     989,389  
    3,394,376     Asahi Kasei Corp     49,739,575  
    2,006,550     Astellas Pharma Inc     34,018,246  
    111,927     Autobacs Seven Co Ltd     1,901,152  
    1,741,921     Brother Industries Ltd     35,734,324  
    644,304     Canon Inc     20,673,520  
    45,636     Cawachi Ltd     871,313  
    3,900     Central Japan Railway Co     783,030  
    188,457     CKD Corp     2,783,575  
    10,946     Computer Engineering & Consulting Ltd     239,261  
    251,633     Cosmo Energy Holdings Co Ltd     9,271,597  
    25,934     Daikyo Inc     530,134  
    62,319     Daiwabo Holdings Co Ltd     3,716,325  
    709,162     DCM Holdings Co Ltd     6,477,016  
    249,909     Denka Co Ltd     8,551,647  
    81,385     Dexerials Corp     894,559  
    61,878     Doutor Nichires Holdings Co Ltd     1,088,434  
    15,183     DTS Corp     622,262  
    6,621     Ehime Bank Ltd (The)     73,017  
    331,696     Fancl Corp     17,039,056  
    1,687,225     Fuji Electric Co Ltd     13,591,263  
    5,928,957     Fujitsu Ltd     43,351,459  
    13,418     Fuji Oil Holdings Inc     407,888  
    30,189     Fuyo General Lease Co Ltd     1,812,162  
    148,912     Geo Holdings Corp     2,165,826  
    20,435     Gunze Ltd     1,068,488  
    52,300     Hakuhodo DY Holdings Inc     882,391  
    244,367     Hanwa Co Ltd     8,237,605  
    19,400     Hitachi High-Technologies Corp     761,099  
    13,041,391     Hitachi Ltd     85,128,557  
    2,031     Hokuetsu Bank Ltd (The)     40,911  
    26,600     Honda Motor Co Ltd     787,977  
    11,300     Horiba Ltd     699,748  
    255,849     House Foods Group Inc     7,585,267  
    5,701,968     ITOCHU Corp     99,635,339  
    17,051     Itochu Techno-Solutions Corp     377,167  
    161,711     Kanematsu Corp     2,398,232  
    29,300     KDDI Corp     774,687  
    132,317     Keihin Corp     2,780,569  
    1,500     Keyence Corp     849,162  
    9,975     Kobayashi Pharmaceutical Co Ltd     715,811  
    53,669     Kohnan Shoji Co Ltd     1,237,583  
    13,171     Kokuyo Co Ltd     228,485  
    37,295     Kose Corp     6,876,579  
    50,667     Mandom Corp     1,521,926  
 

 

  See accompanying notes to the financial statements.   25


GMO International Equity Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Japan — continued  
    5,773,212     Marubeni Corp     47,302,554  
    2,119     Maruwa Co Ltd     158,224  
    9,448,156     Mitsubishi Chemical Holdings Corp     84,653,041  
    728,316     Mitsubishi Corp     20,769,426  
    2,480,387     Mitsubishi Electric Corp     33,483,919  
    716,841     Mitsubishi Gas Chemical Co Inc     14,901,604  
    226,607     Mitsubishi Tanabe Pharma Corp     3,779,575  
    1,279,033     Mitsui & Co Ltd     21,307,127  
    344,314     Mitsui Chemicals Inc     8,898,848  
    3,178     Mitsui Sugar Co Ltd     86,612  
    80,150     Modec Inc     2,425,719  
    76,266     Namura Shipbuilding Co Ltd     342,344  
    376,472     NET One Systems Co Ltd     8,719,615  
    303,914     Nichias Corp     3,950,765  
    111,309     Nippo Corp     2,065,929  
    2,039,544     Nippon Telegraph & Telephone Corp     90,741,292  
    68,233     Nippon Signal Co Ltd     699,447  
    104,512     Nishi-Nippon Financial Holdings Inc     1,215,541  
    88,887     Nisshin Seifun Group Inc     1,777,832  
    83,680     Nisshinbo Holdings Inc     938,279  
    31,300     NTT DOCOMO Inc     811,162  
    707     NuFlare Technology Inc     39,298  
    134,392     Okinawa Electric Power Co (The)     2,701,095  
    235,946     Pola Orbis Holdings Inc     8,315,160  
    94,802     Press Kogyo Co Ltd     496,443  
    1,219,980     Prima Meat Packers Ltd     6,056,115  
    139,600     Resona Holdings Inc     791,842  
    199,486     Rohto Pharmaceutical Co Ltd     6,372,749  
    37,957     San-A Co Ltd     1,770,284  
    6,003     Sankyu Inc     318,407  
    100,187     Seiko Holdings Corp     2,801,419  
    1,235,828     Sekisui Chemical Co Ltd     21,469,023  
    53,200     Showa Corp     847,432  
    33,455     Softbank Technology Corp     738,979  
    11,724,287     Sojitz Corp     40,798,939  
    8,910,063     Sumitomo Chemical Co Ltd     50,571,861  
    52,700     Sumitomo Dainippon Pharma Co Ltd     1,121,409  
    66,227     Sumitomo Forestry Co Ltd     1,069,736  
    234,005     Sumitomo Heavy Industries Ltd     7,613,855  
    27,200     Suntory Beverage & Food Ltd     1,114,132  
    142,203     T-Gaia Corp     3,742,236  
    156,350     Tokyo Electron Ltd     26,618,548  
    43,361     Tokyo Seimitsu Co Ltd     1,347,423  
    151,295     Tokyu Construction Co Ltd     1,390,114  
    1,126,904     Tosoh Corp     17,681,394  
    48,637     Towa Pharmaceutical Co Ltd     3,385,641  
    1,019,254     Toyota Tsusho Corp     34,723,643  
    27,982     TPR Co Ltd     656,327  
    228,267     TS Tech Co Ltd     8,612,722  
    76,619     TSI Holdings Co Ltd     507,962  
    422,116     Ube Industries Ltd     10,740,488  
Shares     Description   Value ($)  
    Japan — continued  
    6,003     UKC Holdings Corp     132,246  
    197,814     Valor Holdings Co Ltd     4,196,379  
    23,304     Warabeya Nichiyo Holdings Co Ltd     458,509  
    26,746     Yahagi Construction Co Ltd     199,467  
    547,363     Zeon Corp     5,867,430  
     

 

 

 
    Total Japan     1,107,233,813  
     

 

 

 
    Malta — 0.0%

 

    15,858,986     BGP Holdings Plc * (a)      
     

 

 

 
    Netherlands — 2.7%

 

    77,343     ASR Nederland NV     3,697,707  
    91,694     BinckBank NV     591,807  
    16,849     Corbion NV     529,779  
    171,411     Heineken Holding NV     16,354,915  
    6,431,127     ING Groep NV     87,359,018  
    31,461     Koninklijke Ahold Delhaize NV     766,371  
     

 

 

 
    Total Netherlands     109,299,597  
     

 

 

 
    New Zealand — 0.1%

 

    481,967     Air New Zealand Ltd     1,052,189  
    208,052     Chorus Ltd     636,030  
     

 

 

 
    Total New Zealand     1,688,219  
     

 

 

 
    Norway — 3.7%

 

    33,335     Aker ASA – A Shares     2,611,733  
    10,483     Austevoll Seafood ASA     137,940  
    157,490     Bakkafrost P/F     8,984,724  
    437,753     BW LPG Ltd *     1,707,782  
    2,877,863     DNB ASA     58,506,982  
    2,399,926     Equinor ASA     61,558,590  
    303,618     Leroy Seafood Group ASA     2,308,739  
    52,097     Salmar ASA     2,508,271  
    10,853     SpareBank 1 Nord Norge     84,892  
    1,203,318     Storebrand ASA     10,652,929  
     

 

 

 
    Total Norway     149,062,582  
     

 

 

 
    Portugal — 0.1%

 

    130,405     Altri SGPS SA     1,202,551  
    291,299     CTT-Correios de Portugal SA     1,132,521  
    156,727     Navigator Co SA (The)     783,139  
    639,463     REN-Redes Energeticas Nacionais SGPS SA     1,811,204  
     

 

 

 
    Total Portugal     4,929,415  
     

 

 

 
    Singapore — 0.4%

 

    237,535     DBS Group Holdings Ltd     4,318,155  
    1,208,946     Mapletree North Asia Commercial Trust (REIT)     1,021,617  
    681,886     Venture Corp Ltd     9,002,425  
    81,474     Yanlord Land Group Ltd     90,280  
     

 

 

 
    Total Singapore     14,432,477  
     

 

 

 
 

 

26   See accompanying notes to the financial statements.  


GMO International Equity Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Spain — 0.7%

 

    439,475     Ebro Foods SA     9,456,523  
    330,696     Ence Energia y Celulosa SA     3,101,624  
    1,769,921     International Consolidated Airlines Group SA     15,886,639  
    492,850     Unicaja Banco SA     771,071  
     

 

 

 
    Total Spain     29,215,857  
     

 

 

 
    Sweden — 5.8%

 

    187,013     Atlas Copco AB – A Shares     5,331,291  
    294,522     Epiroc AB – Class A *     3,059,500  
    5,748     Granges AB     67,331  
    308,414     Kindred Group Plc SDR     3,792,835  
    52,970     Klovern AB – B Shares     72,589  
    101,687     Oriflame Holding AG     2,958,699  
    2,955,839     Sandvik AB     51,740,876  
    374,746     SAS AB *     829,682  
    101,246     Securitas AB – B Shares     1,801,842  
    50,275     SKF AB – B Shares     966,413  
    3,643,925     Svenska Cellulosa AB SCA – Class B     42,419,710  
    29,328     Swedish Orphan Biovitrum AB *     934,632  
    490,329     Swedish Match AB     26,212,269  
    5,216,803     Volvo AB – B Shares     89,869,310  
    94,381     Wihlborgs Fastigheter AB     1,138,351  
     

 

 

 
    Total Sweden     231,195,330  
     

 

 

 
    Switzerland — 5.2%

 

    51,443     Ascom Holding AG (Registered)     1,014,244  
    6,111     Autoneum Holding AG     1,452,148  
    1,566     Banque Cantonale Vaudoise (Registered)     1,173,482  
    5,028     BKW AG     356,654  
    303     Bobst Group SA (Registered)     25,960  
    13,954     Bucher Industries AG (Registered)     4,889,322  
    3,009     Emmi AG (Registered)     2,298,591  
    15,301     Galenica AG *     907,275  
    250,496     GAM Holding AG *     1,934,406  
    20,698     Georg Fischer AG (Registered)     27,091,633  
    10,879     Implenia AG (Registered)     692,823  
    8,453     Kardex AG (Registered) *     1,515,047  
    4,802     Komax Holding AG (Registered)     1,611,669  
    453,393     Logitech International SA (Registered)     22,362,480  
    270,392     Novartis AG (Registered)     22,432,291  
    41,399     Roche Holding AG     10,379,721  
    96,993     Roche Holding AG     24,049,760  
    351,880     Sika AG (Registered)     52,115,577  
    274,704     Swiss Re AG     24,715,213  
    1,448     Valora Holding AG (Registered) *     419,805  
    53,896     Vontobel Holding AG (Registered)     3,845,774  
    4,556     Zehnder Group AG – Class RG     215,675  
     

 

 

 
    Total Switzerland     205,499,550  
     

 

 

 
Shares     Description   Value ($)  
    United Kingdom — 15.6%

 

    2,947,306     3i Group Plc     34,318,928  
    275,233     Ashtead Group Plc     8,445,960  
    1,415,066     AstraZeneca Plc     106,800,345  
    331,507     Bellway Plc     12,558,881  
    665,385     Berkeley Group Holdings Plc (The)     31,473,468  
    197,953     Bovis Homes Group Plc     2,893,030  
    1,314,640     British American Tobacco Plc     63,572,378  
    679,748     Cairn Energy Plc *     2,110,215  
    904,161     Coca-Cola HBC AG *     30,958,559  
    3,780,523     Debenhams Plc     641,761  
    57,199     Diageo Plc Sponsored ADR     7,974,113  
    40,126     easyJet Plc     794,917  
    1,316,673     Electrocomponents Plc     12,691,378  
    3,064,322     Ferrexpo Plc     6,185,609  
    72,590     Fevertree Drinks Plc     3,509,380  
    6,564,594     Firstgroup Plc *     7,576,734  
    363,350     Galliford Try Plc     4,582,327  
    5,996,209     GlaxoSmithKline Plc     121,440,441  
    117,113     Halfords Group Plc     500,771  
    17,200     HSBC Holdings Plc Sponsored ADR     756,972  
    294,196     Hunting Plc *     3,186,743  
    1,148,371     IG Group Holdings Plc     13,484,914  
    911,779     Inchcape Plc     8,190,951  
    2,271,486     Indivior Plc *     7,986,030  
    32,426     Intermediate Capital Group Plc     442,075  
    1,996,658     Legal & General Group Plc     6,598,236  
    356,328     National Express Group Plc     1,832,059  
    171,024     Next Plc     12,210,935  
    419,548     Nomad Foods Ltd *     8,747,576  
    2,029,114     Persimmon Plc     64,194,967  
    744,267     Plus500 Ltd     14,869,036  
    218,521     QinetiQ Group Plc     769,520  
    1,044,964     Royal Mail Plc     6,076,692  
    61,871     Savills Plc     642,460  
    171,300     Spectris Plc     5,237,020  
    39,179     TUI AG     723,181  
    313,257     Vesuvius Plc     2,523,667  
    806,134     William Hill Plc     2,693,416  
     

 

 

 
    Total United Kingdom     620,195,645  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $3,746,997,683)
    3,921,139,422  
     

 

 

 
    PREFERRED STOCKS (b) — 0.6%

 

    Germany — 0.6%

 

    12,419     Bayerische Motoren Werke AG     1,041,423  
    143,742     Jungheinrich AG     5,183,491  
    115,318     Volkswagen AG     18,850,775  
     

 

 

 
    Total Germany     25,075,689  
     

 

 

 
    TOTAL PREFERRED STOCKS
(COST $22,817,543)
    25,075,689  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   27


GMO International Equity Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    MUTUAL FUNDS — 0.6%

 

    United States — 0.6%

 

    Affiliated Issuers — 0.6%

 

    894,473     GMO U.S. Treasury Fund     22,343,940  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $22,343,940)
    22,343,940  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.2%

 

    Money Market Fund — 0.2%

 

    9,905,611     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (c)     9,905,611  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $9,905,611)
    9,905,611  
     

 

 

 
    TOTAL INVESTMENTS — 99.7%
(Cost $3,802,064,777)
    3,978,464,662  
    Other Assets and Liabilities (net) — 0.3%     11,536,457  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $3,990,001,119  
     

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Futures Contracts

 

Number
of
Contracts +

 

Type

  Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation)
($)
 
Buys        
124   Mini MSCI EAFE   September 2018   $ 12,144,560     $ (323,533
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

    

Sales - Fund is short the futures contract.

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

Notes to Schedule of Investments:

 

*

Non-income producing security.

 

(a)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

 

(b)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(c)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

28   See accompanying notes to the financial statements.  


GMO International Large/Mid Cap Equity Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    93.6

Mutual Funds

    2.5  

Preferred Stocks

    1.5  

Short-Term Investments

    0.4  

Futures Contracts

    0.0

Other

    2.0  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country Summary¤   % of Investments  

Japan

    27.1

United Kingdom

    16.0  

Germany

    9.9  

France

    8.8  

Hong Kong

    5.8  

Switzerland

    5.6  

Italy

    4.2  

Sweden

    4.0  

Netherlands

    3.7  

Australia

    3.5  

United States

    2.5  

Other Developed

    2.3 ‡ 

Austria

    1.9  

Finland

    1.8  

European Union

    1.5  

Denmark

    1.4  
 

 

 

 
    100.0 % 
 

 

 

 
 
Industry Group Summary   % of Equity Investments#  

Capital Goods

    13.2

Pharmaceuticals, Biotechnology & Life Sciences

    12.8  

Materials

    12.2  

Automobiles & Components

    8.0  

Banks

    7.2  

Food, Beverage & Tobacco

    7.0  

Consumer Durables & Apparel

    6.8  

Technology Hardware & Equipment

    5.9  

Diversified Financials

    5.4  

Real Estate

    4.6  

Insurance

    3.6  

Energy

    2.8  

Transportation

    2.5  

Telecommunication Services

    2.3  

Household & Personal Products

    2.0  

Semiconductors & Semiconductor Equipment

    1.7  

Software & Services

    1.0  

Consumer Services

    0.3  

Utilities

    0.3  

Commercial & Professional Services

    0.2  

Retailing

    0.2  

Media

    0.0
 

 

 

 
    100.0 % 
 

 

 

 
&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above shows country exposure in the Fund. The table excludes short-term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap contracts and other derivative financial instruments, if any.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

29


GMO International Large/Mid Cap Equity Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    COMMON STOCKS — 93.6%

 

    Australia — 3.5%

 

    6,941     Caltex Australia Ltd     150,830  
    7,780     Downer EDI Ltd     43,282  
    5,949     Fairfax Media Ltd     3,780  
    3,637     Macquarie Group Ltd     340,180  
    6,387     Mineral Resources Ltd     69,573  
    3,309     Westpac Banking Corp     67,960  
     

 

 

 
    Total Australia     675,605  
     

 

 

 
    Austria — 1.9%

 

    6,976     OMV AG     369,846  
    85     voestalpine AG     3,821  
     

 

 

 
    Total Austria     373,667  
     

 

 

 
    Belgium — 0.0%

 

    361     bpost SA     5,471  
     

 

 

 
    Denmark — 1.4%

 

    1,500     Novo Nordisk A/S Sponsored ADR     73,755  
    3,969     Novo Nordisk A/S – Class B     195,379  
     

 

 

 
    Total Denmark     269,134  
     

 

 

 
    Finland — 1.8%

 

    9,138     UPM – Kymmene Oyj     352,494  
     

 

 

 
    France — 8.7%

 

    4,915     AXA SA     123,862  
    7,464     BNP Paribas SA     439,428  
    548     Christian Dior SE     236,437  
    1,526     L’Oreal SA     365,333  
    800     Sanofi ADR     34,280  
    818     SCOR SE     33,068  
    4,240     Societe Generale SA     173,616  
    13,100     STMicroelectronics NV – NY Shares     271,039  
    1,016     STMicroelectronics NV     20,963  
     

 

 

 
    Total France     1,698,026  
     

 

 

 
    Germany — 8.3%

 

    2,383     Allianz SE (Registered)     507,917  
    4,392     Bayerische Motoren Werke AG     425,175  
    3,686     Daimler AG (Registered Shares)     238,375  
    11,919     Deutsche Lufthansa AG (Registered)     311,414  
    773     Volkswagen AG     124,429  
     

 

 

 
    Total Germany     1,607,310  
     

 

 

 
    Hong Kong — 5.8%

 

    6,000     BOC Hong Kong Holdings Ltd     29,303  
    54,000     SJM Holdings Ltd     61,139  
    257,000     WH Group Ltd     194,094  
    62,000     Wharf Holdings Ltd (The)     177,057  
Shares     Description   Value ($)  
    Hong Kong — continued  
    61,000     Wharf Real Estate Investment Co Ltd     404,725  
    41,000     Wheelock & Co Ltd     257,443  
     

 

 

 
    Total Hong Kong     1,123,761  
     

 

 

 
    Ireland — 0.6%

 

    800     ICON Plc *     119,216  
     

 

 

 
    Israel — 0.0%

 

    400     Teva Pharmaceutical Industries Ltd Sponsored ADR *     9,164  
     

 

 

 
    Italy — 4.2%

 

    293     ASTM SPA     5,980  
    10,069     Enel SPA     49,781  
    5,405     EXOR NV     351,698  
    23,500     Fiat Chrysler Automobiles NV *     402,085  
     

 

 

 
    Total Italy     809,544  
     

 

 

 
    Japan — 26.9%

 

    29,100     Asahi Kasei Corp     426,418  
    11,300     Brother Industries Ltd     231,812  
    7,100     Canon Inc     227,815  
    26,000     Fujitsu Ltd     190,107  
    60,000     Hitachi Ltd     391,654  
    1,500     House Foods Group Inc     44,471  
    26,600     ITOCHU Corp     464,804  
    2,280     K’s Holdings Corp     27,599  
    55,800     Marubeni Corp     457,195  
    44,200     Mitsubishi Chemical Holdings Corp     396,021  
    20,400     Mitsubishi Electric Corp     275,389  
    6,200     Mitsubishi Gas Chemical Co Inc     128,885  
    9,700     Nippon Telegraph & Telephone Corp     431,562  
    2,300     Nisshinbo Holdings Inc     25,789  
    6,600     Otsuka Holdings Co Ltd     309,639  
    1,300     Rohto Pharmaceutical Co Ltd     41,530  
    18,900     Sekisui Chemical Co Ltd     328,334  
    63,300     Sojitz Corp     220,276  
    38,000     Sumitomo Chemical Co Ltd     215,681  
    100     Tokyo Electron Ltd     17,025  
    10,700     Toyota Tsusho Corp     364,524  
     

 

 

 
    Total Japan     5,216,530  
     

 

 

 
    Malta — 0.0%

 

    15,998,662     BGP Holdings Plc * (a)      
     

 

 

 
    Netherlands — 3.7%

 

    3,162     Heineken Holding NV     301,697  
    30,187     ING Groep NV     410,054  
     

 

 

 
    Total Netherlands     711,751  
     

 

 

 
 

 

30   See accompanying notes to the financial statements.  


GMO International Large/Mid Cap Equity Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Norway — 0.9%

 

    8,883     DNB ASA     180,591  
     

 

 

 
    Singapore — 0.7%

 

    800     DBS Group Holdings Ltd     14,543  
    9,100     Venture Corp Ltd     120,141  
     

 

 

 
    Total Singapore     134,684  
     

 

 

 
    Sweden — 3.9%

 

    1,171     Epiroc AB – Class A *     12,164  
    24,826     Svenska Cellulosa AB SCA – Class B     289,005  
    749     Swedish Match AB     40,041  
    24,348     Volvo AB – B Shares     419,440  
     

 

 

 
    Total Sweden     760,650  
     

 

 

 
    Switzerland — 5.5%

 

    16     Bucher Industries AG (Registered)     5,606  
    152     Georg Fischer AG (Registered)     198,953  
    1,762     Roche Holding AG     436,894  
    272     Roche Holding AG     68,197  
    2,414     Sika AG (Registered)     357,528  
     

 

 

 
    Total Switzerland     1,067,178  
     

 

 

 
    United Kingdom — 15.8%

 

    20,589     3i Group Plc     239,742  
    7,242     AstraZeneca Plc     546,581  
    6,485     Berkeley Group Holdings Plc (The)     306,748  
    10,459     British American Tobacco Plc     505,768  
    2,036     Coca-Cola HBC AG *     69,713  
    11,507     Electrocomponents Plc     110,916  
    8,042     Ferrexpo Plc     16,234  
    26,239     GlaxoSmithKline Plc     531,415  
    400     HSBC Holdings Plc Sponsored ADR     17,604  
    3,673     IG Group Holdings Plc     43,131  
    6,300     Nomad Foods Ltd *     131,355  
    12,143     Persimmon Plc     384,167  
    1,307     Plus500 Ltd     26,111  
    24,773     Royal Mail Plc     144,060  
     

 

 

 
    Total United Kingdom     3,073,545  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $17,298,023)
    18,188,321  
     

 

 

 
Shares     Description   Value ($)  
    PREFERRED STOCKS (b) — 1.5%

 

    Germany — 1.5%

 

    4,657     Porsche Automobil Holding SE     294,645  
     

 

 

 
    TOTAL PREFERRED STOCKS
(COST $214,775)
    294,645  
     

 

 

 
    MUTUAL FUNDS — 2.5%

 

    United States — 2.5%

 

          Affiliated Issuers — 2.5%  
    19,124     GMO U.S. Treasury Fund     477,713  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $477,713)
    477,713  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.4%

 

    Money Market Fund — 0.4%

 

    69,503     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (c)     69,503  
     

 

 

 
    Total Money Market Funds     69,503  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $69,503)
    69,503  
     

 

 

 
    TOTAL INVESTMENTS — 98.0%
(Cost $18,060,014)
    19,030,182  
    Other Assets and Liabilities (net) — 2.0%     394,742  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $19,424,924  
     

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Futures Contracts

 

Number
of
Contracts +

 

Type

  Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation)
($)
 
Buys        
3   Mini MSCI EAFE   September 2018   $ 293,820     $ 218  
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

  

Sales - Fund is short the futures contract.

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

  See accompanying notes to the financial statements.   31


GMO International Large/Mid Cap Equity Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Notes to Schedule of Investments:

 

*

Non-income producing security.

 

(a)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

 

(b)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(c)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

32   See accompanying notes to the financial statements.  


GMO Quality Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    98.1

Short-Term Investments

    1.4  

Mutual Funds

    0.7  

Other

    (0.2
 

 

 

 
    100.0 % 
 

 

 

 
 
Country Summary¤   % of Investments  

United States

    83.4

United Kingdom

    6.9  

Switzerland

    5.7  

Taiwan

    2.2  

Germany

    1.8  
 

 

 

 
    100.0 % 
 

 

 

 
 
Industry Group Summary   % of Equity Investments#  

Software & Services

    29.5

Health Care Equipment & Services

    13.2  

Technology Hardware & Equipment

    9.9  

Pharmaceuticals, Biotechnology & Life Sciences

    9.7  

Semiconductors & Semiconductor Equipment

    6.8  

Food, Beverage & Tobacco

    6.5  

Banks

    5.4  

Capital Goods

    5.0  

Household & Personal Products

    4.7  

Food & Staples Retailing

    3.2  

Retailing

    3.0  

Diversified Financials

    2.6  

Consumer Services

    0.4  

Consumer Durables & Apparel

    0.1  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above shows country exposure in the Fund. The table excludes short-term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap contracts and other derivative financial instruments, if any.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

 

33


GMO Quality Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    COMMON STOCKS — 98.1%

 

    Banks — 5.3%

 

    3,368,046     US Bancorp     182,244,969  
    3,338,662     Wells Fargo & Co.     195,244,954  
     

 

 

 
    Total Banks     377,489,923  
     

 

 

 
    Capital Goods — 4.9%

 

    562,653     3M Co.     118,674,771  
    514,294     Honeywell International, Inc.     81,803,603  
    1,156,887     United Technologies Corp.     152,362,018  
     

 

 

 
    Total Capital Goods     352,840,392  
     

 

 

 
    Consumer Durables & Apparel — 0.1%

 

    81,910     VF Corp.     7,546,368  
     

 

 

 
    Consumer Services — 0.4%

 

    1,446,577     Compass Group Plc     31,146,619  
     

 

 

 
    Diversified Financials — 2.5%

 

    1,720,146     American Express Co.     182,301,073  
     

 

 

 
    Food & Staples Retailing — 3.1%

 

    951,973     Costco Wholesale Corp.     221,933,465  
     

 

 

 
    Food, Beverage & Tobacco — 6.4%

 

    2,564,579     British American Tobacco Plc     124,015,994  
    2,439,355     Coca-Cola Co. (The)     108,722,052  
    1,394,849     Nestle SA (Registered)     116,926,101  
    278,567     PepsiCo, Inc.     31,202,290  
    975,007     Philip Morris International, Inc.     75,943,295  
     

 

 

 
    Total Food, Beverage & Tobacco     456,809,732  
     

 

 

 
    Health Care Equipment & Services — 13.0%

 

    1,458,247     Abbott Laboratories     97,469,229  
    690,520     Anthem, Inc.     182,801,360  
    361,600     Becton Dickinson and Co.     94,692,192  
    2,337,670     Medtronic Plc     225,374,765  
    293,016     Stryker Corp.     49,645,701  
    1,036,803     UnitedHealth Group, Inc.     278,340,133  
     

 

 

 
    Total Health Care Equipment & Services     928,323,380  
     

 

 

 
    Household & Personal Products — 4.6%

 

    1,729,340     Reckitt Benckiser Group Plc     147,309,007  
    3,231,325     Unilever Plc     184,136,192  
     

 

 

 
    Total Household & Personal Products     331,445,199  
     

 

 

 
    Pharmaceuticals, Biotechnology & Life Sciences — 9.5%

 

    1,675,508     Johnson & Johnson     225,674,173  
    2,149,241     Merck & Co., Inc.     147,416,440  
    1,493,136     Novartis AG (Registered)     123,873,714  

Shares/

Par Value†

    Description   Value ($)  
    Pharmaceuticals, Biotechnology & Life Sciences — continued

 

    471,912     Pfizer, Inc.     19,593,786  
    664,540     Roche Holding AG     164,775,064  
     

 

 

 
    Total Pharmaceuticals, Biotechnology & Life Sciences     681,333,177  
     

 

 

 
    Retailing — 3.0%

 

    1,921,050     TJX Cos, Inc. (The)     211,257,869  
     

 

 

 
    Semiconductors & Semiconductor Equipment — 6.7%

 

    2,878,210     QUALCOMM, Inc.     197,761,809  
    18,359,790     Taiwan Semiconductor Manufacturing Co Ltd     153,830,965  
    1,131,581     Texas Instruments, Inc.     127,189,705  
     

 

 

 
    Total Semiconductors & Semiconductor Equipment     478,782,479  
     

 

 

 
    Software & Services — 28.9%

 

    1,413,062     Accenture Plc – Class A     238,906,392  
    176,055     Alphabet, Inc. – Class A *     216,864,549  
    201,923     Alphabet, Inc. – Class C *     245,980,580  
    2,171,758     Cognizant Technology Solutions Corp. – Class A     170,330,980  
    635,972     Facebook, Inc. – Class A *     111,759,360  
    349,852      Mastercard, Inc. – Class A     75,414,097  
    3,634,015     Microsoft Corp.     408,208,905  
    7,189,545     Oracle Corp.     349,268,096  
    1,072,629     SAP SE     128,766,730  
    873,139     Teradata Corp. *     36,209,074  
    625,808     Visa, Inc. – Class A     91,924,937  
     

 

 

 
    Total Software & Services     2,073,633,700  
     

 

 

 
    Technology Hardware & Equipment — 9.7%

 

    528,265     Amphenol Corp. – Class A     49,963,304  
    2,011,290     Apple, Inc.     457,829,943  
    3,999,564     Cisco Systems, Inc.     191,059,172  
     

 

 

 
    Total Technology Hardware & Equipment     698,852,419  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $4,527,040,959)
    7,033,695,795  
     

 

 

 
    MUTUAL FUNDS — 0.7%

 

    Affiliated Issuers — 0.7%

 

    2,045,410     GMO U.S. Treasury Fund     51,094,345  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $51,089,904)
    51,094,345  
     

 

 

 
 

 

34   See accompanying notes to the financial statements.  


GMO Quality Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares/

Par Value†

    Description   Value ($)  
    SHORT-TERM INVESTMENTS — 1.4%

 

    Money Market Funds — 0.2%

 

    13,188,942     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (a)     13,188,942  
     

 

 

 
    U.S. Government — 1.2%

 

    5,000,000     U.S. Treasury Bill, 2.01%, due 11/29/18 (b)     4,975,365  
    63,000,000     U.S. Treasury Bill, 2.05%, due 12/20/18 (b)     62,610,052  
    22,000,000     U.S. Treasury Bill, 2.21%, due 02/21/19 (b)     21,770,925  
     

 

 

 
    TOTAL U.S. GOVERNMENT
(COST $89,349,096)
    89,356,342  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $102,538,038)
    102,545,284  
     

 

 

 
    TOTAL INVESTMENTS — 100.2%
(Cost $4,680,668,901)
    7,187,335,424  
    Other Assets and Liabilities (net) — (0.2%)     (16,543,271
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $7,170,792,153  
     

 

 

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

*

Non-income producing security.

 

(a)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(b)

The rate shown represents yield-to-maturity.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

  See accompanying notes to the financial statements.   35


GMO Resources Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    88.7

Preferred Stocks

    8.5  

Mutual Funds

    2.4  

Short-Term Investments

    0.2  

Rights/Warrants

    0.0

Other

    0.2  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country Summary¤   % of Investments  

United States

    16.3

Russia

    14.2  

United Kingdom

    13.8  

Norway

    8.1  

Japan

    5.4  

Australia

    4.7  

France

    4.6  

Other Emerging

    4.5 † 

Brazil

    4.4  

Other Developed

    3.3 ‡ 

Chile

    3.2  

Israel

    2.5  

China

    2.3  

Sweden

    2.3  

Thailand

    2.2  

Denmark

    2.0  

Poland

    1.9  

Spain

    1.8  

South Africa

    1.5  

Argentina

    1.0  
 

 

 

 
    100.0 % 
 

 

 

 
 
Industry Group Summary   % of Equity Investments#  

Energy

    39.0

Industrial Metals

    38.6  

Agriculture

    18.7  

Water

    3.7  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above shows country exposure in the Fund. The table excludes short-term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap contracts and other derivative financial instruments, if any.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

36


GMO Resources Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    COMMON STOCKS — 88.7%

 

    Argentina — 1.0%

 

    578,300     Adecoagro SA *     4,632,183  
     

 

 

 
    Australia — 4.6%

 

    1,047,536     Ausdrill Ltd     1,218,337  
    233,874     Beach Energy Ltd     326,905  
    424,574     Mineral Resources Ltd     4,624,837  
    157,262     Nufarm Ltd     774,233  
    244,343     OZ Minerals Ltd     1,588,679  
    794,939     Sandfire Resources NL     4,053,507  
    2,245,927     South32 Ltd     5,617,359  
    94,962     Woodside Petroleum Ltd     2,519,356  
     

 

 

 
    Total Australia     20,723,213  
     

 

 

 
    Austria — 0.7%

 

    57,249     OMV AG     3,035,169  
     

 

 

 
    Brazil — 1.0%

 

    342,400     Cosan SA Industria e Comercio     2,925,418  
    302,357     Sao Martinho SA     1,406,709  
     

 

 

 
    Total Brazil     4,332,127  
     

 

 

 
    Canada — 0.9%

 

    86,500     Canadian Solar Inc *     1,242,140  
    21,531     Nutrien Ltd     1,219,300  
    30,140     Nutrien Ltd     1,693,845  
     

 

 

 
    Total Canada     4,155,285  
     

 

 

 
    China — 2.3%

 

    2,222,000     China High Speed Transmission Equipment Group Co Ltd     2,471,768  
    1,535,000     China Singyes Solar Technologies Holdings Ltd     485,260  
    1,071,914     Inner Mongolia Eerduosi Resourses Co Ltd – Class A     1,359,382  
    1,297,100     Shenzhen Zhongjin Lingnan Nonfemet Co Ltd     878,082  
    3,284,200     Xinjiang Goldwind Science & Technology Co Ltd – Class H     3,519,313  
    5,062,000     Xinyi Solar Holdings Ltd     1,509,831  
     

 

 

 
    Total China     10,223,636  
     

 

 

 
    Colombia — 0.8%

 

    3,125,056     Ecopetrol SA     3,508,590  
     

 

 

 
    Denmark — 2.0%

 

    129,074     Vestas Wind Systems A/S     9,053,042  
     

 

 

 
    Finland — 0.2%

 

    49,394     Kemira Oyj     654,902  
     

 

 

 
    France — 4.6%

 

    218,120     Suez     3,156,851  
Shares     Description   Value ($)  
    France — continued

 

    181,580     TOTAL SA     11,386,484  
    177,406     Veolia Environnement SA     3,737,085  
    33,592     Vilmorin & Cie SA     2,330,489  
     

 

 

 
    Total France     20,610,909  
     

 

 

 
    Germany — 0.7%

 

    55,676     CropEnergies AG     298,205  
    34,359     K+S AG (Registered)     781,606  
    69,356     Nordex SE *     718,295  
    370,435     PNE Wind AG     1,218,910  
    32,938     Senvion SA *     268,570  
     

 

 

 
    Total Germany     3,285,586  
     

 

 

 
    Hungary — 0.6%

 

    247,117     MOL Hungarian Oil & Gas Plc     2,521,762  
     

 

 

 
    India — 0.5%

 

    954,634     Oil & Natural Gas Corp Ltd *     2,422,556  
     

 

 

 
    Israel — 2.5%

 

    1,132,173     Israel Chemicals Ltd     6,615,459  
    12,847     Israel Corp Ltd (The)     3,865,254  
    12,876     Jerusalem Oil Exploration *     720,476  
     

 

 

 
    Total Israel     11,201,189  
     

 

 

 
    Italy — 0.4%

 

    325,959     Saipem SPA *     1,743,179  
     

 

 

 
    Japan — 5.4%

 

    98,200     Ebara Corp     3,356,002  
    289,600     Hitachi Zosen Corp     1,245,289  
    145,600     Kubota Corp     2,275,826  
    106,400     Kumiai Chemical Industry Co Ltd     906,896  
    24,900     Kurita Water Industries Ltd     739,101  
    232,300     Mitsubishi Materials Corp     6,281,410  
    29,300     Modec Inc     886,757  
    37,700     Nittetsu Mining Co Ltd     1,736,064  
    14,400     Organo Corp     405,871  
    76,300     Shinko Plantech Co Ltd     714,028  
    235,800     Sumitomo Forestry Co Ltd     3,808,776  
    127,200     Takuma Co Ltd     1,567,084  
     

 

 

 
    Total Japan     23,923,104  
     

 

 

 
    Netherlands — 0.3%

 

    62,531     SBM Offshore NV     1,011,686  
    19,601     SIF Holding NV     385,942  
     

 

 

 
    Total Netherlands     1,397,628  
     

 

 

 
    Norway — 8.1%

 

    560,801     Austevoll Seafood ASA     7,379,260  
    48,908     Bakkafrost P/F     2,790,176  
 

 

  See accompanying notes to the financial statements.   37


GMO Resources Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Norway — continued

 

    187,275     BW Offshore Ltd *     1,335,600  
    250,243     Equinor ASA     6,418,784  
    182,713     Grieg Seafood ASA     2,102,043  
    72,515     Marine Harvest ASA     1,566,157  
    131,624     Ocean Yield ASA     1,001,874  
    178,032     Odfjell Drilling Ltd *     791,828  
    84,843     Salmar ASA     4,084,866  
    202,347     Subsea 7 SA     2,750,977  
    24,260     TGS NOPEC Geophysical Co ASA     920,053  
    109,802     Yara International ASA     5,052,354  
     

 

 

 
    Total Norway     36,193,972  
     

 

 

 
    Pakistan — 0.8%

 

    2,562,500     Engro Fertilizers Ltd     1,630,501  
    559,500     Fauji Fertilizer Co Ltd     440,958  
    46,120     Millat Tractors Ltd     466,025  
    798,400     Oil & Gas Development Co Ltd     977,683  
     

 

 

 
    Total Pakistan     3,515,167  
     

 

 

 
    Poland — 1.9%

 

    268,834     KGHM Polska Miedz SA *     6,577,089  
    1,228,635     Polskie Gornictwo Naftowe i Gazownictwo SA     1,924,753  
     

 

 

 
    Total Poland     8,501,842  
     

 

 

 
    Qatar — 0.1%

 

    93,117     Gulf International Services QSC *     443,339  
     

 

 

 
    Russia — 12.2%

 

    1,636,830     Gazprom Neft PJSC     8,150,798  
    161,479     LUKOIL PJSC Sponsored ADR     11,158,619  
    581,535     MMC Norilsk Nickel PJSC ADR     9,650,780  
    31,880     Novatek PJSC Sponsered GDR (Registered)     5,331,163  
    315,037     PhosAgro PJSC GDR (Registered)     4,174,453  
    575,419     Ros Agro Plc GDR (Registered)     5,889,651  
    610,322     Rosneft PJSC GDR (Registered)     3,887,373  
    82,111     Tatneft PJSC Sponsored ADR     5,693,223  
    98,620     TMK PJSC GDR (Registered)     415,327  
     

 

 

 
    Total Russia     54,351,387  
     

 

 

 
    Singapore — 0.1%

 

    3,529,686     Ezion Holdings Ltd *     190,370  
    2,725,600     Ezra Holdings Ltd * (a)      
     

 

 

 
    Total Singapore     190,370  
     

 

 

 
    South Africa — 1.5%

 

    179,383     African Rainbow Minerals Ltd     1,536,506  
    135,497     Sasol Ltd     5,307,327  
     

 

 

 
    Total South Africa     6,843,833  
     

 

 

 
Shares     Description   Value ($)  
    South Korea — 0.8%

 

    8,464     Korea Zinc Co Ltd     3,081,540  
    647     Young Poong Corp     421,936  
     

 

 

 
    Total South Korea     3,503,476  
     

 

 

 
    Spain — 1.8%

 

    60,768     Fomento de Construcciones y Contratas SA *     849,210  
    335,203     Repsol SA     6,446,919  
    17,785     Tecnicas Reunidas SA     601,500  
     

 

 

 
    Total Spain     7,897,629  
     

 

 

 
    Sweden — 2.2%

 

    235,989     Boliden AB     6,179,788  
    65,762     Holmen AB – B Shares     1,692,805  
    180,547     Svenska Cellulosa AB SCA – Class B     2,101,786  
     

 

 

 
    Total Sweden     9,974,379  
     

 

 

 
    Switzerland — 0.1%

 

    436     Gurit Holding AG     371,751  
     

 

 

 
    Thailand — 2.2%

 

    2,153,900     Esso Thailand Pcl (Foreign Registered)     1,039,930  
    703,164     PTT Exploration & Production Pcl (Foreign Registered)     3,063,704  
    3,559,010     PTT Pcl (Foreign Registered)     5,714,140  
     

 

 

 
    Total Thailand     9,817,774  
     

 

 

 
    Turkey — 0.2%

 

    911,938     Koza Anadolu Metal Madencilik Isletmeleri AS *     801,467  
    29,469     Turk Traktor ve Ziraat Makineleri AS     204,434  
     

 

 

 
    Total Turkey     1,005,901  
     

 

 

 
    Ukraine — 0.7%

 

    230,957     Kernel Holding SA     3,079,756  
     

 

 

 
    United Kingdom — 13.7%

 

    794,687     Anglo American Plc     15,958,244  
    64,659     Antofagasta Plc     677,304  
    627,931     BHP Billiton Plc     13,434,298  
    347,921     BP Plc     2,477,602  
    180,807     Central Asia Metals Plc     503,622  
    1,573,441     EnQuest Plc *     881,038  
    313,844     Glencore Plc *     1,278,623  
    85,178     John Wood Group Plc     793,668  
    290,453     Petrofac Ltd     2,476,857  
    199,668     Polypipe Group Plc     959,409  
    528,296     Premier Oil Plc *     850,338  
    425,613     Rio Tinto Plc     20,213,373  
    25,528     Royal Dutch Shell Plc A Shares (London)     830,524  
     

 

 

 
    Total United Kingdom     61,334,900  
     

 

 

 
 

 

38   See accompanying notes to the financial statements.  


GMO Resources Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    United States — 13.8%

 

    22,200     AGCO Corp.     1,324,452  
    74,600     Albemarle Corp.     7,125,792  
    33,300     American Vanguard Corp.     729,270  
    34,000     C&J Energy Services, Inc. *     712,300  
    270,902     Chesapeake Energy Corp. *     1,200,096  
    16,800     Deere & Co.     2,415,840  
    438,508     Denbury Resources, Inc. *     2,442,489  
    145,584     Ensco Plc – Class A     995,795  
    92,900     First Solar, Inc. *     4,838,232  
    1,700,354     Freeport-McMoRan, Inc.     23,889,974  
    23,100     Mosaic Co. (The)     722,337  
    118,500     Noble Corp Plc *     722,850  
    98,600     Renewable Energy Group, Inc. *     2,657,270  
    27,600     Rexnord Corp. *     801,228  
    98,300     Rowan Cos Plc – Class A *     1,380,132  
    204,555     SolarEdge Technologies, Inc. *     9,808,412  
     

 

 

 
    Total United States     61,766,469  
     

 

 

 
   

TOTAL COMMON STOCKS

(COST $347,182,776)

    396,216,005  
     

 

 

 
    PREFERRED STOCKS (b) — 8.5%

 

    Brazil — 3.4%

 

    1,986,899     Bradespar SA     15,156,258  
     

 

 

 
    Chile — 3.1%

 

    328,912     Sociedad Quimica y Minera de Chile SA Sponsored ADR     14,014,940  
     

 

 

 
    Russia — 2.0%

 

    58,073     Bashneft PJSC     1,455,728  
    8,633,884     Surgutneftegas OJSC     4,791,590  
    357,301     Tatneft PJSC     2,786,876  
     

 

 

 
    Total Russia     9,034,194  
     

 

 

 
   

TOTAL PREFERRED STOCKS

(COST $28,876,553)

    38,205,392  
     

 

 

 
    RIGHTS/WARRANTS — 0.0%

 

    Australia — 0.0%

 

    491,800     Ausdrill Ltd, Expires 09/05/18     51,265  
     

 

 

 
    Singapore — 0.0%

 

    2,117,812     Ezion Holdings Ltd, Expires 04/16/23 * (c)      
     

 

 

 
   

TOTAL RIGHTS/WARRANTS

(COST $0)

    51,265  
     

 

 

 
Shares     Description   Value ($)  
    MUTUAL FUNDS — 2.4%

 

    United States — 2.4%

 

          Affiliated Issuers — 2.4%      
    425,964     GMO U.S. Treasury Fund     10,640,570  
     

 

 

 
   

TOTAL MUTUAL FUNDS

(COST $10,638,444)

    10,640,570  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.2%

 

    Money Market Fund — 0.2%

 

    751,939     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (d)     751,939  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $751,939)
    751,939  
     

 

 

 
   

TOTAL INVESTMENTS — 99.8%

(Cost $387,449,712)

    445,865,171  
    Other Assets and Liabilities (net) — 0.2%     1,068,606  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $446,933,777  
     

 

 

 

Notes to Schedule of Investments:

 

*

Non-income producing security.

 

(a)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

 

(b)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(c)

Investment valued using significant unobservable inputs (Note 2).

 

(d)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

  See accompanying notes to the financial statements.   39


GMO Risk Premium Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Short-Term Investments

    53.9

Debt Obligations

    46.4  

Written Options

    (0.6

Other

    0.3  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

 

40


GMO Risk Premium Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Par Value† /
Shares
    Description   Value ($)  
    DEBT OBLIGATIONS — 46.4%

 

    U.S. Government — 39.0%

 

    85,000,000     U.S. Treasury Note, Variable Rate,
USBM + 0.03%, 2.12%, due 04/30/20 (a)
    85,012,417  
    91,000,000     U.S. Treasury Note, Variable Rate,
USBM + 0.04%, 2.13%, due 07/31/20
    90,989,568  
    25,000,000     U.S. Treasury Note, Variable Rate,
USBM + 0.05%, 2.14%, due 10/31/19
    25,015,426  
     

 

 

 
    Total U.S. Government     201,017,411  
     

 

 

 
    U.S. Government Agency — 7.4%

 

    8,000,000     Federal Home Loan Banks, Variable Rate, 1 mo. USD LIBOR - 0.11%, 1.96%, due 04/22/19     7,998,917  
    10,000,000     Federal Home Loan Banks, Variable Rate 3 mo. USD LIBOR - 0.16%, 2.17%, due 06/12/19     10,005,357  
    20,000,000     Federal Home Loan Banks, Variable Rate 3 mo. USD LIBOR - 0.24%, 2.10%, due 04/13/20     19,987,531  
     

 

 

 
    Total U.S. Government Agency     37,991,805  
     

 

 

 
   

TOTAL DEBT OBLIGATIONS

(COST $238,978,475)

      239,009,216  
     

 

 

 
    SHORT-TERM INVESTMENTS — 53.9%

 

    Money Market Funds — 0.4%

 

    1,731,761     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (b)     1,731,761  
     

 

 

 
    Total Money Market Funds     1,731,761  
     

 

 

 

Par Value†

    Description   Value ($)  
    U.S. Government — 53.5%

 

    4,800,000     U.S. Treasury Bill, 1.96%, due 11/15/18 (c)     4,780,464  
    1,500,000     U.S. Treasury Bill, 1.99%, due 11/23/18 (c)     1,493,150  
        47,400,000     U.S. Treasury Bill, 2.05%, due 12/20/18 (a) (c)     47,106,611  
    45,950,000     U.S. Treasury Note, 1.25%, due 12/31/18     45,813,210  
    62,350,000     U.S. Treasury Note, 1.25%, due 01/31/19 (a)     62,096,703  
    70,000,000     U.S. Treasury Note, 1.38%, due 02/28/19     69,693,750  
    45,000,000     U.S. Treasury Note, 1.00%, due 03/15/19     44,702,930  
     

 

 

 
    Total U.S. Government     275,686,818  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $277,442,192)     277,418,579  
     

 

 

 
    TOTAL INVESTMENTS — 100.3%
(Cost $516,420,667)
    516,427,795  
    Other Assets and Liabilities (net) — (0.3%)     (1,429,836
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $514,997,959  
     

 

 

 
 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Written Options - Puts

Index Options

 

Description

    

Counterparty

     Exercise
Price
       Expiration
Date
       Number of
Contracts
       Notional
Amount
       Value ($)  

FTSE 100 Index

     MSLC        7,550.00          09/21/18          536          GBP       39,837,771          (1,005,641

FTSE 100 Index

     MSLC        7,575.00          09/21/18          169          GBP       12,560,790          (386,687

FTSE 100 Index

     MSLC        7,600.00          09/21/18          97          GBP       7,209,447          (247,252

S&P 500 Index

     MSLC        2,900.00          09/07/18          743          USD       215,582,936          (891,600

S&P 500 Index

     MSLC        2,895.00          09/04/18          378          USD       109,677,456          (105,840

S&P 500 Index

     MSLC        2,915.00          09/05/18          371          USD       107,646,392          (534,240
                               

 

 

 
                
TOTAL INDEX OPTIONS - PUTS
(Premiums $4,083,175)

 
       (3,171,260
                               

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

  See accompanying notes to the financial statements.   41


GMO Risk Premium Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Notes to Schedule of Investments:

The rates shown on variable rate notes are the current interest rates at August 31, 2018, which are subject to change based on the terms of the security.

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

(a)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(b)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(c)

The rate shown represents yield-to-maturity.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

42   See accompanying notes to the financial statements.  


GMO Tax-Managed International Equities Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    95.6

Preferred Stocks

    2.0  

Mutual Funds

    1.9  

Short-Term Investments

    0.2  

Rights/Warrants

    0.0

Futures Contracts

    0.0

Other

    0.3  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country Summary¤   % of Investments  

Japan

    24.3

United Kingdom

    14.2  

Germany

    9.8  

France

    7.1  

Sweden

    5.1  

Other Emerging

    4.7 † 

Italy

    4.5  

Switzerland

    4.5  

Australia

    3.8  

Other Developed

    3.6 ‡ 

Hong Kong

    3.6  

China

    3.2  

United States

    2.2  

Canada

    1.7  

Austria

    1.6  

South Korea

    1.6  

Netherlands

    1.5  

European Union

    1.5  

Norway

    1.4  

Colombia

    0.1  
 

 

 

 
    100.0 % 
 

 

 

 
Industry Group Summary   % of Equity Investments#  

Capital Goods

    13.4

Materials

    11.9  

Banks

    9.0  

Pharmaceuticals, Biotechnology & Life Sciences

    8.9  

Automobiles & Components

    7.7  

Food, Beverage & Tobacco

    7.2  

Technology Hardware & Equipment

    4.9  

Insurance

    4.7  

Consumer Durables & Apparel

    4.4  

Semiconductors & Semiconductor Equipment

    4.3  

Telecommunication Services

    3.8  

Energy

    3.6  

Diversified Financials

    3.5  

Real Estate

    3.1  

Transportation

    2.1  

Household & Personal Products

    1.6  

Utilities

    1.5  

Retailing

    1.4  

Software & Services

    1.3  

Consumer Services

    0.7  

Food & Staples Retailing

    0.4  

Health Care Equipment & Services

    0.4  

Media

    0.1  

Commercial & Professional Services

    0.1  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above shows country exposure in the Fund. The table excludes short-term investments. The table excludes exposure through forward currency contracts and includes exposure through other derivative financial instruments, if any. The table takes into account the market value of securities and options and the notional amounts of swap contracts and other derivative financial instruments, if any.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

43


GMO Tax-Managed International Equities Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    COMMON STOCKS — 95.6%

 

    Australia — 3.8%

 

    674     Altium Ltd     13,615  
    25,843     BlueScope Steel Ltd     321,665  
    9,216     Caltex Australia Ltd     200,266  
    621     CIMIC Group Ltd     22,025  
    21,619     Costa Group Holdings Ltd     112,542  
    3,449     CSL Ltd     565,417  
    22,500     CSR Ltd     69,755  
    6,153     Genworth Mortgage Insurance Australia Ltd     11,694  
    353     LendLease Group     5,206  
    2,911     Macquarie Group Ltd     272,275  
    6,658     Mineral Resources Ltd     72,525  
    6,804     Nine Entertainment Co Holdings Ltd     11,822  
    19,984     OZ Minerals Ltd     129,933  
    1,760     Primary Health Care Ltd     3,524  
    5,908     Sandfire Resources NL     30,126  
    47,548     South32 Ltd     118,924  
    2,999     WorleyParsons Ltd     44,346  
     

 

 

 
    Total Australia     2,005,660  
     

 

 

 
    Austria — 1.6%

 

    7,048     OMV AG     373,664  
    6,409     Raiffeisen Bank International AG     182,443  
    6,732     voestalpine AG     302,592  
     

 

 

 
    Total Austria     858,699  
     

 

 

 
    Belgium — 0.3%

 

    2,430     Ageas     125,827  
    4,294     AGFA-Gevaert NV *     18,857  
    32     UCB SA     2,929  
     

 

 

 
    Total Belgium     147,613  
     

 

 

 
    Brazil — 0.5%

 

    1,600     Banco do Brasil SA     11,824  
    900     Banco Santander Brasil SA     7,645  
    3,300     Cia de Saneamento Basico do Estado de Sao Paulo     19,769  
    33,500     JBS SA     77,312  
    2,500     Kroton Educacional SA     6,273  
    5,400     Petrobras Distribuidora SA     26,224  
    10,182     Vale SA     134,040  
     

 

 

 
    Total Brazil     283,087  
     

 

 

 
    Canada — 1.7%

 

    1,700     Bank of Montreal     139,332  
    1,400     BRP Inc Sub Voting     73,079  
    100     Canadian Imperial Bank of Commerce     9,372  
    100     Canadian Imperial Bank of Commerce     9,368  
    500     Canfor Corp *     11,529  
    800     Magna International Inc     43,316  
    3,100     Magna International Inc     167,772  
Shares     Description   Value ($)  
    Canada — continued

 

    200     National Bank of Canada     10,009  
    2,700     Royal Bank of Canada     214,469  
    200     Royal Bank of Canada     15,904  
    3,100     Sun Life Financial Inc     123,194  
    1,000     TFI International Inc     37,119  
    500     Toronto-Dominion Bank (The)     30,134  
    100     West Fraser Timber Co Ltd     6,634  
     

 

 

 
    Total Canada     891,231  
     

 

 

 
    China — 3.2%

 

    8,000     Agile Group Holdings Ltd     13,085  
    249,000     Agricultural Bank of China Ltd – Class H     120,660  
    2,000     Anhui Conch Cement Co Ltd – Class H     12,201  
    10,000     ANTA Sports Products Ltd     54,532  
    300     Baidu Inc Sponsored ADR *     67,944  
    36,000     Bank of Communications Co Ltd – Class H     26,016  
    18,000     Beijing Capital International Airport Co Ltd – Class H     19,187  
    66,000     China CITIC Bank Corp Ltd – Class H     41,236  
    88,000     China Communications Services Corp Ltd – Class H     72,907  
    14,000     China Evergrande Group *     50,315  
    78,200     China National Building Material Co Ltd – Class H     73,275  
    102,000     China Petroleum & Chemical Corp – Class H     102,631  
    35,500     China Railway Construction Corp Ltd – Class H     42,945  
    44,000     China Resources Cement Holdings Ltd     51,455  
    5,000     China Resources Pharmaceutical Group Ltd     8,001  
    31,000     China Shenhua Energy Co Ltd – Class H     69,239  
    234,000     China Telecom Corp Ltd – Class H     110,051  
    300     China Yuchai International Ltd     6,033  
    18,000     Chongqing Rural Commercial Bank Co Ltd – Class H     9,709  
    11,000     Country Garden Holdings Co Ltd     16,399  
    46,000     Dongfeng Motor Group Co Ltd – Class H     51,422  
    40,000     Geely Automobile Holdings Ltd     85,163  
    28,800     Guangzhou R&F Properties Co Ltd – Class H     58,201  
    7,000     Haier Electronics Group Co Ltd *     18,255  
    20,000     Harbin Electric Co Ltd – Class H     6,292  
    20,000     Huabao International Holdings Ltd     11,785  
    18,000     Kingboard Holdings Ltd     64,078  
    18,000     Kingboard Laminates Holdings Ltd     17,018  
    18,000     Lee & Man Paper Manufacturing Ltd     17,271  
    6,000     Lonking Holdings Ltd     2,066  
    13,000     People’s Insurance Co Group of China Ltd (The) – Class H     5,639  
    80,000     Postal Savings Bank of China Co Ltd – Class H     47,154  
    14,100     Shanghai Pharmaceuticals Holding Co Ltd – Class H     37,038  
    16,000     Shenzhen Expressway Co Ltd – Class H     15,524  
    32,000     Shimao Property Holdings Ltd     95,564  
    28,500     Sino Biopharmaceutical Ltd     36,121  
    23,000     Sinopec Engineering Group Co Ltd – Class H     23,985  
    5,500     Sinotruk Hong Kong Ltd     8,214  
 

 

44   See accompanying notes to the financial statements.  


GMO Tax-Managed International Equities Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    China — continued

 

    34,000     TravelSky Technology Ltd – Class H     87,302  
    31,000     Weichai Power Co Ltd – Class H     32,877  
     

 

 

 
    Total China     1,688,790  
     

 

 

 
    Colombia — 0.1%

 

    2,700     Ecopetrol SA Sponsored ADR     61,020  
     

 

 

 
    Denmark — 0.5%

 

    700     Novo Nordisk A/S Sponsored ADR     34,419  
    3,210     Novo Nordisk A/S – Class B     158,016  
    592     Royal Unibrew A/S     51,017  
     

 

 

 
    Total Denmark     243,452  
     

 

 

 
    Finland — 0.9%

 

    12,720     UPM-Kymmene Oyj     490,667  
     

 

 

 
    France — 7.2%

 

    9,407     Air France-KLM *     90,311  
    3,723     AXA SA     93,823  
    4,352     BNP Paribas SA     256,215  
    1,342     Christian Dior SE     579,012  
    411     Cie Generale des Etablissements Michelin     48,645  
    1,101     CNP Assurances     25,447  
    2,933     Derichebourg SA     16,426  
    665     Jacquet Metal Service     19,430  
    2,455     L’Oreal SA     587,742  
    19     LVMH Moet Hennessy Louis Vuitton SE     6,661  
    8,643     Peugeot SA     238,152  
    4,232     Renault SA     365,522  
    4,442     Sanofi     381,449  
    1,000     Sanofi ADR     42,850  
    9,700     STMicroelectronics NV – NY Shares     200,693  
    38,588     STMicroelectronics NV     796,170  
    195     TOTAL SA     12,228  
     

 

 

 
    Total France     3,760,776  
     

 

 

 
    Germany — 8.7%

 

    5,768     Allianz SE (Registered)     1,229,402  
    192     BASF SE     17,742  
    6,964     Bayer AG (Registered)     649,910  
    6,555     Bayerische Motoren Werke AG     634,568  
    787     Covestro AG     67,006  
    3,568     Daimler AG (Registered Shares)     230,744  
    29,200     Deutsche Lufthansa AG (Registered)     762,925  
    5,282     Duerr AG     243,366  
    806     Elmos Semiconductor AG     20,820  
    3,652     Freenet AG     97,100  
    174     Hannover Rueck SE     23,896  
    131     Henkel AG & Co KGaA     14,618  
    160     Isra Vision AG     11,135  
    3,945     Leoni AG     170,201  
Shares     Description   Value ($)  
    Germany — continued

 

    543     Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen (Registered)     116,981  
    591     Siltronic AG     85,677  
    125     Uniper SE     3,820  
    873     Volkswagen AG     140,526  
    1,594     Wacker Neuson SE     44,069  
     

 

 

 
    Total Germany     4,564,506  
     

 

 

 
    Greece — 0.0%

 

    559     Mytilineos Holdings SA     5,595  
     

 

 

 
    Hong Kong — 3.7%

 

    84,000     BOC Hong Kong Holdings Ltd     410,239  
    11,200     Dah Sing Banking Group Ltd     23,101  
    8,000     Kerry Properties Ltd     30,339  
    43,000     Link (REIT)     428,595  
    2,000     Minth Group Ltd     8,202  
    624,000     WH Group Ltd     471,263  
    43,000     Wharf Holdings Ltd (The)     122,797  
    43,000     Wharf Real Estate Investment Co Ltd     285,298  
    22,000     Wheelock & Co Ltd     138,140  
     

 

 

 
    Total Hong Kong     1,917,974  
     

 

 

 
    Hungary — 0.2%

 

    2,708     MOL Hungarian Oil & Gas Plc     27,634  
    900     OTP Bank Plc     33,112  
    1,681     Richter Gedeon Nyrt     33,009  
     

 

 

 
    Total Hungary     93,755  
     

 

 

 
    India — 0.8%

 

    388     Bata India Ltd     5,933  
    589     Cadila Healthcare Ltd     3,360  
    5,291     Firstsource Solutions Ltd     5,626  
    6,013     HCL Technologies Ltd     88,588  
    538     Hero MotoCorp Ltd     24,754  
    11,445     Hindalco Industries Ltd     38,520  
    980     Hindustan Petroleum Corp Ltd     3,517  
    512     Indiabulls Housing Finance Ltd     9,112  
    1,056     Indian Oil Corp Ltd     2,323  
    1,126     Just Dial Ltd *     8,880  
    2,139     Karnataka Bank Ltd (The)     3,606  
    1,182     Mahindra & Mahindra Ltd     16,109  
    537     Maruti Suzuki India Ltd     68,974  
    139     Merck Ltd     6,865  
    517     NIIT Technologies Ltd     10,274  
    3,486     NMDC Ltd     5,483  
    2,833     PTC India Ltd     3,350  
    1,398     Reliance Industries Ltd     24,461  
    3,365     Rural Electrification Corp Ltd     5,693  
    4,026     Syndicate Bank *     2,284  
    3,907     Tech Mahindra Ltd     42,223  
 

 

  See accompanying notes to the financial statements.   45


GMO Tax-Managed International Equities Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    India — continued

 

    469     UPL Ltd     4,724  
    7,571     Vedanta Ltd     24,439  
    2,526     Wipro Ltd     10,700  
    700     Yes Bank Ltd     3,394  
    1,066     Zee Entertainment Enterprises Ltd     7,524  
     

 

 

 
    Total India     430,716  
     

 

 

 
    Ireland — 0.5%

 

    6,190     Smurfit Kappa Group Plc     252,797  
     

 

 

 
    Italy — 4.6%

 

    11,005     Arnoldo Mondadori Editore SPA *     16,819  
    429     Datalogic SPA     16,007  
    139     El.En. SPA     4,480  
    130,904     Enel SPA     647,181  
    9,589     EXOR NV     623,948  
    43,100     Fiat Chrysler Automobiles NV *     737,441  
    12,706     Fiat Chrysler Automobiles NV *     215,110  
    1,145     Poste Italiane SPA     8,820  
    391     Prima Industrie SPA     14,707  
    12,969     Societa Cattolica di Assicurazioni SC     105,254  
     

 

 

 
    Total Italy     2,389,767  
     

 

 

 
    Japan — 24.7%

 

    600     Acom Co Ltd     2,449  
    900     Arakawa Chemical Industries Ltd     13,694  
    5,900     Asahi Group Holdings Ltd     266,428  
    41,600     Asahi Kasei Corp     609,587  
    19,600     Astellas Pharma Inc     332,291  
    22,200     Brother Industries Ltd     455,418  
    3,500     Canon Inc     112,303  
    100     Central Japan Railway Co     20,078  
    1,900     CKD Corp     28,064  
    200     Dai-ichi Seiko Co Ltd     3,005  
    1,600     Daito Trust Construction Co Ltd     239,815  
    1,800     Daiwa House Industry Co Ltd     54,835  
    1,600     Fancl Corp     82,191  
    6,000     Fuji Electric Co Ltd     48,332  
    2,600     Hanwa Co Ltd     87,646  
    29,800     Haseko Corp     386,055  
    150,000     Hitachi Ltd     979,135  
    300     Horiba Ltd     18,577  
    400     House Foods Group Inc     11,859  
    2,500     Idemitsu Kosan Co Ltd     126,183  
    59,600     ITOCHU Corp     1,041,441  
    1,400     Juki Corp     16,446  
    11,640     K’s Holdings Corp     140,899  
    1,400     Kamei Corp     17,413  
    22,900     KDDI Corp     605,472  
    500     Keihin Corp     10,507  
    100     Keyence Corp     56,611  
Shares     Description   Value ($)  
    Japan — continued

 

    500     Kirin Holdings Co Ltd     12,356  
    1,100     Kitz Corp     9,636  
    200     Kose Corp     36,877  
    500     Mandom Corp     15,019  
    65,600     Marubeni Corp     537,491  
    5,300     Medipal Holdings Corp     106,890  
    107,600     Mitsubishi Chemical Holdings Corp     964,068  
    11,600     Mitsubishi Corp     330,798  
    26,700     Mitsubishi Electric Corp     360,436  
    3,100     Mitsubishi Gas Chemical Co Inc     64,442  
    300     Modec Inc     9,079  
    300     Nagase & Co Ltd     5,001  
    6,600     NET One Systems Co Ltd     152,865  
    3,400     Nexon Co Ltd *     42,670  
    2,000     Nichias Corp     25,999  
    400     Nihon Unisys Ltd     9,765  
    22,200     Nippon Telegraph & Telephone Corp     987,700  
    400     Nisshin Oillio Group Ltd (The)     10,814  
    600     NTT DOCOMO Inc     15,549  
    400     Pola Orbis Holdings Inc     14,097  
    7,000     Prima Meat Packers Ltd     34,749  
    1,200     Rohm Co Ltd     108,416  
    1,300     Rohto Pharmaceutical Co Ltd     41,530  
    600     Showa Corp     9,557  
    3,000     Showa Denko KK     142,491  
    127,500     Sojitz Corp     443,683  
    90,000     Sumitomo Chemical Co Ltd     510,823  
    14,000     Sumitomo Corp     227,024  
    300     Suntory Beverage & Food Ltd     12,288  
    220     Suzuken Co Ltd     9,990  
    500     T-Gaia Corp     13,158  
    100     TDK Corp     11,216  
    4,100     Tokyo Electron Ltd     698,024  
    32,200     Tosoh Corp     505,226  
    14,900     Toyota Tsusho Corp     507,609  
    7,660     USS Co Ltd     144,290  
    400     Yamazaki Baking Co Ltd     7,782  
     

 

 

 
    Total Japan     12,906,142  
     

 

 

 
    Malaysia — 0.0%

 

    7,200     Top Glove Corp Berhad     19,508  
     

 

 

 
    Malta — 0.0%

 

    1,718,063     BGP Holdings Plc * (a)      
     

 

 

 
    Mexico — 0.4%

 

    6,400     Arca Continental SAB de CV     39,579  
    330     Gruma SAB de CV – Class B     4,175  
    6,300     OHL Mexico SAB de CV     9,493  
    49,400     Wal-Mart de Mexico SAB de CV     136,782  
     

 

 

 
    Total Mexico     190,029  
     

 

 

 
 

 

46   See accompanying notes to the financial statements.  


GMO Tax-Managed International Equities Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Netherlands — 1.5%

 

    757     Heineken Holding NV     72,228  
    54,184     ING Groep NV     736,024  
     

 

 

 
    Total Netherlands     808,252  
     

 

 

 
    New Zealand — 0.0%

 

    5,242     Spark New Zealand Ltd     13,840  
     

 

 

 
    Norway — 1.5%

 

    133     Aker ASA – A Shares     10,420  
    159     Bakkafrost P/F     9,071  
    12,050     DNB ASA     244,977  
    14,481     Equinor ASA     371,441  
    1,419     Leroy Seafood Group ASA     10,790  
    228     Salmar ASA     10,977  
    2,652     SpareBank 1 SR Bank ASA     29,924  
    706     Storebrand ASA     6,250  
    5,161     Subsea 7 SA     70,166  
     

 

 

 
    Total Norway     764,016  
     

 

 

 
    Poland — 0.0%

 

    100     KGHM Polska Miedz SA *     2,447  
     

 

 

 
    Portugal — 0.0%

 

    19,283     Sonae SGPS SA     20,514  
     

 

 

 
    Russia — 0.3%

 

    6,717     Gazprom PJSC Sponsored ADR     29,628  
    72,000     Inter RAO UES PJSC     4,315  
    398     LUKOIL PJSC Sponsored ADR     27,503  
    341,000     RusHydro PJSC     3,220  
    5,791     Sberbank of Russia Sponsored ADR     63,066  
     

 

 

 
    Total Russia     127,732  
     

 

 

 
    Singapore — 0.9%

 

    19,400     DBS Group Holdings Ltd     352,673  
    6,200     Venture Corp Ltd     81,854  
    37,400     Yanlord Land Group Ltd     41,443  
     

 

 

 
    Total Singapore     475,970  
     

 

 

 
    South Africa — 0.8%

 

    7,452     Absa Group Ltd     82,420  
    366     Astral Foods Ltd     6,446  
    4,867     Barloworld Ltd     41,394  
    3,080     Bidvest Group Ltd (The)     45,262  
    2,006     Clicks Group Ltd     27,705  
    1,413     Imperial Holdings Ltd     19,799  
    125     Kumba Iron Ore Ltd     2,253  
    1,232     Liberty Holdings Ltd     9,747  
    1,988     Mondi Ltd     55,470  
    25     Naspers Ltd – N Shares     5,551  
    2,079     Nedbank Group Ltd     39,326  
Shares     Description   Value ($)  
    South Africa — continued

 

    2,621     Raubex Group Ltd     3,895  
    6,809     Standard Bank Group Ltd     86,301  
     

 

 

 
    Total South Africa     425,569  
     

 

 

 
    South Korea — 1.3%

 

    47     Chong Kun Dang Pharmaceutical Corp     4,580  
    41     Coway Co Ltd     3,365  
    52     DB Insurance Co Ltd     2,990  
    153     E-MART Inc     29,478  
    1,864     Hana Financial Group Inc     71,477  
    128     Hankook Tire Co Ltd     5,364  
    648     Hanwha Life Insurance Co Ltd     2,823  
    58     Hyundai Department Store Co Ltd     5,187  
    625     Hyundai Marine & Fire Insurance Co Ltd     20,880  
    4,987     Industrial Bank of Korea     66,756  
    1,518     KB Financial Group Inc     70,186  
    114     Kia Motors Corp     3,283  
    47     Korea Investment Holdings Co Ltd     3,008  
    39     KT&G Corp     3,538  
    57     LG Corp     3,662  
    1,060     LG Electronics Inc     73,079  
    80     LOTTE Himart Co Ltd     5,143  
    14     Lotte Shopping Co Ltd     2,263  
    783     Meritz Fire & Marine Insurance Co Ltd     12,836  
    75     NHN Entertainment Corp *     4,062  
    1,221     Shinhan Financial Group Co Ltd     47,957  
    119     Shinsegae Inc     34,694  
    52     SK Holdings Co Ltd     12,290  
    1,312     SK Hynix Inc     97,849  
    1,600     SK Telecom Co Ltd Sponsored ADR     41,616  
    3,340     Woori Bank *     48,922  
     

 

 

 
    Total South Korea     677,288  
     

 

 

 
    Spain — 0.6%

 

    1,514     Amadeus IT Group SA     140,398  
    614     Ferrovial SA     13,258  
    2,769     Grifols SA     81,415  
    5,669     International Consolidated Airlines Group SA     50,885  
     

 

 

 
    Total Spain     285,956  
     

 

 

 
    Sweden — 5.1%

 

    7,676     Atlas Copco AB – A Shares     218,824  
    1,915     Atlas Copco AB – B Shares     50,647  
    1,647     Bufab AB     19,379  
    10,456     Epiroc AB – Class A *     108,617  
    909     Epiroc AB – Class B *     8,693  
    1,492     Kindred Group Plc SDR     18,349  
    917     Oriflame Holding AG     26,681  
    32,842     Sandvik AB     574,887  
    836     SKF AB – B Shares     16,070  
    27,815     Svenska Cellulosa AB SCA – Class B     323,801  
 

 

  See accompanying notes to the financial statements.   47


GMO Tax-Managed International Equities Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Sweden — continued

 

    433     Swedish Orphan Biovitrum AB *     13,799  
    4,755     Swedish Match AB     254,195  
    2,991     Volvo AB – A Shares     51,587  
    58,205     Volvo AB – B Shares     1,002,691  
     

 

 

 
    Total Sweden     2,688,220  
     

 

 

 
    Switzerland — 4.5%

 

    698     ALSO Holding AG (Registered) *     83,066  
    656     Baloise Holding AG (Registered)     100,815  
    44     Bell Food Group AG (Registered)     13,672  
    327     BKW AG     23,195  
    690     Bobst Group SA (Registered)     59,116  
    32     Comet Holding AG (Registered) *     3,177  
    227     Georg Fischer AG (Registered)     297,121  
    137     Idorsia Ltd *     3,464  
    2,750     Logitech International SA (Registered)     135,637  
    6,937     Nestle SA (Registered)     581,508  
    588     Novartis AG (Registered)     48,782  
    255     Orior AG     22,550  
    696     Roche Holding AG – Genusschein     172,576  
    247     Roche Holding AG     61,929  
    2,700     Sika AG (Registered)     399,886  
    322     Swatch Group AG (The) (Registered)     26,074  
    943     Swiss Life Holding AG (Registered) *     341,567  
     

 

 

 
    Total Switzerland     2,374,135  
     

 

 

 
    Taiwan — 0.8%

 

    8,093     ASE Technology Holding Co Ltd     19,915  
    4,000     Asustek Computer Inc     34,087  
    22,428     Chang Hwa Commercial Bank Ltd *     13,955  
    2,020     Chicony Power Technology Co Ltd     2,907  
    5,000     Formosa Chemicals & Fibre Corp     20,037  
    4,000     Formosa Plastics Corp     14,663  
    2,000     Fubon Financial Holding Co Ltd     3,316  
    8,000     Gigabyte Technology Co Ltd     13,650  
    22,200     Hon Hai Precision Industry Co Ltd     58,320  
    62,000     Inventec Corp     55,648  
    4,000     Micro-Star International Co Ltd     13,827  
    4,000     Mitac Holdings Corp *     4,626  
    5,000     Nan Ya Plastics Corp     13,914  
    9,000     Novatek Microelectronics Corp     44,130  
    2,000     Phison Electronics Corp     16,557  
    9,000     Pou Chen Corp     9,923  
    7,000     Radiant Opto-Electronics Corp     15,376  
    11,000     Sunplus Technology Co Ltd     5,018  
    2,304     Topco Scientific Co Ltd     5,853  
    2,000     Uni-President Enterprises Corp     5,061  
    109,000     United Microelectronics Corp     61,786  
    7,000     Walsin Lihwa Corp     4,953  
    7,000     Yuanta Financial Holding Co Ltd     3,547  
     

 

 

 
    Total Taiwan     441,069  
     

 

 

 
Shares     Description   Value ($)  
    Thailand — 0.3%

 

    10,000     Amata Corp Pcl NVDR     6,511  
    17,900     GFPT Pcl NVDR     8,096  
    15,400     Indorama Ventures Pcl NVDR     28,247  
    6,200     PTT Exploration & Production Pcl NVDR     27,014  
    2,800     PTT Global Chemical Pcl NVDR     6,998  
    27,200     PTT Pcl NVDR     43,671  
    6,600     Supalai Pcl NVDR     4,880  
    9,200     Thai Airways International Pcl NVDR *     3,682  
     

 

 

 
    Total Thailand     129,099  
     

 

 

 
    Turkey — 0.2%

 

    19,508     KOC Holding AS     44,581  
    32,221     Turkiye Is Bankasi – Class C     19,620  
    22,954     Turkiye Sise ve Cam Fabrikalari AS     21,577  
     

 

 

 
    Total Turkey     85,778  
     

 

 

 
    United Kingdom — 14.4%

 

    48,521     3i Group Plc     564,987  
    2,452     Ashtead Group Plc     75,243  
    11,366     AstraZeneca Plc     857,835  
    735     Bellway Plc     27,845  
    5,601     Berkeley Group Holdings Plc (The)     264,934  
    861     Bovis Homes Group Plc     12,583  
    14,691     British American Tobacco Plc     710,416  
    9,658     Coca-Cola HBC AG *     330,691  
    13,484     Diageo Plc     471,596  
    13,532     Electrocomponents Plc     130,435  
    29,374     Ferrexpo Plc     59,294  
    223     Fevertree Drinks Plc     10,781  
    50,198     GlaxoSmithKline Plc     1,016,653  
    100,290     HSBC Holdings Plc     872,920  
    8,669     IG Group Holdings Plc     101,797  
    19,452     Inchcape Plc     174,747  
    13,143     Legal & General Group Plc     43,433  
    2,013     Man Group Plc     4,492  
    1,218     Morgan Sindall Group Plc     23,212  
    2,013     Next Plc     143,726  
    2,800     Nomad Foods Ltd *     58,380  
    22,669     Persimmon Plc     717,178  
    8,397     Plus500 Ltd     167,756  
    834     QinetiQ Group Plc     2,937  
    7,369     Royal Dutch Shell Plc A Shares (London)     239,742  
    7,428     Royal Mail Plc     43,195  
    7,290     RPS Group Plc     22,215  
    295     Spectris Plc     9,019  
    10,383     Spirent Communications Plc     15,940  
    100,605     Thomas Cook Group Plc     109,306  
    13,083     TUI AG     241,491  
 

 

48   See accompanying notes to the financial statements.  


GMO Tax-Managed International Equities Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    United Kingdom — continued

 

    1,528     William Hill Plc     5,105  
     

 

 

 
    Total United Kingdom     7,529,884  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $35,716,148)
    50,051,553  
     

 

 

 
    PREFERRED STOCKS (b) — 2.0%

 

    Brazil — 0.4%

 

    15,133     Banco Bradesco SA     105,442  
    7,900     Bradespar SA     60,262  
    500     Braskem SA – Class A     7,268  
    7,600     Centrais Eletricas Brasileiras SA – Class B *     33,773  
    2,700     Cia Energetica de Sao Paulo – Class B     11,070  
    6,219     Itausa – Investimentos Itau SA     14,642  
     

 

 

 
    Total Brazil     232,457  
     

 

 

 
    Germany — 1.3%

 

    1,142     Bayerische Motoren Werke AG     95,765  
    133     Henkel AG & Co KGaA     16,976  
    2,994     Porsche Automobil Holding SE     189,428  
    2,144     Volkswagen AG     350,475  
     

 

 

 
    Total Germany     652,644  
     

 

 

 
    South Korea — 0.3%

 

    97     Hyundai Motor Co     6,825  
    263     Hyundai Motor Co 2nd Preference     20,222  
    142     LG Electronics Inc     3,953  
    3,850     Samsung Electronics Co Ltd     137,181  
     

 

 

 
    Total South Korea     168,181  
     

 

 

 
    TOTAL PREFERRED STOCKS
(COST $753,406)
    1,053,282  
     

 

 

 
    RIGHTS/WARRANTS — 0.0%

 

    Thailand — 0.0%

 

    1,650     Supalai Pcl, Expires 10/19/18 *     1,003  
     

 

 

 
    TOTAL RIGHTS/WARRANTS
(COST $0)
    1,003  
     

 

 

 
Shares     Description   Value ($)  
    MUTUAL FUNDS — 1.9%

 

    United States — 1.9%

 

          Affiliated Issuers — 1.9%  
    40,111     GMO U.S. Treasury Fund     1,001,983  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $1,001,906)
    1,001,983  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.2%

 

    Money Market Fund — 0.2%

 

    105,298     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (c)     105,298  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $105,298)
    105,298  
     

 

 

 
    TOTAL INVESTMENTS — 99.7% (Cost $37,576,758)     52,213,119  
    Other Assets and Liabilities (net) — 0.3%     150,187  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $52,363,306  
     

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Futures Contracts

 

Number
of
Contracts +

 

Type

  Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation)
($)
 
Buys        
8   Mini MSCI EAFE   September 2018     783,520       (17,979
3   Mini MSCI Emerging Markets   September 2018     158,235       (2,906
     

 

 

   

 

 

 
  $ 941,755     $ (20,885
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

  Sales

- Fund is short the futures contract.

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

Notes to Schedule of Investments:

 

*

Non-income producing security.

 

(a)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

 

(b)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

(c)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

  See accompanying notes to the financial statements.   49


GMO U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    99.4

Mutual Funds

    0.9  

Short-Term Investments

    0.1  

Other

    (0.4
 

 

 

 
    100.0 % 
 

 

 

 
 
Industry Group Summary   % of Equity Investments#  

Pharmaceuticals, Biotechnology & Life Sciences

    12.1

Software & Services

    10.7  

Capital Goods

    10.1  

Technology Hardware & Equipment

    9.5  

Semiconductors & Semiconductor Equipment

    6.5  

Retailing

    5.2  

Health Care Equipment & Services

    5.1  

Insurance

    4.9  

Consumer Durables & Apparel

    4.1  

Materials

    4.0  

Automobiles & Components

    3.9  

Diversified Financials

    3.3  

Banks

    3.0  

Energy

    2.9  

Real Estate

    2.8  

Household & Personal Products

    2.5  

Food, Beverage & Tobacco

    2.3  

Commercial & Professional Services

    2.1  

Media

    2.0  

Telecommunication Services

    1.1  

Consumer Services

    1.1  

Food & Staples Retailing

    0.4  

Utilities

    0.2  

Transportation

    0.2  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

 

50


GMO U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    COMMON STOCKS — 99.4%

 

    Automobiles & Components — 3.8%

 

    85,070     American Axle & Manufacturing Holdings, Inc. *     1,506,590  
    71,800     Aptiv Plc     6,319,118  
    90,345     BorgWarner, Inc.     3,954,400  
    17,061     Cooper-Standard Holding, Inc. *     2,361,754  
    134,844     Dana, Inc.     2,638,897  
    322,516     General Motors Co.     11,626,702  
    86,500     Gentex Corp.     2,022,370  
    36,509     Lear Corp.     5,921,760  
    61,421     Modine Manufacturing Co. *     1,034,944  
    35,730     Stoneridge, Inc. *     1,069,399  
    20,283     Tower International, Inc.     685,565  
     

 

 

 
    Total Automobiles & Components     39,141,499  
     

 

 

 
    Banks — 3.0%

 

    3,519     American National Bankshares, Inc.     144,807  
    162,654     Citizens Financial Group, Inc.     6,694,839  
    3,744     CNB Financial Corp.     115,427  
    4,361     Federal Agricultural Mortgage Corp. – Class C     336,102  
    115,473     Fifth Third Bancorp     3,398,370  
    2,723     First Bancorp, Inc.     79,729  
    4,637     German American Bancorp, Inc.     174,305  
    83,593     JPMorgan Chase & Co.     9,578,086  
    48,661     Popular, Inc.     2,449,595  
    317,567     Regions Financial Corp.     6,179,854  
    64,068     TCF Financial Corp.     1,624,124  
    4,084     Territorial Bancorp, Inc.     122,030  
     

 

 

 
    Total Banks     30,897,268  
     

 

 

 
    Capital Goods — 10.0%

 

    23,820     Applied Industrial Technologies, Inc.     1,835,331  
    102,555     Caterpillar, Inc.     14,239,762  
    13,300     Crane Co.     1,214,024  
    69,426     Cummins, Inc.     9,844,607  
    39,968     Deere & Co.     5,747,398  
    138,130     Emerson Electric Co.     10,598,715  
    29,094     Federal Signal Corp.     757,317  
    24,548     Fortive Corp.     2,061,541  
    159,375     Honeywell International, Inc.     25,350,188  
    34,964     Ingersoll-Rand Plc     3,541,504  
    46,124     ITT, Inc.     2,726,390  
    72,140     Meritor, Inc. *     1,562,552  
    33,696     Moog, Inc. – Class A     2,658,951  
    43,131     Oshkosh Corp.     3,030,384  
    16,459     Parker-Hannifin Corp.     2,890,200  
    24,804     SPX Corp. *     843,088  
    20,023     Teledyne Technologies, Inc. *     4,750,657  
    85,891     Textron, Inc.     5,929,056  
    40,579     Timken Co. (The)     1,974,168  
    28,396     Universal Forest Products, Inc.     1,063,714  
     

 

 

 
    Total Capital Goods     102,619,547  
     

 

 

 
Shares     Description   Value ($)  
    Commercial & Professional Services — 2.1%

 

    122,899     ACCO Brands Corp.     1,523,948  
    35,009     Brady Corp. – Class A     1,416,114  
    30,406     Deluxe Corp.     1,800,643  
    27,046     FTI Consulting, Inc. *     2,061,446  
    12,506     Heidrick & Struggles International, Inc.     552,765  
    40,604     Herman Miller, Inc.     1,555,133  
    9,307     ICF International, Inc.     759,917  
    19,880     Insperity, Inc.     2,382,618  
    21,268     Kforce, Inc.     894,319  
    41,004     Knoll, Inc.     965,234  
    18,200     Korn/Ferry International     1,221,766  
    19,425     ManpowerGroup, Inc.     1,820,705  
    10,500     MSA Safety, Inc.     1,061,445  
    14,800     Resources Connection, Inc.     244,940  
    41,036     Robert Half International, Inc.     3,208,195  
     

 

 

 
    Total Commercial & Professional Services     21,469,188  
     

 

 

 
    Consumer Durables & Apparel — 4.1%

 

    29,945     Acushnet Holdings Corp.     810,012  
    5,360     Bassett Furniture Industries, Inc.     125,156  
    58,954     Brunswick Corp.     3,915,725  
    77,499     Callaway Golf Co.     1,767,752  
    25,096     Columbia Sportswear Co.     2,276,207  
    5,530     Culp, Inc.     140,186  
    13,600     Deckers Outdoor Corp. *     1,657,024  
    67,936     DR Horton, Inc.     3,023,831  
    3,569     Flexsteel Industries, Inc.     127,342  
    69,187     Garmin Ltd.     4,714,402  
    13,000     Helen of Troy Ltd. *     1,546,350  
    5,360     Johnson Outdoors, Inc. – Class A     542,861  
    41,790     La-Z-Boy, Inc.     1,389,517  
    18,971     Movado Group, Inc.     808,165  
    907     NVR, Inc. *     2,420,284  
    8,000     Oxford Industries, Inc.     744,720  
    45,766     PVH Corp.     6,551,861  
    7,900     Rocky Brands, Inc.     238,185  
    73,574     VF Corp.     6,778,373  
    52,119     Wolverine World Wide, Inc.     2,042,022  
     

 

 

 
    Total Consumer Durables & Apparel     41,619,975  
     

 

 

 
    Consumer Services — 1.0%

 

    33,926     Adtalem Global Education, Inc. *     1,623,359  
    5,125     American Public Education, Inc. *     178,094  
    47,384     Bloomin’ Brands, Inc.     914,511  
    21,300     Carrols Restaurant Group, Inc. *     336,540  
    3,148     Graham Holdings Co. – Class B     1,771,222  
    13,302     Grand Canyon Education, Inc. *     1,584,801  
    26,800     K12, Inc. *     443,808  
    22,339     Regis Corp. *     477,831  
    78,330     Service Corp. International     3,286,727  
     

 

 

 
    Total Consumer Services     10,616,893  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   51


GMO U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Diversified Financials — 3.2%

 

    59,614     Ameriprise Financial, Inc.     8,462,804  
    57,300     Capital One Financial Corp.     5,677,857  
    67,291     E*TRADE Financial Corp. *     3,960,748  
    35,730     Enova International, Inc. *     1,186,236  
    44,415     Legg Mason, Inc.     1,385,748  
    39,293     Raymond James Financial, Inc.     3,655,821  
    102,109     State Street Corp.     8,874,293  
     

 

 

 
    Total Diversified Financials     33,203,507  
     

 

 

 
    Energy — 2.9%

 

    63,400     Anadarko Petroleum Corp.     4,082,960  
    298,086     Denbury Resources, Inc. *     1,660,339  
    347,617     Marathon Oil Corp.     7,477,242  
    79,327     Murphy Oil Corp.     2,445,651  
    117,204     Phillips 66     13,889,846  
     

 

 

 
    Total Energy     29,556,038  
     

 

 

 
    Food & Staples Retailing — 0.4%

 

    29,700     Performance Food Group Co. *     983,070  
    83,880     US Foods Holding Corp. *     2,733,649  
     

 

 

 
    Total Food & Staples Retailing     3,716,719  
     

 

 

 
    Food, Beverage & Tobacco — 2.3%

 

    216,570     Archer-Daniels-Midland Co.     10,915,128  
    68,920     Conagra Brands, Inc.     2,532,810  
    81,007     PepsiCo, Inc.     9,073,594  
    16,600     Universal Corp.     992,680  
     

 

 

 
    Total Food, Beverage & Tobacco     23,514,212  
     

 

 

 
    Health Care Equipment & Services — 5.1%

 

    27,770     Anthem, Inc.     7,351,552  
    263,417     Baxter International, Inc.     19,590,322  
    165,121     Danaher Corp.     17,096,628  
    64,578     McKesson Corp.     8,314,418  
     

 

 

 
    Total Health Care Equipment & Services     52,352,920  
     

 

 

 
    Household & Personal Products — 2.5%

 

    106,047     Estee Lauder Cos, Inc. (The) – Class A     14,859,306  
    16,164     Inter Parfums, Inc.     1,055,509  
    111,017     Procter & Gamble Co. (The)     9,208,860  
     

 

 

 
    Total Household & Personal Products     25,123,675  
     

 

 

 
    Insurance — 4.9%

 

    223,388     Aflac, Inc.     10,329,461  
    113,702     Allstate Corp. (The)     11,435,010  
    64,398     Fidelity National Financial, Inc.     2,582,360  
    41,904     First American Financial Corp.     2,382,661  
    46,413     Lincoln National Corp.     3,043,765  
    142,280     Old Republic International Corp.     3,155,770  
    220,507     Progressive Corp. (The)     14,890,838  
Shares     Description   Value ($)  
    Insurance — continued

 

    15,738     Reinsurance Group of America, Inc.     2,248,173  
     

 

 

 
    Total Insurance     50,068,038  
     

 

 

 
    Materials — 4.0%

 

    49,949     Avery Dennison Corp.     5,253,636  
    33,348     Boise Cascade Co.     1,457,307  
    31,959     Cabot Corp.     2,074,778  
    32,300     Celanese Corp.     3,773,609  
    68,227     Eastman Chemical Co.     6,620,066  
    168,192     Huntsman Corp.     5,128,174  
    70,779     LyondellBasell Industries NV – Class A     7,982,456  
    15,951     Materion Corp.     1,017,674  
    18,500     Mercer International, Inc.     327,450  
    24,400     PolyOne Corp.     1,031,144  
    40,100     Reliance Steel & Aluminum Co.     3,524,389  
    37,431     Trinseo SA     2,887,802  
     

 

 

 
    Total Materials     41,078,485  
     

 

 

 
    Media — 2.0%

 

    24,900     AMC Networks, Inc. – Class A *     1,563,969  
    24,106     CBS Corp. – Class B NVDR     1,278,100  
    84,560     Gannett Co., Inc.     869,277  
    16,504     John Wiley & Sons, Inc. – Class A     1,065,333  
    12,200     Marcus Corp. (The)     495,320  
    36,400     New Media Investment Group, Inc.     578,760  
    208,652     News Corp. – Class A     2,727,082  
    101,650     News Corp. – Class B     1,382,440  
    52,589     Omnicom Group, Inc.     3,645,470  
    19,482     Scholastic Corp.     819,023  
    115,885     TEGNA, Inc.     1,348,901  
    43,600     Tribune Media Co. – Class A     1,608,404  
    115,600     Viacom, Inc. – Class B     3,384,768  
     

 

 

 
    Total Media     20,766,847  
     

 

 

 
    Pharmaceuticals, Biotechnology & Life Sciences — 12.0%

 

    103,153     AbbVie, Inc.     9,900,625  
    67,100     Amgen, Inc.     13,407,251  
    55,597     Bruker Corp.     1,978,141  
    281,059     Eli Lilly & Co.     29,693,883  
    60,092     Johnson & Johnson     8,093,792  
    412,131     Merck & Co., Inc.     28,268,065  
    756,638     Pfizer, Inc.     31,415,610  
     

 

 

 
    Total Pharmaceuticals, Biotechnology & Life Sciences     122,757,367  
     

 

 

 
    Real Estate — 2.8%

 

    85,921     Apple Hospitality REIT, Inc.     1,516,505  
    161,149     CBRE Group, Inc. – Class A *     7,865,683  
    63,293     CoreCivic, Inc. (REIT)     1,638,656  
    24,200     Hersha Hospitality Trust (REIT)     571,120  
    246,581     Host Hotels & Resorts, Inc. (REIT)     5,308,889  
 

 

52   See accompanying notes to the financial statements.  


GMO U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    Real Estate — continued

 

    24,688     Jones Lang LaSalle, Inc.     3,765,414  
    82,955     Piedmont Office Realty Trust, Inc. – Class A (REIT)     1,645,827  
    27,393     PotlatchDeltic Corp. (REIT)     1,323,082  
    37,400     Rayonier, Inc. (REIT)     1,302,642  
    79,600     Sunstone Hotel Investors, Inc. (REIT)     1,335,688  
    104,960     Xenia Hotels & Resorts, Inc. (REIT)     2,546,329  
     

 

 

 
    Total Real Estate     28,819,835  
     

 

 

 
    Retailing — 5.2%

 

    500     Amazon.com, Inc. *     1,006,355  
    106,593     American Eagle Outfitters, Inc.     2,767,154  
    14,900     Asbury Automotive Group, Inc. *     1,110,050  
    69,240     Best Buy Co., Inc.     5,508,734  
    32,400     Dick’s Sporting Goods, Inc.     1,213,056  
    49,681     Foot Locker, Inc.     2,449,273  
    98,817     Gap Inc. (The)     2,999,096  
    16,589     Group 1 Automotive, Inc.     1,278,846  
    118,163     Kohl’s Corp.     9,347,875  
    40,400     Liberty TripAdvisor Holdings, Inc. – Class A *     640,340  
    118,303     Macy’s, Inc.     4,323,975  
    17,000     Penske Automotive Group, Inc.     894,710  
    256,968     Qurate Retail, Inc.*     5,342,365  
    15,653     Shutterfly, Inc.*     1,215,925  
    20,400     Sonic Automotive, Inc. – Class A     438,600  
    45,938     Tailored Brands, Inc.     1,081,380  
    79,400     TJX Cos., Inc. (The)     8,731,618  
    51,893     Urban Outfitters, Inc. *     2,411,987  
     

 

 

 
    Total Retailing     52,761,339  
     

 

 

 
    Semiconductors & Semiconductor Equipment — 6.5%

 

    189,428     Applied Materials, Inc.     8,149,193  
    12,251     Cabot Microelectronics Corp.     1,381,055  
    474,400     Intel Corp.     22,975,192  
    60,442     KLA-Tencor Corp.     7,023,965  
    45,054     Kulicke & Soffa Industries, Inc.     1,161,943  
    52,404     Maxim Integrated Products, Inc.     3,168,870  
    362,796     Micron Technology, Inc. *     19,054,046  
    140,281     ON Semiconductor Corp. *     2,993,596  
    20,700     Rudolph Technologies, Inc. *     575,460  
     

 

 

 
    Total Semiconductors & Semiconductor Equipment     66,483,320  
     

 

 

 
    Software & Services — 10.6%

 

    114,900     Activision Blizzard, Inc.     8,284,290  
    62,730     Adobe Systems, Inc. *     16,529,982  
    1,000     Alphabet, Inc. – Class C *     1,218,190  
    50,577     Amdocs Ltd.     3,301,667  
    44,400     Booz Allen Hamilton Holding Corp. – Class A     2,271,504  
    130,813     CA, Inc.     5,729,609  
    6,300     CACI International, Inc. – Class A *     1,228,500  
Shares     Description   Value ($)  
    Software & Services — continued

 

    87,205     Cadence Design Systems, Inc. *     4,102,123  
    43,727     Citrix Systems, Inc. *     4,985,753  
    25,030     CSG Systems International, Inc.     934,870  
    308,055     eBay, Inc. *     10,661,784  
    15,344     IAC/InterActiveCorp *     3,025,837  
    52,095     Intuit, Inc.     11,433,290  
    98,175     Mastercard, Inc. – Class A     21,162,603  
    34,953     Microsoft Corp.     3,926,270  
    33,348     Progress Software Corp.     1,364,934  
    19,710     Sykes Enterprises, Inc. *     596,030  
    71,219     Synopsys, Inc. *     7,274,309  
    27,200     XO Group, Inc. *     817,632  
     

 

 

 
    Total Software & Services     108,849,177  
     

 

 

 
    Technology Hardware & Equipment — 9.5%

 

    58,455     Apple, Inc.     13,306,112  
    42,933     Arrow Electronics, Inc. *     3,328,595  
    51,978     Avnet, Inc.     2,515,735  
    605,614     Hewlett Packard Enterprise Co.     10,010,799  
    980,940     HP, Inc.     24,180,171  
    22,020     Insight Enterprises, Inc. *     1,214,183  
    26,700     Keysight Technologies, Inc. *     1,732,563  
    35,307     Motorola Solutions, Inc.     4,532,007  
    112,795     NetApp, Inc.     9,791,734  
    81,583     Seagate Technology Plc     4,367,954  
    174,503     TE Connectivity Ltd.     15,998,435  
    80,222     Vishay Intertechnology, Inc.     1,909,284  
    62,014     Western Digital Corp.     3,921,765  
     

 

 

 
    Total Technology Hardware & Equipment     96,809,337  
     

 

 

 
    Telecommunication Services — 1.1%

 

    83,271     Telephone & Data Systems, Inc.     2,501,461  
    166,800     Verizon Communications, Inc.     9,068,916  
     

 

 

 
    Total Telecommunication Services     11,570,377  
     

 

 

 
    Transportation — 0.2%

 

    17,865     Landstar System, Inc.     2,068,767  
     

 

 

 
    Utilities — 0.2%

 

    104,000     Vistra Energy Corp.*     2,448,160  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $910,261,616)
    1,018,312,490  
     

 

 

 
    MUTUAL FUNDS — 0.9%

 

    Affiliated Issuers — 0.9%

 

    363,175     GMO U.S. Treasury Fund     9,072,109  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $9,072,109)
    9,072,109  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   53


GMO U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares     Description   Value ($)  
    SHORT-TERM INVESTMENTS — 0.1%

 

    Money Market Funds — 0.1%

 

    1,255,731     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (a)     1,255,731  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $1,255,731)
    1,255,731  
     

 

 

 
    TOTAL INVESTMENTS — 100.4%
(Cost $920,589,456)
    1,028,640,330  
    Other Assets and Liabilities (net) — (0.4%)     (4,522,993
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $1,024,117,337  
     

 

 

 

Notes to Schedule of Investments:

 

*

Non-income producing security.

 

(a)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 55.

 

 

54   See accompanying notes to the financial statements.  


GMO Trust Funds

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Portfolio Abbreviations:

ADR - American Depositary Receipt

CPO - Ordinary Participation Certificate (Certificado de Participacion Ordinares), representing a bundle of shares of the multiple series of one issuer that trade together as a unit.

ETF - Exchange-Traded Fund

Foreign Registered - Shares issued to foreign investors in markets that have foreign ownership limits.

GDR - Global Depository Receipt

LIBOR - London Interbank Offered Rate

NVDR - Non-Voting Depository Receipt

OJSC - Open Joint-Stock Company

OTC - Over-the-Counter

PJSC- Private Joint-Stock Company

QPSC - Qatari Public Shareholding Company

Reg S - Security exempt from registration under Regulation S of the Securities Act of 1933, which exempts from registration securities offered and sold outside the United States. Security may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act of 1933.

REIT - Real Estate Investment Trust

SDR - Swedish Depositary Reciept

USBM - U.S. Treasury 3 Month Bill Money Market Yield

USD LIBOR - London Interbank Offered Rate denominated in United States Dollars.

Counterparty Abbreviations:

GS - Goldman Sachs International

MSCI - Morgan Stanley & Co. International PLC

MSLC - Morgan Stanley & Co. LLC

Currency Abbreviations:

 

GBP - British Pound

PHP - Philippine Peso

THB - Thai Bhat

USD - United States Dollar

 
 

 

  See accompanying notes to the financial statements.   55


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited)

 

 

     Climate
Change
Fund
     Emerging
Domestic
Opportunities
Fund
     Emerging
Markets Fund
     Foreign Small
Companies
Fund
 

Assets:

           

Investments in affiliated issuers, at value (Notes 2 and 10)(a)

   $ 1,665,159      $ 91,359,746      $ 135,120,515      $ 639,328  

Investments in unaffiliated issuers, at value (Note 2)(b)

     87,183,415        1,511,596,618        3,593,469,105        20,117,021  

Foreign currency, at value (Note 2)(c)

     14,769        882,860        21,703,219        10,694  

Cash

     1        30        1,623,798         

Receivable for investments sold

            8,963,998        8,121,724         

Receivable for Fund shares sold

            29,760        123,266         

Dividend withholding tax receivable

     16,828        38,538        19,389        226,676  

Dividends and interest receivable

     86,674        7,614,983        9,197,062        46,061  

Unrealized appreciation on open forward currency contracts (Note 4)

            1,641,047                

Receivable for variation margin on open futures contracts (Note 4)

            43,090        1,649,200         

Due from broker (Note 2)

                   15,216,000        25,968  

Receivable for open OTC swap contracts (Note 4)

                   770,262         

Receivable for expenses reimbursed and/or waived by GMO (Note 5)

     34,420        26,445        455,871        17,201  

Miscellaneous receivable

            240        130,156         
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

     89,001,266        1,622,197,355        3,787,599,567        21,082,949  
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           

Payable for investments purchased

     5,583        8,145,994        15,548,834        926  

Payable for Fund shares repurchased

                   16,393,793         

Accrued foreign capital gains tax payable (Note 2)

     3,535               783,515         

Payable to affiliate for (Note 5):

 

     

Management fee

     44,914        1,034,794        2,395,178        10,478  

Shareholder service fee

     11,228        184,145        258,471        2,621  

Payable to agents unaffiliated with GMO

     11        396        840        6  

Payable for variation margin on open futures contracts (Note 4)

                          2,820  

Unrealized depreciation on open forward currency contracts (Note 4)

            2,116,950                

Miscellaneous payable

                   926,314         

Payable for open OTC swap contracts (Note 4)

            915,351                

Payable for reverse repurchase agreements (Note 2)

                   40         

Payable to Trustees and related expenses

     307        7,353        14,820        1,540  

Accrued expenses

     58,600        642,663        1,509,746        246,184  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

     124,178        13,047,646        37,831,551        264,575  
  

 

 

    

 

 

    

 

 

    

 

 

 

Net assets

   $ 88,877,088      $ 1,609,149,709      $ 3,749,768,016      $ 20,818,374  
  

 

 

    

 

 

    

 

 

    

 

 

 

(a)  Cost of investments – affiliated issuers:

   $ 1,665,159      $ 69,959,396      $ 103,114,726      $ 639,328  

(b)  Cost of investments – unaffiliated issuers:

   $ 90,188,954      $ 1,615,148,031      $ 3,620,293,838      $ 20,476,137  

(c)  Cost of foreign currency:

   $ 14,746      $ 887,217      $ 21,646,193      $ 10,686  

 

56   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     Climate
Change
Fund
    Emerging
Domestic
Opportunities
Fund
    Emerging
Markets Fund
    Foreign Small
Companies
Fund
 

Net assets consist of:

 

Paid-in capital

   $ 90,467,120     $ 1,675,811,516     $ 5,027,964,918     $ 21,629,666  

Accumulated undistributed (distributions in excess of) net investment income

     830,528       2,857,657       81,028,889       (761,756

Accumulated net realized gain (loss)

     588,688       14,916,159       (1,343,763,221     361,824  

Net unrealized appreciation (depreciation)

     (3,009,248     (84,435,623     (15,462,570     (411,360
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 88,877,088     $ 1,609,149,709     $ 3,749,768,016     $ 20,818,374  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net assets attributable to:

 

Class II

   $     $ 488,374,530     $ 362,509,163     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class III

   $ 88,877,088     $ 138,734,015     $ 297,410,202     $ 20,818,374  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class IV

   $     $ 207,587,867     $ 88,926,018     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class V

   $     $ 774,453,297     $ 152,210,047     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class VI

   $     $     $ 2,848,712,586     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares outstanding:

 

Class II

           22,299,025       11,219,534        
  

 

 

   

 

 

   

 

 

   

 

 

 

Class III

     3,898,670       6,332,594       9,178,865       1,716,604  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class IV

           9,466,959       2,769,610        
  

 

 

   

 

 

   

 

 

   

 

 

 

Class V

           35,351,262       4,755,047        
  

 

 

   

 

 

   

 

 

   

 

 

 

Class VI

                 88,768,337        
  

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value per share:

 

Class II

   $     $ 21.90     $ 32.31     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class III

   $ 22.80     $ 21.91     $ 32.40     $ 12.13  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class IV

   $     $ 21.93     $ 32.11     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class V

   $     $ 21.91     $ 32.01     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class VI

   $     $     $ 32.09     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   57


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     International
Equity Fund
     International
Large/Mid
Cap Equity
Fund
     Quality Fund      Resources
Fund
 

Assets:

           

Investments in affiliated issuers, at value (Notes 2 and 10)(a)

   $ 22,343,940      $ 477,713      $ 51,094,345      $ 10,640,570  

Investments in unaffiliated issuers, at value (Note 2)(b)

     3,956,120,722        18,552,469        7,136,241,079        435,224,601  

Foreign currency, at value (Note 2)(c)

     925,121        448,150        17        43,427  

Cash

     8               205        28  

Receivable for investments sold

     18               40,698,585         

Receivable for Fund shares sold

     373,602        7,728        3,313,885         

Dividend withholding tax receivable

     6,145,066        203,802        2,183,850        40,213  

Dividends and interest receivable

     6,214,201        42,850        11,136,196        1,363,203  

Due from broker (Note 2)

     632,276        15,631                

Receivable for expenses reimbursed and/or waived by GMO (Note 5)

     111,232        12,441        94,144         
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

     3,992,866,186        19,760,784        7,244,762,306        447,312,042  
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

           

Payable for investments purchased

                          7,245  

Payable for Fund shares repurchased

     30,044               70,756,392         

Accrued foreign capital gains tax payable (Note 2)

                          11,021  

Payable for recoupment of past waived and/or reimbursement fees (Note 5)

                          6,599  

Payable to affiliate for (Note 5):

 

     

Management fee

     1,699,968        6,676        1,994,257        187,181  

Shareholder service fee

     332,130        2,639        643,174        42,263  

Payable to agents unaffiliated with GMO

     870        13        1,390        66  

Payable for variation margin on open futures contracts (Note 4)

     87,420        2,115                

Payable to Trustees and related expenses

     16,025        368        25,174        689  

Accrued expenses

     698,610        324,049        549,766        123,201  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

     2,865,067        335,860        73,970,153        378,265  
  

 

 

    

 

 

    

 

 

    

 

 

 

Net assets

   $ 3,990,001,119      $ 19,424,924      $ 7,170,792,153      $ 446,933,777  
  

 

 

    

 

 

    

 

 

    

 

 

 

(a)  Cost of investments – affiliated issuers:

   $ 22,343,940      $ 477,713      $ 51,089,904      $ 10,638,444  

(b)  Cost of investments – unaffiliated issuers:

   $ 3,779,720,837      $ 17,582,301      $ 4,629,578,997      $ 376,811,268  

(c)  Cost of foreign currency:

   $ 929,380      $ 450,973      $ 16      $ 43,683  

 

58   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     International
Equity Fund
    International
Large/Mid
Cap Equity
Fund
    Quality Fund      Resources
Fund
 

Net assets consist of:

 

Paid-in capital

   $ 4,818,446,332     $ 18,710,844     $ 3,959,914,008      $ 426,851,806  

Accumulated undistributed (distributions in excess of) net investment income

     54,161,844       (1,240,721     50,856,044        (4,227,833

Accumulated net realized gain (loss)

     (1,058,046,896     1,156,722       653,368,735        (34,085,409

Net unrealized appreciation (depreciation)

     175,439,839       798,079       2,506,653,366        58,395,213  
  

 

 

   

 

 

   

 

 

    

 

 

 
   $ 3,990,001,119     $ 19,424,924     $ 7,170,792,153      $ 446,933,777  
  

 

 

   

 

 

   

 

 

    

 

 

 

Net assets attributable to:

 

Class II

   $ 20,851,709     $     $      $  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class III

   $ 467,095,862     $ 19,424,924     $ 3,199,674,120      $ 119,927,347  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class IV

   $ 3,502,053,548     $     $ 1,179,485,157      $ 327,006,430  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class V

   $     $     $ 168,316,284      $  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class VI

   $     $     $ 2,623,316,592      $  
  

 

 

   

 

 

   

 

 

    

 

 

 

Shares outstanding:

 

Class II

     946,449                     
  

 

 

   

 

 

   

 

 

    

 

 

 

Class III

     20,942,188       889,001       120,749,595        5,937,620  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class IV

     157,292,511             44,437,723        16,243,699  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class V

                 6,340,738         
  

 

 

   

 

 

   

 

 

    

 

 

 

Class VI

                 98,981,887         
  

 

 

   

 

 

   

 

 

    

 

 

 

Net asset value per share:

 

Class II

   $ 22.03     $     $      $  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class III

   $ 22.30     $ 21.85     $ 26.50      $ 20.20  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class IV

   $ 22.26     $     $ 26.54      $ 20.13  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class V

   $     $     $ 26.55      $  
  

 

 

   

 

 

   

 

 

    

 

 

 

Class VI

   $     $     $ 26.50      $  
  

 

 

   

 

 

   

 

 

    

 

 

 

 

  See accompanying notes to the financial statements.   59


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     Risk Premium
Fund
     Tax-Managed
International
Equities
Fund
     U.S. Equity
Fund (formerly
U.S. Equity
Allocation Fund)
 

Assets:

 

     

Investments in affiliated issuers, at value (Notes 2 and 10)(a)

   $      $ 1,001,983      $ 9,072,109  

Investments in unaffiliated issuers, at value (Note 2)(b)

     516,427,795        51,211,136        1,019,568,221  

Foreign currency, at value (Note 2)(c)

            26,846         

Cash

     34               120,001  

Receivable for investments sold

     851,973        19,680         

Dividend withholding tax receivable

            81,587         

Dividends and interest receivable

     857,857        92,032        1,902,948  

Receivable for variation margin on open futures contracts (Note 4)

            930         

Due from broker (Note 2)

     322,879        55,431        295,008  

Receivable for expenses reimbursed and/or waived by GMO (Note 5)

     9,381        19,793        27,061  
  

 

 

    

 

 

    

 

 

 

Total assets

     518,469,919        52,509,418        1,030,985,348  
  

 

 

    

 

 

    

 

 

 

Liabilities:

        

Payable for Fund shares repurchased

                   6,372,786  

Accrued foreign capital gains tax payable (Note 2)

            3,479         

Payable to affiliate for (Note 5):

 

  

Management fee

     198,058        22,327        269,943  

Shareholder service fee

     25,839        6,698        57,519  

Payable to agents unaffiliated with GMO

     23        12        233  

Payable for variation margin on open futures contracts (Note 4)

            5,640        2,696  

Written options outstanding, at value (Note 4)(d)

     3,171,260                

Payable to Trustees and related expenses

     250        410        4,329  

Accrued expenses

     76,530        107,546        160,505  
  

 

 

    

 

 

    

 

 

 

Total liabilities

     3,471,960        146,112        6,868,011  
  

 

 

    

 

 

    

 

 

 

Net assets

   $ 514,997,959      $ 52,363,306      $ 1,024,117,337  
  

 

 

    

 

 

    

 

 

 

(a)  Cost of investments – affiliated issuers:

   $      $ 1,001,906      $ 9,072,109  

(b)  Cost of investments – unaffiliated issuers:

   $ 516,420,667      $ 36,574,852      $ 911,517,347  

(c)  Cost of foreign currency:

   $      $ 27,045      $  

(d)  Premiums on written options:

   $ 4,083,175      $      $  

 

60   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     Risk Premium
Fund
     Tax-Managed
International
Equities
Fund
    U.S. Equity
Fund (formerly
U.S. Equity
Allocation Fund)
 

Net assets consist of:

 

Paid-in capital

   $ 496,465,837      $ 48,723,720     $ 846,300,604  

Accumulated undistributed (distributions in excess of) net investment income

     1,696,766        354,723       8,056,166  

Accumulated net realized gain (loss)

     15,916,313        (11,305,926     61,709,693  

Net unrealized appreciation (depreciation)

     919,043        14,590,789       108,050,874  
  

 

 

    

 

 

   

 

 

 
   $ 514,997,959      $ 52,363,306     $ 1,024,117,337  
  

 

 

    

 

 

   

 

 

 

Net assets attributable to:

 

Class III

   $ 20,372,446      $ 52,363,306     $ 81,047,158  
  

 

 

    

 

 

   

 

 

 

Class IV

   $      $     $ 38,064,179  
  

 

 

    

 

 

   

 

 

 

Class V

   $      $     $ 61,864,018  
  

 

 

    

 

 

   

 

 

 

Class VI

   $ 494,625,513      $     $ 843,141,982  
  

 

 

    

 

 

   

 

 

 

Shares outstanding:

 

Class III

     722,761        3,450,082       5,434,621  
  

 

 

    

 

 

   

 

 

 

Class IV

                  2,550,002  
  

 

 

    

 

 

   

 

 

 

Class V

                  4,166,356  
  

 

 

    

 

 

   

 

 

 

Class VI

     17,448,971              56,939,582  
  

 

 

    

 

 

   

 

 

 

Net asset value per share:

 

Class III

   $ 28.19      $ 15.18     $ 14.91  
  

 

 

    

 

 

   

 

 

 

Class IV

   $      $     $ 14.93  
  

 

 

    

 

 

   

 

 

 

Class V

   $      $     $ 14.85  
  

 

 

    

 

 

   

 

 

 

Class VI

   $ 28.35      $     $ 14.81  
  

 

 

    

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   61


GMO Trust Funds

 

Statements of Operations — Six Months Ended August 31, 2018 (Unaudited)

 

 

     Climate
Change
Fund
    Emerging
Domestic
Opportunities
Fund
    Emerging
Markets Fund
    Foreign Small
Companies
Fund
 

Investment Income:

        

Dividends from unaffiliated issuers (Net of withholding tax) (Note 2)(a)

   $ 1,027,185     $ 24,658,284     $ 120,888,128     $ 625,472  

Interest

     325       338,975       1,509,554       6,284  

Dividends from affiliated issuers (Note 10)

     22,745       1,065,696       637,499       8,601  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

     1,050,255       26,062,955       123,035,181       640,357  
  

 

 

   

 

 

   

 

 

   

 

 

 

Expenses:

        

Management fee (Note 5)

     201,436       7,803,856       16,577,839       122,598  

Shareholder service fee – Class II (Note 5)

           650,266       444,279        

Shareholder service fee – Class III (Note 5)

     50,359       101,842       248,375       25,554  

Shareholder service fee – Class IV (Note 5)

           143,001       112,747       3,397 *  

Shareholder service fee – Class V (Note 5)

           459,725       73,255        

Shareholder service fee – Class VI (Note 5)

                 907,109        

Audit and tax fees

     36,742       73,066       136,014       85,868  

Fees related to tax refunds received (Note 2)

                       45,000  

Custodian, fund accounting agent and transfer agent fees

     39,803       786,673       1,673,656       57,794  

Legal fees

     4,284       17,976       34,814       3,966  

Registration fees

     2,555       3,784       26,644       1,852  

Trustees’ fees and related expenses (Note 5)

     383       26,615       55,844       1,608  

Miscellaneous

     6,458       12,565       29,197       12,280  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     342,020       10,079,369       20,319,773       359,917  

Fees and expenses reimbursed and/or waived by GMO (Note 5)

     (99,042     (111,231     (3,044,441     (114,599
  

 

 

   

 

 

   

 

 

   

 

 

 

Net expenses

     242,978       9,968,138       17,275,332       245,318  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     807,277       16,094,817       105,759,849       395,039  
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized and unrealized gain (loss):

        

Net realized gain (loss) on:

        

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(b)

     709,034       27,002,253       153,832,826       8,654,489  

Investments in affiliated issuers

     1,564       1,567,434       17,367       (68

Futures contracts

           (16,688,997     5,417,937       56,936  

Swap contracts

           11,620,600       (1,933,685      

Forward currency contracts

           1,448,654              

Foreign currency and foreign currency related transactions

     18,361       (2,537,746     (5,204,337     18,455  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

     728,959       22,412,198 **      152,130,108       8,729,812  
  

 

 

   

 

 

   

 

 

   

 

 

 

Change in net unrealized appreciation (depreciation) on:

        

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(c)

     (4,489,595     (368,801,181     (739,284,056     (11,946,627

Investments in affiliated issuers

     300       (6,858,984     (6,187,086      

Futures contracts

           624,073       (38,650,166     28,047  

Swap contracts

           (915,351     334,321        

Forward currency contracts

           (2,831,675            

Foreign currency and foreign currency related transactions

     (778     (403,362     621       (56,287
  

 

 

   

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

     (4,490,073     (379,186,480     (783,786,366     (11,974,867
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

     (3,761,114     (356,774,282     (631,656,258     (3,245,055
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

   $ (2,953,837   $ (340,679,465   $ (525,896,409   $ (2,850,016
  

 

 

   

 

 

   

 

 

   

 

 

 

(a)  Withholding tax:

   $ 141,524     $ 2,795,660     $ 16,538,859     $ 56,689  

(b)  Foreign capital gains tax on net realized gain (loss):

   $ 22     $ 682,286     $ 1,355,480     $  

(c)  Foreign capital gains tax on change in net unrealized appreciation (depreciation):

   $ 3,535     $ (277,504   $ (1,177,816   $  

*   Class IV liquidated on May 2, 2018.

        

**   For the details related to in-kind redemption realized gain (loss) please refer to Note 6.

        

 

62   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Operations — Six Months Ended August 31, 2018 (Unaudited) — (Continued)

 

 

     International
Equity Fund
    International
Large/Mid
Cap Equity
Fund
    Quality Fund     Resources
Fund
 

Investment Income:

 

Dividends from unaffiliated issuers (Net of withholding tax) (Note 2)(a)

   $ 108,149,590     $ 1,782,673     $ 74,977,522     $ 8,315,299  

Interest

     48,505       8,440       1,045,885       11,556  

Dividends from affiliated issuers (Note 10)

     496,061       9,235       507,894       88,516  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

     108,694,156       1,800,348       76,531,301       8,415,371  
  

 

 

   

 

 

   

 

 

   

 

 

 

Expenses:

 

Management fee (Note 5)

     11,521,028       94,331       12,485,280       987,127  

Shareholder service fee – Class II (Note 5)

     24,106                    

Shareholder service fee – Class III (Note 5)

     361,315       37,037       2,505,729       57,164  

Shareholder service fee – Class IV (Note 5)

     1,847,135       119     496,395       159,316  

Shareholder service fee – Class V (Note 5)

                 69,689        

Shareholder service fee – Class VI (Note 5)

                 857,004        

Audit and tax fees

     93,620       128,391       58,347       53,572  

Fees related to tax refunds received (Note 2)

           70,000              

Custodian, fund accounting agent and transfer agent fees

     513,681       45,869       505,832       91,108  

Legal fees

     33,978       3,500       53,144       4,587  

Registration fees

     16,407       8,710       12,141       1,341  

Trustees’ fees and related expenses (Note 5)

     56,331       789       89,927       4,057  

Recoupment of past waived and/or reimbursed fees (Note 5)

                       53,546  

Miscellaneous

     29,588       9,116       20,006       6,436  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     14,497,189       397,862       17,153,494       1,418,254  

Fees and expenses reimbursed and/or waived by GMO (Note 5)

     (639,095     (92,529     (622,932      
  

 

 

   

 

 

   

 

 

   

 

 

 

Net expenses

     13,858,094       305,333       16,530,562       1,418,254  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     94,836,062       1,495,015       60,000,739       6,997,117  
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized and unrealized gain (loss):

 

Net realized gain (loss) on:

 

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(b)

     201,049,825       7,147,536       737,301,397       14,182,257  

Investments in affiliated issuers

     (806     (4,142     (22,597     2,131  

Futures contracts

     1,598,326       (44,252            

Foreign currency and foreign currency related transactions

     (575,456     6,118       (336,842     5,728  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

     202,071,889 **      7,105,260       736,941,958 **      14,190,116  
  

 

 

   

 

 

   

 

 

   

 

 

 

Change in net unrealized appreciation (depreciation) on:

 

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(c)

     (573,495,426     (11,588,153     (119,111,075     (31,965,976

Investments in affiliated issuers

     15,646       726       24,902       3,930  

Futures contracts

     (318,157     24,622              

Foreign currency and foreign currency related transactions

     (998,578     (94,450     (56,126     (17,839
  

 

 

   

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

     (574,796,515     (11,657,255     (119,142,299     (31,979,885
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

     (372,724,626     (4,551,995     617,799,659       (17,789,769
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

   $ (277,888,564   $ (3,056,980   $ 677,800,398     $ (10,792,652
  

 

 

   

 

 

   

 

 

   

 

 

 

(a)  Withholding tax:

   $ 13,355,664     $ 162,096     $ 2,333,786     $ 784,296  

(b)  Foreign capital gains tax on net realized gain (loss):

   $     $     $     $  

(c)  Foreign capital gains tax on change in net unrealized appreciation (depreciation):

   $     $     $     $ 11,021  

*   Class IV liquidated on May 2, 2018.

        

**   For the details related to in-kind redemption realized gain (loss) please refer to Note 6.

        

 

  See accompanying notes to the financial statements.   63


GMO Trust Funds

 

Statements of Operations — Six Months Ended August 31, 2018 (Unaudited) — (Continued)

 

 

     Risk
Premium
Fund
    Tax-Managed
International
Equities
Fund
    U.S. Equity
Fund (formerly
U.S. Equity
Allocation Fund)
 

Investment Income:

 

Dividends from unaffiliated issuers (Net of withholding tax) (Note 2)(a)

   $ 11,056     $ 1,255,230     $ 11,746,058  

Interest

     2,673,269       347       1,115  

Dividends from affiliated issuers (Note 10)

           9,503       86,242  
  

 

 

   

 

 

   

 

 

 

Total investment income

     2,684,325       1,265,080       11,833,415  
  

 

 

   

 

 

   

 

 

 

Expenses:

 

Management fee (Note 5)

     623,600       142,389       1,893,413  

Shareholder service fee – Class III (Note 5)

     7,207       42,717       58,936  

Shareholder service fee – Class IV (Note 5)

                 18,412  

Shareholder service fee – Class V (Note 5)

                 27,561  

Shareholder service fee – Class VI (Note 5)

     73,575             286,358  

Audit and tax fees

     26,966       69,257       34,969  

Custodian, fund accounting agent and transfer agent fees

     17,209       51,174       107,591  

Legal fees

     670       3,396       10,062  

Registration fees

     1,621       1,983       10,877  

Trustees’ fees and related expenses (Note 5)

     1,966       763       15,079  

Miscellaneous

     13,135       21,500     6,923  
  

 

 

   

 

 

   

 

 

 

Total expenses

     765,949       333,179       2,470,181  

Fees and expenses reimbursed and/or waived by GMO (Note 5)

     (59,430     (119,016     (165,879
  

 

 

   

 

 

   

 

 

 

Net expenses

     706,519       214,163       2,304,302  
  

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     1,977,806       1,050,917       9,529,113  
  

 

 

   

 

 

   

 

 

 

Realized and unrealized gain (loss):

 

Net realized gain (loss) on:

 

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(b)

     (122,167     4,333,726       98,566,458  

Investments in affiliated issuers

           (331     (889

Futures contracts

           (66,891     296,689  

Written options

     20,185,755              

Foreign currency and foreign currency related transactions

     4,864       4,247        
  

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

     20,068,452       4,270,751       98,862,258 ** 
  

 

 

   

 

 

   

 

 

 

Change in net unrealized appreciation (depreciation) on:

 

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(c)

     177,174       (9,570,854     (49,979,211

Investments in affiliated issuers

           504       2,988  

Futures contracts

           25,864       (74,241

Written options

     484,900              

Foreign currency and foreign currency related transactions

           (20,521      
  

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

     662,074       (9,565,007     (50,050,464
  

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

     20,730,526       (5,294,256     48,811,794  
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

   $ 22,708,332     $ (4,243,339   $ 58,340,907  
  

 

 

   

 

 

   

 

 

 

(a)  Withholding tax:

   $     $ 146,673     $ 3,485  

(b)  Foreign capital gains tax on net realized gain (loss):

   $     $ 204     $  

(c)  Foreign capital gains tax on change in net unrealized appreciation (depreciation):

   $     $ (5,664   $  

*   Includes $17,519 of pricing related fees.

      

**   For the details related to in-kind redemption realized gain (loss) please refer to Note 6.

      

 

64   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Changes in Net Assets

 

 

       Climate Change Fund     Emerging Domestic
Opportunities Fund
 
       Six Months
Ended
August 31,
2018
(Unaudited)
    Period from
April 5, 2017
(commencement
of operations)
through
February 28,
2018
    Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
 

Increase (decrease) in net assets:

 

Operations:

 

Net investment income (loss)

     $ 807,277     $ 167,335     $ 16,094,817     $ 23,919,255  

Net realized gain (loss)

       728,959       1,128,320       22,412,198       415,071,691  

Change in net unrealized appreciation (depreciation)

       (4,490,073     1,480,825       (379,186,480     136,074,872  
    

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

       (2,953,837     2,776,480       (340,679,465     575,065,818  
    

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

 

Net investment income

 

Class II

                   (11,989     (8,577,224

Class III

       (100,304     (176,067     (14,148     (1,697,769

Class IV

                   (27,075     (4,239,894

Class V

                   (98,673     (16,995,140

Class VI

                        
    

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

       (100,304     (176,067     (151,885     (31,510,027
    

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gains

 

Class II

                   (54,666,816      

Class III

       (645,226     (491,078     (15,482,732      

Class IV

                   (28,490,240      

Class V

                   (103,830,685      
    

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net realized gains

       (645,226     (491,078     (202,470,473      
    

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

 

Class II

                   (62,088,911     (60,122,470

Class III

       65,882,370       24,584,750       54,695,886       (39,709,374

Class IV

                   (21,562,813     (119,146,650

Class V

                   (225,018,254     61,706,976  

Class VI

                         (16,244,932 )* 
    

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

       65,882,370       24,584,750       (253,974,092     (173,516,450
    

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

 

Class II

                   903,488       617,648  

Class III

                   237,969       118,506  

Class IV

                   458,040       312,031  

Class V

                   1,524,273       1,095,122  

Class VI

                         2,117
    

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

                   3,123,770       2,145,424  
    

 

 

   

 

 

   

 

 

   

 

 

 
          

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

       65,882,370       24,584,750       (250,850,322     (171,371,026
    

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

       62,183,003       26,694,085       (794,152,145     372,184,765  
Net assets:

 

 

Beginning of period

       26,694,085             2,403,301,854       2,031,117,089  
    

 

 

   

 

 

   

 

 

   

 

 

 

End of period

     $ 88,877,088     $ 26,694,085     $ 1,609,149,709     $ 2,403,301,854  
    

 

 

   

 

 

   

 

 

   

 

 

 

Accumulatedundistributed (distributions in excess of) net investment income

     $ 830,528     $ 123,555     $ 2,857,657     $ (13,085,275
    

 

 

   

 

 

   

 

 

   

 

 

 

*   Class VI liquidated on March 29, 2017.

          

 

  See accompanying notes to the financial statements.   65


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

       Emerging Markets Fund     Foreign Small
Companies Fund
 
       Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
    Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
 

Increase (decrease) in net assets:

          

Operations:

          

Net investment income (loss)

     $ 105,759,849     $ 120,564,814     $ 395,039     $ 12,365,256  

Net realized gain (loss)

       152,130,108       633,257,899       8,729,812       152,983,283  

Change in net unrealized appreciation (depreciation)

       (783,786,366     362,984,717       (11,974,867     (55,110,759
    

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

       (525,896,409     1,116,807,430       (2,850,016     110,237,780  
    

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

 

Net investment income

 

Class II

       (559,145     (11,956,275            

Class III

       (491,220     (5,490,308     (500,282     (3,824,869

Class IV

       (103,306     (14,250,088         (9,440,862

Class V

       (336,961     (4,213,667            

Class VI

       (6,032,853     (100,502,683            
    

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

       (7,523,485     (136,413,021     (500,282     (13,265,731
    

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gains

 

Class III

                   (6,786,050     (13,747,999

Class IV

                   (4,785,668 )*      (32,945,889
    

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net realized gains

                   (11,571,718     (46,693,888
    

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

 

Class II

       (69,149,457     (111,903,150            

Class III

       (53,465,498     42,508,224       (26,191,430     (209,670,456

Class IV

       (365,097,799     (225,782,751     (83,615,656 )*      (514,884,481

Class V

       1,459,503       33,512,592              

Class VI

       (339,965,322     (650,491,952            
    

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

       (826,218,573     (912,157,037     (109,807,086     (724,554,937
    

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

 

Class II

       679,950       1,611,194              

Class III

       552,041       737,313       502,997       398,979  

Class IV

       267,836       2,193,709       111,351     830,322  

Class V

       297,557       479,079              

Class VI

       5,572,062       11,838,878              
    

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

       7,369,446       16,860,173       614,348       1,229,301  
    

 

 

   

 

 

   

 

 

   

 

 

 
          

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

       (818,849,127     (895,296,864     (109,192,738     (723,325,636
    

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

       (1,352,269,021     85,097,545       (124,114,754     (673,047,475
Net assets:

 

   

Beginning of period

       5,102,037,037       5,016,939,492       144,933,128       817,980,603  
    

 

 

   

 

 

   

 

 

   

 

 

 

End of period

     $ 3,749,768,016     $ 5,102,037,037     $ 20,818,374     $ 144,933,128  
    

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

     $ 81,028,889     $ (17,207,475   $ (761,756   $ (656,513
    

 

 

   

 

 

   

 

 

   

 

 

 

*   Class IV liquidated on May 2, 2018.

          

 

66   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     International Equity Fund     International Large/Mid
Cap Equity Fund
 
     Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
    Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
 

Increase (decrease) in net assets:

        

Operations:

        

Net investment income (loss)

   $ 94,836,062     $ 136,645,091     $ 1,495,015     $ 3,484,528  

Net realized gain (loss)

     202,071,889       333,135,160       7,105,260       13,685,525  

Change in net unrealized appreciation (depreciation)

     (574,796,515     611,006,576       (11,657,255     5,607,263  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     (277,888,564     1,080,786,827       (3,056,980     22,777,316  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

 

Net investment income

 

Class II

     (127,773     (592,109            

Class III

     (2,974,721     (15,748,937     (1,280,278     (520,210

Class IV

     (23,752,827     (157,085,524           (3,905,515
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (26,855,321     (173,426,570     (1,280,278     (4,425,725
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gains

 

Class III

                 (6,061,300     (391,628

Class IV

                 (7,293 )*      (9,849,041
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net realized gains

                 (6,068,593     (10,240,669
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

 

Class II

     (1,374,741     11,254,887              

Class III

     14,620,062       (340,134,465     (51,304,726     41,540,025  

Class IV

     (786,185,281     (1,324,181,462     (759,212 )*      (152,989,906

Class VI

                       (616,556 )** 
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (772,939,960     (1,653,061,040     (52,063,938     (112,066,437
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (1,077,683,845     (745,700,783     (62,469,789     (103,955,515
Net assets:

 

   

Beginning of period

     5,067,684,964       5,813,385,747       81,894,713       185,850,228  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 3,990,001,119     $ 5,067,684,964     $ 19,424,924     $ 81,894,713  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 54,161,844     $ (13,818,897   $ (1,240,721   $ (1,455,458
  

 

 

   

 

 

   

 

 

   

 

 

 

*   Class IV liquidated on May 2, 2018.

        

**   Class VI liquidated on March 29, 2017.

        

 

  See accompanying notes to the financial statements.   67


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     Quality Fund     Resources Fund  
     Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
    Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
 

Increase (decrease) in net assets:

        

Operations:

        

Net investment income (loss)

   $ 60,000,739     $ 128,619,753     $ 6,997,117     $ 4,986,637  

Net realized gain (loss)

     736,941,958       713,188,332       14,190,116       12,979,215  

Change in net unrealized appreciation (depreciation)

     (119,142,299     922,881,868       (31,979,885     42,871,047  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     677,800,398       1,764,689,953       (10,792,652     60,836,899  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

 

Net investment income

 

Class III

     (9,648,385     (56,641,958     (1,210,304     (880,349

Class IV

     (2,589,123     (15,493,213     (3,958,941     (10,056,534

Class V

     (531,314     (4,742,268            

Class VI

     (8,282,287     (59,448,671            
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (21,051,109     (136,326,110     (5,169,245     (10,936,883
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gains

 

Class III

     (127,597,321     (219,320,323            

Class IV

     (32,388,457     (58,604,732            

Class V

     (6,404,746     (16,385,208            

Class VI

     (98,407,812     (218,783,386            
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net realized gains

     (264,798,336     (513,093,649            
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

 

Class III

     (491,714,569     (524,533,540     69,453,590       27,821,128  

Class IV

     164,022,512       (403,819,622     42,877,778       59,123,014  

Class V

     2,748,338       (369,399,954            

Class VI

     (1,096,280,666     (249,653,450            
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (1,421,224,385     (1,547,406,566     112,331,368       86,944,142  
  

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

 

Class III

                 65,215       60,364  

Class IV

                 265,521       507,680  
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

                 330,736       568,044  
  

 

 

   

 

 

   

 

 

   

 

 

 
        

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

     (1,421,224,385     (1,547,406,566     112,662,104       87,512,186  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (1,029,273,432     (432,136,372     96,700,207       137,412,202  
Net assets:

 

   

Beginning of period

     8,200,065,585       8,632,201,957       350,233,570       212,821,368  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 7,170,792,153     $ 8,200,065,585     $ 446,933,777     $ 350,233,570  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 50,856,044     $ 11,906,414     $ (4,227,833   $ (6,055,705
  

 

 

   

 

 

   

 

 

   

 

 

 

 

68   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

       Risk Premium Fund     Tax-Managed International
Equities Fund
 
       Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
    Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
 

Increase (decrease) in net assets:

          

Operations:

          

Net investment income (loss)

     $ 1,977,806     $ 703,236     $ 1,050,917     $ 2,489,190  

Net realized gain (loss)

       20,068,452       9,097,108       4,270,751       17,588,975  

Change in net unrealized appreciation (depreciation)

       662,074       (427,540     (9,565,007     4,161,943  
    

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

       22,708,332       9,372,804       (4,243,339     24,240,108  
    

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

 

Net investment income

 

Class III

       (12,004     (7,176     (170,302     (3,315,762

Class VI

       (488,192     (463,232            
    

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

       (500,196     (470,408     (170,302     (3,315,762
    

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gains

 

Class III

             (717,032     (1,772,940      

Class VI

             (23,541,333            
    

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net realized gains

             (24,258,365     (1,772,940      
    

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

 

Class III

       16,130,706       (1,182,676     (10,231,845     (67,875,263

Class VI

       330,972,666       1,739,919              
    

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

       347,103,372       557,243       (10,231,845     (67,875,263
    

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

 

Class III

       365       1,406              

Class VI

       14,488       45,191              
    

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

       14,853       46,597              
    

 

 

   

 

 

   

 

 

   

 

 

 
          

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

       347,118,225       603,840       (10,231,845     (67,875,263
    

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

       369,326,361       (14,752,129     (16,418,426     (46,950,917
Net assets:

 

   

Beginning of period

       145,671,598       160,423,727       68,781,732       115,732,649  
    

 

 

   

 

 

   

 

 

   

 

 

 

End of period

     $ 514,997,959     $ 145,671,598     $ 52,363,306     $ 68,781,732  
    

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

     $ 1,696,766     $ 219,156     $ 354,723     $ (525,892
    

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   69


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     U.S. Equity Fund (formerly
U.S. Equity Allocation Fund)
 
     Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended
February 28,
2018
 

Increase (decrease) in net assets:

    

Operations:

    

Net investment income (loss)

   $ 9,529,113     $ 29,498,514  

Net realized gain (loss)

     98,862,258       190,117,350  

Change in net unrealized appreciation (depreciation)

     (50,050,464     (18,454,310
  

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     58,340,907       201,161,554  
  

 

 

   

 

 

 

Distributions to shareholders from:

 

Net investment income

 

Class III

     (304,223     (1,071,935

Class IV

     (153,095     (426,461

Class V

     (270,988     (2,144,892

Class VI

     (3,711,164     (24,505,927
  

 

 

   

 

 

 

Total distributions from net investment income

     (4,439,470     (28,149,215
  

 

 

   

 

 

 

Net realized gains

 

Class III

     (5,831,017     (6,499,591

Class IV

     (2,776,836     (2,930,389

Class V

     (4,999,533     (12,130,947

Class VI

     (66,800,944     (123,226,362
  

 

 

   

 

 

 

Total distributions from net realized gains

     (80,408,330     (144,787,289
  

 

 

   

 

 

 

Net share transactions (Note 9):

 

Class III

     6,006,081       (32,682,528

Class IV

     3,118,523       18,607,196  

Class V

     3,360,595       (106,801,014

Class VI

     (335,577,315     (294,652,578
  

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (323,092,116     (415,528,924
  

 

 

   

 

 

 

Total increase (decrease) in net assets

     (349,599,009     (387,303,874
Net assets:

 

Beginning of period

     1,373,716,346       1,761,020,220  
  

 

 

   

 

 

 

End of period

   $ 1,024,117,337     $ 1,373,716,346  
  

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 8,056,166     $ 2,966,523  
  

 

 

   

 

 

 

 

70   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

CLIMATE CHANGE FUND

 

     Class III Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Period from
April 5, 2017
(commencement
of operations)
through
February 28,
2018

Net asset value, beginning of period

     $ 23.81     $ 20.00
    

 

 

     

 

 

 

Income (loss) from investment operations:

        

Net investment income (loss)(a)

       0.29       0.23

Net realized and unrealized gain (loss)

       (1.09 )       4.41
    

 

 

     

 

 

 

Total from investment operations

       (0.80 )       4.64
    

 

 

     

 

 

 

Less distributions to shareholders:

        

From net investment income

       (0.03 )       (0.22 )

From net realized gains

       (0.18 )       (0.61 )
    

 

 

     

 

 

 

Total distributions

       (0.21 )       (0.83 )
    

 

 

     

 

 

 

Net asset value, end of period

     $ 22.80     $ 23.81
    

 

 

     

 

 

 

Total Return(b)

       (3.40 )%**       23.28 %**

Ratios/Supplemental Data:

        

Net assets, end of period (000’s)

     $ 88,877     $ 26,694

Net expenses to average daily net assets(c)

       0.72 %*       0.78 %*

Net investment income (loss) to average daily net assets(a)

       2.40 %*       1.09 %*

Portfolio turnover rate(d)

       18 %**       44 %**

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.30 %*       0.73 %*

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the periods ended August 31, 2018 and February 28, 2018, including transactions in USTF, was 102%, 174%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   71


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

EMERGING DOMESTIC OPPORTUNITIES FUND

 

    Class II Shares   Class III Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014   2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 28.86     $ 22.64     $ 19.36     $ 23.99     $ 22.55     $ 24.60     $ 28.86     $ 22.64     $ 19.35     $ 23.98     $ 22.54     $ 24.59
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(a)

      0.19       0.25       0.25       0.34       0.28       0.26       0.22       0.27       0.27       0.36       0.29       0.30

Net realized and unrealized gain (loss)

      (4.41 )       6.33       3.68       (4.60 )       1.55       (1.22 )       (4.43 )       6.32       3.68       (4.60 )       1.55       (1.24 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (4.22 )       6.58       3.93       (4.26 )       1.83       (0.96 )       (4.21 )       6.59       3.95       (4.24 )       1.84       (0.94 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.00 )(b)       (0.36 )       (0.65 )       (0.37 )       (0.23 )       (0.30 )       (0.00 )(b)       (0.37 )       (0.66 )       (0.39 )       (0.24 )       (0.32 )

From net realized gains

      (2.74 )                         (0.16 )       (0.79 )       (2.74 )                         (0.16 )       (0.79 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (2.74 )       (0.36 )       (0.65 )       (0.37 )       (0.39 )       (1.09 )       (2.74 )       (0.37 )       (0.66 )       (0.39 )       (0.40 )       (1.11 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 21.90     $ 28.86     $ 22.64     $ 19.36     $ 23.99     $ 22.55     $ 21.91     $ 28.86     $ 22.64     $ 19.35     $ 23.98     $ 22.54
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      (15.05 )%**       29.10 %       20.62 %       (17.91 )%       8.18 %       (4.01 )%       (15.00 )%**       29.17 %       20.73 %       (17.86 )%       8.23 %       (3.95 )%

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 488,375     $ 700,211     $ 603,565     $ 556,539     $ 738,035     $ 621,278     $ 138,734     $ 121,511     $ 129,068     $ 242,740     $ 336,488     $ 384,757

Net expenses to average daily net assets(d)

      1.05 %*       1.06 %       1.06 %       1.07 %       1.07 %       1.07 %(e)       0.98 %*       0.99 %       0.99 %       1.00 %       1.00 %       1.00 %(e)

Net investment income (loss) to average daily net assets(a)

      1.42 %*       0.96 %       1.12 %       1.51 %       1.21 %       1.09 %       1.66 %*       1.05 %       1.26 %       1.61 %       1.26 %       1.23 %

Portfolio turnover rate

      120 %(f)**       201 %(f)       227 %(f)       250 %       204 %       274 %       120 %(f)**       201 %(f)       227 %(f)       250 %       204 %       274 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.01 %*       0.02 %       0.04 %       0.04 %       0.03 %       0.03 %       0.01 %*       0.02 %       0.05 %       0.04 %       0.03 %       0.03 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.04     $ 0.03     $ 0.02     $ 0.04     $ 0.03     $ 0.10     $ 0.05     $ 0.02     $ 0.02     $ 0.03     $ 0.03     $ 0.09

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

Distributions from net investment income were less than $0.01 per share.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 135%, 254% and 271%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

72   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

EMERGING DOMESTIC OPPORTUNITIES FUND (continued)

 

    Class IV Shares   Class V Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Period from
November 29,
2013
(commencement
of operations)
through
February 28,
2014
    2018   2017   2016   2015   2014   2018   2017   2016   2015

Net asset value, beginning of period

    $ 28.88     $ 22.65     $ 19.36     $ 24.00     $ 22.56     $ 24.60     $ 28.85     $ 22.62     $ 19.35     $ 23.98     $ 22.54     $ 24.52
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(a)

      0.21       0.27       0.29       0.36       0.30       0.31       0.21       0.29       0.23       0.37       0.31       0.01

Net realized and unrealized gain (loss)

      (4.42 )       6.34       3.67       (4.60 )       1.56       (1.23 )       (4.41 )       6.33       3.73       (4.59 )       1.55       (1.20 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (4.21 )       6.61       3.96       (4.24 )       1.86       (0.92 )       (4.20 )       6.62       3.96       (4.22 )       1.86       (1.19 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.00 )(b)       (0.38 )       (0.67 )       (0.40 )       (0.26 )       (0.33 )       (0.00 )(b)       (0.39 )       (0.69 )       (0.41 )       (0.26 )       (0.34 )

From net realized gains

      (2.74 )                         (0.16 )       (0.79 )       (2.74 )                         (0.16 )       (0.45 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (2.74 )       (0.38 )       (0.67 )       (0.40 )       (0.42 )       (1.12 )       (2.74 )       (0.39 )       (0.69 )       (0.41 )       (0.42 )       (0.79 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 21.93     $ 28.88     $ 22.65     $ 19.36     $ 24.00     $ 22.56     $ 21.91     $ 28.85     $ 22.62     $ 19.35     $ 23.98     $ 22.54
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      (14.99 )%**       29.24 %       20.80 %       (17.84 )%       8.29 %       (3.88 )%       (14.97 )%**       29.31 %       20.78 %       (17.79 )%       8.32 %       (4.95 )%**

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 207,588     $ 300,730     $ 335,225     $ 745,300     $ 686,589     $ 659,592     $ 774,453     $ 1,280,851     $ 948,052     $ 322,379     $ 255,379     $ 235,753

Net expenses to average daily net assets(d)

      0.93 %*       0.94 %       0.95 %       0.96 %       0.95 %       0.95 %(e)       0.91 %*       0.92 %       0.93 %       0.94 %       0.93 %       0.94 %(e)*

Net investment income (loss) to average daily net assets(a)

      1.58 %*       1.05 %       1.34 %       1.61 %       1.29 %       1.29 %       1.59 %*       1.09 %       1.04 %       1.65 %       1.32 %       0.09 %

Portfolio turnover rate

      120 %(f)**       201 %(f)       227 %(f)       250 %       204 %       274 %       120 %(f)**       201 %(f)       227 %(f)       250 %       204 %       274 %**††

Fees and expenses reimbursed and/ or waived by GMO to average daily net assets:

      0.01 %*       0.02 %       0.04 %       0.04 %       0.03 %       0.03 %       0.01 %*       0.02 %       0.05 %       0.04 %       0.03 %       0.06 %*

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.04     $ 0.02     $ 0.03     $ 0.03     $ 0.03     $ 0.10     $ 0.04     $ 0.03     $ 0.03     $ 0.04     $ 0.03     $ 0.02

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

Distributions from net investment income were less than $0.01 per share.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 135%, 254% and 271%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

††

Calculation represents portfolio turnover of the Fund for the year ended February 28, 2014.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   73


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

EMERGING MARKETS FUND

 

    Class II Shares   Class III Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017(a)   2016(a)   2015(a)   2014(a)   2018   2017(a)   2016(a)   2015(a)   2014(a)

Net asset value, beginning of period

    $ 36.42     $ 29.98     $ 22.80     $ 30.48     $ 30.60     $ 35.22     $ 36.51     $ 30.05     $ 22.83     $ 30.57     $ 30.69     $ 35.31
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(b)

      0.81       0.75       0.57       0.72       0.84       0.75       0.82       0.72       0.57       0.66       0.81       0.81

Net realized and unrealized gain (loss)

      (4.87 )       6.58       7.22       (7.59 )       0.00 (c)        (4.56 )       (4.88 )       6.64       7.27       (7.56 )       0.06       (4.62 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (4.06 )       7.33       7.79       (6.87 )       0.84       (3.81 )       (4.06 )       7.36       7.84       (6.90 )       0.87       (3.81 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.05 )       (0.89 )       (0.61 )       (0.81 )       (0.96 )       (0.81 )       (0.05 )       (0.90 )       (0.62 )       (0.84 )       (0.99 )       (0.81 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.05 )       (0.89 )       (0.61 )       (0.81 )       (0.96 )       (0.81 )       (0.05 )       (0.90 )       (0.62 )       (0.84 )       (0.99 )       (0.81 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 32.31     $ 36.42     $ 29.98     $ 22.80     $ 30.48     $ 30.60     $ 32.40     $ 36.51     $ 30.05     $ 22.83     $ 30.57     $ 30.69
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

      (11.15 )%**       24.66 %       34.47 %       (22.76 )%       2.84 %       (10.92 )%       (11.11 )%**       24.71 %       34.67 %       (22.80 )%       2.91 %       (10.87 )%

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 362,509     $ 479,640     $ 498,564     $ 532,366     $ 1,000,299     $ 1,308,100     $ 297,410     $ 390,827     $ 301,786     $ 189,907     $ 283,712     $ 447,963

Net expenses to average daily net assets(e)

      0.93 %*       0.96 %       1.07 %       1.09 %       1.07 %       1.06 %(f)       0.88 %*       0.91 %       1.01 %       1.04 %       1.02 %       1.01 %(f)

Net investment income (loss) to average daily net assets(b)

      4.73 %*       2.25 %       2.08 %       2.57 %       2.66 %       2.33 %       4.73 %*       2.14 %       2.07 %       2.45 %       2.55 %       2.45 %

Portfolio turnover rate

      52 %(g)**       87 %(g)       62 %(g)       104 %       94 %       98 %       52 %(g)**       87 %(g)       62 %(g)       104 %       94 %       98 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.13 %*       0.13 %       0.04 %       0.03 %       0.03 %       0.03 %       0.11 %*       0.11 %       0.03 %       0.01 %       0.01 %       0.01 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.06     $ 0.11     $ 0.09 (a)      $ 0.10 (a)      $ 0.11 (a)      $ 0.10 (a)      $ 0.06     $ 0.11     $ 0.09 (a)      $ 0.10 (a)      $ 0.11 (a)      $ 0.11 (a) 

 

(a) 

Per share amounts were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

Net realized and unrealized gain (loss) was less than $0.01 per share.

(d) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(e) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(f) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(g) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 69%, 117% and 80%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

74   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

EMERGING MARKETS FUND (continued)

 

    Class IV Shares   Class V Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017(a)   2016(a)   2015(a)   2014(a)   2018   2017(a)   2016(a)   2015(a)   2014(a)

Net asset value, beginning of period

    $ 36.16     $ 29.78     $ 22.65     $ 30.30     $ 30.45     $ 35.04     $ 36.07     $ 29.70     $ 22.59     $ 30.24     $ 30.39     $ 34.98
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(b)

      0.61       0.83       0.53       0.69       0.84       0.84       0.86       0.77       0.61       0.72       0.87       0.78

Net realized and unrealized gain (loss)

      (4.62 )       6.47       7.24       (7.50 )       0.00 (c)        (4.59 )       (4.86 )       6.53       7.15       (7.50 )       0.00 (c)        (4.50 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (4.01 )       7.30       7.77       (6.81 )       0.84       (3.75 )       (4.00 )       7.30       7.76       (6.78 )       0.87       (3.72 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.04 )       (0.92 )       (0.64 )       (0.84 )       (0.99 )       (0.84 )       (0.06 )       (0.93 )       (0.65 )       (0.87 )       (1.02 )       (0.87 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.04 )       (0.92 )       (0.64 )       (0.84 )       (0.99 )       (0.84 )       (0.06 )       (0.93 )       (0.65 )       (0.87 )       (1.02 )       (0.87 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 32.11     $ 36.16     $ 29.78     $ 22.65     $ 30.30     $ 30.45     $ 32.01     $ 36.07     $ 29.70     $ 22.59     $ 30.24     $ 30.39
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

      (11.10 )%**       24.74 %       34.61 %       (22.69 )%       2.88 %       (10.81 )%       (11.08 )%**       24.83 %       34.67 %       (22.67 )%       2.93 %       (10.74 )%

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 88,926     $ 485,104     $ 582,311     $ 268,085     $ 837,963     $ 748,429     $ 152,210     $ 170,962     $ 110,257     $ 269,570     $ 170,125     $ 406,384

Net expenses to average daily net assets(e)

      0.82 %*       0.87 %       0.96 %       0.99 %       0.97 %       0.96 %(f)       0.78 %*       0.81 %       0.91 %       0.94 %       0.92 %       0.91 %(f)

Net investment income (loss) to average daily net assets(b)

      3.55 %*       2.50 %       1.92 %       2.55 %       2.64 %       2.57 %       5.06 %*       2.29 %       2.24 %       2.69 %       2.77 %       2.39 %

Portfolio turnover rate

      52 %(g)**       87 %(g)       62 %(g)       104 %       94 %       98 %       52 %(g)**       87 %(g)       62 %(g)       104 %       94 %       98 %

Fees and expenses reimbursed and/ or waived by GMO to average daily net assets:

      0.11 %*       0.11 %       0.03 %       0.01 %       0.01 %       0.01 %       0.14 %*       0.14 %       0.06 %       0.04 %       0.04 %       0.04 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.04     $ 0.11     $ 0.09 (a)      $ 0.10 (a)      $ 0.11 (a)      $ 0.10 (a)      $ 0.06     $ 0.11     $ 0.08 (a)      $ 0.10 (a)      $ 0.10 (a)      $ 0.10 (a) 

 

(a) 

Per share amounts were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

Net realized and unrealized gain (loss) was less than $0.01 per share.

(d) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(e) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(f) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(g) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 69%, 117% and 80%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   75


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

EMERGING MARKETS FUND (continued)

 

     Class VI Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017(a)   2016(a)   2015(a)   2014(a)

Net asset value, beginning of period

     $ 36.16     $ 29.77     $ 22.62     $ 30.30     $ 30.45     $ 35.04
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(b)

       0.83       0.78       0.63       0.69       0.90       0.78

Net realized and unrealized gain (loss)

       (4.83 )       6.56       7.17       (7.50 )       (0.03 )(c)       (4.47 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (4.00 )       7.34       7.80       (6.81 )       0.87       (3.69 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.07 )       (0.95 )       (0.65 )       (0.87 )       (1.02 )       (0.90 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.07 )       (0.95 )       (0.65 )       (0.87 )       (1.02 )       (0.90 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 32.09     $ 36.16     $ 29.77     $ 22.62     $ 30.30     $ 30.45
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

       (11.08 )%**       24.90 %       34.83 %       (22.71 )%       2.96 %       (10.69 )%

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 2,848,713     $ 3,575,505     $ 3,524,022     $ 3,661,271     $ 5,194,557     $ 5,220,293

Net expenses to average daily net assets(e)

       0.75 %*       0.78 %       0.89 %       0.91 %       0.89 %       0.88 %(f)

Net investment income (loss) to average daily net assets(b)

       4.86 %*       2.36 %       2.32 %       2.61 %       2.79 %       2.43 %

Portfolio turnover rate

       52 %(g)**       87 %(g)       62 %(g)       104 %       94 %       98 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.14 %*       0.14 %       0.06 %       0.04 %       0.04 %       0.04 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

     $ 0.06     $ 0.11     $ 0.08 (a)      $ 0.09 (a)      $ 0.11 (a)      $ 0.10 (a) 

 

(a) 

Per share amounts were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

The amount shown for a share outstanding does not correspond with the aggregate net realized and unrealized gain (loss) on investments due to the timing of purchases and redemptions of Fund shares in relation to fluctuating market values of the investments of the Fund.

(d) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(e) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(f) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(g) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 69%, 117% and 80%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

76   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

FOREIGN SMALL COMPANIES FUND

 

     Class III Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

     $ 14.27     $ 14.41     $ 12.94     $ 15.31     $ 17.29     $ 14.40
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(a)

       0.14       0.41       0.26       0.26       0.20       0.27

Net realized and unrealized gain (loss)

       (0.53 )       2.93       1.56       (1.86 )       (1.34 )       3.62
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (0.39 )       3.34       1.82       (1.60 )       (1.14 )       3.89
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.11 )       (0.35 )       (0.35 )       (0.28 )       (0.23 )       (0.48 )

From net realized gains

       (1.64 )       (3.13 )             (0.49 )       (0.61 )       (0.52 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (1.75 )       (3.48 )       (0.35 )       (0.77 )       (0.84 )       (1.00 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 12.13     $ 14.27     $ 14.41     $ 12.94     $ 15.31     $ 17.29
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

       (2.95 )%(c)**       23.52 %       14.25 %       (10.82 )%       (6.34 )%       27.54 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 20,818     $ 55,169     $ 246,852     $ 316,303     $ 353,778     $ 236,393

Net expenses to average daily net assets(d)

       1.29 %*       0.52 %       0.86 %       0.86 %       0.85 %       0.86 %(e)

Net investment income (loss) to average daily net assets(a)

       2.19 %*       2.67 %       1.84 %       1.73 %       1.26 %       1.73 %

Portfolio turnover rate

       16 %(f)**       106 %(f)       49 %(f)       60 %       58 %       57 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.62 %*       0.44 %       0.07 %       0.07 %       0.07 %       0.07 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

     $ 0.19     $ 0.04     $ 0.02     $ 0.01     $ 0.01     $ 0.00 (g) 

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Refunds of taxes withheld by certain countries and any related interest received during the period had a positive impact to total return, adding 1.26%.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 32%, 128% and 51%, respectively, of the average value of its portfolio.

(g) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   77


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

INTERNATIONAL EQUITY FUND

 

    Class II Shares   Class III Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014   2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 23.63     $ 20.18     $ 18.17     $ 23.43     $ 26.16     $ 20.94     $ 23.92     $ 20.41     $ 18.38     $ 23.70     $ 26.44     $ 21.16
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(a)

      0.44       0.41       0.70       0.57       0.66       0.80       0.46       0.61       0.63       0.59       0.69       0.86

Net realized and unrealized gain (loss)

      (1.90 )       3.78       2.07       (5.19 )       (1.42 )       4.88       (1.94 )       3.64       2.19       (5.25 )       (1.45 )       4.90
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (1.46 )       4.19       2.77       (4.62 )       (0.76 )       5.68       (1.48 )       4.25       2.82       (4.66 )       (0.76 )       5.76
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.14 )       (0.74 )       (0.76 )       (0.64 )       (1.07 )       (0.46 )       (0.14 )       (0.74 )       (0.79 )       (0.66 )       (1.08 )       (0.48 )

From net realized gains

                              (0.90 )                                     (0.90 )      
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.14 )       (0.74 )       (0.76 )       (0.64 )       (1.97 )       (0.46 )       (0.14 )       (0.74 )       (0.79 )       (0.66 )       (1.98 )       (0.48 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 22.03     $ 23.63     $ 20.18     $ 18.17     $ 23.43     $ 26.16     $ 22.30     $ 23.92     $ 20.41     $ 18.38     $ 23.70     $ 26.44
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

      (6.20 )%**       20.85 %       15.45 %       (19.99 )%       (2.55 )%       27.41 %       (6.18 )%**       20.96 %       15.53 %       (19.95 )%       (2.50 )%       27.53 %

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 20,852     $ 23,736     $ 10,302     $ 81,206     $ 118,737     $ 139,401     $ 467,096     $ 485,782     $ 731,060     $ 1,043,305     $ 1,523,128     $ 1,555,509

Net expenses to average daily net assets(c)

      0.72 %*       0.72 %       0.72 %       0.72 %       0.72 %       0.72 %(d)       0.65 %*       0.65 %       0.65 %       0.65 %       0.65 %       0.65 %(d)

Net investment income (loss) to average daily net assets(a)

      3.84 %*       1.77 %       3.62 %       2.65 %       2.63 %       3.47 %       3.91 %*       2.68 %       3.16 %       2.70 %       2.73 %       3.62 %

Portfolio turnover rate

      21 %(e)**       45 %(e)       27 %(e)       75 %       70 %       48 %       21 %(e)**       45 %(e)       27 %(e)       75 %       70 %       48 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.03 %*       0.04 %       0.04 %       0.04 %       0.04 %       0.04 %       0.03 %*       0.04 %       0.04 %       0.04 %       0.04 %       0.04 %

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(e) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 26%, 61% and 50%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

78   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

INTERNATIONAL EQUITY FUND (continued)

 

     Class IV Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

     $ 23.87     $ 20.38     $ 18.36     $ 23.66     $ 26.41     $ 21.14
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(a)

       0.48       0.56       0.63       0.62       0.67       0.89

Net realized and unrealized gain (loss)

       (1.94 )       3.69       2.19       (5.25 )       (1.42 )       4.88
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (1.46 )       4.25       2.82       (4.63 )       (0.75 )       5.77
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.15 )       (0.76 )       (0.80 )       (0.67 )       (1.10 )       (0.50 )

From net realized gains

                               (0.90 )      
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.15 )       (0.76 )       (0.80 )       (0.67 )       (2.00 )       (0.50 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 22.26     $ 23.87     $ 20.38     $ 18.36     $ 23.66     $ 26.41
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

       (6.13 )%**       20.98 %       15.57 %       (19.85 )%       (2.47 )%       27.60 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 3,502,054     $ 4,558,167     $ 5,072,024     $ 7,051,400     $ 11,374,017     $ 11,926,293

Net expenses to average daily net assets(c)

       0.59 %*       0.59 %       0.59 %       0.59 %       0.59 %       0.59 %(d)

Net investment income (loss) to average daily net assets(a)

       4.14 %*       2.45 %       3.19 %       2.80 %       2.66 %       3.74 %

Portfolio turnover rate

       21 %(e)**       45 %(e)       27 %(e)       75 %       70 %       48 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.03 %*       0.04 %       0.04 %       0.04 %       0.04 %       0.04 %

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(e) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 26%, 61% and 50%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   79


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

INTERNATIONAL LARGE/MID CAP EQUITY FUND

 

     Class III Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

     $ 26.33     $ 25.44     $ 23.46     $ 30.16     $ 35.20     $ 28.96
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(a)

       0.74       1.01       0.96       0.81       0.92       1.18

Net realized and unrealized gain (loss)

       (1.98 )       4.06       2.40       (6.71 )       (2.19 )       6.56
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (1.24 )       5.07       3.36       (5.90 )       (1.27 )       7.74
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.55 )       (0.90 )       (1.38 )       (0.80 )       (1.46 )       (1.50 )

From net realized gains

       (2.69 )       (3.28 )                   (2.31 )      
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (3.24 )       (4.18 )       (1.38 )       (0.80 )       (3.77 )       (1.50 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 21.85     $ 26.33     $ 25.44     $ 23.46     $ 30.16     $ 35.20
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

       (4.97 )%(c)**       20.64 %       14.70 %       (19.82 )%       (3.33 )%       27.30 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 19,425     $ 81,119     $ 39,141     $ 459,614     $ 592,365     $ 598,840

Net expenses to average daily net assets(d)

       1.23 %*       0.60 %       0.54 %       0.53 %       0.53 %       0.53 %(e)

Net investment income (loss) to average daily net assets(a)

       6.03 %*       3.81 %       3.84 %       2.90 %       2.80 %       3.70 %

Portfolio turnover rate

       18 %(f)**       47 %(f)       26 %(f)       88 %       82 %       54 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.37 %*       0.28 %       0.08 %       0.06 %       0.07 %       0.06 %

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c)

Refunds of taxes withheld by certain countries and any related interest received during the period had a positive impact to total return, adding 2.22%.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 69%, 128% and 51%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

80   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

QUALITY FUND

 

    Class III Shares   Class IV Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014   2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 25.13     $ 22.05     $ 18.99     $ 22.98     $ 25.08     $ 23.81     $ 25.17     $ 22.08     $ 19.01     $ 23.01     $ 25.10     $ 23.83
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(a)

      0.19       0.36       0.35       0.38       0.42       0.51       0.20       0.37       0.36       0.39       0.43       0.53

Net realized and unrealized gain (loss)

      2.26       4.70       3.44       (1.04 )       2.91       3.70       2.25       4.70       3.45       (1.05 )       2.92       3.70
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      2.45       5.06       3.79       (0.66 )       3.33       4.21       2.45       5.07       3.81       (0.66 )       3.35       4.23
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.08 )       (0.41 )       (0.35 )       (0.42 )       (0.49 )       (0.53 )       (0.08 )       (0.41 )       (0.36 )       (0.43 )       (0.50 )       (0.55 )

From net realized gains

      (1.00 )       (1.57 )       (0.38 )       (2.91 )       (4.94 )       (2.41 )       (1.00 )       (1.57 )       (0.38 )       (2.91 )       (4.94 )       (2.41 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (1.08 )       (1.98 )       (0.73 )       (3.33 )       (5.43 )       (2.94 )       (1.08 )       (1.98 )       (0.74 )       (3.34 )       (5.44 )       (2.96 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 26.50     $ 25.13     $ 22.05     $ 18.99     $ 22.98     $ 25.08     $ 26.54     $ 25.17     $ 22.08     $ 19.01     $ 23.01     $ 25.10
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

      9.97 %**       23.32 %       20.25 %       (2.89 )%       14.73 %       18.38 %       9.98 %**       23.37 %       20.33 %       (2.88 )%       14.81 %       18.43 %

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 3,199,674     $ 3,524,103     $ 3,587,627     $ 3,968,156     $ 5,336,063     $ 5,747,512     $ 1,179,485     $ 957,900     $ 1,222,874     $ 1,294,033     $ 2,201,876     $ 2,134,444

Net expenses to average daily net assets(c)

      0.48 %*       0.48 %       0.48 %       0.48 %       0.48 %       0.48 %(d)       0.44 %*       0.44 %       0.44 %       0.44 %       0.44 %       0.44 %(d)

Net investment income (loss) to average daily net assets(a)

      1.53 %*       1.48 %       1.72 %       1.79 %       1.71 %       2.04 %       1.59 %*       1.53 %       1.76 %       1.83 %       1.77 %       2.07 %

Portfolio turnover rate

      10 %**(e)       10 %(e)       29 %(e)       37 %       60 %       48 %       10 %**(e)       10 %(e)       29 %(e)       37 %       60 %       48 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.02 %*       0.02 %       0.02 %       0.02 %       0.02 %       0.01 %       0.02 %*       0.02 %       0.02 %       0.02 %       0.02 %       0.01 %

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(e) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 11%, 23% and 48%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   81


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

QUALITY FUND (continued)

 

    Class V Shares   Class VI Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014   2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 25.17     $ 22.08     $ 19.01     $ 23.01     $ 25.10     $ 23.82     $ 25.13     $ 22.05     $ 18.99     $ 22.99     $ 25.09     $ 23.82
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(a)

      0.20       0.41       0.36       0.39       0.44       0.56       0.21       0.38       0.36       0.40       0.45       0.54

Net realized and unrealized gain (loss)

      2.26       4.66       3.46       (1.05 )       2.92       3.68       2.24       4.70       3.46       (1.04 )       2.90       3.70
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      2.46       5.07       3.82       (0.66 )       3.36       4.24       2.45       5.08       3.82       (0.64 )       3.35       4.24
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.08 )       (0.41 )       (0.37 )       (0.43 )       (0.51 )       (0.55 )       (0.08 )       (0.43 )       (0.38 )       (0.45 )       (0.51 )       (0.56 )

From net realized gains

      (1.00 )       (1.57 )       (0.38 )       (2.91 )       (4.94 )       (2.41 )       (1.00 )       (1.57 )       (0.38 )       (2.91 )       (4.94 )       (2.41 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (1.08 )       (1.98 )       (0.75 )       (3.34 )       (5.45 )       (2.96 )       (1.08 )       (2.00 )       (0.76 )       (3.36 )       (5.45 )       (2.97 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 26.55     $ 25.17     $ 22.08     $ 19.01     $ 23.01     $ 25.10     $ 26.50     $ 25.13     $ 22.05     $ 18.99     $ 22.99     $ 25.09
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

      10.03 %**       23.38 %       20.39 %       (2.89 )%       14.86 %       18.49 %       10.01 %**       23.43 %       20.39 %       (2.83 )%       14.83 %       18.50 %

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 168,316     $ 156,086     $ 462,677     $ 277,186     $ 267,809     $ 653,307     $ 2,623,317     $ 3,561,976     $ 3,359,025     $ 1,732,420     $ 2,496,930     $ 3,675,950

Net expenses to average daily net assets(c)

      0.42 %*       0.42 %       0.42 %       0.42 %       0.42 %       0.42 %(d)       0.39 %*       0.39 %       0.39 %       0.39 %       0.39 %       0.39 %(d)

Net investment income (loss) to average daily net assets(a)

      1.60 %*       1.74 %       1.72 %       1.85 %       1.81 %       2.22 %       1.64 %*       1.57 %       1.73 %       1.88 %       1.83 %       2.13 %

Portfolio turnover rate

      10 %**(e)       10 %(e)       29 %(e)       37 %       60 %       48 %       10 %**(e)       10 %(e)       29 %(e)       37 %       60 %       48 %

Fees and expenses reimbursed and/ or waived by GMO to average daily net assets:

      0.02 %*       0.02 %       0.02 %       0.02 %       0.02 %       0.01 %       0.02 %*       0.02 %       0.02 %       0.02 %       0.02 %       0.01 %

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(e) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 11%, 23% and 48%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

82   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

RESOURCES FUND

 

    Class III Shares   Class IV Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014   2018   2017   2016   2015   2014(a)

Net asset value, beginning of period

    $ 20.88     $ 17.31     $ 11.74     $ 16.33     $ 21.88     $ 21.59     $ 20.81     $ 17.25     $ 11.71     $ 16.28     $ 21.86     $ 21.40
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(b)

      0.36       0.33       0.30       0.47       0.87       0.51       0.38       0.38       0.34       0.46       0.75       0.45

Net realized and unrealized gain (loss)

      (0.79 )       4.02       5.75       (4.67 )       (3.77 )       0.45       (0.81 )       3.97       5.68       (4.63 )       (3.65 )       0.70
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (0.43 )       4.35       6.05       (4.20 )       (2.90 )       0.96       (0.43 )       4.35       6.02       (4.17 )       (2.90 )       1.15
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.25 )       (0.78 )       (0.48 )       (0.39 )       (1.03 )       (0.40 )       (0.25 )       (0.79 )       (0.48 )       (0.40 )       (1.06 )       (0.42 )

From net realized gains

                              (1.62 )       (0.27 )                               (1.62 )       (0.27 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.25 )       (0.78 )       (0.48 )       (0.39 )       (2.65 )       (0.67 )       (0.25 )       (0.79 )       (0.48 )       (0.40 )       (2.68 )       (0.69 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 20.20     $ 20.88     $ 17.31     $ 11.74     $ 16.33     $ 21.88     $ 20.13     $ 20.81     $ 17.25     $ 11.71     $ 16.28     $ 21.86
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      (2.11 )%**       26.00 %       51.75 %       (25.76 )%       (12.81 )%       4.54 %       (2.13 )%**       26.12 %       51.72 %       (25.68 )%       (12.82 )%       5.48 %**

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 119,927     $ 54,037     $ 22,562     $ 13,864     $ 23,734     $ 81,646     $ 327,006     $ 296,196     $ 190,260     $ 170,919     $ 119,308     $ 138,358

Net expenses to average daily net assets(d)

      0.75 %(e)*       0.76 %(e)       0.77 %       0.77 %       0.76 %       0.75 %(f)       0.71 %(e)*       0.71 %(e)       0.72 %       0.72 %       0.71 %       0.70 %*(f)

Net investment income (loss) to average daily net assets(b)

      3.41 %*       1.77 %       1.99 %       3.36 %       4.01 %       2.36 %       3.58 %*       2.04 %       2.26 %       3.31 %       3.58 %       2.23 %*

Portfolio turnover rate

      23 %**(g)       48 %(g)       29 %(g)       130 %       126 %       40 %       23 %(g)**       48 %(g)       29 %(g)       130 %       126 %       40 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

            0.06 %(d)       0.10 %       0.10 %       0.08 %       0.10 %             0.06 %(d)       0.10 %       0.11 %       0.09 %       0.11 %*

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.02     $ 0.05     $ 0.02     $ 0.03     $ 0.07     $ 0.06     $ 0.02     $ 0.04     $ 0.02     $ 0.02     $ 0.03     $ 0.03

 

(a) 

Period from March 20, 2013 (commencement of operations) through February 28, 2014.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

Includes recoupment of past reimbursed and/or waived fees (Note 5).

(f) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(g) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 48%, 85% and 40%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   83


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

RISK PREMIUM FUND

 

    Class III Shares   Class VI Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017(a)   2016(a)   2015(a)   2014(a)   2018   2017(a)   2016(a)   2015(a)   2014(a)

Net asset value, beginning of period

    $ 26.74     $ 29.93     $ 26.91     $ 29.73     $ 31.74     $ 31.59     $ 26.88     $ 30.07     $ 27.00     $ 29.82     $ 31.80     $ 31.59
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(b)

      0.19       0.10       (0.05 )       (0.12 )       (0.18 )       (0.18 )       0.20       0.14       (0.02 )       (0.12 )       (0.15 )       (0.15 )

Net realized and unrealized gain (loss)

      1.35       1.78       5.22       (0.30 )       1.02       2.13       1.37       1.78       5.24       (0.30 )       1.02       2.16
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      1.54       1.88       5.17       (0.42 )       0.84       1.95       1.57       1.92       5.22       (0.42 )       0.87       2.01
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.09 )       (0.06 )                               (0.10 )       (0.10 )                        

From net realized gains

            (5.01 )       (2.15 )       (2.40 )       (2.85 )       (1.80 )             (5.01 )       (2.15 )       (2.40 )       (2.85 )       (1.80 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.09 )       (5.07 )       (2.15 )       (2.40 )       (2.85 )       (1.80 )       (0.10 )       (5.11 )       (2.15 )       (2.40 )       (2.85 )       (1.80 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 28.19     $ 26.74     $ 29.93     $ 26.91     $ 29.73     $ 31.74     $ 28.35     $ 26.88     $ 30.07     $ 27.00     $ 29.82     $ 31.80
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      5.78 %**       6.09 %       19.50 %       (1.66 )%       3.19 %       6.42 %       5.87 %**       6.17 %       19.62 %       (1.65 )%       3.29 %       6.61 %

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 20,372     $ 3,434     $ 5,049     $ 6,807     $ 4,832     $ 7,489     $ 494,626     $ 142,238     $ 155,375     $ 223,854     $ 432,465     $ 730,196

Net expenses to average daily net assets

      0.60 %*       0.60 %       0.61 %       0.60 %       0.61 %(d)       0.60 %(d)(e)       0.51 %*       0.51 %       0.51 %       0.51 %       0.51 %(d)       0.51 %(d)(e)

Net investment income (loss) to average daily net assets(b)

      1.37 %*       0.34 %       (0.16 )%       (0.45 )%       (0.58 )%       (0.57 )%       1.43 %*       0.47 %       (0.07 )%       (0.37 )%       (0.49 )%       (0.48 )%

Portfolio turnover rate

      26 %**       0 %       0 %       0 %       112 %       0 %       26 %**       0 %       0 %       0 %       112 %       0 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.04 %*       0.08 %       0.06 %       0.05 %       0.04 %       0.05 %       0.04 %*       0.08 %       0.06 %       0.05 %       0.03 %       0.05 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.00 (f)      $ 0.01     $ 0.02 (a)      $ 0.08 (a)      $ 0.14 (a)      $ 0.01 (a)      $ 0.00 (f)      $ 0.01     $ 0.02 (a)      $ 0.07 (a)      $ 0.13 (a)      $ 0.01 (a) 

 

(a) 

Per share amounts were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c)

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f)

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

84   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

TAX-MANAGED INTERNATIONAL EQUITIES FUND

 

     Class III Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

     $ 17.00     $ 14.28     $ 12.92     $ 16.80     $ 18.03     $ 14.56
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(a)

       0.30       0.38       0.41       0.40       0.47       0.57

Net realized and unrealized gain (loss)

       (1.55 )       2.84       1.50       (3.82 )       (1.05 )       3.37
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (1.25 )       3.22       1.91       (3.42 )       (0.58 )       3.94
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.04 )       (0.50 )       (0.55 )       (0.46 )       (0.65 )       (0.47 )

From net realized gains

       (0.53 )                              
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.57 )       (0.50 )       (0.55 )       (0.46 )       (0.65 )       (0.47 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 15.18     $ 17.00     $ 14.28     $ 12.92     $ 16.80     $ 18.03
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

       (7.44 )%**       22.70 %       15.05 %       (20.63 )%       (3.10 )%       27.37 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 52,363     $ 68,782     $ 115,733     $ 215,977     $ 427,048     $ 485,665

Net expenses to average daily net assets(c)

       0.75 %*       0.70 %       0.68 %       0.66 %       0.66 %       0.66 %

Net investment income (loss) to average daily net assets(a)

       3.69 %*       2.35 %       2.95 %       2.59 %       2.71 %       3.54 %

Portfolio turnover rate

       12 %(d)**       43 %(d)       47 %(d)       79 %       69 %       49 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.42 %*       0.34 %       0.23 %       0.14 %       0.12 %       0.10 %

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 28%, 80% and 54%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   85


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

U.S. EQUITY FUND (FORMERLY U.S. EQUITY ALLOCATION FUND)

 

    Class III Shares   Class IV Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014   2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 15.41     $ 15.14     $ 13.79     $ 16.61     $ 17.27     $ 14.51     $ 15.42     $ 15.16     $ 13.76     $ 16.58     $ 17.24     $ 14.48
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(a)

      0.11       0.27       0.27       0.24       0.28       0.28       0.12       0.30       0.25       0.25       0.29       0.29

Net realized and unrealized gain (loss)

      0.63       1.73       2.89       (1.20 )       1.66       2.77       0.64       1.70       2.92       (1.20 )       1.66       2.77
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      0.74       2.00       3.16       (0.96 )       1.94       3.05       0.76       2.00       3.17       (0.95 )       1.95       3.06
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.06 )       (0.28 )       (0.34 )       (0.26 )       (0.31 )       (0.29 )       (0.07 )       (0.29 )       (0.30 )       (0.27 )       (0.32 )       (0.30 )

From net realized gains

      (1.18 )       (1.45 )       (1.47 )       (1.60 )       (2.29 )             (1.18 )       (1.45 )       (1.47 )       (1.60 )       (2.29 )      
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (1.24 )       (1.73 )       (1.81 )       (1.86 )       (2.60 )       (0.29 )       (1.25 )       (1.74 )       (1.77 )       (1.87 )       (2.61 )       (0.30 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 14.91     $ 15.41     $ 15.14     $ 13.79     $ 16.61     $ 17.27     $ 14.93     $ 15.42     $ 15.16     $ 13.76     $ 16.58     $ 17.24
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

      5.06 %**       13.76 %       23.59 %       (6.17 )%       12.18 %       21.11 %       5.15 %**       13.74 %       23.69 %       (6.10 )%       12.27 %       21.21 %

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 81,047     $ 77,297     $ 109,726     $ 194,615     $ 286,934     $ 488,982     $ 38,064     $ 36,025     $ 16,707     $ 513,751     $ 431,841     $ 288,782

Net expenses to average daily net assets(c)

      0.46 %*       0.46 %       0.46 %       0.46 %       0.46 %       0.46 %(d)       0.41 %*       0.41 %       0.41 %       0.41 %       0.41 %       0.41 %(d)

Net investment income (loss) to average daily net assets(a)

      1.46 %*       1.78 %       1.80 %       1.57 %       1.59 %       1.71 %       1.51 %*       1.94 %       1.73 %       1.65 %       1.63 %       1.75 %

Portfolio turnover rate

      47 %**(e)       79 %(e)       66 %(e)       89 %       67 %       74 %       47 %**(e)       79 %(e)       66 %(e)       89 %       67 %       74 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.03 %*       0.02 %       0.02 %       0.02 %       0.02 %       0.02 %       0.03 %*       0.02 %       0.02 %       0.02 %       0.02 %       0.02 %

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(e) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 55%, 100% and 91%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

86   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

U.S. EQUITY FUND (FORMERLY U.S. EQUITY ALLOCATION FUND) (continued)

 

    Class V Shares   Class VI Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended
February 28,

2018
  Period from
August 9,
2016
through
February 28,

2017
  Period
from
March 1,
2014
through
July 30,

2014(a)
  Period from
January 21,
2014
(commencement
of operations)
through
February 28,

2014
  Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 15.35     $ 15.09     $ 14.95     $ 17.24     $ 17.17     $ 15.31     $ 15.06     $ 13.73     $ 16.54     $ 17.21     $ 14.47
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                           

Net investment income (loss)(b)

      0.12       0.29       0.16       0.12       0.04       0.12       0.29       0.27       0.26       0.30       0.30

Net realized and unrealized gain (loss)

      0.62       1.71       1.50       0.90       0.03       0.63       1.71       2.89       (1.19 )       1.65       2.74
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      0.74       2.00       1.66       1.02       0.07       0.75       2.00       3.16       (0.93 )       1.95       3.04
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                           

From net investment income

      (0.06 )       (0.29 )       (0.19 )       (0.04 )             (0.07 )       (0.30 )       (0.36 )       (0.28 )       (0.33 )       (0.30 )

From net realized gains

      (1.18 )       (1.45 )       (1.33 )       (0.43 )             (1.18 )       (1.45 )       (1.47 )       (1.60 )       (2.29 )      
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (1.24 )       (1.74 )       (1.52 )       (0.47 )             (1.25 )       (1.75 )       (1.83 )       (1.88 )       (2.62 )       (0.30 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 14.85     $ 15.35     $ 15.09     $ 17.79     $ 17.24     $ 14.81     $ 15.31     $ 15.06     $ 13.73     $ 16.54     $ 17.21
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      5.10 %**       13.84 %       11.37 %**       5.88 %**       0.39 %**       5.13 %**       13.84 %       23.68 %       (6.02 )%       12.28 %       21.14 %

Ratios/Supplemental Data:

                                           

Net assets, end of period (000’s)

    $ 61,864     $ 60,386     $ 164,652     $ 220,333     $ 259,581     $ 843,142     $ 1,200,008     $ 1,469,935     $ 3,838,628     $ 6,031,361     $ 7,082,304

Net expenses to average daily net assets(e)

      0.40 %       0.40 %       0.40 %*       0.40 %*       0.40 %*(d)       0.37 %*       0.37 %       0.37 %       0.37 %       0.37 %       0.37 %(d)

Net investment income (loss) to average daily net assets(b)

      1.53 %*       1.88 %       1.93 %*       1.69 %*       1.97 %*       1.57 %*       1.88 %       1.87 %       1.68 %       1.70 %       1.85 %

Portfolio turnover rate

      47 %**(f)       79 %(f)       66 %(f)**       34 %**(g)       74 %**       47 %**(f)       79 %(f)       66 %(f)       89 %       67 %       74 %

Fees and expenses reimbursed and/ or waived by GMO to average daily net assets:

      0.03 %*       0.02 %       0.02 %*       0.02 %*       0.01 %*       0.03 %*       0.02 %       0.02 %       0.02 %       0.02 %       0.02 %

 

(a) 

The class was inactive from July 31, 2014 to August 8, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(e) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(f) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018, the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 55%, 100% and 91%, respectively, of the average value of its portfolio.

(g) 

Calculation represents portfolio turnover of the fund for the period ended July 30, 2014.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   87


GMO Trust Funds

 

Notes to Financial Statements

August 31, 2018 (Unaudited)

 

 

1.

Organization

Each of Climate Change Fund, Emerging Domestic Opportunities Fund, Emerging Markets Fund, Foreign Small Companies Fund, International Equity Fund, International Large/Mid Cap Equity Fund, Quality Fund, Resources Fund, Risk Premium Fund, Tax-Managed International Equities Fund and U.S. Equity Fund (formerly U.S. Equity Allocation Fund) (each a “Fund” and collectively the “Funds”) is a series of GMO Trust (the “Trust”). The Trust is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust was established as a Massachusetts business trust under the laws of The Commonwealth of Massachusetts on June 24, 1985. The Declaration of Trust permits the Trustees of the Trust (“Trustees”) to create an unlimited number of series of shares (Funds) and to subdivide Funds into classes. The Funds are advised and managed by Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”).

The Funds may invest in GMO U.S. Treasury Fund and in money market funds unaffiliated with GMO. The Funds may also invest in other GMO Funds (“underlying funds”). The financial statements of the underlying funds should be read in conjunction with the Funds’ financial statements. The financial statements are available without charge on the Securities and Exchange Commission’s (“SEC”) website at www.sec.gov or on GMO’s website at www.gmo.com.

The following table provides information about the Funds’ principal investment objectives and benchmarks (if any):

 

     
Fund Name   Benchmark   Investment Objective
Climate Change Fund   Not Applicable   High total return
Emerging Domestic Opportunities Fund   Not Applicable   Total Return
Emerging Markets Fund   S&P/IFCI Composite Index   Total return in excess of benchmark
Foreign Small Companies Fund   S&P Developed ex-U.S. Small Cap Index   Total return in excess of benchmark
International Equity Fund   Not Applicable   High total return
International Large/Mid Cap Equity Fund   Not Applicable   High total return
Quality Fund   Not Applicable   Total return
Resources Fund   Not Applicable   Total return
Risk Premium Fund   Not Applicable   Total return
Tax-Managed International Equities Fund   Not Applicable   High after-tax total return
U.S. Equity Fund (formerly U.S. Equity Allocation Fund)   Not Applicable   High total return

International Large/Mid Cap Equity Fund currently limits subscriptions.

 

2.

Significant accounting policies

The following is a summary of significant accounting policies followed by each Fund in the preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and have been consistently followed by the Funds in preparing these financial statements. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates. The accounting records of the Funds are maintained in U.S. dollars.

Portfolio valuation

Exchange-traded securities (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price or (iii) most recent quoted price published by the exchange (if no reported last sale or official closing price) or (iv) the quoted price provided by a pricing source (in the event GMO deems the private market to be a more reliable indicator of market value than the exchange). Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within that range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. Cleared derivatives are valued using the price quoted (which may be based on a model) by the relevant clearing house. If an updated quote for a cleared derivative is not available when a Fund calculates

 

88


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

its net asset value, the derivative will generally be valued using an industry standard model, which may differ from the model used by the relevant clearing house. Over-the-counter (“OTC”) derivatives are generally valued at the price determined by an industry standard model. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. Shares of the underlying funds and other open-end registered investment companies are valued at their most recent net asset value. If quotations are not readily available or circumstances make an existing valuation methodology or procedure unreliable, derivatives and other securities are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Because of the uncertainty inherent in pricing, and in particular fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See the table below for information about securities and derivatives, if any, that were fair valued using methods determined in good faith by or at the direction of the Trustees. The Funds and/or the underlying funds classify such securities as Level 3 (levels defined below). For the period ended August 31, 2018, the Funds did not reduce the value of any of their OTC derivatives contracts, if any, based on the creditworthiness of their counterparties. See Note 4 “Derivative financial instruments” for a further discussion on valuation of derivatives.

The foregoing valuation methodologies are modified for equities that trade in non-U.S. securities markets that close before the close of the New York Stock Exchange (“NYSE”) due to time zone differences, including the value of equities that underlie futures, options and other derivatives (to the extent the market for those derivatives closes prior to the close of the NYSE). In those cases, the price will generally be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees that are intended to reflect valuation changes through the NYSE close. The table below shows the percentage of the net assets of the Funds, held either directly or through investments in the underlying funds, if any, that were valued using fair value inputs obtained from that independent pricing service as of August 31, 2018. These securities listed on foreign exchanges (including the value of equity securities that underlie futures, options and other derivatives (to the extent the market for such instruments closes prior to the close of the NYSE)) are classified as Level 2 (levels defined below) in the table below.

“Quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If a market quotation for a security does not involve a bid or an ask, the “quoted price” may be the price provided by a market participant or other third-party pricing source in accordance with the market practice for that security. If an updated quoted price for a security is not available when a Fund calculates its net asset value, the Fund will generally use the last quoted price so long as GMO believes that the last quoted price continues to represent that security’s fair value.

In the case of derivatives, prices determined by a model may reflect an estimate of the average of bid and ask prices, regardless of whether a Fund has a long position or a short position.

As discussed above, certain of the Funds and underlying funds invest in securities and/or derivatives which may have been fair valued using methods determined in good faith by or at the direction of the Trustees or fair valued using inputs obtained from an independent pricing service. The table below presents securities and/or derivatives on a net basis, based on market values or unrealized

 

89


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

appreciation/(depreciation), which will tend to understate the Funds’ exposure. The net aggregate direct and indirect exposure to these valuation methodologies (based on each Fund’s net assets) as of August 31, 2018 is as follows:

Securities and derivatives

 

     
Fund Name   Fair valued using
methods determined in
good faith by or at the
direction of the Trustees
    Fair valued using
inputs obtained
from an
independent
pricing service (Net)
 

Climate Change Fund

    0% §      65%  

Emerging Domestic Opportunities Fund

          66%  

Emerging Markets Fund

    < 1%       87%  

Foreign Small Companies Fund

          91%  

International Equity Fund

    0% §      95%  

International Large/Mid Cap Equity Fund

    0% §      90%  

Quality Fund

          16%  

Resources Fund

    0% §      78%  

Risk Premium Fund

          (1)%  

Tax-Managed International Equities Fund

    0% §      93%  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

           

 

  §

Represents the interest in securities that were determined to have a value of zero at August 31, 2018.

U.S. GAAP requires the Funds to disclose the fair value of their investments in a three-level hierarchy (Levels 1, 2 and 3). The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Funds’ investments. The inputs or methodologies used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers into or out of an investment’s assigned level within the fair value hierarchy. In addition, in periods of market dislocation, the observability of prices and inputs may be reduced for many instruments. This condition, as well as changes related to the liquidity of investments, could cause a security to be reclassified between levels.

U.S. GAAP requires additional disclosures about fair value measurements for material Level 3 securities and derivatives, if any (determined by each category of asset or liability as compared to a Fund’s total net assets separately identified in the table below). At August 31, 2018, direct material Level 3 classes of investments or derivatives with significant unobservable inputs subject to this additional disclosure are described in the Level 3 securities and derivatives table below.

The three levels are defined as follows:

Level 1 – Valuations based on quoted prices for identical securities in active markets.

The types of assets and liabilities categorized in Level 1 generally include actively traded domestic and certain foreign equity securities; certain U.S. government obligations; derivatives actively traded on a national securities exchange (such as some futures and options); and shares of open-end mutual funds (even if their investments are valued using Level 2 or Level 3 inputs).

Level 2 – Valuations determined using other significant direct or indirect observable inputs.

The types of assets and liabilities categorized in Level 2 generally include cleared derivatives and certain OTC derivatives such as swaps, options, swaptions, and forward currency contracts valued using industry standard models; certain restricted securities valued at the most recent available market or quoted price; certain securities that are valued at the local price and adjusted by applying a premium or discount when the holdings exceed foreign ownership limitations; and certain foreign equity securities that are adjusted based on inputs from an independent pricing service approved by the Trustees, including the value of equity securities that underlie futures, options and other derivatives (to the extent the market for such instruments closes prior to the close of the NYSE) to reflect estimated valuation changes through the NYSE close.

 

90


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Level 3 – Valuations based primarily on inputs that are unobservable and significant.

The types of assets and liabilities categorized in Level 3 generally include, but are not limited to, securities whose trading has been suspended or that have been de-listed from their current primary trading exchange valued at the most recent available market or quoted price; securities in default or bankruptcy proceedings for which there is no current market quotation valued at the most recent available market or quoted price; third-party investment funds where valuations are provided by fund sponsors and which are adjusted for liquidity considerations as well as the timing of the receipt of information; certain equity securities valued based on the last traded exchange price adjusted for the movement in a relevant index and/or a security type conversion discount; certain securities that are valued using a price from a comparable security related to the same issuer; and certain recently acquired equity securities that have yet to begin trading that are valued at cost.

The following is a summary of the respective levels assigned to the Funds’ direct securities and derivatives, if any, as of August 31, 2018:

 

         
Description   Level 1     Level 2     Level 3     Total  

Climate Change Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Argentina

  $ 863,903     $     $     $ 863,903  

Australia

          1,538,845       0 §      1,538,845  

Austria

          175,196             175,196  

Brazil

          1,364,026             1,364,026  

Canada

    1,441,390                   1,441,390  

China

          4,689,326             4,689,326  

Denmark

          4,020,894             4,020,894  

Finland

          209,687             209,687  

France

          6,661,254             6,661,254  

Germany

          4,083,231             4,083,231  

Israel

          1,379,270             1,379,270  

Italy

          2,106,193             2,106,193  

Japan

          8,164,671             8,164,671  

Netherlands

          1,484,584             1,484,584  

Norway

          5,461,404             5,461,404  

Pakistan

          791,219             791,219  

Poland

          1,726,781             1,726,781  

Portugal

          864,622             864,622  

Russia

          4,305,631             4,305,631  

South Africa

          72,025             72,025  

South Korea

          1,288,376             1,288,376  

Spain

          2,665,308             2,665,308  

Sweden

          927,482             927,482  

Switzerland

          203,781             203,781  

Taiwan

          180,441             180,441  

Thailand

          112,820             112,820  

Ukraine

          579,102             579,102  

United Kingdom

          2,478,315             2,478,315  

United States

    23,860,088                   23,860,088  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    26,165,381       57,534,484       0 §      83,699,865  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Chile

    3,229,838                   3,229,838  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

    3,229,838                   3,229,838  
   

 

 

   

 

 

   

 

 

   

 

 

 

MUTUAL FUNDS

         

United States

    1,665,159                   1,665,159  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    1,665,159                   1,665,159  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    253,712                   253,712  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    31,314,090       57,534,484       0 §      88,848,574  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 31,314,090     $ 57,534,484     $ 0 §    $ 88,848,574  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

91


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Emerging Domestic Opportunities Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Belgium

  $ 9,267,062     $     $     $ 9,267,062  

Brazil

          32,346,936             32,346,936  

China

    89,357,783       161,641,799             250,999,582  

France

          31,294,420             31,294,420  

Hong Kong

          67,755,077             67,755,077  

India

          248,425,041       21,310,628       269,735,669  

Indonesia

          17,202,988             17,202,988  

Mexico

    15,558,606                   15,558,606  

Peru

    10,831,670                   10,831,670  

Philippines

          49,859,667             49,859,667  

Russia

          17,075,814             17,075,814  

South Africa

          8,586,130             8,586,130  

South Korea

          8,932,802             8,932,802  

Switzerland

          40,533,572             40,533,572  

Taiwan

          127,235,031             127,235,031  

Thailand

          69,237,591             69,237,591  

United Kingdom

          99,966,218             99,966,218  

United States

    14,342,302                   14,342,302  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    139,357,423       980,093,086       21,310,628       1,140,761,137  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Brazil

          39,075,253             39,075,253  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

          39,075,253             39,075,253  
   

 

 

   

 

 

   

 

 

   

 

 

 

Investment Funds

         

Brazil

    10,368,035                   10,368,035  

China

    24,425,118       9,846,832             34,271,950  

Mexico

    16,199,412                   16,199,412  

Taiwan

    96,038,494                   96,038,494  

Thailand

          36,827,694             36,827,694  

United States

    101,996,421                   101,996,421  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENT FUNDS

    249,027,480       46,674,526             295,702,006  
   

 

 

   

 

 

   

 

 

   

 

 

 

Debt Obligations

         

Brazil

          17,630,237             17,630,237  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

          17,630,237             17,630,237  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

         

United States

    55,855,727                   55,855,727  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    55,855,727                   55,855,727  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    53,932,004                   53,932,004  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    498,172,634       1,083,473,102       21,310,628       1,602,956,364  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          1,641,047             1,641,047  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 498,172,634     $ 1,085,114,149     $ 21,310,628     $ 1,604,597,411  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

92


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Emerging Domestic Opportunities Fund (continued)

         

Liability Valuation Inputs

         

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

  $     $ (2,116,950   $     $ (2,116,950

Futures Contracts

         

Equity Risk

    (512,178                 (512,178

Swap Contracts

         

Equity Risk

          (915,351           (915,351
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (512,178   $ (3,032,301   $     $ (3,544,479
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Emerging Markets Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Brazil

  $ 19,866,098     $ 49,031,052     $     $ 68,897,150  

Chile

          2,896,859             2,896,859  

China

    54,222,542       683,506,573       678,957       738,408,072  

Colombia

    6,204,037                   6,204,037  

Czech Republic

          5,888,384             5,888,384  

Egypt

          376,942             376,942  

India

          141,222,269             141,222,269  

Indonesia

    969,807       99,930,464             100,900,271  

Malaysia

          3,965,858             3,965,858  

Mexico

    114,134,844                   114,134,844  

Pakistan

          5,407,816             5,407,816  

Peru

    2,834,260                   2,834,260  

Philippines

          38,824,888             38,824,888  

Poland

          89,301,847             89,301,847  

Qatar

          50,112,900             50,112,900  

Russia

    40,589,944       488,396,922             528,986,866  

South Africa

    726,310       174,403,751             175,130,061  

South Korea

          206,127,973             206,127,973  

Sri Lanka

          834,693             834,693  

Taiwan

    63,284,914       697,464,962             760,749,876  

Thailand

          208,820,140             208,820,140  

Turkey

          165,902,233             165,902,233  

United Arab Emirates

          28,698,145             28,698,145  

United Kingdom

          23,358,099             23,358,099  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    302,832,756       3,164,472,770       678,957       3,467,984,483  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Brazil

          14,431,509             14,431,509  

Colombia

    230,371                   230,371  

Russia

          13,239,659             13,239,659  

South Korea

          62,268,870             62,268,870  

Taiwan

          1,224,107             1,224,107  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

    230,371       91,164,145             91,394,516  
   

 

 

   

 

 

   

 

 

   

 

 

 

Investment Funds

         

Russia

                99,022       99,022  

Thailand

          9,335,665             9,335,665  

United States

    70,250,843                   70,250,843  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENT FUNDS

    70,250,843       9,335,665       99,022       79,685,530  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

93


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Emerging Markets Fund (continued)

         

Asset Valuation Inputs (continued)

         

Mutual Funds

         

United States

  $ 84,508,659     $     $     $ 84,508,659  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    84,508,659                   84,508,659  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    5,016,432                   5,016,432  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    462,839,061       3,264,972,580       777,979       3,728,589,620  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Swap Contracts

         

Equity Risk

          770,262             770,262  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 462,839,061     $ 3,265,742,842     $ 777,979     $ 3,729,359,882  
   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Valuation Inputs

         

Derivatives^

         

Futures Contracts

         

Equity Risk

  $ (20,827,310   $     $     $ (20,827,310
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Foreign Small Companies Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Australia

  $     $ 655,200     $     $ 655,200  

Austria

          264,184             264,184  

Belgium

          237,571             237,571  

Brazil

          61,083             61,083  

Canada

    1,184,893                   1,184,893  

China

          437,590             437,590  

Finland

          237,031             237,031  

France

          1,087,797             1,087,797  

Germany

          1,185,595             1,185,595  

Hong Kong

          372,335             372,335  

India

          444,715             444,715  

Indonesia

          19,792             19,792  

Italy

          542,185             542,185  

Japan

          5,016,194             5,016,194  

Malaysia

          328,821             328,821  

Norway

          215,129             215,129  

Poland

          32,942             32,942  

Portugal

          159,531             159,531  

Singapore

          441,021             441,021  

South Africa

          108,694             108,694  

South Korea

          1,438,841             1,438,841  

Spain

          435,300             435,300  

Sweden

          545,415             545,415  

Switzerland

          1,099,644             1,099,644  

Taiwan

          550,481             550,481  

Turkey

          3,730             3,730  

United Kingdom

          2,928,242             2,928,242  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    1,184,893       18,849,063             20,033,956  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

94


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Foreign Small Companies Fund (continued)

         

Asset Valuation Inputs (continued)

         

Preferred Stocks

         

Germany

  $     $ 37,353     $     $ 37,353  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

          37,353             37,353  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

         

United States

    639,328                   639,328  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    639,328                   639,328  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    45,712                   45,712  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    1,869,933       18,886,416             20,756,349  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,869,933     $ 18,886,416     $     $ 20,756,349  
   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Valuation Inputs

         

Derivatives^

         

Futures Contracts

         

Equity Risk

  $ (4,801   $     $     $ (4,801
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

International Equity Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Australia

  $     $ 196,293,815     $     $ 196,293,815  

Austria

          32,202,810             32,202,810  

Belgium

          20,676,512             20,676,512  

Denmark

    20,549,471       46,779,327             67,328,798  

Finland

          8,356,342             8,356,342  

France

    47,013,705       268,800,445             315,814,150  

Germany

          465,551,416             465,551,416  

Hong Kong

          137,032,866             137,032,866  

Ireland

    7,869,895                   7,869,895  

Israel

          9,614,025             9,614,025  

Italy

    77,915,929       109,730,379             187,646,308  

Japan

          1,107,233,813             1,107,233,813  

Malta

                0 §      0 § 

Netherlands

          109,299,597             109,299,597  

New Zealand

          1,688,219             1,688,219  

Norway

          149,062,582             149,062,582  

Portugal

          4,929,415             4,929,415  

Singapore

          14,432,477             14,432,477  

Spain

          29,215,857             29,215,857  

Sweden

          231,195,330             231,195,330  

Switzerland

          205,499,550             205,499,550  

United Kingdom

    17,478,661       602,716,984             620,195,645  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    170,827,661       3,750,311,761       0 §      3,921,139,422  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Germany

          25,075,689             25,075,689  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

          25,075,689             25,075,689  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

         

United States

    22,343,940                   22,343,940  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    22,343,940                   22,343,940  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

95


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

International Equity Fund (continued)

         

Asset Valuation Inputs (continued)

         

Short-Term Investments

  $ 9,905,611     $     $     $ 9,905,611  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    203,077,212       3,775,387,450       0 §      3,978,464,662  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 203,077,212     $ 3,775,387,450     $ 0 §    $ 3,978,464,662  
   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Valuation Inputs

         

Derivatives^

         

Futures Contracts

         

Equity Risk

  $ (323,533   $     $     $ (323,533
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

International Large/Mid Cap Equity Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Australia

  $     $ 675,605     $     $ 675,605  

Austria

          373,667             373,667  

Belgium

          5,471             5,471  

Denmark

    73,755       195,379             269,134  

Finland

          352,494             352,494  

France

    305,319       1,392,707             1,698,026  

Germany

          1,607,310             1,607,310  

Hong Kong

          1,123,761             1,123,761  

Ireland

    119,216                   119,216  

Israel

    9,164                   9,164  

Italy

    402,085       407,459             809,544  

Japan

          5,216,530             5,216,530  

Malta

                0 §      0 § 

Netherlands

          711,751             711,751  

Norway

          180,591             180,591  

Singapore

          134,684             134,684  

Sweden

          760,650             760,650  

Switzerland

          1,067,178             1,067,178  

United Kingdom

    148,959       2,924,586             3,073,545  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    1,058,498       17,129,823       0 §      18,188,321  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Germany

          294,645             294,645  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

          294,645             294,645  
   

 

 

   

 

 

   

 

 

   

 

 

 

MUTUAL FUNDS

         

United States

    477,713                   477,713  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    477,713                   477,713  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    69,503                   69,503  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    1,605,714       17,424,468       0 §      19,030,182  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Futures Contracts

         

Equity Risk

    218                   218  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,605,932     $ 17,424,468     $ 0 §    $ 19,030,400  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

96


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Quality Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Germany

  $     $ 128,766,730     $         —     $ 128,766,730  

Switzerland

          405,574,879             405,574,879  

Taiwan

          153,830,965             153,830,965  

United Kingdom

          486,607,812             486,607,812  

United States

    5,858,915,409                   5,858,915,409  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    5,858,915,409       1,174,780,386             7,033,695,795  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

         

United States

    51,094,345                   51,094,345  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    51,094,345                   51,094,345  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    102,545,284                   102,545,284  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    6,012,555,038       1,174,780,386             7,187,335,424  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 6,012,555,038     $ 1,174,780,386     $     $ 7,187,335,424  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Resources Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Argentina

  $ 4,632,183     $     $     $ 4,632,183  

Australia

          20,723,213             20,723,213  

Austria

          3,035,169             3,035,169  

Brazil

          4,332,127             4,332,127  

Canada

    4,155,285                   4,155,285  

China

          10,223,636             10,223,636  

Colombia

    3,508,590                   3,508,590  

Denmark

          9,053,042             9,053,042  

Finland

          654,902             654,902  

France

          20,610,909             20,610,909  

Germany

          3,285,586             3,285,586  

Hungary

          2,521,762             2,521,762  

India

          2,422,556             2,422,556  

Israel

          11,201,189             11,201,189  

Italy

          1,743,179             1,743,179  

Japan

          23,923,104             23,923,104  

Netherlands

          1,397,628             1,397,628  

Norway

          36,193,972             36,193,972  

Pakistan

          3,515,167             3,515,167  

Poland

          8,501,842             8,501,842  

Qatar

          443,339             443,339  

Russia

          54,351,387             54,351,387  

Singapore

          190,370       0 §      190,370  

South Africa

          6,843,833             6,843,833  

South Korea

          3,503,476             3,503,476  

Spain

          7,897,629             7,897,629  

Sweden

          9,974,379             9,974,379  

Switzerland

          371,751             371,751  

Thailand

          9,817,774             9,817,774  

Turkey

          1,005,901             1,005,901  

Ukraine

          3,079,756             3,079,756  
                                 

 

97


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Resources Fund (continued)

         

Asset Valuation Inputs (continued)

         

United Kingdom

  $     $ 61,334,900     $     $ 61,334,900  

United States

    61,766,469                   61,766,469  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    74,062,527       322,153,478       0 §      396,216,005  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Brazil

          15,156,258             15,156,258  

Chile

    14,014,940                   14,014,940  

Russia

          9,034,194             9,034,194  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

    14,014,940       24,190,452             38,205,392  
   

 

 

   

 

 

   

 

 

   

 

 

 

Rights/Warrants

         

Australia

          51,265             51,265  

Singapore

                0 §      0 § 
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL RIGHTS/WARRANTS

          51,265       0 §      51,265  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

         

United States

    10,640,570                   10,640,570  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    10,640,570                   10,640,570  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    751,939                   751,939  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    99,469,976       346,395,195       0 §      445,865,171  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 99,469,976     $ 346,395,195     $ 0 §    $ 445,865,171  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Risk Premium Fund

         

Asset Valuation Inputs

         

Debt Obligations

         

United States

  $ 239,009,216     $     $     $ 239,009,216  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

    239,009,216                   239,009,216  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    277,418,579                   277,418,579  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    516,427,795                   516,427,795  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 516,427,795     $     $     $ 516,427,795  
   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Valuation Inputs

         

Derivatives^

         

Written Options

         

Equity Risk

  $ (1,531,680   $ (1,639,580   $     $ (3,171,260
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Tax-Managed International Equities Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Australia

  $     $ 2,005,660     $     $ 2,005,660  

Austria

          858,699             858,699  

Belgium

          147,613             147,613  

Brazil

          283,087             283,087  

Canada

    891,231                   891,231  

China

    73,977       1,614,813             1,688,790  
                                 

 

98


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Tax-Managed International Equities Fund (continued)

         

Asset Valuation Inputs (continued)

         

Colombia

  $ 61,020     $     $     $ 61,020  

Denmark

    34,419       209,033             243,452  

Finland

          490,667             490,667  

France

    243,543       3,517,233             3,760,776  

Germany

          4,564,506             4,564,506  

Greece

          5,595             5,595  

Hong Kong

          1,917,974             1,917,974  

Hungary

          93,755             93,755  

India

          430,716             430,716  

Ireland

          252,797             252,797  

Italy

    737,441       1,652,326             2,389,767  

Japan

          12,906,142             12,906,142  

Malaysia

          19,508             19,508  

Malta

                0 §      0 § 

Mexico

    190,029                   190,029  

Netherlands

          808,252             808,252  

New Zealand

          13,840             13,840  

Norway

          764,016             764,016  

Poland

          2,447             2,447  

Portugal

          20,514             20,514  

Russia

          127,732             127,732  

Singapore

          475,970             475,970  

South Africa

          425,569             425,569  

South Korea

    41,616       635,672             677,288  

Spain

          285,956             285,956  

Sweden

          2,688,220             2,688,220  

Switzerland

          2,374,135             2,374,135  

Taiwan

          441,069             441,069  

Thailand

          129,099             129,099  

Turkey

          85,778             85,778  

United Kingdom

    58,380       7,471,504             7,529,884  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    2,331,656       47,719,897       0 §      50,051,553  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Brazil

          232,457             232,457  

Germany

          652,644             652,644  

South Korea

          168,181             168,181  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

          1,053,282             1,053,282  
   

 

 

   

 

 

   

 

 

   

 

 

 

Rights/Warrants

         

Thailand

    1,003                   1,003  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL RIGHTS/WARRANTS

    1,003                   1,003  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

         

United States

    1,001,983                   1,001,983  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    1,001,983                   1,001,983  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    105,298                   105,298  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    3,439,940       48,773,179       0 §      52,213,119  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 3,439,940     $ 48,773,179     $ 0 §    $ 52,213,119  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

99


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Tax-Managed International Equities Fund (continued)

         

Liability Valuation Inputs

         

Derivatives^

         

Futures Contracts

         

Equity Risk

  $ (20,885   $     $     $ (20,885
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

         

Asset Valuation Inputs

         

Common Stocks

  $ 1,018,312,490     $     $     $ 1,018,312,490  

Mutual Funds

    9,072,109                   9,072,109  

Short-Term Investments

    1,255,731                   1,255,731  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    1,028,640,330                   1,028,640,330  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,028,640,330     $     $     $ 1,028,640,330  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

The risks referenced in the tables above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.

 

  ^

The tables above are based on market values or unrealized appreciation/(depreciation), in the case of forward currency contracts, rather than the notional amounts of derivatives. The uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Funds’ net asset values than the uncertainties surrounding inputs for a non-derivative security with the same market value. Excludes purchased options, fully funded total return swaps and rights/warrants, if any, which are included in investments.

  §

Represents the interest in securities that were determined to have a value of zero at August 31, 2018.

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs of the underlying funds, please refer to the underlying funds’ Notes to Financial Statements.

For all Funds for the period ended August 31, 2018, there were no significant transfers between Level 1 and Level 2.

The following is a reconciliation of securities and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 

                     
     Balances
as of
February 28,
2018
    Purchases     Sales     Accrued
Discounts/
Premiums
    Total
Realized
Gain/
(Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Transfer
into
Level 3†
    Transfer
out of
Level 3†
    Balances
as of
August 31,
2018
    Net Change in
Unrealized
Appreciation
(Depreciation)
from
Investments
Still Held as
of August 31,
2018
 
Climate Change Fund                                                            
Common Stocks                      

Australia

  $ 12,229     $     $     $     $     $ (12,229   $     $     $ 0 §    $ (12,229
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 12,229     $     $     $     $     $ (12,229   $     $     $ 0 §    $ (12,229
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 
Emerging Domestic Opportunities Fund                                                            
Common Stocks                      

India

  $ 27,450,114     $     $     $     $     $ (5,823,180   $     $ (316,306 )‡    $ 21,310,628     $ (4,991,589
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 27,450,114     $     $     $     $     $ (5,823,180   $     $ (316,306   $ 21,310,628     $ (4,991,589
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 

 

100


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

                     
     Balances
as of
February 28,
2018
    Purchases     Sales     Accrued
Discounts/
Premiums
    Total
Realized
Gain/
(Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Transfer
into
Level 3†
    Transfer
out of
Level 3†
    Balances
as of
August 31,
2018
    Net Change in
Unrealized
Appreciation
(Depreciation)
from
Investments
Still Held as
of August 31,
2018
 
Emerging Markets Fund                                                            
Common Stocks                      

China

  $ 680,939     $     $     $     $     $ (1,982   $     $     $ 678,957     $ (1,982

India

    1,802,252                               (1,305,638           (496,614 )‡             
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 2,483,191     $     $     $     $     $ (1,307,620   $     $ (496,614   $ 678,957     $ (1,982
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
Investment Funds                      

India

  $ 98,736     $     $ (289,993   $     $ 289,993     $ (98,736   $     $     $     $  

Russia

    2,704,993             (2,217,163               $ (388,808                 99,022       (388,808
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investment Funds

  $ 2,803,729     $     $ (2,507,156   $     $ 289,993     $ (487,544   $     $     $ 99,022     $ (388,808
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 5,286,920     $     $ (2,507,156   $     $ 289,993     $ (1,795,164   $     $ (496,614   $ 777,979     $ (390,790
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 
Resources Fund                                                            
Common Stocks                      

Singapore

  $ 197,420     $     $     $     $     $ (7,050   $     $ (190,370 )‡    $ 0 §    $ (7,050
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 197,420     $     $     $     $     $ (7,050   $     $ (190,370   $ 0 §    $ (7,050
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 
Tax-Managed International Equities Fund                                                            
Rights/Warrants                      

Brazil

  $ 1,369     $     $ 0     $     $ 0     $ (1,369   $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,369     $     $ 0     $     $ 0     $ (1,369   $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 

 

 

The Funds account for securities and derivatives, if any, transferred into and out of Level 3 at the value at the end of the period.

 

Financial assets transferred between Level 2 and Level 3 were due to a change in observable and/or unobservable inputs.

  §

Represents the interest in securities that were determined to have a value of zero at August 31, 2018.

 

101


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The net aggregate direct and indirect exposure to investments in securities and/or derivatives using Level 3 inputs and presented on a net basis, which will tend to understate the Funds’ exposure, (based on each Fund’s net assets) as of August 31, 2018 were as follows:

 

   
Fund Name   Level 3 securities
and derivatives
 

Climate Change Fund

    0% § 

Emerging Domestic Opportunities Fund

    1%

Emerging Markets Fund

    <1%  

Foreign Small Companies Fund

     

International Equity Fund

    0% § 

International Large/Mid Cap Equity Fund

    0% § 

Quality Fund

     

Resources Fund

    0% § 

Risk Premium Fund

     

Tax-Managed International Equities Fund

    0% § 

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

     

 

  *

Includes Dixon Technologies India Ltd, which represents 0.89% of the Fund’s total net assets and is valued using the exchange last traded price and is restricted from sale until September 14, 2018.

  §

Represents the interest in securities that were determined to have a value of zero at August 31, 2018.

Cash

Cash and foreign currency, if any, in the Statements of Assets and Liabilities consist of cash balances held with the custodian.

Due to/from broker

Due to/from broker in the Statements of Assets and Liabilities includes collateral on swap contracts, futures contracts, option contracts and forward currency contracts, if any, and may include marked-to-market amounts related to foreign currency or cash owed.

Foreign currency translation

The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm Eastern time. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated in the Statements of Operations from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.

Taxes and distributions

Each Fund has elected to be treated or intends to elect to be treated and intends to qualify each tax year as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). Each Fund intends to distribute its net investment income, if any, and its net realized short-term and long-term capital gains, if any, after giving effect to any available capital loss carryforwards for U.S. federal income tax purposes. Therefore, each Fund makes no provision for U.S. federal income or excise taxes.

The policy of each Fund is to declare and pay dividends of its net investment income, if any, at least annually, although the Funds are permitted to, and will from time to time, declare and pay dividends of net investment income, if any, more frequently. Each Fund also intends to distribute net realized short-term and long-term capital gains, if any, at least annually. In addition, each Fund may, from time to time at their discretion, make unscheduled distributions in advance of large redemptions by shareholders or as otherwise deemed appropriate by a Fund. Typically, all distributions are reinvested in additional shares of each Fund at net asset value, unless GMO or its agents receive and process a shareholder election to receive cash distributions. Distributions to shareholders are recorded by each Fund on the ex-dividend date.

 

102


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Taxes on foreign interest and dividend income are generally withheld in accordance with the applicable country’s tax treaty with the United States. The foreign withholding rates applicable to a Fund’s investments in certain jurisdictions may be higher if a significant portion of the Fund is held by non-U.S. shareholders. Each Fund may be subject to taxation on realized capital gains, repatriation proceeds and other transaction-based charges imposed by certain countries in which it invests. Transaction-based charges are generally calculated as a percentage of the transaction amount. Taxes related to capital gains realized during the period ended August 31, 2018, if any, are reflected as part of Net realized gain (loss) in the Statements of Operations. Changes in tax liabilities related to capital gain taxes on unrealized investment gains, if any, are reflected as part of Change in net unrealized appreciation (depreciation) in the Statements of Operations.

Certain Funds have previously filed for and/or may file for additional tax refunds with respect to certain taxes withheld by certain countries. Generally, the amount of such refunds that a Fund reasonably determines are collectible and free from significant contingencies are reflected in a Fund’s net asset value and are reflected as Dividends from unaffiliated issuers in the Statements of Operations. In certain circumstances, a Fund’s receipt of such refunds may cause the Fund and/or its shareholders to be liable for U.S. federal income taxes, interest charges and related fees.

Foreign taxes paid by each Fund may be treated, to the extent permissible by the Code (and other applicable U.S. federal tax guidance) and if that Fund so elects, as if paid by U.S. shareholders of that Fund.

Income and capital gain distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP. Certain capital accounts in the financial statements are periodically adjusted for permanent differences in order to reflect their tax character. These adjustments have no impact on net assets or net asset value per share. Temporary differences that arise from recognizing certain items of income, expense, gain or loss in different periods for financial statement and tax purposes will likely reverse at some time in the future. Distributions in excess of net investment income or net realized gains are temporary over-distributions for financial statement purposes resulting from differences in the recognition or classification of income or distributions for financial statement and tax purposes.

Distributions in excess of a Fund’s tax basis earnings and profits, if significant, are reported in the Funds’ financial statements as a return of capital.

As of February 28, 2018, certain Funds elected to defer to March 1, 2018 late-year ordinary losses and post-October capital losses. The Funds’ loss deferrals are as follows:

 

     
Fund Name   Late-Year
Ordinary Loss
Deferral ($)
    Post-October
Capital Losses ($)
 

Climate Change Fund

           

Emerging Domestic Opportunities Fund

    (2,255,504)        

Emerging Markets Fund

    (3,555,452)        

Foreign Small Companies Fund

           

International Equity Fund

           

International Large/Mid Cap Equity Fund

           

Quality Fund

           

Resources Fund

          (74,843)  

Risk Premium Fund

          (3,798,674)  

Tax-Managed International Equities Fund

           

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

           

As of February 28, 2018, certain Funds had capital loss carryforwards available to offset future realized gains, if any, to the extent permitted by the Code. Net capital losses recognized in taxable years beginning on or after March 1, 2011 are carried forward without expiration and generally retain their short-term and/or long-term tax character, as applicable. Utilization of the capital loss

 

103


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

carryforwards, post-October capital losses, late-year ordinary losses, and losses realized subsequent to February 28, 2018, if any, could be subject to further limitations imposed by the Code related to share ownership activity. The Funds’ capital loss carryforwards are as follows:

 

     
     Short-Term ($)     Long-Term ($)  
     
Fund Name   No
Expiration
Date
    No
Expiration
Date
 
Climate Change Fund            
Emerging Domestic Opportunities Fund            
Emerging Markets Fund     (128,012,850)       (1,321,484,489)  
Foreign Small Companies Fund            
International Equity Fund     (692,086,892)       (425,794,508)  
International Large/Mid Cap Equity Fund            
Quality Fund            
Resources Fund     (20,440,224)       (24,899,575)  
Risk Premium Fund            
Tax-Managed International Equities Fund     (15,390,229)        
U.S. Equity Fund (formerly U.S. Equity Allocation Fund)            

As of August 31, 2018, the approximate total cost, aggregate investment-level gross/net unrealized appreciation (depreciation) in the value of total investments (including total securities sold short, if any), and the net unrealized appreciation (depreciation) of outstanding financial instruments for U.S. federal income tax purposes were as follows:

 

     Total Investments     Outstanding
Financial
Instruments
 
           
Fund Name   Aggregate
Cost ($)
    Gross Unrealized
Appreciation ($)
    Gross Unrealized
(Depreciation) ($)
    Net Unrealized
Appreciation
(Depreciation) ($)
    Net Unrealized
Appreciation
(Depreciation) ($)
 

Climate Change Fund

    91,965,273       2,941,355       (6,058,054)       (3,116,699)        

Emerging Domestic Opportunities Fund

    1,724,389,763       54,440,496       (175,873,895)       (121,433,399)       (1,903,432)  

Emerging Markets Fund

    3,769,577,233       342,006,251       (382,993,864)       (40,987,613)       (20,057,048)  

Foreign Small Companies Fund

    21,293,934       1,848,693       (2,386,278)       (537,585)       (4,801)  

International Equity Fund

    3,823,310,236       384,838,215       (229,683,789)       155,154,426       (323,533)  

International Large/Mid Cap Equity Fund

    18,478,776       1,615,106       (1,063,700)       551,406       218  

Quality Fund

    4,689,812,376       2,514,712,432       (17,189,384)       2,497,523,048        

Resources Fund

    400,982,923       60,697,843       (15,815,595)       44,882,248        

Risk Premium Fund

    516,420,667       51,620       (44,492)       7,128       911,915  

Tax-Managed International Equities Fund

    38,071,842       15,080,451       (939,174)       14,141,277       (20,885)  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

    921,649,177       126,361,287       (19,370,134)       106,991,153        

The Funds are subject to authoritative guidance related to the accounting and disclosure of uncertain tax positions under U.S. GAAP. This guidance sets forth a minimum threshold for the financial statement recognition of tax positions taken based on the technical merits of such positions. United States and non-U.S. tax rules (including the interpretation and application of tax laws) are subject to

 

104


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

change. The Funds file tax returns and/or adopt certain tax positions in various jurisdictions. Non-U.S. taxes are provided for based on the Funds’ understanding of the prevailing tax rules of the non-U.S. markets in which they invest. Recently enacted tax rules, including interpretations of tax laws and tax legislation/initiatives currently under consideration in various jurisdictions, including the U.S., might affect the way the Funds and their investors are taxed prospectively and/or retroactively. Prior to the expiration of the relevant statutes of limitations, if any, the Funds are subject to examination by U.S. federal, state, local and non-U.S. jurisdictions with respect to the tax returns they have filed and the tax positions they have adopted. The Funds’ U.S. federal income tax returns are generally subject to examination by the Internal Revenue Service for a period of three years after they are filed. State, local and/or non-U.S. tax returns and/or other filings may be subject to examination for different periods, depending upon the tax rules of each applicable jurisdiction.

Security transactions and related investment income

Security transactions are accounted for in the financial statements on trade date. For purposes of daily net asset value calculations, the Funds’ policy is that security transactions are generally accounted for on the following business day. GMO may override that policy and a Fund may account for security transactions on trade date if it experiences significant purchases or redemptions or engages in significant portfolio transactions. Dividend income, net of applicable foreign withholding taxes, if any, is recorded on the ex-dividend date or, if later, when a Fund is informed of the ex-dividend date. Income dividends and capital gain distributions from the underlying funds are recorded on the ex-dividend date. Interest income is recorded on the accrual basis and is adjusted for the amortization of premiums and accretion of discounts. Principal on inflation-indexed securities is adjusted for inflation and any increase or decrease is recorded as interest income or investment loss. Coupon income is not recognized on securities for which collection is not expected. Paydown gains and losses on mortgage-related and other asset-backed securities, if any, are recorded as components of interest income in the Statements of Operations. Non-cash dividends, if any, are recorded at the fair market value of the asset received. In determining the net gain or loss on securities sold, the Funds use the identified cost basis.

Expenses and class allocations

Most of the expenses of the Trust are directly attributable to an individual Fund. Generally, common expenses are allocated among the Funds based on, among other things, the nature and type of expense and the relative size of the Funds. Investment income, common expenses, purchase premiums and redemption fees, if any, and realized and unrealized gains and losses are allocated among the classes of shares of the Funds, if applicable, based on the relative net assets of each class. Shareholder service fees, if any, which are directly attributable to a class of shares, are charged to that class’s operations. In addition, the Funds may incur fees and expenses indirectly as a shareholder in the underlying funds. Because the underlying funds have different expense and fee levels and the Funds may own different proportions of the underlying funds at different times, the amount of fees and expenses indirectly incurred by a Fund will vary (see Note 5).

State Street Bank and Trust Company (“State Street”) serves as the Funds’ custodian and fund accounting agent except for Emerging Markets Fund’s holdings in Indian assets, for which Brown Brothers Harriman & Co. (“BBH”) serves as custodian. Prior to November 3, 2017, BBH served as the Funds’ custodian and fund accounting agent except for Climate Change Fund, Quality Fund, U.S. Equity Allocation Fund and Risk Premium Fund. State Street serves as the transfer agent for all Funds. Prior to December 31, 2013, State Street’s transfer agent fees may have been reduced by an earnings allowance calculated on the average daily cash balances each Fund maintained in a State Street transfer agent account. Earnings allowances were reported as a reduction of expenses in the Statements of Operations. Effective January 1, 2014, any cash balances maintained at the transfer agent are held in a Demand Deposit Account and interest income earned, if any, is shown as interest income in the Statements of Operations. Any cash balances maintained at the custodian are held in a Demand Deposit Account and interest income earned, if any, is shown as interest income in the Statements of Operations.

Purchases and redemptions of Fund shares

Purchase premiums and redemption fees (if applicable) are paid to and retained by a Fund to help offset estimated portfolio transaction costs and other related costs (e.g., bid to ask spreads, stamp duties, and transfer fees) incurred by the Fund (directly or indirectly through investments in underlying funds) as a result of an investor’s purchase or redemption by allocating estimated transaction costs to the purchasing or redeeming shareholder. Such fees are recorded as a component of the Funds’ net share transactions. A Fund may impose a new purchase premium and redemption fee or modify an existing fee at any time.

Purchase premiums are not charged on reinvestments of dividends or other distributions. Redemption fees apply to all shares of a Fund regardless of how the shares were acquired (e.g., by direct purchase or by reinvestment of dividends or other distributions).

 

105


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

If GMO determines that any portion of a cash purchase or redemption, as applicable, is offset by a corresponding cash redemption or purchase occurring on the same day, it ordinarily will waive or reduce the purchase premium or redemption fee with respect to that portion.

GMO also may waive or reduce the purchase premium or redemption fee for a cash purchase or redemption of a Fund’s shares if the Fund will not incur transaction costs or will incur reduced transaction costs.

GMO also may reduce the purchase premium to the extent that securities are used to purchase a Fund’s shares (taking into account transaction costs, stamp duties or transfer fees). GMO may reduce redemption fees to the extent a Fund uses portfolio securities to redeem its shares (taking into account transaction costs, stamp duties or transfer fees).

As of August 31, 2018, the premium on cash purchases and the fee on cash redemptions were as follows:

 

                       
     Climate Change Fund  

Emerging Domestic Opportunities Fund

 

 

Emerging Markets Fund

 

 

Foreign Small Companies Fund

 

  International Equity Fund   International Large/Mid Cap Equity Fund   Quality Fund  

Resources Fund

 

  Risk Premium Fund (a)   Tax-Managed International Equities Fund   U.S. Equity Fund (formerly U.S. Equity
Allocation Fund)
Purchase Premium     0.80%   0.80%   0.50%         0.30%      
Redemption Fee     0.80%   0.80%   0.50%         0.30%      

 

  (a)

Prior to May 18, 2018, the premium on cash purchases and the fee on cash redemptions were each 0.15% of the amount invested or redeemed.

Recently-issued accounting guidance

In March 2017, the Financial Accounting Standards Board (“FASB”) issued an amendment to U.S. GAAP, which amends the required amortization period for purchased callable debt securities that have been purchased at a premium. The scope of the amendment is limited to debt securities that have an explicit non-contingent call feature at a fixed price on a preset date or dates. The amendment requires that the aforementioned premium on such debt securities shall be amortized through the next call date, whereas current U.S. GAAP requires amortization through the maturity date of the security. This amendment does not apply to debt securities purchased at a discount and is effective for fiscal years beginning after December 15, 2018. GMO is currently evaluating the impact, if any, of this guidance on the Fund’s financial statements and disclosures.

Other matters

Emerging Markets Fund (“EMF”)

Indian regulators alleged in 2002 that EMF violated some conditions under which it was granted permission to operate in India and have restricted some of EMF’s locally held assets pending resolution of the dispute. Although these locally held assets remain the property of EMF, a portion of the assets are not permitted to be withdrawn from EMF’s local custodial account located in India. The amount of restricted assets is small relative to the size of EMF, representing approximately 0.10% of the Fund’s total net assets as of August 31, 2018 and is included within miscellaneous payable within the Statements of Assets and Liabilities. The effect of this claim on the value of the restricted assets, and all matters relating to EMF’s response to these allegations, are subject to the supervision and control of GMO Trust’s Board of Trustees. Any costs in respect of this matter will be borne by EMF.

 

106


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

3.

Investment and other risks

The following chart identifies selected risks associated with each Fund. Risks not marked for a particular Fund may, however, still apply to some extent to that Fund at various times.

 

                       
     Climate Change Fund   Emerging Domestic Opportunities Fund   Emerging Markets Fund   Foreign Small Companies Fund   International Equity Fund   International Large/Mid Cap Equity Fund   Quality Fund   Resources Fund   Risk Premium Fund   Tax-Managed International Equities Fund   U.S. Equity Fund (formerly U.S. Equity
Allocation Fund)
Commodities Risk   X                           X            
Counterparty Risk   X   X   X   X   X   X   X   X   X   X   X
Credit Risk       X                           X        
Currency Risk   X   X   X   X   X   X   X   X   X   X    
Derivatives and Short Sales Risk   X   X   X   X   X   X   X   X   X   X   X
Focused Investment Risk   X   X   X   X   X   X   X   X   X   X   X
Fund of Funds Risk       X   X                                
Illiquidity Risk   X   X   X   X   X   X   X   X   X   X   X
Large Shareholder Risk   X   X   X   X   X   X   X   X   X   X   X
Leveraging Risk   X   X   X   X   X   X   X   X       X   X
Management and Operational Risk   X   X   X   X   X   X   X   X   X   X   X
Market Disruption and Geopolitical Risk   X   X   X   X   X   X   X   X   X   X   X
Market Risk – Equities   X   X   X   X   X   X   X   X   X   X   X
Market Risk – Fixed Income       X                           X        
Merger Arbitrage Risk   X                           X            
Non-Diversified Funds   X   X   X               X   X   X   X    
Non-U.S. Investment Risk   X   X   X   X   X   X   X   X   X   X    
Small Company Risk   X   X   X   X   X       X   X   X   X   X

Investing in mutual funds involves many risks. The risks of investing in a particular Fund depend on the types of investments in its portfolio and the investment strategies GMO employs on its behalf. This section does not describe every potential risk of investing in the Funds. Funds could be subject to additional risks because of the types of investments they make and market conditions, which may change over time.

Each Fund that invests in other GMO Funds or other investment companies (collectively, “Underlying Funds”) is exposed to the risks to which the Underlying Funds in which it invests are exposed, as well as the risk that the Underlying Funds will not perform as expected. Therefore, unless otherwise noted, the selected risks summarized below include both direct and indirect risks, and references in this section to investments made by a Fund include those made both directly by the Fund and indirectly by the Fund through Underlying Funds.

 

107


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

An investment in a Fund is not a bank deposit and, therefore, is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.

• COMMODITIES RISK. Commodity prices can be extremely volatile and are affected by many factors. Exposure to commodities can cause the value of a Fund’s shares to decline or fluctuate in a rapid and unpredictable manner. The value of commodity-related derivatives or indirect investments in commodities may fluctuate more than the commodity, commodities or commodity index to which they relate. See “Derivatives and Short Sales Risk” for a discussion of specific risks of a Fund’s derivatives investments, including commodity-related derivatives.

• COUNTERPARTY RISK. Funds that enter into contracts with counterparties, such as repurchase or reverse repurchase agreements or OTC derivatives contracts, or that lend their securities run the risk that the counterparty will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. If a counterparty fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, the Fund could miss investment opportunities or otherwise be forced to hold investments it would prefer to sell, resulting in losses for the Fund. In addition, a Fund may suffer losses if a counterparty fails to comply with applicable laws, regulations or other requirements. The Funds are not subject to any limit on their exposure to any one counterparty nor to a requirement that counterparties with whom they enter into contracts maintain a specific rating by a nationally recognized rating organization. Counterparty risk is pronounced during unusually adverse market conditions and is particularly acute in environments in which financial services firms are exposed (as they were in 2008) to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions.

Participants in OTC derivatives markets typically are not subject to the same level of credit evaluation and regulatory oversight as are members of exchange-based markets, and, therefore, OTC derivatives generally expose a Fund to greater counterparty risk than exchange-traded derivatives. A Fund is subject to the risk that a counterparty will not settle a derivative in accordance with its terms because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem. If a counterparty’s obligation to a Fund is not collateralized, then the Fund is essentially an unsecured creditor of the counterparty. If a counterparty defaults, the Fund will have contractual remedies (whether or not the obligation is collateralized), but the Fund may be unable to enforce them, thus causing the Fund to suffer a loss. Counterparty risk is greater for derivatives with longer maturities because of the longer time during which events may occur that prevent settlement. Counterparty risk also is greater when a Fund has entered into derivatives contracts with a single or small group of counterparties as it sometimes does as a result of its use of swaps and other OTC derivatives. Funds that use swap contracts are subject, in particular, to the creditworthiness of the counterparties because some types of swap contracts have terms longer than six months (and, in some cases, decades). The creditworthiness of a counterparty may be adversely affected by greater than average volatility in the markets, even if the counterparty’s net market exposure is small relative to its capital. Counterparty risk still exists even if a counterparty’s obligations are secured by collateral because the Fund’s interest in the collateral may not be perfected or additional collateral may not be posted promptly as required. GMO’s view with respect to a particular counterparty is subject to change. The fact, however, that it changes adversely (whether due to external events or otherwise) does not mean that a Fund’s existing transactions with that counterparty will necessarily be terminated or modified. In addition, a Fund may enter into new transactions with a counterparty that GMO no longer considers a desirable counterparty (for example, re-establishing the transaction with a lower notional amount or entering into a countervailing trade with the same counterparty). Counterparty risk also will be greater if a counterparty’s obligations exceed the value of the collateral held by the Fund (if any).

The Funds also are subject to counterparty risk because they execute their securities transactions through brokers and dealers. If a broker or dealer fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, the Funds could miss investment opportunities or be unable to dispose of investments they would prefer to sell, resulting in losses for the Funds. Counterparty risk with respect to derivatives has been and will continue to be affected by new rules and regulations relating to the derivatives market. As described under “Derivatives and Short Sales Risk,” some derivatives transactions are required to be centrally cleared, and a party to a cleared derivatives transaction is subject to the credit risk of the clearing house and the clearing member through which it holds its cleared position. Credit risk of market participants with respect to derivatives that are centrally cleared is concentrated in a few clearing houses, and it is not clear how an insolvency proceeding of a clearing house would be conducted and what impact an insolvency of a clearing house would have on the financial system. Also, in the event of a counterparty’s (or its affiliate’s) insolvency, the possibility exists that the Funds’ ability to exercise remedies, such as the termination of transactions, netting of obligations or realization on collateral, could be stayed or eliminated under new special resolution regimes adopted in the United States, the European Union and various other jurisdictions. Such regimes provide governmental authorities with broad

 

108


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

authority to intervene when a financial institution is experiencing financial difficulty. In particular, in the European Union, governmental authorities could reduce, eliminate, or convert to equity the liabilities to the Funds of a counterparty experiencing financial difficulties (sometimes referred to as a “bail in”).

• CREDIT RISK. This is the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner. The market price of a fixed income investment will normally decline as a result (and/or in anticipation) of the issuer’s, guarantor’s, or obligor’s failure to meet its payment obligations, or a downgrading of the credit rating of the investment. This risk is particularly acute in environments in which financial services firms are exposed (as they were in 2008) to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. Fixed income investments also are subject to illiquidity risk. See “Illiquidity Risk.”

All fixed income investments are subject to credit risk. Financial strength and solvency of an issuer are the primary factors influencing credit risk. The risk varies depending upon whether the issuer is a corporation, a government or government entity, whether the particular security has a priority over other obligations of the issuer in payment of principal and interest and whether it has any collateral backing or credit enhancement. Credit risk may change over the term of a fixed income investment. U.S. government securities are subject to varying degrees of credit risk depending upon whether the securities are supported by the full faith and credit of the United States, supported by the ability to borrow from the U.S. Treasury, supported only by the credit of the issuing U.S. government agency, instrumentality, or corporation, or otherwise supported by the United States. For example, issuers of many types of U.S. government securities (e.g., the Federal Home Loan Mortgage Corporation (“Freddie Mac”), Federal National Mortgage Association (“Fannie Mae”), and Federal Home Loan Banks), although chartered or sponsored by Congress, are not funded by Congressional appropriations and their fixed income securities, including mortgage-backed and other asset-backed securities, are neither guaranteed nor insured by the U.S. government. These securities are subject to more credit risk than U.S. government securities that are supported by the full faith and credit of the United States (e.g., U.S. Treasury bonds). Investments in sovereign or quasi-sovereign debt involve the risk that the governmental entities responsible for repayment may be unable or unwilling to pay interest and repay principal when due. A governmental entity’s ability and willingness to pay interest and repay principal in a timely manner may be affected by a variety of factors, including its cash flow, the size of its reserves, its access to foreign exchange, the relative size of its debt service burden to its economy as a whole, and political constraints. Investments in quasi-sovereign issuers are subject to the additional risk that the issuer may default independently of its sovereign. Sovereign debt risk is greater for fixed income securities issued or guaranteed by emerging countries.

In many cases, the credit risk and market price of a fixed income investment are reflected in its credit ratings, and a Fund holding a rated investment is subject to the risk that the investment’s rating will be downgraded, resulting in a decrease in the market price of the fixed income investment.

Securities issued by the U.S. government historically have presented minimal credit risk. However, events in 2011 led several major rating agencies to downgrade the long-term credit rating of U.S. bonds and introduced greater uncertainty about the repayment by the United States of its obligations. A further credit rating downgrade could decrease, and a default in the payment of principal or interest on U.S. government securities would decrease, the market price of a Fund’s investments and increase the volatility of a Fund’s portfolio.

Asset-backed securities may be backed by many types of assets and their payment of interest and repayment of principal largely depend on the cash flows generated by the assets backing them. The obligations of issuers also may be subject to bankruptcy, insolvency and other laws affecting the rights and remedies of creditors. A Fund also is exposed to credit risk on a reference security to the extent it writes protection under credit default swaps. See “Derivatives and Short Sales Risk” for more information regarding risks associated with the use of credit default swaps.

The extent to which the market price of a fixed income investment changes in response to a credit event depends on many factors and can be difficult to predict. For example, even though the effective duration of a long-term floating rate security is very short, an adverse credit event or change in the perceived creditworthiness of its issuer could cause its market price to decline much more than its effective duration would suggest.

Credit risk is particularly pronounced for below investment grade investments (commonly referred to as “junk bonds”). The sovereign debt of many non-U.S. governments, including their sub-divisions and instrumentalities, is below investment grade. Many

 

109


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

asset-backed securities also are below investment grade. Below investment grade investments have speculative characteristics, often are less liquid than higher quality investments, present a greater risk of default and are more susceptible to real or perceived adverse industry conditions. Investments in distressed or defaulted or other low quality debt investments generally are considered speculative and may involve substantial risks not normally associated with investments in higher quality investments, including adverse business, financial or economic conditions that lead to payment defaults and insolvency proceedings on the part of their issuers. In particular, distressed or defaulted obligations might be repaid, if at all, only after lengthy workout or bankruptcy proceedings, during which the issuer does not make any interest or other payments and a Fund incurs additional expenses in seeking recovery. If GMO’s assessment of the eventual recovery value of a distressed or defaulted debt investment proves incorrect, a Fund may lose a substantial portion or all of its investment or may be required to accept cash or instruments worth less than its original investment. In the event of a default of sovereign debt, the Funds may be unable to pursue legal action against the issuer.

• CURRENCY RISK. Currency risk is the risk that fluctuations in exchange rates will adversely affect the market value of a Fund’s investments. Currency risk includes the risk that the currencies in which a Fund’s investments are traded, in which a Fund receives income, or in which a Fund has taken a position will decline in value. Currency risk also includes the risk that the currency to which the Fund has obtained exposure through hedging declines in value relative to the currency being hedged, in which event the Fund may realize a loss on both the hedging instrument and the currency being hedged. Currency exchange rates can fluctuate significantly for many reasons. See “Market Disruption and Geopolitical Risk.”

Many of the Funds use derivatives to take currency positions that are under- or over-weighted (in some cases significantly) relative to the currency exposure of their portfolios and their benchmarks. If the exchange rates of the currencies involved do not move as expected, a Fund could lose money on both its holdings of a particular currency and the derivative. See also “Non-U.S. Investment Risk.”

Some currencies are illiquid (e.g., some emerging country currencies), and a Fund may not be able to convert them into U.S. dollars or may only be able to do so at an unfavorable exchange rate. Exchange rates for many currencies are affected by exchange control regulations.

Derivative transactions in foreign currencies (such as futures, forwards, options and swaps) may involve leveraging risk in addition to currency risk, as described under “Leveraging Risk.” In addition, the obligations of counterparties in currency derivative transactions are often not secured by collateral, which increases counterparty risk (see “Counterparty Risk”).

• DERIVATIVES AND SHORT SALES RISK. All of the Funds may invest in derivatives, which are financial contracts whose value depends on, or is derived from, the value of underlying assets, such as securities, commodities or currencies, reference rates, such as interest rates, currency exchange rates, inflation rates, or indices. Derivatives involve the risk that their value may not change as expected relative to changes in the value of the assets, rates, or indices they are designed to track. Derivatives include, but are not limited to, futures contracts, forward contracts, foreign currency contracts, swap contracts, contracts for differences, options on securities and indices, options on futures contracts, options on swap contracts, interest rate caps, floors and collars, reverse repurchase agreements, and other OTC contracts.

The use of derivatives involves risks that are potentially greater than, the risks of investing directly in securities. In particular, a Fund’s use of OTC derivatives exposes it to the risk that the counterparties will be unable or unwilling to make timely settlement payments or otherwise honor their obligations. An OTC derivatives contract typically can be closed, or the position transferred, only with the consent of the other party to the contract. If the counterparty defaults, the Fund will still have contractual remedies but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund, and if it does, the Fund may decide not to pursue its claims against the counterparty to avoid the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments GMO believes are owed to the Fund under an OTC derivatives contract, or those payments may be delayed or made only after the Fund has incurred the cost of litigation.

A Fund may invest in derivatives that (i) do not require the counterparty to post collateral (e.g., foreign currency forwards), (ii) require collateral but that do not provide for the Fund’s security interest in it to be perfected, (iii) require a significant upfront deposit by the Fund unrelated to the derivative’s fundamental fair (or intrinsic) value, or (iv) do not require that collateral be regularly marked-to-market. When a counterparty’s obligations are not fully secured by collateral, a Fund runs a greater risk of not being able to recover what it is owed if the counterparty defaults. Derivatives also present other risks described in this section, including market risk, illiquidity risk, currency risk, credit risk, and counterparty risk.

 

110


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used may not produce valuations that are consistent with the values a Fund realizes when it closes or sells an OTC derivative. Valuation risk is more pronounced when a Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, inaccurate valuations may result in increased cash payments to counterparties, under-collateralization and/or errors in the calculation of a Fund’s net asset value.

A Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the cost of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of a Fund, the Funds will not be permitted to trade with that counterparty.

Swap contracts and other OTC derivatives are highly susceptible to illiquidity risk (see “Illiquidity Risk”) and counterparty risk (see “Counterparty Risk”). These derivatives also are subject to documentation risk, which is the risk that ambiguities, inconsistencies or errors in the documentation relating to a derivative transaction may lead to a dispute with the counterparty or unintended investment results. In addition, see “Commodities Risk” for a discussion of risks specific to commodity-related derivatives. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. See “Leveraging Risk.”

A Fund’s use of derivatives may be subject to special tax rules and could generate additional taxable income for shareholders. In addition, the tax treatment of a Fund’s use of derivatives will sometimes be unclear. The SEC has proposed a rule under the 1940 Act, regulating the use by registered investment companies of derivatives and many related instruments. That rule, if adopted as proposed, would, among other things, restrict a Fund’s ability to engage in derivatives transactions or so increase the cost of derivatives transactions that a Fund would be unable to implement its investment strategy.

Derivatives Regulation. The U.S. government has enacted legislation that provides for new regulation of the derivatives market, including clearing, margin, reporting, and registration requirements. The European Union (and some other countries) have adopted similar requirements, which affect a Fund when it enters into a derivatives transaction with a counterparty subject to those requirements. Because these U.S. and European Union requirements are new and evolving (and some of the rules are not yet final), their impact on the Funds remains unclear.

Transactions in some types of swaps (including interest rate swaps and credit default swaps on North American and European indices) are required to be centrally cleared. In a transaction involving those swaps (“cleared derivatives”), a Fund’s counterparty is a clearing house rather than a bank or broker. Since the Funds are not members of clearing houses and only members of a clearing house (“clearing members”) can participate directly in the clearing house, the Funds hold cleared derivatives through accounts at clearing members. In cleared derivatives positions, the Funds make payments (including margin payments) to and receive payments from a clearing house through their accounts at clearing members. Clearing members guarantee performance of their clients’ obligations to the clearing house.

In some ways, cleared derivative arrangements are less favorable to mutual funds than bilateral arrangements, for example, by requiring that funds provide more margin for their cleared derivatives positions. Also, as a general matter, in contrast to a bilateral derivatives position, following a period of notice to a Fund, a clearing member at any time can require termination of an existing cleared derivatives position or an increase in the margin required at the outset of a transaction. Clearing houses also have broad rights to increase the margin required for existing positions or to terminate those positions at any time. Any increase in margin requirements or termination of existing cleared derivatives positions by the clearing member or the clearing house could interfere with the ability of a Fund to pursue its investment strategy. Further, any increase in margin requirements by a clearing member could expose a Fund to greater credit risk to its clearing member because margin for cleared derivatives positions in excess of a clearing house’s margin requirements typically is held by the clearing member (see “Counterparty Risk”). Also, a Fund is subject to risk if it enters into a derivatives transaction that is required to be cleared (or that GMO expects to be cleared), and no clearing member is willing or able to clear the transaction on the Fund’s behalf. While the documentation in place between the Funds and their clearing members generally provides that the clearing members will accept for clearing all cleared derivatives transactions that are within credit limits (specified in advance) for each Fund, the Funds are still subject to the risk that no clearing member will be willing or able to clear a transaction. In those cases, the position might have to be terminated, and the Fund could lose some or all of the benefit of the position, including loss of an increase in the value of the position and loss of hedging protection. In addition, the documentation governing the

 

111


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

relationship between the Funds and clearing members is drafted by the clearing members and generally is less favorable to the Funds than the documentation for typical bilateral derivatives. For example, documentation relating to cleared derivatives generally includes a one-way indemnity by the Funds in favor of the clearing member for losses the clearing member incurs as the Funds’ clearing member. Also, such documentation typically does not provide the Funds any remedies if the clearing member defaults or becomes insolvent. While futures contracts entail similar risks, the risks may be more pronounced for cleared derivatives due to their more limited liquidity and market history.

Some types of cleared derivatives are required to be executed on an exchange or on a swap execution facility. A swap execution facility is a trading platform where multiple market participants can execute derivatives by accepting bids and offers made by multiple other participants in the platform. While this execution requirement is designed to increase transparency and liquidity in the cleared derivatives market, trading on a swap execution facility can create additional costs and risks for the Funds. For example, swap execution facilities typically charge fees, and if a Fund executes derivatives on a swap execution facility through a broker intermediary, the intermediary may impose fees as well. Also, a Fund may be required to indemnify a swap execution facility, or a broker intermediary who executes cleared derivatives on a swap execution facility on the Fund’s behalf, against any losses or costs that may be incurred as a result of the Fund’s transactions on the swap execution facility.

If a Fund wishes to execute a package of transactions that include a swap that is required to be executed on a swap execution facility as well as other transactions (for example, a transaction that includes both a security and an interest rate swap that hedges interest rate exposure with respect to such security), the Fund may be unable to execute all components of the package on the swap execution facility. In that case, the Fund would need to trade some components of the package on the swap execution facility and other components in another manner, which could subject the Fund to the risk that some components would be executed successfully and others would not, or that the components would be executed at different times, leaving the Fund with an unhedged position for a period of time.

The U.S. government and the European Union have adopted mandatory minimum margin requirements for bilateral derivatives. New variation margin requirements became effective in March 2017 and new initial margin requirements will become effective in 2020. Such requirements could increase the amount of margin a Fund needs to provide in connection with its derivatives transactions and, therefore, make derivatives transactions more expensive.

These and other new rules and regulations could, among other things, further restrict a Fund’s ability to engage in, or increase the cost to the Fund of, derivatives transactions, for example, by making some types of derivatives no longer available to the Fund or otherwise limiting liquidity. The implementation of the clearing requirement has increased the cost of derivatives transactions for the Funds, since the Funds have to pay fees to their clearing members and are typically required to post more margin for cleared derivatives than they historically posted for bilateral derivatives. The cost of derivatives transactions is expected to increase further as clearing members raise their fees to cover the cost of additional capital requirements and other regulatory changes applicable to the clearing members. These rules and regulations are new and evolving, and, therefore, their potential impact on the Funds and the financial system are not yet known. While the new rules and regulations and central clearing of some derivatives transactions are designed to reduce systemic risk (i.e., the risk that the interdependence of large derivatives dealers could cause them to suffer liquidity, solvency or other challenges simultaneously), there is no assurance that they will achieve that result, and in the meantime, as noted above, central clearing and related requirements expose the Funds to new kinds of costs and risks.

Options. The Funds, particularly Risk Premium Fund, are permitted to write options. The market price of an option is affected by many factors, including changes in the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant stock market and underlying securities. The market price of an option also may be adversely affected if the market for the option becomes less liquid. In addition, since an American-style option allows the holder to exercise its rights any time before the option’s expiration, the writer of an American-style option has no control over when it will be required to fulfill its obligations as a writer of the option. (The writer of a European-style option is not subject to this risk because the holder may only exercise the option on its expiration date.) If a Fund writes a call option and does not hold the underlying security or instrument, the Fund’s potential loss is theoretically unlimited.

National securities exchanges generally have established limits on the maximum number of options an investor or group of investors acting in concert may write. A Fund, GMO, and other funds advised by GMO likely constitute such a group. When applicable, these limits restrict a Fund’s ability to purchase or write options on a particular security.

 

112


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Unlike exchange-traded options, which are standardized with respect to the underlying instrument, expiration date, contract size, and strike price, the terms of OTC options (i.e., options not traded on exchanges) generally are established through negotiation with the other party to the option contract. While a Fund has greater flexibility to tailor an OTC option, OTC options generally expose a Fund to greater credit risk than exchange-traded options, which are guaranteed by the clearing organization of the exchanges where they are traded. Purchasing and writing put and call options are highly specialized activities and entail greater than ordinary market risks.

Special tax rules apply to a Fund’s transactions in options, which could increase the taxes payable by shareholders subject to U.S. income taxation. In particular, a Fund’s options transactions potentially could cause a substantial portion of the Fund’s distributions to be taxable at ordinary income tax rates. See the Funds’ Prospectus and Statement of Additional Information for more information.

Short Investment Exposure. Some Funds may sell securities or currencies short as part of their investment programs in an attempt to increase their returns or for hedging purposes. Short sales expose a Fund to the risk that it will be required to acquire, convert, or exchange a security or currency to replace the borrowed security or currency when the security or currency sold short has appreciated in value, thus resulting in a loss to the Fund. Purchasing a security or currency to close out a short position can itself cause the price of the security or currency to rise further, thereby exacerbating any losses. A Fund that sells short a security or currency it does not own typically pays borrowing fees to a broker and is required to pay the broker any dividends or interest it receives on a borrowed security.

A Fund also may create short investment exposure by taking a derivative position in which the value of the derivative moves in the opposite direction from the price of an underlying asset, pool of assets, rate, currency or index.

Short sales of securities or currencies a Fund does not own and “short” derivative positions involve forms of investment leverage, and the amount of the Fund’s potential loss is theoretically unlimited. A Fund is subject to increased leveraging risk and other investment risks described in this “Investment and other risks” section to the extent it sells short securities or currencies it does not own or takes “short” derivative positions.

• FOCUSED INVESTMENT RISK. Funds with investments that are focused in a limited number of asset classes, sectors, industries, issuers, currencies, countries, or regions (or in sectors within a country or region) that are subject to the same or similar risk factors and funds with investments whose prices are closely correlated are subject to greater overall risk than funds with investments that are more diversified or whose prices are not as closely correlated.

A Fund that invests in the securities of a small number of issuers has greater exposure to adverse developments affecting those issuers and to a decline in the market price of those issuers’ securities than Funds investing in the securities of a larger number of issuers. Securities, sectors, or companies that share common characteristics are often subject to similar business risks and regulatory burdens and often react similarly to specific economic, market, political or other developments.

Similarly, Funds having a significant portion of their assets in investments tied economically (or related) to a particular geographic region, country or market (e.g., emerging markets), or to sectors within a region, country, or market (e.g., Russian oil) have more exposure to regional and country economic risks than funds making investments throughout the world. The political and economic prospects of one country or group of countries within the same geographic region may affect other countries in that region, and a recession, debt crisis or decline in the value of the currency of one country can spread to other countries. Furthermore, companies in a particular geographic region or country are vulnerable to events affecting other companies in that region or country because they often share common characteristics, are exposed to similar business risks and regulatory burdens, and react similarly to specific economic, market, political or other developments. See also “Non-U.S. Investment Risk.”

Because Resources Fund concentrates its investments in the natural resources sector, it is particularly exposed to adverse developments, including adverse price movements, affecting issuers in the natural resources sector and is subject to greater risks than a fund that invests in a wider range of industries. In addition, the market prices of securities of companies in the natural resources sector are often more volatile (particularly in the short term) than those of securities of companies in other industries. Some of the commodities used as raw materials or produced by these companies are subject to broad price fluctuations as a result of industry-wide supply and demand factors. Companies in the natural resources sector often have limited pricing power over the supplies they purchase and the products they sell, which can affect their profitability, and are often capital-intensive and use significant amounts of leverage. Projects in the natural resources sector may take extended periods of time to complete, and companies cannot ensure that the market will be favorable at the time the project begins production. Companies in the natural resources sector also may be subject to special risks associated with natural or man-made disasters. In addition, companies in the natural resources sector can be especially

 

113


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

affected by political and economic developments, government regulations including changes in tax law or interpretations of law, energy conservation, and the success of exploration projects. Specifically, companies in the natural resources sector can be significantly affected by import controls, worldwide competition and cartels, and changes in consumer sentiment and spending, and can be subject to liability for, among other things, environmental damage, depletion of resources, and mandated expenditures for safety and pollution control. Resources Fund’s concentration in the securities of natural resource companies exposes it to the price movements of natural resources to a greater extent than if it were more broadly diversified. Because Resources Fund invests primarily in the natural resources sector, it runs the risk of performing poorly during an economic downturn or a decline in demand for natural resources.

Because Climate Change Fund focuses its investments in securities of companies involved in climate change-related industries, the Fund will be more susceptible to events or factors affecting these companies, and the market prices of its portfolio securities may be more volatile than those of mutual funds that are more diversified. Climate Change Fund is particularly exposed to such developments as changes in global and regional climates, environmental protection regulatory actions, changes in government standards and subsidy levels, changes in taxation and other domestic and international political, regulatory and economic developments (such as potential cut-backs on funding for the Environmental Protection Agency and other policies and actions by the Trump administration). Companies involved in alternative fuels also may be adversely affected by the increased use of, or decreases in prices for, oil or other fossil fuels. In addition, scientific developments, such as breakthroughs in the remediation of global warming, and changes in governmental policies relating to the effects of pollution may affect investments in pollution control, which could in turn affect these companies. Such companies also may be significantly affected by technological changes in industries focusing on energy, pollution control and mitigation of global warming. Because society’s focus on climate change issues is relatively new, the emphasis and direction of governmental policies is subject to significant change, and rapid technological change could render even new approaches and products obsolete. Some companies involved in climate change-related industries are in the early stages of operation and have limited operating histories and smaller market capitalizations on average than companies in other sectors. As a result of these and other factors, the market prices of securities of companies involved in climate change-related industries tend to be considerably more volatile than those of companies in more established sectors and industries.

Because Risk Premium Fund may hold a limited number of options contracts relating to relatively few stock indices, the Fund is subject to focused investment risk.

• FUND OF FUNDS RISK. Funds that invest in Underlying Funds (including underlying GMO Funds) are exposed to the risk that the Underlying Funds will not perform as expected. The Funds also are indirectly exposed to all of the risks to which the Underlying Funds are exposed.

Absent reimbursement, a Fund bears the fees and expenses of an Underlying Fund (including purchase premiums and redemption fees, if any) in which it invests, and may incur additional expenses when investing in an Underlying Fund. In addition, total Fund expenses will increase if a Fund makes a new or further investment in Underlying Funds with higher fees or expenses than the average fees and expenses of the Underlying Funds then in the Fund’s portfolio.

In addition, to the extent a Fund invests in shares of underlying GMO Funds, it is indirectly subject to Large Shareholder Risk when an underlying GMO Fund has large shareholders (e.g., other GMO Funds). See “Large Shareholder Risk.”

At any particular time, one Underlying Fund may be purchasing securities of an issuer whose securities are being sold by another Underlying Fund, resulting in a Fund that holds each Underlying Fund indirectly incurring the costs associated with the two transactions without changing its exposure to those securities.

Investments in exchange-traded funds (“ETFs”) involve the risk that an ETF’s performance may not track the performance of the index it is designed to track. In addition, ETFs often use derivatives to track the performance of an index, and, therefore, investments in those ETFs are subject to the same derivatives risks discussed in “Derivatives and Short Sales Risk.” ETFs are investment companies that typically hold a portfolio of securities designed to track the price, performance, and dividend yield of a particular securities market index (or sector of an index). As investment companies, ETFs incur their own management and other fees and expenses, such as trustee fees, operating expenses, registration fees, and marketing expenses, and a Fund that invests in ETFs will bear a proportionate share of such fees and expenses. As a result, an investment by a Fund in an ETF could lead to higher operating expenses and lower returns than if the Fund were to invest directly in the securities underlying the ETF.

 

114


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

A Fund’s investments in one or more Underlying Funds could affect the amount, timing and character of its distributions and could cause the Fund to recognize taxable income in excess of the cash generated by such investments, requiring the Fund in turn to liquidate investments at disadvantageous times to generate cash needed to make required distributions.

• ILLIQUIDITY RISK. Illiquidity risk is the risk that low trading volume, lack of a market maker, large position size, or legal restrictions (including daily price fluctuation limits or “circuit breakers”) limits, delays or prevents a Fund from selling particular securities or closing derivative positions at desirable prices. In addition to these risks, a Fund is exposed to illiquidity risk when it has an obligation to purchase particular securities (e.g., as a result of entering into reverse repurchase agreements, writing a put, or closing a short position). To the extent a Fund’s investments include asset-backed securities, distressed, defaulted or other low quality debt securities, emerging country debt or equity securities, securities of companies with smaller market capitalizations or smaller total float adjusted market capitalizations, or emerging market securities, it is subject to increased illiquidity risk. These types of investments can be difficult to value, exposing a Fund to the risk that the price at which it sells them will be less than the price at which they were valued when held by the Fund. Illiquidity risk also may be greater in times of financial stress. For example, Inflation-Protected Securities issued by the U.S. Treasury (“TIPS”) have experienced periods of greatly reduced liquidity during disruptions in fixed income markets, such as the events surrounding the bankruptcy of Lehman Brothers in 2008. Less liquid securities are more susceptible than other securities to price declines when market prices decline generally.

A Fund may buy securities or other investments that are less liquid than those in its benchmark. The more illiquid investments a Fund has, the greater the likelihood of its paying redemption proceeds in-kind.

Historically, the credit markets have experienced periods characterized by a significant lack of liquidity, and they may experience similar periods in the future. A lack of liquidity could require a Fund to sell securities to satisfy collateral posting requirements and meet redemptions, which could, in turn, create downward price pressure on the securities being sold.

A Fund’s, and particularly Risk Premium Fund’s, ability to use options as part of its investment program depends on the liquidity of the options market. That market may not be liquid when a Fund seeks to close out an option position, and the hours of trading for options on an exchange may not conform to the hours during which the underlying securities are traded. To the extent that the options markets close before the markets for the underlying securities, significant price and rate movements can take place in the markets for those securities that are not immediately reflected in the options markets. If a Fund receives a redemption request and is unable to close out an option it has sold, the Fund may temporarily be leveraged in relation to its assets.

• LARGE SHAREHOLDER RISK. To the extent a large number of shares of a Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy (e.g., GMO asset allocation accounts), the Fund is subject to the risk that a redemption by those shareholders of all or a large portion of their Fund shares will adversely affect the Fund’s performance by forcing the Fund to sell portfolio securities, potentially at disadvantageous prices, to raise the cash needed to satisfy the redemption request. In addition, the Funds and other accounts over which GMO has investment discretion that invest in the Funds are not limited in how often they may sell Fund shares. The Asset Allocation Funds and separate accounts managed by GMO for its clients hold substantial percentages of the outstanding shares of many Funds, and asset allocation decisions by GMO may result in substantial redemptions from (or investments in) those Funds. These transactions may adversely affect the Fund’s performance to the extent that the Fund is required to sell investments when it would not have otherwise done so. Redemptions of a large number of shares also may increase transaction costs or, by necessitating a sale of portfolio securities, have adverse tax consequences for Fund shareholders. Further, from time to time a Fund may trade in anticipation of a purchase or redemption order that ultimately is not received or differs in size from the actual order, leading to temporary underexposure or overexposure to the Fund’s intended investment program. In addition, redemptions and purchases of shares by a large shareholder or group of shareholders could limit the use of any capital loss carryforwards to offset future realized capital gains (if any) and other losses that would otherwise reduce distributable net investment income. In addition, large shareholders may limit or prevent a Fund’s use of equalization for U.S. federal tax purposes.

To the extent a Fund invests in other GMO Funds subject to large shareholder risk, the Fund is indirectly subject to this risk.

• LEVERAGING RISK. The use of traditional borrowing (including to meet redemption requests), reverse repurchase agreements and other derivatives and securities lending creates leverage (i.e., a Fund’s investment exposures exceed its net asset value). Leverage increases a Fund’s losses when the value of its investments (including derivatives) declines. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish or maintain the derivative position), adverse

 

115


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In the case of swaps, the risk of loss generally is related to a notional principal amount, even if the parties have not made any initial investment. Some derivatives, similar to short sales, have the potential for unlimited loss, regardless of the size of the initial investment. Similarly, a Fund’s portfolio will be leveraged and can incur losses if the value of the Fund’s assets declines between the time a redemption request is received or deemed to be received by a Fund (which in some cases may be the business day prior to actual receipt of the transaction activity by the Fund) and the time at which the Fund liquidates assets to meet redemption requests. Such a decline in the value of a Fund’s assets is more likely in the case of Funds managed from GMO’s non-U.S. offices for which the time period between the NAV determination and corresponding liquidation of assets could be longer due to time zone differences and market schedules. In the case of redemptions representing a significant portion of a Fund’s portfolio, the leverage effects described above can be significant and could expose a Fund and non-redeeming shareholders to material losses.

A Fund may manage some of its derivative positions by offsetting derivative positions against one another or against other assets. To the extent offsetting positions do not behave in relation to one another as expected, a Fund may perform as if it were leveraged.

Some Funds are permitted to purchase securities on margin or to sell securities short, either of which creates leverage. To the extent the market prices of securities pledged to counterparties to secure a Fund’s margin account or short sale decline, the Fund may be required to deposit additional funds with the counterparty to avoid having the pledged securities liquidated to compensate for the decline.

• MANAGEMENT AND OPERATIONAL RISK. Each Fund is subject to management risk because it relies on GMO to achieve its investment objective. Each Fund runs the risk that GMO’s investment techniques will fail to produce desired results and may cause the Fund to incur significant losses. GMO also may fail to use derivatives effectively, choosing to hedge or not to hedge positions at disadvantageous times. In the case of Tax-Managed International Equities Fund, GMO’s tax-management strategies may be ineffective or limited by market conditions, the timing of cash flows into and out of the Fund, and current or future changes in tax legislation and regulation.

For many Funds, GMO uses quantitative models as part of its investment process. GMO’s models may not accurately predict future market movements, or characteristics. In addition, they are based on assumptions that can limit their effectiveness, and they rely on data that is subject to limitations (e.g., inaccuracies, staleness) that could adversely affect their predictive value. The Funds also run the risk that GMO’s assessment of an investment (including a security’s fundamental fair (or intrinsic) value) is wrong.

GMO relies on quantitative models in making investment decisions. The usefulness of GMO’s models may be diminished by the faulty incorporation of mathematical models into computer code, by reliance on proprietary and third-party technology that includes errors, omissions, bugs, or viruses, and by the retrieval of limited or imperfect data for processing by the model. These risks are present in the ordinary course of business and are more likely to occur when GMO is making changes to its models. Any of these risks could adversely affect a Fund’s performance.

There can be no assurance that key GMO personnel will continue to be employed by GMO. The loss of their services could have an adverse impact on GMO’s ability to achieve the Funds’ investment objectives.

The Funds also are subject to a risk of loss resulting from other services provided by GMO and other service providers, including pricing, administrative, accounting, tax, legal, custody, transfer agency, and other services. Operational risk includes the possibility of loss caused by inadequate procedures and controls, human error, and system failures by a service provider. For example, trading delays or errors could prevent a Fund from benefiting from investment gains or avoiding losses. In addition, a service provider may be unable to provide a net asset value (“NAV”) for a Fund or share class on a timely basis. GMO is not contractually liable to the Funds for losses associated with operational risk absent its willful misfeasance, bad faith, gross negligence, or reckless disregard of its contractual obligations to provide services to the Funds. Other Fund service providers also have contractual limitations on their liability to the Funds for losses resulting from their errors.

The Funds and their service providers (including GMO) are susceptible to cyber-attacks and to technological malfunctions that may have effects similar to those of a cyber-attack. Cyber-attacks include, among others, stealing or corrupting data maintained online or digitally, preventing legitimate users from accessing information or services on a website, releasing confidential information without authorization, and disrupting operations. Successful cyber-attacks against, or security breakdowns of, a Fund, GMO, a sub-adviser, or a custodian, transfer agent, or other service provider may adversely affect the Fund or its shareholders. For instance, cyber-attacks

 

116


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

may interfere with the processing of shareholder transactions, affect a Fund’s ability to calculate its net asset value, cause the release or misappropriation of private shareholder information or confidential Fund information, impede trading, cause reputational damage, and subject the Fund to regulatory fines, penalties or financial losses, and additional compliance costs. The Funds’ service providers regularly experience cyber-attacks and expect they will continue to do so. While GMO has established business continuity plans and systems designed to prevent, detect and respond to cyber-attacks, those plans and systems have inherent limitations. Similar types of cyber security risks also are present for issuers of securities in which the Funds invest, which could have material adverse consequences for those issuers and result in a decline in the market price of their securities. Furthermore, as a result of cyber-attacks, technological disruptions, malfunctions, or failures, an exchange or market may close or suspend trading in specific securities or the entire market, which could prevent the Funds from, among other things, buying or selling securities or accurately pricing their investments. The Funds cannot directly control cyber security plans and systems of their service providers, the Funds’ counterparties, issuers of securities in which the Funds invest, or securities markets and exchanges.

• MARKET DISRUPTION AND GEOPOLITICAL RISK. The Funds are subject to the risk that geopolitical and other events (e.g., wars and terrorism) will disrupt securities markets and adversely affect global economies and markets, thereby reducing the value of the Funds’ investments. Sudden or significant changes in the supply or prices of commodities or in other economic inputs (e.g., the marked decline in oil prices that began in late 2014) may have material and unexpected effects on both global securities markets and individual countries, regions, sectors, companies, or industries. Terrorism in the United States and around the world has increased geopolitical risk. The terrorist attacks on September 11, 2001 resulted in the closure of some U.S. securities markets for four days, and similar attacks are possible in the future. Securities markets may be susceptible to market manipulation or other fraudulent trading practices, which could disrupt their orderly functioning or reduce the prices of securities traded on them, including securities held by the Funds. Fraud and other deceptive practices committed by an issuer of securities held by a Fund undermine GMO’s due diligence efforts and, when discovered, will likely cause a steep decline in the market price of those securities and thus negatively affect the value of the Fund’s investments. In addition, when discovered, financial fraud may contribute to overall market volatility, which can negatively affect a Fund’s investment program as well as the rates or indices underlying a Fund’s investments.

While the U.S. government has always honored its credit obligations, a default by the U.S. government (as has been threatened in recent years) would be highly disruptive to the U.S. and global securities markets and could significantly reduce the value of the Funds’ investments. Similarly, political events within the United States have resulted, and may in the future result, in a shutdown of government services, which could adversely affect the U.S. economy, reduce the value of many Fund investments, and impair the operation of the U.S. or other securities markets. Uncertainty over the sovereign debt of several European Union countries, as well as uncertainty over the continued existence of the European Union itself, has disrupted and may continue to disrupt markets in the United States and around the world. If a country changes its currency or if the European Union dissolves, the world’s securities markets likely will be significantly disrupted. In June 2016, the United Kingdom approved a referendum to leave the European Union (commonly known as “Brexit”) and in March 2017, the United Kingdom commenced the formal process of withdrawing from the European Union. Brexit has resulted in volatility in European and global markets and could have negative long-term impacts on financial markets in the United Kingdom and throughout Europe. Considerable uncertainty exists over the potential consequences and precise timeframe for Brexit, how it will be conducted, how negotiations of trade agreements will proceed, and how the financial markets will react, and as this process unfolds markets may be further disrupted. The consequences of the United Kingdom’s or another country’s exit from the European Union also could threaten the stability of the euro for remaining countries and could negatively affect the financial markets of other countries in the European region and beyond. War, terrorism, economic uncertainty, and related geopolitical events, such as sanctions, tariffs, the imposition of exchange controls or other cross-border trade barriers, have led, and in the future may lead, to increased short-term market volatility and may have adverse long-term effects on U.S. and world economies and markets generally. Likewise, natural and environmental disasters, such as the earthquake and tsunami in Japan in early 2011, and systemic market dislocations of the kind surrounding the insolvency of Lehman Brothers in 2008, if repeated, would be highly disruptive to economies and markets, adversely affecting individual companies and industries, securities markets, interest rates, credit ratings, inflation, investor sentiment, and other factors affecting the market price of the Funds’ investments. During such market disruptions, the Funds’ exposure to the risks described elsewhere in this “Investment and other risks” section will likely increase. Market disruptions, including sudden government interventions, can also prevent the Funds from implementing their investment programs and achieving their investment objectives. For example, a market disruption may adversely affect the orderly functioning of the securities markets and may cause the Funds’ derivatives counterparties to discontinue offering derivatives on some underlying commodities, securities, reference rates, or indices, or to offer them on a more limited basis. To the extent a Fund has focused its investments in the stock index of a particular region, adverse geopolitical and other events in that region could have a disproportionate impact on the Fund.

 

117


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

• MARKET RISK. All of the Funds are subject to market risk, which is the risk that the market price of their holdings will decline. Market risks include:

Equities — Funds that invest in equities run the risk that the market price of an equity will decline. That decline may be attributable to factors affecting the issuer, such as poor performance by the issuer’s management or reduced demand for its goods or services, or to factors affecting a particular industry, such as a decline in demand, labor or raw material shortages, or increased production costs. A decline also may result from general market conditions not specifically related to a company or industry, such as real or perceived adverse economic conditions, changes in the general outlook for corporate earnings, changes in interest or currency rates, or adverse investor sentiment generally. The market prices of equities are volatile and can decline in a rapid or unpredictable manner. If a Fund purchases an equity for what GMO believes is less than its fundamental fair (or intrinsic) value, the Fund runs the risk that the market price of the equity will not appreciate or will decline due to GMO’s incorrect assessment. The market prices of equities trading at high multiples of current earnings often are more sensitive to changes in future earnings expectations than the market prices of equities trading at lower multiples.

Because of Risk Premium Fund’s emphasis on writing put options on stock indices, GMO expects the Fund’s net asset value to decline when those indices decline in value. Also, Risk Premium Fund’s investment strategy of writing put options on stock indices can be expected to cause the Fund to underperform relative to those indices when the markets associated with those indices rise sharply because of the Fund’s lack of exposure to the upside of those markets.

Fixed Income — Funds that invest in fixed income investments (including bonds, notes, bills, synthetic debt instruments, and asset-backed securities) are subject to various market risks. The market price of a fixed income investment can decline due to market-related factors, including rising interest rates and widening credit spreads, or decreased liquidity due to market uncertainty about the value of a fixed income investment (or class of fixed income investments). In addition, the market price of fixed income investments with complex structures, such as asset-backed securities and sovereign and quasi-sovereign debt instruments, can decline due to uncertainty about their credit quality and the reliability of their payment streams. Some fixed income investments also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as was provided by the fixed income investment. When interest rates rise, fixed income investments also may be repaid more slowly than anticipated, causing a decrease in their market price. During periods of economic uncertainty and change, the market price of a Fund’s investments in below investment grade investments (commonly referred to as “junk bonds”) may be particularly volatile. Often below investment grade investments are subject to greater sensitivity to interest rate and economic changes than higher rated investments and can be more difficult to value, exposing a Fund to the risk that the price at which it sells them will be less than the price at which they were valued when held by the Fund. See “Credit Risk” and “Illiquidity Risk” for more information about these risks.

A risk run by each Fund with significant investment in fixed income investments is that an increase in prevailing interest rates will cause the market price of those securities to decline. The risk associated with increases in interest rates (also called “interest rate risk”) is generally greater for Funds investing in fixed income investments with longer durations. In addition, in managing some Funds, GMO may seek to evaluate potential investments in part by considering the volatility of interest rates. The value of a Fund’s investments may be significantly reduced if GMO’s assessment proves incorrect.

The extent to which the market price of a fixed income investment changes with changes in interest rates is referred to as interest rate duration, which can be measured mathematically or empirically. A longer-maturity investment generally has longer interest rate duration because its fixed rate is locked in for a longer period of time. Floating-rate or adjustable-rate investments, generally have shorter interest rate durations because their interest rates are not fixed but rather float up and down as interest rates change. Conversely, inverse floating-rate investments have durations that move in the opposite direction from short-term interest rates and thus tend to underperform fixed rate investments when interest rates rise but outperform them when interest rates decline. Fixed income investments paying no interest, such as zero coupon and principal-only securities, are subject to additional interest rate risk.

The market price of inflation-indexed bonds (including TIPS) typically declines during periods of rising real interest rates (i.e., nominal interest rate minus inflation) and increases during periods of declining real interest rates. In some interest rate environments, such as when real interest rates are rising faster than nominal interest rates, the market price of inflation-indexed bonds may decline more than the price of non-inflation-indexed (or nominal) fixed income bonds with similar maturities.

Generally, when interest rates on short term U.S. Treasury obligations equal or approach zero, a Fund that invests a substantial portion of its assets in U.S. Treasury obligations, such as U.S. Treasury Fund, will have a negative return unless GMO waives or reduces its management fees.

 

118


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Fixed income securities denominated in foreign currencies also are subject to currency risk. See “Currency Risk.”

In response to government intervention, economic or market developments, or other factors, markets for fixed income investments may experience periods of high volatility, reduced liquidity or both. During those periods, a Fund could have unusually high shareholder redemptions, requiring it to generate cash by selling portfolio assets when it would otherwise not do so, including at unfavorable prices. Fixed income investments may be difficult to value during such periods. In recent years, central banks and governmental financial regulators, including the U.S. Federal Reserve, have kept interest rates historically low by purchasing bonds. However, the U.S. Federal Reserve recently has increased interest rates and continued economic recovery and the Federal Reserve’s conclusion of its quantitative easing program increase the likelihood that interest rates will increase in the United States and throughout the financial system. A substantial increase in interest rates could have an adverse effect on prices for fixed income investments and on the performance of the Funds. Other actions by central banks or regulators (such as intervention in foreign currency markets or currency controls) also could have a material adverse effect on the Funds.

• MERGER ARBITRAGE RISK. Some Funds engage in transactions in which the Fund purchases securities at prices below the value of the consideration GMO expects the Fund to receive upon consummation of a proposed merger, exchange offer, tender offer, or other similar transaction (“merger arbitrage transactions”). The purchase price paid by the Fund may substantially exceed the market price of the securities before the announcement of the transaction.

If a Fund engages in merger arbitrage and the merger later appears unlikely to be consummated or, in fact, is not consummated or is delayed, the market price of the securities purchased by the Fund is likely to decline sharply, resulting in losses to the Fund. The risk/reward payout of merger arbitrage strategies typically is asymmetric, with the losses in failed transactions often far exceeding the gains in successful transactions. A proposed merger can fail to be consummated for many reasons, including regulatory and antitrust restrictions, industry weakness, company specific events, failed financings, and general market declines.

Merger arbitrage strategies are subject to the risk of overall market movements, and a Fund may experience losses even if a transaction is consummated. A Fund’s investments in derivatives or short sales of securities to hedge or otherwise adjust long or short investment exposure in connection with a merger arbitrage may not perform as GMO expected or may otherwise reduce the Fund’s gains or increase its losses. Also, a Fund may be unable to hedge against market fluctuations or other risks. In addition, a Fund may sell securities short when GMO expects the Fund to receive the securities upon consummation of a transaction; if the Fund does not actually receive the securities, the Fund will have an unintended “naked” short position and may be required to cover its short position at a time when the securities sold short have appreciated in value, thus resulting in a loss. A Fund’s merger arbitrage transactions could result in tax inefficiencies, including larger distributions of net investment income and net realized capital gains than otherwise would be the case.

• NON-DIVERSIFIED FUNDS. Some of the Funds are not “diversified” investment companies within the meaning of the 1940 Act. This means they are allowed to invest in the securities of relatively few issuers. As a result, they may be subject to greater credit, market and other risks than if their investments were more diversified, and poor performance by a single investment may have a greater impact on their performance.

The following Funds are not diversified investment companies within the meaning of the 1940 Act:

 

   

Climate Change Fund

   

Emerging Domestic Opportunities Fund

   

Emerging Markets Fund

   

Quality Fund

   

Resources Fund

   

Risk Premium Fund

   

Tax-Managed International Equities Fund

• NON-U.S. INVESTMENT RISK. Funds that invest in non-U.S. securities are subject to more risks than Funds that invest only in U.S. securities. Many non-U.S. securities markets include securities of only a small number of companies in a small number of industries. As a result, the market prices of securities traded on those markets often fluctuate more than those of U.S. securities. In addition, issuers of non-U.S. securities often are not subject to as much regulation as U.S. issuers, and the reporting, accounting, custody, and auditing standards to which those issuers are subject often are not as rigorous as U.S. standards. Transactions in non-U.S.

 

119


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

securities generally involve higher commission rates, transfer taxes, and custodial costs. In addition, some countries limit a Fund’s ability to profit from short-term trading (as defined in that country).

A Fund may be subject to non-U.S. taxation, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments; (ii) transactions in those investments; and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. A Fund may seek a refund of taxes paid, but its efforts may not be successful, in which case the Fund will have incurred additional expenses for no benefit. In addition, a Fund’s pursuit of a tax refund may subject it to administrative and judicial proceedings in the country where it is seeking the refund. A Fund’s decision to seek a refund is in its sole discretion, and, particularly in light of the cost involved, it may decide not to seek a refund, even if it is entitled to one. The outcome of a Fund’s efforts to obtain a refund is inherently unpredictable. Accordingly, a refund is not typically reflected in a Fund’s net asset value until it is received or until GMO is confident that it will be received. In some cases, the amount of a refund could be material to a Fund’s net asset value. Generally, absent a determination that a refund is collectible and free from significant contingencies, a refund is not reflected in a Fund’s net asset value. See “Taxes, Non-U.S. Taxes” in the GMO Trust Statement of Additional Information for additional information. For information on possible special Singapore tax consequences of an investment in the Funds, see the Funds’ Prospectus and Statement of Additional Information.

Investing in non-U.S. securities also exposes a Fund to the risk of nationalization, expropriation, or confiscatory taxation of assets of their issuers, government involvement in every country, including the U.S., or in the affairs of specific companies or industries (including wholly or partially state-owned enterprises), adverse changes in investment regulations, capital requirements or exchange controls (which may include suspension of the ability to transfer currency from a country), and adverse political and diplomatic developments, including the imposition of economic sanctions.

In some non-U.S. securities markets, custody arrangements for securities provide significantly less protection than custody arrangements in U.S. securities markets, and prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose a Fund to credit and other risks it does not have in the United States. Fluctuations in currency exchange rates also affect the market prices of a Fund’s non-U.S. securities (see “Currency Risk”).

The Funds need a license to invest directly in securities traded in many non-U.S. securities markets. These licenses are often subject to limitations, including maximum investment amounts. Once a license is obtained, a Fund’s ability to continue to invest directly is subject to the risk that the license will be terminated or suspended. If a license to invest in a particular market is terminated or suspended, to obtain exposure to that market the Fund will be required to purchase American Depositary Receipts, Global Depositary Receipts, shares of other funds that are licensed to invest directly, or derivative instruments. The receipt of a non-U.S. license by one of GMO’s clients may preclude a Fund from obtaining a similar license. In addition, the activities of a GMO client could cause the suspension or revocation of a Fund’s license.

Funds that invest a significant portion of their assets in securities of issuers tied economically to emerging countries (or investments related to emerging markets) are subject to greater non-U.S. investment risk than Funds investing primarily in more developed non-U.S. countries (or markets). The risks of investing in those securities include: greater fluctuations in currency exchange rates; increased risk of default (by both government and private issuers); greater social, economic, and political uncertainty and instability (including the risk of war or natural disaster); increased risk of nationalization, expropriation, or other confiscation of issuer assets; greater governmental involvement in the economy or in the affairs of specific companies or industries (including wholly or partially state-owned enterprises); less governmental supervision and regulation of securities markets and participants in those markets; controls on investment, capital controls and limitations on repatriation of invested capital, dividends, interest and other income and on a Fund’s ability to exchange local currencies for U.S. dollars; inability to purchase and sell investments or otherwise settle security or derivative transactions (i.e., a market freeze); unavailability of currency hedging techniques; less rigorous auditing and financial reporting standards and resulting unavailability of material information about issuers; slower clearance and settlement; difficulties in obtaining and enforcing legal judgments; and significantly smaller market capitalizations of issuers. In addition, the economies of emerging countries may depend predominantly on only a few industries or revenues from particular commodities and often are more volatile than the economies of developed countries.

• SMALL COMPANY RISK. Companies with smaller market capitalizations tend to have limited product lines, markets, or financial resources, lack the competitive strength of larger companies, have less experienced managers and depend on fewer key employees than larger companies. In addition, their securities often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations. Market risk and illiquidity risk are particularly pronounced for the securities of these companies.

 

120


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Temporary Defensive Positions. Temporary defensive positions are positions that are inconsistent with a Fund’s principal investment strategies and are taken in response to adverse market, economic, political or other conditions. The Funds normally do not take temporary defensive positions. To the extent a Fund takes a temporary defensive position, or otherwise holds cash, cash equivalents, or high quality debt investments on a temporary basis, the Fund may not achieve its investment objective.

 

4.

Derivative financial instruments

Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices that are used to increase, decrease or adjust elements of the investment exposures of a Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.

The Funds may use derivatives to gain long investment exposure to securities or other assets. For example, a Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Funds also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.

The Funds may use derivatives in an attempt to reduce their investment exposures (which may result in a reduction below zero). A Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that GMO believes is highly correlated with the relevant currency.

The Funds may use derivatives in an attempt to adjust elements of their investment exposures to various securities, sectors, markets, indices, and currencies without actually having to sell existing investments or make new direct investments. For example, if a Fund holds a large proportion of stocks of companies in a particular sector and GMO believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposures, a Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currencies in which its equities are traded.

The Funds may use derivatives to effect transactions intended as substitutes for securities lending.

The Funds may have investment exposures in excess of their net assets (i.e., they may be leveraged). While GMO expects that Risk Premium Fund’s option positions typically will be fully collateralized at the time when the Fund is selling them, from time to time the Fund may have investment exposures in excess of its net assets (i.e., it may be leveraged). For example, if Risk Premium Fund receives a redemption request and is unable to close out an option it had sold, the Fund may temporarily have gross investment exposures in excess of its net assets (i.e., the Fund will be leveraged) and therefore is subject to heightened risk of loss. Risk Premium Fund’s performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.

A Fund’s foreign currency exposure may differ significantly from the currencies in which its equities are traded.

Certain derivatives transactions that may be used by the Funds, including certain interest rate swaps and certain credit default index swaps, are required to be transacted through a central clearing organization. The Funds hold cleared derivatives transactions, if any, through clearing members, who are members of derivatives clearing houses. Certain other derivatives, including futures and certain options, are transacted on exchanges. The Funds hold exchange-traded derivatives through clearing brokers that are typically members of the exchanges. In contrast to bilateral derivatives transactions, following a period of advance notice to the Fund, clearing brokers generally can require termination of existing cleared or exchange-traded derivatives transactions at any time and increases in margin above the margin that it required at the beginning of a transaction. Clearing houses and exchanges also have broad rights to increase margin requirements for existing transactions and to terminate transactions. Any such increase or termination could interfere with the ability of a Fund to pursue its investment strategy. Also, a Fund is subject to execution risk if it enters into a derivatives transaction that is required to be cleared (or that GMO expects to be cleared), and no clearing member is willing or able to clear the transaction on the Fund’s behalf. In that case, the transaction might have to be terminated, and the Fund could lose some or all of the benefit of any increase in the value of the transaction after the time of the transaction.

 

121


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. See “Investment and other risks” above for further information.

For Funds that held derivatives during the period ended August 31, 2018, the following table shows how the Fund used these derivatives (marked with an X):

 

                     
Type of Derivative and Objective for Use   Climate
Change
Fund
    Emerging
Domestic
Opportunities
Fund
    Emerging
Markets
Fund
   

Foreign

Small
Companies
Fund

    International
Equity
Fund
    International
Large/Mid
Cap Equity
Fund
    Resources
Fund
   

Risk

Premium

Fund

   

Tax-Managed

International

Equities
Fund

   

U.S.
Equity

Fund
(formerly
U.S.
Equity

Allocation

Fund)

 
Forward currency contracts                                                                                

Hedge foreign currency exposure in the underlying funds’ investments relative to the U.S. dollar

            X                                                                  
Futures contracts                                                                                

Adjust exposure to certain securities markets

            X       X       X       X       X                       X       X  

Maintain the diversity and liquidity of the portfolio

                            X       X       X                       X       X  
Options (Written)                                                                                

Substitute for direct equity investment

                                                            X                  
Swap contracts                                                                                

Substitute for direct equity investment

            X       X                                                          

Achieve returns comparable to holding and lending a direct equity position

            X       X                                                          
Rights and/or warrants                                                                                

Received as a result of corporate actions

    X       X       X               X       X       X               X          

Forward currency contracts

The Funds may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market price of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked-to-market daily using rates supplied by a quotation service and changes in value are recorded by each Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was settled.

These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose a Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. Forward currency contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

 

122


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Futures contracts

The Funds may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, a Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (and if the futures are traded outside the U.S. and the market for such futures is closed prior to the close of the NYSE due to time zone differences, the values will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees to reflect estimated valuation changes through the NYSE close). The value of each of the Fund’s futures contracts is marked-to-market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by each Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin as recorded in the Statements of Assets and Liabilities. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Funds to the risk that they may not be able to enter into a closing transaction due to an illiquid market. Futures contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Options

The Funds may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. “Quanto” options are cash-settled options in which the underlying asset (often an index) is denominated in a currency other than the currency in which the option is settled. By purchasing options a Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. A Fund pays a premium for a purchased option. That premium, if any, which is disclosed in the Schedule of Investments, is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. Purchased option contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

The Funds may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies they own or in which they may invest. Writing options alters a Fund’s exposure to the underlying asset by, in the case of a call option, obligating that Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating that Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When a Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, a Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that a Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of the option. OTC options expose a Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. Written option contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

When an option contract is closed, that Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed in the Statements of Operations.

Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions (and if the market of the underlying reference security closes or the official closing time of the underlying index occurs prior to the close of the NYSE due to time zone differences, the values will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees to reflect estimated valuation changes through the NYSE close). The Funds value OTC options using industry models and inputs provided by primary pricing sources.

 

123


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Swap contracts

The Funds may directly or indirectly use various swap contracts, including, without limitation, swaps on securities and securities indices, total return swaps, interest rate swaps, basis swaps, currency swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps, municipal swaps, dividend swaps, volatility swaps, correlation swaps and other types of available swaps. A swap contract is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap contract and during the term of the transaction, a Fund and/or the swap counterparty may post or receive cash or securities as collateral.

Initial upfront payments received or made upon entering into a swap contract are included in the fair market value of the swap. The Funds do not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap contract and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses in the Statements of Operations. A liquidation payment received or made at the termination of the swap contract is recorded as realized gain or loss in the Statements of Operations. The periodic frequency of payments received may differ from periodic payment frequencies made and their frequencies could be monthly, quarterly, semiannually, annually or at maturity.

Interest rate swap contracts involve an exchange by the parties of their respective commitments to pay or rights to receive interest (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal). Basis swaps are interest rate swaps that involve the exchange of two floating interest rate payments and may involve the exchange of two different currencies.

Total return swap contracts involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or futures contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.

In a credit default swap contract, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.

For credit default swap contracts on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap contracts on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.

Variance swap contracts involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.

Generally, the Funds price their OTC swap contracts daily using industry standard models that may incorporate quotations from market makers or pricing vendors and record the change in value, if any, as unrealized gain or loss in the Statements of Operations. Gains or losses are realized upon the termination of the swap contracts or reset dates, as appropriate. Cleared swap contracts are valued using the quote (which may be based on a model) published by the relevant clearing house. If an updated quote for a cleared

 

124


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

swap contract is not available by the time that a Fund calculates its net asset value on any business day, then that swap contract will generally be valued using an industry standard model, which may differ from the model used by the relevant clearing house.

The values assigned to swap contracts may differ significantly from the values realized upon termination, and the differences could be material. Entering into swap contracts involves counterparty credit, legal, and documentation risk that is generally not reflected in the value assigned to the swap contract. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that a Fund has amounts on deposit in excess of amounts owed by that Fund, or that any collateral the other party posts is insufficient or not timely received by a Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. Swap contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Rights and warrants

The Funds may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in the section entitled “Options” above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit a Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. Rights and/or warrants outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

As provided by U.S. GAAP, the table below is based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Funds (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.

The following is a summary of the valuations of derivative instruments categorized by risk exposure.

The Effect of Derivative Instruments on the Statements of Assets and Liabilities as of August 31, 2018 and the Statements of Operations for the period ended August 31, 2018^:

The risks referenced in the tables below are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Portfolio valuation” sections for a further discussion of risks.

 

             
     Credit
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Climate Change Fund

             

Net Realized Gain (Loss) on

             

Investments (rights and/or warrants)

  $         —     $ 8     $     $         —     $         —     $ 8  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 8     $     $     $     $ 8  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
               

Emerging Domestic Opportunities Fund

 

           

Asset Derivatives

             

Unrealized Appreciation on Forward Currency Contracts

  $     $     $ 1,641,047     $     $     $ 1,641,047  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 1,641,047     $     $     $ 1,641,047  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ 1,641,047     $     $     $ 1,641,047  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

 

125


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

             
     Credit
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Emerging Domestic Opportunities Fund (continued)

 

       

Liability Derivatives

             

Unrealized Depreciation on Forward Currency Contracts

  $     $     $ (2,116,950   $     $     $ (2,116,950

Unrealized Depreciation on Futures Contracts¤

          (512,178                       (512,178

Swap Contracts, at value¤

          (915,351                       (915,351
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (1,427,529   $ (2,116,950   $     $     $ (3,544,479
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $         —     $ (1,427,529   $ (2,116,950   $         —     $         —     $ (3,544,479
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Investments (rights and/or warrants)

  $     $ 2,156,918     $     $     $     $ 2,156,918  

Investments (fully funded total return swaps)

          8,328,170                         8,328,170  

Forward Currency Contracts

                1,448,654                   1,448,654  

Futures Contracts

          (16,688,997                       (16,688,997

Swap Contracts

          3,292,430                         3,292,430  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (2,911,479   $ 1,448,654     $     $     $ (1,462,825
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Investments (rights and/or warrants)

  $     $ (1,789,923   $     $     $     $ (1,789,923

Investments (fully funded total return swaps)¤

          (9,632,908                       (9,632,908

Forward Currency Contracts

                (2,831,675                 (2,831,675

Futures Contracts

          624,073                         624,073  

Swap Contracts

          (915,351                       (915,351
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (11,714,109   $ (2,831,675   $     $     $ (14,545,784
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
               

Emerging Markets Fund

             

Asset Derivatives

             

Swap Contracts, at value¤

  $     $ 770,262     $     $     $     $ 770,262  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 770,262     $     $     $     $ 770,262  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $ 770,262     $     $     $     $ 770,262  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
               

Liability Derivatives

             

Unrealized Depreciation on Futures Contracts¤

  $         —     $ (20,827,310   $     $         —     $         —     $ (20,827,310
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (20,827,310   $     $     $     $ (20,827,310
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $ (20,827,310   $     $     $     $ (20,827,310
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Futures Contracts

  $     $ 5,417,937     $     $     $     $ 5,417,937  

Swap Contracts

          (1,933,685                       (1,933,685
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 3,484,252     $     $     $     $ 3,484,252  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Investments (rights and/or warrants)

  $     $ (423,736   $     $     $     $ (423,736

Futures Contracts

          (38,650,166                       (38,650,166

Swap Contracts

          334,321                         334,321  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (38,739,581   $     $     $     $ (38,739,581
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

 

126


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

             
     Credit
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Foreign Small Companies Fund

             

Liability Derivatives

             

Unrealized Depreciation on Futures Contracts¤

  $     $ (4,801   $     $     $     $ (4,801
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (4,801   $     $     $     $ (4,801
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $       $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $ (4,801   $     $     $     $ (4,801
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Futures Contracts

  $     $ 56,936     $     $     $     $ 56,936  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 56,936     $     $     $     $ 56,936  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Futures Contracts

  $     $ 28,047     $     $     $     $ 28,047  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 28,047     $     $     $     $ 28,047  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
               

International Equity Fund

             

Liability Derivatives

             

Unrealized Depreciation on Futures Contracts¤

  $     $ (323,533   $     $     $     $ (323,533
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (323,533   $     $     $     $ (323,533
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $ (323,533   $     $     $     $ (323,533
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Investments (rights and/or warrants)

  $     $ 624,176     $     $     $     $ 624,176  

Futures Contracts

          1,598,326                         1,598,326  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 2,222,502     $     $     $     $ 2,222,502  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Futures Contracts

  $     $ (318,157   $     $     $     $ (318,157
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (318,157   $     $     $     $ (318,157
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
               

International Large/Mid Cap Equity Fund

 

         

Asset Derivatives

             

Unrealized Appreciation on Futures Contracts¤

  $     $ 218     $     $     $     $ 218  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 218     $     $     $     $ 218  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $ 218     $     $     $     $ 218  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Investments (rights and/or warrants)

  $     $ 3,964     $     $     $     $ 3,964  

Futures Contracts

          (44,252                       (44,252
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (40,288   $     $     $     $ (40,288
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Futures Contracts

  $     $ 24,622     $     $     $     $ 24,622  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 24,622     $     $     $     $ 24,622  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

 

127


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

             
     Credit
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Resources Fund

             

Asset Derivatives

             

Investments, at value (rights and/or warrants)

  $     $ 51,265     $     $     $     $ 51,265  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 51,265     $     $     $     $ 51,265  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $ 51,265     $     $     $     $ 51,265  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Investments (rights and/or warrants)

  $     $ 9,123     $     $     $     $ 9,123  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 9,123     $     $     $     $ 9,123  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Investments (rights and/or warrants)

  $     $ 51,265     $     $     $     $ 51,265  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 51,265     $     $     $     $ 51,265  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
               

Risk Premium Fund

             

Liability Derivatives

             

Written Options, at value

  $     $ (3,171,260   $     $     $     $ (3,171,260
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (3,171,260   $     $     $     $ (3,171,260
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $ (3,171,260   $     $     $     $ (3,171,260
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Written Options

  $     $ 20,185,755     $     $     $     $ 20,185,755  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 20,185,755     $     $     $     $ 20,185,755  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Written Options

  $     $ 484,900     $     $     $     $ 484,900  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 484,900     $     $     $     $ 484,900  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
               

Tax-Managed International Equities Fund

 

         

Asset Derivatives

             

Investments, at value (rights and/or warrants)

  $     $ 1,003     $     $     $     $ 1,003  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 1,003     $     $     $     $ 1,003  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $ 1,003     $     $     $     $ 1,003  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Derivatives

             

Unrealized Depreciation on Futures Contracts¤

  $     $ (20,885   $     $     $     $ (20,885
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (20,885   $     $     $     $ (20,885
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $ (20,885   $     $     $     $ (20,885
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

             

Investments (rights and/or warrants)

  $     $ 2,404     $     $     $     $ 2,404  

Futures Contracts

          (66,891                       (66,891
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (64,487   $     $     $     $ (64,487
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

 

128


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

             
     Credit
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Tax-Managed International Equities Fund (continued)

 

         

Change in Net Appreciation (Depreciation) on

             

Investments (rights and/or warrants)

  $     $ (1,376   $     $     $     $ (1,376

Futures Contracts

          25,864                         25,864  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 24,488     $     $     $     $ 24,488  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

             

Net Realized Gain (Loss) on

             

Futures Contracts

  $     $ 296,689     $     $     $     $ 296,689  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 296,689     $     $     $     $ 296,689  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

             

Futures Contracts

  $     $ (74,241   $     $     $     $ (74,241
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (74,241   $     $     $     $ (74,241
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                 

 

  ^

Because the Funds recognize changes in value through the Statements of Operations, they do not qualify for hedge accounting under authoritative guidance for derivative instruments. The Funds’ investments in derivatives may represent an economic hedge; however, they are considered to be non-hedge transactions for the purpose of these tables.

  ¤

The table includes cumulative unrealized appreciation/depreciation of futures and value of cleared swap contracts, if any, as reported in the Schedule of Investments. Period end variation margin on open futures and cleared swap contracts, if any, is reported within the Statements of Assets and Liabilities.

Certain Funds are party to International Swaps and Derivatives Association, Inc. Master Agreements, Global Master Repurchase Agreements or other similar types of agreements (collectively, “Master Agreements”) that generally govern the terms of OTC derivative transactions, repurchase agreements and reverse repurchase agreements. The Master Agreements may include collateral posting terms and set-off provisions that apply in the event of a default and/or termination event. Upon the occurrence of such an event, including the bankruptcy or insolvency of the counterparty, the Master Agreements may permit the non-defaulting party to calculate a single net payment to close out applicable transactions. However, there is no guarantee that the terms of a Master Agreement will be enforceable; for example, when bankruptcy or insolvency laws impose restrictions on or prohibitions against the right of offset. Additionally, the set-off and netting provisions of a Master Agreement may not extend to the obligations of the counterparty’s affiliates or across varying types of transactions. Because no such event has occurred, the Funds do not presently have a legally enforceable right of set-off and these amounts have not been offset in the Statements of Assets and Liabilities, but have been presented separately in the table below. Termination events may also include a decline in the net assets of a Fund below a certain level over a specified period of time and may entitle a counterparty to elect an early termination of all the transactions under the Master Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse impact on a Fund’s operations. An estimate of the aggregate net payment, if any, that may need to be paid by a Fund (or may be received by a Fund) in such an event is represented by the Net Amounts in the tables below. For more information about other uncertainties and risks, see “Investments and other risks” above.

For financial reporting purposes, in the Statements of Assets and Liabilities any cash collateral that has been pledged to cover obligations of the Funds is reported as Due from Broker and any cash collateral received from the counterparty is reported as Due to Broker. Any non-cash collateral pledged by the Funds is noted in the Schedules of Investments. The tables below show the potential effect of netting arrangements made available by the Master Agreements on the financial position of the Funds. For financial reporting purposes, the Funds’ Statements of Assets and Liabilities generally show derivative assets and derivative liabilities (regardless of whether they are subject to netting arrangements) on a gross basis, which reflects the full risks and exposures of the Fund prior to netting. See Note 2 for information on repurchase agreements and reverse repurchase agreements held by the Funds at August 31, 2018, if any.

 

129


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The tables above present the Funds’ derivative assets and liabilities by type of financial instrument. The following tables present the Funds’ OTC and/or exchange-traded derivative assets and liabilities by counterparty net of amounts that may be available for offset under the Master Agreements by the terms of the agreement and net of the related collateral received or pledged by the Funds as of August 31, 2018:

Emerging Domestic Opportunities Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Morgan Stanley & Co. International PLC

  $ 1,641,047     $         —     $ 1,641,047     $         —  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,641,047     $     $ 1,641,047     $  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Goldman Sachs International

  $ 915,351     $ (729,596   $     $ 185,755  

Morgan Stanley & Co. International PLC

    2,116,950       (475,903     (1,641,047    
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 3,032,301     $ (1,205,499   $ (1,641,047   $ 185,755  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Emerging Markets Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Morgan Stanley & Co. International PLC

  $ 770,262     $ (410,000   $         —     $ 360,262  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 770,262     $ (410,000   $     $ 360,262  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Risk Premium Fund

 

         
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Morgan Stanley & Co. LLC

  $ 3,171,260     $ (3,171,260   $         —     $         —
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 3,171,260     $ (3,171,260   $     $  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

  *

The actual collateral received and/or pledged is more than the amount shown.

 

130


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The average derivative activity of notional amounts (forward currency contracts, futures contracts and swap contracts), market values (rights and/ or warrants) and number of contracts (options) outstanding, based on absolute values, at each month-end, was as follows for the period ended August 31, 2018:

 

           
Fund Name   Forward
Currency
Contracts ($)
    Futures
Contracts ($)
    Swap
Contracts ($)
    Options
(Contracts)
    Rights and/or
Warrants ($)
 

Climate Change Fund

                            4,343

Emerging Domestic Opportunities Fund

    149,915,848       107,608,105       41,579,308 **            1,296,437  

Emerging Markets Fund

          295,978,200       23,860,744 **            99,537  

Foreign Small Companies Fund

          498,380                    

International Equity Fund

          34,052,673                   93,117  

International Large/Mid Cap Equity Fund

          697,622                   608  

Resources Fund

                            25,002  

Risk Premium Fund

                      1,928        

Tax-Managed International Equities Fund

          875,927                   1,288  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

          2,717,663                    

 

  *

During the period ended August 31, 2018, the Fund did not hold this investment type at any month-end; therefore, the average amount outstanding was calculated using daily outstanding absolute values.

  **

Includes fully funded total return swap average derivative activity for the period ended August 31, 2018.

 

5.

Fees and other transactions with affiliates

GMO receives a management fee for the services it provides to each Fund. Management fees are paid monthly at the annual rate equal to the percentage of each Fund’s average daily net assets set forth in the table below:

 

                       
     Climate
Change
Fund
    Emerging
Domestic
Opportunities
Fund
    Emerging
Markets
Fund
    Foreign
Small
Companies
Fund
    International
Equity Fund
    International
Large/Mid
Cap Equity
Fund
    Quality
Fund
    Resources
Fund
    Risk
Premium
Fund
    Tax-Managed
International
Equities Fund
    U.S. Equity
Fund
(formerly
U.S. Equity
Allocation
Fund)
 

Management Fee

    0.60%(a)       0.75%       0.75%(b)       0.60%(c)       0.50%       0.38%       0.33%       0.50%       0.45%       0.50%       0.31%  

 

  (a) 

GMO has voluntarily agreed to reduce its annual management fee by 0.15% through December 31, 2018.

  (b) 

GMO has contractually agreed to reduce, through at least June 30, 2019, its annual management fee to an annual rate of 0.65% of the fund’s average daily net asset value.

  (c) 

Prior to June 30, 2017, the management fee was 0.70%. For the period from May 1, 2017 through July 31, 2017, GMO waived its management fee.

 

131


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

In addition, each class of shares of certain Funds pays GMO directly or indirectly a shareholder service fee for providing client services and reporting, such as performance information, client account information, personal and electronic access to Fund information, access to analysis and explanations of Fund reports, and assistance in maintaining and correcting client-related information. Shareholder service fees are paid monthly at the annual rate equal to the percentage of each applicable Class’s average daily net assets set forth in the table below:

 

           
Fund Name   Class II     Class III     Class IV     Class V     Class VI  

Climate Change Fund

            0.15%       0.10%     0.085%     0.055%

Emerging Domestic Opportunities Fund

    0.22%       0.15%       0.105%       0.085%       0.055%

Emerging Markets Fund

    0.22%       0.15%       0.105%       0.085%       0.055%  

Foreign Small Companies Fund

            0.15%       0.10%                

International Equity Fund

    0.22%       0.15%       0.09%                  

International Large/Mid Cap Equity Fund

            0.15%       0.09%             0.055%

Quality Fund

            0.15%       0.105%       0.085%       0.055%  

Resources Fund

            0.15%       0.10%       0.085%     0.055%

Risk Premium Fund

            0.15%       0.10%     0.085%     0.055%  

Tax-Managed International Equities Fund

            0.15%                          

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

            0.15%       0.10%       0.085%       0.055%  

 

  *

Class is offered but has no shareholders as of August 31, 2018.

For each Fund, other than Climate Change Fund and Resources Fund, GMO has contractually agreed to reimburse the Fund for its “Specified Operating Expenses” (as defined below). For Climate Change Fund and Resources Fund, GMO has contractually agreed to reimburse the Fund for the portion of its “Specified Operating Expenses” (as defined below) that exceeds 0.10% of the Fund’s average daily net assets (“Expense Threshold Amount”). Any such reimbursements are paid to a Fund concurrently with the Fund’s payment of management fees to GMO.

Subject to the exclusions noted below, “Specified Operating Expenses” means: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses, expenses of non-investment related legal services provided to the Funds by or at the direction of GMO, organizational and start-up expenses, federal securities law filing expenses, printing expenses, state and federal registration fees and custody expenses. In the case of Emerging Markets Fund, “Specified Operating Expenses” does not include custody expenses, and in the case of Emerging Domestic Opportunities Fund, “Specified Operating Expenses” only includes custody expenses to the extent that they exceed 0.10% of the Fund’s average daily net assets.

For Climate Change Fund and Resources Fund, GMO is permitted to recover from the Fund, on a class-by-class basis, as applicable, the “Specified Operating Expenses” GMO has borne or reimbursed (whether through reduction of its fees or otherwise) to the extent that the Funds’ “Specified Operating Expenses” later fall below the Expense Threshold Amount or the lower expense limit in effect when GMO seeks to recover the expenses. A Fund, however, is not obligated to pay any such amount more than three years after GMO bore or reimbursed an expense. The amount GMO is entitled to recover may not cause a Fund to exceed the Expense Threshold Amount or the lower expense limit in effect when GMO seeks recovery.

For the six month period ended August 31, 2018, GMO recouped the following previously recorded waivers and/or reimbursements.

 

   
     Recoupment Amount ($)  

Resources Fund

    53,546  

 

132


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

On August 31, 2018, the waivers and/or reimbursements subject to possible future recoupment are as follows:

 

       
     Expiring
year ending
February 28, 2019
    Expiring
year ending
February 29, 2020
    Expiring
year ending
February 28, 2021
 

Climate Change Fund, Class III

                $60,800  

Resources Fund, Class III

                 

Resources Fund, Class IV

                $14,937  

For each Fund that pays GMO a management fee, GMO has contractually agreed to waive or reduce that fee, but not below zero, to the extent necessary to offset the management fees paid to GMO that are directly or indirectly borne by the Fund as a result of the Fund’s direct or indirect investments in other GMO Funds.

For each Fund that charges a shareholder service fee, GMO has contractually agreed to waive or reduce the shareholder service fee charged to holders of each class of shares of the Fund, but not below zero, to the extent necessary to offset the shareholder service fees directly or indirectly borne by the class of shares of the Fund as a result of the Fund’s direct or indirect investments in other GMO Funds.

In addition, for Emerging Markets Fund only, GMO has contractually agreed to waive the shareholder service fees charged to holders of each class of shares of the Fund to the extent necessary to prevent the shareholder service fees borne by each class of shares of the Fund from exceeding the percentage of the class’s average daily net assets as follows: 0.20% for Class II shares, 0.15% for Class III shares, 0.10% of Class IV shares, 0.05% for Class V shares, and 0.02% for Class VI shares.

These contractual waivers and reimbursements will continue through at least June 30, 2019 for each Fund unless the Funds’ Board of Trustees authorizes their modification or termination or reduces the fee rates paid to GMO under the Fund’s management contract or servicing and supplemental support agreement.

The Funds’ portion of the gross fees paid by the Trust to the Trust’s independent Trustees and their legal counsel and any agents unaffiliated with GMO during the period ended August 31, 2018 is shown in the table below and is included in the Statements of Operations.

 

     
Fund Name   Independent Trustees and
their legal counsel ($)
    Agent unaffiliated
with GMO ($)
 

Climate Change Fund

    383       18  

Emerging Domestic Opportunities Fund

    26,615       2,515  

Emerging Markets Fund

    55,844       5,107  

Foreign Small Companies Fund

    1,608       144  

International Equity Fund

    56,331       5,290  

International Large/Mid Cap Equity Fund

    789       20  

Quality Fund

    89,927       8,406  

Resources Fund

    4,057       374  

Risk Premium Fund

    1,966       171  

Tax-Managed International Equities Fund

    763       20  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

    15,079       1,449  

 

133


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Certain Funds incur fees and expenses indirectly as a shareholder in the underlying funds. For the period ended August 31, 2018 these indirect fees and expenses expressed as an annualized percentage of each Fund’s average daily net assets were as follows:

 

         
Fund Name   Indirect Net Expenses
(excluding shareholder
service fees)
    Indirect Shareholder
Service Fees
    Indirect Interest
Expense
    Total Indirect
Expenses
 

Climate Change Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

Emerging Domestic Opportunities Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

Emerging Markets Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

Foreign Small Companies Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

International Equity Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

International Large/Mid Cap Equity Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

Quality Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

Resources Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

Risk Premium Fund

    0.000%       0.000%       0.000%       0.000%  

Tax-Managed International Equities Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

    < 0.001%       0.000%       0.000%       < 0.001%  

The Funds are permitted to purchase or sell securities from or to certain other GMO funds under specified conditions outlined in procedures adopted by the Trustees. The procedures have been designed to ensure that any purchase or sale of securities by a Fund from another fund or portfolio that is or could be considered an affiliate by virtue of having a common investment adviser (or affiliated investment advisers), common Trustees and/or common officers complies with Rule 17a-7 of the 1940 Act. Further, as defined under the procedures, each transaction is effectuated at the current market price. During the period ended August 31, 2018, the Funds did not engage in these transactions.

 

6.

Purchases and sales of securities

Cost of purchases and proceeds from sales of securities, excluding short-term investments and including GMO U.S. Treasury Fund, if applicable, for the period ended August 31, 2018 are noted in the table below:

 

         
     Purchases ($)     Purchases ($)     Sales ($)     Sales ($)  
         
Fund Name   U.S. Government
Securities
    Investments (Non-U.S.
Government Securities)
    U.S. Government
Securities
    Investments (Non-U.S.
Government Securities)
 

Climate Change Fund

          130,377,758             64,748,169  

Emerging Domestic Opportunities Fund

          2,677,084,861             3,010,554,891  

Emerging Markets Fund

          2,994,003,396             3,731,093,071  

Foreign Small Companies Fund

          15,524,132             133,296,539  

International Equity Fund

          1,191,775,814             1,888,173,840  

International Large/Mid Cap Equity Fund

          36,052,410             93,794,820  

Quality Fund

          835,428,637             2,415,053,685  

Resources Fund

          298,323,610             184,321,193  

Risk Premium Fund

    195,974,014             31,850,281        

Tax-Managed International Equities Fund

          15,700,293             26,815,783  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

          653,067,305             810,539,536  

 

134


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Included in the table above are cost of purchases and proceeds from sales of securities for in-kind transactions, excluding short-term investments, in accordance with U.S. GAAP for the period ended August 31, 2018. In-kind transactions are noted in the table below:

 

     
Fund Name   Purchases ($)     Sales ($)  

Emerging Domestic Opportunities Fund

          69,588,804  

International Equity Fund

          580,193,344  

Quality Fund

          186,934,301  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

          232,339,705  

For the period ended August 31, 2018, the Funds had the following net realized gains/(losses) attributed to redemption in-kind transactions:

 

   
Fund Name   Net realized gains/(losses)
attributed to redemption
in-kind transactions ($)
 

Emerging Domestic Opportunities Fund

    4,338,176  

International Equity Fund

    128,714,535  

Quality Fund

    73,748,233  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

    35,493,518  

 

7.

Guarantees

In the normal course of business the Funds enter into contracts with third-party service providers that contain a variety of representations and warranties and that provide general indemnifications. The Funds’ maximum exposure under these arrangements is unknown, as it involves possible future claims that may or may not be made against the Funds. Based on experience, GMO is of the view that the risk of loss to the Funds in connection with the Funds’ indemnification obligations is remote; however, there can be no assurance that such obligations will not result in material liabilities that adversely affect the Funds.

 

135


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

8.

Principal shareholders and related parties as of August 31, 2018

 

         
Fund Name   Number of
shareholders that held
more than 10% of the
outstanding shares of
the Fund
    Percentage of
outstanding shares of
the Fund held by those
shareholders owning
greater than 10% of the
outstanding shares of
the Fund
    Percentage of the
shares of the Fund held
by senior management
of GMO and GMO
Trust officers
    Percentage of the
Fund’s shares held by
accounts for which
GMO has
investment discretion
 

Climate Change Fund

    2       46.89%       20.09%        

Emerging Domestic Opportunities Fund

                2.01%        

Emerging Markets Fund

    3 ¥      36.20%       0.37%       68.91%  

Foreign Small Companies Fund

    1       77.55%       0.23%        

International Equity Fund

    4 §      62.05%       0.01%       90.49%  

International Large/Mid Cap Equity Fund

    1       88.66%              

Quality Fund

                0.27%       15.17%  

Resources Fund

    1 ‡      14.17%       4.82%       14.17%  

Risk Premium Fund

    3 ¥      95.37%       0.09%       99.81%  

Tax-Managed International Equities Fund

    4       68.14%       0.15%        

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

    3     64.67%       0.04%       97.51%  

 

  #

Two of the shareholders are other funds of the Trust.

  ¥

Three of the shareholders are other funds of the Trust.

  §

Four of the shareholders are other funds of the Trust.

 

One of the shareholders is another fund managed by GMO.

 

9.

Share transactions

The Declaration of Trust permits each Fund to issue an unlimited number of shares of beneficial interest (without par value). Transactions in the Funds’ shares were as follows:

 

     
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Climate Change Fund

         

Class III:*

         

Shares sold

    2,745,405     $ 65,139,655       1,093,126     $ 23,929,134  

Shares issued to shareholders in reinvestment of distributions

    31,904       742,715       28,235       655,616  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    2,777,309     $ 65,882,370       1,121,361     $ 24,584,750  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Emerging Domestic Opportunities Fund

         

Class II:

         

Shares sold

    1,403,923     $ 39,825,156       1,817,724     $ 49,043,727  

Shares issued to shareholders in reinvestment of distributions

    2,329,884       53,354,353       272,286       7,617,993  

Shares repurchased

    (5,695,986     (155,268,420     (4,486,864     (116,784,190

Purchase premiums

          28,182             74,964  

Redemption fees

          875,306             542,684  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (1,962,179   $ (61,185,423     (2,396,854   $ (59,504,822
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

136


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Emerging Domestic Opportunities Fund (continued)

         

Class III:

         

Shares sold

    2,424,051     $ 65,256,647           $  

Shares issued to shareholders in reinvestment of distributions

    417,466       9,559,964       60,784       1,697,769  

Shares repurchased

    (718,854     (20,120,725     (1,551,984     (41,407,143

Purchase premiums

          6,784             14,320  

Redemption fees

          231,185             104,186  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    2,122,663     $ 54,933,855       (1,491,200   $ (39,590,868
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

         

Shares sold

        $           $  

Shares issued to shareholders in reinvestment of distributions

    1,244,211       28,517,315       151,953       4,239,893  

Shares repurchased

    (2,190,732     (50,080,128     (4,539,880     (123,386,543

Purchase premiums

          13,628             37,899  

Redemption fees

          444,412             274,132  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (946,521   $ (21,104,773     (4,387,927   $ (118,834,619
   

 

 

   

 

 

   

 

 

   

 

 

 

Class V:

         

Shares sold

    1,820,723     $ 41,577,280       2,321,991     $ 57,701,679  

Shares issued to shareholders in reinvestment of distributions

    4,536,048       103,875,493       598,836       16,696,891  

Shares repurchased

    (15,409,292 )(a)      (370,471,027 )(a)      (422,783     (12,691,594

Purchase premiums

          51,127             132,470  

Redemption fees

          1,473,146             962,652  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (9,052,521   $ (223,493,981     2,498,044     $ 62,802,098  
   

 

 

   

 

 

   

 

 

   

 

 

 

Class VI:

         

Shares sold

        546,851     $ 12,564,071  

Shares issued to shareholders in reinvestment of distributions

               

Shares repurchased

        (1,215,116     (28,809,003

Purchase premiums

              48  

Redemption fees

              2,069  
       

 

 

   

 

 

 

Net increase (decrease)

        (668,265   $ (16,242,815
       

 

 

   

 

 

 
                                 

Emerging Markets Fund

         

Class II:

         

Shares sold

    382,834     $ 12,777,308       2,144,525     $ 76,615,465  

Shares issued to shareholders in reinvestment of distributions

    14,201       468,615       298,236       10,137,847  

Shares repurchased

    (2,348,742     (82,395,380     (5,901,364     (198,656,462

Purchase premiums

          31,745             412,144  

Redemption fees

          648,205             1,199,050  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (1,951,707   $ (68,469,507     (3,458,603   $ (110,291,956
   

 

 

   

 

 

   

 

 

   

 

 

 

Class III:

         

Shares sold

    15,971     $ 548,072       5,262,213     $ 189,034,182  

Shares issued to shareholders in reinvestment of distributions

    9,820       324,942       160,773       5,490,307  

Shares repurchased

    (1,550,530     (54,338,512     (4,761,245     (152,016,265

Purchase premiums

          26,110             163,459  

Redemption fees

          525,931             573,854  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (1,524,739   $ (52,913,457     661,741     $ 43,245,537  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

137


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Emerging Markets Fund (continued)

         

Class IV:

         

Shares sold

        $       12,287,373     $ 414,505,112  

Shares issued to shareholders in reinvestment of distributions

                200,918       6,727,048  

Shares repurchased

    (10,644,250     (365,097,799     (18,629,708     (647,014,911

Purchase premiums

          23,230             616,336  

Redemption fees

          244,606             1,577,373  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (10,644,250   $ (364,829,963     (6,141,417   $ (223,589,042
   

 

 

   

 

 

   

 

 

   

 

 

 

Class V:

         

Shares sold

    516,683     $ 17,513,705       913,530     $ 29,688,750  

Shares issued to shareholders in reinvestment of distributions

    10,311       336,961       124,905       4,213,667  

Shares repurchased

    (512,064     (16,391,163     (10,910     (389,825

Purchase premiums

          13,742             124,417  

Redemption fees

          283,815             354,662  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    14,930     $ 1,757,060       1,027,525     $ 33,991,671  
   

 

 

   

 

 

   

 

 

   

 

 

 

Class VI:

         

Shares sold

    12,862,348     $ 437,841,910       14,003,693     $ 460,981,387  

Shares issued to shareholders in reinvestment of distributions

    182,383       5,974,874       2,950,428       99,601,307  

Shares repurchased

    (23,167,070     (783,782,106     (36,424,149     (1,211,074,646

Purchase premiums

          258,349             2,981,424  

Redemption fees

          5,313,713             8,857,454  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (10,122,339   $ (334,393,260     (19,470,028   $ (638,653,074
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Foreign Small Companies Fund

         

Class III:

         

Shares sold

    278,363     $ 3,698,515       1,205,904     $ 18,448,098  

Shares issued to shareholders in reinvestment of distributions

    565,882       7,279,296       1,155,505       17,572,868  

Shares repurchased

    (2,992,472     (37,169,241     (15,628,838 )(b)      (245,691,422 )(b) 

Purchase premiums

          2,500             1,984  

Redemption fees

          500,497             396,995  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (2,148,227   $ (25,688,433     (13,267,429   $ (209,271,477
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

         

Shares sold

        $       4,509,349     $ 70,616,166  

Shares issued to shareholders in reinvestment of distributions

    357,739       4,785,668       2,798,225       42,386,751  

Shares repurchased

    (6,662,855     (88,401,324     (40,727,929 )(c)      (627,887,398 )(c) 

Purchase premiums

                      5,741  

Redemption fees

          111,351             824,581  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (6,305,116   $ (83,504,305     (33,420,355   $ (514,054,159
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

International Equity Fund

         

Class II:

         

Shares sold

    2,557     $ 57,696       489,231     $ 11,146,918  

Shares issued to shareholders in reinvestment of distributions

    3,474       77,458       15,844       367,095  

Shares repurchased

    (64,179     (1,509,895     (11,060     (259,126
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (58,148   $ (1,374,741     494,015     $ 11,254,887  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

138


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

International Equity Fund (continued)

         

Class III:

         

Shares sold

    1,183,775     $ 27,155,977       5,618,387     $ 134,845,293  

Shares issued to shareholders in reinvestment of distributions

    131,741       2,974,721       676,948       15,748,936  

Shares repurchased

    (682,668     (15,510,636     (21,799,987     (490,728,694
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    632,848     $ 14,620,062       (15,504,652   $ (340,134,465
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

         

Shares sold

    3,778,448     $ 86,694,851       8,188,636     $ 186,191,569  

Shares issued to shareholders in reinvestment of distributions

    1,053,700       23,750,403       6,749,246       156,837,529  

Shares repurchased

    (38,471,833 )(d)      (896,630,535 )(d)      (72,887,892     (1,667,210,560
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (33,639,685   $ (786,185,281     (57,950,010   $ (1,324,181,462
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

International Large/Mid Cap Equity Fund

         

Class III:

         

Shares sold

    33,809     $ 857,442       2,952,020     $ 78,517,708  

Shares issued to shareholders in reinvestment of distributions

    323,566       7,341,579       19,019       497,829  

Shares repurchased

    (2,549,691     (59,503,747     (1,428,325     (37,475,512
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (2,192,316   $ (51,304,726     1,542,714     $ 41,540,025  
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

         

Shares sold

        $       25,357     $ 667,693  

Shares issued to shareholders in reinvestment of distributions

    286       7,293       524,624       13,754,556  

Shares repurchased

    (29,812     (766,505     (6,273,065     (167,412,155
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (29,526   $ (759,212     (5,723,084   $ (152,989,906
   

 

 

   

 

 

   

 

 

   

 

 

 

Class VI:

         

Shares issued to shareholders in reinvestment of distributions

            $  

Shares repurchased

        (23,527     (616,556
       

 

 

   

 

 

 

Net increase (decrease)

        (23,527   $ (616,556
       

 

 

   

 

 

 
                                 

Quality Fund

         

Class III:

         

Shares sold

    4,999,255     $ 127,675,060       9,569,371     $ 233,792,192  

Shares issued to shareholders in reinvestment of distributions

    4,915,586       122,594,705       9,710,900       236,338,887  

Shares repurchased

    (29,386,790     (741,984,334     (41,778,688     (994,664,619
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (19,471,949   $ (491,714,569     (22,498,417   $ (524,533,540
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

         

Shares sold

    10,469,920     $ 266,668,875       2,687,351     $ 65,544,766  

Shares issued to shareholders in reinvestment of distributions

    1,400,223       34,977,580       3,024,905       73,674,810  

Shares repurchased

    (5,487,538     (137,623,943     (23,049,188     (543,039,198
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    6,382,605     $ 164,022,512       (17,336,932   $ (403,819,622
   

 

 

   

 

 

   

 

 

   

 

 

 

Class V:

         

Shares sold

    239,817     $ 5,820,348       15,240,672     $ 355,202,520  

Shares issued to shareholders in reinvestment of distributions

    277,665       6,936,060       753,632       18,275,903  

Shares repurchased

    (377,095     (10,008,070     (30,753,264     (742,878,377
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    140,387     $ 2,748,338       (14,758,960   $ (369,399,954
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

139


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Quality Fund (continued)

         

Class VI:

 

Shares sold

    2,258,052     $ 56,219,211       29,403,277     $ 709,386,725  

Shares issued to shareholders in reinvestment of distributions

    4,267,320       106,426,965       11,410,443       277,711,590  

Shares repurchased

    (49,268,309 )(e)      (1,258,926,842 )(e)      (51,435,726     (1,236,751,765
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (42,742,937   $ (1,096,280,666     (10,622,006   $ (249,653,450
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Resources Fund

         

Class III:

         

Shares sold

    3,362,415     $ 69,698,482       1,468,960     $ 30,964,916  

Shares issued to shareholders in reinvestment of distributions

    56,304       1,180,123       48,976       868,248  

Shares repurchased

    (68,504     (1,425,015     (234,190     (4,012,036

Purchase premiums

          64,593             43,889  

Redemption fees

          622             16,475  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    3,350,215     $ 69,518,805       1,283,746     $ 27,881,492  
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

         

Shares sold

    1,869,732     $ 39,919,557       5,366,277     $ 102,162,843  

Shares issued to shareholders in reinvestment of distributions

    189,479       3,958,221       549,915       9,781,398  

Shares repurchased

    (46,839     (1,000,000     (2,712,619     (52,821,227

Purchase premiums

          262,056             351,383  

Redemption fees

          3,465             156,297  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    2,012,372     $ 43,143,299       3,203,573     $ 59,630,694  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Risk Premium Fund

         

Class III:

         

Shares sold

    594,623     $ 16,138,183           $  

Shares issued to shareholders in reinvestment of distributions

    439       12,004       25,484       724,208  

Shares repurchased

    (719     (19,481     (65,778     (1,906,884

Purchase premiums

          1             122  

Redemption fees

          364             1,284  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    594,343     $ 16,131,071       (40,294   $ (1,181,270
   

 

 

   

 

 

   

 

 

   

 

 

 

Class VI:

         

Shares sold

    16,009,368     $ 436,903,057       122,003     $ 3,443,846  

Shares issued to shareholders in reinvestment of distributions

    17,752       488,192       845,070       24,004,565  

Shares repurchased

    (3,868,755     (106,418,583     (844,262     (25,708,492

Purchase premiums

          27             5,052  

Redemption fees

          14,461             40,139  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    12,158,365     $ 330,987,154       122,811     $ 1,785,110  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Tax-Managed International Equities Fund

         

Class III:

         

Shares sold

        $       34,844     $ 588,984  

Shares issued to shareholders in reinvestment of distributions

    87,480       1,364,580       118,562       1,953,043  

Shares repurchased

    (682,577     (11,596,425     (4,210,695     (70,417,290
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (595,097   $ (10,231,845     (4,057,289   $ (67,875,263
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

140


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

         

Class III:

         

Shares sold

    84,910     $ 1,237,983       1,426,974     $ 22,200,337  

Shares issued to shareholders in reinvestment of distributions

    422,457       6,125,631       503,101       7,560,282  

Shares repurchased

    (88,781     (1,357,533     (4,161,819     (62,443,147
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    418,586     $ 6,006,081       (2,231,744   $ (32,682,528
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

 

Shares sold

    12,309     $ 188,592       4,181,151     $ 64,392,213  

Shares issued to shareholders in reinvestment of distributions

    201,925       2,929,931       221,349       3,311,107  

Shares repurchased

                (3,169,071     (49,096,124
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    214,234     $ 3,118,523       1,233,429     $ 18,607,196  
   

 

 

   

 

 

   

 

 

   

 

 

 

Class V:

         

Shares sold

    292,730     $ 4,423,147           $  

Shares issued to shareholders in reinvestment of distributions

    365,248       5,270,521       953,644       14,275,839  

Shares repurchased

    (426,470     (6,333,073     (7,929,615     (121,076,853
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    231,508     $ 3,360,595       (6,975,971   $ (106,801,014
   

 

 

   

 

 

   

 

 

   

 

 

 

Class VI:

         

Shares sold

    491,745     $ 7,216,011       3,148,627     $ 46,726,515  

Shares issued to shareholders in reinvestment of distributions

    4,899,200       70,499,485       9,856,724       147,659,798  

Shares repurchased

    (26,844,454 )(f)      (413,292,811 )(f)      (32,244,150     (489,038,891
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (21,453,509   $ (335,577,315     (19,238,799   $ (294,652,578
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

  *

The period under the heading “Year Ended February 28, 2018” represents the period from April 5, 2017 (commencement of operations) through February 28, 2018.

   

Class VI liquidated on March 29, 2017.

 

Class IV liquidated on May 2, 2018.

  (a) 

2,739,717 shares and $69,588,804 were redeemed in-kind by affiliates.

  (b)

2,421,878 shares and $37,805,522 were redeemed in-kind by affiliates.

  (c) 

32,418,183 shares and $503,881,179 were redeemed in-kind by affiliates.

  (d) 

24,923,605 shares and $580,193,344 were redeemed in-kind by affiliates.

  (e) 

7,279,373 shares and $186,934,301 were redeemed in-kind by affiliates.

  (f) 

14,819,129 shares and $232,339,705 were redeemed in-kind by affiliates.

 

10.

Investments in affiliated companies and other Funds of the Trust

An affiliated company for the purposes of this disclosure is a company in which a Fund has or had direct ownership of at least 5% of the issuer’s voting securities or an investment in other funds of GMO Trust. A summary of the Funds’ transactions involving companies that are or were affiliates during the period ended August 31, 2018 is set forth below:

 

               
Affiliate   Value,
beginning of
period
    Purchases     Sales
Proceeds
    Dividend
Income*
    Net Realized
Gain
(Loss)
    Net
Increase/
Decrease in
Unrealized
Appreciation/
Depreciation
    Value, end of
period
 

Climate Change Fund

               

GMO U.S. Treasury Fund

  $ 751,549     $ 54,807,746     $ 53,896,000     $ 22,745     $ 1,564     $ 300     $ 1,665,159  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

 

141


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

               
Affiliate   Value,
beginning of
period
    Purchases     Sales
Proceeds
    Dividend
Income*
    Net Realized
Gain
(Loss)
    Net
Increase/
Decrease in
Unrealized
Appreciation/
Depreciation
    Value, end of
period
 

Emerging Domestic Opportunities Fund

               

CMI Ltd

  $ 4,657,808     $     $ 15,696     $     $ (5,059   $ (1,606,411   $ 3,030,642  

Gayatri Highways Ltd

    1,147,898                               (831,592    

Gayatri Projects Ltd

    34,529,636       3,618,675       1,861,829             1,562,974       (5,376,079     32,473,377  

GMO U.S. Treasury Fund

    130,824,583       426,065,696       501,090,000       1,065,696       9,519       45,929       55,855,727  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 171,159,925     $ 429,684,371     $ 502,967,525     $ 1,065,696     $ 1,567,434     $ (7,768,153   $ 91,359,746  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Emerging Markets Fund

               

Anilana Hotels & Properties Ltd

  $ 788,630     $     $     $     $     $ 46,063     $ 834,693  

Gayatri Highways Ltd

    1,802,252                               (1,305,638     496,614  

Gayatri Projects Ltd

    54,213,078                               (4,932,529     49,280,549  

GMO U.S. Treasury Fund

    97,620,412       790,625,862       803,760,000       637,499       17,367       5,018       84,508,659  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 154,424,372     $ 790,625,862     $ 803,760,000     $ 637,499     $ 17,367     $ (6,187,086   $ 135,120,515  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Foreign Small Companies Fund

               

GMO U.S. Treasury Fund

  $ 1,595,796     $ 7,748,600     $ 8,705,000     $ 8,601     $ (68   $     $ 639,328  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

International Equity Fund

               

GMO U.S. Treasury Fund

  $ 61,069,100     $ 240,760,000     $ 279,500,000     $ 496,061     $ (806   $ 15,646     $ 22,343,940  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

International Large/Mid Cap Equity Fund

               

GMO U.S. Treasury Fund

  $ 1,181,128     $ 27,000,001     $ 27,700,000     $ 9,235     $ (4,142   $ 726     $ 477,713  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Quality Fund

               

GMO U.S. Treasury Fund

  $ 51,092,040     $ 76,000,000     $ 76,000,000     $ 507,894     $ (22,597   $ 24,902     $ 51,094,345  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Resources Fund

               

GMO U.S. Treasury Fund

  $ 6,504,509     $ 101,680,000     $ 97,550,000     $ 88,516     $ 2,131     $ 3,930     $ 10,640,570  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Tax-Managed International Equities Fund

               

GMO U.S. Treasury Fund

  $ 1,066,810     $ 8,830,000     $ 8,895,000     $ 9,503     $ (331   $ 504     $ 1,001,983  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

               

GMO U.S. Treasury Fund

  $ 7,460,010     $ 91,300,000     $ 89,690,000     $ 86,242     $ (889   $ 2,988     $ 9,072,109  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

 

  #

No longer an affiliated at period end.

  *

The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2018 through August 31, 2018. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 28, 2019.

 

142


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

11.

Subsequent Events

Effective October 1, 2018, Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”) has agreed to irrevocably reduce GMO Risk Premium Fund’s (the “Fund”) management fee to an annual rate of 0.25% of the Fund’s average daily net assets (a reduction of 0.20%).

GMO has contractually agreed to waive its fees and/or reimburse GMO Climate Change Fund (the “Fund”) to the extent that the Fund’s total annual fund operating expenses (after applying all other contractual and voluntary expense limitation arrangements in effect at the time) exceed the following amounts for each class of shares, in each case representing the average daily net assets for the indicated class of shares: 0.77% for Class III shares; 0.72% for Class IV shares; 0.705% for Class V shares; and 0.675% for Class VI shares (each, an “Expense Cap”). Fees and expenses of the “non-interested” Trustees and legal counsel and independent compliance consultant to the “non-interested” Trustees, investment-related costs (such as brokerage commissions, interest, and acquired fund fees and expenses), taxes, litigation and indemnification expenses, judgments, and other extraordinary or non-recurring expenses not incurred in the ordinary course of the Fund’s business, are excluded from the Expense Cap. GMO also has contractually agreed to waive or reduce the Fund’s management fees and shareholder service fees to the extent necessary to offset the management fees and shareholder service fees paid to GMO that are directly or indirectly borne by the Fund or a class of shares of the Fund as a result of the Fund’s direct or indirect investments in other series of GMO Trust. Management fees and shareholder service fees will not be waived below zero. The reimbursement and waiver arrangements described above, including the Expense Cap, will remain in effect through September 25, 2019, and may not be terminated prior to such date without the action or consent of the Trust’s Board of Trustees.

GMO International Large/Mid Cap Equity Fund is scheduled to liquidate on October 31, 2018.

 

143


GMO Trust Funds

 

Board Review of Investment Management Agreements

August 31, 2018 (Unaudited)

 

 

GMO Climate Change Fund

Approval of renewal of management agreement for GMO Climate Change Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel

 

144


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Emerging Domestic Opportunities Fund

Approval of renewal of management agreement and sub-advisory agreement for GMO Emerging Domestic Opportunities Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”), and the sub-advisory agreement among the Manager, GMO Singapore Pte. Limited (“GMO Singapore”), and the Trust, on behalf of the Fund.

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and sub-advisory agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management and sub-advisory agreements of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager. In addition, the Trustees reviewed the fee payable by the Manager to GMO Singapore under the Fund’s sub-advisory agreement and considered the services that GMO Singapore provided the Fund. The Trustees noted that GMO Singapore’s sub-advisory fee was paid by the Manager out of the Manager’s management fee and not directly by the Fund.

 

145


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management and sub-advisory agreements were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement and sub-advisory agreement for another year.

GMO Emerging Markets Fund

Approval of renewal of management agreement and sub-advisory agreement for GMO Emerging Markets Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”), and the sub-advisory agreement among the Manager, GMO Singapore Pte. Limited (“GMO Singapore”), and the Trust, on behalf of the Fund.

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and sub-advisory agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management and sub-advisory agreements of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

 

146


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager. In addition, the Trustees reviewed the fee payable by the Manager to GMO Singapore under the Fund’s sub-advisory agreement and considered the services that GMO Singapore provided the Fund. The Trustees noted that GMO Singapore’s sub-advisory fee was paid by the Manager out of the Manager’s management fee and not directly by the Fund.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management and sub-advisory agreements were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement and sub-advisory agreement for another year.

GMO Foreign Small Companies Fund

Approval of renewal of management agreement for GMO Foreign Small Companies Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

 

147


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

 

148


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

GMO International Equity Fund

Approval of renewal of management agreement for GMO International Equity Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s

 

149


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO International Large/Mid Cap Equity Fund

Approval of renewal of management agreement for GMO International Large/Mid Cap Equity Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

 

150


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Quality Fund

Approval of renewal of management agreement for GMO Quality Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed

 

151


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Resources Fund

Approval of renewal of management agreement for GMO Resources Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

 

152


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Risk Premium Fund

Approval of renewal of management agreement for GMO Risk Premium Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the

 

153


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Tax-Managed International Equities Fund

Approval of renewal of management agreement for GMO Tax-Managed International Equities Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

 

154


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

 

155


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO U.S. Equity Fund

Approval of renewal of management agreement for GMO U.S. Equity Fund (formerly, GMO U.S. Equity Allocation Fund) (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any

 

156


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel, and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

 

157


GMO Trust Funds

(A Series of GMO Trust)

 

Fund Expenses

August 31, 2018 (Unaudited)

 

 

Expense Examples: The following information is in relation to expenses for the six month period ended August 31, 2018.

As a shareholder of the Funds, you may incur two types of costs: (1) transaction costs, including purchase premium and redemption fees, if applicable; and (2) ongoing costs, including direct and/or indirect management fees, direct and/or indirect shareholder services fees, and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Funds and to compare these costs with the ongoing costs of investing in other mutual funds.

These examples are based on an investment of $1,000 invested at the beginning of the period and held for the entire period, March 1, 2018 through August 31, 2018.

Actual Expenses

This section of the table for each class below provides information about actual account values and actual expenses. You may use the information in this section, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, a $10,000,000 account value divided by $1,000 = 10,000), then multiply the result by the number under the heading entitled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes

This section of the table for each class below provides information about hypothetical account values and hypothetical expenses based on the Funds’ actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Funds’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Funds with other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as purchase premium and redemption fees. Therefore, this section of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

 

    Actual     Hypothetical    

 

 
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Annualized
Expense Ratio
 

Climate Change Fund

 

       

Class III

    $1,000.00       $966.00       $3.57       $1,000.00       $1,021.58       $3.67       0.72%  

Emerging Domestic Opportunities Fund

 

       

Class II

    $1,000.00       $849.50       $4.89       $1,000.00       $1,019.91       $5.35       1.05%  

Class III

    $1,000.00       $850.00       $4.57       $1,000.00       $1,020.27       $4.99       0.98%  

Class IV

    $1,000.00       $850.10       $4.34       $1,000.00       $1,020.52       $4.74       0.93%  

Class V

    $1,000.00       $850.30       $4.24       $1,000.00       $1,020.62       $4.63       0.91%  

Emerging Markets Fund

 

       

Class II

    $1,000.00       $888.50       $4.43       $1,000.00       $1,020.52       $4.74       0.93%  

Class III

    $1,000.00       $888.90       $4.19       $1,000.00       $1,020.77       $4.48       0.88%  

Class IV

    $1,000.00       $889.00       $3.90       $1,000.00       $1,021.07       $4.18       0.82%  

Class V

    $1,000.00       $889.20       $3.71       $1,000.00       $1,021.27       $3.97       0.78%  

Class VI

    $1,000.00       $889.20       $3.57       $1,000.00       $1,021.42       $3.82       0.75%  

Foreign Small Companies Fund

 

       

Class III

    $1,000.00       $970.50       $6.41       $1,000.00       $1,018.70       $6.56       1.29%  

International Equity Fund

 

       

Class II

    $1,000.00       $938.00       $3.52       $1,000.00       $1,021.58       $3.67       0.72%  

Class III

    $1,000.00       $938.20       $3.18       $1,000.00       $1,021.93       $3.31       0.65%  

Class IV

    $1,000.00       $938.70       $2.88       $1,000.00       $1,022.23       $3.01       0.59%  

International Large/Mid Cap Equity Fund

 

       

Class III

    $1,000.00       $950.30       $6.05       $1,000.00       $1,019.00       $6.26       1.23%  

 

158


GMO Trust Funds

(A Series of GMO Trust)

 

Fund Expenses — (Continued)

August 31, 2018 (Unaudited)

 

 

    Actual     Hypothetical    

 

 
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Annualized
Expense Ratio
 

Quality Fund

 

       

Class III

    $1,000.00       $1,099.70       $2.54       $1,000.00       $1,022.79       $2.45       0.48%  

Class IV

    $1,000.00       $1,099.80       $2.33       $1,000.00       $1,022.99       $2.24       0.44%  

Class V

    $1,000.00       $1,100.30       $2.22       $1,000.00       $1,023.09       $2.14       0.42%  

Class VI

    $1,000.00       $1,100.10       $2.06       $1,000.00       $1,023.24       $1.99       0.39%  

Resources Fund

 

       

Class III

    $1,000.00       $978.90       $3.74       $1,000.00       $1,021.42       $3.82       0.75%  

Class IV

    $1,000.00       $978.70       $3.54       $1,000.00       $1,021.63       $3.62       0.71%  

Risk Premium Fund

 

       

Class III

    $1,000.00       $1,057.80       $3.11       $1,000.00       $1,022.18       $3.06       0.60%  

Class VI

    $1,000.00       $1,058.70       $2.65       $1,000.00       $1,022.64       $2.60       0.51%  

Tax-Managed International Equities Fund

 

       

Class III

    $1,000.00       $925.60       $3.64       $1,000.00       $1,021.42       $3.82       0.75%  

U.S. Equity Fund (formerly U.S. Equity Allocation Fund)

 

       

Class III

    $1,000.00       $1,050.60       $2.38       $1,000.00       $1,022.89       $2.35       0.46%  

Class IV

    $1,000.00       $1,051.50       $2.12       $1,000.00       $1,023.14       $2.09       0.41%  

Class V

    $1,000.00       $1,051.00       $2.07       $1,000.00       $1,023.19       $2.04       0.40%  

Class VI

    $1,000.00       $1,051.30       $1.91       $1,000.00       $1,023.34       $1.89       0.37%  

 

  *

Expenses are calculated using each class’s annualized net expense ratio (including indirect expenses incurred) for the six months ended August 31, 2018, multiplied by the average account value over the period, multiplied by 184 days in the period, divided by 365 days in the year.

 

159


GMO Trust

Semiannual Report

August 31, 2018

Alpha Only Fund

Benchmark-Free Allocation Fund

Benchmark-Free Fund

Global Asset Allocation Fund

Global Developed Equity Allocation Fund

Global Equity Allocation Fund

Implementation Fund

International Developed Equity Allocation Fund

International Equity Allocation Fund

SGM Major Markets Fund

Special Opportunities Fund

Strategic Opportunities Allocation Fund


 

 

 

 

For a free copy of the Funds’ proxy voting guidelines, shareholders may call 1-617-346-7646 (collect), visit GMO’s website at www.gmo.com or visit the Securities and Exchange Commission’s website at www.sec.gov. Information regarding how the Funds voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available on GMO’s website at

www.gmo.com or on the Securities and Exchange Commission’s website at www.sec.gov.

The Funds file their complete schedule of portfolio holdings with the Securities and Exchange Commission for the first and third quarter of each fiscal year on Form N-Q, which is available on the Commission’s website at www.sec.gov. The Funds’ Form N-Q may be reviewed and copied at the Commission’s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference Room may be obtained by calling 1-800-SEC-0330. The Funds have a policy with respect to disclosure of portfolio holdings under which they may also make a complete schedule of portfolio holdings available on GMO’s website at www.gmo.com.

This report is prepared for the general information of shareholders. It is authorized for distribution to prospective investors only when preceded or accompanied by a prospectus for the GMO Trust, which contains a complete discussion of the risks associated with an investment in these Funds and other important information. The GMO Trust prospectus can be obtained at www.gmo.com. The GMO Trust Statement of Additional Information includes additional information about the Trustees of GMO Trust and is available without charge, upon request, by calling 1-617-346-7646 (collect).

An investment in the Funds is subject to risk, including the possible loss of principal amount invested. There can be no assurance that the Funds will achieve their stated investment objectives. Please see the Funds’ prospectus regarding specific principal risks for each Fund. General risks may include: market risk-equities, management and operational risk, market risk-asset backed securities, credit risk, non-U.S. investment risk, small company risk and derivatives risk.

The Funds are distributed by Funds Distributor LLC. Funds Distributor LLC is not affiliated with GMO.


TABLE OF CONTENTS

 

Alpha Only Fund

  

Investment Concentration Summary

     1  

Schedule of Investments

     2  

Benchmark-Free Allocation Fund

  

Investment Concentration Summary

     11  

Schedule of Investments

     12  

Benchmark-Free Fund

  

Investment Concentration Summary

     13  

Schedule of Investments

     14  

Global Asset Allocation Fund

  

Investment Concentration Summary

     38  

Schedule of Investments

     39  

Global Developed Equity Allocation Fund

  

Investment Concentration Summary

     40  

Schedule of Investments

     41  

Global Equity Allocation Fund

  

Investment Concentration Summary

     42  

Schedule of Investments

     43  

Implementation Fund

  

Investment Concentration Summary

     44  

Schedule of Investments

     46  

International Developed Equity Allocation Fund

  

Investment Concentration Summary

     76  

Schedule of Investments

     77  

International Equity Allocation Fund

  

Investment Concentration Summary

     78  

Schedule of Investments

     79  

SGM Major Markets Fund

  

Investment Concentration Summary

     80  

Schedule of Investments

     81  

Special Opportunities Fund

  

Investment Concentration Summary

     84  

Schedule of Investments

     85  

Strategic Opportunities Allocation Fund

  

Investment Concentration Summary

     86  

Schedule of Investments

     87  

Portfolio, Counterparty and Currency Abbreviations

     95  

Fund Financial Statements:

  

Statements of Assets and Liabilities

     96  

Statements of Operations

     102  

Statements of Changes in Net Assets

     105  

Financial Highlights

     111  

Notes to Financial Statements

     124  

Board Review of Investment Management Agreements

     187  

Fund Expenses

     202  

 

   


GMO Alpha Only Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    88.0

Short-Term Investments

    6.5  

Mutual Funds

    6.3  

Preferred Stocks

    1.0  

Forward Currency Contracts

    0.3  

Rights/Warrants

    0.0

Futures Contracts

    (3.6

Other

    1.5  
 

 

 

 
    100.0
 

 

 

 

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts. The Fund’s investment program involves having both long and short investment exposures. The additional short exposures that the Fund has to future contracts based on notional amounts are (89.3)% of net assets.

 

^

Rounds to 0.0%.

 

 

1


GMO Alpha Only Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    COMMON STOCKS — 88.0%

 

    Australia — 0.9%

 

    9,534     AusNet Services     11,300  
    2,998     Australia & New Zealand Banking Group Ltd     63,710  
    2,064     Brickworks Ltd     25,973  
    6,771     Caltex Australia Ltd     147,136  
    340     CIMIC Group Ltd     12,059  
    1,954     Crown Resorts Ltd     19,982  
    7,034     CSR Ltd     21,807  
    5,206     GPT Group (The) (REIT)     19,365  
    16,536     Insurance Australia Group Ltd     91,899  
    5,758     Mineral Resources Ltd     62,721  
    52,317     Mirvac Group (REIT)     91,660  
    10,897     Nine Entertainment Co Holdings Ltd     18,934  
    7,145     Sandfire Resources NL     36,433  
    129,686     Scentre Group (REIT)     383,953  
    4,839     Westpac Banking Corp     99,383  
     

 

 

 
    Total Australia     1,106,315  
     

 

 

 
    Austria — 0.3%

 

    4,498     OMV AG     238,470  
    1,003     Vienna Insurance Group AG Wiener Versicherung Gruppe     27,353  
    1,729     voestalpine AG     77,716  
    951     Zumtobel Group AG *     7,641  
     

 

 

 
    Total Austria     351,180  
     

 

 

 
    Belgium — 0.1%

 

    3,708     AGFA-Gevaert NV *     16,283  
    168     Barco NV     23,118  
    682     KBC Group NV     48,490  
     

 

 

 
    Total Belgium     87,891  
     

 

 

 
    Brazil — 2.2%

 

    45,239     Banco Bradesco SA     278,891  
    19,600     Banco do Brasil SA     144,843  
    89,400     Banco Santander Brasil SA     759,431  
    12,800     Centrais Eletricas Brasileiras SA *     49,716  
    65,200     Cia de Saneamento Basico do Estado de Sao Paulo     390,582  
    4,400     Cia de Saneamento Basico do Estado de Sao Paulo ADR     26,444  
    10,100     Cia de Saneamento de Minas Gerais-COPASA     103,849  
    295,200     JBS SA     681,270  
    3,800     Mahle-Metal Leve SA     23,538  
    5,600     MRV Engenharia e Participacoes SA     17,873  
    5,154     Sul America SA     29,066  
    16,900     Via Varejo SA     70,121  
     

 

 

 
    Total Brazil     2,575,624  
     

 

 

 
    
Shares
    Description   Value ($)  
    Chile — 0.0%

 

    1,237     Cia Cervecerias Unidas SA     16,307  
     

 

 

 
    China — 12.1%

 

    442,000     Agile Group Holdings Ltd     722,926  
    2,367,000     Agricultural Bank of China Ltd – Class H     1,146,992  
    56,000     BAIC Motor Corp Ltd – Class H     47,116  
    1,020,000     Bank of China Ltd – Class H     458,344  
    679,000     Bank of Communications Co Ltd – Class H     490,699  
    133,000     China Cinda Asset Management Co Ltd – Class H     34,425  
    971,000     China CITIC Bank Corp Ltd – Class H     606,669  
    408,000     China Communications Services Corp Ltd – Class H     338,024  
    479,000     China Construction Bank Corp – Class H     421,873  
    4,000     China Everbright Ltd     7,011  
    566,000     China Huarong Asset Management Co Ltd – Class H     117,661  
    91,000     China Lesso Group Holdings Ltd     52,516  
    35,000     China Lilang Ltd     38,822  
    400     China Mobile Ltd Sponsored ADR     19,196  
    1,504,000     China Petroleum & Chemical Corp – Class H     1,513,304  
    62,000     China Pioneer Pharma Holdings Ltd     15,407  
    637,000     China Railway Construction Corp Ltd – Class H     770,596  
    327,000     China Railway Group Ltd – Class H     282,619  
    182,500     China Resources Pharmaceutical Group Ltd     292,053  
    52,000     China SCE Group Holdings Ltd     23,343  
    338,000     China Shenhua Energy Co Ltd – Class H     754,923  
    54,000     China Shineway Pharmaceutical Group Ltd     76,311  
    2,126,000     China Telecom Corp Ltd – Class H     999,863  
    52,000     China Travel International Investment Hong Kong Ltd     16,907  
    6,200     China Vanke Co Ltd – Class H     21,510  
    1,200     China Yuchai International Ltd     24,132  
    466,000     Chongqing Rural Commercial Bank Co Ltd – Class H     251,351  
    99,000     Dah Chong Hong Holdings Ltd     43,055  
    626,000     Dongfeng Motor Group Co Ltd – Class H     699,791  
    21,000     Far East Horizon Ltd     19,877  
    272,400     Guangzhou R&F Properties Co Ltd – Class H     550,487  
    250,000     Haier Electronics Group Co Ltd *     651,963  
    16,000     Harbin Electric Co Ltd – Class H     5,034  
    66,000     Hua Hong Semiconductor Ltd     180,206  
    107,000     Kingboard Holdings Ltd     380,909  
    114,000     Kingboard Laminates Holdings Ltd     107,781  
    16,000     Lee & Man Paper Manufacturing Ltd     15,352  
    565,000     Lonking Holdings Ltd     194,530  
    43,000     Nexteer Automotive Group Ltd     72,530  
    84,000     People’s Insurance Co Group of China Ltd (The) – Class H     36,437  
 

 

2   See accompanying notes to the financial statements.  


GMO Alpha Only Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    China — continued  
    335,000     Postal Savings Bank of China Co Ltd – Class H     197,456  
    21,000     Road King Infrastructure Ltd     35,680  
    19,000     Shandong Chenming Paper Holdings Ltd – Class H     13,208  
    52,000     Shanghai Industrial Holdings Ltd     123,987  
    18,800     Shanghai Pharmaceuticals Holding Co Ltd – Class H     49,384  
    282,500     Shimao Property Holdings Ltd     843,650  
    17,000     Sinotruk Hong Kong Ltd     25,390  
    78,000     Tianneng Power International Ltd     96,952  
    17,000     Uni-President China Holdings Ltd     16,752  
    341,000     Weichai Power Co Ltd – Class H     361,652  
    63,500     XTEP International Holdings Ltd     42,427  
    156,000     Yuzhou Properties Co Ltd     83,014  
    4,000     Zhejiang Expressway Co Ltd – Class H     3,176  
     

 

 

 
    Total China     14,395,273  
     

 

 

 
    Colombia — 0.0%

 

    10,111     Ecopetrol SA     11,352  
     

 

 

 
    Czech Republic — 0.0%

 

    4,446     Moneta Money Bank AS     15,540  
     

 

 

 
    Denmark — 0.0%

 

    94     Schouw & Co AB     7,432  
     

 

 

 
    Egypt — 0.0%

 

    15,874     Talaat Moustafa Group     10,410  
     

 

 

 
    Finland — 0.4%

 

    3,665     Fortum Oyj     92,764  
    337     Kesko Oyj – B Shares     19,631  
    336     Metso Oyj     11,800  
    682     Neste Oyj     59,213  
    518     Orion Oyj – Class B     19,050  
    4,248     Stora Enso Oyj – R Shares     79,064  
    4,918     UPM-Kymmene Oyj     189,709  
     

 

 

 
    Total Finland     471,231  
     

 

 

 
    France — 1.5%

 

    181     ArcelorMittal     5,459  
    1,546     AXA SA     38,960  
    1,891     BNP Paribas SA     111,329  
    157     Casino Guichard Perrachon SA     5,001  
    4,026     CNP Assurances     93,052  
    2,131     Coface SA     19,993  
    22     Covivio (REIT)     2,301  
    8,640     Credit Agricole SA     118,217  
    374     Kaufman & Broad SA     19,695  
    
Shares
    Description   Value ($)  
    France — continued  
    1,382     Metropole Television SA     27,362  
    13,240     Natixis SA     88,549  
    1,438     Neopost SA     38,597  
    430     Nexity SA     26,278  
    940     Orange SA     15,218  
    716     Peugeot SA     19,729  
    1,069     Rallye SA     11,098  
    1,659     Renault SA     143,289  
    10,584     Sanofi     908,884  
    500     Sanofi ADR     21,425  
    1,877     Societe Generale SA     76,858  
    205     TOTAL SA     12,855  
    1,020     Unibail-Rodamco-Westfield *     10,653  
    75     Wendel SA     11,105  
     

 

 

 
    Total France     1,825,907  
     

 

 

 
    Germany — 3.2%

 

    2,553     Allianz SE (Registered)     544,151  
    231     Axel Springer SE     16,782  
    4,456     BASF SE     411,759  
    7,490     Bayerische Motoren Werke AG     725,082  
    226     Covestro AG     19,242  
    5,683     Daimler AG (Registered Shares)     367,521  
    15,859     Deutsche Lufthansa AG (Registered)     414,357  
    5,520     Deutsche Pfandbriefbank AG     80,809  
    735     Evonik Industries AG     27,391  
    7,900     SAP AG     948,378  
    591     Software AG     29,144  
    1,216     Volkswagen AG     195,738  
     

 

 

 
    Total Germany     3,780,354  
     

 

 

 
    Greece — 0.0%

 

    6,562     FF Group * (a)     36,561  
     

 

 

 
    Hong Kong — 0.5%

 

    28,000     BOC Hong Kong Holdings Ltd     136,746  
    6,000     Cathay Pacific Airways Ltd     8,945  
    23,000     CK Asset Holdings Ltd     164,030  
    12,000     First Pacific Co Ltd     5,462  
    800     Hang Seng Bank Ltd     21,703  
    14,000     HK Electric Investments & HK Electric Investments Ltd – Class SS     14,160  
    14,500     Kerry Properties Ltd     54,989  
    96,000     Li & Fung Ltd     27,284  
    8,000     NWS Holdings Ltd     14,259  
    4,000     PCCW Ltd     2,126  
    38,000     SJM Holdings Ltd     43,024  
    13,000     Wharf Real Estate Investment Co Ltd     86,253  
    4,000     Yue Yuen Industrial Holdings Ltd     11,089  
     

 

 

 
    Total Hong Kong     590,070  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   3


GMO Alpha Only Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Hungary — 0.0%

 

    26,274     Magyar Telekom Telecommunications Plc     38,513  
    1,102     MOL Hungarian Oil & Gas Plc     11,245  
     

 

 

 
    Total Hungary     49,758  
     

 

 

 
    India — 3.1%

 

    996     Balkrishna Industries Ltd     19,075  
    955     Divi’s Laboratories Ltd     17,647  
    29,389     Firstsource Solutions Ltd     31,250  
    359     Grasim Industries Ltd     5,429  
    24,655     HCL Technologies Ltd     363,235  
    3,707     Hero MotoCorp Ltd     170,561  
    2,840     Hexaware Technologies Ltd     17,576  
    608     Ipca Laboratories Ltd     6,606  
    23,177     ITC Ltd     104,551  
    1,960     Jubilant Life Sciences Ltd *     19,918  
    17,728     Karnataka Bank Ltd (The)     29,891  
    4,488     KPIT Technologies Ltd     19,192  
    4,493     Larsen & Toubro Infotech Ltd     113,269  
    30,547     Mahindra & Mahindra Ltd     416,316  
    6,522     Mindtree Ltd     102,752  
    10,246     Mphasis Ltd     182,896  
    8,672     NIIT Technologies Ltd     172,325  
    179,801     Oil & Natural Gas Corp Ltd     456,277  
    188,731     Power Finance Corp Ltd     225,018  
    57,507     PTC India Ltd     67,994  
    32,188     Reliance Capital Ltd     213,803  
    2,862     Reliance Home Finance Ltd *     2,644  
    223,854     Rural Electrification Corp Ltd     378,742  
    46,598     Tata Global Beverages Ltd     154,559  
    1,362     Tata Motors Ltd *     5,116  
    37,357     Tata Steel Ltd     316,881  
    12,321     Tech Mahindra Ltd     133,154  
     

 

 

 
    Total India     3,746,677  
     

 

 

 
    Indonesia — 0.2%

 

    71,200     Adaro Energy Tbk PT     9,028  
    8,700     Bank Negara Indonesia Persero Tbk PT     4,609  
    9,400     Gudang Garam Tbk PT     46,592  
    62,700     Indo Tambangraya Megah Tbk PT     120,482  
    83,600     Media Nusantara Citra Tbk PT     5,138  
    62,600     XL Axiata Tbk PT *     13,511  
     

 

 

 
    Total Indonesia     199,360  
     

 

 

 
    Ireland — 0.0%

 

    820     Bank of Ireland Group Plc     6,718  
     

 

 

 
    Israel — 0.1%

 

    80     Azrieli Group Ltd     4,155  
    11,347     Bank Leumi Le-Israel BM     76,222  
    10,565     Bezeq The Israeli Telecommunication Corp Ltd     12,626  
    
Shares
    Description   Value ($)  
    Israel — continued

 

    1,075     First International Bank of Israel Ltd     24,901  
    2,738     Harel Insurance Investments & Financial Services Ltd     22,352  
    2,729     Israel Chemicals Ltd     15,946  
    687     Teva Pharmaceutical Industries Ltd *     15,762  
     

 

 

 
    Total Israel     171,964  
     

 

 

 
    Italy — 1.2%

 

    39,704     A2A SPA     68,249  
    792     ASTM SPA     16,165  
    6,300     Enav SPA     31,147  
    32,727     Enel SPA     161,800  
    1,572     ERG SPA     32,561  
    5,599     EXOR NV     364,322  
    13,900     Fiat Chrysler Automobiles NV *     237,829  
    14,171     FinecoBank Banca Fineco SPA     168,932  
    29,841     Iren SPA     69,989  
    2,711     Mediobanca Banca di Credito Finanziario SPA     25,244  
    22,292     Poste Italiane SPA     171,721  
    8,179     Societa Cattolica di Assicurazioni SC     66,379  
    2,705     Societa Iniziative Autostradali e Servizi SPA     37,710  
    55,090     Telecom Italia SPA-RSP     30,663  
     

 

 

 
    Total Italy     1,482,711  
     

 

 

 
    Japan — 7.0%

 

    900     Aeon Co Ltd     19,490  
    600     AEON Financial Service Co Ltd     12,272  
    900     AGC Inc     36,004  
    4,900     Aisin Seiki Co Ltd     226,639  
    1,300     Alfresa Holdings Corp     32,586  
    29,500     Asahi Kasei Corp     432,279  
    21,800     Canon Inc     699,488  
    200     Central Japan Railway Co     40,155  
    900     Chugoku Bank Ltd (The)     9,843  
    1,500     Chugoku Electric Power Co Inc (The)     18,727  
    100     Daiichi Sankyo Co Ltd     3,903  
    500     Daiwa House Industry Co Ltd     15,232  
    800     DIC Corp     28,392  
    400     Eisai Co Ltd     36,223  
    14,000     Fuji Electric Co Ltd     112,775  
    2,200     FUJIFILM Holdings Corp     92,924  
    4,000     Fukuoka Financial Group Inc     22,427  
    2,300     Gree Inc     11,645  
    6,100     Hachijuni Bank Ltd (The)     27,260  
    400     Hakuhodo DY Holdings Inc     6,749  
    105     Hirose Electric Co Ltd     12,478  
    4,200     Hiroshima Bank Ltd (The)     29,379  
    600     Hisamitsu Pharmaceutical Co Inc     43,830  
    35,000     Hitachi Ltd     228,465  
 

 

4   See accompanying notes to the financial statements.  


GMO Alpha Only Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Japan — continued

 

    900     Hokuriku Electric Power Co *     8,835  
    15,100     Honda Motor Co Ltd     447,310  
    1,200     Ibiden Co Ltd     17,409  
    1,800     Isuzu Motors Ltd     25,987  
    36,100     ITOCHU Corp     630,806  
    4     Japan Prime Realty Investment Corp (REIT)     14,470  
    1,700     JFE Holdings Inc     37,160  
    5,300     JXTG Holdings Inc     37,317  
    500     Kamigumi Co Ltd     10,146  
    3,000     Kaneka Corp     27,381  
    9,800     KDDI Corp     259,110  
    5,200     Kirin Holdings Co Ltd     128,504  
    500     Kitz Corp     4,380  
    2,100     Konica Minolta Inc     21,356  
    1,400     Kurita Water Industries Ltd     41,556  
    500     Kyowa Hakko Kirin Co Ltd     8,869  
    900     Kyushu Financial Group Inc     4,378  
    19,200     Marubeni Corp     157,314  
    300     Maruichi Steel Tube Ltd     9,194  
    9,980     Mebuki Financial Group Inc     35,372  
    50,400     Mitsubishi Chemical Holdings Corp     451,571  
    10,200     Mitsubishi Corp     290,874  
    26,900     Mitsubishi Electric Corp     363,136  
    1,500     Mitsubishi Gas Chemical Co Inc     31,182  
    7,900     Mitsubishi Tanabe Pharma Corp     131,764  
    4,900     Mitsubishi UFJ Financial Group Inc     29,619  
    3,800     Mitsubishi UFJ Lease & Finance Co Ltd     21,367  
    3,900     Mitsui & Co Ltd     64,969  
    1,200     Mitsui Mining & Smelting Co Ltd     34,377  
    4,300     NEC Corp     118,718  
    2,100     NET One Systems Co Ltd     48,639  
    1,000     Nichiha Corp     28,078  
    16,600     Nippon Telegraph & Telephone Corp     738,550  
    1,200     Nippon Flour Mills Co Ltd     20,072  
    3,400     Nisshin Seifun Group Inc     68,003  
    500     NOK Corp     9,547  
    2,100     Nomura Real Estate Holdings Inc     45,491  
    140     Nomura Research Institute Ltd     6,961  
    2,200     NTT DOCOMO Inc     57,015  
    2,000     Oji Holdings Corp     13,689  
    3,500     Resona Holdings Inc     19,853  
    100     Rohm Co Ltd     9,035  
    200     Sankyo Co Ltd     7,656  
    2,900     SBI Holdings Inc     79,938  
    3,400     Seiko Epson Corp     58,108  
    2,500     Sekisui Chemical Co Ltd     43,430  
    1,000     Shinsei Bank Ltd     15,370  
    4,700     Showa Denko KK     223,236  
    2,400     Showa Shell Sekiyu KK     48,411  
    21,100     Sojitz Corp     73,425  
    
Shares
    Description   Value ($)  
    Japan — continued

 

    38,000     Sumitomo Chemical Co Ltd     215,681  
    4,400     Sumitomo Corp     71,350  
    2,200     Sumitomo Dainippon Pharma Co Ltd     46,814  
    200     Sumitomo Heavy Industries Ltd     6,507  
    7,300     Sumitomo Mitsui Financial Group Inc     286,988  
    1,250     Suzuken Co Ltd     56,763  
    100     Taisho Pharmaceutical Holdings Co Ltd     10,839  
    1,900     Takeda Pharmaceutical Co Ltd     79,156  
    800     Tocalo Co Ltd     9,249  
    1,200     Tohoku Electric Power Co Inc     15,020  
    400     Tokio Marine Holdings Inc     18,849  
    4,300     Tokyo Electric Power Co Holdings Inc *     19,877  
    300     Tokyo Electron Ltd     51,075  
    100     Toyoda Gosei Co Ltd     2,495  
    3,600     Toyota Tsusho Corp     122,644  
    200     Trend Micro Inc     12,576  
    600     USS Co Ltd     11,302  
    1,000     Yamaguchi Financial Group Inc     11,000  
    1,000     Yokohama Rubber Co Ltd (The)     21,006  
     

 

 

 
    Total Japan     8,347,294  
     

 

 

 
    Malaysia — 0.4%

 

    11,600     AirAsia Berhad     9,694  
    16,800     Alliance Financial Group Berhad     16,866  
    3,300     AMMB Holdings Berhad     3,286  
    4,000     Berjaya Sports Toto Berhad     2,151  
    3,800     Hong Leong Financial Group Berhad     18,110  
    32,375     IOI Properties Group Berhad *     13,785  
    115,200     Petronas Chemicals Group Berhad     264,808  
    13,341     RHB Bank Berhad     17,517  
    12,300     RHB Capital Berhad * (a)      
    71,900     Supermax Corp Berhad     58,679  
    7,800     UMW Holdings Berhad     11,304  
    8,600     Westports Holdings Berhad     7,766  
     

 

 

 
    Total Malaysia     423,966  
     

 

 

 
    Mexico — 1.0%

 

    1,900     OHL Mexico SAB de CV     2,863  
    408,400     Wal-Mart de Mexico SAB de CV     1,130,808  
     

 

 

 
    Total Mexico     1,133,671  
     

 

 

 
    Netherlands — 0.9%

 

    453     ASR Nederland NV     21,657  
    53,797     ING Groep NV     730,767  
    7,953     Koninklijke Ahold Delhaize NV     193,730  
    457     Koninklijke Philips NV     20,420  
    2,783     Signify NV     78,449  
     

 

 

 
    Total Netherlands     1,045,023  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   5


GMO Alpha Only Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    New Zealand — 0.0%

 

    3,835     Contact Energy Ltd     14,081  
    6,852     Meridian Energy Ltd     14,695  
     

 

 

 
    Total New Zealand     28,776  
     

 

 

 
    Norway — 1.0%

 

    889     Aker ASA – A Shares     69,651  
    2,486     Austevoll Seafood ASA     32,712  
    22,587     DNB ASA     459,194  
    16,911     Equinor ASA     433,771  
    1,069     Gjensidige Forsikring ASA     17,870  
    2,174     Norsk Hydro ASA     11,987  
    3,762     Storebrand ASA     33,305  
    7,349     Subsea 7 SA     99,912  
     

 

 

 
    Total Norway     1,158,402  
     

 

 

 
    Philippines — 0.1%

 

    555     Globe Telecom Inc     21,971  
    8,480     International Container Terminal Services Inc     14,856  
    188,000     Megaworld Corp     16,145  
    27,300     Robinsons Land Corp     10,883  
     

 

 

 
    Total Philippines     63,855  
     

 

 

 
    Poland — 0.1%

 

    2,301     Asseco Poland SA     28,507  
    510     Bank Handlowy w Warszawie SA     9,360  
    45,966     Energa SA     103,970  
    747     Grupa Azoty SA     7,660  
    1,738     PGE Polska Grupa Energetyczna SA *     4,217  
     

 

 

 
    Total Poland     153,714  
     

 

 

 
    Portugal — 0.0%

 

    41,678     Sonae SGPS SA     44,339  
     

 

 

 
    Qatar — 0.0%

 

    1,134     Barwa Real Estate Co     11,213  
     

 

 

 
    Russia — 0.5%

 

    97,553     Gazprom PJSC Sponsored ADR     430,296  
    1,404     LUKOIL PJSC Sponsored ADR     97,020  
    2,826     Sistema PJSC Sponsered GDR (Registered)     6,829  
     

 

 

 
    Total Russia     534,145  
     

 

 

 
    Singapore — 0.2%

 

    800     City Developments Ltd     5,410  
    18,700     Golden Agri-Resources Ltd     3,882  
    27,900     Hutchison Port Holdings Trust – Class U     6,835  
    7,900     Oversea-Chinese Banking Corp Ltd     65,017  
    5,600     Singapore Press Holdings Ltd     11,429  
    12,900     Suntec Real Estate Investment Trust     17,574  
    
Shares
    Description   Value ($)  
    Singapore — continued

 

    2,700     United Overseas Bank Ltd     53,213  
    2,600     UOL Group Ltd     13,088  
    38,400     Yangzijiang Shipbuilding Holdings Ltd     29,944  
     

 

 

 
    Total Singapore     206,392  
     

 

 

 
    South Africa — 2.9%

 

    83,786     Absa Group Ltd     926,685  
    587     Anglo American Platinum Ltd     17,191  
    392     Barloworld Ltd     3,334  
    4,578     Imperial Holdings Ltd     64,147  
    34,552     Liberty Holdings Ltd     273,362  
    21,583     Metair Investments Ltd     25,662  
    170,032     MMI Holdings Ltd *     198,287  
    758     Mondi Ltd     21,150  
    37,418     Nedbank Group Ltd     707,790  
    1,117     Omnia Holdings Ltd     9,880  
    16,044     Reunert Ltd     83,110  
    77,732     Standard Bank Group Ltd     985,212  
    11,888     Telkom SA SOC Ltd     40,677  
    7,412     Wilson Bayly Holmes-Ovcon Ltd     75,588  
     

 

 

 
    Total South Africa     3,432,075  
     

 

 

 
    South Korea — 3.5%

 

    1,933     BNK Financial Group Inc     14,489  
    293     CJ ENM Co Ltd     66,291  
    185     Daelim Industrial Co Ltd     13,610  
    2,890     DGB Financial Group Inc     26,607  
    442     E-MART Inc     85,160  
    88     GS Holdings Corp     4,198  
    90     GS Home Shopping Inc     16,766  
    5,915     Hana Financial Group Inc     226,815  
    1,091     Hankook Tire Co Ltd     45,721  
    29,980     Hanwha Life Insurance Co Ltd     130,613  
    4,946     Hyundai Marine & Fire Insurance Co Ltd     165,237  
    60,510     Industrial Bank of Korea     809,990  
    7,284     Kia Motors Corp     209,764  
    173     Korea Investment Holdings Co Ltd     11,073  
    2,511     Korea United Pharm Inc     64,471  
    4,781     Korean Reinsurance Co     44,686  
    87     KT Corp     2,259  
    142     Kumho Petrochemical Co Ltd     13,002  
    6,057     Kwang Dong Pharmaceutical Co Ltd     40,915  
    1,828     LF Corp     43,606  
    8,566     LG Corp     550,304  
    2,643     LOTTE Himart Co Ltd     169,914  
    313     LS Corp     18,883  
    474     NH Investment & Securities Co Ltd     5,724  
    1,163     Samjin Pharmaceutical Co Ltd     57,568  
    4,764     Samsung Electronics Co Ltd     207,094  
    13,800     Shinhan Financial Group Co Ltd     542,022  
 

 

6   See accompanying notes to the financial statements.  


GMO Alpha Only Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    South Korea — continued

 

    497     SK Holdings Co Ltd     117,466  
    17,700     SK Telecom Co Ltd Sponsored ADR     460,377  
    1,345     Woori Bank     19,701  
     

 

 

 
    Total South Korea     4,184,326  
     

 

 

 
    Spain — 0.5%

 

    21,259     Banco Santander SA     105,640  
    10,968     Endesa SA     245,391  
    21,924     International Consolidated Airlines Group SA     196,788  
    5,010     Repsol SA     96,357  
     

 

 

 
    Total Spain     644,176  
     

 

 

 
    Sweden — 1.2%

 

    7,549     Alfa Laval AB     202,364  
    1,559     Granges AB     18,262  
    1,803     Hemfosa Fastigheter AB     24,529  
    602     ICA Gruppen AB     18,337  
    598     Loomis AB – Class B     19,246  
    2,931     Nordea Bank AB     31,673  
    629     Oriflame Holding AG     18,301  
    6,684     Resurs Holding AB     48,834  
    8,158     Sandvik AB     142,803  
    3,604     SKF AB – B Shares     69,278  
    4,256     SSAB AB – Series A     18,550  
    25,752     Svenska Cellulosa AB SCA – Class B     299,784  
    13,311     Swedbank AB – A Shares     309,938  
    12,738     Volvo AB – B Shares     219,436  
     

 

 

 
    Total Sweden     1,441,335  
     

 

 

 
    Switzerland — 3.1%

 

    456     BKW AG     32,346  
    139     Bucher Industries AG (Registered)     48,704  
    40     Inficon Holding AG (Registered) *     20,351  
    8,934     Nestle SA (Registered)     748,911  
    17,913     Novartis AG (Registered)     1,486,100  
    92     Pargesa Holding SA     7,466  
    4,985     Roche Holding AG     1,236,049  
    366     Swiss Re AG     32,929  
    424     Zurich Insurance Group AG     129,078  
     

 

 

 
    Total Switzerland     3,741,934  
     

 

 

 
    Taiwan — 5.8%

 

    70,000     Asia Vital Components Co Ltd     66,736  
    66,000     Asustek Computer Inc     562,430  
    9,000     Cathay Financial Holding Co Ltd     15,426  
    8,520     Chang Hwa Commercial Bank Ltd *     5,301  
    44,000     China Airlines Ltd     13,488  
    16,775     China Life Insurance Co Ltd     16,697  
    43,000     Coretronic Corp     80,897  
    63,000     CTBC Financial Holding Co Ltd     44,304  
    
Shares
    Description   Value ($)  
    Taiwan — continued

 

    11,000     Elan Microelectronics Corp     19,437  
    35,277     Eva Airways Corp     17,920  
    25,000     Far Eastern New Century Corp     29,119  
    50,000     Formosa Chemicals & Fibre Corp     200,372  
    92,000     Formosa Plastics Corp     337,261  
    3,000     Formosa Taffeta Co Ltd     3,492  
    30,000     Fubon Financial Holding Co Ltd     49,739  
    136,000     Gigabyte Technology Co Ltd     232,054  
    263,000     Grand Pacific Petrochemical     253,644  
    57,000     Holtek Semiconductor Inc     157,255  
    342,525     Hon Hai Precision Industry Co Ltd     899,826  
    6,721     Hua Nan Financial Holdings Co Ltd – Class C     3,940  
    8,000     Inventec Corp     7,180  
    56,000     Lite-On Semiconductor Corp     63,886  
    1,000     Lotes Co Ltd     7,648  
    11,000     Micro-Star International Co Ltd     38,025  
    155,000     Mitac Holdings Corp *     179,277  
    337,000     Nan Ya Plastics Corp     937,805  
    91,000     Novatek Microelectronics Corp     446,200  
    28,000     Phison Electronics Corp     231,801  
    376,000     Pou Chen Corp     414,577  
    2,000     Primax Electronics Ltd     3,716  
    143,000     Radiant Opto-Electronics Corp     314,101  
    24,000     Shin Kong Financial Holding Co Ltd     9,493  
    9,000     Simplo Technology Co Ltd     65,958  
    13,248     SinoPac Financial Holdings Co Ltd     4,856  
    7,000     Sitronix Technology Corp     22,080  
    112,350     Synnex Technology International Corp     150,373  
    33,063     Taiwan Business Bank     11,954  
    12,000     Taiwan Fertilizer Co Ltd     16,546  
    20,131     Taiwan Semiconductor Manufacturing Co Ltd Sponsored ADR     877,712  
    3,000     Transcend Information Inc     7,258  
    25,000     Uni-President Enterprises Corp     63,260  
    12,000     United Integrated Services Co Ltd     24,220  
    29,000     Walsin Lihwa Corp     20,519  
    7,000     WPG Holdings Ltd     8,866  
    95,000     Yuanta Financial Holding Co Ltd     48,135  
     

 

 

 
    Total Taiwan     6,984,784  
     

 

 

 
    Thailand — 1.8%

 

    28,100     Com7 Pcl (Foreign Registered)     16,495  
    2,800     Glow Energy Pcl (Foreign Registered)     8,041  
    227,400     Indorama Ventures Pcl (Foreign Registered)     417,095  
    21,000     Krung Thai Bank Pcl (Foreign Registered)     12,454  
    365,300     PTT Global Chemical Pcl (Foreign Registered)     913,006  
    443,800     PTT Pcl (Foreign Registered)     712,540  
    236,600     Quality Houses Pcl (Foreign Registered)     25,015  
    54,500     Thanachart Capital Pcl (Foreign Registered)     89,529  
     

 

 

 
    Total Thailand     2,194,175  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   7


GMO Alpha Only Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Turkey — 0.7%

 

    175,125     KOC Holding AS     400,209  
    1,778     TAV Havalimanlari Holding AS     8,946  
    475,181     Turkiye Is Bankasi – Class C     289,346  
    15,179     Turkiye Sise ve Cam Fabrikalari AS     14,268  
    143,796     Turkiye Vakiflar Bankasi TAO – Class D     76,005  
     

 

 

 
    Total Turkey     788,774  
     

 

 

 
    United Arab Emirates — 0.0%

 

    7,875     Abu Dhabi Commercial Bank PJSC     15,220  
    4,957     Emaar Malls PJSC     2,698  
     

 

 

 
    Total United Arab Emirates     17,918  
     

 

 

 
    United Kingdom — 6.6%

 

    24,450     3i Group Plc     284,700  
    5,386     888 Holdings Plc     16,307  
    734     Antofagasta Plc     7,689  
    2,100     AstraZeneca Plc Sponsored ADR     80,514  
    531     AstraZeneca Plc     40,077  
    7,736     Barratt Developments Plc     54,426  
    3,185     Bellway Plc     120,661  
    1,850     Berkeley Group Holdings Plc (The)     87,507  
    152     BHP Billiton Plc     3,252  
    500     BP Plc Sponsored ADR     21,440  
    14,806     British American Tobacco Plc     715,977  
    400     British American Tobacco Plc Sponsored ADR     19,352  
    2,117     Britvic Plc     22,402  
    9,151     Cobham Plc *     14,790  
    9,654     Direct Line Insurance Group Plc     41,474  
    1,788     easyJet Plc     35,421  
    4,185     Electrocomponents Plc     40,339  
    2,862     Evraz Plc     18,508  
    12,309     Ferrexpo Plc     24,847  
    654     Galliford Try Plc     8,248  
    22,500     GlaxoSmithKline Plc Sponsored ADR     911,250  
    4,999     Grainger Plc     19,938  
    1,658     Hammerson Plc (REIT)     10,154  
    45,789     HSBC Holdings Plc     398,546  
    2,600     HSBC Holdings Plc Sponsored ADR     114,426  
    8,754     IG Group Holdings Plc     102,795  
    528     Imperial Brands Plc     18,812  
    4,773     Intu Properties Plc (REIT)     9,779  
    5,193     Investec Plc     34,160  
    6,818     J Sainsbury Plc     28,700  
    1,649     Land Securities Group Plc (REIT)     19,628  
    170,328     Legal & General Group Plc     562,873  
    599,897     Lloyds Banking Group Plc     462,112  
    1,227     Meggitt Plc     8,574  
    1,812     Mondi Plc     50,494  
    2,990     Northgate Plc     15,890  
    
Shares
    Description   Value ($)  
    United Kingdom — Continued

 

    11,204     Persimmon Plc     354,460  
    3,866     Plus500 Ltd     77,235  
    15,832     QinetiQ Group Plc     55,752  
    10,256     Quilter Plc     18,727  
    11,472     Reckitt Benckiser Group Plc     977,210  
    2,867     Royal Dutch Shell Plc A Shares (London)     93,275  
    206     Royal Dutch Shell Plc B Shares (London)     6,819  
    11,628     Royal Dutch Shell Plc – Class A     378,182  
    1,200     Royal Dutch Shell Plc – Class A Sponsored ADR     78,276  
    900     Royal Dutch Shell Plc – Class B Sponsored ADR     60,642  
    21,905     Royal Mail Plc     127,382  
    1,785     Savills Plc     18,535  
    5,923     Segro Plc (REIT)     50,641  
    2,321     Spectris Plc     70,958  
    5,174     TUI AG     95,504  
    14,068     Unilever Plc     801,661  
    1,767     Vedanta Resources Plc     19,195  
    5,365     Vesuvius Plc     43,222  
    26,154     William Hill Plc     87,385  
     

 

 

 
    Total United Kingdom     7,841,123  
     

 

 

 
    United States — 24.9%

 

    3,111     3M Co.     656,172  
    7,371     Abbott Laboratories     492,678  
    6,400     Accenture Plc – Class A     1,082,048  
    1,800     Alphabet, Inc. – Class C *     2,192,742  
    8,729     American Express Co.     925,099  
    3,100     Amphenol Corp. – Class A     293,198  
    3,569     Anthem, Inc.     944,821  
    10,475     Apple, Inc.     2,384,424  
    1,779     Becton Dickinson and Co.     465,867  
    20,851     Cisco Systems, Inc.     996,052  
    12,367     Coca-Cola Co. (The)     551,197  
    10,266     Cognizant Technology Solutions Corp. – Class A     805,162  
    4,814     Costco Wholesale Corp.     1,122,288  
    3,522     Facebook, Inc. – Class A *     618,921  
    2,600     Honeywell International, Inc.     413,556  
    8,400     Johnson & Johnson     1,131,396  
    1,563     Mastercard, Inc. – Class A     336,920  
    11,667     Medtronic Plc     1,124,816  
    13,611     Merck & Co., Inc.     933,579  
    19,551     Microsoft Corp.     2,196,164  
    36,182     Oracle Corp.     1,757,722  
    1,766     PepsiCo, Inc.     197,810  
    5,384     Philip Morris International, Inc.     419,360  
    14,909     QUALCOMM, Inc.     1,024,397  
    1,526     Stryker Corp.     258,550  
 

 

8   See accompanying notes to the financial statements.  


GMO Alpha Only Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    United States — continued

 

    4,100     Teradata Corp. *     170,027  
    6,381     Texas Instruments, Inc.     717,224  
    9,016     TJX Cos., Inc. (The)     991,490  
    5,292     UnitedHealth Group, Inc.     1,420,690  
    5,889     United Technologies Corp.     775,581  
    16,953     US Bancorp     917,327  
    3,500     Visa, Inc. – Class A     514,115  
    16,323     Wells Fargo & Co.     954,569  
     

 

 

 
    Total United States     29,785,962  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $104,171,004)
    105,146,007  
     

 

 

 
    PREFERRED STOCKS (b) — 1.0%

 

    Brazil — 0.2%

 

    11,368     Banco Bradesco SA     79,209  
    2,400     Banco Bradesco SA ADR     16,656  
    18,800     Banco do Estado do Rio Grande do Sul SA – Class B     67,619  
    1,140     Itau Unibanco Holding SA     11,831  
     

 

 

 
    Total Brazil     175,315  
     

 

 

 
    Colombia — 0.0%

 

    37,891     Grupo Aval Acciones y Valores SA     14,927  
     

 

 

 
    Germany — 0.3%

 

    136     Draegerwerk AG & Co KGaA     10,977  
    243     Sixt SE     20,306  
    2,036     Volkswagen AG     332,820  
     

 

 

 
    Total Germany     364,103  
     

 

 

 
    Russia — 0.0%

 

    27,445     Surgutneftegas OJSC     15,231  
     

 

 

 
    South Korea — 0.5%

 

    12,700     Samsung Electronics Co Ltd     452,517  
    148     Samsung Electronics Co Ltd GDR     130,431  
     

 

 

 
    Total South Korea     582,948  
     

 

 

 
    TOTAL PREFERRED STOCKS
(COST $1,064,876)
    1,152,524  
     

 

 

 
    RIGHTS/WARRANTS — 0.0%

 

    Thailand — 0.0%

 

    3,633     BTS Group Holdings Pcl (Foreign Registered), Expires 12/31/19 *      
     

 

 

 
    TOTAL RIGHTS/WARRANTS
(COST $0)
     
     

 

 

 
    
Shares
    Description   Value ($)  
    MUTUAL FUNDS — 6.3%  
    United States — 6.3%  
          Affiliated Issuers — 6.3%      
    299,286     GMO U.S. Treasury Fund     7,476,175  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $7,476,175)
    7,476,175  
     

 

 

 
    SHORT-TERM INVESTMENTS — 6.5%

 

    Money Market Fund — 0.2%

 

    257,226     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (c)     257,226  
     

 

 

 
    U.S. Government — 6.3%

 

    2,600,000     U.S. Treasury Bill, 1.13%, due 01/10/19 (d) (e)     2,580,170  
    2,500,000     U.S. Treasury Bill, 1.96%, due 11/08/18 (d) (e)     2,490,792  
    2,500,000     U.S. Treasury Bill, 1.96%, due 11/15/18 (d) (e)     2,489,825  
     

 

 

 
    Total U.S. Government     7,560,787  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $7,817,314)
    7,818,013  
     

 

 

 
    TOTAL INVESTMENTS — 101.8%
(Cost $120,529,369)
    121,592,719  
    Other Assets and Liabilities (net) — (1.8%)     (2,095,057
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $119,497,662  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   9


GMO Alpha Only Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Forward Currency Contracts

 

Settlement
Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
   

Net
Un-
realized
Appre-
ciation
(Depre-
ciation)
($)

 
10/15/2018   GS     AUD       25,764       USD       19,030     $ 508  
10/15/2018   MSCI     AUD       1,407,424       USD       1,041,652       29,843  
10/15/2018   SSB     AUD       89,395       USD       66,185       1,918  
10/12/2018   BOA     CHF       274,396       USD       277,701       (6,308
10/12/2018   MSCI     CHF       769,511       USD       780,576       (15,896
10/12/2018   SSB     CHF       9,485       USD       9,598       (220
09/19/2018   MSCI     EUR       8,402,469       USD       9,820,154       57,040  
09/19/2018   SSB     EUR       371,682       USD       436,135       4,266  
09/19/2018   BCLY     GBP       57,661       USD       75,814       1,018  
09/19/2018   GS     GBP       302,239       USD       398,250       6,197  
09/19/2018   JPM     GBP       3,287,927       USD       4,371,089       106,120  
09/19/2018   SSB     GBP       19,765       USD       25,963       325  
09/18/2018   BCLY     JPY       165,741,813       USD       1,497,043       4,053  
09/18/2018   JPM     JPY       1,323,360,425       USD       12,067,687       146,958  
09/18/2018   SSB     JPY       1,293,670       USD       11,696       42  
10/12/2018   BOA     NOK       8,141,592       USD       1,013,984       41,717  
10/12/2018   GS     NOK       865,660       USD       106,105       2,728  
10/12/2018   BCLY     SEK       9,171,200       USD       1,054,825       49,070  
10/12/2018   GS     SEK       106,552       USD       12,115       430  
10/12/2018   SSB     SEK       2,539,796       USD       290,103       11,578  
09/18/2018   GS     USD       354,167       JPY       38,973,700       (3,095
09/18/2018   JPM     USD       4,620,498       JPY       507,715,600       (47,035
09/19/2018   JPM     USD       474,708       EUR       404,200       (5,054
           

 

 

 
            $ 386,203  
           

 

 

 

Futures Contracts

 

Number

of
Contracts +

 

Type

  Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation) ($)
 
Sales        
735   S&P 500 E-Mini   September 2018   $ 106,652,175     $ (4,276,176
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

 

Sales - Fund is short the futures contract.

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

Notes to Schedule of Investments:

 

*

Non-income producing security.

 

(a)

Investment valued using significant unobservable inputs (Note 2).

 

(b)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(c)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(d)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(e)

The rate shown represents yield-to-maturity.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

 

10   See accompanying notes to the financial statements.  


GMO Benchmark-Free Allocation Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    52.3

Debt Obligations

    38.9  

Short-Term Investments

    6.2  

Preferred Stocks

    0.8  

Mutual Funds

    0.3  

Investment Funds

    0.3  

Swap Contracts

    0.1  

Forward Currency Contracts

    0.1  

Loan Participations

    0.0

Purchased Options

    0.0

Rights/Warrants

    0.0

Loan Assignments

    0.0

Reverse Repurchase Agreements

    (0.0 )^ 

Written/Credit Linked Options

    (0.0 )^ 

Futures Contracts

    (0.6

Securities Sold Short

    (2.6

Other

    4.2  
 

 

 

 
    100.0 % 
 

 

 

 

 

Country/Region Summary¤   Debt Obligations as a
% of Total Net Assets
 

United States

    11.6

Other Emerging

    1.9 † 

Canada

    1.5  

Other Developed

    0.2 ‡ 

Euro Region

    0.0 ^# 

Japan

    (1.2

United Kingdom

    (3.4
 

 

 

 
    10.6 % 
 

 

 

 

 

Country/Region Summary¤   Equity Investments as a
% of Total Net Assets
 

United States

    8.7

China

    6.1  

Other Developed

    5.5 ‡ 

Taiwan

    4.3  

Japan

    3.9  

Other Emerging

    3.3 † 

United Kingdom

    3.2  

South Korea

    2.3  

Germany

    2.3  

Russia

    2.2  

South Africa

    2.0  

Brazil

    1.3  

India

    1.3  

Canada

    1.3  

Thailand

    1.2  

Switzerland

    1.1  

France

    1.1  
 

 

 

 
    51.1 % 
 

 

 

 
&

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments. The table includes exposure through the use of certain derivative financial instruments and excludes exposure through certain currency linked derivatives such as forward currency contracts and currency options. The table is based on duration adjusted net exposures (both investments and derivatives), taking into account the market value of securities and the notional amounts of swaps and other derivative financial instruments. For example, U.S. asset-backed securities may represent a relatively small percentage due to their short duration, even though they represent a large percentage of market value (direct and indirect). Duration is based on GMO’s models. The greater the duration of a bond, the greater its contribution to the concentration percentage. Credit default swap exposures are factored into the duration adjusted exposure using the reference security and applying the same methodology to that security. The tables are not normalized, thus, due to the exclusions listed above and negative exposures, which may be attributable to derivatives or short sales, if any, the tables may not total to 100%.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Total Net Assets.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Total Net Assets.

 

#

“Euro Region” is comprised of derivative financial instruments attributed to the Eurozone and not a particular country.

 

^

Rounds to 0.0%.

 

 

11


GMO Benchmark-Free Allocation Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    MUTUAL FUNDS — 100.0%

 

    Affiliated Issuers — 100.0%

 

    11,641,097     GMO Emerging Country Debt Fund, Class IV     312,563,466  
    7,378,718     GMO High Yield Fund, Class VI     150,525,852  
    732,425,047     GMO Implementation Fund     9,946,332,141  
    21,167,843     GMO Opportunistic Income Fund, Class VI     565,393,078  
    11,259,912     GMO Risk Premium Fund, Class VI     319,218,502  
    29,398,146     GMO SGM Major Markets Fund, Class VI     941,622,617  
    16,155,873     GMO Special Opportunities Fund, Class VI     316,816,668  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $12,214,810,128)
    12,552,472,324  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.1%

 

    Money Market Funds — 0.1%

 

    7,583,551     State Street Institutional Treasury Plus Money Market Fund-Premier Class, 1.88% (a)     7,583,551  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $7,583,551)
    7,583,551  
     

 

 

 
    TOTAL INVESTMENTS — 100.1%
(Cost $12,222,393,679)
    12,560,055,875  
    Other Assets and Liabilities (net) — (0.1%)     (6,936,476
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $12,553,119,399  
     

 

 

 

Notes to Schedule of Investments:

 

(a)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

 

12   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    54.8

Debt Obligations

    33.8  

Short-Term Investments

    9.7  

Preferred Stocks

    1.1  

Investment Funds

    0.3  

Swap Contracts

    0.1  

Forward Currency Contracts

    0.1  

Loan Participations

    0.0

Rights/Warrants

    0.0

Purchased Options

    0.0

Loan Assignments

    0.0

Written/Credit Linked Options

    (0.0 )^ 

Reverse Repurchase Agreements

    (0.0 )^ 

Futures Contracts

    (0.5

Securities Sold Short

    (1.3

Other

    1.9  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary¤   Debt Obligations as a
% of Total Net Assets
 

United States

    12.7

Other Emerging

    2.2 † 

Euro Region

    0.0 ^# 

Other Developed

    (1.1 )‡ 
 

 

 

 
    13.8 % 
 

 

 

 
 
Country/Region Summary¤   Equity Investments as a
% of Total Net Assets
 

China

    8.1

United States

    6.3  

Taiwan

    5.1  

Japan

    4.7  

Other Developed

    4.3 ‡ 

Other Emerging

    3.6 † 

United Kingdom

    3.2  

South Korea

    3.2  

Russia

    2.5  

Germany

    2.1  

India

    2.0  

South Africa

    2.0  

Brazil

    1.5  

Thailand

    1.5  

Canada

    1.5  

France

    1.2  

Switzerland

    1.1  

Sweden

    1.0  
 

 

 

 
    54.9 % 
 

 

 

 
&

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments. The table includes exposure through the use of certain derivative financial instruments and excludes exposure through the use of certain currency linked derivatives such as forward currency contracts and currency options. The table is based on duration adjusted net exposures (both investments and derivatives), taking into account the market value of securities and the notional amounts of swaps and other derivative financial instruments. For example, U.S. asset-backed securities may represent a relatively small percentage due to their short duration, even though they represent a large percentage of market value (direct and indirect). Duration is based on GMO’s models. The greater the duration of a bond, the greater its contribution to the concentration percentage. Credit default swap exposures are factored into the duration adjusted exposure using the reference security and applying the same methodology to that security. The tables are not normalized, thus, due to the exclusions listed above and negative exposures, which may be attributable to derivatives or short sales, if any, the tables may not total to 100%.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Total Net Assets.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Total Net Assets.

 

#

“Euro Region” is comprised of derivative financial instruments attributed to the Eurozone and not a particular country.

 

^

Rounds to 0.0%.

 

 

13


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    COMMON STOCKS — 41.4%

 

    Australia — 0.8%

 

    7,764     Altium Ltd     156,843  
    35,634     Australia & New Zealand Banking Group Ltd     757,250  
    191,041     Beach Energy Ltd     267,034  
    12,054     Brickworks Ltd     151,688  
    228,449     Caltex Australia Ltd     4,964,262  
    52,601     Charter Hall Group (REIT)     269,648  
    40,010     Codan Ltd     89,625  
    204,284     Costa Group Holdings Ltd     1,063,438  
    8,241     Credit Corp Group Ltd     136,797  
    34,164     Cromwell Property Group (REIT)     27,155  
    7,022     Crown Resorts Ltd     71,810  
    12,985     CSL Ltd     2,128,714  
    215,016     CSR Ltd     666,595  
    611,645     Downer EDI Ltd     3,402,747  
    7,585     Elders Ltd     36,382  
    15,707     Folkestone Education Trust (REIT)     31,138  
    33,484     GDI Property Group (REIT)     30,555  
    181,394     Genworth Mortgage Insurance Australia Ltd     344,758  
    5,324     Lovisa Holdings Ltd     41,646  
    92,187     Macquarie Group Ltd     8,622,546  
    3,238     McMillan Shakespeare Ltd     41,655  
    319,075     Metcash Ltd     635,327  
    186,543     Mineral Resources Ltd     2,031,992  
    33,169     Mirvac Group (REIT)     58,112  
    3,161     Monadelphous Group Ltd     32,680  
    242,495     Nine Entertainment Co Holdings Ltd     421,341  
    171,413     OZ Minerals Ltd     1,114,500  
    15,539     Pact Group Holdings Ltd     46,023  
    148,096     Sandfire Resources NL     755,163  
    381,954     Scentre Group (REIT)     1,130,826  
    15,786     Shopping Centres Australasia Property Group (REIT)     27,402  
    54,876     Sigma Healthcare Ltd     22,509  
    5,731     St Barbara Ltd     16,173  
    34,403     Stockland (REIT)     102,358  
    13,028     Virtus Health Ltd     54,522  
    25,340     WPP AUNZ Ltd     15,659  
     

 

 

 
    Total Australia     29,766,873  
     

 

 

 
    Austria — 0.2%

 

    1,657     FACC AG     41,823  
    2,064     Oesterreichische Post AG     91,205  
    101,346     OMV AG     5,373,059  
    3,242     POLYTEC Holding AG     40,155  
    5,220     S IMMO AG     109,684  
    3,638     Vienna Insurance Group AG Wiener Versicherung Gruppe     99,213  
    
Shares
    Description   Value ($)  
    Austria — continued

 

    27,310     voestalpine AG     1,227,538  
     

 

 

 
    Total Austria     6,982,677  
     

 

 

 
    Belgium — 0.1%

 

    22,610     AGFA-Gevaert NV *     99,289  
    3,540     Barco NV     487,124  
    1,729     D’ieteren SA     76,669  
    8,507     KBC Group NV     604,846  
    6,372     UCB SA     583,288  
     

 

 

 
    Total Belgium     1,851,216  
     

 

 

 
    Brazil — 1.1%

 

    167,000     Ambev SA ADR     776,550  
    14,700     Banco Bradesco SA     90,623  
    295,600     Banco BTG Pactual SA     1,487,761  
    484,600     Banco do Brasil SA     3,581,169  
    919,400     Banco Santander Brasil SA     7,810,081  
    20,500     BB Seguridade Participacoes SA     123,208  
    1,040,500     Cia de Saneamento Basico do Estado de Sao Paulo     6,233,140  
    134,900     Cia de Saneamento Basico do Estado de Sao Paulo ADR     810,749  
    38,500     Cia de Saneamento de Minas Gerais-COPASA     395,861  
    37,700     Cielo SA     139,763  
    13,200     Construtora Tenda SA *     95,603  
    7,000     Cosan SA     59,807  
    3,600     Embraer SA Sponsored ADR (a)     69,084  
    10,500     Equatorial Energia SA     146,940  
    296,800     Estacio Participacoes SA     1,642,452  
    178,700     Grendene SA     314,132  
    4,257,200     JBS SA     9,824,871  
    110,000     Kroton Educacional SA     276,006  
    27,200     Mahle-Metal Leve SA     168,485  
    79,100     MRV Engenharia e Participacoes SA     252,461  
    9,700     Multiplus SA     57,941  
    651,740     Petrobras Distribuidora SA     3,165,014  
    15,000     QGEP Participacoes SA     44,929  
    1,850     Qualicorp Consultoria e Corretora de Seguros SA     7,158  
    2,400     SLC Agricola SA     38,889  
    7,900     Smiles Fidelidade SA     100,682  
    36,000     Tim Participacoes SA     108,625  
    43,000     Transmissora Alianca de Energia Eletrica SA     212,197  
    18,500     Ultrapar Participacoes SA     186,994  
    7,900     Ultrapar Participacoes SA Sponsored ADR     80,738  
    155,900     Via Varejo SA     646,856  
     

 

 

 
    Total Brazil     38,948,769  
     

 

 

 
 

 

14   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Canada — 1.6%

 

    28,600     AGF Management Ltd – Class B     134,782  
    17,200     Bank of Montreal     1,409,873  
    34,300     Bank of Montreal (a) (b)     2,811,228  
    24,000     Bank of Nova Scotia (The)     1,389,600  
    38,900     Bank of Nova Scotia (The)     2,251,431  
    11,600     Baytex Energy Corp *     34,684  
    51,837     BRP Inc Sub Voting     2,705,852  
    9,000     Canaccord Genuity Group Inc     48,621  
    4,100     Canadian Imperial Bank of Commerce     384,088  
    31,500     Canadian Imperial Bank of Commerce     2,952,069  
    41,700     Canfor Corp *     961,497  
    4,200     Canfor Pulp Products Inc     88,087  
    1,200     Cascades Inc     12,202  
    1,800     Celestica Inc *     22,138  
    3,800     Cogeco Inc     180,740  
    600     Constellation Software Inc     457,513  
    6,200     Dollarama Inc     234,460  
    21,300     Empire Co Ltd – A Shares     406,087  
    600     George Weston Ltd     46,731  
    1,400     Industrial Alliance Insurance & Financial Services Inc     58,038  
    10,000     Interfor Corp *     172,107  
    15,100     Labrador Iron Ore Royalty Corp     293,900  
    26,400     Magna International Inc (b)     1,428,768  
    47,200     Magna International Inc     2,555,672  
    4,500     Martinrea International Inc     48,690  
    5,700     Medical Facilities Corp     68,618  
    7,900     Metro Inc     247,352  
    31,700     National Bank of Canada     1,586,457  
    6,800     Norbord Inc     258,765  
    28,200     Rogers Sugar Inc     117,122  
    201,400     Royal Bank of Canada     15,997,796  
    50,700     Russel Metals Inc     1,108,407  
    120,100     Sun Life Financial Inc (b)     4,772,774  
    27,300     Sun Life Financial Inc     1,085,096  
    13,400     TFI International Inc     497,392  
    94,500     Toronto-Dominion Bank (The)     5,695,345  
    69,500     Transcontinental Inc – Class A     1,693,031  
    3,900     Valener Inc     59,919  
    11,200     Wajax Corp     237,646  
    48,600     West Fraser Timber Co Ltd     3,223,986  
    9,400     ZCL Composites Inc     56,112  
     

 

 

 
    Total Canada     57,794,676  
     

 

 

 
    Chile — 0.0%

 

    42,485     AES Gener SA     10,670  
    3,516     Inversiones La Construccion SA     57,328  
     

 

 

 
    Total Chile     67,998  
     

 

 

 
    
Shares
    Description   Value ($)  
    China — 5.8%

 

    88,000     361 Degrees International Ltd     25,256  
    6,000     AAC Technologies Holdings Inc     66,685  
    2,709,668     Agile Group Holdings Ltd     4,431,878  
    36,013,000     Agricultural Bank of China Ltd – Class H     17,451,041  
    106,300     Anhui Conch Cement Co Ltd – Class A     579,068  
    133,500     Anhui Conch Cement Co Ltd – Class H     814,407  
    36,000     Anhui Expressway Co Ltd – Class H     20,881  
    17,000     ANTA Sports Products Ltd     92,705  
    2,465,500     BAIC Motor Corp Ltd – Class H     2,074,373  
    23,200     Baidu Inc Sponsored ADR * (b)     5,254,336  
    2,973,000     Bank of China Ltd – Class H     1,335,939  
    5,497,000     Bank of Communications Co Ltd – Class H     3,972,566  
    44,000     Baoye Group Co Ltd – Class H *     25,978  
    175,000     Cabbeen Fashion Ltd     56,434  
    42,100     Cangzhou Mingzhu Plastic Co Ltd – Class A     28,841  
    15,400     Changyou.com Ltd ADR     207,746  
    3,776,000     China CITIC Bank Corp Ltd – Class H     2,359,201  
    6,604,000     China Communications Services Corp Ltd – Class H     5,471,355  
    454,600     China Construction Bank Corp – Class A     458,816  
    2,866,000     China Construction Bank Corp – Class H     2,524,190  
    1,381,000     China Everbright Bank Co Ltd – Class H     577,432  
    2,154,000     China Greenfresh Group Co Ltd *     323,815  
    1,114,000     China Huarong Asset Management Co Ltd – Class H     231,580  
    3,279,000     China Lesso Group Holdings Ltd     1,892,304  
    222,000     China Lilang Ltd     246,243  
    2,850,000     China Machinery Engineering Corp – Class H     1,387,857  
    90,000     China Medical System Holdings Ltd     149,170  
    125,000     China Mobile Ltd     1,175,690  
    4,134,900     China National Building Material Co Ltd – Class H     3,874,461  
    174,000     China Overseas Land & Investment Ltd     551,497  
    13,900     China Petroleum & Chemical Corp ADR     1,380,409  
    492,800     China Petroleum & Chemical Corp – Class A     494,288  
    18,344,000     China Petroleum & Chemical Corp – Class H     18,457,484  
    162,000     China Pioneer Pharma Holdings Ltd     40,256  
    8,601,000     China Railway Construction Corp Ltd – Class H     10,404,856  
    2,521,042     China Railway Group Ltd – Class H     2,178,884  
    430,000     China Resources Cement Holdings Ltd     502,857  
    172,000     China Resources Land Ltd     599,979  
    1,418,500     China Resources Pharmaceutical Group Ltd     2,270,009  
    359,000     China SCE Group Holdings Ltd     161,158  
    45,600     China Shenhua Energy Co Ltd – Class A     123,771  
    1,473,000     China Shenhua Energy Co Ltd – Class H     3,289,946  
    495,000     China Shineway Pharmaceutical Group Ltd     699,520  
 

 

  See accompanying notes to the financial statements.   15


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    China — continued

 

    27,144,000     China Telecom Corp Ltd – Class H     12,765,892  
    288,000     China Travel International Investment Hong Kong Ltd     93,638  
    60,700     China Vanke Co Ltd – Class A     214,192  
    139,900     China Vanke Co Ltd – Class H     485,369  
    111,097     China Yangtze Power Co Ltd – Class A     257,664  
    23,300     China Yuchai International Ltd     468,563  
    38,100     Chongqing Department Store Co Ltd – Class A     160,262  
    3,649,000     Chongqing Rural Commercial Bank Co Ltd – Class H     1,968,200  
    82,000     CIFI Holdings Group Co Ltd     47,627  
    45,000     CNOOC Ltd     79,847  
    230,000     Country Garden Holdings Co Ltd     342,883  
    25,517     Country Garden Services Holdings Co Ltd *     43,109  
    100,000     Dah Chong Hong Holdings Ltd     43,490  
    221,099     Daqin Railway Co Ltd – Class A     279,540  
    20,100     Dashang Co Ltd – Class A     84,354  
    6,160,000     Dongfeng Motor Group Co Ltd – Class H     6,886,122  
    9,000     ENN Energy Holdings Ltd     82,045  
    97,100     Fangda Special Steel Technology Co Ltd – Class A     157,907  
    528,000     Geely Automobile Holdings Ltd     1,124,156  
    99,700     Gree Electric Appliances Inc of Zhuhai – Class A *     569,643  
    232,000     Guangdong Investment Ltd     411,865  
    762,000     Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd – Class H     2,807,539  
    4,705,079     Guangzhou R&F Properties Co Ltd – Class H     9,508,392  
    2,373,000     Haier Electronics Group Co Ltd *     6,188,428  
    24,000     Haitian International Holdings Ltd     48,164  
    1,544,000     Harbin Electric Co Ltd – Class H     485,770  
    114,300     Heilan Home Co Ltd – Class A     167,034  
    51,200     Henan Shuanghui Investment & Development Co Ltd – Class A     174,425  
    8,000     Hengan International Group Co Ltd     72,076  
    558,000     Hua Hong Semiconductor Ltd     1,523,556  
    2,842,000     Huabao International Holdings Ltd     1,674,675  
    74,000     IGG Inc     89,492  
    217,800     Industrial & Commercial Bank of China Ltd – Class A     173,713  
    1,969,000     Industrial and Commercial Bank of China Ltd – Class H     1,454,299  
    76,000     Jiangsu Expressway Co Ltd – Class H     96,118  
    49,000     JNBY Design Ltd     83,493  
    1,129,000     Kingboard Holdings Ltd     4,019,127  
    956,500     Kingboard Laminates Holdings Ltd     904,322  
    9,500     Legend Holdings Corp – Class H     29,418  
    499,680     Livzon Pharmaceutical Group Inc – Class H     2,018,349  
    92,400     Logan Property Holdings Co Ltd     115,610  
    
Shares
    Description   Value ($)  
    China — continued

 

    78,500     Longfor Group Holdings Ltd     218,350  
    7,152,000     Lonking Holdings Ltd     2,462,439  
    7,500     Momo Inc Sponsored ADR *     347,175  
    600     NetEase Inc ADR (a)     118,626  
    19,000     Nine Dragons Paper Holdings Ltd     21,576  
    136,000     People’s Insurance Co Group of China Ltd (The) – Class H     58,994  
    360,000     PICC Property & Casualty Co Ltd – Class H     405,924  
    8,418,000     Postal Savings Bank of China Co Ltd – Class H     4,961,741  
    1,235,000     Powerlong Real Estate Holdings Ltd     631,630  
    102,000     Qingling Motors Co Ltd – Class H     27,822  
    278,000     Road King Infrastructure Ltd     472,332  
    597,000     Shanghai Industrial Holdings Ltd     1,423,463  
    1,510,200     Shanghai Pharmaceuticals Holding Co Ltd – Class H     3,966,994  
    206,638     Shanghai SMI Holding Co Ltd – Class A     173,481  
    38,000     Shenzhen Expressway Co Ltd – Class H     36,869  
    152,000     Shenzhen Investment Ltd     49,806  
    8,000     Shenzhou International Group Holdings Ltd.     105,077  
    3,442,000     Shimao Property Holdings Ltd     10,279,093  
    1,120,000     Sino Biopharmaceutical Ltd     1,419,498  
    122,500     Sino-Ocean Group Holding Ltd     62,328  
    1,638,000     Sinotruk Hong Kong Ltd     2,446,383  
    2,046,000     SSY Group Ltd     1,903,659  
    349,098     Suning Universal Co Ltd – Class A     172,861  
    38,800     Tencent Holdings Ltd     1,667,901  
    3,800     Tencent Holdings Ltd ADR     163,932  
    267,500     Texhong Textile Group Ltd     460,349  
    646,000     Tianjin Port Development Holdings Ltd *     75,765  
    1,076,000     Tianneng Power International Ltd     1,337,438  
    35,000     Times China Holdings Ltd     41,569  
    1,749,000     TravelSky Technology Ltd – Class H     4,490,909  
    179,000     Uni-President China Holdings Ltd     176,389  
    3,089,000     Weichai Power Co Ltd – Class H     3,276,079  
    523,000     Xinhua Winshare Publishing and Media Co Ltd – Class H     348,630  
    2,006,000     Xtep International Holdings Ltd     1,340,300  
    42,000     Yuexiu Transport Infrastructure Ltd     32,662  
    5,945,000     Yuzhou Properties Co Ltd     3,163,563  
    6,000     YY Inc ADR *     458,580  
    306,000     Zhejiang Expressway Co Ltd – Class H     242,951  
    66,286     Zhejiang Weixing New Building Materials Co Ltd – Class A     164,456  
     

 

 

 
    Total China     205,673,124  
     

 

 

 
    Colombia — 0.1%

 

    144,314     Almacenes Exito SA     751,381  
    86,031     Ecopetrol SA     96,590  
 

 

16   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Colombia — continued

 

    71,500     Ecopetrol SA Sponsored ADR     1,615,900  
     

 

 

 
    Total Colombia     2,463,871  
     

 

 

 
    Czech Republic — 0.0%  
    15,021     Moneta Money Bank AS     52,504  
    252     Philip Morris CR AS     168,930  
     

 

 

 
    Total Czech Republic     221,434  
     

 

 

 
    Denmark — 0.2%

 

    36,300     Novo Nordisk A/S Sponsored ADR     1,784,871  
    109,852     Novo Nordisk A/S – Class B     5,407,592  
    376     Rockwool International A/S – Class B     163,384  
    9,927     Royal Unibrew A/S     855,476  
    8,488     Scandinavian Tobacco Group A/S     139,736  
    2,578     Schouw & Co AB     203,834  
    536     SimCorp A/S     50,769  
    3,592     Spar Nord Bank A/S     35,136  
     

 

 

 
    Total Denmark     8,640,798  
     

 

 

 
    Egypt — 0.0%

 

    37,976     Global Telecom Holding SAE *     9,052  
     

 

 

 
    Finland — 0.3%

 

    2,441     Cramo Oyj     51,607  
    4,644     DNA Oyj     98,813  
    4,169     Finnair Oyj     36,368  
    359     Kesko Oyj – B Shares     20,912  
    9,849     Metsa Board Oyj     99,240  
    39,545     Neste Oyj     3,433,401  
    19,281     Stora Enso Oyj – R Shares     358,858  
    2,487     Tieto Oyj     80,723  
    122,894     UPM-Kymmene Oyj     4,740,571  
     

 

 

 
    Total Finland     8,920,493  
     

 

 

 
    France — 1.3%

 

    3,147     AKWEL     76,516  
    7,526     Alten SA     779,303  
    13,315     AXA SA     335,548  
    94,725     BNP Paribas SA     5,576,740  
    1,005     Bonduelle SCA     33,480  
    17,283     Christian Dior SE     7,456,830  
    95,650     CNP Assurances     2,210,736  
    29,187     Coface SA     273,835  
    42,523     Credit Agricole SA     581,823  
    462     Dassault Systemes SE     74,974  
    8,748     Derichebourg SA     48,993  
    2,791     Eramet     239,118  
    2,576     Gaztransport Et Technigaz SA     176,245  
    655     Interparfums SA     30,374  
    
Shares
    Description   Value ($)  
    France — continued  
    1,220     Ipsen SA     217,408  
    4,876     IPSOS (b)     154,562  
    2,872     Jacquet Metal Service     83,913  
    2,352     Kaufman & Broad SA     123,858  
    33,628     L’Oreal SA     8,050,741  
    2,254     Mersen SA     88,254  
    10,993     Metropole Television SA     217,649  
    94,349     Natixis SA     631,004  
    430     Nexity SA     26,278  
    7,715     Peugeot SA     212,582  
    2,381     Rallye SA     24,719  
    46,321     Sanofi     3,977,740  
    36,800     Sanofi ADR (a)     1,576,880  
    4,034     Schneider Electric SE     327,823  
    22,080     SCOR SE     892,589  
    27,897     Societe Generale SA     1,142,306  
    322,900     STMicroelectronics NV – NY Shares (Registered)     6,680,801  
    174,745     STMicroelectronics NV     3,605,441  
    614     Vilmorin & Cie SA     42,597  
     

 

 

 
    Total France     45,971,660  
     

 

 

 
    Germany — 2.1%

 

    937     Aareal Bank AG     38,100  
    55,416     Allianz SE (Registered)     11,811,465  
    814     Amadeus Fire AG     93,838  
    44,833     BASF SE     4,142,817  
    4,182     Bayer AG (Registered)     390,282  
    145,041     Bayerische Motoren Werke AG     14,040,944  
    3,883     Cewe Stiftung & Co KGAA     356,997  
    80,745     Covestro AG (b)     6,874,744  
    194,909     Daimler AG (Registered Shares)     12,604,828  
    462,371     Deutsche Lufthansa AG (Registered)     12,080,626  
    34,496     Deutsche Pfandbriefbank AG     504,997  
    2,222     Elmos Semiconductor AG     57,397  
    7,135     Henkel AG & Co KGaA     796,165  
    2,917     Isra Vision AG     203,004  
    728     Koenig & Bauer AG     50,495  
    1,419     Muenchener Rueckversicherungs-Gesellschaft AG (Registered)     305,701  
    752     Rheinmetall AG     82,011  
    4,149     RWE AG     105,231  
    38,579     SAP AG     4,631,323  
    805     Siltronic AG     116,701  
    7,175     Software AG     353,822  
    2,158     Takkt AG     37,646  
    20,664     Talanx AG     780,299  
    18,791     Volkswagen AG     3,024,765  
    4,783     Wacker Neuson SE     132,235  
    654     Washtec AG     63,493  
 

 

  See accompanying notes to the financial statements.   17


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Germany — continued  
    2,753     Wuestenrot & Wuerttembergische AG     63,594  
     

 

 

 
    Total Germany     73,743,520  
     

 

 

 
    Greece — 0.0%

 

    12,055     FF Group * (c)     67,166  
     

 

 

 
    Hong Kong — 0.5%

 

    352,400     BOC Hong Kong Holdings Ltd     1,721,049  
    751,400     Champion (REIT)     552,666  
    38,000     CK Asset Holdings Ltd     271,006  
    41,700     Dah Sing Banking Group Ltd     86,010  
    2,800     Dah Sing Financial Holdings Ltd     17,415  
    78,000     Fortune Real Estate Investment Trust     93,433  
    8,100     Hang Seng Bank Ltd     219,746  
    90,100     Hysan Development Co Ltd     462,331  
    841,638     I-CABLE Communications Ltd *     9,547  
    35,000     Johnson Electric Holdings Ltd     102,626  
    221,800     Kerry Properties Ltd     841,137  
    54,800     Luk Fook Holdings International Ltd     190,688  
    1,739,900     SJM Holdings Ltd     1,969,935  
    10,300     SmarTone Telecommunications Holdings Ltd     10,422  
    7,669,500     WH Group Ltd     5,792,232  
    689,100     Wharf Holdings Ltd (The)     1,967,899  
    407,100     Wharf Real Estate Investment Co Ltd     2,701,046  
    339,500     Wheelock & Co Ltd     2,131,751  
    39,425     Xinyi Automobile Glass Hong Kong Enterprises Ltd *     9,596  
    18,000     Xinyi Glass Holdings Ltd     22,502  
    8,400     Yue Yuen Industrial Holdings Ltd     23,287  
     

 

 

 
    Total Hong Kong     19,196,324  
     

 

 

 
    Hungary — 0.0%

 

    733,294     Magyar Telekom Telecommunications Plc     1,074,870  
    7,155     Richter Gedeon Nyrt     140,498  
     

 

 

 
    Total Hungary     1,215,368  
     

 

 

 
    India — 1.6%

 

    565     ACC Ltd     13,109  
    23,117     Apollo Tyres Ltd     82,114  
    31,638     Aurobindo Pharma Ltd     318,380  
    2,476     Bajaj Auto Ltd     96,235  
    13,132     Balmer Lawrie & Co Ltd     42,622  
    137,242     Balrampur Chini Mills Ltd *     147,929  
    22,023     Bata India Ltd     336,778  
    11,377     Castrol India Ltd     25,518  
    12,475     Divi’s Laboratories Ltd     230,518  
    583,463     Firstsource Solutions Ltd     620,409  
    7,479     Gujarat State Petronet Ltd     20,279  
    873,986     HCL Technologies Ltd     12,876,195  
    
Shares
    Description   Value ($)  
    India — continued  
    46,273     Hero MotoCorp Ltd     2,129,048  
    278,822     Hexaware Technologies Ltd     1,725,555  
    66,933     Hindustan Unilever Ltd     1,677,581  
    108,196     HT Media Ltd     84,219  
    18,105     IDFC Bank Ltd     12,189  
    319,360     ITC Ltd     1,440,632  
    87,812     Jamna Auto Industries Ltd     100,819  
    20,330     Jubilant Life Sciences Ltd *     206,601  
    83,020     Just Dial Ltd *     654,736  
    12,597     KPIT Technologies Ltd     53,870  
    52,988     Larsen & Toubro Infotech Ltd     1,335,831  
    2,258     Mahanagar Gas Ltd     27,490  
    195,698     Mahindra & Mahindra Ltd     2,667,111  
    53,299     Maruti Suzuki India Ltd     6,845,885  
    11,280     Mastek Ltd     85,739  
    3,014     Merck Ltd     148,850  
    119,432     Mphasis Ltd     2,131,914  
    306     MRF Ltd     319,106  
    77,100     NHPC Ltd     27,631  
    120,379     NIIT Technologies Ltd     2,392,105  
    959,843     Oil & Natural Gas Corp Ltd     2,435,774  
    10,626     Oil India Ltd     32,054  
    400     Oracle Financial Services Software Ltd     23,603  
    2,838     Pidilite Industries Ltd     46,781  
    1,301     Piramal Enterprises Ltd     58,922  
    607,485     Power Finance Corp Ltd     724,285  
    739,608     PTC India Ltd     874,488  
    20,493     Rajesh Exports Ltd     192,067  
    400,527     Reliance Capital Ltd     2,660,423  
    3,690     Repco Home Finance Ltd     28,303  
    2,842,573     Rural Electrification Corp Ltd     4,809,390  
    116,413     Sonata Software Ltd     578,896  
    4,342     Tata Motors Ltd – Class A *     8,716  
    116,736     Tech Mahindra Ltd     1,261,575  
    40,975     Vakrangee Ltd     22,284  
    70,349     VIP Industries Ltd     619,829  
    322,015     Wipro Ltd     1,363,985  
    118,333     Zee Entertainment Enterprises Ltd     835,192  
     

 

 

 
    Total India     55,453,565  
     

 

 

 
    Indonesia — 0.2%

 

    2,114,300     Adaro Energy Tbk PT     268,074  
    134,000     Bank Central Asia Tbk PT     225,694  
    423,000     Bank Mandiri Persero Tbk PT     197,091  
    193,700     Bank Negara Indonesia Persero Tbk PT     102,605  
    1,202,700     Bank Pembangunan Daerah Jawa Timur Tbk PT     54,701  
    3,791,700     Bank Rakyat Indonesia Persero Tbk PT     819,259  
    655,000     Bukit Asam Tbk PT     180,133  
    165,100     Bumi Serpong Damai Tbk PT *     13,467  
 

 

18   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Indonesia — continued  
    2,551,400     Erajaya Swasembada Tbk PT     464,663  
    38,100     Gudang Garam Tbk PT     188,848  
    45,300     Indah Kiat Pulp & Paper Corp Tbk PT     58,775  
    1,092,900     Indo Tambangraya Megah Tbk PT     2,100,077  
    56,200     Link Net Tbk PT     16,412  
    78,500     Matahari Department Store Tbk PT     39,987  
    1,112,400     Mitra Pinasthika Mustika Tbk PT     74,026  
    2,601,400     Modernland Realty Tbk PT     44,908  
    6,154,600     Panin Financial Tbk PT *     85,308  
    112,900     PP Persero Tbk PT     14,577  
    965,000     Ramayana Lestari Sentosa Tbk PT     83,218  
    1,305,400     Surya Semesta Internusa Tbk PT     43,086  
    1,127,700     Telekomunikasi Indonesia Persero Tbk PT     267,855  
    2,200     Telekomunikasi Indonesia Persero Tbk PT Sponsored ADR     52,074  
    60,200     United Tractors Tbk PT     140,637  
    629,800     Waskita Beton Precast Tbk PT     16,689  
    67,400     XL Axiata Tbk PT *     14,547  
     

 

 

 
    Total Indonesia     5,566,711  
     

 

 

 
    Ireland — 0.1%

 

    12,600     ICON Plc *     1,877,652  
     

 

 

 
    Israel — 0.0%

 

    70,703     Bank Leumi Le-Israel BM     474,936  
    8,692     Discount Investment Corp Ltd (Registered)     26,254  
    5,220     First International Bank of Israel Ltd     120,915  
    9,801     Harel Insurance Investments & Financial Services Ltd     80,013  
    4,077     Nova Measuring Instruments Ltd *     122,619  
     

 

 

 
    Total Israel     824,737  
     

 

 

 
    Italy — 0.9%

 

    38,149     ACEA SPA     543,758  
    9,853     ASTM SPA     201,100  
    93,324     Cofide SPA     50,294  
    6,272     El.En. SPA     202,172  
    21,564     Enav SPA     106,610  
    487,312     Enel SPA     2,409,241  
    27,769     ERG SPA     575,191  
    150,644     EXOR NV     9,802,270  
    16,566     Falck Renewables SPA     39,231  
    31,164     Fiat Chrysler Automobiles NV *     527,600  
    624,000     Fiat Chrysler Automobiles NV *     10,676,640  
    37,665     Fincantieri SPA     55,839  
    5,940     FinecoBank Banca Fineco SPA     70,811  
    46,897     Hera SPA     147,128  
    439,595     Iren SPA     1,031,018  
    8,260     La Doria SPA     94,783  
    9,666     MARR SPA     271,622  
    
Shares
    Description   Value ($)  
    Italy — continued

 

    12,147     Mediobanca Banca di Credito Finanziario SPA     113,108  
    39,317     Poste Italiane SPA     302,869  
    1,507     Prima Industrie SPA     56,684  
    18,681     Recordati SPA     654,432  
    682     Reply SPA     45,119  
    26,638     Saras SPA     67,375  
    209,443     Societa Cattolica di Assicurazioni SC     1,699,796  
    21,964     Societa Iniziative Autostradali e Servizi SPA     306,194  
    566,952     Telecom Italia SPA-RSP     315,569  
    42,012     Unipol Gruppo SPA     173,463  
     

 

 

 
    Total Italy     30,539,917  
     

 

 

 
    Japan — 4.9%

 

    27,300     Aisin Seiki Co Ltd     1,262,705  
    16,000     AOKI Holdings Inc (b)     215,809  
    777,000     Asahi Kasei Corp (b)     11,385,789  
    523,300     Astellas Pharma Inc (b)     8,871,819  
    215,900     Brother Industries Ltd     4,429,042  
    237,300     Canon Inc     7,614,149  
    1,700     Capcom Co Ltd     39,623  
    10,400     Cawachi Ltd     198,564  
    500     Central Japan Railway Co     100,388  
    27,200     CKD Corp     401,753  
    32,900     Concordia Financial Group Ltd     157,874  
    13,500     Cosmo Energy Holdings Co Ltd (b)     497,417  
    7,100     Daiwabo Holdings Co Ltd     423,401  
    1,200     DCM Holdings Co Ltd     10,960  
    16,160     Denka Co Ltd     552,980  
    11,500     DTS Corp     471,317  
    8,200     Ehime Bank Ltd (The)     90,430  
    1,500     Eisai Co Ltd     135,835  
    9,500     Elecom Co Ltd     251,118  
    3,900     Exedy Corp     122,610  
    37,200     Fancl Corp     1,910,945  
    216,000     Fuji Electric Co Ltd     1,739,965  
    1,800     Fujicco Co Ltd     39,268  
    8,200     FUJIFILM Holdings Corp     346,354  
    355,000     Fujitsu Ltd     2,595,696  
    14,000     Fukuoka Financial Group Inc     78,494  
    1,900     Fuyo General Lease Co Ltd     114,052  
    3,800     Hakuhodo DY Holdings Inc     64,113  
    1,600     Hamakyorex Co Ltd     53,761  
    32,060     Hanwa Co Ltd     1,080,742  
    2,500     Heiwado Co Ltd     65,459  
    1,700     Hisamitsu Pharmaceutical Co Inc     124,186  
    1,846,000     Hitachi Ltd     12,049,889  
    30,600     Honda Motor Co Ltd     906,470  
    1,000     Horiba Ltd     61,925  
 

 

  See accompanying notes to the financial statements.   19


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Japan — continued  
    1,100     Hosokawa Micron Corp     66,573  
    32,700     House Foods Group Inc     969,471  
    5,200     Isuzu Motors Ltd     75,072  
    874,400     ITOCHU Corp     15,279,135  
    3,000     Japan Aviation Electronics Industry Ltd     54,902  
    8,900     JSR Corp     172,643  
    1,800     JTEKT Corp     25,196  
    30,700     JXTG Holdings Inc     216,154  
    1,100     Kaken Pharmaceutical Co Ltd     56,499  
    97,400     Kanematsu Corp     1,444,477  
    1,000     Kasai Kogyo Co Ltd     11,007  
    600     Kato Sangyo Co Ltd     19,486  
    28,200     KDDI Corp     745,603  
    9,700     Keihin Corp     203,840  
    300     Keyence Corp     169,832  
    34,500     Kirin Holdings Co Ltd (b)     852,572  
    16,000     Kitz Corp     140,154  
    14,600     Konica Minolta Inc     148,478  
    1,300     Kose Corp     239,698  
    13,100     Kyowa Exeo Corp (b)     366,337  
    6,000     Makino Milling Machine Co Ltd     55,379  
    339,300     Marubeni Corp     2,780,039  
    66,000     MCJ Co Ltd     596,663  
    3,300     Medipal Holdings Corp     66,554  
    1,616,000     Mitsubishi Chemical Holdings Corp     14,478,943  
    47,900     Mitsubishi Corp     1,365,967  
    663,000     Mitsubishi Electric Corp     8,950,151  
    103,600     Mitsubishi Gas Chemical Co Inc (b)     2,153,624  
    122,500     Mitsubishi Tanabe Pharma Corp     2,043,176  
    21,700     Mitsui & Co Ltd     361,495  
    32,300     Mitsui Chemicals Inc (b)     834,798  
    6,000     Mitsui Sugar Co Ltd     163,521  
    3,800     Mitsui Mining & Smelting Co Ltd     108,860  
    300     Modec Inc     9,079  
    600     Nachi-Fujikoshi Corp     29,108  
    1,100     NEC Corp     30,370  
    8,300     NET One Systems Co Ltd     192,240  
    52,000     Nichias Corp (b)     675,980  
    21,400     Nichiha Corp     600,872  
    2,900     Nihon Unisys Ltd     70,798  
    29,400     Nippo Corp     545,673  
    347,100     Nippon Telegraph & Telephone Corp     15,442,816  
    2,000     Nippon Flour Mills Co Ltd     33,453  
    4,000     Nisshin Oillio Group Ltd (The)     108,135  
    12,200     Nisshin Seifun Group Inc     244,013  
    23,000     Nisshinbo Holdings Inc     257,892  
    900     Nissin Corp     18,841  
    4,800     Nomura Real Estate Holdings Inc     103,979  
    500     Noritake Co Ltd     30,032  
    5,900     Noritsu Koki Co Ltd     153,548  
    
Shares
    Description   Value ($)  
    Japan — continued  
    37,500     NTT DOCOMO Inc     971,839  
    1,800     Okamura Corp     24,533  
    15,100     Open House Co Ltd     882,652  
    13,700     ORIX Corp     220,319  
    9,800     Osaki Electric Co Ltd     71,987  
    1,700     Otsuka Holdings Co Ltd     79,755  
    80,800     Pola Orbis Holdings Inc     2,847,537  
    2,300     Pressance Corp     35,191  
    173,000     Prima Meat Packers Ltd     858,791  
    5,500     Renesas Electronics Corp *     41,547  
    6,500     Resona Holdings Inc     36,869  
    1,900     Rion Co Ltd     40,208  
    32,800     Rohto Pharmaceutical Co Ltd     1,047,824  
    6,600     Roland DG Corp     154,876  
    7,500     Seiko Holdings Corp     209,714  
    157,300     Sekisui Chemical Co Ltd     2,732,643  
    13,600     Showa Corp     216,637  
    8,100     Showa Denko KK (b)     384,727  
    1,495,300     Sojitz Corp     5,203,443  
    1,217,000     Sumitomo Chemical Co Ltd (b)     6,907,466  
    12,700     Sumitomo Dainippon Pharma Co Ltd (b)     270,245  
    4,700     Sumitomo Forestry Co Ltd     75,917  
    11,240     Sumitomo Heavy Industries Ltd     365,718  
    15,500     Sumitomo Mitsui Financial Group Inc     609,358  
    4,300     Sumitomo Mitsui Trust Holdings Inc     172,537  
    2,300     Suntory Beverage & Food Ltd     94,210  
    1,300     Suzuken Co Ltd     59,034  
    200     T RAD Co Ltd     5,469  
    23,900     T-Gaia Corp     628,956  
    200     Taisho Pharmaceutical Holdings Co Ltd     21,678  
    3,400     Takara Holdings Inc     33,704  
    26,100     Takeda Pharmaceutical Co Ltd     1,087,356  
    10,200     Tatsuta Electric Wire and Cable Co Ltd     55,680  
    13,800     Tocalo Co Ltd     159,548  
    500     Token Corp     35,389  
    8,200     Tokio Marine Holdings Inc     386,399  
    34,000     Tokyo Electron Ltd     5,788,491  
    17,600     Tokyu Construction Co Ltd     161,711  
    2,000     Toshiba Machine Co Ltd     9,377  
    127,300     Tosoh Corp     1,997,368  
    2,000     Toyo Suisan Kaisha Ltd     73,664  
    101,100     Toyota Tsusho Corp     3,444,245  
    8,500     TPR Co Ltd     199,370  
    29,400     TS Tech Co Ltd     1,109,289  
    9,800     UKC Holdings Corp     215,894  
    1,600     Ushio Inc     21,096  
    10,800     Wacoal Holdings Corp     319,581  
    1,800     Yamazaki Baking Co Ltd     35,018  
    500     Yellow Hat Ltd     13,918  
 

 

20   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Japan — continued  
    12,300     Yuasa Trading Co Ltd     428,957  
     

 

 

 
    Total Japan     173,075,765  
     

 

 

 
    Malaysia — 0.2%  
    475,900     DRB-Hicom Berhad     262,103  
    156,500     KSL Holdings Berhad *     32,339  
    121,400     Malayan Flour Mills Berhad     34,768  
    159,600     Padini Holdings Berhad     232,264  
    10,500     Petronas Dagangan Berhad     69,321  
    69,400     Sapura Energy Berhad *     5,698  
    1,048,900     Supermax Corp Berhad     856,026  
    31,500     Tenaga Nasional Berhad     120,082  
    1,311,300     Top Glove Corp Berhad     3,552,905  
    83,000     UOA Development Berhad     49,020  
    53,600     YTL Power International Berhad     14,859  
     

 

 

 
    Total Malaysia     5,229,385  
     

 

 

 
    Mexico — 0.6%

 

    109,125     Arca Continental SAB de CV     674,847  
    16,000     Banco Santander Mexico SA Institucion de Banca Multiple Grupo Financiero Santand – Class B     25,350  
    18,100     Becle SAB de CV     25,693  
    136,929     Bolsa Mexicana de Valores SAB de CV     275,789  
    168,800     Cemex SAB de CV *     119,629  
    43,500     Cemex SAB de CV Sponsored ADR * (a)     308,415  
    61,900     Corp Inmobiliaria Vesta SAB de CV     87,641  
    3,700     El Puerto de Liverpool SAB de CV – Class C1     26,114  
    55,000     Fibra Uno Administracion SA de CV (REIT)     71,970  
    24,400     Fomento Economico Mexicano SAB de CV     233,716  
    4,500     Fomento Economico Mexicano SAB de CV Sponsored ADR     431,460  
    114,600     Gentera SAB de CV     116,308  
    33,350     Grupo Aeroportuario del Centro Norte SAB de CV     219,229  
    200     Grupo Aeroportuario del Centro Norte SAB de CV ADR     10,542  
    800     Grupo Aeroportuario del Pacifico SAB de CV ADR     82,648  
    8,200     Grupo Aeroportuario del Pacifico SAB de CV – Class B     84,729  
    400     Grupo Aeroportuario del Sureste SAB de CV ADR     75,036  
    2,785     Grupo Aeroportuario del Sureste SAB de CV – Class B     52,226  
    14,500     Grupo Bimbo SAB de CV – Class A     30,275  
    30,800     Grupo Financiero Banorte SAB de CV – Class O     210,076  
    17,400     Grupo Financiero Inbursa SAB de CV – Class O     27,687  
    
Shares
    Description   Value ($)  
    Mexico — continued  
    148,142     Grupo Herdez SAB de CV     318,612  
    18,700     Grupo Lala SAB de CV     19,899  
    53,500     Grupo Mexico SAB de CV – Series B     156,563  
    1,620     Industrias Penoles SAB de CV     27,445  
    105,300     Megacable Holdings SAB de CV CPO     496,317  
    26,500     Mexichem SAB de CV     89,423  
    11,245     Promotora y Operadora de Infraestructura SAB de CV     119,511  
    16,900     Unifin Financiera SAB de CV SOFOM ENR     43,114  
    6,113,838     Wal-Mart de Mexico SAB de CV     16,928,437  
     

 

 

 
    Total Mexico     21,388,701  
     

 

 

 
    Netherlands — 0.4%

 

    20,799     ASR Nederland NV     994,384  
    6,513     ForFarmers NV     72,838  
    30,715     Heineken Holding NV     2,930,624  
    470,729     ING Groep NV     6,394,280  
    2,728     Koninklijke Ahold Delhaize NV     66,452  
    2,545     Koninklijke Volkerwessels NV     54,676  
    14,036     Signify NV (b)     395,654  
    27,200     Wolters Kluwer NV     1,725,656  
     

 

 

 
    Total Netherlands     12,634,564  
     

 

 

 
    New Zealand — 0.0%

 

    676,416     Air New Zealand Ltd     1,476,693  
     

 

 

 
    Norway — 0.7%

 

    7,063     Aker ASA – A Shares     553,373  
    14,079     Aker Solutions ASA *     95,847  
    38,955     Austevoll Seafood ASA     512,587  
    27,356     Bakkafrost P/F     1,560,646  
    2,589     Borregaard ASA     24,614  
    469,929     DNB ASA     9,553,661  
    2,317     Entra ASA     33,592  
    300,557     Equinor ASA     7,709,348  
    11,107     Grieg Seafood ASA     127,782  
    42,773     Kvaerner ASA *     79,083  
    66,481     Leroy Seafood Group ASA     505,528  
    3,999     Marine Harvest ASA     86,369  
    9,498     Salmar ASA     457,292  
    5,489     Selvaag Bolig ASA     27,744  
    24,304     SpareBank 1 Nord Norge     190,105  
    10,671     SpareBank 1 SR Bank ASA     120,407  
    122,489     Storebrand ASA     1,084,390  
    89,740     Subsea 7 SA     1,220,046  
    13,044     TGS NOPEC Geophysical Co ASA     494,689  
     

 

 

 
    Total Norway     24,437,103  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   21


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Pakistan — 0.0%

 

    13,100     Engro Corp Ltd     34,715  
    38,000     Engro Fertilizers Ltd     24,179  
    37,600     Oil & Gas Development Co Ltd     46,043  
    6,350     Pakistan Oilfields Ltd     32,903  
     

 

 

 
    Total Pakistan     137,840  
     

 

 

 
    Peru — 0.0%

 

    500     Credicorp Ltd     109,010  
     

 

 

 
    Philippines — 0.0%

 

    279,000     Belle Corp     16,073  
    78,900     DMCI Holdings Inc     18,897  
    56,200     Eagle Cement Corp     17,069  
    107,500     First Gen Corp     34,190  
    1,890     GT Capital Holdings Inc     30,977  
    31,400     Jollibee Foods Corp     169,192  
    269,200     Lopez Holding Corp     23,660  
    266,200     LT Group Inc     85,619  
    42,600     Manila Electric Co     297,445  
    169,800     Manila Water Co Inc     77,505  
    492,000     Megaworld Corp     42,253  
    377,000     Metro Pacific Investments Corp     38,460  
    682,325     Nickel Asia Corp     69,330  
    134,500     Petron Corp     22,793  
    38,285     Pilipinas Shell Petroleum Corp     41,171  
    19,720     Puregold Price Club Inc     16,967  
    95,250     Semirara Mining & Power Corp     51,665  
     

 

 

 
    Total Philippines     1,053,266  
     

 

 

 
    Poland — 0.1%

 

    108,611     Asseco Poland SA     1,345,568  
    7,207     Bank Millennium SA *     17,492  
    11,945     Bank Polska Kasa Opieki SA     376,369  
    607     Bank Zachodni WBK SA     61,707  
    2,441     Budimex SA     75,013  
    501     CCC SA     29,181  
    2,863     CD Projekt SA *     159,506  
    42,398     Cyfrowy Polsat SA *     257,115  
    1,730     Dino Polska SA *     42,513  
    221,733     Energa SA     501,536  
    2,590     Grupa Lotos SA     48,693  
    60,510     Impexmetal SA *     65,107  
    2,120     KRUK SA     118,310  
    52     LPP SA     129,531  
    20,194     Polski Koncern Naftowy ORLEN SA     535,349  
    211,860     Polskie Gornictwo Naftowe i Gazownictwo SA *     331,895  
    28,536     Powszechna Kasa Oszczednosci Bank Polski SA     325,171  
    45,054     Powszechny Zaklad Ubezpieczen SA     542,573  
    
Shares
    Description   Value ($)  
    Poland — continued  
    684     Stalprodukt SA     85,516  
    1,608     Warsaw Stock Exchange     17,958  
     

 

 

 
    Total Poland     5,066,103  
     

 

 

 
    Portugal — 0.0%

 

    5,537     Altri SGPS SA     51,060  
    11,994     Navigator Co SA (The)     59,932  
    1,615     Semapa-Sociedade de Investimento e Gestao     33,397  
    391,292     Sonae SGPS SA     416,275  
     

 

 

 
    Total Portugal     560,664  
     

 

 

 
    Qatar — 0.0%

 

    23,108     Barwa Real Estate Co     228,499  
    7,847     Doha Bank QPSC     55,378  
    4,865     Masraf Al Rayan QSC     50,388  
    1,272     Qatar Electricity & Water Co QSC     66,815  
    13,840     Qatar Gas Transport Co Ltd     66,483  
    5,364     Qatar Insurance Co SAQ     54,243  
    1,532     Qatar Islamic Bank SAQ     58,915  
    12,331     Qatar National Bank QPSC     602,961  
    874     Qatar National Cement Co QSC     13,777  
    1,678     Qatar Navigation QSC     30,125  
     

 

 

 
    Total Qatar     1,227,584  
     

 

 

 
    Russia — 0.7%

 

    180,300     Aeroflot PJSC     308,837  
    492,700     Alrosa PJSC     741,106  
    1,327,000     ENEL RUSSIA PJSC     21,875  
    21,000     Gazprom Neft PJSC     104,572  
    1,381,973     Gazprom PJSC Sponsored ADR     6,095,731  
    18,080     Globaltrans Investment Plc Sponsored GDR (Registered)     199,015  
    3,853,000     Inter RAO UES PJSC     230,934  
    69,622     LUKOIL PJSC Sponsored ADR     4,811,061  
    14,840     M.Video PJSC *     95,323  
    143,400     Magnitogorsk Iron & Steel OJSC     103,236  
    4,588     Magnitogorsk Iron & Steel Works PJSC Sponsored GDR (Registered)     43,810  
    78,331     MMC Norilsk Nickel PJSC ADR     1,299,931  
    131,400     Mobile TeleSystems PJSC Sponsored ADR     1,018,350  
    349,700     Moscow Exchange MICEX-RTS PJSC     507,935  
    12,810     Novatek PJSC     205,904  
    8,843     Novatek PJSC Sponsered GDR (Registered)     1,478,779  
    70,760     Novolipetsk Steel PJSC     173,624  
    24,024     Novolipetsk Steel PJSC GDR     583,452  
    3,740     PhosAgro PJSC GDR (Registered)     49,558  
    1,116     Polyus PJSC     72,417  
    5,687     Polyus PJSC GDR (Registered)     184,331  
    16,000     QIWI Plc Sponsored ADR *     227,200  
 

 

22   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Russia — continued  
    13,680     Raspadskaya OJSC *     20,195  
    349,700     Rostelecom PJSC     350,527  
    1,611     Rostelecom PJSC Sponsored ADR     9,685  
    1,470     Safmar Financial Investment     17,479  
    109,000     Sberbank of Russia PJSC     292,989  
    325,372     Sberbank of Russia Sponsored ADR     3,543,392  
    5,900     Severstal PJSC     95,063  
    23,869     Severstal PJSC GDR (Registered)     384,081  
    121,700     Surgutneftegas PJSC     51,885  
    8,454     Surgutneftegas PJSC Sponsored ADR     35,187  
    37,760     Tatneft PJSC     438,902  
    11,815     Tatneft PJSC Sponsored ADR     819,201  
    6,125     TCS Group Holding Plc GDR (Registered)     112,753  
     

 

 

 
    Total Russia     24,728,320  
     

 

 

 
    Singapore — 0.1%

 

    13,900     China Aviation Oil Singapore Corp Ltd     15,784  
    67,700     Frasers Centrepoint Trust (REIT)     113,406  
    87,800     Japfa Ltd     42,896  
    320,000     Mapletree North Asia Commercial Trust (REIT)     270,415  
    13,300     Oversea-Chinese Banking Corp Ltd     109,458  
    29,000     Parkway Life Real Estate Investment Trust     56,611  
    54,600     UMS Holdings Ltd     29,699  
    15,700     United Overseas Bank Ltd     309,423  
    215,800     Venture Corp Ltd     2,849,044  
    710,400     Yangzijiang Shipbuilding Holdings Ltd     553,961  
    416,600     Yanlord Land Group Ltd     461,631  
     

 

 

 
    Total Singapore            4,812,328  
     

 

 

 
    South Africa — 1.4%

 

    832,507     Absa Group Ltd     9,207,641  
    15,674     Alviva Holdings Ltd     19,410  
    105,991     Astral Foods Ltd     1,866,673  
    456,352     Aveng Ltd *     1,551  
    33,124     AVI Ltd     261,371  
    211,412     Barloworld Ltd     1,798,065  
    5,681     BID Corp Ltd     121,215  
    3,730     Bidvest Group Ltd (The)     54,814  
    1,616,217     Blue Label Telecoms Ltd     787,362  
    6,864     Brait SE *     17,434  
    1,458     Capitec Bank Holdings Ltd     99,573  
    21,774     Clicks Group Ltd     300,721  
    12,978     Coronation Fund Managers Ltd     50,841  
    13,581     Dis-Chem Pharmacies Ltd     31,276  
    9,847     Discovery Ltd     117,334  
    1,715     Distell Group Holdings Ltd *     14,235  
    21,287     Emira Property Fund Ltd (REIT)     23,127  
    26,584     Exxaro Resources Ltd     269,457  
    105,101     FirstRand Ltd     505,618  
    
Shares
    Description   Value ($)  
    South Africa — continued  
    10,470     Foschini Group Ltd (The)     124,388  
    172,917     Growthpoint Properties Ltd (REIT)     299,344  
    4,953     Hyprop Investments Ltd (REIT)     34,381  
    8,438     Imperial Holdings Ltd     118,233  
    4,003     JSE Ltd     44,110  
    108,906     Kumba Iron Ore Ltd     1,963,257  
    23,626     Lewis Group Ltd     45,507  
    349,146     Liberty Holdings Ltd     2,762,313  
    6,434     Massmart Holdings Ltd     48,495  
    1,434,339     Merafe Resources Ltd     147,340  
    50,505     Metair Investments Ltd     60,051  
    62,576     MMI Holdings Ltd     72,975  
    77,391     Mondi Ltd     2,159,372  
    143,436     Mr Price Group Ltd     2,198,879  
    22,244     MTN Group Ltd     134,682  
    373,979     Murray & Roberts Holdings Ltd     394,717  
    471,619     Nedbank Group Ltd     8,921,036  
    117,778     Old Mutual Ltd *     243,651  
    23,293     Pepkor Holdings Ltd *     28,525  
    12,507     Rand Merchant Investment Holdings Ltd     34,767  
    128,729     Raubex Group Ltd     191,315  
    91,304     Redefine Properties Ltd (REIT)     64,306  
    7,079     Reinet Investments SCA     137,071  
    6,583     Resilient Ltd (REIT)     25,519  
    250,635     Reunert Ltd     1,298,324  
    64,666     RMB Holdings Ltd     371,136  
    48,338     Sanlam Ltd     260,887  
    1,864     Santam Ltd     38,467  
    12,163     Sappi Ltd     83,076  
    6,688     Sasol Ltd     261,964  
    1,000     Sasol Ltd Sponsored ADR     39,260  
    11,742     Shoprite Holdings Ltd     163,003  
    17,829     Sibanye Gold Ltd *     10,314  
    7,102     SPAR Group Ltd (The)     99,079  
    855,154     Standard Bank Group Ltd     10,838,622  
    211,205     Steinhoff International Holdings NV *     40,256  
    73,334     Telkom SA SOC Ltd     250,925  
    8,193     Tiger Brands Ltd     159,502  
    78,445     Truworths International Ltd     459,112  
    9,546     Vodacom Group Ltd     82,098  
    67,591     Wilson Bayly Holmes-Ovcon Ltd     689,295  
     

 

 

 
    Total South Africa     50,947,272  
     

 

 

 
    South Korea — 1.9%

 

    2,119     Aekyung Petrochemical Co Ltd     21,503  
    52,802     BNK Financial Group Inc     395,778  
    233     Celltrion Pharm Inc *     16,775  
    6,956     Cheil Worldwide Inc     120,594  
    6,029     Chong Kun Dang Pharmaceutical Corp     587,440  
    750     CJ ENM Co Ltd     169,686  
 

 

  See accompanying notes to the financial statements.   23


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    South Korea — continued

 

    11,089     Daou Data Corp     115,539  
    9,695     Daou Technology Inc     197,632  
    10,441     DB Insurance Co Ltd     600,294  
    11,366     DGB Financial Group Inc     104,641  
    21,573     Dongwha Pharm Co Ltd     224,636  
    24,043     Dongwon Development Co Ltd     90,356  
    2,002     E-MART Inc     385,723  
    5,492     F&F Co Ltd     495,331  
    3,573     Fila Korea Ltd     133,948  
    5,858     Grand Korea Leisure Co Ltd     127,061  
    7,087     Green Cross Holdings Corp     195,028  
    2,378     GS Home Shopping Inc     442,995  
    55,111     Hana Financial Group Inc     2,113,275  
    4,346     Hankook Tire Co Ltd     182,130  
    15,855     Hankook Tire Worldwide Co Ltd     259,234  
    357     Hanwha Aerospace Co Ltd *     8,016  
    158     HLB Inc *     14,752  
    1,163     Huons Co Ltd     103,877  
    1,388     Hyundai Department Store Co Ltd     124,136  
    2,038     Hyundai Home Shopping Network Corp     207,758  
    10,462     Hyundai Hy Communications & Network Co Ltd     38,447  
    8,394     Hyundai Marine & Fire Insurance Co Ltd     280,429  
    2,984     Hyundai Mobis Co Ltd     600,483  
    230     Hyundai Wia Corp     8,810  
    584,603     Industrial Bank of Korea     7,825,527  
    51,763     JB Financial Group Co Ltd     288,834  
    15,276     Kangwon Land Inc     397,368  
    69,427     KB Financial Group Inc     3,209,995  
    177,040     Kia Motors Corp     5,098,390  
    15,538     Korea Asset In Trust Co Ltd (REIT)     75,518  
    5,424     Korea United Pharm Inc     139,264  
    627     Korea Zinc Co Ltd     228,276  
    16,802     Korean Reinsurance Co     157,040  
    7,637     KT Hitel Co Ltd *     38,363  
    6,301     KT Skylife Co Ltd     75,279  
    8,637     KT&G Corp     783,443  
    25,588     Kwang Dong Pharmaceutical Co Ltd     172,845  
    13,187     Kwangju Bank Co Ltd     133,843  
    4,218     Kyobo Securities Co Ltd     37,137  
    45,915     LF Corp     1,095,290  
    60,145     LG Corp     3,863,887  
    110,963     LG Electronics Inc     7,650,087  
    33,829     LOTTE Himart Co Ltd     2,174,803  
    1,509     LS Corp     91,039  
    6,289     Meritz Financial Group Inc     69,462  
    665     Meritz Fire & Marine Insurance Co Ltd     10,902  
    1,145     S&T Motiv Co Ltd     33,128  
    21,841     Samjin Pharmaceutical Co Ltd     1,081,130  
    1,432     Samsung Card Co Ltd     45,337  
    
Shares
    Description   Value ($)  
    South Korea — continued

 

    1,153     Samsung Engineering Co Ltd *     17,440  
    535     Samsung Fire & Marine Insurance Co Ltd     127,355  
    354     Samsung SDS Co Ltd     77,136  
    6,821     Seoyon E-Hwa Co Ltd     37,193  
    20,258     Shinhan Financial Group Co Ltd     795,673  
    484     Shinsegae Inc     141,107  
    818     Sindoh Co Ltd     37,701  
    9,117     SK Holdings Co Ltd     2,154,808  
    169,932     SK Hynix Inc     12,673,483  
    1,165     SK Innovation Co Ltd     201,967  
    2,374     SK Networks Co Ltd     9,551  
    589     SK Telecom Co Ltd     138,682  
    222,000     SK Telecom Co Ltd Sponsored ADR     5,774,220  
    17,498     SL Corp     315,932  
    379     Spigen Korea Co Ltd     17,705  
    862     Unid Co Ltd     38,861  
    96     ViroMed Co Ltd *     20,455  
    180,474     Woori Bank     2,643,457  
     

 

 

 
    Total South Korea     68,365,220  
     

 

 

 
    Spain — 0.3%

 

    1,854     ACS Actividades de Construccion y Servicios SA     77,131  
    20,280     Aena SME SA (b)     3,586,674  
    12,339     Ebro Foods SA     265,508  
    47,224     Ence Energia y Celulosa SA     442,917  
    22,200     Endesa SA     496,688  
    250,003     International Consolidated Airlines Group SA     2,244,003  
    8,957     Naturgy Energy Group SA     240,414  
    168,714     Repsol SA     3,244,856  
    18,359     Unicaja Banco SA     28,723  
     

 

 

 
    Total Spain     10,626,914  
     

 

 

 
    Sweden — 1.0%

 

    24,547     Acando AB     96,312  
    15,028     Alfa Laval AB     402,851  
    11,765     Bufab AB     138,431  
    6,544     Castellum AB     118,376  
    30,489     Electrolux AB – Series B     680,319  
    9,096     Epiroc AB – Class A *     94,489  
    8,521     Granges AB     99,813  
    6,557     Hemfosa Fastigheter AB     89,205  
    8,412     KappAhl AB     32,043  
    16,474     Kindred Group Plc SDR     202,595  
    32,522     Klovern AB – B Shares     44,567  
    4,438     KNOW IT AB     88,629  
    3,251     Loomis AB – Class B     104,629  
    37,752     Nobina AB     278,385  
    2,270     Nolato AB – B Shares     160,370  
 

 

24   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Sweden — continued

 

    30,357     Nordea Bank AB     328,041  
    9,916     Oriflame Holding AG     288,517  
    7,581     Peab AB     68,321  
    28,394     Resurs Holding AB     207,452  
    480,115     Sandvik AB     8,404,237  
    2,387     SKF AB – B Shares     45,884  
    30,614     SSAB AB – Series A     133,434  
    698,230     Svenska Cellulosa AB – Class B     8,128,245  
    43,283     Swedbank AB – A Shares     1,007,816  
    29,731     Swedish Match AB (b)     1,589,376  
    5,157     Tethys Oil AB     57,689  
    10,437     Volvo AB – A Shares     180,012  
    770,544     Volvo AB – B Shares     13,274,079  
    2,445     Wihlborgs Fastigheter AB     29,490  
     

 

 

 
    Total Sweden     36,373,607  
     

 

 

 
    Switzerland — 1.1%

 

    3,840     ALSO Holding AG (Registered) *     456,979  
    215     Autoneum Holding AG     51,090  
    235     Bell Food Group AG (Registered)     73,021  
    10,071     BKW AG     714,373  
    4,729     Bobst Group SA (Registered)     405,158  
    148     Bossard Holding AG (Registered) – A Shares     30,556  
    2,008     Bucher Industries AG (Registered)     703,580  
    467     Coltene Holding AG (Registered)     55,468  
    377     Comet Holding AG (Registered) *     37,428  
    32     Emmi AG (Registered)     24,445  
    1,228     Galenica AG *     72,814  
    55,875     GAM Holding AG *     431,484  
    3,340     Georg Fischer AG (Registered)     4,371,729  
    30     Gurit Holding AG     25,579  
    851     Inficon Holding AG (Registered) *     432,960  
    3,686     Kardex AG (Registered) *     660,649  
    42     LEM Holding SA (Registered)     53,408  
    2,800     Luxoft Holding Inc *     130,480  
    41,557     Nestle SA (Registered)     3,483,601  
    104,830     Novartis AG (Registered)     8,696,918  
    2,393     Orior AG     211,614  
    5,751     Roche Holding AG     1,441,914  
    42,298     Roche Holding AG     10,487,940  
    42,348     Sika AG (Registered) (b)     6,271,997  
    4,635     Swiss Re AG     417,013  
    736     Swissquote Group Holding SA     54,469  
    1,604     Zehnder Group AG – Class RG     75,931  
    1,522     Zurich Insurance Group AG     463,342  
     

 

 

 
    Total Switzerland     40,335,940  
     

 

 

 
    Taiwan — 2.7%

 

    298,000     AcBel Polytech Inc     196,467  
    
Shares
    Description   Value ($)  
    Taiwan — continued

 

    32,000     Actron Technology Corp     104,272  
    37,000     Advantech Co Ltd     251,940  
    23,000     Alpha Networks Inc     13,212  
    226,000     Ardentec Corp     280,738  
    39,000     Asia Pacific Telecom Co Ltd *     9,297  
    194,000     Asia Vital Components Co Ltd     184,955  
    595,029     Asustek Computer Inc     5,070,643  
    8,400     Aurora Corp     29,806  
    123,000     Catcher Technology Co Ltd     1,507,307  
    292,000     Cathay Financial Holding Co Ltd     500,491  
    232,560     Chailease Holding Co Ltd     791,186  
    9,150     Chicony Electronics Co Ltd     19,257  
    9,155     Chicony Power Technology Co Ltd     13,176  
    110,000     Chin-Poon Industrial Co Ltd     135,989  
    306,000     China Motor Corp     256,915  
    7,000     Chlitina Holding Ltd     62,646  
    10,000     Chong Hong Construction Co Ltd     26,499  
    350,000     Chunghwa Telecom Co Ltd     1,237,035  
    600     Chunghwa Telecom Co Ltd Sponsored ADR     21,114  
    7,000     Cleanaway Co Ltd     41,363  
    1,200,000     Coretronic Corp     2,257,605  
    1,122,000     CTBC Financial Holding Co Ltd     789,040  
    60,000     CTCI Corp     91,918  
    96,000     Cyberlink Corp     232,276  
    58,000     Dynapack International Technology Corp     75,731  
    61,000     Elan Microelectronics Corp     107,789  
    206,000     Elitegroup Computer Systems Co Ltd *     107,003  
    172,000     Far Eastern Department Stores Ltd     98,026  
    182,000     Far Eastern New Century Corp     211,987  
    192,000     Far EasTone Telecommunications Co Ltd     457,974  
    97,000     Farglory Land Development Co Ltd     99,486  
    56,000     Formosa Advanced Technologies Co Ltd     65,689  
    323,000     Formosa Chemicals & Fibre Corp     1,294,401  
    55,000     Formosa Petrochemical Corp     225,846  
    340,000     Formosa Plastics Corp     1,246,400  
    84,600     Formosan Rubber Group Inc     39,265  
    435,000     Foxconn Technology Co Ltd     1,105,975  
    4,260,000     Fubon Financial Holding Co Ltd     7,062,872  
    1,951,000     Gigabyte Technology Co Ltd     3,328,948  
    2,482,000     Grand Pacific Petrochemical     2,393,707  
    1,420,000     Great Wall Enterprise Co Ltd *     1,932,513  
    72,000     Greatek Electronics Inc     122,568  
    43,000     Green Seal Holding Ltd     48,645  
    219,000     Highwealth Construction Corp     355,789  
    28,000     Holiday Entertainment Co Ltd     53,643  
    757,000     Holtek Semiconductor Inc     2,088,460  
    3,477,300     Hon Hai Precision Industry Co Ltd     9,134,993  
    59,000     Huaku Development Co Ltd     125,171  
    83,000     IEI Integration Corp     102,722  
 

 

  See accompanying notes to the financial statements.   25


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Taiwan — continued

 

    27,000     International Games System Co Ltd     133,739  
    2,501,000     Inventec Corp     2,244,758  
    18,000     ITEQ Corp     38,868  
    15,000     King’s Town Bank Co Ltd     15,090  
    601,000     Lite-On Semiconductor Corp     685,630  
    29,000     Makalot Industrial Co Ltd     150,363  
    83,000     Mercuries Life Insurance Co Ltd     43,104  
    8,000     Merida Industry Co Ltd     38,423  
    1,651,000     Mitac Holdings Corp *     1,909,586  
    2,659,000     Nan Ya Plastics Corp     7,399,480  
    4,000     Nien Made Enterprise Co Ltd     31,024  
    590,000     Novatek Microelectronics Corp     2,892,942  
    1,045,105     OptoTech Corp     776,782  
    2,052,000     Pegatron Corp     4,422,819  
    177,000     Phison Electronics Corp     1,465,315  
    3,951,000     Pou Chen Corp     4,356,371  
    355,000     Quanta Computer Inc     610,782  
    21,000     Quanta Storage Inc     17,706  
    1,991,000     Radiant Opto-Electronics Corp     4,373,258  
    152,000     Realtek Semiconductor Corp     737,709  
    27,000     Rechi Precision Co Ltd     26,397  
    111,000     Ruentex Development Co Ltd     124,998  
    220,000     Ruentex Industries Ltd     451,330  
    37,000     Sercomm Corp     65,044  
    34,000     Sheng Yu Steel Co Ltd     23,833  
    54,000     Shinkong Insurance Co Ltd     70,002  
    25,000     Sigurd Microelectronics Corp     28,371  
    62,800     Simplo Technology Co Ltd     460,240  
    9,000     Sinbon Electronics Co Ltd     25,548  
    31,050     Sinmag Equipment Corp     141,652  
    53,000     Sitronix Technology Corp     167,177  
    85,000     Soft-World International Corp     200,429  
    47,000     Standard Chemical & Pharmaceutical Co Ltd     48,813  
    1,214,000     Sunplus Technology Co Ltd     553,810  
    190,000     Syncmold Enterprise Corp     362,865  
    37,000     Synnex Technology International Corp     49,522  
    32,700     TaiDoc Technology Corp     184,353  
    501,000     Taiwan Semiconductor Co Ltd     1,198,950  
    276,000     Taiwan Semiconductor Manufacturing Co Ltd     2,312,518  
    129,542     Taiwan Semiconductor Manufacturing Co Ltd Sponsored ADR     5,648,031  
    256,000     Taiwan Surface Mounting Technology Corp     275,366  
    16,000     Test Research Inc     28,086  
    32,000     Tong Hsing Electronic Industries Ltd     88,120  
    187,470     TOPBI International Holdings Ltd     599,692  
    145,485     Topco Scientific Co Ltd     369,609  
    24,000     Transcend Information Inc     58,068  
    70,000     Tripod Technology Corp     216,082  
    
Shares
    Description   Value ($)  
    Taiwan — continued

 

    22,000     TXC Corp     25,546  
    850,000     Uni-President Enterprises Corp     2,150,831  
    162,000     United Integrated Services Co Ltd     326,974  
    29,000     Wah Lee Industrial Corp     52,336  
    100,000     Waterland Financial Holdings Co Ltd     34,519  
    17,855     Wistron NeWeb Corp     39,882  
    66,000     Youngtek Electronics Corp     100,816  
    479,000     Yuanta Financial Holding Co Ltd     242,702  
    10,000     Yulon Finance Corp     33,549  
    102,000     Yungtay Engineering Co Ltd     155,553  
    6,000     Zeng Hsing Industrial Co Ltd     27,928  
     

 

 

 
    Total Taiwan     95,324,041  
     

 

 

 
    Thailand — 0.8%

 

    172,200     Advanced Info Service Pcl NVDR     1,062,958  
    183,600     Amata Corp Pcl NVDR     119,545  
    285,500     AP Thailand Pcl NVDR     82,019  
    14,700     Bangkok Bank Pcl (Foreign Registered) (d)     93,419  
    14,700     Bangkok Bank Pcl NVDR     92,072  
    87,200     Bangkok Dusit Medical Services Pcl NVDR     69,962  
    127,700     Central Pattana Pcl NVDR     321,861  
    633,400     Com7 PCL NVDR     371,810  
    101,700     Glow Energy Pcl NVDR     292,068  
    69,200     Hana Microelectronics Pcl NVDR     81,495  
    1,178,500     Home Product Center PCL NVDR     525,596  
    1,784,200     Indorama Ventures Pcl NVDR     3,272,563  
    154,900     Intouch Holdings Pcl NVDR     262,724  
    20,200     KCE Electronics Pcl (Foreign Registered)     27,972  
    310,900     LPN Development Pcl NVDR     94,077  
    86,200     MC Group Pcl NVDR     34,503  
    91,300     Mega Lifesciences Pcl (Foreign Registered)     98,388  
    386,000     Mega Lifesciences Pcl NVDR     415,966  
    147,500     Pruksa Holding Pcl NVDR     91,024  
    94,400     PTT Exploration & Production Pcl NVDR     411,303  
    1,597,900     PTT Global Chemical Pcl NVDR     3,993,683  
    1,675,000     PTT Pcl (Foreign Registered)     2,689,283  
    2,769,400     PTT Pcl NVDR     4,446,447  
    3,292,200     Quality Houses Pcl NVDR     348,072  
    84,300     Ratchaburi Electricity Generating Holding Pcl NVDR     134,579  
    1,067,500     Sansiri Pcl NVDR     52,539  
    74,700     Siam Cement Pcl (The) (Foreign Registered)     1,031,933  
    7,500     Siam Cement Pcl (The) NVDR     103,608  
    433,200     Siamgas & Petrochemicals Pcl NVDR     158,920  
    77,600     Somboon Advance Technology PCL     56,437  
    778,700     Star Petroleum Refining Pcl NVDR     354,586  
    251,400     Supalai Pcl NVDR     185,889  
    9,192,200     Thai Beverage Pcl     4,149,138  
    124,400     Thai Oil Pcl NVDR     320,331  
    52,600     Thai Vegetable Oil Pcl NVDR     47,417  
 

 

26   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Thailand — continued

 

    835,700     Thanachart Capital Pcl (Foreign Registered)     1,372,836  
    430,400     Thanachart Capital Pcl NVDR     707,034  
    62,600     Tipco Asphalt Pcl NVDR     29,272  
    323,200     TTW Pcl NVDR     122,429  
     

 

 

 
    Total Thailand     28,125,758  
     

 

 

 
    Turkey — 0.4%

 

    6,659     Aksa Akrilik Kimya Sanayii AS     11,340  
    112,180     Albaraka Turk Katilim Bankas AS     21,550  
    32,414     Aselsan Elektronik Sanayi Ve Ticaret AS     127,907  
    7,050     Aygaz AS     12,873  
    28,990     BIM Birlesik Magazalar AS     322,937  
    125,123     EIS Eczacibasi Ilac ve Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS     70,702  
    1,862,002     Emlak Konut Gayrimenkul Yatirim Ortakligi AS (REIT)     521,457  
    135,485     Enka Insaat ve Sanayi AS     105,987  
    942,454     Eregli Demir ve Celik Fabrikalari TAS     1,701,747  
    50,909     Ford Otomotiv Sanayi AS     519,239  
    161,854     Haci Omer Sabanci Holding AS     175,869  
    66,057     Ipek Dogal Enerji Kaynaklari Arastirma Ve Uretim AS *     49,143  
    75,880     Is Gayrimenkul Yatirim Ortakligi AS (REIT)     10,759  
    1,497,040     KOC Holding AS     3,421,144  
    5,302     Otokar Otomotiv Ve Savunma Sanayi AS     57,633  
    170,508     Petkim Petrokimya Holding AS     143,197  
    83,295     Selcuk Ecza Deposu Ticaret ve Sanayi AS     39,575  
    498,954     Soda Sanayii AS     615,955  
    68,331     TAV Havalimanlari Holding AS     343,797  
    63,592     Tekfen Holding AS     198,670  
    41,543     Trakya Cam Sanayii AS     27,419  
    25,562     Tupras Turkiye Petrol Rafineriler AS     459,600  
    15,477     Turk Telekomunikasyon AS *     8,623  
    1,260     Turk Traktor ve Ziraat Makineleri AS     8,741  
    120,800     Turkcell Iletisim Hizmetleri AS     194,415  
    418,759     Turkiye Garanti Bankasi AS     380,517  
    199,782     Turkiye Halk Bankasi AS     186,957  
    6,438,596     Turkiye Is Bankasi – Class C     3,920,575  
    446,267     Turkiye Sinai Kalkinma Bankasi AS     51,761  
     

 

 

 
    Total Turkey     13,710,089  
     

 

 

 
    United Arab Emirates — 0.0%

 

    8,817     Abu Dhabi Commercial Bank PJSC     17,040  
    198,902     Air Arabia PJSC     54,688  
    163,883     Aldar Properties PJSC     86,041  
    325,089     DAMAC Properties Dubai Co PJSC     185,763  
    221,353     Dana Gas PJSC     66,819  
    2,487     DP World Ltd     53,193  
    41,680     Dubai Investments PJSC     22,569  
    39,527     Dubai Islamic Bank PJSC     55,079  
    
Shares
    Description   Value ($)  
    United Arab Emirates — continued

 

    96,645     DXB Entertainments PJSC *     9,100  
    32,329     Emaar Development PJSC *     46,538  
    104,946     Emaar Properties PJSC     143,020  
    30,444     Emirates Telecommunications Group Co PJSC     140,394  
    8,958     First Abu Dhabi Bank PJSC     36,094  
    353,662     RAK Properties PJSC     59,706  
     

 

 

 
    Total United Arab Emirates     976,044  
     

 

 

 
    United Kingdom — 3.0%

 

    590,481     3i Group Plc     6,875,660  
    15,949     Ashmore Group Plc     73,646  
    28,555     Ashtead Group Plc     876,255  
    134,483     AstraZeneca Plc     10,149,937  
    1,278     AVEVA Group Plc     47,083  
    121,797     Aviva Plc     766,275  
    32,731     BAE Systems Plc     257,560  
    37,171     Barratt Developments Plc     261,515  
    2,757     Beazley Plc     21,300  
    37,555     Bellway Plc     1,422,741  
    110,021     Berkeley Group Holdings Plc (The)     5,204,118  
    30,793     Bovis Homes Group Plc     450,031  
    441,348     BP Plc     3,142,911  
    242,870     British American Tobacco Plc     11,744,526  
    7,600     British American Tobacco Plc Sponsored ADR     367,688  
    12,614     Britvic Plc     133,479  
    10,795     Central Asia Metals Plc     30,068  
    13,892     Close Brothers Group Plc     288,227  
    17,232     CMC Markets Plc     38,198  
    130,034     Coca-Cola HBC AG *     4,452,377  
    46,480     Computacenter Plc     817,270  
    3,662     Costain Group Plc     20,228  
    2,280     Cranswick Plc     95,529  
    17,831     Dart Group Plc     226,388  
    1,523     Derwent London Plc (REIT)     60,142  
    2,300     Diageo Plc Sponsored ADR (a)     320,643  
    26,906     Direct Line Insurance Group Plc     115,590  
    57,274     EI Group Plc *     116,199  
    248,360     Electrocomponents Plc     2,393,936  
    486,757     Ferrexpo Plc     982,563  
    6,547     Fevertree Drinks Plc     316,516  
    1,309     Fidessa Group Plc     65,542  
    113,770     Firstgroup Plc *     131,311  
    47,720     Galliford Try Plc     601,813  
    1,267     Games Workshop Group Plc     58,556  
    185,435     GlaxoSmithKline Plc     3,755,591  
    164,100     GlaxoSmithKline Plc Sponsored ADR     6,646,050  
    16,508     Grainger Plc     65,840  
    21,400     HSBC Holdings Plc Sponsored ADR     941,814  
 

 

  See accompanying notes to the financial statements.   27


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    United Kingdom — continued

 

    15,342     Hunting Plc *     166,185  
    183,402     IG Group Holdings Plc     2,153,625  
    6,262     Imperial Brands Plc     223,112  
    56,585     Inchcape Plc     508,330  
    509,142     Indivior Plc *     1,790,028  
    15,182     Intermediate Capital Group Plc     206,982  
    33,162     J Sainsbury Plc     139,592  
    19,655     John Laing Group Plc     80,504  
    10,898     Jupiter Fund Management Plc     59,334  
    16,565     Land Securities Group Plc (REIT)     197,175  
    787,150     Legal & General Group Plc     2,601,247  
    2,830,072     Lloyds Banking Group Plc     2,180,060  
    21,385     Lookers Plc     29,203  
    10,316     Morgan Advanced Materials Plc     45,513  
    9,205     Morgan Sindall Group Plc     175,425  
    4,327     Next Plc     308,943  
    73,500     Nomad Foods Ltd *     1,532,475  
    1,467     Northgate Plc     7,796  
    23,094     Numis Corp Plc     126,767  
    401,148     Persimmon Plc     12,691,097  
    104,152     Plus500 Ltd     2,080,758  
    5,228     Polypipe Group Plc     25,121  
    238,122     QinetiQ Group Plc     838,545  
    2,547     Quilter Plc     4,651  
    57,976     Reckitt Benckiser Group Plc     4,938,524  
    36,908     Redrow Plc     262,206  
    27,508     Royal Dutch Shell Plc – Class A     894,653  
    11,200     Royal Dutch Shell Plc – Class A Sponsored ADR     730,576  
    11,700     Royal Dutch Shell Plc – Class B Sponsored ADR (a)     788,346  
    124,055     Royal Mail Plc     721,407  
    43,911     RPS Group Plc     133,809  
    6,068     Safestore Holdings Plc (REIT)     41,838  
    32,609     Segro Plc (REIT)     278,805  
    15,305     Softcat Plc     168,682  
    11,544     Spectris Plc     352,926  
    13,760     SSP Group Plc     123,907  
    44,119     Stock Spirits Group Plc     110,474  
    14,528     Tate & Lyle Plc     126,466  
    5,947     Telford Homes Plc     31,950  
    18,257     TUI AG     336,995  
    2,744     TUI AG     50,618  
    71,883     Unilever Plc     4,096,234  
    47,908     Vesuvius Plc     385,957  
    4,348     Virgin Money Holdings UK Plc     21,554  
    210,478     William Hill Plc     703,239  
     

 

 

 
    Total United Kingdom     107,806,750  
     

 

 

 
    United States — 4.2%

 

    15,373     3M Co. (a)     3,242,473  
    
Shares
    Description   Value ($)  
    United States — continued

 

    37,974     Abbott Laboratories     2,538,182  
    32,482     Accenture Plc – Class A     5,491,732  
    9,325     Alphabet, Inc. – Class C *     11,359,622  
    44,094     American Express Co.     4,673,082  
    15,004     Amphenol Corp. – Class A (a)     1,419,078  
    18,069     Anthem, Inc. (a)     4,783,406  
    52,175     Apple, Inc.     11,876,595  
    9,134     Becton Dickinson and Co. (a)     2,391,921  
    105,384     Cisco Systems, Inc. (a)     5,034,194  
    62,675     Coca-Cola Co. (The)     2,793,425  
    52,317     Cognizant Technology Solutions Corp. – Class A     4,103,222  
    24,167     Costco Wholesale Corp. (a)     5,634,053  
    17,142     Facebook, Inc. – Class A *     3,012,364  
    13,110     Honeywell International, Inc.     2,085,277  
    44,026     Johnson & Johnson     5,929,862  
    7,623     Mastercard, Inc. – Class A     1,643,214  
    59,211     Medtronic Plc (a)     5,708,532  
    66,339     Merck & Co., Inc.     4,550,192  
    99,499     Microsoft Corp.     11,176,723  
    184,859     Oracle Corp. (a)     8,980,450  
    8,437     PepsiCo, Inc. (a)     945,028  
    26,536     Philip Morris International, Inc.     2,066,889  
    75,884     QUALCOMM, Inc. (a)     5,213,990  
    7,670     Stryker Corp. (a)     1,299,528  
    20,936     Teradata Corp. * (a) (b)     868,216  
    32,002     Texas Instruments, Inc. (a)     3,597,025  
    46,674     TJX Cos., Inc. (The) (b)     5,132,740  
    27,114     UnitedHealth Group, Inc.     7,279,024  
    29,569     United Technologies Corp.     3,894,237  
    85,784     US Bancorp (a) (b)     4,641,772  
    17,000     Visa, Inc. – Class A     2,497,130  
    83,139     Wells Fargo & Co.     4,861,969  
     

 

 

 
    Total United States     150,725,147  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $1,434,776,409)
    1,475,051,709  
     

 

 

 
    PREFERRED STOCKS (e) — 0.8%

 

    Brazil — 0.2%

 

    116,500     Banco do Estado do Rio Grande do Sul SA – Class B     419,024  
    610,200     Braskem SA – Class A     8,870,379  
    29,300     Centrais Eletricas Brasileiras SA – Class B *     130,203  
    13,000     Cia de Saneamento do Parana     27,129  
    90,900     Cia Energetica de Minas Gerais     166,486  
    9,700     Telefonica Brasil SA     95,307  
     

 

 

 
    Total Brazil     9,708,528  
     

 

 

 
 

 

28   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Colombia — 0.0%

 

    68,395     Grupo Aval Acciones y Valores SA     26,944  
     

 

 

 
    Germany — 0.1%

 

    9,655     Bayerische Motoren Werke AG     809,641  
    1,143     Draegerwerk AG & Co KGaA     92,255  
    2,272     Sixt SE     189,858  
    10,093     Volkswagen AG     1,649,880  
     

 

 

 
    Total Germany     2,741,634  
     

 

 

 
    Russia — 0.1%

 

    4,372     Bashneft PJSC     109,594  
    1,020,600     Sberbank of Russia PJSC     2,421,610  
    76,000     Surgutneftegas PJSC     42,178  
    77     Transneft PJSC     162,755  
     

 

 

 
    Total Russia     2,736,137  
     

 

 

 
    South Korea — 0.4%

 

    967     Hyundai Motor Co 2nd Preference     74,353  
    38,442     LG Electronics Inc     1,070,122  
    316,358     Samsung Electronics Co Ltd     11,272,240  
    1,079     Samsung Electronics Co Ltd GDR     950,912  
     

 

 

 
    Total South Korea     13,367,627  
     

 

 

 
    Sweden — 0.0%

 

    2,540     Akelius Residential Property AB     94,852  
     

 

 

 
    Taiwan — 0.0%

 

    14,463     CTBC Financial Holding Co Ltd     29,243  
     

 

 

 
    TOTAL PREFERRED STOCKS
(COST $27,320,710)
    28,704,965  
     

 

 

 
    RIGHTS/WARRANTS — 0.0%

 

    Thailand — 0.0%

 

    48,800     Supalai Pcl Rights, Expires 10/19/18 *     29,670  
    74,250     Supalai Public Co Rights, Expires 10/19/18 *     45,144  
     

 

 

 
    Total Thailand     74,814  
     

 

 

 
    TOTAL RIGHTS/WARRANTS
(COST $60,200)
    74,814  
     

 

 

 
    INVESTMENT FUNDS — 0.1%

 

    United States — 0.1%

 

    40,181     iShares MSCI Emerging Markets ETF     1,734,614  
     

 

 

 
    TOTAL INVESTMENT FUNDS
(COST $1,772,002)
    1,734,614  
     

 

 

 
    
Par Value†
    Description   Value ($)  
    DEBT OBLIGATIONS — 21.1%

 

    United States — 21.1%

 

    Asset-Backed Securities — 3.6%

 

    309,795     AMMC CLO 21 Ltd., Series 17-21A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.85%, 3.20%, due 11/02/30     310,160  
    1,302,000     AMMC CLO XI Ltd., Series 12-11A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 04/30/31     1,301,786  
    1,048,955     AMMC CLO XII Ltd., Series 13-12A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 11/10/30     1,048,944  
    424,827     AMMC CLO XIII Ltd., Series 13-13A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.95%, 3.29%, due 07/24/29     425,854  
    725,116     AMMC CLO XIV Ltd., Series 14-14A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.95%, 3.29%, due 07/25/29     726,503  
    158,974     Anchorage Capital CLO Ltd., Series 15-6A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.24%, due 07/15/30     159,169  
    956,560     Apidos CLO XII, Series 13-12A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 04/15/31     955,044  
    434,000     Apidos CLO XV, Series 13-15A, Class XRR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     433,994  
    1,076,701     Apidos CLO XVI, Series 13-16A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 0.98%, 3.32%, due 01/19/25     1,077,267  
    379,750     Ares XXXIIR CLO Ltd., Series 14-32RA, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.96%, due 05/15/30     379,747  
    482,259     Atlas Senior Loan Fund III Ltd., Series 13-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.91%, due 11/17/27     482,255  
    325,500     Atlas Senior Loan Fund XI Ltd., Series 18-11A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 07/26/31     325,477  
    331,374     Avery Point III CLO Ltd., Series 13-3A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 1.12%, 3.45%, due 01/18/25     331,460  
    563,017     Avery Point IV CLO Ltd., Series 14-1A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 1.10%, 3.44%, due 04/25/26     563,170  
    4,783,911     B&M CLO Ltd., Series 14-1A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 0.73%, 3.07%, due 04/16/26     4,768,741  
    1,071,000     Babson CLO Ltd., Series 14-IA, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.15%, 3.50%, due 07/20/25     1,071,209  
    309,795     Bain Capital Credit CLO, Series 17-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.15%, due 07/20/30     309,765  
 

 

  See accompanying notes to the financial statements.   29


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    United States — continued  
          Asset-Backed Securities — continued  
    190,219     Ballyrock CLO LLC, Series 13-1A, Class A, 144A, Variable Rate, 3 mo. LIBOR + 1.18%, 3.50%, due 05/20/25     190,281  
    347,200     Barings CLO Ltd., Series 18-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 3.06%, due 04/15/30     347,189  
    684,341     Bayview Commercial Mortgage Pass-Through Trust, Series 06-SP1, Class M3, 144A, Variable Rate, 1 mo. LIBOR + 0.57%, 2.63%, due 04/25/36     680,931  
    268,489     Benefit Street Partners CLO III Ltd., Series 13-IIIA, Class X,, 144A, Variable Rate, 3 mo. LIBOR + 0.85%, 3.20%, due 07/20/29     268,665  
    155,000     Black Diamond CLO Ltd., Series 17-IA, Class X, 144A, Variable Rate, 3 mo. LIBOR + 1.00%, 3.34%, due 04/24/29     155,240  
    698,317     BlueMountain CLO Ltd., Series 13-3A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 0.89%, 3.23%, due 10/29/25     697,970  
    569,625     BlueMountain CLO Ltd., Series 15-4A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.55%, 2.90%, due 04/20/30     569,616  
    379,750     BlueMountain CLO Ltd., Series 15-3A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     379,744  
    399,402     Brookside Mill CLO Ltd., Series 13-1A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 01/17/28     399,397  
    560,790     Canyon Capital CLO Ltd., Series 16-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.04%, due 07/15/31     560,782  
    1,085,000     Carlyle Global Market Strategies CLO Ltd., Series 14-2RA, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.01%, due 05/15/31     1,084,990  
    371,754     Catamaran CLO Ltd., Series 14-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/22/30     371,671  
    1,073,956     CBAM Ltd., Series 17-3A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.04%, due 10/17/29     1,073,940  
    344,905     CBAM Ltd., Series 17-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.15%, due 07/20/30     344,949  
    1,807,137     CBAM Ltd., Series 17-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 01/15/31     1,807,112  
    868,000     Cent CLO, Series C17A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 3.00%, due 04/30/31     867,930  
    774,487     CIFC Funding II Ltd., Series 13-2A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.98%, due 10/18/30     774,378  
    347,200     CIFC Funding III Ltd., Series 17-3A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.15%, due 07/20/30     347,374  
    
Par Value†
    Description   Value ($)  
    United States — continued  
          Asset-Backed Securities — continued  
    994,605     CIFC Funding IV Ltd., Series 17-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 10/24/30     994,910  
    3,404,278     Crest G-Star LP, Series 01-1A, Class D, 144A, 9.00%, due 11/28/35     1,157,455  
    732,375     Crown Point CLO Ltd., Series 18-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     732,364  
    263,408     CVP Cascade CLO-1 Ltd., Series 13-CLO1, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.15%, 3.49%, due 01/16/26     263,480  
    760,825     Dryden 30 Senior Loan Fund, Series 13-30A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.91%, due 11/15/28     760,819  
    114,115     Dryden XXVIII Senior Loan Fund, Series 13-28A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.06%, due 08/15/30     114,126  
    413,060     Elevation CLO Ltd., Series 14-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 10/15/29     413,054  
    296,887     Galaxy XV CLO Ltd., Series 13-15A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 10/15/30     297,730  
    1,070,172     Galaxy XX CLO Ltd., Series 15-20A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     1,069,863  
    576,460     Galaxy XXVII CLO Ltd., Series 18-27A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.92%, due 05/16/31     576,386  
    5,381,653     GCO Education Loan Funding Master Trust-II, Series 07-1A, Class A6L, 144A, Variable Rate, 3 mo. LIBOR + 0.11%, 2.42%, due 11/25/26     5,361,784  
    266,910     GCO Education Loan Funding Trust, Series 06-1, Class A9L, Variable Rate, 3 mo. LIBOR + 0.16%, 2.47%, due 05/25/26     265,675  
    922,591     Goldentree Loan Management US CLO 2 Ltd., Series 17-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 11/28/30     922,421  
    570,675     Goldentree Loan Opportunities XI Ltd., Series 15-11A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.93%, due 01/18/31     570,581  
    578,284     Greywolf CLO V Ltd., Series 15-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 01/27/31     578,168  
    165,232     Halcyon Loan Advisors Funding Ltd., Series 13-1X, Class A1, Reg. S, 3 mo. LIBOR + 1.15%, 3.49%, due 04/15/25     165,239  
    248,305     Halcyon Loan Advisors Funding Ltd., Series 13-1A, Class A1, 144A, Variable Rate, 3 mo. LIBOR + 1.15%, 3.49%, due 04/15/25     248,316  
 

 

30   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    United States — continued  
          Asset-Backed Securities — continued  
    1,809,422     Halcyon Loan Advisors Funding Ltd., Series 14-1A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.13%, 3.46%, due 04/18/26     1,809,797  
    556,605     Highbridge Loan Management Ltd., Series 6A-2015, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 02/05/31     556,598  
    206,530     Highbridge Loan Management Ltd., Series 3A-2014, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.13%, due 07/18/29     206,631  
    258,163     Highbridge Loan Management Ltd., Series 13-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 3.00%, due 10/20/29     258,158  
    2,043,776     Higher Education Funding I, Series 05-1, Class A5, Variable Rate, 3 mo. LIBOR + 0.16%, 2.47%, due 02/25/32     2,041,569  
    751,905     ICG US CLO Ltd., Series 14-2A, Class XRR, 144A, Variable Rate, 3 mo. LIBOR + 0.55%, 2.89%, due 01/15/31     751,894  
    516,325     Jamestown CLO X Ltd., Series 17-10A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.25%, due 07/17/29     516,911  
    279,398     KeyCorp Student Loan Trust, Series 00-A, Class A2, Variable Rate, 3 mo. LIBOR + 0.32%, 2.63%, due 05/25/29     278,353  
    323,576     KeyCorp Student Loan Trust, Series 06-A, Class 2A4, Variable Rate, 3 mo. LIBOR + 0.31%, 2.65%, due 09/27/35     323,608  
    1,247,390     KeyCorp Student Loan Trust, Series 99-B, Class CTFS, Variable Rate, 3 mo. LIBOR + 0.90%, 3.21%, due 11/25/36     1,249,006  
    66,396     KeyCorp Student Loan Trust, Series 05-A, Class 2A4, Variable Rate, 3 mo. LIBOR + 0.34%, 2.68%, due 06/27/38     66,391  
    224,665     KeyCorp Student Loan Trust, Series 04-A, Class 2B, Variable Rate, 3 mo. LIBOR + 0.53%, 2.87%, due 01/27/42     224,750  
    618,450     Kingsland VIII Ltd., Series 18-8A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.05%, due 04/20/31     618,440  
    326,100     KKR CLO Ltd., Series 9, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.95%, 3.29%, due 07/15/30     326,500  
    624,701     LCM XVIII LP, Series 18A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     624,691  
    440,235     LCM XXV Ltd., Series 25,A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.95%, 3.30%, due 07/20/30     441,201  
    288,422     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 05-1A, Class A, 144A, Variable Rate, 1 mo. LIBOR + 0.25%, 2.31%, due 02/25/30     283,585  
    
Par Value†
    Description   Value ($)  
    United States — continued  
          Asset-Backed Securities — continued  
    61,690     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 05-2A, Class 1A, 144A, Variable Rate, 1 mo. LIBOR + 0.25%, 2.31%, due 09/25/30     61,624  
    1,618,210     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 07-2A, Class 1A3, 144A, Variable Rate, 1 mo. LIBOR + 0.27%, 2.33%, due 06/25/37     1,595,716  
    1,098,020     Madison Park Funding XIII Ltd., Series 14-13A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 04/19/30     1,097,879  
    603,228     Magnetite IX Ltd., Series 14-9A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.00%, 3.34%, due 07/25/26     603,507  
    1,898,750     Marathon CLO VI Ltd., Series 14-6A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.04%, due 05/13/28     1,898,731  
    2,049,472     Montana Higher Education Student Assistance Corp., Series 12-1, Class A2, Variable Rate, 1 mo. LIBOR + 1.00%, 3.08%, due 05/20/30     2,067,441  
    4,734,537     Montana Higher Education Student Assistance Corp., Series 05-1, Class B, Variable Rate, 3 mo. LIBOR + 0.12%, 2.44%, due 06/20/30     4,729,519  
    201,519     Morgan Stanley Dean Witter Capital I Trust, Series 01-TOP3, Class E, 144A, Variable Rate, 7.86%, due 07/15/33     212,887  
    619,590     Mountain View CLO LLC, Series 17-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 01/16/31     619,642  
    2,836,000     Mountain View CLO Ltd., Series 14-1A, Class ARR, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.14%, due 10/15/26     2,830,810  
    591,980     Mountain View CLO Ltd., Series 13-1A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 10/12/30     591,971  
    6,723     National Collegiate Student Loan Trust, Series 06-1, Class A4, Variable Rate, 1 mo. LIBOR + 0.25%, 2.31%, due 03/27/28     6,721  
    4,786,052     National Collegiate Student Loan Trust, Series 07-2, Class A3, Variable Rate, 1 mo. LIBOR + 0.23%, 2.29%, due 03/26/29     4,694,922  
    1,276,618     National Collegiate Student Loan Trust, Series 07-1, Class A3, Variable Rate, 1 mo. LIBOR + 0.24%, 2.30%, due 07/25/30     1,259,070  
    92,301     Nationslink Funding Corp. Commercial Loan Pass Through Certificate, Series 99-LTL1, Class D, 144A, 6.45%, due 01/22/26     93,494  
    296,056     Navient Private Education Loan Trust, Series 14-CTA, Class A, 144A, Variable Rate, 1 mo. LIBOR + 0.70%, 2.76%, due 09/16/24     296,395  
 

 

  See accompanying notes to the financial statements.   31


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    United States — continued  
          Asset-Backed Securities — continued  
    1,139,250     Navient Student Loan Trust, Series 16-2A, Class A2, 144A, Variable Rate, 1 mo. LIBOR + 1.05%, 3.11%, due 06/25/65     1,150,591  
    285,288     Neuberger Berman CLO XV, Series 13-15A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 10/15/29     285,248  
    369,171     Neuberger Berman CLO XVII Ltd., Series 14-17A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 1.00%, 3.35%, due 04/22/29     369,737  
    474,170     Newcastle CDO V Ltd., Series 04-5A, Class 3, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 2.20%, due 12/24/39     473,536  
    1,870,276     Ocean Trails CLO IV, Series 13-4A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.24%, due 08/13/25     1,870,293  
    247,380     Octagon Investment Partners XIV Ltd., Series 12-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.88%, 3.22%, due 07/15/19     247,394  
    258,434     Octagon Investment Partners XV Ltd., Series 13-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.14%, due 07/19/30     258,615  
    704,264     Octagon Investment Partners XVII Ltd., Series 13-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 01/25/31     704,254  
    221,282     OFSI Fund V Ltd., Series 17-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.85%, 3.19%, due 08/16/29     221,486  
    2,165,683     OFSI Fund VI Ltd., Series 14-6A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 03/20/25     2,160,268  
    326,100     OHA Credit Partners XIV Ltd., Series 17-14A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 01/21/30     326,046  
    567,957     OZLM Funding Ltd., Series 13-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 3.00%, due 10/22/30     567,876  
    1,519,000     OZLM VI Ltd., Series 14-6A, Class XS, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.04%, due 04/17/31     1,518,977  
    263,054     OZLM XI Ltd., Series 15-11A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 10/30/30     263,121  
    3,468,292     Palmer Square Loan Funding Ltd., Series 18-1A, Class A1, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 04/15/26     3,436,574  
    1,017,730     Seneca Park CLO Ltd., Series 14-1A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 1.12%, 3.46%, due 07/17/26     1,017,802  
    
Par Value†
    Description   Value ($)  
    United States — continued  
          Asset-Backed Securities — continued  
    516,325     Shackleton CLO Ltd., Series 13-3A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 07/15/30     516,318  
    434,055     Silvermore CLO Ltd., Series 14-1A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.17%, 3.48%, due 05/15/26     434,223  
    1,764,619     SLC Student Loan Trust, Series 08-2, Class A3, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 09/15/18     1,764,605  
    1,807,758     SLM Private Credit Student Loan Trust, Series 07-A, Class A3, Variable Rate, 3 mo. LIBOR + 0.17%, 2.51%, due 12/15/26     1,807,286  
    704,670     SLM Private Education Loan Trust, Series 14-A, Class A2B, 144A, Variable Rate, 1 mo. LIBOR + 1.15%, 3.21%, due 01/15/26     707,450  
    208,791     SLM Private Education Loan Trust, Series 11-A, Class A2, 144A, 4.37%, due 04/17/28     209,299  
    1,323,700     SLM Private Education Loan Trust, Series 11-B, Class A3, 144A, Variable Rate, 1 mo. LIBOR + 2.25%, 4.31%, due 06/16/42     1,358,480  
    2,219,654     SLM Private Education Loan Trust, Series 11-A, Class A3, 144A, Variable Rate, 1 mo. LIBOR + 2.50%, 4.56%, due 01/15/43     2,267,520  
    2,107,973     SLM Private Education Loan Trust, Series 10-A, Class 2A, 144A, Variable Rate, 1 mo. LIBOR + 3.25%, 5.31%, due 05/16/44     2,147,746  
    942,071     SLM Private Education Loan Trust, Series 11-C, Class A2B, 144A, 4.54%, due 10/17/44     952,702  
    1,951,677     SLM Student Loan Trust, Series 07-3, Class A3, Variable Rate, 3 mo. LIBOR + 0.04%, 2.38%, due 04/25/19     1,946,741  
    5,789,888     SLM Student Loan Trust, Series 07-6, Class A4, Variable Rate, 3 mo. LIBOR + 0.38%, 2.72%, due 10/25/24     5,800,707  
    590,294     South Carolina Student Loan Corp., Series 05, Class A3, Variable Rate, 3 mo. LIBOR + 0.14%, 2.44%, due 12/01/23     590,176  
    376,658     South Carolina Student Loan Corp., Series 10-1, Class A2, Variable Rate, 3 mo. LIBOR + 1.00%, 3.34%, due 07/25/25     378,462  
    726,120     Symphony CLO V Ltd., Series 07-5A, Class A1, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 01/15/24     726,358  
    206,530     Telos CLO, Series 13-3A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 1.00%, 3.34%, due 07/17/19     206,724  
    734,400     Telos CLO Ltd., Series 14-6A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.27%, 3.61%, due 01/17/27     734,624  
    810,133     Telos CLO Ltd., Series 14-5A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 04/17/28     810,120  
 

 

32   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    United States — continued  
          Asset-Backed Securities — continued  
    751,769     Telos CLO Ltd., Series 13-4A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 01/17/30     751,757  
    128,844     THL Credit Wind River CLO Ltd., Series 17-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.25%, due 07/20/30     129,006  
    557,631     THL Credit Wind River CLO Ltd., Series 17-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.92%, due 11/20/30     557,628  
    1,231,475     TICP CLO I-2 Ltd., Series 18-IA, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.63%, 2.99%, due 04/26/28     1,231,415  
    1,605,800     TICP CLO III-2 Ltd., Series 18-3R, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.55%, 2.91%, due 04/20/28     1,605,728  
    1,085,000     Tryon Park CLO Ltd., Series 13-1A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.55%, 2.90%, due 04/15/29     1,084,957  
    600,428     Velocity Commercial Capital Loan Trust, Series 15-1, Class AFL, 144A, Variable Rate, 1 mo. LIBOR + 2.43%, 4.49%, due 06/25/45     604,412  
    714,598     Velocity Commercial Capital Loan Trust, Series 17-1, Class AFL, 144A, Variable Rate, 1 mo. LIBOR + 1.25%, 3.31%, due 05/25/47     719,178  
    305,014     Venture VII CDO Ltd., Series 06-7A, Class A1A, 144A, Variable Rate, 3 mo. LIBOR + 0.23%, 2.58%, due 01/20/22     304,411  
    1,771,716     Voya CLO Ltd., Series 13-3A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.05%, 3.38%, due 01/18/26     1,772,036  
    387,244     Voya CLO Ltd., Series 17-3A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.15%, due 07/20/30     387,191  
    929,385     Voya CLO Ltd., Series 13-1A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 10/15/30     929,372  
    360,763     Voya CLO Ltd., Series 14-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.63%, 2.96%, due 04/18/31     360,757  
    418,567     Westchester CLO Ltd., Series 07-1A, Class C, 144A, Variable Rate, 3 mo. LIBOR + 0.85%, 3.19%, due 08/01/22     418,228  
    1,224,000     WhiteHorse Ltd., Series 18-12A, Class X, Variable Rate, 3 mo. LIBOR + 0.75%, 3.18%, due 10/15/31     1,224,000  
    4,264,286     WhiteHorse VIII Ltd., Series 14-1A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.24%, due 05/01/26     4,261,416  
    135,286     Ziggurat CLO Ltd., Series 14-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.24%, due 04/17/29     135,386  
     

 

 

 
    Total Asset-Backed Securities     128,031,724  
     

 

 

 
    U.S. Government — 16.5%

 

    57,898,592     U.S. Treasury Inflation Indexed Bond, 0.63%, due 04/15/23 (f)     57,551,804  
    
Par Value†
    Description   Value ($)  
    United States — continued  
          U.S. Government — continued  
    26,200,498     U.S. Treasury Inflation Indexed Bond, 0.25%, due 01/15/25 (f)     25,385,576  
    64,676,845     U.S. Treasury Inflation Indexed Bond, 0.63%, due 01/15/26 (f)     64,007,339  
    92,062,642     U.S. Treasury Inflation Indexed Bond, 0.38%, due 01/15/27 (f)     89,005,875  
    3,608,370     U.S. Treasury Inflation Indexed Bond, 0.38%, due 07/15/27 (f)     3,492,179  
    59,083,252     U.S. Treasury Inflation Indexed Bond, 0.50%, due 01/15/28 (f)     57,436,922  
    82,650,746     U.S. Treasury Inflation Indexed Bond, 1.75%, due 01/15/28 (f)     89,616,869  
    63,592,600     U.S. Treasury Inflation Indexed Bond, 2.50%, due 01/15/29 (f)     74,086,207  
    850,000     U.S. Treasury Note, 0.75%, due 10/31/18     848,300  
    7,900,000     U.S. Treasury Note, Variable Rate, USBM + 0.05%, 2.14%, due 10/31/19     7,904,874  
    8,900,000     U.S. Treasury Note, Variable Rate, USBM + 0.00%, 2.09%, due 01/31/20 (b)     8,899,042  
    15,750,000     U.S. Treasury Note, 2.25%, due 03/31/20 (b)     15,665,098  
    18,000,000     U.S. Treasury Note, 2.38%, due 04/30/20     17,931,094  
    22,000,000     U.S. Treasury Note, 2.50%, due 05/31/20     21,953,594  
    12,000,000     U.S. Treasury Note, 2.50%, due 06/30/20     11,971,875  
    9,500,000     U.S. Treasury Note, Variable Rate, USBM + 0.04%, 2.13%, due 07/31/20     9,498,911  
    15,000,000     U.S. Treasury Note, 2.63%, due 07/31/20     14,996,484  
    20,200,000     U.S. Treasury Note, 2.63%, due 08/31/20     20,193,687  
     

 

 

 
    Total U.S. Government     590,445,730  
     

 

 

 
    U.S. Government Agency — 1.0%

 

    10,500,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR + 0.22%, 2.12%, due 11/09/18     10,503,053  
    3,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.24%, 2.08%, due 03/06/19     3,000,173  
    10,500,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.16%, 2.18%, due 02/07/20     10,501,691  
    8,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.24%, 2.10%, due 04/13/20     7,995,012  
    95,002     Government National Mortgage Association, Series 12-H15, Class FA, Variable Rate, 1 mo. LIBOR + 0.45%, 2.55%, due 05/20/62     95,103  
    2,098,533     Government National Mortgage Association, Series 17-H12, Class FE, Variable Rate, 1 mo. LIBOR + 0.20%, 2.30%, due 06/20/66     2,095,051  
    648,526     Government National Mortgage Association, Series 17-H05, Class FJ, Variable Rate, 1 mo. LIBOR + 0.27%, 2.37%, due 01/20/67     647,866  
 

 

  See accompanying notes to the financial statements.   33


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

Shares /
Par Value†
    Description   Value ($)  
    United States — continued  
          U.S. Government Agency — continued  
    632,538     Government National Mortgage Association, Series 17-H13, Class FJ, Variable Rate, 1 mo. LIBOR + 0.20%, 2.30%, due 05/20/67     631,679  
     

 

 

 
    Total U.S. Government Agency     35,469,628  
     

 

 

 
    Total United States     753,947,082  
   

 

 

 
    TOTAL DEBT OBLIGATIONS
(COST $759,831,551)
    753,947,082  
     

 

 

 
    MUTUAL FUNDS — 31.2%

 

    United States — 31.2%

 

  Affiliated Issuers — 31.2%

 

    4,088,529     GMO Emerging Country Debt Fund, Class IV     109,777,006  
    13,350,523     GMO Emerging Markets Fund, Class VI     428,418,296  
    7,332,394     GMO Opportunistic Income Fund, Class VI     195,848,231  
    4,081,954     GMO Risk Premium Fund, Class VI     115,723,391  
    4,759,278     GMO SGM Major Markets Fund, Class VI     152,439,658  
    5,686,502     GMO Special Opportunities Fund, Class VI     111,512,311  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $1,053,663,365)
    1,113,718,893  
     

 

 

 
    SHORT-TERM INVESTMENTS — 6.1%

 

  Foreign Government Obligations — 2.4%

 

JPY

    1,900,000,000     Japan Treasury Discount Bill, Zero Coupon, due 09/18/18     17,100,889  

JPY

    1,937,000,000     Japan Treasury Discount Bill, Zero Coupon, due 10/09/18     17,435,231  

JPY

    1,788,500,000     Japan Treasury Discount Bill, Zero Coupon, due 10/22/18     16,099,365  

JPY

    2,840,000,000     Japan Treasury Discount Bill, Zero Coupon, due 11/12/18     25,566,774  

GBP

    1,300,000     United Kingdom Treasury Bill, Zero Coupon, due 09/10/18     1,685,173  

GBP

    4,500,000     United Kingdom Treasury Bill, Zero Coupon, due 11/19/18     5,824,721  
     

 

 

 
    TOTAL FOREIGN GOVERNMENT OBLIGATIONS
(COST $83,868,810)
    83,712,153  
     

 

 

 
  Money Market Funds — 0.1%

 

    5,188,461     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (g)     5,188,461  
     

 

 

 
Par Value† /
Shares
    Description   Value ($)  
    Repurchase Agreements — 3.2%

 

    115,734,491     Daiwa Capital Markets America Inc. Repurchase Agreement, dated 08/31/18, maturing on 09/04/18 with a maturity value of $115,759,695 and an effective yield of 1.96%, collateralized by a U.S. Treasury Note with maturity date 03/31/25 and a market value of $118,058,788.     115,734,491  
     

 

 

 
    U.S. Government — 0.3%

 

    11,055,000     U.S. Treasury Note, 1.38%, due 11/30/18     11,035,321  
     

 

 

 
    U.S. Government Agency — 0.1%

 

    2,000,000     Federal Home Loan Banks, Zero Coupon, due 09/10/18     1,999,354  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $217,835,399)
    217,669,780  
     

 

 

 
    TOTAL INVESTMENTS — 100.7%
(Cost $3,495,259,636)
    3,590,901,857  
     

 

 

 
    SECURITIES SOLD SHORT — (1.3)%

 

    Common Stocks — (1.3)%

 

    Brazil — (0.1)%

 

    (91,500   Pagseguro Digital Ltd – Class A *     (2,643,435
     

 

 

 
    Canada — (0.2)%

 

    (26,000   Agnico Eagle Mines Ltd     (897,520
    (20,850   Algonquin Power & Utilities Corp     (215,798
    (148,200   Barrick Gold Corp     (1,544,244
    (36,500   Cameco Corp     (379,965
    (72,400   Enbridge Inc     (2,473,908
     

 

 

 
    Total Canada     (5,511,435
     

 

 

 
    Denmark — (0.0)%

 

    (43   AP Moller – Maersk A/S – Class A *     (62,092
    (714   AP Moller – Maersk A/S – Class B     (1,106,551
     

 

 

 
    Total Denmark     (1,168,643
     

 

 

 
    Finland — (0.0)%

 

    (6,760   Outokumpu Oyj     (39,707
     

 

 

 
    France — (0.1)%

 

    (7,271   Air Liquide SA     (915,070
    (19,442   DBV Technologies SA *     (863,009
    (835   Iliad SA     (107,795
    (1,407   Wendel SA     (208,320
     

 

 

 
    Total France     (2,094,194
     

 

 

 
    Germany — (0.2)%

 

    (390,351   Deutsche Bank AG (Registered)     (4,400,605
 

 

34   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Germany — continued

 

    (1,334   GEA Group AG     (50,671
    (74,353   thyssenkrupp AG     (1,718,100
     

 

 

 
    Total Germany     (6,169,376
     

 

 

 
    Israel — (0.0)%

 

    (5,300   CyberArk Software Ltd *     (399,726
    (7,100   Wix.com Ltd *     (788,810
     

 

 

 
    Total Israel     (1,188,536
     

 

 

 
    Italy — (0.2)%

 

    (205,172   BPER Banca     (906,184
    (88,178   Brembo SPA     (1,179,732
    (634,163   Saipem SPA *     (3,391,406
     

 

 

 
    Total Italy     (5,477,322
     

 

 

 
    Japan — (0.2)%

 

    (18,000   Acom Co Ltd     (73,475
    (48   Daiwa House Investment Corp (REIT)     (111,320
    (800   FP Corp     (45,047
    (2,800   Fujitsu General Ltd     (46,186
    (18,700   Hokkaido Electric Power Co Inc     (127,469
    (95   Hulic Reit Inc (REIT)     (139,611
    (143   Invincible Investment Corp (REIT)     (61,943
    (22,200   Isetan Mitsukoshi Holdings Ltd     (250,967
    (2,300   JGC Corp     (46,284
    (2,900   JINS Inc     (148,907
    (44,100   Kansai Paint Co Ltd     (871,584
    (16,900   Keikyu Corp     (292,024
    (7,600   Kenedix Inc     (48,930
    (1,100   Kintetsu Group Holdings Co Ltd     (43,146
    (89,700   Kyushu Electric Power Co Inc     (1,003,660
    (34,800   Mitsui OSK Lines Ltd     (934,793
    (3,400   Murata Manufacturing Co Ltd     (586,280
    (1,800   Nifco Inc     (49,381
    (8,400   Nippon Paint Holdings Co Ltd     (332,027
    (1,300   NOF Corp     (43,133
    (2,000   Nomura Real Estate Holdings Inc     (43,324
    (127,100   Orient Corp     (179,549
    (11,900   Rakuten Inc     (90,984
    (1,600   Royal Holdings Co Ltd     (39,660
    (3,200   Saizeriya Co Ltd     (64,112
    (1,000   Seria Co Ltd     (40,920
    (14,900   Seven Bank Ltd     (46,403
    (7,000   Shimano Inc     (1,080,099
    (2,300   Takasago Thermal Engineering Co Ltd     (40,645
    (4,600   Toyo Tire & Rubber Co Ltd     (75,410
    (2,000   UACJ Corp     (45,470
    (4,700   Yoshinoya Holdings Co Ltd     (79,151
     

 

 

 
    Total Japan     (7,081,894
     

 

 

 
    
Shares
    Description   Value ($)  
    Netherlands — (0.0)%

 

    (68,707   Altice NV *     (206,753
    (14,382   Boskalis Westminster     (411,565
     

 

 

 
    Total Netherlands     (618,318
     

 

 

 
    Singapore — (0.0)%

 

    (14,600   UOL Group Ltd     (73,496
     

 

 

 
    Spain — (0.2)%

 

    (613,203   Bankia SA     (2,297,109
    (48,427   Cellnex Telecom SA     (1,242,030
    (84,984   Ferrovial SA     (1,835,098
    (85,279   Merlin Properties Socimi SA (REIT)     (1,189,258
    (2,335   Neinor Homes SA *     (42,927
     

 

 

 
    Total Spain     (6,606,422
     

 

 

 
    Sweden — (0.0)%

 

    (2,059   Industrivarden AB – Class A     (45,218
     

 

 

 
    Switzerland — (0.1)%

 

    (112,848   Credit Suisse Group AG (Registered) *     (1,689,850
    (23,609   LafargeHolcim Ltd (Registered) *     (1,148,455
     

 

 

 
    Total Switzerland     (2,838,305
     

 

 

 
    United Kingdom — (0.1)%

 

    (90,078   AA Plc     (130,404
    (217,727   Cobham Plc *     (351,904
    (88,864   GVC Holdings Plc     (1,269,549
    (5,742   Just Eat Plc *     (57,173
    (494,565   Melrose Industries Plc     (1,431,364
    (1,531   Ted Baker Plc     (43,834
    (42,715   Travis Perkins Plc     (638,299
     

 

 

 
    Total United Kingdom     (3,922,527
     

 

 

 
    United States — (0.0)%

 

    (78,587   Altice USA, Inc. – Class A     (1,408,279
     

 

 

 
    TOTAL COMMON STOCKS
(PROCEEDS $49,149,255)
    (46,887,107
     

 

 

 
    TOTAL SECURITIES SOLD SHORT (PROCEEDS $49,149,255)     (46,887,107
    Other Assets and Liabilities (net) — 0.6%     22,309,281  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $3,566,324,031  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   35


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Forward Currency Contracts

 

Settlement
Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
   

Net
Un-
realized
Appre-
ciation
(Depre-
ciation)  ($)

 
10/15/2018   GS     AUD       182,983       USD       135,154       3,606  
10/15/2018   MSCI     AUD       5,141,220       USD       3,806,077       110,009  
10/15/2018   SSB     AUD       634,348       USD       469,650       13,612  
10/12/2018   BOA     CHF       881,191       USD       891,851       (20,214
10/12/2018   MSCI     CHF       2,892,468       USD       2,934,058       (59,749
10/12/2018   SSB     CHF       33,946       USD       34,349       (786
09/19/2018   MSCI     EUR       33,055,051       USD       38,650,183       242,397  
09/19/2018   SSB     EUR       2,919,485       USD       3,422,836       30,587  
09/10/2018   BCLY     GBP       1,300,000       USD       1,749,062       63,371  
09/19/2018   BCLY     GBP       511,396       USD       672,393       9,030  
09/19/2018   GS     GBP       4,355,462       USD       5,734,536       84,803  
09/19/2018   JPM     GBP       11,883,324       USD       15,798,119       383,542  
09/19/2018   SSB     GBP       91,895       USD       120,712       1,509  
11/19/2018   JPM     GBP       4,500,000       USD       5,743,873       (108,871

Settlement
Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
   

Net
Un-
realized
Appre-
ciation
(Depre-
ciation)  ($)

 
09/18/2018   BCLY     JPY       1,175,968,317       USD       10,621,790       28,758  
09/18/2018   JPM     JPY       2,815,520,272       USD       25,682,141       320,151  
09/18/2018   MSCI     JPY       1,900,000,000       USD       17,335,331       220,278  
09/18/2018   SSB     JPY       17,071,267       USD       154,334       557  
10/09/2018   MSCI     JPY       1,937,000,000       USD       17,622,227       147,200  
10/22/2018   GS     JPY       1,788,500,000       USD       16,046,115       (104,490
11/13/2018   JPM     JPY       2,840,000,000       USD       25,782,602       96,227  
10/12/2018   BOA     NOK       36,123,524       USD       4,498,233       184,372  
10/12/2018   GS     NOK       6,330,208       USD       775,888       19,937  
10/12/2018   BCLY     SEK       27,587,282       USD       3,172,949       147,605  
10/12/2018   GS     SEK       783,753       USD       89,110       3,160  
10/12/2018   SSB     SEK       17,814,181       USD       2,034,766       81,184  
09/18/2018   BCLY     USD       1,040,089       JPY       113,597,600       (16,811
09/18/2018   GS     USD       705,678       JPY       77,665,400       (6,074
09/19/2018   JPM     USD       1,974,736       EUR       1,732,700       38,547  
09/19/2018   MSCI     USD       1,726,041       EUR       1,469,600       (18,463
09/19/2018   MSCI     USD       886,239       GBP       669,300       (18,049
           

 

 

 
  $ 1,876,935  
           

 

 

 
 

 

Reverse Repurchase Agreements

 

Average balance outstanding

   $ (46,057,969

Average interest rate

     0.51

Maximum balance outstanding

   $ (46,057,969

Average balance outstanding was calculated based on daily face value balances outstanding during the period that the Fund had entered into reverse repurchase agreements. Average interest rate was calculated based on interest received and/or paid during the period that the Fund had entered into reverse repurchase agreements.

 

Futures Contracts

 

Number
of
Contracts +

  Type   Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation) ($)
 
Buys    
120   Mini
MSCI
Emerging
Markets
  September
2018
    6,329,400       (469,455
     

 

 

   

 

 

 
Sales    
2,060   S&P 500
E-Mini
  September
2018
    298,916,300       (12,071,454
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

    

Sales - Fund is short the futures contract.

 

 

36   See accompanying notes to the financial statements.  


GMO Benchmark-Free Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Swap Contracts

OTC Total Return Swaps

 

Fund Pays

   Fund Receives  

Counterparty

  Notional
Amount
 

Expiration
Date

  Periodic
Payment
Frequency
  Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Total Return on Equity Basket (h)

   1 Month Federal Funds
Rate minus 1.00%
  MORD   USD   6,331,328   05/18/2020   Monthly           (428,917     (428,917

Total Return on Equity Basket (h)

   1 Month Federal Funds
Rate minus 0.75%
  MORD   USD   219,971   05/18/2020   Monthly           (23,945     (23,945

Total Return on Equity Basket (h)

   1 Month Federal Funds
Rate minus 0.75%
  MORD   USD   861,962   05/18/2020   Monthly           (86,079     (86,079

Total Return on Equity Basket (h)

   1 Month Federal Funds
Rate minus 0.40%
  MORD   USD   1,325,928   05/18/2020   Monthly           22,882       22,882  

Total Return on Equity Basket (h)

   1 Month Federal Funds
Rate minus 0.40%
  MORD   USD   857,083   05/18/2020   Monthly           (62,322     (62,322

Total Return on Equity Basket (h)

   1 Month Federal Funds
Rate minus 0.40%
  MORD   USD   6,686,271   05/18/2020   Monthly           (11,047     (11,047

Total Return on Equity Basket (h)

   1 Month Federal Funds
Rate minus 1.75%
  MORD   USD   1,880,032   05/18/2020   Monthly           (53,649     (53,649

Total Return on Equity Basket (h)

   1 Month Federal Funds
Rate minus 3.38%
  MORD   USD   154,280   05/18/2020   Monthly           14,422       14,422  
              

 

 

   

 

 

   

 

 

 
  $     $ (628,655   $ (628,655
 

 

 

   

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

*

Non-income producing security.

 

(a)

All or a portion of this security is out on loan (Note 2).

 

(b)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on securities sold short, OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(c)

Investment valued using significant unobservable inputs (Note 2).

 

(d)

Security valued at the local price and adjusted by applying a premium or discount since holding exceeds foreign ownership limits.

 

(e)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(f)

Indexed security in which price and/or coupon is linked to the price of a specific instrument or financial statistic (Note 2).

 

(g)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(h)

Periodic payments made/received are based on the total return of the referenced entity. Custom equity basket swap which has a notional amount of less than 1% of the Fund’s total net assets.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

 

  See accompanying notes to the financial statements.   37


GMO Global Asset Allocation Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    56.9

Debt Obligations

    30.1  

Short-Term Investments

    14.6  

Mutual Funds

    2.3  

Preferred Stocks

    0.6  

Investment Funds

    0.4  

Swap Contracts

    0.1  

Loan Participations

    0.0

Rights/Warrants

    0.0

Forward Currency Contracts

    0.0

Purchased Options

    0.0

Loan Assignments

    0.0

Written/Credit Linked Options

    (0.0 )^ 

Reverse Repurchase Agreements

    (0.0 )^ 

Futures Contracts

    (0.3

Other

    (4.7
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary¤   Debt Obligations as a
% of Total Net Assets
 

United States

    19.4

Other Emerging

    2.1 † 

Euro Region

    0.0 ^# 

Other Developed

    (0.5 )‡ 
 

 

 

 
    21.0 % 
 

 

 

 
 
Country/Region Summary¤   Equity Investments as a
% of Total Net Assets
 

United States

    14.5

Japan

    6.0  

Other Emerging

    5.4 † 

Taiwan

    4.2  

United Kingdom

    4.1  

China

    4.0  

Other Developed

    3.2 ‡ 

Germany

    2.8  

Russia

    2.7  

France

    1.7  

Switzerland

    1.6  

South Korea

    1.5  

Sweden

    1.3  

Thailand

    1.2  

Australia

    1.1  

Italy

    1.0  
 

 

 

 
    56.3 % 
 

 

 

 
&

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”), except for GMO Alpha Only Fund. Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments. The table includes exposure through the use of certain derivative financial instruments and excludes exposure through certain currency linked derivatives such as forward currency contracts and currency options. The table is based on duration adjusted net exposures (both investments and derivatives), taking into account the market value of securities and the notional amounts of swaps and other derivative financial instruments. For example, U.S. asset-backed securities may represent a relatively small percentage due to their short duration, even though they represent a large percentage of market value (direct and indirect). Duration is based on GMO’s models. The greater the duration of a bond, the greater its contribution to the concentration percentage. Credit default swap exposures are factored into the duration adjusted exposure using the reference security and applying the same methodology to that security. The tables are not normalized, thus, due to the exclusions listed above and negative exposures, which may be attributable to derivatives or short sales, if any, the tables may not total to 100%.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

#

“Euro Region” is comprised of derivative financial instruments attributed to the Eurozone and not a particular country.

 

^

Rounds to 0.0%.

 

 

38


GMO Global Asset Allocation Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares /
Par Value†
    Description   Value ($)  
    MUTUAL FUNDS — 100.0%

 

    Affiliated Issuers — 100.0%

 

    3,250,240     GMO Alpha Only Fund, Class IV     65,752,355  
    11,882,491     GMO Asset Allocation Bond Fund, Class VI     265,692,501  
    15,591,767     GMO Core Plus Bond Fund, Class IV     331,792,810  
    1,646,536     GMO Emerging Country Debt Fund, Class IV     44,209,497  
    12,836,231     GMO Emerging Markets Fund, Class VI     411,914,641  
    20,564,664     GMO International Equity Fund, Class IV     457,769,422  
    1,160,142     GMO Opportunistic Income Fund, Class VI     30,987,404  
    6,174,318     GMO Quality Fund, Class VI     163,619,435  
    1,984,450     GMO Risk Premium Fund, Class VI     56,259,164  
    2,063,930     GMO SGM Major Markets Fund, Class VI     66,107,674  
    10,934,914     GMO U.S. Equity Fund, Class VI     161,946,076  
    5,433,415     GMO U.S. Treasury Fund     135,726,701  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $2,165,505,034)
    2,191,777,680  
     

 

 

 
    DEBT OBLIGATIONS — 0.0%

 

    Asset-Backed Securities — 0.0%

 

    30,275     ACE Securities Corp., Series 06-ASL1, Class A,Variable Rate, 1 mo. LIBOR + .28%, 2.34%, due 02/25/36     16,100  
    22,927     GMAC Mortgage Corp. Loan Trust, Series 04-HE3, Class A3, FSA, Variable Rate, 1 mo. LIBOR + .50%, 2.56%, due 10/25/34     21,461  
    19,476     Mellon Residential Funding Corp., Series 04-TBC1, Class A, 144A, Variable Rate, 1 mo. LIBOR + .25%, 2.31%, due 02/26/34     18,412  
     

 

 

 
    Total Asset-Backed Securities     55,973  
     

 

 

 
    TOTAL DEBT OBLIGATIONS
(COST $49,950)
    55,973  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.0%

 

    Money Market Funds — 0.0%

 

    315,238     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (a)     315,238  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $315,238)     315,238  
     

 

 

 
    TOTAL INVESTMENTS — 100.0%
(Cost $2,165,870,222)
    2,192,148,891  
    Other Assets and Liabilities (net) — (0.0%)     (97,513
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $2,192,051,378  
     

 

 

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

These securities are primarily backed by subprime mortgages.

 

(a)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any,

please refer to page 95.

 

 

  See accompanying notes to the financial statements.   39


GMO Global Developed Equity Allocation Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    97.9

Short-Term Investments

    1.4  

Preferred Stocks

    0.5  

Investment Funds

    0.2  

Other

    0.1  

Swap Contracts

    0.0

Futures Contracts

    (0.1
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary¤   % of Investments  

United States

    40.9

Japan

    12.7  

United Kingdom

    8.7  

Germany

    6.0  

Other Emerging

    4.7 † 

Switzerland

    3.7  

France

    3.7  

Taiwan

    2.6  

Sweden

    2.6  

Australia

    2.2  

China

    2.2  

Italy

    2.1  

Other Developed

    2.0 ‡ 

Norway

    1.7  

Hong Kong

    1.6  

Russia

    1.4  

Netherlands

    1.2  
 

 

 

 
    100 % 
 

 

 

 

 

&

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments and includes exposure through the use of derivative financial instruments, if any. The table excludes exposure through forward currency contracts, if any.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

^

Rounds to 0.0%.

 

 

40


GMO Global Developed Equity Allocation Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    MUTUAL FUNDS — 100.0%

 

    Affiliated Issuers — 100.0%

 

    1,388,882     GMO Emerging Markets Fund, Class VI     44,569,208  
    9,350,529     GMO International Equity Fund, Class IV     208,142,765  
    4,004,766     GMO Quality Fund, Class VI     106,126,304  
    6,854,662     GMO U.S. Equity Fund, Class VI     101,517,540  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $422,557,332)
    460,355,817  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.0%

 

    Money Market Funds — 0.0%

 

    121,679     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (a)     121,679  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $121,679)
    121,679  
     

 

 

 
    TOTAL INVESTMENTS — 100.0%
(Cost $422,679,011)
    460,477,496  
    Other Assets and Liabilities (net) — (0.0%)     (49,744
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $460,427,752  
     

 

 

 

Notes to Schedule of Investments:

 

(a)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

 

  See accompanying notes to the financial statements.   41


GMO Global Equity Allocation Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    96.9

Mutual Funds

    1.1  

Preferred Stocks

    0.9  

Investment Funds

    0.5  

Short-Term Investments

    0.4  

Swap Contracts

    0.0

Futures Contracts

    (0.1

Other

    0.3  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary¤   % of Investments  

United States

    32.1

Japan

    10.7  

United Kingdom

    7.4  

Taiwan

    6.0  

China

    5.7  

Germany

    5.1  

Other Emerging

    4.5 † 

Russia

    3.7  

France

    3.1  

Switzerland

    3.0  

Sweden

    2.2  

Korea

    2.2  

Australia

    1.9  

Italy

    1.8  

Other Developed

    1.7 ‡ 

Thailand

    1.5  

Norway

    1.4  

South Africa

    1.3  

Hong Kong

    1.3  

India

    1.2  

Turkey

    1.1  

Netherlands

    1.1  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments and includes exposure through the use of derivative financial instruments, if any. The table excludes exposure through forward currency contracts, if any.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

^

Rounds to 0.0%.

 

 

42


GMO Global Equity Allocation Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    MUTUAL FUNDS — 100.0%

 

    Affiliated Issuers — 100.0%

 

    16,099,997     GMO Emerging Markets Fund, Class VI     516,648,904  
    34,962,573     GMO International Equity Fund, Class IV     778,266,880  
    13,629,897     GMO Quality Fund, Class VI     361,192,275  
    24,127,786     GMO U.S. Equity Fund, Class VI     357,332,506  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $1,952,524,582)
    2,013,440,565  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.0%

 

    Money Market Funds — 0.0%

 

    656,642     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (a)     656,642  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $656,642)     656,642  
     

 

 

 
    TOTAL INVESTMENTS — 100.0%
(Cost $1,953,181,224)
    2,014,097,207  
    Other Assets and Liabilities (net) — (0.0%)     (167,643
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $2,013,929,564  
     

 

 

 

Notes to Schedule of Investments:

 

(a)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any,

please refer to page 95.

 

 

  See accompanying notes to the financial statements.   43


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Investment Concentration Summary (a)

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    63.7

Debt Obligations

    30.9  

Short-Term Investments

    4.0  

Preferred Stocks

    1.0  

Mutual Funds

    0.4  

Investment Funds

    0.3  

Forward Currency Contracts

    0.1  

Purchased Options

    0.0

Rights/Warrants

    0.0

Reverse Repurchase Agreements

    0.0

Swap Contracts

    0.0

Written Options

    (0.0 )^ 

Futures Contracts

    (0.6

Securities Sold Short

    (3.3

Other

    3.5  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary¤   Debt Obligations as a
% of Total Net Assets
 

United States

    13.5

Other Developed

    0.3 ‡ 

Other Emerging

    0.0 ^† 

Euro Region

    0.0 ^§ 

United Kingdom

    (3.4
 

 

 

 
    10.4 % 
 

 

 

 
 
Country/Region Summary¤   Equity Investments %
of Total Net Assets
 

United States

    9.1

China

    7.7  

Taiwan

    5.4  

Japan

    5.0  

Other Developed

    4.8 ‡ 

United Kingdom

    3.8  

South Korea

    3.0  

Other Emerging

    2.9 † 

Germany

    2.8  

Russia

    2.7  

South Africa

    2.5  

Brazil

    1.7  

Canada

    1.6  

India

    1.6  

Thailand

    1.5  

France

    1.4  

Switzerland

    1.4  

Mexico

    1.2  

Sweden

    1.1  

Australia

    1.0  
 

 

 

 
    62.2 % 
 

 

 

 
Industry Group Summary   % of Equity Investments#  

Banks

    12.2

Materials

    8.2  

Capital Goods

    7.7  

Energy

    7.6  

Technology Hardware & Equipment

    7.3  

Software & Services

    6.4  

Pharmaceuticals, Biotechnology & Life Sciences

    5.9  

Food, Beverage & Tobacco

    4.9  

Semiconductors & Semiconductor Equipment

    4.9  

Automobiles & Components

    4.3  

Real Estate

    3.8  

Telecommunication Services

    3.6  

Diversified Financials

    3.5  

Health Care Equipment & Services

    3.2  

Consumer Durables & Apparel

    3.2  

Insurance

    2.9  

Utilities

    2.1  

Food & Staples Retailing

    1.8  

Transportation

    1.7  

Retailing

    1.6  

Household & Personal Products

    1.5  

Media

    0.8  

Consumer Services

    0.4  

Commercial & Professional Services

    0.4  

Commercial Services & Supplies

    0.1  
 

 

 

 
    100.0
 

 

 

 

 

(a)

GMO Implementation SPC Ltd. is a 100% owned subsidiary of GMO Implementation Fund. As such, the holdings of GMO Implementation SPC Ltd. have been included with GMO Implementation Fund.

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments. The table includes exposure through the use of certain derivative financial instruments and excludes exposure through certain currency linked derivatives such as forward currency contracts and currency options. The table is based on duration adjusted net exposures (both investments and derivatives), taking into account the market value of securities and the notional amounts of swaps and other derivative financial instruments. For example, U.S. asset-backed securities may represent a relatively small percentage due to their short duration, even though they represent a large percentage of market value (direct and indirect). Duration is based on GMO’s models. The greater the duration of a bond, the greater its contribution to the concentration percentage. Credit default swap exposures are factored into the duration adjusted exposure using the reference security and applying the same methodology to that security. The table is not normalized, thus, due to the exclusions listed above and negative exposures, which may be attributable to derivatives or short sales, if any, the table may not total to 100%.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Total Net Assets.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Total Net Assets.

 

§

“Euro Region” is comprised of derivative financial instruments attributed to the Eurozone and not a particular country.

 

 

44


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Investment Concentration Summary (a) — (Continued)

August 31, 2018 (Unaudited)

 

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

45


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    COMMON STOCKS — 63.7%

 

    Australia — 1.0%

 

    36,784     Abacus Property Group (REIT)     92,251  
    22,945     Altium Ltd     463,518  
    25,734     Appen Ltd     284,331  
    148,173     Australia & New Zealand Banking Group Ltd     3,148,791  
    95,610     Australian Pharmaceutical Industries Ltd     126,873  
    936,820     Beach Energy Ltd     1,309,472  
    38,445     Brickworks Ltd     483,793  
    909,496     Caltex Australia Ltd     19,763,606  
    199,698     Charter Hall Group (REIT)     1,023,708  
    112,691     Codan Ltd     252,435  
    718,992     Costa Group Holdings Ltd     3,742,844  
    56,000     Credit Corp Group Ltd     929,573  
    783,981     Cromwell Property Group (REIT)     623,148  
    58,963     Crown Resorts Ltd     602,978  
    45,489     CSL Ltd     7,457,303  
    139,470     CSR Ltd     432,387  
    1,556,055     Downer EDI Ltd     8,656,757  
    41,300     Elders Ltd     198,100  
    70,481     Folkestone Education Trust (REIT)     139,725  
    115,427     GDI Property Group (REIT)     105,330  
    502,436     Genworth Mortgage Insurance Australia Ltd     954,933  
    13,892     Goodman Group (REIT)     106,999  
    108,734     GWA Group Ltd     235,473  
    32,120     IDP Education Ltd     251,277  
    150,395     Insurance Australia Group Ltd     835,826  
    292,275     Macquarie Group Ltd (REIT)     27,337,419  
    25,797     McMillan Shakespeare Ltd     331,867  
    387,487     Metcash Ltd     771,546  
    538,526     Mineral Resources Ltd     5,866,103  
    22,547     Monadelphous Group Ltd     233,101  
    89,649     Monash IVF Group Ltd     78,384  
    2,359,171     Nine Entertainment Co Holdings Ltd     4,099,121  
    170,289     NRW Holdings Ltd *     257,906  
    543,468     OZ Minerals Ltd     3,533,542  
    41,963     Qantas Airways Ltd     194,262  
    305,367     Sandfire Resources NL     1,557,110  
    1,636,186     Scentre Group (REIT)     4,844,150  
    54,850     St Barbara Ltd     154,785  
    298,897     Tassal Group Ltd     955,506  
    50,166     Virtus Health Ltd     209,945  
     

 

 

 
    Total Australia     102,646,178  
     

 

 

 
    Austria — 0.3%

 

    43,489     FACC AG     1,097,674  
    378,429     OMV AG     20,063,162  
    23,033     POLYTEC Holding AG     285,284  
    
Shares
    Description   Value ($)  
    Austria — continued

 

    14,552     S IMMO AG     305,770  
    18,674     Vienna Insurance Group AG Wiener Versicherung Gruppe     509,266  
    106,216     voestalpine AG     4,774,229  
     

 

 

 
    Total Austria     27,035,385  
     

 

 

 
    Belgium — 0.1%

 

    300,759     AGFA-Gevaert NV *     1,320,745  
    9,177     Barco NV     1,262,806  
    44,599     KBC Group NV     3,170,979  
    31,712     UCB SA     2,902,895  
     

 

 

 
    Total Belgium     8,657,425  
     

 

 

 
    Brazil — 1.5%

 

    2,328,900     Ambev SA ADR     10,829,385  
    127,240     Banco Bradesco SA     784,414  
    803,200     Banco BTG Pactual SA     4,042,523  
    1,800,200     Banco do Brasil SA     13,303,386  
    1,906,000     Banco Santander Brasil SA     16,191,009  
    354,400     BB Seguridade Participacoes SA     2,130,002  
    569,700     Centrais Eletricas Brasileiras SA *     2,212,726  
    2,697,600     Cia de Saneamento Basico do Estado de Sao Paulo     16,160,035  
    648,100     Cia de Saneamento Basico do Estado de Sao Paulo ADR     3,895,081  
    161,900     Cia de Saneamento de Minas Gerais-COPASA     1,664,671  
    605,100     Cielo SA     2,243,257  
    38,900     Construtora Tenda SA *     281,739  
    99,500     Cosan SA     850,114  
    179,700     Equatorial Energia SA     2,514,768  
    1,061,800     Estacio Participacoes SA     5,875,862  
    531,900     Grendene SA     935,014  
    7,300     Guararapes Confeccoes SA     188,275  
    13,371,600     JBS SA     30,859,306  
    1,132,800     Kroton Educacional SA     2,842,360  
    39,100     Mahle-Metal Leve SA     242,197  
    312,900     MRV Engenharia e Participacoes SA     998,674  
    1,975,507     Oi SA     6,558,683  
    2,090,700     Petrobras Distribuidora SA     10,152,966  
    222,700     QGEP Participacoes SA     667,045  
    26,200     Qualicorp Consultoria e Corretora de Seguros SA     101,375  
    143,300     Smiles Fidelidade SA     1,826,300  
    148,600     Tim Participacoes SA     448,379  
    788,200     Transmissora Alianca de Energia Eletrica SA     3,889,622  
    519,100     Ultrapar Participacoes SA     5,246,949  
    112,900     Ultrapar Participacoes SA Sponsored ADR     1,153,838  
 

 

46   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Brazil — continued  
    533,000     Via Varejo SA     2,211,510  
     

 

 

 
    Total Brazil     151,301,465  
     

 

 

 
    Canada — 1.8%

 

    139,500     AGF Management Ltd – Class B     657,414  
    899,200     Alignvest Acquisition II Corp – Class A *     6,704,380  
    8,800     ATS Automation Tooling Systems Inc *     149,162  
    93,500     Bank of Montreal     7,664,134  
    101,100     Bank of Montreal (b)     8,286,156  
    32,400     Bank of Nova Scotia (The)     1,875,228  
    72,300     Bank of Nova Scotia (The)     4,186,170  
    97,100     Bird Construction Inc     573,671  
    121,248     BRP Inc Sub Voting     6,329,053  
    133,400     Canadian Imperial Bank of Commerce     12,501,778  
    12,300     Canadian Imperial Bank of Commerce     1,152,264  
    150,200     Canfor Corp *     3,463,232  
    6,900     Canfor Pulp Products Inc     144,715  
    11,800     Cogeco Inc     561,246  
    5,400     Constellation Software Inc     4,117,614  
    67,600     Empire Co Ltd – A Shares     1,288,803  
    43,100     Finning International Inc     1,001,703  
    3,600     George Weston Ltd     280,386  
    9,500     Industrial Alliance Insurance & Financial Services Inc     393,831  
    12,400     Interfor Corp *     213,413  
    19,400     Labrador Iron Ore Royalty Corp     377,594  
    182,000     Magna International Inc     9,854,498  
    131,100     Magna International Inc     7,095,132  
    86,700     Metro Inc     2,714,607  
    13,500     Morguard North American Residential (REIT)     169,655  
    36,200     National Bank of Canada     1,811,664  
    13,300     Norbord Inc     506,113  
    5,800     Power Corp of Canada     130,000  
    10,500     Rocky Mountain Dealerships Inc     83,920  
    501,000     Rogers Sugar Inc     2,080,782  
    22,800     Royal Bank of Canada (b)     1,813,056  
    570,800     Royal Bank of Canada     45,340,328  
    79,900     Russel Metals Inc     1,746,779  
    315,500     Sun Life Financial Inc     12,537,970  
    73,200     Sun Life Financial Inc     2,909,490  
    38,000     TFI International Inc     1,410,513  
    344,600     Toronto-Dominion Bank (The)     20,768,421  
    79,400     Transat AT Inc *     556,713  
    198,720     Transcontinental Inc – Class A     4,840,850  
    6,300     Wajax Corp     133,676  
    166,700     West Fraser Timber Co Ltd     11,058,405  
     

 

 

 
    Total Canada     189,484,519  
     

 

 

 
    
Shares
    Description   Value ($)  
    Chile — 0.0%

 

    608,693     AES Gener SA     152,876  
    10,540,667     Enel Chile SA     1,030,614  
     

 

 

 
    Total Chile     1,183,490  
     

 

 

 
    China — 8.1%

 

    5,254,000     361 Degrees International Ltd     1,507,923  
    88,000     AAC Technologies Holdings Inc     978,046  
    11,019,000     Agile Group Holdings Ltd     18,022,451  
    2,403,000     Agricultural Bank of China Ltd – Class A     1,278,370  
    119,264,000     Agricultural Bank of China Ltd – Class H     57,792,489  
    1,369,719     Anhui Conch Cement Co Ltd – Class A     7,461,532  
    2,728,500     Anhui Conch Cement Co Ltd – Class H     16,645,018  
    139,000     ANTA Sports Products Ltd     758,000  
    3,452,500     BAIC Motor Corp Ltd – Class H     2,904,795  
    79,900     Baidu Inc Sponsored ADR *     18,095,752  
    51,801,000     Bank of China Ltd – Class H     23,277,157  
    15,371,000     Bank of Communications Co Ltd – Class H     11,108,297  
    1,412,600     Cangzhou Mingzhu Plastic Co Ltd – Class A     967,722  
    294,600     Changyou.com Ltd ADR     3,974,154  
    11,759,000     China CITIC Bank Corp Ltd – Class H     7,346,885  
    18,974,000     China Communications Services Corp Ltd – Class H     15,719,789  
    12,961,080     China Construction Bank Corp – Class A     13,081,274  
    39,058,000     China Construction Bank – Class H     34,399,793  
    2,448,000     China Everbright Bank Co Ltd – Class H     1,023,573  
    6,149,000     China Greenfresh Group Co Ltd *     924,390  
    9,318,000     China Huarong Asset Management Co Ltd – Class H     1,937,038  
    10,236,000     China Lesso Group Holdings Ltd     5,907,174  
    553,000     China Lilang Ltd     613,390  
    11,351,000     China Machinery Engineering Corp – Class H     5,527,566  
    261,000     China Medical System Holdings Ltd     432,594  
    1,796,000     China Mobile Ltd     16,892,308  
    10,584,600     China National Building Material Co Ltd – Class H     9,917,924  
    2,748,000     China Overseas Land & Investment Ltd     8,709,856  
    23,925     China Petroleum & Chemical Corp ADR     2,375,992  
    9,474,946     China Petroleum & Chemical Corp – Class A     9,503,560  
    66,600,000     China Petroleum & Chemical Corp – Class H     67,012,018  
 

 

  See accompanying notes to the financial statements.   47


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    China — continued  
    26,663,200     China Railway Construction Corp Ltd – Class H     32,255,173  
    2,648,000     China Railway Group Ltd – Class H     2,288,612  
    4,864,000     China Resources Cement Holdings Ltd     5,688,126  
    2,130,000     China Resources Land Ltd     7,429,976  
    5,431,000     China Resources Pharmaceutical Group Ltd     8,691,166  
    1,846,000     China SCE Group Holdings Ltd     828,684  
    1,001,457     China Shenhua Energy Co Ltd – Class A     2,718,224  
    4,452,500     China Shenhua Energy Co Ltd – Class H     9,944,661  
    1,552,000     China Shineway Pharmaceutical Group Ltd     2,193,243  
    77,810,000     China Telecom Corp Ltd – Class H     36,594,240  
    1,124,000     China Travel International Investment Hong Kong Ltd     365,449  
    727,593     China Vanke Co Ltd – Class A     2,567,455  
    562,200     China Vanke Co Ltd – Class H     1,950,497  
    2,000,002     China Yangtze Power Co Ltd – Class A     4,638,538  
    21,900     China Yuchai International Ltd     440,409  
    785,166     Chongqing Department Store Co Ltd – Class A     3,302,687  
    9,269,069     Chongqing Rural Commercial Bank Co Ltd – Class H     4,999,557  
    932,000     CIFI Holdings Group Co Ltd     541,324  
    3,174,000     Country Garden Holdings Co Ltd     4,731,790  
    170,827     Country Garden Services Holdings Co Ltd *     288,602  
    385,000     Dah Chong Hong Holdings Ltd     167,437  
    3,842,892     Daqin Railway Co Ltd – Class A     4,858,639  
    318,900     Dashang Co Ltd – Class A     1,338,338  
    16,788,000     Dongfeng Motor Group Co Ltd – Class H     18,766,919  
    69,000     ENN Energy Holdings Ltd     629,015  
    1,539,200     Fangda Special Steel Technology Co Ltd – Class A     2,503,096  
    8,587,000     Geely Automobile Holdings Ltd     18,282,437  
    1,286,900     Gree Electric Appliances Inc of Zhuhai – Class A *     7,352,800  
    4,454,000     Guangdong Investment Ltd     7,907,095  
    2,078,000     Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd – Class H     7,656,255  
    12,435,600     Guangzhou R&F Properties Co Ltd – Class H     25,130,833  
    5,336,000     Haier Electronics Group Co Ltd *     13,915,488  
    321,000     Haitian International Holdings Ltd     644,195  
    4,353,700     Harbin Electric Co Ltd – Class H     1,369,752  
    1,812,400     Heilan Home Co Ltd – Class A     2,648,575  
    927,299     Henan Shuanghui Investment & Development Co Ltd – Class A     3,159,071  
    
Shares
    Description   Value ($)  
    China — continued  
    67,500     Hengan International Group Co Ltd     608,145  
    921,000     Hi Sun Technology China Ltd *     137,600  
    1,010,000     Hua Hong Semiconductor Ltd     2,757,692  
    11,246,000     Huabao International Holdings Ltd     6,626,809  
    217,000     IGG Inc     262,429  
    2,836,146     Industrial & Commercial Bank of China Ltd – Class A     2,262,051  
    26,682,000     Industrial and Commercial Bank of China Ltd – Class H     19,707,261  
    738,000     Jiangsu Expressway Co Ltd – Class H     933,358  
    221,000     JNBY Design Ltd     376,571  
    822,000     Ju Teng International Holdings Ltd     154,985  
    3,452,500     Kingboard Holdings Ltd     12,290,553  
    2,286,000     Kingboard Laminates Holdings Ltd     2,161,297  
    1,349,530     Livzon Pharmaceutical Group Inc – Class H     5,451,135  
    1,206,000     Logan Property Holdings Co Ltd     1,508,938  
    1,400,500     Longfor Group Holdings Ltd     3,895,527  
    16,459,000     Lonking Holdings Ltd     5,666,845  
    447,900     Offshore Oil Engineering Co Ltd – Class A     394,069  
    5,127,000     PICC Property & Casualty Co Ltd – Class H     5,781,028  
    17,969,000     Postal Savings Bank of China Co Ltd – Class H     10,591,294  
    2,431,000     Powerlong Real Estate Holdings Ltd     1,243,314  
    1,973,000     Shanghai Industrial Holdings Ltd     4,704,343  
    4,944,400     Shanghai Pharmaceuticals Holding Co Ltd – Class H     12,987,951  
    3,284,568     Shanghai SMI Holding Co Ltd – Class A     2,757,530  
    126,160     Shenzhen Expressway Co Ltd – Class A     155,280  
    1,504,000     Shenzhen Expressway Co Ltd – Class H     1,459,234  
    28,000     Shenzhou International Group Holdings Ltd     367,770  
    10,939,576     Shimao Property Holdings Ltd     32,669,645  
    2,701,500     Sino Biopharmaceutical Ltd     3,423,905  
    2,811,000     Sinotruk Hong Kong Ltd     4,198,279  
    4,808,000     SSY Group Ltd     4,473,505  
    5,546,231     Suning Universal Co Ltd – Class A     2,746,293  
    563,000     Tencent Holdings Ltd     24,201,756  
    71,400     Tencent Holdings Ltd ADR     3,080,196  
    1,631,000     Texhong Textile Group Ltd     2,806,838  
    654,000     Tianjin Development Holdings Ltd *     246,025  
    914,000     Tianjin Port Development Holdings Ltd *     107,198  
    3,930,000     Tianneng Power International Ltd     4,884,882  
    321,000     Times China Holdings Ltd     381,246  
    5,025,000     TravelSky Technology Ltd – Class H     12,902,698  
    1,016,000     Uni-President China Holdings Ltd     1,001,181  
 

 

48   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    China — continued  
    9,373,000     Weichai Power Co Ltd – Class H     9,940,656  
    2,429,000     XTEP International Holdings Ltd     1,622,926  
    2,908,000     Yadea Group Holdings Ltd     1,085,627  
    8,989,000     Yuzhou Properties Co Ltd     4,783,392  
    45,400     YY Inc ADR *     3,469,922  
    3,878,000     Zhejiang Expressway Co Ltd – Class H     3,078,962  
    1,051,472     Zhejiang Weixing New Building Materials Co Ltd – Class A     2,608,710  
    122,000     Zhongsheng Group Holdings Ltd     267,895  
     

 

 

 
    Total China     844,109,934  
     

 

 

 
    Colombia — 0.1%

 

    405,978     Almacenes Exito SA     2,113,754  
    1,361,849     Ecopetrol SA     1,528,987  
    350,679     Ecopetrol SA Sponsored ADR     7,925,345  
     

 

 

 
    Total Colombia     11,568,086  
     

 

 

 
    Czech Republic — 0.0%

 

    59,876     CEZ AS     1,517,824  
    222,250     Moneta Money Bank AS     776,844  
     

 

 

 
    Total Czech Republic     2,294,668  
     

 

 

 
    Denmark — 0.2%

 

    106,500     Novo Nordisk A/S Sponsored ADR     5,236,605  
    332,780     Novo Nordisk A/S – Class B     16,381,482  
    796     Rockwool International A/S – Class B     345,888  
    26,518     Royal Unibrew A/S     2,285,232  
    22,029     Scandinavian Tobacco Group A/S     362,658  
    1,897     Schouw & Co AB     149,989  
    22,545     Spar Nord Bank A/S     220,529  
     

 

 

 
    Total Denmark     24,982,383  
     

 

 

 
    Egypt — 0.0%

 

    544,093     Global Telecom Holding SAE *     129,694  
     

 

 

 
    Finland — 0.3%

 

    12,286     DNA Oyj     261,416  
    23,971     Finnair Oyj     209,108  
    3,986     Kemira Oyj     52,849  
    36,224     Metsa Board Oyj     364,999  
    150,247     Neste Oyj     13,044,838  
    8,911     Sanoma Oyj     92,462  
    79,744     Stora Enso Oyj – R Shares     1,484,196  
    11,675     Tieto Oyj     378,947  
    422,354     UPM-Kymmene Oyj     16,292,082  
     

 

 

 
    Total Finland     32,180,897  
     

 

 

 
    France — 1.4%

 

    2,966     Alten SA     307,124  
    1,504     Amundi SA     108,463  
    
Shares
    Description   Value ($)  
    France — continued

 

    25,783     ArcelorMittal     777,643  
    31,106     AXA SA     783,895  
    386,057     BNP Paribas SA     22,728,314  
    51,386     Christian Dior SE     22,170,728  
    279,087     CNP Assurances     6,450,472  
    51,734     Coface SA *     485,373  
    133,585     Credit Agricole SA     1,827,782  
    1,372     Dassault Systemes SE     222,650  
    37,919     Derichebourg SA     212,364  
    5,509     Eramet     471,982  
    14,611     Gaztransport Et Technigaz SA     999,658  
    2,642     Interparfums SA     122,515  
    1,574     Ipsen SA     280,492  
    6,965     Kaufman & Broad SA     366,781  
    100,863     L’Oreal SA     24,147,196  
    11,479     Mersen SA     449,454  
    46,875     Metropole Television SA     928,073  
    281,324     Natixis SA     1,881,490  
    5,374     Neopost SA     144,241  
    1,370     Nexity SA     83,723  
    42,253     Peugeot SA     1,164,255  
    12,761     Rallye SA     132,481  
    12,989     Renault SA     1,121,872  
    165,970     Sanofi     14,252,401  
    59,900     Sanofi ADR     2,566,715  
    14,406     Schneider Electric SA     1,170,702  
    58,511     SCOR SE     2,365,320  
    167,176     Societe Generale SA     6,845,404  
    795,100     STMicroelectronics NV – NY Shares (Registered)     16,450,619  
    706,342     STMicroelectronics NV     14,573,660  
    2,506     Ubisoft Entertainment SA *     269,991  
    3,168     Vilmorin & Cie SA     219,784  
     

 

 

 
    Total France     147,083,617  
     

 

 

 
    Germany — 2.8%

 

    2,387     Aareal Bank AG     97,060  
    210,649     Allianz SE (Registered)     44,898,104  
    1,646     Amadeus Fire AG     189,750  
    249,408     BASF SE     23,046,680  
    12,091     Bauer AG     225,161  
    14,535     Bayer AG (Registered)     1,356,469  
    477,115     Bayerische Motoren Werke AG     46,187,942  
    1,429     Cewe Stiftung & Co KGAA     131,380  
    234,927     Covestro AG     20,002,018  
    552,876     Daimler AG (Registered Shares)     35,754,669  
    1,491,289     Deutsche Lufthansa AG (Registered)     38,963,742  
    134,259     Deutsche Pfandbriefbank AG * (a)     1,965,458  
    4,362     Eckert & Ziegler AG     238,956  
    18,903     Elmos Semiconductor AG     488,284  
 

 

  See accompanying notes to the financial statements.   49


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Germany — continued

 

    2,718     Gesco AG     95,797  
    29,472     Henkel AG & Co KGaA     3,288,657  
    4,845     Isra Vision AG     337,180  
    14,995     Kloeckner & Co SE     158,800  
    8,436     Leoni AG     363,958  
    174,500     Linde AG-Tender     39,730,425  
    2,835     OHB SE     119,435  
    6,687     Salzgitter AG     302,853  
    183,547     SAP SE     22,034,410  
    798     Siltronic AG     115,686  
    1,545     Sixt SE     198,459  
    15,568     Software AG     767,708  
    5,517     STADA Arzneimittel AG     519,656  
    7,406     Takkt AG     129,195  
    43,863     Talanx AG *     1,656,322  
    52,260     Volkswagen AG     8,412,230  
    42,119     Wacker Neuson SE     1,164,460  
    31,622     Wuestenrot & Wuerttembergische AG     730,460  
     

 

 

 
    Total Germany     293,671,364  
     

 

 

 
    Greece — 0.0%

 

    17,677     JUMBO SA     264,218  
    124,640     Public Power Corp SA *     241,710  
     

 

 

 
    Total Greece     505,928  
     

 

 

 
    Hong Kong — 0.5%

 

    1,407,000     BOC Hong Kong Holdings Ltd     6,871,498  
    241,500     CK Asset Holdings Ltd     1,722,313  
    520,000     Dah Sing Banking Group Ltd     1,072,553  
    319,200     Dah Sing Financial Holdings Ltd     1,985,333  
    86,500     HKBN Ltd     128,514  
    140,000     Hysan Development Co Ltd     718,383  
    2,520,213     I-CABLE Communications Ltd *     28,586  
    271,000     Johnson Electric Holdings Ltd     794,621  
    1,100,500     Kerry Properties Ltd     4,173,451  
    170,000     Luk Fook Holdings International Ltd     591,550  
    536,000     Singamas Container Holdings Ltd     69,041  
    5,244,000     SJM Holdings Ltd     5,937,318  
    16,408,500     WH Group Ltd     12,392,182  
    1,950,000     Wharf Holdings Ltd (The)     5,568,718  
    1,189,000     Wharf Real Estate Investment Co Ltd     7,888,831  
    1,109,000     Wheelock & Co Ltd     6,963,509  
    160,500     Xinyi Automobile Glass Hong Kong Enterprises Ltd *     39,068  
     

 

 

 
    Total Hong Kong     56,945,469  
     

 

 

 
    Hungary — 0.0%

 

    2,257,270     Magyar Telekom Telecommunications Plc     3,308,730  
    
Shares
    Description   Value ($)  
    Hungary — continued

 

    60,455     Richter Gedeon Nyrt     1,187,117  
     

 

 

 
    Total Hungary     4,495,847  
     

 

 

 
    India — 1.6%

 

    8,089     ACC Ltd     187,673  
    124,149     Apollo Tyres Ltd     440,989  
    426,783     Aurobindo Pharma Ltd     4,294,808  
    460,769     Balrampur Chini Mills Ltd     496,648  
    81,154     Bata India Ltd     1,241,016  
    224,796     Castrol India Ltd     504,203  
    353,952     Chambal Fertilizers and Chemicals Ltd     828,224  
    211,718     Divi’s Laboratories Ltd     3,912,210  
    1,665,930     Firstsource Solutions Ltd     1,771,421  
    2,368,269     HCL Technologies Ltd     34,891,055  
    139,506     Hero MotoCorp Ltd     6,418,752  
    945,148     Hexaware Technologies Ltd     5,849,269  
    52,696     Hindustan Unilever Ltd     1,320,751  
    259,399     IDFC Bank Ltd     174,639  
    37,652     Ipca Laboratories Ltd     409,078  
    961,829     ITC Ltd     4,338,807  
    258,625     Jamna Auto Industries Ltd     296,934  
    1,523,344     Jaypee Infratech Ltd *     78,686  
    68,095     Jubilant Life Sciences Ltd     692,007  
    264,237     Just Dial Ltd *     2,083,900  
    265,044     KPIT Technologies Ltd     1,133,426  
    159,442     Larsen & Toubro Infotech Ltd     4,019,544  
    38,577     Mahanagar Gas Ltd     469,662  
    701,364     Mahindra & Mahindra Ltd     9,558,684  
    30,314     Maruti Suzuki India Ltd     3,893,622  
    36,733     Mastek Ltd     279,207  
    7,531     Merck Ltd     371,928  
    457,902     Mphasis Ltd     8,173,754  
    976     MRF Ltd     1,017,800  
    1,337,409     NHPC Ltd     479,302  
    368,736     NIIT Technologies Ltd     7,327,319  
    19,326     Nucleus Software Exports Ltd     123,713  
    3,829,260     Oil & Natural Gas Corp Ltd     9,717,436  
    199,634     Oil India Ltd     602,212  
    58,704     Pidilite Industries Ltd     967,673  
    4,473,302     Power Finance Corp Ltd     5,333,378  
    1,932,887     PTC India Ltd     2,285,382  
    60,355     Rajesh Exports Ltd     565,666  
    24,601     Raymond Ltd     292,621  
    1,135,724     Reliance Capital Ltd     7,543,827  
    8,247,301     Rural Electrification Corp Ltd     13,953,727  
    276,615     Sonata Software Ltd     1,375,544  
    130,455     Steel Authority of India Ltd *     147,983  
    822,544     Tata Global Beverages Ltd     2,728,268  
    62,204     Tata Motors Ltd – Class A *     124,862  
    18,022     Tata Steel Ltd     152,872  
 

 

50   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    India — continued

 

    701,055     Tech Mahindra Ltd     7,576,357  
    45,968     TV Today Network Ltd     293,222  
    587,060     Vakrangee Ltd     319,268  
    53,318     VIP Industries Ltd     469,772  
    1,792,239     Wipro Ltd     7,591,532  
    295,573     Zee Entertainment Enterprises Ltd     2,086,148  
    17,704     Zensar Technologies Ltd     419,831  
    68,926     Zuari Agro Chemicals Ltd     309,424  
     

 

 

 
    Total India     171,936,036  
     

 

 

 
    Indonesia — 0.5%

 

    31,743,100     Adaro Energy Tbk PT     4,024,732  
    2,230,800     Bank Central Asia Tbk PT     3,757,300  
    6,878,700     Bank Mandiri Persero Tbk PT     3,205,040  
    3,330,700     Bank Negara Indonesia Persero Tbk PT     1,764,303  
    15,990,400     Bank Pembangunan Daerah Jawa Timur Tbk PT     727,276  
    57,522,900     Bank Rakyat Indonesia Persero Tbk PT     12,428,768  
    8,955,500     Bukit Asam Tbk PT     2,462,880  
    2,465,200     Bumi Serpong Damai Tbk PT *     201,078  
    5,203,200     Erajaya Swasembada Tbk PT     947,610  
    2,540,600     Gajah Tunggal Tbk PT     109,557  
    85,400     Gudang Garam Tbk PT     423,296  
    3,495,500     Harum Energy Tbk PT     607,670  
    721,200     Indah Kiat Pulp & Paper Corp Tbk PT     935,738  
    4,969,100     Indo Tambangraya Megah Tbk PT     9,548,445  
    2,283,500     Indofood Sukses Makmur Tbk PT     988,278  
    839,100     Link Net Tbk PT     245,043  
    1,210,400     Matahari Department Store Tbk PT     616,572  
    38,853,900     Modernland Realty Tbk PT     670,730  
    28,601,800     Panin Financial Tbk PT *     396,444  
    1,686,100     PP Persero Tbk PT     217,702  
    2,553,300     Ramayana Lestari Sentosa Tbk PT     220,187  
    19,497,600     Surya Semesta Internusa Tbk PT     643,533  
    16,548,900     Telekomunikasi Indonesia Persero Tbk PT     3,930,745  
    44,500     Telekomunikasi Indonesia Persero Tbk PT Sponsored ADR     1,053,315  
    957,400     United Tractors Tbk PT     2,236,639  
    9,406,700     Waskita Beton Precast Tbk PT     249,266  
    966,100     XL Axiata Tbk PT *     208,516  
     

 

 

 
    Total Indonesia     52,820,663  
     

 

 

 
    Ireland — 0.1%

 

    31,300     ICON Plc * (a)     4,664,326  
    1,290     Smurfit Kappa Group Plc     52,683  
     

 

 

 
    Total Ireland     4,717,009  
     

 

 

 
    
Shares
    Description   Value ($)  
    Israel — 0.4%

 

    273,732     Bank Leumi Le-Israel BM     1,838,750  
    33,881     Discount Investment Corp Ltd (Registered)     102,336  
    26,548     First International Bank of Israel Ltd     614,956  
    107,914     Frutarom Industries Ltd     11,002,800  
    56,101     Harel Insurance Investments & Financial Services Ltd     457,994  
    29,471     Nova Measuring Instruments Ltd *     886,363  
    366,910     Orbotech Ltd *     23,474,902  
    7,112     SodaStream International Ltd *     1,008,886  
     

 

 

 
    Total Israel     39,386,987  
     

 

 

 
    Italy — 1.0%

 

    178,721     Arnoldo Mondadori Editore SPA *     273,139  
    45,260     ASTM SPA     923,757  
    25,038     Carraro SpA     68,926  
    22,770     Credito Emiliano SPA     143,517  
    3,708     El.En. SPA     119,524  
    107,703     Enav SPA     532,472  
    3,734,753     Enel SPA     18,464,392  
    75,832     ERG SPA     1,570,741  
    483,524     EXOR NV     31,462,472  
    356,697     Falck Renewables SPA     844,717  
    140,282     Fiat Chrysler Automobiles NV *     2,374,945  
    1,816,224     Fiat Chrysler Automobiles NV *     31,075,593  
    97,206     Fincantieri SPA *     144,110  
    97,315     FinecoBank Banca Fineco SPA     1,160,090  
    211,180     Hera SPA     662,524  
    154,487     IMMSI SPA *     75,624  
    1,289,607     Iren SPA     3,024,621  
    31,456     La Doria SPA     360,957  
    52,980     Mediobanca Banca di Credito Finanziario SPA     493,330  
    75,953     Piaggio & C SPA     164,558  
    226,659     Poste Italiane SPA     1,746,015  
    13,622     Prima Industrie SPA     512,377  
    21,065     Recordati SPA     737,948  
    4,804     Reply SPA     317,818  
    4,202     Sabaf SPA     67,356  
    43,168     Saras SPA     109,184  
    541,362     Societa Cattolica di Assicurazioni SC     4,393,581  
    89,709     Societa Iniziative Autostradali e Servizi SPA     1,250,609  
    1,357,900     Telecom Italia SPA *     864,738  
    1,711,000     Telecom Italia SPA-RSP     952,351  
    153,539     Unipol Gruppo SPA     633,947  
     

 

 

 
    Total Italy     105,525,933  
     

 

 

 
    Japan — 5.5%

 

    108,600     Aisin Seiki Co Ltd     5,023,067  
 

 

  See accompanying notes to the financial statements.   51


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Japan — continued

 

    65,200     AOKI Holdings Inc     879,421  
    11,800     Asahi Diamond Industrial Co Ltd     87,182  
    2,006,600     Asahi Kasei Corp     29,403,764  
    1,546,400     Astellas Pharma Inc     26,217,047  
    10,200     Bank of the Ryukyus Ltd     121,100  
    10,300     Belluna Co Ltd     113,339  
    586,700     Brother Industries Ltd     12,035,751  
    1,046,300     Canon Inc     33,572,202  
    1,900     Central Japan Railway Co     381,476  
    2,600     Chukyo Bank Ltd (The)     54,031  
    64,400     CKD Corp     951,210  
    22,800     Concordia Financial Group Ltd     109,408  
    6,600     Dai-ichi Seiko Co Ltd     99,161  
    12,800     Daiwabo Holdings Co Ltd     763,314  
    82,100     DCM Holdings Co Ltd     749,847  
    56,600     Denka Co Ltd     1,936,798  
    4,300     Duskin Co Ltd     103,432  
    105,700     Fancl Corp     5,429,756  
    791,000     Fuji Electric Co Ltd     6,371,817  
    7,800     Fuji Media Holdings Inc     133,994  
    6,600     Fuji Pharma Co Ltd     105,749  
    51,800     FUJIFILM Holdings Corp (a)     2,187,944  
    1,732,000     Fujitsu Ltd     12,664,070  
    1,200     Fuji Oil Holdings Inc     36,478  
    8,300     Fuji Soft Inc     408,455  
    90,000     Fukuoka Financial Group Inc     504,606  
    6,900     Fuyo General Lease Co Ltd     414,188  
    3,400     Gree Inc     17,214  
    14,600     Hakuhodo DY Holdings Inc     246,327  
    10,600     Hamakyorex Co Ltd     356,169  
    5,600     Hanwa Co Ltd     188,776  
    8,600     Heiwado Co Ltd     225,179  
    6,000     Hisamitsu Pharmaceutical Co Inc     438,303  
    700     Hitachi High-Technologies Corp     27,462  
    5,741,000     Hitachi Ltd     37,474,764  
    6,800     Hochiki Corp     100,659  
    201,000     Honda Motor Co Ltd     5,954,263  
    2,900     Horiba Ltd     179,581  
    4,200     Hosokawa Micron Corp     254,186  
    83,500     House Foods Group Inc (a)     2,475,561  
    19,200     Idemitsu Kosan Co Ltd     969,085  
    41,700     Isuzu Motors Ltd     602,022  
    2,744,000     ITOCHU Corp     47,948,247  
    3,300     JSP Corp     83,400  
    52,900     JSR Corp     1,026,158  
    29,700     JTEKT Corp     415,739  
    7,000     Juki Corp     82,232  
    149,200     JXTG Holdings Inc     1,050,496  
    6,200     Kaken Pharmaceutical Co Ltd     318,446  
    7,700     Kamei Corp     95,772  
    
Shares
    Description   Value ($)  
    Japan — continued

 

    258,400     Kanematsu Corp     3,832,165  
    7,200     Kato Sangyo Co Ltd     233,826  
    109,100     KDDI Corp     2,884,586  
    59,000     Keihin Corp (a)     1,239,852  
    188,000     Kirin Holdings Co Ltd     4,645,902  
    109,500     Kitz Corp     959,177  
    12,600     Konica Minolta Inc     128,139  
    35,700     Kose Corp     6,582,487  
    20,800     Kyosan Electric Manufacturing Co Ltd     121,746  
    12,500     Kyowa Exeo Corp     349,558  
    23,800     Leopalace21 Corp     126,218  
    4,000     Makino Milling Machine Co Ltd     36,919  
    9,000     Mandom Corp     270,340  
    2,553,800     Marubeni Corp     20,924,446  
    82,200     MCJ Co Ltd     743,117  
    15,804     Medipal Holdings Corp     318,733  
    4,554,700     Mitsubishi Chemical Holdings Corp     40,808,937  
    382,000     Mitsubishi Corp     10,893,514  
    1,887,500     Mitsubishi Electric Corp     25,480,256  
    299,100     Mitsubishi Gas Chemical Co Inc     6,217,654  
    503,500     Mitsubishi Tanabe Pharma Corp (a)     8,397,869  
    147,900     Mitsui Chemicals Inc     3,822,498  
    11,900     Mitsui Mining & Smelting Co Ltd     340,905  
    43,000     Modec Inc     1,301,384  
    4,200     NEC Corp     115,957  
    131,800     NET One Systems Co Ltd     3,052,671  
    158,000     Nichias Corp     2,053,939  
    32,000     Nichiha Corp     898,501  
    97,100     Nippo Corp     1,802,205  
    5,000     Nippon Soda Co Ltd     28,503  
    1,130,400     Nippon Telegraph & Telephone Corp     50,292,593  
    6,900     Nippon Valqua Industries Ltd     201,307  
    7,600     Nippon Flour Mills Co Ltd     127,123  
    32,300     Nisshin Oillio Group Ltd (The)     873,192  
    57,900     Nisshin Seifun Group Inc     1,158,060  
    59,600     Nisshinbo Holdings Inc     668,277  
    43,900     Nomura Real Estate Holdings Inc     950,973  
    3,500     Noritake Co Ltd     210,225  
    36,400     NSK Ltd     412,617  
    228,200     NTT DOCOMO Inc     5,913,967  
    11,800     Osaki Electric Co Ltd     86,679  
    8,200     Otsuka Holdings Co Ltd     384,703  
    83,900     Pola Orbis Holdings Inc     2,956,786  
    309,000     Prima Meat Packers Ltd     1,533,910  
    29,200     Resona Holdings Inc (a)     165,629  
    18,000     Rohm Co Ltd     1,626,235  
    70,100     Rohto Pharmaceutical Co Ltd     2,239,404  
    6,200     Sakata INX Corp     82,426  
    9,700     SBI Holdings Inc     267,378  
    3,800     Seiko Epson Corp     64,944  
 

 

52   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Japan — continued

 

    532,200     Sekisui Chemical Co Ltd     9,245,472  
    10,500     Shin-Etsu Polymer Co Ltd     88,249  
    9,200     Shiseido Co Ltd     647,683  
    79,800     Showa Corp     1,271,149  
    37,100     Showa Denko KK     1,762,143  
    4,639,700     Sojitz Corp     16,145,531  
    62,900     Sony Corp     3,576,659  
    1,500     Starzen Co Ltd     62,671  
    114,000     Sumitomo Bakelite Co Ltd     1,124,268  
    4,133,000     Sumitomo Chemical Co Ltd     23,458,140  
    22,500     Sumitomo Corp     364,861  
    71,700     Sumitomo Dainippon Pharma Co Ltd     1,525,712  
    94,300     Sumitomo Mitsui Financial Group Inc     3,707,257  
    3,700     Sumitomo Mitsui Trust Holdings Inc     148,462  
    2,000     Suntory Beverage & Food Ltd     81,921  
    19,300     T-Gaia Corp     507,902  
    5,000     Taikisha Ltd     161,147  
    139,900     Takeda Pharmaceutical Co Ltd     5,828,397  
    93,200     Tatsuta Electric Wire and Cable Co Ltd     508,765  
    2,537     TIS Inc     122,202  
    52,300     Tocalo Co Ltd     604,664  
    10,600     Tochigi Bank Ltd (The)     35,374  
    7,600     Token Corp     537,906  
    32,000     Tokio Marine Holdings Inc     1,507,897  
    600     Tokyo Century Corp     33,157  
    106,300     Tokyo Electron Ltd (a)     18,097,548  
    12,600     Tokyo Gas Co Ltd (a)     298,334  
    3,900     Tokyo Seimitsu Co Ltd     121,191  
    104,700     Tokyu Construction Co Ltd     961,994  
    321,200     Tosoh Corp     5,039,705  
    3,800     Toyo Ink SC Holdings Co Ltd     97,231  
    14,900     Toyo Suisan Kaisha Ltd     548,798  
    409,400     Toyota Tsusho Corp     13,947,318  
    105,000     TS Tech Co Ltd     3,961,746  
    17,000     Unipres Corp     330,473  
    5,900     Vital KSK Holdings Inc     67,047  
    28,000     Wacoal Holdings Corp     828,543  
    29,700     Warabeya Nichiyo Holdings Co Ltd     584,351  
    5,700     Yamazen Corp     63,455  
    12,100     Zeon Corp     129,705  
     

 

 

 
    Total Japan     578,352,108  
     

 

 

 
    Malaysia — 0.2%

 

    1,383,100     DRB-Hicom Berhad     761,744  
    1,915,800     KSL Holdings Berhad *     395,883  
    154,400     Padini Holdings Berhad     224,697  
    796,300     Petronas Chemicals Group Berhad     1,830,441  
    159,000     Petronas Dagangan Berhad     1,049,710  
    75,960     PPB Group Bhd     310,336  
    994,400     Sapura Energy Berhad *     81,647  
    
Shares
    Description   Value ($)  
    Malaysia — continued

 

    2,486,000     Supermax Corp Berhad     2,028,869  
    355,400     Ta Ann Holdings Berhad     237,569  
    421,400     Tenaga Nasional Berhad     1,606,429  
    3,016,200     Top Glove Corp Berhad     8,172,251  
    767,300     YTL Power International Berhad     212,706  
     

 

 

 
    Total Malaysia     16,912,282  
     

 

 

 
    Mexico — 1.2%

 

    869,262     Arca Continental SAB de CV     5,375,659  
    315,492     Banco Santander Mexico SA Institucion de Banca Multiple Grupo Financiero Santand – Class B     499,860  
    275,400     Becle SAB de CV     390,932  
    1,460,246     Bolsa Mexicana de Valores SAB de CV     2,941,090  
    3,204,700     Cemex SAB de CV *     2,271,189  
    812,500     Cemex SAB de CV Sponsored ADR * (b)     5,760,625  
    1,363,200     Corp Inmobiliaria Vesta SAB de CV     1,930,075  
    117,000     Credito Real SAB de CV SOFOM ER     151,323  
    1,179,700     Fibra Uno Administracion SA de CV (REIT)     1,543,686  
    546,200     Fomento Economico Mexicano SAB de CV     5,231,787  
    98,900     Fomento Economico Mexicano SAB de CV Sponsored ADR     9,482,532  
    1,514,100     Gentera SAB de CV     1,536,667  
    640,200     Grupo Aeroportuario del Centro Norte SAB de CV     4,208,410  
    13,900     Grupo Aeroportuario del Centro Norte SAB de CV ADR (a)     732,669  
    16,000     Grupo Aeroportuario del Pacifico SAB de CV ADR     1,652,960  
    167,200     Grupo Aeroportuario del Pacifico SAB de CV – Class B     1,727,638  
    7,600     Grupo Aeroportuario del Sureste SAB de CV ADR     1,425,684  
    59,030     Grupo Aeroportuario del Sureste SAB de CV – Class B     1,106,956  
    666,500     Grupo Financiero Banorte SAB de CV – Class O     4,545,955  
    226,200     Grupo Financiero Inbursa SAB de CV – Class O     359,926  
    247,513     Grupo Herdez SAB de CV     532,331  
    268,000     Grupo Lala SAB de CV     285,180  
    883,200     Grupo Mexico SAB de CV – Series B     2,584,615  
    261,900     Megacable Holdings SAB de CV CPO     1,234,430  
    599,900     Mexichem SAB de CV     2,024,342  
    227,290     Promotora y Operadora de Infraestructura SAB de CV     2,415,631  
    249,600     Unifin Financiera SAB de CV SOFOM ENR     636,762  
 

 

  See accompanying notes to the financial statements.   53


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Mexico — continued

 

    23,421,250     Wal-Mart de Mexico SAB de CV     64,850,453  
     

 

 

 
    Total Mexico     127,439,367  
     

 

 

 
    Netherlands — 0.8%

 

    67,714     ASR Nederland NV (a)     3,237,352  
    51,709     ForFarmers NV     578,283  
    115,269     Gemalto NV *     6,695,438  
    72,332     Heineken Holding NV     6,901,446  
    1,647,624     ING Groep NV     22,380,963  
    75,774     Koninklijke Ahold Delhaize NV (a)     1,845,808  
    2     Koninklijke DSM NV     210  
    353,300     NXP Semiconductors NV * (c)     32,906,362  
    46,638     Signify NV     1,314,658  
    1,528     Vastned Retail NV (REIT)     62,967  
    95,971     Wolters Kluwer NV     6,088,711  
     

 

 

 
    Total Netherlands     82,012,198  
     

 

 

 
    New Zealand — 0.0%

 

    1,303,125     Air New Zealand Ltd     2,844,871  
     

 

 

 
    Norway — 0.7%

 

    22,321     Aker ASA – A Shares     1,748,807  
    121,320     Aker Solutions ASA *     825,920  
    17,716     Atea ASA *     262,504  
    157,766     Austevoll Seafood ASA     2,075,953  
    60,234     Bakkafrost P/F     3,436,319  
    162,657     BW LPG Ltd *     634,565  
    996,706     DNB ASA     20,263,043  
    10,211     Entra ASA     148,041  
    1,158,242     Equinor ASA     29,709,143  
    13,894     Grieg Seafood ASA     159,845  
    384,556     Kongsberg Automotive ASA *     447,419  
    172,400     Kvaerner ASA *     318,749  
    177,370     Leroy Seafood Group ASA     1,348,737  
    30,617     Salmar ASA     1,474,091  
    24,632     Selvaag Bolig ASA     124,503  
    23,706     SpareBank 1 Nord Norge     185,428  
    45,694     SpareBank 1 SR Bank ASA     515,591  
    488,467     Storebrand ASA     4,324,380  
    178,907     Subsea 7 SA     2,432,302  
    46,872     TGS NOPEC Geophysical Co ASA     1,777,605  
     

 

 

 
    Total Norway     72,212,945  
     

 

 

 
    Pakistan — 0.0%

 

    736,500     Engro Fertilizers Ltd     468,630  
    455,100     Oil & Gas Development Co Ltd     557,294  
    117,350     Pakistan Oilfields Ltd     608,052  
     

 

 

 
    Total Pakistan     1,633,976  
     

 

 

 
    
Shares
    Description   Value ($)  
    Philippines — 0.1%

 

    4,171,000     Belle Corp     240,282  
    1,179,200     DMCI Holdings Inc     282,429  
    839,500     Eagle Cement Corp     254,966  
    27,910     GT Capital Holdings Inc     457,441  
    157,030     Jollibee Foods Corp     846,123  
    4,214,400     LT Group Inc     1,355,494  
    631,090     Manila Electric Co     4,406,444  
    1,217,700     Manila Water Co Inc     555,816  
    14,546,000     Megaworld Corp     1,249,202  
    5,573,000     Metro Pacific Investments Corp     568,539  
    8,548,084     Nickel Asia Corp     868,553  
    2,216,325     Petron Corp     375,597  
    351,200     Pilipinas Shell Petroleum Corp     377,673  
    294,670     Puregold Price Club Inc     253,534  
    1,422,725     Semirara Mining & Power Corp     771,702  
     

 

 

 
    Total Philippines     12,863,795  
     

 

 

 
    Poland — 0.7%

 

    352,822     Asseco Poland SA     4,371,068  
    106,637     Bank Millennium SA *     258,812  
    282,385     Bank Polska Kasa Opieki SA     8,897,524  
    6,608     Bank Zachodni WBK SA     671,762  
    36,454     Budimex SA     1,120,241  
    7,698     CCC SA     448,370  
    75,629     CD Projekt SA *     4,213,504  
    176,992     Cyfrowy Polsat SA *     1,073,337  
    26,119     Dino Polska SA *     641,857  
    355,602     Enea SA *     818,459  
    1,209,434     Energa SA     2,735,607  
    38,562     Grupa Lotos SA     724,985  
    31,371     KRUK SA     1,750,704  
    773     LPP SA     1,925,529  
    231,790     PGE Polska Grupa Energetyczna SA *     562,472  
    420,455     Polski Koncern Naftowy ORLEN SA     11,146,389  
    4,114,347     Polskie Gornictwo Naftowe i Gazownictwo SA *     6,445,446  
    637,239     Powszechna Kasa Oszczednosci Bank Polski SA     7,261,419  
    999,743     Powszechny Zaklad Ubezpieczen SA     12,039,635  
    10,210     Stalprodukt SA     1,276,486  
    2,472,919     Tauron Polska Energia SA *     1,336,417  
    23,797     Warsaw Stock Exchange     265,769  
     

 

 

 
    Total Poland     69,985,792  
     

 

 

 
    Portugal — 0.0%

 

    16,934     Altri SGPS SA     156,160  
    62,829     Mota-Engil SGPS SA *     195,106  
    144,533     Navigator Co SA (The)     722,208  
    1,112,143     Sonae SGPS SA     1,183,151  
     

 

 

 
    Total Portugal     2,256,625  
     

 

 

 
 

 

54   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Qatar — 0.3%

 

    367,475     Barwa Real Estate Co     3,633,703  
    88,110     Doha Bank QPSC     621,814  
    71,985     Masraf Al Rayan QSC     745,564  
    24,950     Qatar Electricity & Water Co QSC     1,310,570  
    203,607     Qatar Gas Transport Co Ltd     978,061  
    102,103     Qatar Insurance Co SAQ     1,032,502  
    33,541     Qatar Islamic Bank SAQ     1,289,867  
    314,589     Qatar National Bank QPSC     15,382,768  
    13,048     Qatar National Cement Co QSC     205,674  
    28,093     Qatar Navigation QSC     504,351  
     

 

 

 
    Total Qatar     25,704,874  
     

 

 

 
    Russia — 2.6%

 

    2,361,900     Aeroflot PJSC     4,045,720  
    6,325,700     Alrosa PJSC     9,514,941  
    131,620     Gazprom Neft PJSC     655,418  
    321,830     Gazprom PJSC     716,210  
    10,684,448     Gazprom PJSC Sponsored ADR     47,127,925  
    293,961     Globaltrans Investment Plc Sponsored GDR (Registered)     3,235,760  
    38,712,000     Inter RAO UES PJSC     2,320,246  
    717,108     LUKOIL PJSC Sponsored ADR     49,554,030  
    248,750     M.Video PJSC *     1,597,815  
    105,668     Magnit PJSC Sponsored GDR (Registered)     1,563,224  
    784,100     Magnitogorsk Iron & Steel OJSC     564,486  
    16,193     Magnitogorsk Iron & Steel Works PJSC Sponsored GDR (Registered)     154,624  
    506,881     MMC Norilsk Nickel PJSC ADR     8,411,870  
    1,661,600     Mobile TeleSystems PJSC Sponsored ADR     12,877,400  
    5,313,680     Moscow Exchange MICEX-RTS PJSC     7,718,053  
    173,530     Novatek PJSC     2,789,262  
    144,512     Novatek PJSC Sponsered GDR (Registered)     24,166,157  
    1,291,120     Novolipetsk Steel PJSC     3,168,022  
    305,505     Novolipetsk Steel PJSC GDR     7,419,563  
    91,187     PhosAgro PJSC GDR (Registered)     1,208,289  
    17,320     Polyus PJSC     1,123,898  
    92,559     Polyus PJSC GDR (Registered)     3,000,095  
    218,817     QIWI Plc Sponsored ADR *     3,107,201  
    4,563,885     Rostelecom PJSC     4,574,672  
    7,939     Rostelecom PJSC Sponsored ADR     47,728  
    5,520     Safmar Financial Investment     65,636  
    1,561,000     Sberbank of Russia PJSC     4,195,931  
    2,832,100     Sberbank of Russia Sponsored ADR     30,842,356  
    43,340     Severstal PJSC     698,310  
    280,582     Severstal PJSC GDR (Registered)     4,514,904  
    1,448,200     Surgutneftegas OJSC     617,413  
    2,323,711     Surgutneftegas PJSC Sponsored ADR     9,671,790  
    
Shares
    Description   Value ($)  
    Russia — continued

 

    552,420     Tatneft PJSC     6,421,027  
    241,330     Tatneft PJSC Sponsored ADR     16,732,782  
    66,668     TCS Group Holding Plc GDR (Registered)     1,227,270  
     

 

 

 
    Total Russia     275,650,028  
     

 

 

 
    Singapore — 0.1%

 

    303,400     Oversea-Chinese Banking Corp Ltd     2,496,960  
    605,200     Sino Grandness Food Industry Group Ltd *     88,174  
    63,800     United Overseas Bank Ltd     1,257,402  
    292,400     Venture Corp Ltd     3,860,336  
    6,840,600     Yangzijiang Shipbuilding Holdings Ltd     5,334,213  
    1,115,300     Yanlord Land Group Ltd     1,235,855  
     

 

 

 
    Total Singapore     14,272,940  
     

 

 

 
    South Africa — 2.5%

 

    3,403,961     Absa Group Ltd     37,648,273  
    1,494,532     African Phoenix Investments Ltd *     60,015  
    248,111     Alviva Holdings Ltd     307,250  
    70,136     Aspen Pharmacare Holdings Ltd     1,390,326  
    259,967     Astral Foods Ltd     4,578,439  
    730,043     AVI Ltd     5,760,540  
    800,123     Barloworld Ltd     6,805,068  
    99,686     Bid Corp Ltd     2,126,991  
    75,818     Bidvest Group Ltd (The)     1,114,181  
    3,816,558     Blue Label Telecoms Ltd     1,859,288  
    98,344     Brait SE *     249,781  
    34,590     Capitec Bank Holdings Ltd     2,362,304  
    509,701     Clicks Group Ltd     7,039,482  
    192,024     Coronation Fund Managers Ltd     752,245  
    207,103     Dis-Chem Pharmacies Ltd     476,939  
    181,013     Discovery Ltd     2,156,896  
    24,400     Distell Group Holdings Ltd *     202,528  
    1,056,337     Emira Property Fund Ltd (REIT)     1,147,621  
    422,401     Exxaro Resources Ltd     4,281,483  
    1,740,858     FirstRand Ltd     8,374,894  
    220,470     Foschini Group Ltd (The)     2,619,280  
    3,398,234     Growthpoint Properties Ltd (REIT)     5,882,832  
    187,479     Hyprop Investments Ltd (REIT)     1,301,379  
    353,253     Imperial Holdings Ltd     4,949,782  
    59,228     JSE Ltd     652,650  
    505,204     Kumba Iron Ore Ltd     9,107,351  
    522,500     Lewis Group Ltd     1,006,402  
    980,956     Liberty Holdings Ltd     7,760,957  
    97,359     Massmart Holdings Ltd     733,818  
    269,759     Metair Investments Ltd     320,745  
    246,867     MMI Holdings Ltd     287,891  
    300,088     Mondi Ltd     8,373,090  
    882,747     Mr Price Group Ltd     13,532,543  
 

 

  See accompanying notes to the financial statements.   55


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    South Africa — continued

 

    308,511     MTN Group Ltd     1,867,954  
    952,078     Murray & Roberts Holdings Ltd     1,004,874  
    1,288,886     Nedbank Group Ltd     24,380,269  
    1,871,397     Old Mutual Ltd *     3,871,417  
    67,008     Omnia Holdings Ltd     592,697  
    185,060     Rand Merchant Investment Holdings Ltd     514,426  
    1,856,867     Redefine Properties Ltd (REIT)     1,307,813  
    166,062     Reinet Investments SCA     3,215,459  
    100,093     Resilient REIT Ltd     388,016  
    668,086     Reunert Ltd     3,460,777  
    1,170,851     RMB Holdings Ltd     6,719,833  
    1,667,230     SA Corporate Real Estate Ltd (REIT)     496,776  
    908,209     Sanlam Ltd     4,901,740  
    39,167     Santam Ltd     808,281  
    199,975     Sappi Ltd     1,365,874  
    110,328     Sasol Ltd     4,321,474  
    13,800     Sasol Ltd Sponsored ADR     541,788  
    243,032     Shoprite Holdings Ltd     3,373,779  
    255,439     Sibanye Gold Ltd *     147,776  
    166,666     SPAR Group Ltd (The)     2,325,128  
    2,549,100     Standard Bank Group Ltd     32,308,486  
    3,025,964     Steinhoff International Holdings NV *     576,753  
    163,562     Telkom SA SOC Ltd     559,656  
    172,169     Tiger Brands Ltd     3,351,809  
    1,384,921     Truworths International Ltd     8,105,477  
    432,734     Tsogo Sun Holdings Ltd     619,002  
    178,222     Vodacom Group Ltd     1,532,755  
    214,768     Wilson Bayly Holmes-Ovcon Ltd     2,190,211  
     

 

 

 
    Total South Africa     260,073,564  
     

 

 

 
    South Korea — 2.5%

 

    71,974     Aekyung Petrochemical Co Ltd     730,355  
    769,992     BNK Financial Group Inc     5,771,489  
    3,310     Celltrion Pharm Inc *     238,308  
    24,501     Cheil Worldwide Inc     424,765  
    19,747     Chong Kun Dang Pharmaceutical Corp     1,924,062  
    2,413     CJ ENM Co Ltd     545,937  
    2,072     Crown Haitai Holdings Co Ltd     26,144  
    348     Dae Han Flour Mills Co Ltd     55,462  
    55,165     Daeduck Electronics Co     413,220  
    4,156     Daihan Pharmaceutical Co Ltd     178,056  
    58,765     Daishin Securities Co Ltd     643,928  
    79,434     Daou Data Corp     827,640  
    156,009     Daou Technology Inc     3,180,227  
    153,929     DB Insurance Co Ltd     8,849,982  
    13,203     DGB Financial Group Inc     121,553  
    2,789     DongKook Pharmaceutical Co Ltd     173,687  
    29,060     Dongsuh Cos Inc     591,258  
    74,571     Dongwha Pharm Co Ltd     776,497  
    
Shares
    Description   Value ($)  
    South Korea — continued

 

    519,194     Dongwon Development Co Ltd     1,951,176  
    17,913     E-MART Inc     3,451,280  
    25,053     F&F Co Ltd     2,259,564  
    12,079     Fila Korea Ltd     452,829  
    2,331     GOLFZON Co Ltd     84,269  
    87,842     Grand Korea Leisure Co Ltd     1,905,312  
    24,639     Green Cross Holdings Corp     678,043  
    6,148     GS Home Shopping Inc     1,145,305  
    138,495     Hana Financial Group Inc     5,310,702  
    18,269     Hankook Tire Co Ltd     765,609  
    165,854     Hankook Tire Worldwide Co Ltd     2,711,759  
    5,922     Hansol Paper Co Ltd     110,038  
    5,108     Hanwha Aerospace Co Ltd *     114,699  
    8,387     Harim Holdings Co Ltd     80,216  
    2,250     HLB Inc *     210,081  
    7,021     Huons Co Ltd     627,102  
    6,743     Hyundai Corp     173,531  
    5,599     Hyundai Department Store Co Ltd     500,746  
    44,491     Hyundai Greenfood Co Ltd     521,676  
    29,329     Hyundai Home Shopping Network Corp     2,989,857  
    202,138     Hyundai Hy Communications & Network Co Ltd     742,842  
    144,949     Hyundai Marine & Fire Insurance Co Ltd     4,842,497  
    38,193     Hyundai Mobis Co Ltd     7,685,744  
    3,295     Hyundai Wia Corp     126,211  
    1,463,115     Industrial Bank of Korea     19,585,336  
    411,059     JB Financial Group Co Ltd     2,293,682  
    2,015     Kangnam Jevisco Co Ltd     48,765  
    221,749     Kangwon Land Inc     5,768,258  
    198,271     KB Financial Group Inc     9,167,167  
    426,937     Kia Motors Corp     12,294,912  
    184,556     Korea Asset In Trust Co Ltd (REIT)     896,976  
    6,493     Korea Zinc Co Ltd     2,363,946  
    99,845     Korean Reinsurance Co     933,199  
    9,500     KT Corp Sponsored ADR     131,195  
    67,372     KT Hitel Co Ltd *     338,434  
    72,297     KT Skylife Co Ltd     863,747  
    132,665     KT&G Corp     12,033,754  
    105,630     Kwang Dong Pharmaceutical Co Ltd     713,524  
    87,280     Kyobo Securities Co Ltd     768,441  
    34,866     Kyungdong Pharm Co Ltd     405,737  
    180,038     LF Corp     4,294,760  
    202,258     LG Corp     12,993,633  
    319,279     LG Electronics Inc     22,011,952  
    128,971     LOTTE Himart Co Ltd     8,291,305  
    6,431     LS Corp     387,985  
    25,123     Maeil Holdings Co Ltd     321,521  
    31,307     Meritz Fire & Marine Insurance Co Ltd     513,243  
 

 

56   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    South Korea — continued

 

    20,094     NHN KCP Corp *     266,071  
    1,279     Ottogi Corp     832,834  
    22,493     S&T Motiv Co Ltd     650,779  
    71,503     Samjin Pharmaceutical Co Ltd     3,539,399  
    29,592     Samsung Card Co Ltd     936,870  
    16,407     Samsung Engineering Co Ltd *     248,172  
    11,356     Samsung SDS Co Ltd     2,474,462  
    74,706     Seohan Co Ltd     143,515  
    11,140     Shinhan Financial Group Co Ltd     437,545  
    1,815     Shinsegae Inc     529,152  
    20,485     Sindoh Co Ltd     944,138  
    38,268     SK Holdings Co Ltd     9,044,663  
    470,184     SK Hynix Inc     35,066,196  
    12,854     SK Innovation Co Ltd     2,228,401  
    34,018     SK Networks Co Ltd     136,859  
    685,141     SK Telecom Co Ltd Sponsored ADR     17,820,517  
    79,037     SL Corp     1,427,041  
    6,563     Spigen Korea Co Ltd     306,586  
    180     Taekwang Industrial Co Ltd     260,161  
    17,739     Tongyang Life Insurance Co Ltd     104,693  
    2,447     Unid Co Ltd     110,315  
    1,363     ViroMed Co Ltd *     290,419  
    84,258     Woori Bank     1,234,152  
     

 

 

 
    Total South Korea     261,368,070  
     

 

 

 
    Spain — 0.6%

 

    10,910     Aena SME SA     1,929,518  
    1,221,384     Atlantica Yield Plc     25,203,259  
    43,406     Ebro Foods SA     934,000  
    284,698     Ence Energia y Celulosa SA     2,670,205  
    31,430     Faes Farma SA     137,110  
    2,093,770     International Consolidated Airlines Group SA     18,793,476  
    38,539     Naturgy Energy Group SA     1,034,421  
    6,003     Papeles y Cartones de Europa SA     116,217  
    442,056     Repsol SA     8,502,010  
    80,007     Unicaja Banco SA     125,172  
     

 

 

 
    Total Spain     59,445,388  
     

 

 

 
    Sweden — 1.1%

 

    53,593     Alfa Laval AB (a)     1,436,653  
    52,786     Atlas Copco AB – A Shares     1,504,802  
    10,344     Bufab AB     121,711  
    118,492     Electrolux AB – Series B     2,643,980  
    139,599     Epiroc AB – Class A *     1,450,157  
    36,123     Granges AB     423,138  
    44,036     Hemfosa Fastigheter AB     599,092  
    231,797     Kindred Group Plc SDR     2,850,609  
    145,182     Klovern AB – B Shares     198,954  
    4,772     Loomis AB – Class B     153,580  
    
Shares
    Description   Value ($)  
    Sweden — continued

 

    17,891     Mr. Green & Co AB *     82,914  
    41,964     Nobina AB     309,444  
    8,270     Nolato AB – B Shares     584,254  
    48,633     Oriflame Holding AG     1,415,033  
    102,671     Resurs Holding AB     750,133  
    1,166,940     Sandvik AB     20,426,856  
    133,066     SAS AB *     294,606  
    18,487     Skandinaviska Enskilda Banken AB     197,358  
    41,734     SKF AB – B Shares     802,233  
    148,578     SSAB AB – Series A     647,589  
    2,102,555     Svenska Cellulosa AB SCA – Class B     24,476,292  
    228,914     Swedbank AB – A Shares     5,330,111  
    8,379     Swedish Orphan Biovitrum AB *     267,024  
    129,877     Swedish Match AB     6,943,034  
    39,741     Volvo AB – A Shares     685,433  
    2,407,187     Volvo AB – B Shares     41,468,354  
     

 

 

 
    Total Sweden     116,063,344  
     

 

 

 
    Switzerland — 1.5%

 

    12,612     ALSO Holding AG (Registered) *     1,500,892  
    4,534     Ascom Holding AG (Registered)     89,392  
    23,654     BKW AG     1,677,865  
    9,609     Bobst Group SA (Registered)     823,252  
    1,186     Bossard Holding AG (Registered) – A Shares     244,865  
    5,616     Bucher Industries AG (Registered)     1,967,782  
    3,648     Galenica AG *     216,309  
    136,303     GAM Holding AG *     1,052,573  
    11,274     Georg Fischer AG (Registered)     14,756,550  
    390     Gurit Holding AG     332,529  
    464     Helvetia Holding AG (Registered)     278,447  
    2,133     Inficon Holding AG (Registered) *     1,085,199  
    9,168     Kardex AG (Registered) *     1,643,198  
    16,729     Lonza Group AG (Registered) *     5,384,663  
    195,420     Nestle SA (Registered)     16,381,485  
    424,837     Novartis AG (Registered)     35,245,374  
    8,573     Orior AG     758,114  
    147,265     Roche Holding AG     36,514,882  
    15,909     Roche Holding AG     3,988,767  
    156,020     Sika AG (Registered)     23,107,515  
    61,977     Swiss Re AG     5,576,092  
    1,962     Zehnder Group AG – Class RG     92,879  
    7,960     Zurich Insurance Group AG     2,423,259  
     

 

 

 
    Total Switzerland     155,141,883  
     

 

 

 
    Taiwan — 5.4%

 

    302,000     Ability Enterprise Co Ltd     143,001  
    940,000     AcBel Polytech Inc     619,727  
    170,000     Actron Technology Corp     553,945  
    488,000     Advantech Co Ltd     3,322,890  
 

 

  See accompanying notes to the financial statements.   57


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Taiwan — continued

 

    1,934,000     Alpha Networks Inc     1,110,939  
    225,000     Altek Corp     231,244  
    607,000     AmTRAN Technology Co Ltd *     254,952  
    400,000     Arcadyan Technology Corp     783,109  
    552,000     Asia Pacific Telecom Co Ltd *     131,595  
    813,000     Asia Vital Components Co Ltd     775,094  
    4,750,799     Asustek Computer Inc     40,484,757  
    1,970,000     Catcher Technology Co Ltd     24,141,429  
    3,975,000     Cathay Financial Holding Co Ltd     6,813,189  
    3,468,000     Chailease Holding Co Ltd     11,798,389  
    259,000     Chaun-Choung Technology Corp     808,840  
    333,660     Chicony Electronics Co Ltd     702,233  
    464,310     Chicony Power Technology Co Ltd     668,238  
    1,159,000     Chin-Poon Industrial Co Ltd     1,432,828  
    566,000     China Motor Corp     475,209  
    206,000     Chlitina Holding Ltd     1,843,590  
    254,000     Chong Hong Construction Co Ltd     673,068  
    4,847,000     Chunghwa Telecom Co Ltd     17,131,174  
    59,100     Chunghwa Telecom Co Ltd Sponsored ADR     2,079,729  
    122,000     Cleanaway Co Ltd     720,893  
    3,373,000     Coretronic Corp     6,345,751  
    20,473,000     CTBC Financial Holding Co Ltd     14,397,522  
    744,000     CTCI Corp     1,139,789  
    50,000     Cyberlink Corp     120,977  
    61,000     Depo Auto Parts Ind Co Ltd     149,929  
    102,000     Dynapack International Technology Corp     133,182  
    1,053,000     Elan Microelectronics Corp     1,860,692  
    96,800     Elite Advanced Laser Corp     234,070  
    642,000     Elitegroup Computer Systems Co Ltd *     333,476  
    612,000     Everlight Electronics Co Ltd     633,369  
    505,000     Far Eastern Department Stores Ltd     287,810  
    829,000     Far Eastern New Century Corp     965,588  
    3,231,000     Far EasTone Telecommunications Co Ltd     7,706,850  
    461,000     Farglory Land Development Co Ltd     472,813  
    177,000     Feng TAY Enterprise Co Ltd     1,073,558  
    1,676,000     Formosa Chemicals & Fibre Corp     6,716,458  
    941,000     Formosa Petrochemical Corp     3,864,028  
    2,535,000     Formosa Plastics Corp     9,293,009  
    6,937,000     Foxconn Technology Co Ltd     17,637,131  
    11,963,000     Fubon Financial Holding Co Ltd     19,834,071  
    317,000     Gemtek Technology Corp     235,904  
    7,644,000     Gigabyte Technology Co Ltd     13,042,790  
    8,844,000     Grand Pacific Petrochemical     8,529,390  
    20,000     Grape King Bio Ltd     141,504  
    3,069,000     Great Wall Enterprise Co Ltd     4,176,677  
    442,000     Greatek Electronics Inc     752,429  
    771,000     Green Seal Holding Ltd     872,213  
    
Shares
    Description   Value ($)  
    Taiwan — continued

 

    3,270,000     Highwealth Construction Corp     5,312,459  
    155,000     Hiroca Holdings Ltd     464,173  
    2,074,000     Holtek Semiconductor Inc     5,721,883  
    11,637,663     Hon Hai Precision Industry Co Ltd     30,572,562  
    598,000     Huaku Development Co Ltd     1,268,681  
    667,000     IEI Integration Corp *     825,487  
    2,096,000     Innolux Corp     781,484  
    85,000     International Games System Co Ltd     421,029  
    5,788,000     Inventec Corp     5,194,986  
    107,000     Iron Force Industrial Co Ltd     290,860  
    555,000     ITEQ Corp     1,198,442  
    47,000     King Slide Works Co Ltd     598,303  
    430,000     Kinik Co     917,109  
    125,000     Kung Long Batteries Industrial Co Ltd     588,392  
    75,000     Lion Travel Service Co Ltd     227,259  
    1,888,000     Lite-On Semiconductor Corp     2,153,860  
    238,000     Makalot Industrial Co Ltd     1,234,010  
    26,000     MediaTek Inc     213,001  
    3,955,776     Mercuries Life Insurance Co Ltd *     2,054,344  
    151,000     Merida Industry Co Ltd     725,240  
    597,000     Micro-Star International Co Ltd     2,063,726  
    3,299,000     Mitac Holdings Corp     3,815,702  
    7,178,000     Nan Ya Plastics Corp     19,974,978  
    324,000     Nanya Technology Corp     736,529  
    4,325,000     Novatek Microelectronics Corp     21,206,736  
    74,000     Nuvoton Technology Corp     135,309  
    92,000     On-Bright Electronics Inc     634,848  
    3,373,445     OptoTech Corp     2,507,338  
    7,379,000     Pegatron Corp     15,904,474  
    677,000     Phison Electronics Corp     5,604,622  
    13,594,566     Pou Chen Corp     14,989,364  
    257,808     Powertech Technology Inc     764,739  
    4,149,000     Quanta Computer Inc     7,138,403  
    810,000     Quanta Storage Inc     682,950  
    10,322,020     Radiant Opto-Electronics Corp     22,672,456  
    2,334,000     Realtek Semiconductor Corp     11,327,717  
    590,000     Rechi Precision Co Ltd     576,834  
    905,400     Ruentex Development Co Ltd     1,019,578  
    2,816,000     Ruentex Industries Ltd     5,777,026  
    502,000     Sercomm Corp     882,487  
    672,000     Sheng Yu Steel Co Ltd     471,057  
    268,000     Shin Zu Shing Co Ltd     779,967  
    67,000     Sigurd Microelectronics Corp     76,035  
    901,400     Simplo Technology Co Ltd     6,606,051  
    365,000     Sinbon Electronics Co Ltd     1,036,100  
    551,000     Sitronix Technology Corp     1,738,012  
    416,000     Soft-World International Corp     980,921  
    141,000     Standard Chemical & Pharmaceutical Co Ltd     146,438  
    2,755,000     Sunplus Technology Co Ltd     1,256,793  
 

 

58   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Taiwan — continued

 

    853,000     Syncmold Enterprise Corp     1,629,073  
    313,000     Synnex Technology International Corp     418,930  
    126,000     TaiDoc Technology Corp     710,351  
    2,015,000     Taiwan Semiconductor Co Ltd     4,822,124  
    4,345,000     Taiwan Semiconductor Manufacturing Co Ltd     36,405,402  
    886,823     Taiwan Semiconductor Manufacturing Co Ltd Sponsored ADR     38,665,483  
    843,000     Taiwan Surface Mounting Technology Corp     906,771  
    665,000     Teco Electric and Machinery Co Ltd     487,088  
    353,000     Tong Hsing Electronic Industries Ltd     972,071  
    534,000     TOPBI International Holdings Ltd     1,708,195  
    1,000,188     Topco Scientific Co Ltd     2,541,005  
    560,000     Transcend Information Inc     1,354,914  
    1,065,000     Tripod Technology Corp     3,287,540  
    668,000     TXC Corp     775,679  
    3,167,000     Uni-President Enterprises Corp     8,013,742  
    2,077,000     United Integrated Services Co Ltd     4,192,129  
    587,000     United Microelectronics Corp     332,737  
    176,000     Wah Lee Industrial Corp     317,625  
    694,000     Walsin Lihwa Corp     491,039  
    1,477,000     Waterland Financial Holdings Co Ltd     509,845  
    154,798     Wistron NeWeb Corp     345,771  
    660,000     Youngtek Electronics Corp     1,008,160  
    2,244,000     Yuanta Financial Holding Co Ltd     1,137,000  
    148,000     Yulon Finance Corp     496,523  
     

 

 

 
    Total Taiwan     562,450,993  
     

 

 

 
    Thailand — 1.5%

 

    1,629,800     Advanced Info Service Pcl (Foreign Registered)     10,060,452  
    1,595,300     Amata Corp Pcl (Foreign Registered)     1,038,730  
    3,194,000     AP Thailand Pcl (Foreign Registered)     917,575  
    2,620,700     AP Thailand Pcl NVDR     752,876  
    151,500     Bangkok Bank Pcl (Foreign Registered) (d)     962,791  
    2,307,400     Central Pattana Pcl (Foreign Registered)     5,815,676  
    317,800     Central Pattana Pcl NVDR     800,997  
    1,058,200     Com7 PCL NVDR     621,171  
    511,200     Delta Electronics Thailand Pcl (Foreign Registered)     1,089,506  
    759,800     Glow Energy Pcl (Foreign Registered)     2,182,038  
    564,100     Glow Energy Pcl NVDR     1,620,014  
    1,243,000     Hana Microelectronics Pcl (Foreign Registered)     1,463,840  
    6,688,500     Home Product Center PCL NVDR     2,982,984  
    5,081,600     Indorama Ventures Pcl NVDR     9,320,623  
    3,195,800     Intouch Holdings Pcl NVDR      5,420,361  
    
Shares
    Description   Value ($)  
    Thailand — continued

 

    289,300     KCE Electronics Pcl (Foreign Registered)     400,612  
    5,220,500     LPN Development Pcl (Foreign Registered)     1,579,703  
    567,500     LPN Development Pcl NVDR     171,723  
    464,800     MC Group Pcl (Foreign Registered)     186,044  
    922,900     MC Group Pcl NVDR     369,405  
    400,500     Mega Lifesciences Pcl (Foreign Registered)     431,592  
    540,500     Mega Lifesciences Pcl NVDR     582,460  
    418,800     Pruksa Holding Pcl (Foreign Registered)     258,447  
    1,757,100     Pruksa Holding Pcl NVDR     1,084,330  
    715,100     PTT Exploration & Production Pcl (Foreign Registered)     3,115,709  
    150,400     PTT Exploration & Production Pcl NVDR     655,297  
    1,315,300     PTT Global Chemical Pcl (Foreign Registered)     3,287,372  
    5,717,800     PTT Global Chemical Pcl NVDR     14,290,681  
    14,330,000     PTT Pcl (Foreign Registered)     23,007,416  
    6,867,100     PTT Pcl NVDR     11,025,563  
    8,215,100     Quality Houses Pcl (Foreign Registered)     868,553  
    12,413,700     Quality Houses Pcl NVDR     1,312,455  
    794,400     Ratchaburi Electricity Generating Holding Pcl (Foreign Registered)     1,268,202  
    772,200     Ratchaburi Electricity Generating Holding Pcl NVDR     1,232,761  
    31,718,900     Sansiri Pcl (Foreign Registered)     1,561,107  
    3,137,400     SC Asset Corp Pcl (Foreign Registered)     339,455  
    961,500     Siam Cement Pcl (The) (Foreign Registered)     13,282,510  
    9,771,000     Star Petroleum Refining Pcl NVDR     4,449,287  
    2,530,300     Star Petroleum Refining Pcl (Foreign Registered)     1,152,189  
    1,658,625     Supalai Pcl (Foreign Registered)     1,226,416  
    2,061,000     Supalai Pcl NVDR     1,523,938  
    26,821,300     Thai Beverage Pcl     12,106,489  
    286,700     Thai Oil Pcl (Foreign Registered)     738,256  
    1,315,400     Thai Oil Pcl NVDR     3,387,168  
    532,100     Thai Vegetable Oil Pcl (Foreign Registered)     479,667  
    101,900     Thai Vegetable Oil Pcl NVDR     91,859  
    4,448,000     Thanachart Capital Pcl (Foreign Registered)     7,306,898  
    104,800     Thanachart Capital Pcl NVDR     172,159  
    1,638,600     TTW Pcl (Foreign Registered)     620,709  
    2,462,500     TTW Pcl NVDR     932,805  
     

 

 

 
    Total Thailand     159,548,871  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   59


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Turkey — 1.0%

 

    178,389     Aksa Akrilik Kimya Sanayii AS     303,796  
    1,145,291     Albaraka Turk Katilim Bankas AS     220,012  
    648,953     Aselsan Elektronik Sanayi Ve Ticaret AS     2,560,788  
    134,724     Aygaz AS     246,007  
    443,434     BIM Birlesik Magazalar AS     4,939,677  
    1,723,159     EIS Eczacibasi Ilac ve Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS     973,690  
    29,869,903     Emlak Konut Gayrimenkul Yatirim Ortakligi AS (REIT)     8,365,115  
    736,522     Enka Insaat ve Sanayi AS     576,163  
    6,750,926     Eregli Demir ve Celik Fabrikalari TAS     12,189,842  
    206,994     Ford Otomotiv Sanayi AS     2,111,206  
    2,601,295     Haci Omer Sabanci Holding AS     2,826,541  
    1,004,059     Ipek Dogal Enerji Kaynaklari Arastirma Ve Uretim AS *     746,973  
    1,280,685     Is Gayrimenkul Yatirim Ortakligi AS (REIT)     181,590  
    3,826,541     KOC Holding AS     8,744,688  
    26,658     Otokar Otomotiv Ve Savunma Sanayi AS     289,776  
    3,344,628     Petkim Petrokimya Holding AS     2,808,910  
    8,281,939     Soda Sanayii AS     10,223,997  
    487,060     TAV Havalimanlari Holding AS     2,450,570  
    583,638     Tekfen Holding AS     1,823,367  
    613,247     Trakya Cam Sanayii AS     404,744  
    351,450     Tupras Turkiye Petrol Rafineriler AS     6,319,009  
    590,247     Turk Hava Yollari AO *     1,465,866  
    221,740     Turk Telekomunikasyon AS *     123,548  
    24,292     Turk Traktor ve Ziraat Makineleri AS     168,520  
    2,612,559     Turkcell Iletisim Hizmetleri AS     4,204,630  
    77,800     Turkcell Iletisim Hizmetleri AS ADR     316,646  
    5,565,331     Turkiye Garanti Bankasi AS     5,057,096  
    2,787,574     Turkiye Halk Bankasi AS     2,608,626  
    19,477,520     Turkiye Is Bankasi – Class C     11,860,205  
    6,823,744     Turkiye Sinai Kalkinma Bankasi AS     791,459  
    1,142,382     Turkiye Sise ve Cam Fabrikalari AS     1,073,842  
    3,826,651     Turkiye Vakiflar Bankasi TAO – Class D     2,022,624  
     

 

 

 
    Total Turkey     98,999,523  
     

 

 

 
    United Arab Emirates — 0.1%

 

    130,461     Abu Dhabi Commercial Bank PJSC     252,140  
    3,059,356     Air Arabia PJSC     841,162  
    2,419,381     Aldar Properties PJSC     1,270,207  
    2,221,090     DAMAC Properties Dubai Co PJSC     1,269,182  
    3,307,412     Dana Gas PJSC     998,391  
    39,348     DP World Ltd     841,592  
    659,788     Dubai Investments PJSC     357,259  
    537,228     Dubai Islamic Bank PJSC     748,606  
    1,384,638     DXB Entertainments PJSC *     130,379  
    
Shares
    Description   Value ($)  
    United Arab Emirates — continued

 

    483,056     Emaar Development PJSC *     695,366  
    1,960,740     Emaar Properties PJSC     2,672,095  
    460,241     Emirates Telecommunications Group Co PJSC     2,122,424  
    132,541     First Abu Dhabi Bank PJSC     534,037  
    1,390,617     RAK Properties PJSC     234,768  
     

 

 

 
    Total United Arab Emirates     12,967,608  
     

 

 

 
    United Kingdom — 3.9%

 

    1,715,924     3i Group Plc     19,980,508  
    31,563     888 Holdings Plc     95,563  
    50,460     Ashmore Group Plc     233,004  
    90,250     Ashtead Group Plc     2,769,464  
    492,932     AstraZeneca Plc     37,203,429  
    2,247     AVEVA Group Plc     82,782  
    463,489     Aviva Plc     2,916,000  
    149,436     BAE Systems Plc     1,175,909  
    42,321     Beazley Plc     326,970  
    144,413     Bellway Plc     5,470,972  
    285,279     Berkeley Group Holdings Plc (The)     13,494,021  
    104,868     Bovis Homes Group Plc     1,532,618  
    734,598     British American Tobacco Plc     35,523,141  
    39,000     British American Tobacco Plc Sponsored ADR     1,886,820  
    70,625     Britvic Plc     747,338  
    38,180     Central Asia Metals Plc     106,347  
    61,407     Close Brothers Group Plc     1,274,056  
    63,063     CMC Markets Plc     139,792  
    446,923     Coca-Cola HBC AG *     15,302,686  
    63,451     Computacenter Plc     1,115,675  
    41,600     Dart Group Plc     528,166  
    20,800     Diageo Plc Sponsored ADR (b)     2,899,728  
    10,335     easyJet Plc     204,742  
    284,793     EI Group Plc *     577,797  
    768,957     Electrocomponents Plc     7,411,957  
    1,436,413     Ferrexpo Plc     2,899,529  
    21,405     Fevertree Drinks Plc     1,034,830  
    84,871     Galliford Try Plc     1,070,336  
    8,328     Games Workshop Group Plc     384,889  
    4,607     GlaxoSmithKline Plc     93,305  
    811,300     GlaxoSmithKline Plc Sponsored ADR     32,857,650  
    33,940     Grafton Group Plc     338,303  
    75,152     Grainger Plc     299,736  
    10,527     Hostelworld Group Plc     35,625  
    82,500     HSBC Holdings Plc Sponsored ADR     3,630,825  
    824,290     IG Group Holdings Plc     9,679,345  
    384,890     Inchcape Plc     3,457,653  
    868,166     Indivior Plc *     3,052,275  
    18,116     Intermediate Capital Group Plc     246,982  
    29,216     International Personal Finance Plc     83,290  
    20,177     J Sainsbury Plc     84,933  
 

 

60   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    United Kingdom — continued

 

    88,201     John Laing Group Plc     361,260  
    52,058     Jupiter Fund Management Plc     283,428  
    69,405     Land Securities Group Plc (REIT)     826,136  
    3,378,904     Legal & General Group Plc     11,166,061  
    10,140,136     Lloyds Banking Group Plc     7,811,145  
    138,383     McBride Plc     234,002  
    56,323     Morgan Sindall Group Plc     1,073,379  
    42,620     N Brown Group Plc     83,503  
    24,078     Next Plc     1,719,144  
    287,100     Nomad Foods Ltd *     5,986,035  
    5,700     Northgate Plc     30,292  
    45,016     Numis Corp Plc     247,101  
    48,907     Paragon Banking Group Plc     295,703  
    1,196,075     Persimmon Plc     37,840,159  
    325,072     Plus500 Ltd     6,494,319  
    662,225     QinetiQ Group Plc     2,332,020  
    9,029     Quilter Plc     16,486  
    262,341     Reckitt Benckiser Group Plc     22,346,787  
    162,878     Redrow Plc     1,157,136  
    132,791     Royal Dutch Shell Plc – Class A     4,318,811  
    44,700     Royal Dutch Shell Plc – Class A Sponsored ADR     2,915,781  
    49,600     Royal Dutch Shell Plc – Class B Sponsored ADR (b)     3,342,048  
    567,966     Royal Mail Plc     3,302,846  
    49,770     RPS Group Plc     151,663  
    32,336     Safestore Holdings Plc (REIT)     222,955  
    42,546     Savills Plc     441,792  
    6,363     Schroders Plc     254,217  
    176,039     Segro Plc (REIT)     1,505,125  
    274,400     Shire Plc ADR     48,094,088  
    6,021     Smiths Group Plc     126,063  
    12,555     Softcat Plc     138,373  
    93,216     Spectris Plc     2,849,819  
    18,686     St Modwen Properties Plc     95,590  
    203,686     Stock Spirits Group Plc     510,029  
    174,349     Tate & Lyle Plc     1,517,700  
    397,051     Taylor Wimpey Plc     863,706  
    118,375     TUI AG     2,185,011  
    12,871     UDG Healthcare Plc     123,097  
    320,378     Unilever Plc     18,256,655  
    356,410     Vesuvius Plc     2,871,318  
    17,544     Virgin Money Holdings UK Plc     86,968  
    547,022     William Hill Plc     1,827,684  
     

 

 

 
    Total United Kingdom     408,554,426  
     

 

 

 
    United States — 9.7%

 

    73,251     3M Co. (a)     15,450,101  
    167,957     Abbott Laboratories (a)     11,226,246  
    145,055     Accenture Plc – Class A     24,524,449  
    250,900     Aetna, Inc.     50,247,743  
    
Shares
    Description   Value ($)  
    United States — continued

 

    9,298     Allergan Plc (c)     1,782,519  
    41,657     Alphabet, Inc. – Class C * (a)     50,746,141  
    198,193     American Express Co.     21,004,494  
    71,377     Amphenol Corp. – Class A (b)     6,750,837  
    177,900     Andeavor (a)     27,181,341  
    80,666     Anthem, Inc. (b)     21,354,710  
    237,052     Apple, Inc. (b)     53,960,147  
    155,349     Avista Corp. (b)     7,970,957  
    41,381     Becton Dickinson and Co. (b)     10,836,442  
    134,540     Bemis Co., Inc. (b)     6,630,131  
    376,300     CA, Inc.     16,481,940  
    242,600     Cars.com, Inc. * (b)     6,528,366  
    477,071     Cisco Systems, Inc. (b)     22,789,682  
    282,454     Coca-Cola Co. (The)     12,588,975  
    233,031     Cognizant Technology Solutions Corp. – Class A     18,276,621  
    15,426     Colgate-Palmolive Co. (a) (c)     1,024,441  
    109,322     Costco Wholesale Corp.     25,486,238  
    1,148,797     EveryWare Global, Inc. (e)     4,652,628  
    150,100     Express Scripts Holding Co. *     13,211,802  
    80,516     Facebook, Inc. – Class A *     14,149,077  
    58,898     Honeywell International, Inc.     9,368,316  
    190,135     Johnson & Johnson     25,609,283  
    191,093     KLX, Inc. *     14,110,307  
    533,476     LaSalle Hotel Properties (REIT)     18,730,342  
    2     Lennar Corp. (b)     103  
    5,800     Lumentum Holdings, Inc. * (b)     393,820  
    83,200     Macquarie Infrastructure Corp. (b)     3,913,728  
    36,224     Mastercard, Inc. – Class A     7,808,445  
    266,848     Medtronic Plc     25,726,816  
    315,808     Merck & Co., Inc.     21,661,271  
    446,008     Microsoft Corp.     50,100,079  
    478,785     NxStage Medical, Inc. *     13,568,767  
    1,960,195     OneMarket Ltd. *     1,480,812  
    824,561     Oracle Corp.     40,057,173  
    40,310     PepsiCo, Inc. (b)     4,515,123  
    126,089     Philip Morris International, Inc.     9,821,072  
    458,100     Pinnacle Foods, Inc.     30,427,002  
    339,599     QUALCOMM, Inc.     23,333,847  
    405,400     Rockwell Collins, Inc.     55,114,130  
    86,800     Sanchez Energy Corp. * (b)     228,284  
    33,646     Stryker Corp. (a) (b)     5,700,642  
    58,884     Tenet Healthcare Corp. * (b)     1,985,568  
    94,631     Teradata Corp. * (a)     3,924,347  
    16,007     Tesla, Inc. * (b) (c)     4,828,672  
    144,872     Texas Instruments, Inc. (b)     16,283,613  
    205,705     TJX Cos., Inc. (The)     22,621,379  
    940,610     Twenty-First Century Fox, Inc. – Class B (c)     42,233,389  
    119,077     UnitedHealth Group, Inc.     31,967,411  
    133,927     United Technologies Corp.     17,638,186  
    386,891     US Bancorp     20,934,672  
 

 

  See accompanying notes to the financial statements.   61


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    United States — continued

 

    80,700     Visa, Inc. – Class A (a)     11,854,023  
    373,235     Wells Fargo & Co.     21,826,783  
    24,288     Williams Cos, Inc. (The) (c)     718,682  
    90,956     XL Group Ltd.     5,219,965  
     

 

 

 
    Total United States     1,008,562,080  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $6,639,599,467)
    6,657,980,528  
     

 

 

 
    PREFERRED STOCKS (f) — 1.1%

 

    Brazil — 0.3%

 

    527,934     Banco Bradesco SA     3,678,468  
    510,300     Banco do Estado do Rio Grande do Sul SA – Class B     1,835,431  
    1,528,200     Braskem SA – Class A     22,215,198  
    594,775     Centrais Eletricas Brasileiras SA – Class B *     2,643,055  
    1,265,300     Cia Energetica de Minas Gerais     2,317,433  
    4,939     Companhia Energetica de Minas Gerais Sponsored ADR     8,841  
     

 

 

 
    Total Brazil     32,698,426  
     

 

 

 
    Germany — 0.2%

 

    36,050     Bayerische Motoren Werke AG     3,023,053  
    3,025     Draegerwerk AG & Co KGaA     244,156  
    49,769     Henkel AG & Co KGaA     6,352,332  
    21,599     RWE AG     450,793  
    7,959     Sixt SE     665,088  
    24,548     Volkswagen AG     4,012,806  
     

 

 

 
    Total Germany     14,748,228  
     

 

 

 
    Russia — 0.1%

 

    76,389     Bashneft PJSC     1,914,860  
    3,650,500     Sberbank of Russia PJSC     8,661,656  
    1,135,300     Surgutneftegas OJSC *     630,063  
    1,230     Transneft PJSC     2,599,852  
     

 

 

 
    Total Russia     13,806,431  
     

 

 

 
    South Korea — 0.5%

 

    1,171     Hyundai Motor Co     82,396  
    2,023     Hyundai Motor Co 2nd Preference     155,549  
    96,668     LG Electronics Inc     2,690,977  
    1,139,074     Samsung Electronics Co Ltd     40,586,665  
    5,004     Samsung Electronics Co Ltd GDR     4,409,975  
     

 

 

 
    Total South Korea     47,925,562  
     

 

 

 
    Taiwan — 0.0%

 

    220,277     CTBC Financial Holding Co Ltd     445,387  
     

 

 

 
    TOTAL PREFERRED STOCKS
(COST $112,899,144)
    109,624,034  
     

 

 

 
Shares /
Par Value†
    Description   Value ($)  
    RIGHTS/WARRANTS — 0.0%  
    Brazil — 0.0%  
    131,971     Oi SA ADR * (g)     436,824  
     

 

 

 
    Canada — 0.0%  
    449,600     Alignvest Acquisition II Corp * (e)     137,808  
     

 

 

 
    Thailand — 0.0%  
    174,750     Supalai Pcl *     106,246  
    421,725     Supalai Public Co *     256,411  
     

 

 

 
    Total Thailand     362,657  
     

 

 

 
    United States — 0.0%

 

    2,616,810     Media General, Inc. CVR * (e)     130,841  
     

 

 

 
    TOTAL RIGHTS/WARRANTS
(COST $884,049)
    1,068,130  
     

 

 

 
    INVESTMENT FUNDS — 0.3%  
    United States — 0.3%  
    823,592     iShares MSCI Emerging Markets ETF     35,554,467  
     

 

 

 
    TOTAL INVESTMENT FUNDS (COST $36,272,848)     35,554,467  
     

 

 

 
    DEBT OBLIGATIONS — 30.9%  
    Italy — 0.0%  
    Corporate Debt — 0.0%

 

    1,243,000     Intesa Sanpaolo SPA, 144A, 3.88%, due 07/14/27     1,067,255  
    3,977,000     Intesa Sanpaolo SPA, 144A, 4.38%, due 01/12/48     3,045,573  
     

 

 

 
    Total Corporate Debt     4,112,828  
     

 

 

 
    Total Italy     4,112,828  
     

 

 

 
    Jamaica — 0.1%

 

          Corporate Debt — 0.1%      
    2,530,000     Digicel Ltd, 144A, 6.00%, due 04/15/21     2,363,298  
    4,679,000     Digicel Ltd, Reg. S, 6.75%, due 03/01/23     3,942,058  
     

 

 

 
    Total Jamaica     6,305,356  
     

 

 

 
    Japan — 3.5%

 

          Foreign Government Obligations — 3.5%  

JPY

    5,100,000,000     Japan Treasury Discount Bill, Zero Coupon, due 09/18/18     45,902,387  

JPY

    13,140,000,000     Japan Treasury Discount Bill, Zero Coupon, due 09/25/18     118,269,106  

JPY

    11,100,000,000     Japan Treasury Discount Bill, Zero Coupon, due 10/01/18     99,909,890  

JPY

    5,533,000,000     Japan Treasury Discount Bill, Zero Coupon, due 10/09/18     49,803,374  

JPY

    2,365,000,000     Japan Treasury Discount Bill, Zero Coupon, due 10/15/18     21,288,236  
 

 

62   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    Japan — continued

 

          Foreign Government Obligations — continued  

JPY

    3,315,000,000     Japan Treasury Discount Bill, Zero Coupon, due 11/19/18     29,843,861  
     

 

 

 
    Total Foreign Government Obligations     365,016,854  
     

 

 

 
    Total Japan     365,016,854  
     

 

 

 
    Luxembourg — 0.1%

 

          Bank Loans — 0.1%      
    6,273,787     SkillSoft Corp., 1st Lien Term Loan, 6.83%, due 04/28/21 (e)     6,069,889  
     

 

 

 
    Puerto Rico — 0.2%

 

          Asset-Backed Securities — 0.1%      
    720,000     Government Development Bank for Puerto Rico, 4.70%, due 05/01/16     304,200  
    20,000     Government Development Bank for Puerto Rico, 3.88%, due 02/01/17     8,250  
    630,000     Government Development Bank for Puerto Rico, 4.15%, due 08/01/17     259,875  
    790,000     Government Development Bank for Puerto Rico, 4.38%, due 02/01/19     327,850  
    60,000     Government Development Bank for Puerto Rico, 4.50%, due 08/01/19     25,350  
    69,000     Government Development Bank for Puerto Rico, 5.40%, due 08/01/19     29,153  
    2,666,000     Government Development Bank for Puerto Rico, 5.50%, due 08/01/20     1,126,385  
    1,315,000     Government Development Bank for Puerto Rico, 4.90%, due 08/01/21     555,587  
    2,110,000     Government Development Bank for Puerto Rico, 5.00%, due 08/01/23     891,475  
    240,000     Government Development Bank for Puerto Rico, 5.75%, due 08/01/25     103,200  
    714,000     Government Development Bank for Puerto Rico, 5.75%, due 08/01/25     307,020  
    2,529,600     Puerto Rico Commonwealth Government Employees Retirement System – Class A, 6.20%, due 07/01/42     828,444  
    587,400     Puerto Rico Commonwealth Government Employees Retirement System – Class A, 6.20%, due 07/01/39     192,373  
     

 

 

 
    Total Asset-Backed Securities     4,959,162  
     

 

 

 
    Municipal Obligations — 0.1%

 

    3,197,940     Puerto Rico Commonwealth Aqueduct & Sewer Authority, (Senior Lien), 6.00%, due 07/01/44     3,046,038  
    11,381,000     Puerto Rico Commonwealth Aqueduct & Sewer Authority, (Senior Lien), 6.00%, due 07/01/47     10,712,366  
    1,000,000     Puerto Rico Public Buildings Authority, 5.00%, due 07/01/32 (h)     547,500  
    1,500,000     Puerto Rico Public Buildings Authority, 5.25%, due 07/01/33 (h)     821,250  
     

 

 

 
    Total Municipal Obligations     15,127,154  
     

 

 

 
    Total Puerto Rico     20,086,316  
     

 

 

 
    
Par Value†
    Description   Value ($)  
    Spain — 0.0%

 

          Bank Loans — 0.0%      
    747,226     Abengoa S.A., Term Loan Escrow, 7.00%, due 03/31/21 (e)     792,059  
    1,610,616     Abengoa S.A., NM Term Loan A, 7.00%, due 03/31/21 (e)     1,695,174  
    588,378     ABG Orphan Holdco S.a r.l., Term Loan Escrow 2, 7.00%, due 03/31/21 (e)     623,681  
    362,829     ABG Orphan Holdco S.a r.l., USD Facility 1A Escrow Tranche, 7.00%, due 03/31/21 (e)     384,599  
     

 

 

 
    Total Bank Loans     3,495,513  
     

 

 

 
    Corporate Debt — 0.0%

 

    693,668     ABG Orphan Holdco S.a r.l., 144A, 14.00%, due 02/28/21 (e)     735,287  
    717,176     ABG Orphan Holdco S.a r.l., 144A, 14.00%, due 02/28/21 (e)     756,621  
     

 

 

 
    Total Corporate Debt     1,491,908  
     

 

 

 
    Total Spain     4,987,421  
     

 

 

 
  United States — 27.0%

 

      Asset-Backed Securities — 3.7%  
    3,020,551     AccessLex Institute, Series 07-1, Class A4, Variable Rate, 3 mo. LIBOR + 0.06%, 2.40%, due 01/25/23     2,965,900  
    848,730     AMMC CLO 21 Ltd., Series 17-21A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.85%, 3.20%, due 11/02/30     849,729  
    3,576,000     AMMC CLO XI Ltd., Series 12-11A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 04/30/31     3,575,414  
    2,873,770     AMMC CLO XII Ltd., Series 13-12A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 11/10/30     2,873,738  
    1,163,877     AMMC CLO XIII Ltd., Series 13-13A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.95%, 3.29%, due 07/24/29     1,166,691  
    1,986,564     AMMC CLO XIV Ltd., Series 14-14A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.95%, 3.29%, due 07/25/29     1,990,364  
    435,533     Anchorage Capital CLO Ltd., Series 15-6A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.24%, due 07/15/30     436,066  
    1,135,362     Anchorage Capital CLO Ltd., Series 13-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 10/13/30     1,135,344  
    2,620,640     Apidos CLO XII, Series 13-12A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 04/15/31     2,616,486  
    1,192,000     Apidos CLO XV, Series 13-15A, Class XRR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     1,191,982  
 

 

  See accompanying notes to the financial statements.   63


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
  United States — continued

 

      Asset-Backed Securities — continued  
    3,261,771     Apidos CLO XVI, Series 13-16A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 0.98%, 3.32%, due 01/19/25     3,263,484  
    1,043,000     Ares XXXIIR CLO Ltd., Series 14-32RA, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.96%, due 05/15/30     1,042,992  
    1,321,220     Atlas Senior Loan Fund III Ltd., Series 13-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.91%, due 11/17/27     1,321,209  
    894,000     Atlas Senior Loan Fund XI Ltd., Series 18-11A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 07/26/31     893,937  
    936,792     Avery Point III CLO Ltd., Series 13-3A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 1.12%, 3.45%, due 01/18/25     937,036  
    1,546,351     Avery Point IV CLO Ltd., Series 14-1A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 1.10%, 3.44%, due 04/25/26     1,546,771  
    13,139,221     B&M CLO Ltd., Series 14-1A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 0.73%, 3.07%, due 04/16/26     13,097,556  
    3,244,500     Babson CLO Ltd., Series 14-IA, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.15%, 3.50%, due 07/20/25     3,245,133  
    848,730     Bain Capital Credit CLO, Series 17-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.15%, due 07/20/30     848,649  
    522,445     Ballyrock CLO LLC, Series 13-1A, Class A, 144A, Variable Rate, 3 mo. LIBOR + 1.18%, 3.50%, due 05/20/25     522,615  
    953,600     Barings CLO Ltd., Series 18-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 3.06%, due 04/15/30     953,569  
    1,879,573     Bayview Commercial Mortgage Pass-Through Trust, Series 06-SP1, Class M3, 144A, Variable Rate, 1 mo. LIBOR + 0.57%, 2.63%, due 04/25/36     1,870,208  
    735,566     Benefit Street Partners CLO III Ltd., Series 13-IIIA, Class X,, 144A, Variable Rate, 3 mo. LIBOR + 0.85%, 3.20%, due 07/20/29     736,048  
    425,714     Black Diamond CLO Ltd., Series 17-IA, Class X, 144A, Variable Rate, 3 mo. LIBOR + 1.00%, 3.34%, due 04/24/29     426,374  
    1,913,146     BlueMountain CLO Ltd., Series 13-3A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 0.89%, 3.23%, due 10/29/25     1,912,195  
    
Par Value†
    Description   Value ($)  
  United States — continued

 

      Asset-Backed Securities — continued  
    1,564,500     BlueMountain CLO Ltd., Series 15-4A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.55%, 2.90%, due 04/20/30     1,564,477  
    1,043,000     BlueMountain CLO Ltd., Series 15-3A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     1,042,984  
    1,094,485     Brookside Mill CLO Ltd., Series 13-1A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 01/17/28     1,094,469  
    1,540,234     Canyon Capital CLO Ltd., Series 16-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.04%, due 07/15/31     1,540,211  
    2,980,000     Carlyle Global Market Strategies CLO Ltd., Series 14-2RA, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.01%, due 05/15/31     2,979,973  
    1,018,476     Catamaran CLO Ltd., Series 14-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/22/30     1,018,248  
    2,942,264     CBAM Ltd., Series 17-3A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.04%, due 10/17/29     2,942,220  
    944,919     CBAM Ltd., Series 17-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.15%, due 07/20/30     945,039  
    4,950,925     CBAM Ltd., Series 17-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 01/15/31     4,950,856  
    2,384,000     Cent CLO, Series C17A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 3.00%, due 04/30/31     2,383,807  
    10,000,000     Cent CLO 22 Ltd., Series 14-22A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.41%, 3.75%, due 11/07/26     10,011,300  
    2,121,825     CIFC Funding II Ltd., Series 13-2A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.98%, due 10/18/30     2,121,526  
    953,600     CIFC Funding III Ltd., Series 17-3A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.15%, due 07/20/30     954,077  
    2,724,870     CIFC Funding IV Ltd., Series 17-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 10/24/30     2,725,707  
    9,349,998     Crest G-Star LP, Series 01-1A, Class D, 144A, 9.00%, due 11/28/35     3,178,999  
    2,011,500     Crown Point CLO Ltd., Series 18-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     2,011,470  
    721,645     CVP Cascade CLO-1 Ltd., Series 13-CLO1, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.15%, 3.49%, due 01/16/26     721,843  
 

 

64   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
  United States — continued

 

      Asset-Backed Securities — continued  
    2,084,675     Dryden 30 Senior Loan Fund, Series 13-30A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.91%, due 11/15/28     2,084,658  
    312,710     Dryden XXVIII Senior Loan Fund, Series 13-28A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.06%, due 08/15/30     312,740  
    1,131,640     Elevation CLO Ltd., Series 14-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 10/15/29     1,131,623  
    813,366     Galaxy XV CLO Ltd., Series 13-15A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 10/15/30     815,675  
    2,939,273     Galaxy XX CLO Ltd., Series 15-20A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     2,938,427  
    1,583,274     Galaxy XXVII CLO Ltd., Series 18-27A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.92%, due 05/16/31     1,583,068  
    14,759,538     GCO Education Loan Funding Master Trust-II, Series 07-1A, Class A6L, 144A, Variable Rate, 3 mo. LIBOR + 0.11%, 2.42%, due 11/25/26     14,705,046  
    733,080     GCO Education Loan Funding Trust, Series 06-1, Class A9L, Variable Rate, 3 mo. LIBOR + 0.16%, 2.47%, due 05/25/26     729,687  
    2,527,577     Goldentree Loan Management US CLO 2 Ltd., Series 17-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 11/28/30     2,527,110  
    1,563,450     Goldentree Loan Opportunities XI Ltd., Series 15-11A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.93%, due 01/18/31     1,563,192  
    1,584,296     Greywolf CLO V Ltd., Series 15-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 01/27/31     1,583,979  
    680,269     Halcyon Loan Advisors Funding Ltd., Series 13-1A, Class A1, 144A, Variable Rate, 3 mo. LIBOR + 1.15%, 3.49%, due 04/15/25     680,298  
    453,817     Halcyon Loan Advisors Funding Ltd., Series 13-1X, Class A1, Reg. S, 3 mo. LIBOR + 1.15%, 3.49%, due 04/15/25     453,837  
    4,969,657     Halcyon Loan Advisors Funding Ltd., Series 14-1A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.13%, 3.46%, due 04/18/26     4,970,685  
    1,528,740     Highbridge Loan Management Ltd., Series 6A-2015, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 02/05/31     1,528,722  
    
Par Value†
    Description   Value ($)  
  United States — continued

 

      Asset-Backed Securities — continued  
    565,820     Highbridge Loan Management Ltd., Series 3A-2014, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.13%, due 07/18/29     566,097  
    707,275     Highbridge Loan Management Ltd., Series 13-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 3.00%, due 10/20/29     707,264  
    5,613,321     Higher Education Funding I, Series 05-1, Class A5, Variable Rate, 3 mo. LIBOR + .16%, 2.47%, due 02/25/32     5,607,257  
    2,065,140     ICG US CLO Ltd., Series 14-2A, Class XRR, 144A, Variable Rate, 3 mo. LIBOR + 0.55%, 2.89%, due 01/15/31     2,065,111  
    1,414,550     Jamestown CLO X Ltd., Series 17-10A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.25%, due 07/17/29     1,416,154  
    765,452     KeyCorp Student Loan Trust, Series 00-A, Class A2, Variable Rate, 3 mo. LIBOR + 0.32%, 2.63%, due 05/25/29     762,590  
    886,485     KeyCorp Student Loan Trust, Series 06-A, Class 2A4, Variable Rate, 3 mo. LIBOR + 0.31%, 2.65%, due 09/27/35     886,573  
    3,417,412     KeyCorp Student Loan Trust, Series 99-B, Class CTFS, Variable Rate, 3 mo. LIBOR + 0.90%, 3.21%, due 11/25/36     3,421,839  
    181,902     KeyCorp Student Loan Trust, Series 05-A, Class 2A4, Variable Rate, 3 mo. LIBOR + 0.34%, 2.68%, due 06/27/38     181,889  
    615,502     KeyCorp Student Loan Trust, Series 04-A, Class 2B, Variable Rate, 3 mo. LIBOR + 0.53%, 2.87%, due 01/27/42     615,736  
    1,698,600     Kingsland VIII Ltd., Series 18-8A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.05%, due 04/20/31     1,698,573  
    893,400     KKR CLO Ltd., Series 9, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.95%, 3.29%, due 07/15/30     894,497  
    1,711,461     LCM XVIII LP, Series 18A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 04/20/31     1,711,436  
    1,206,090     LCM XXV Ltd., Series 25,A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.95%, 3.30%, due 07/20/30     1,208,736  
    792,115     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 05-1A, Class A, 144A, Variable Rate, 1 mo. LIBOR + .25%, 2.31%, due 02/25/30     778,831  
 

 

  See accompanying notes to the financial statements.   65


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
  United States — continued

 

      Asset-Backed Securities — continued  
    169,010     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 05-2A, Class 1A, 144A, Variable Rate, 1 mo. LIBOR + 0.25%, 2.31%, due 09/25/30     168,829  
    4,444,484     Lehman Brothers Small Balance Commercial Mortgage Trust, Series 07-2A, Class 1A3, 144A, Variable Rate, 1 mo. LIBOR + 0.27%, 2.33%, due 06/25/37     4,382,704  
    3,015,760     Madison Park Funding XIII Ltd., Series 14-13A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 04/19/30     3,015,374  
    1,827,426     Magnetite IX Ltd., Series 14-9A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.00%, 3.34%, due 07/25/26     1,828,270  
    5,215,000     Marathon CLO VI Ltd., Series 14-6A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.04%, due 05/13/28     5,214,948  
    6,648,835     Montana Higher Education Student Assistance Corp., Series 12-1, Class A2, Variable Rate, 1 mo. LIBOR + 1.00%, 3.08%, due 05/20/30     6,707,129  
    12,970,977     Montana Higher Education Student Assistance Corp., Series 05-1, Class B, Variable Rate, 3 mo. LIBOR + 0.12%, 2.44%, due 06/20/30     12,957,228  
    552,093     Morgan Stanley Dean Witter Capital I Trust, Series 01-TOP3, Class E, 144A, Variable Rate, 7.86%, due 07/15/33     583,237  
    1,697,460     Mountain View CLO LLC, Series 17-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 01/16/31     1,697,603  
    12,762,000     Mountain View CLO Ltd., Series 14-1A, Class ARR, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.14%, due 10/15/26     12,738,646  
    1,621,819     Mountain View CLO Ltd., Series 13-1A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 10/12/30     1,621,793  
    18,472     National Collegiate Student Loan Trust, Series 06-1, Class A4, Variable Rate, 1 mo. LIBOR + 0.25%, 2.31%, due 03/27/28     18,469  
    13,145,101     National Collegiate Student Loan Trust, Series 07-2, Class A3, Variable Rate, 1 mo. LIBOR + 0.23%, 2.29%, due 03/26/29     12,894,809  
    3,504,298     National Collegiate Student Loan Trust, Series 07-1, Class A3, Variable Rate, 1 mo. LIBOR + 0.24%, 2.30%, due 07/25/30     3,456,130  
    
Par Value†
    Description   Value ($)  
  United States — continued

 

      Asset-Backed Securities — continued  
    252,873    

Nationslink Funding Corp.

Commercial Loan Pass Through

Certificate, Series 99-LTL1, Class D,

144A, 6.45%, due 01/22/26

    256,141  
    813,132     Navient Private Education Loan Trust, Series 14-CTA, Class A, 144A, Variable Rate, 1 mo. LIBOR + 0.70%, 2.76%, due 09/16/24     814,063  
    3,129,000     Navient Student Loan Trust, Series 16-2A, Class A2, 144A, Variable Rate, 1 mo. LIBOR + 1.05%, 3.11%, due 06/25/65     3,160,149  
    781,775     Neuberger Berman CLO XV, Series 13-15A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 10/15/29     781,666  
    1,013,945     Neuberger Berman CLO XVII Ltd., Series 14-17A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 1.00%, 3.35%, due 04/22/29     1,015,500  
    1,302,328     Newcastle CDO V Ltd., Series 04-5A, Class 3, 144A, Variable Rate, 3 mo. LIBOR + .90%, 2.20%, due 12/24/39     1,300,587  
    16,108,527     Ocean Trails CLO IV, Series 13-4A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.24%, due 08/13/25     16,108,671  
    679,440     Octagon Investment Partners XII Ltd., Series 12-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + .88%, 3.22%, due 07/15/19     679,479  
    708,020     Octagon Investment Partners XV Ltd., Series 13-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.14%, due 07/19/30     708,516  
    1,934,291     Octagon Investment Partners XVII Ltd., Series 13-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 01/25/31     1,934,264  
    606,236     OFSI Fund V Ltd., Series 17-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.85%, 3.19%, due 08/16/29     606,793  
    5,948,142     OFSI Fund VI Ltd., Series 14-6A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 03/20/25     5,933,272  
    893,400     OHA Credit Partners XIV Ltd., Series 17-14A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.95%, due 01/21/30     893,251  
    1,556,005     OZLM Funding Ltd., Series 13-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.65%, 3.00%, due 10/22/30     1,555,782  
    4,172,000     OZLM VI Ltd., Series 14-6A, Class XS, 144A, Variable Rate, 3 mo. LIBOR + 0.70%, 3.04%, due 04/17/31     4,171,937  
 

 

66   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
  United States — continued

 

      Asset-Backed Securities — continued  
    720,676     OZLM XI Ltd., Series 15-11A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 10/30/30     720,860  
    9,525,815     Palmer Square Loan Funding Ltd., Series 18-1A, Class A1, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 04/15/26     9,438,701  
    2,795,240     Seneca Park CLO Ltd., Series 14-1A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 1.12%, 3.46%, due 07/17/26     2,795,438  
    1,414,550     Shackleton CLO Ltd., Series 13-3A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 07/15/30     1,414,530  
    1,192,151     Silvermore CLO Ltd., Series 14-1A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.17%, 3.48%, due 05/15/26     1,192,613  
    4,835,464     SLC Student Loan Trust, Series 08-2, Class A3, Variable Rate, 3 mo. LIBOR + 0.65%, 2.99%, due 09/15/18     4,835,425  
    4,895,465     SLM Private Credit Student Loan Trust, Series 07-A, Class A3, Variable Rate, 3 mo. LIBOR + .17%, 2.51%, due 12/15/26     4,894,185  
    1,933,109     SLM Private Education Loan Trust, Series 14-A, Class A2B, 144A, Variable Rate, 1 mo. LIBOR + 1.15%, 3.21%, due 01/15/26     1,940,737  
    572,395     SLM Private Education Loan Trust, Series 11-A, Class A2, 144A, 4.37%, due 04/17/28     573,785  
    3,635,600     SLM Private Education Loan Trust, Series 11-B, Class A3, 144A, Variable Rate, 1 mo. LIBOR + 2.25%, 4.31%, due 06/16/42     3,731,124  
    6,081,076     SLM Private Education Loan Trust, Series 11-A, Class A3, 144A, Variable Rate, 1 mo. LIBOR + 2.50%, 4.56%, due 01/15/43     6,212,213  
    6,187,721     SLM Private Education Loan Trust, Series 10-A, Class 2A, 144A, Variable Rate, 1 mo. LIBOR + 3.25%, 5.31%, due 05/16/44     6,304,469  
    2,587,440     SLM Private Education Loan Trust, Series 11-C, Class A2B, 144A, 4.54%, due 10/17/44     2,616,638  
    6,077,607     SLM Student Loan Trust, Series 07-3, Class A3, Variable Rate, 3 mo. LIBOR + 0.04%, 2.38%, due 04/25/19     6,062,235  
    15,896,871     SLM Student Loan Trust, Series 07-6, Class A4, Variable Rate, 3 mo. LIBOR + .38%, 2.72%, due 10/25/24     15,926,575  
    1,621,092     South Carolina Student Loan Corp., Series 2005, Class A3, Variable Rate, 3 mo. LIBOR + .14%, 2.44%, due 12/01/23     1,620,768  
    
Par Value†
    Description   Value ($)  
  United States — continued

 

      Asset-Backed Securities — continued  
    1,034,508     South Carolina Student Loan Corp., Series 10-1, Class A2, Variable Rate, 3 mo. LIBOR + 1.00%, 3.34%, due 07/25/25     1,039,463  
    1,992,898     Symphony CLO V Ltd., Series 07-5A, Class A1, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 01/15/24     1,993,550  
    565,820     Telos CLO, Series 13-3A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 1.00%, 3.34%, due 07/17/19     566,352  
    2,224,800     Telos CLO Ltd., Series 14-6A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.27%, 3.61%, due 01/17/27     2,225,479  
    2,225,067     Telos CLO Ltd., Series 14-5A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 04/17/28     2,225,031  
    2,059,585     Telos CLO Ltd., Series 13-4A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.75%, 3.09%, due 01/17/30     2,059,552  
    353,875     THL Credit Wind River CLO Ltd., Series 17-2A, Class X, 144A, Variable Rate, 3 mo. LIBOR + .90%, 3.25%, due 07/20/30     354,322  
    1,527,714     THL Credit Wind River CLO Ltd., Series 17-4A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.92%, due 11/20/30     1,527,705  
    3,382,300     TICP CLO I-2 Ltd., Series 18-IA, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.63%, 2.99%, due 04/26/28     3,382,134  
    4,410,400     TICP CLO III-2 Ltd., Series 18-3R, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.55%, 2.91%, due 04/20/28     4,410,202  
    2,980,000     Tryon Park CLO Ltd., Series 13-1A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.55%, 2.90%, due 04/15/29     2,979,881  
    1,647,217     Velocity Commercial Capital Loan Trust, Series 15-1, Class AFL, 144A, Variable Rate, 1 mo. LIBOR + 2.43%, 4.49%, due 06/25/45     1,658,146  
    3,558,820     Velocity Commercial Capital Loan Trust, Series 17-1, Class AFL, 144A, Variable Rate, 1 mo. LIBOR + 1.25%, 3.31%, due 05/25/47     3,581,629  
    924,012     Venture VII CDO Ltd., Series 06-7A, Class A1A, 144A, Variable Rate, 3 mo. LIBOR + 0.23%, 2.58%, due 01/20/22     922,186  
    4,853,882     Voya CLO Ltd., Series 13-3A, Class A1R, 144A, Variable Rate, 3 mo. LIBOR + 1.05%, 3.38%, due 01/18/26     4,854,760  
    1,060,912     Voya CLO Ltd., Series 17-3A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.80%, 3.15%, due 07/20/30     1,060,769  
 

 

  See accompanying notes to the financial statements.   67


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
  United States — continued

 

      Asset-Backed Securities — continued  
    2,546,190     Voya CLO Ltd., Series 13-1A, Class XR, 144A, Variable Rate, 3 mo. LIBOR + 0.60%, 2.94%, due 10/15/30     2,546,154  
    990,850     Voya CLO Ltd., Series 14-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.63%, 2.96%, due 04/18/31     990,835  
    1,792,571     Westchester CLO Ltd., Series 07-1A, Class C, 144A, Variable Rate, 3 mo. LIBOR + 0.85%, 3.19%, due 08/01/22     1,791,122  
    3,708,000     WhiteHorse Ltd., Series 18-12A, Class X, Variable Rate, 3 mo. LIBOR + 0.75%, 3.18%, due 10/15/31     3,708,000  
    11,682,652     WhiteHorse VIII Ltd., Series 14-1A, Class AR, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.24%, due 05/01/26     11,674,790  
    371,569     Ziggurat CLO Ltd., Series 14-1A, Class X, 144A, Variable Rate, 3 mo. LIBOR + 0.90%, 3.24%, due 04/17/29     371,845  
     

 

 

 
    Total Asset-Backed Securities     387,147,469  
     

 

 

 
    Bank Loans — 0.3%

 

    14,527,000     21st Century Oncology Holdings, Inc., Exit Term Loan, 3 mo. LIBOR + 6.13%, 8.47%, due 01/16/23 (e)     13,655,380  
    2,803,755     Gibson Brands Inc., DIP Term Loan, 11.27%, due 05/01/19 (e)     2,719,643  
    3,649,044     J.C. Penney Corporation, Inc., 2016 Term Loan B, 6.62%, due 06/23/23 (e)     3,357,120  
    5,828,200     Murray Energy Corporation, 2018 Term Loan B2, 9.33%, due 10/17/22 (e)     5,478,508  
    4,112,500     Quorum Health Corp., Term Loan B, 8.83%, due 04/29/22 (e)     4,163,906  
    3,841,800     Sears Holding Corp., Incremental Term Loan, 9.58%, due 07/20/20 (e)     3,880,218  
     

 

 

 
    Total Bank Loans     33,254,775  
     

 

 

 
    Corporate Debt — 0.4%

 

    2,988,000     CHS/Community Health Systems, Inc., 6.88%, due 02/01/22     1,523,880  
    2,191,000     CHS/Community Health Systems, Inc., 144A, 8.13%, due 06/30/24     1,802,097  
    5,461,600     EP Energy LLC / Everest Acquisition Finance, Inc., 144A, 8.00%, due 02/15/25     3,946,006  
    500,000     Frontier Communications Corp., 9.25%, due 07/01/21     472,500  
    4,090,600     Frontier Communications Corp., 6.25%, due 09/15/21     3,620,181  
    3,070,000     Frontier Communications Corp., 8.75%, due 04/15/22     2,471,350  
    1,491,000     Frontier Communications Corp., 7.13%, due 01/15/23     1,015,744  
    
Par Value†
    Description   Value ($)  
  United States — continued

 

    Corporate Debt — continued

 

    3,348,000     Frontier Communications Corp., 11.00%, due 09/15/25     2,561,220  
    414,000     Frontier Communications Corp., 144A, 8.50%, due 04/01/26     389,491  
    5,923,000     Gibson Brands, Inc., 144A, 8.88%, due 08/01/18 (h)     5,153,010  
    4,802,588     iHeartCommunications, Inc., 14.00%, due 02/01/21 (h)     606,327  
    1,899,000     Momentive Performance Materials, Inc., 4.69%, due 04/24/22     2,054,528  
    9,517,000     Murray Energy Corp., 144A, 11.25%, due 04/15/21     6,757,070  
    2,609,000     TRU Taj LLC / TRU Taj Finance, Inc., 144A, 11.00%, due 01/22/19 (e)     2,752,495  
    10,573,000     TRU Taj LLC / TRU Taj Finance, Inc., 144A, 12.00%, due 08/15/21 (e)     7,401,100  
    3,085,000     Westmoreland Coal Co., 144A, 8.75%, due 01/01/22     832,950  
     

 

 

 
    Total Corporate Debt     43,359,949  
     

 

 

 
    U.S. Government — 19.4%

 

    165,032,544     U.S. Treasury Inflation Indexed Bond, 0.63%, due 04/15/23 (i)     164,044,069  
    74,592,907     U.S. Treasury Inflation Indexed Bond, 0.25%, due 01/15/25 (i)     72,272,823  
    246,250,276     U.S. Treasury Inflation Indexed Bond, 0.63%, due 01/15/26 (i)     243,701,201  
    274,703,566     U.S. Treasury Inflation Indexed Bond, 0.38%, due 01/15/27 (i)     265,582,550  
    13,906,080     U.S. Treasury Inflation Indexed Bond, 0.38%, due 07/15/27 (i)     13,458,297  
    198,883,719     U.S. Treasury Inflation Indexed Bond, 0.50%, due 01/15/28 (i)     193,341,907  
    208,972,868     U.S. Treasury Inflation Indexed Bond, 1.75%, due 01/15/28 (i)     226,585,906  
    186,034,027     U.S. Treasury Inflation Indexed Bond, 2.50%, due 01/15/29 (i)     216,732,064  
    43,050,000     U.S. Treasury Note, Variable Rate, USBM + 0.05%, 2.14%, due 10/31/19 (a)     43,076,563  
    49,100,000     U.S. Treasury Note, Variable Rate, USBM + 0.00%, 2.09%, due 01/31/20 (a)     49,094,713  
    43,750,000     U.S. Treasury Note, 2.25%, due 03/31/20 (a)     43,514,160  
    145,250,000     U.S. Treasury Note, Variable Rate, USBM + 0.03%, 2.12%, due 04/30/20 (a)     145,271,218  
    78,000,000     U.S. Treasury Note, 2.38%, due 04/30/20     77,701,407  
    54,000,000     U.S. Treasury Note, 2.50%, due 05/31/20 (a)     53,886,094  
 

 

68   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Par Value†
    Description   Value ($)  
    United States — continued

 

          U.S. Government — continued  
    55,000,000     U.S. Treasury Note, 2.50%, due 06/30/20 (a)     54,871,094  
    74,500,000     U.S. Treasury Note, Variable Rate, USBM + 0.00%, 2.13%, due 07/31/20 (a)     74,491,460  
    47,000,000     U.S. Treasury Note, 2.63%, due 07/31/20     46,988,984  
    40,150,000     U.S. Treasury Note, 2.63%, due 08/31/20     40,137,453  
     

 

 

 
    Total U.S. Government     2,024,751,963  
     

 

 

 
    U.S. Government Agency — 3.2%

 

    28,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.22%, 2.12%, due 11/09/18     28,008,141  
    10,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.22%, 2.12%, due 02/01/19     10,002,605  
    64,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.24%, 2.07%, due 11/25/19     63,961,080  
    62,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.14%, 2.20%, due 12/26/19     62,033,693  
    28,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.16%, 2.18%, due 02/07/20     28,004,510  
    24,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.21%, 2.13%, due 02/10/20     23,986,660  
    42,500,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.24%, 2.10%, due 04/13/20     42,473,503  
    64,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR - 0.21%, 2.10%, due 05/22/20     63,979,532  
    260,927     Government National Mortgage Association, Series 12-H15, Class FA, Variable Rate, 1 mo. LIBOR + 0.45%, 2.55%, due 05/20/62     261,205  
    5,763,713     Government National Mortgage Association, Series 17-12H, Class FE, Variable Rate, 1 mo. LIBOR + .20%, 2.30%, due 06/20/66     5,754,149  
    1,781,204     Government National Mortgage Association, Series 17-H05, Class FJ, Variable Rate, 1 mo. LIBOR + 0.27%, 2.37%, due 01/20/67     1,779,393  
    1,732,933     Government National Mortgage Association, Series 17-H13, Class FJ, Variable Rate, 1 mo. LIBOR + 0.20%, 2.30%, due 05/20/67     1,730,580  
     

 

 

 
    Total U.S. Government Agency     331,975,051  
     

 

 

 
    Total United States     2,820,489,207  
     

 

 

 
    TOTAL DEBT OBLIGATIONS (COST $3,245,848,233)     3,227,067,871  
     

 

 

 
    
Par Value†
    Description   Value ($)  
    MUTUAL FUNDS — 0.4%

 

    United States — 0.4%

 

    628,800     Altaba, Inc.* (b)     43,733,040  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $36,597,904)
    43,733,040  
     

 

 

 
    SHORT-TERM INVESTMENTS — 4.0%

 

    Foreign Government Obligations — 1.4%

 

JPY

    1,100,000,000     Japan Treasury Discount Bill, Zero Coupon, due 10/22/18     9,901,762  

JPY

    10,350,000,000     Japan Treasury Discount Bill, Zero Coupon, due 11/12/18 (a)     93,174,685  

GBP

    8,700,000     United Kingdom Treasury Bill, Zero Coupon, due 09/10/18     11,277,696  

GBP

    22,500,000     United Kingdom Treasury Bill, Zero Coupon, due 11/19/18     29,123,603  
     

 

 

 
    TOTAL FOREIGN GOVERNMENT OBLIGATIONS (COST $143,593,198)     143,477,746  
     

 

 

 
    Money Market Funds — 0.1%  
    10,938,992     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (j) (k)     10,938,992  
     

 

 

 
    Repurchase Agreements — 1.4%

 

    149,999,882     Nomura Securities International Inc. Repurchase Agreement, dated 8/31/18, maturing on 9/04/18 with a maturity value of $150,032,382 and an effective yield of 1.95%, collateralized by a U.S. Treasury Note with maturity date 11/15/26 and a market value of $152,918,145.     149,999,882  
     

 

 

 
    TOTAL REPURCHASE AGREEMENTS
(COST $149,999,882)
    149,999,882  
     

 

 

 
    U.S. Government — 1.0%  
    50,490,000     U.S. Treasury Bill, 1.91%, due 11/01/18 (j) (l)     50,326,497  
    4,000,000     U.S. Treasury Note, 1.00%, due 11/30/18     3,989,351  
    52,350,000     U.S. Treasury Note, 1.38%, due 11/30/18     52,256,811  
     

 

 

 
    Total U.S. Government     106,572,659  
     

 

 

 
    U.S. Government Agency — 0.1%  
    5,500,000     Federal Home Loan Banks, Zero Coupon, due 09/10/18     5,498,223  
     

 

 

 
    TOTAL U.S. GOVERNMENT AGENCY
(COST $5,497,367)
    5,498,223  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS
(COST $416,640,811)
    416,487,502  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   69


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

PURCHASED OPTIONS — 0.0%

 

Description    Exercise
Price
     Expiration
Date
     Number of
Contracts
     Notional
Amount
     Value ($)

Equity Options — Puts — 0.0%

                

Mondelez International, Inc.

     35.00        09/21/18        3,100      USD     13,243,200      12,400

QUALCOMM, Inc.

     50.00        09/21/18        1,200      USD     8,245,200      1,200

Twitter, Inc.

     29.00        09/21/18        2,400      USD     8,443,200      14,400

Allergan Plc (c)

     180.00        10/19/18        400      USD     7,668,400      77,200

NXP Semiconductors NV (c)

     90.00        10/19/18        1,414      USD     13,169,996      332,290

Tesla, Inc. (c)

     365.00        10/19/18        180      USD     5,429,880      1,179,000

Texas Instruments, Inc.

     110.00        10/19/18        1,766      USD     19,849,840      393,818

Walt Disney Co. (The)

     95.00        10/19/18        315      USD     3,528,630      4,095

Colgate-Palmolive Co. (c)

     60.00        11/16/18        1,200      USD     7,969,200      54,000

Williams Cos, Inc. (The) (c)

     26.00        11/16/18        2,000      USD     5,918,000      44,000

Twenty-First Century Fox, Inc. (c) (g)

     40.00        01/18/19        9,406      USD     42,703,240      799,510

Walt Disney Co. (The)

     95.00        04/18/19        1,909      USD     21,384,618      263,442
                

 

                                     Total Equity Options — Puts

                 3,175,355
                

 

 

    TOTAL PURCHASED OPTIONS (COST $4,676,874)                  3,175,355
                    

 

    TOTAL INVESTMENTS — 100.4%
(Cost $10,493,419,330)
                 10,494,690,927
                    

 

                    

 

    
Shares
    Description   Value ($)  
    SECURITIES SOLD SHORT — (3.3)%

 

    Common Stocks — (3.3)%  
          Brazil — (0.1)%      
    (335,100   Pagseguro Digital Ltd – Class A *     (9,681,039
     

 

 

 
    Canada — (0.2)%  
    (70,500   Agnico Eagle Mines Ltd     (2,433,660
    (102,650   Algonquin Power & Utilities Corp *     (1,062,428
    (617,600   Barrick Gold Corp     (6,435,392
    (110,900   Cameco Corp     (1,154,469
    (266,500   Enbridge Inc     (9,106,305
     

 

 

 
    Total Canada     (20,192,254
     

 

 

 
    China — (0.4)%  
    (205,704   Alibaba Group Holding Ltd Sponsored ADR *     (36,000,257
     

 

 

 
    Denmark — (0.0)%  
    (2,044   AP Moller – Maersk A/S – Class A     (2,951,578
     

 

 

 
    France — (0.1)%  
    (62,754   DBV Technologies SA *     (2,785,582
    (23,091   Iliad SA *     (2,980,941
    (4,304   Wendel SA *     (637,249
     

 

 

 
    Total France     (6,403,772
     

 

 

 
    Germany — (0.2)%  
    (1,196,151   Deutsche Bank AG (Registered)     (13,484,753
    
Shares
    Description   Value ($)  
    Germany — continued  
    (371,655   thyssenkrupp AG     (8,587,959
     

 

 

 
    Total Germany     (22,072,712
     

 

 

 
    Israel — (0.0)%  
    (21,100   CyberArk Software Ltd *     (1,591,362
     

 

 

 
    Italy — (0.2)%  
    (45,768   Banco BPM SPA *     (103,233
    (413,476   Leonardo SPA *     (4,630,512
    (1,934,147   Saipem SPA *     (10,343,521
     

 

 

 
    Total Italy     (15,077,266
     

 

 

 
    Japan — (0.5)%  
    (64,100   Acom Co Ltd     (261,653
    (52   Advance Residence Investment Corp (REIT)     (132,777
    (50,000   Chugoku Electric Power Co Inc (The)     (624,231
    (1,522   Daiwa House Investment Corp (REIT)     (3,529,769
    (3,100   FP Corp     (174,558
    (125   GLP J-Reit     (125,200
    (19,200   Hokkaido Electric Power Co Inc     (130,877
    (168   Hulic Reit Inc (REIT)     (246,892
    (1,479   Invincible Investment Corp (REIT)     (640,650
    (7,800   Japan Lifeline Co Ltd     (149,372
    (17,500   Kansai Paint Co Ltd     (345,867
    (4,900   KDDI Corp     (129,555
    (60,600   Keikyu Corp     (1,047,138
 

 

70   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

    
Shares
    Description   Value ($)  
    Japan — continued  
    (145,400   Kyushu Electric Power Co Inc     (1,626,891
    (2,500   Lawson Inc     (146,591
    (16,000   Makino Milling Machine Co Ltd     (147,676
    (122,900   Mitsui OSK Lines Ltd     (3,301,322
    (30,300   Murata Manufacturing Co Ltd     (5,224,791
    (6,400   Nifco Inc     (175,579
    (16,700   Nippon Paint Holdings Co Ltd     (660,101
    (109   Nomura Real Estate Master Fund Inc (REIT)     (151,852
    (406,400   Orient Corp     (574,105
    (4,900   Royal Holdings Co Ltd     (121,458
    (9,400   Saizeriya Co Ltd     (188,330
    (7,400   Seibu Holdings Inc     (133,264
    (49,100   Seven Bank Ltd     (152,912
    (25,900   Shimano Inc     (3,996,365
    (690,635   Takeda Pharmaceutical Co Ltd     (28,772,658
    (90   United Urban Investment Corp (REIT)     (142,015
    (979,360   Yahoo Japan Corp     (3,363,814
    (15,400   Yoshinoya Holdings Co Ltd     (259,348
     

 

 

 
    Total Japan     (56,677,611
     

 

 

 
    Netherlands — (0.0)%

 

    (433,628   Altice NV *     (1,304,877
     

 

 

 
    Singapore — (0.0)%

 

    (232,900   NetLink NBN Trust     (134,094
    (63,200   UOL Group Ltd     (318,148
     

 

 

 
    Total Singapore     (452,242
     

 

 

 
    Spain — (0.1)%

 

    (1,723,272   Bankia SA     (6,455,519
    (128,274   Cellnex Telecom SA     (3,289,903
    (171,909   Ferrovial SA     (3,712,110
     

 

 

 
    Total Spain     (13,457,532
     

 

 

 
    
Shares
    Description   Value ($)  
    Switzerland — (0.1)%

 

    (561,479   Credit Suisse Group AG (Registered)     (8,407,905
    (98,054   LafargeHolcim Ltd (Registered) *     (4,769,818
     

 

 

 
    Total Switzerland     (13,177,723
     

 

 

 
    United Kingdom — (0.1)%

 

    (77,059   Capita Plc     (148,690
    (2,124,934   Cobham Plc *     (3,434,448
    (300,904   GVC Holdings Plc     (4,298,842
    (2,202,087   Melrose Industries Plc     (6,373,253
     

 

 

 
    Total United Kingdom     (14,255,233
     

 

 

 
    United States — (1.3)%

 

    (180,519   Altice USA, Inc. – Class A     (3,234,900
    (36,535   Cigna Corp.     (6,881,002
    (297,620   Conagra Brands, Inc.     (10,937,535
    (214,192   CVS Health Corp.     (16,115,806
    (26,802   International Flavors & Fragrances, Inc.     (3,492,033
    (91,722   KLA-Tencor Corp.     (10,659,014
    (30   Lennar Corp. – A Shares     (1,265
    (282,268   Marathon Petroleum Corp.     (23,227,834
    (72   Marvell Technology Group Ltd.     (1,489
    (92,521   Oclaro, Inc. *     (882,650
    (268,546   Praxair, Inc.     (42,481,292
    (139,006   United Technologies Corp.     (18,307,090
     

 

 

 
    Total United States     (136,221,910
     

 

 

 
    TOTAL COMMON STOCKS (PROCEEDS $349,350,301)     (349,517,368
     

 

 

 
    TOTAL SECURITIES SOLD SHORT
(PROCEEDS $349,350,301)
    (349,517,368 ) 
    Other Assets and Liabilities
(net) — 2.9%
    306,742,750  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $10,451,916,309  
     

 

 

 
 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

 

 

Forward Currency Contracts

 

Settlement
Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
   

Net
Unrealized
Appreciation
(Depreciation) ($)

 
10/05/2018   JPM     AUD       6,240,000       USD       4,612,640       126,891  
10/05/2018   MSCI     AUD       92,020,000       USD       67,561,084       1,410,664  
10/15/2018   GS     AUD       760,174       USD       561,478       14,982  
10/15/2018   MSCI     AUD       26,530,224       USD       19,638,044       565,234  
10/15/2018   SSB     AUD       2,488,918       USD       1,842,712       53,407  
09/05/2018   MSCI     BRL       63,953,694       USD       17,097,632       1,396,154  
10/02/2018   MSCI     BRL       28,932,473       USD       7,007,647       (74,121

Settlement
Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
   

Net
Unrealized
Appreciation
(Depreciation) ($)

 
09/04/2018   GS     CAD       41,069,768       USD       31,340,684       (130,403
09/11/2018   JPM     CAD       8,992,000       USD       6,946,859       55,645  
10/12/2018   BOA     CHF       4,829,862       USD       4,888,121       (110,959
10/12/2018   MSCI     CHF       102,610,134       USD       104,060,028       (2,145,116
10/12/2018   SSB     CHF       185,307       USD       187,506       (4,293
09/19/2018   BCLY     EUR       2,730,000       USD       3,214,125       42,045  
09/19/2018   GS     EUR       7,859,000       USD       9,182,399       50,760  
 

 

  See accompanying notes to the financial statements.   71


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Forward Currency Contracts — continued

 

Settlement
Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
   

Net
Unrealized
Appreciation
(Depreciation) ($)

 
09/19/2018   MSCI     EUR       165,879,952       USD       193,930,478       1,188,927  
09/19/2018   SSB     EUR       16,696,056       USD       19,567,094       167,379  
09/10/2018   BCLY     GBP       8,700,000       USD       11,705,263       424,096  
09/14/2018   JPM     GBP       37,800,000       USD       50,759,125       1,736,729  
09/19/2018   BCLY     GBP       1,996,459       USD       2,624,982       35,254  
09/19/2018   GS     GBP       18,058,350       USD       23,779,599       355,024  
09/19/2018   JPM     GBP       60,685,470       USD       80,677,448       1,958,662  
09/19/2018   SSB     GBP       470,822       USD       618,464       7,732  
11/19/2018   JPM     GBP       22,500,000       USD       28,719,364       (544,353
09/07/2018   GS     JPY       1,057,519,452       USD       9,570,000       51,050  
09/07/2018   MSCI     JPY       1,152,106,851       USD       10,460,000       89,649  
09/18/2018   BCLY     JPY       4,859,218,327       USD       43,890,295       118,831  
09/18/2018   GS     JPY       3,458,472       USD       31,232       78  
09/18/2018   JPM     JPY       13,920,491,910       USD       126,905,718       1,511,000  
09/18/2018   MSCI     JPY       5,100,000,000       USD       46,531,679       591,272  
09/18/2018   SSB     JPY       86,550,104       USD       782,462       2,825  
09/25/2018   MSCI     JPY       13,140,000,000       USD       120,150,325       1,725,959  
10/01/2018   BCLY     JPY       11,100,000,000       USD       100,902,211       819,691  
10/09/2018   MSCI     JPY       5,533,000,000       USD       50,337,524       420,475  
10/15/2018   JPM     JPY       2,365,000,000       USD       21,149,554       (196,093
10/22/2018   GS     JPY       1,100,000,000       USD       9,869,011       (64,266
11/13/2018   JPM     JPY       10,350,000,000       USD       93,961,243       350,686  
11/19/2018   JPM     JPY       3,315,000,000       USD       30,222,608       227,614  
10/12/2018   BOA     NOK       144,724,782       USD       18,024,931       741,940  
10/12/2018   GS     NOK       25,228,402       USD       3,092,260       79,492  
09/05/2018   BCLY     NZD       24,230,000       USD       17,018,745       988,173  
09/05/2018   JPM     NZD       2,080,000       USD       1,410,529       34,400  
09/05/2018   MSCI     NZD       6,330,000       USD       4,308,875       120,946  

Settlement
Date

  Counter-
party
  Currency
Sold
    Currency
Purchased
   

Net
Unrealized
Appreciation
(Depreciation) ($)

 
12/05/2018   MSCI     NZD       32,640,000       USD       21,628,733       29,208  
10/12/2018   BCLY     SEK       136,414,718       USD       15,689,726       729,882  
10/12/2018   GS     SEK       3,551,273       USD       403,769       14,320  
10/12/2018   SSB     SEK       54,036,947       USD       6,172,273       246,341  
09/04/2018   BCLY     USD       3,490,000       CAD       4,552,058       (1,833
09/04/2018   JPM     USD       2,870,000       CAD       3,774,197       22,105  
09/04/2018   MSCI     USD       25,331,806       CAD       32,743,513       (240,992
09/05/2018   MSCI     USD       16,360,023       BRL       63,953,694       (658,524
09/05/2018   MSCI     USD       21,624,163       NZD       32,640,000       (29,535
09/07/2018   GS     USD       8,830,000       JPY       988,860,611       70,938  
09/07/2018   JPM     USD       14,738,901       JPY       1,615,399,211       (198,360
09/07/2018   MSCI     USD       6,110,000       JPY       679,418,436       5,585  
09/14/2018   BCLY     USD       2,351,962       GBP       1,790,000       (30,531
09/14/2018   GS     USD       19,841,965       GBP       15,250,000       (64,410
09/14/2018   JPM     USD       5,021,054       GBP       3,870,000       (2,094
09/14/2018   MSCI     USD       4,018,309       GBP       3,020,000       (101,705
09/18/2018   BCLY     USD       11,080,167       JPY       1,214,803,800       (137,307
09/19/2018   GS     USD       15,631,570       EUR       13,570,469       136,418  
09/19/2018   JPM     USD       16,766,444       EUR       14,520,930       105,918  
09/19/2018   MSCI     USD       11,550,281       GBP       8,712,251       (249,094
10/05/2018   BCLY     USD       1,342,747       AUD       1,820,000       (34,403
10/05/2018   JPM     USD       52,367,149       NOK       426,265,978       (1,476,646
10/12/2018   BOA     USD       1,700,000       CHF       1,677,244       36,007  
11/05/2018   BCLY     USD       78,035,881       SEK       690,137,459       (2,202,517
12/03/2018   GS     USD       22,657,993       CAD       29,535,827       12,330  
           

 

 

 
            $ 10,175,163  
           

 

 

 
 

 

Reverse Repurchase Agreements

 

Average balance outstanding

   $ (6,858,847

Average interest rate

     (1.40 )% 

Maximum balance outstanding

   $ (105,632,950

Average balance outstanding was calculated based on daily face value balances outstanding during the period that the Fund had entered into reverse repurchase agreements. Average interest rate was calculated based on interest received and/or paid during the period that the Fund had entered into reverse repurchase agreements. The Fund had no reverse repurchase agreements outstanding at the end of the period.

 

Futures Contracts

 

Number
of
Contracts +
 

Type

  Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation) ($)
 
Buys        
1,900   Mini MSCI Emerging Markets   September
2018
    100,215,500     $ (7,438,336
     

 

 

   

 

 

 
Sales        
9,305   S&P 500 E-Mini   September
2018
    1,350,202,025     $ (54,588,163
     

 

 

   

 

 

 
+

Buys - Fund is long the futures contract.

  

Sales - Fund is short the futures contract.

 

 

72   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Written Options

Equity Options

 

Description

    

Exercise
Price

     Expiration
Date
       Number of
Contracts
    Notional
Amount
    Value
($)
 

Equity Options – Calls

                    

Walt Disney Co. (The)

     115.00        04/18/19          (1,561     USD       (6,151,300     (944,405

Equity Options – Puts

                    

Twenty-First Century Fox, Inc. (c)

     49.00        10/19/18          (1,370     USD       (17,486,322     (616,500
                    

 

 

 
           
TOTAL WRITTEN EQUITY OPTIONS
(Premiums $1,184,920)

 
    (1,560,905)  
                    

 

 

 

Swap Contracts

OTC Credit Default Swaps

 

Reference Entity

 

Counterparty

 

Notional
Amount

    Annual
Premium
    Implied
Credit
Spread(1)
    Maximum
Potential
Amount of
Future
Payments by
the Fund
Under the
Contract(2)
    Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Buy Protection^:

                     

Sears Roebuck Acceptance Corp.

  GS   USD     3,631,000       5.00     27.07%       N/A     12/20/2018       Quarterly       926,914       223,979       (702,935

Sears Roebuck Acceptance Corp.

  GS   USD     1,365,000       0.00     60.50%       N/A       12/20/2018       At Maturity             42,770       42,770  

Sears Roebuck Acceptance Corp.

  GS   USD     6,000,000       5.00     27.02%       N/A       12/20/2019       Quarterly       960,000       1,128,166       168,166  

Sears Roebuck Acceptance Corp.

  MSCI   USD     685,000       0.00     60.50%       N/A       06/20/2021       Quarterly             78,514       78,514  

Sears Roebuck Acceptance Corp.

  MSCI   USD     685,000       0.00     60.50%       N/A       12/20/2021       At Maturity             82,002       82,002  
                 

 

 

   

 

 

   

 

 

 
                  $ 1,886,914     $ 1,555,431     $ (331,483
                 

 

 

   

 

 

   

 

 

 

 

^

Buy Protection - Fund pays a premium and buys credit protection. If a credit event occurs the Fund will, depending on the terms of the particular swap contract, either (i) receive from the seller of protection an amount equal to notional amount of the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index. Sell Protection - Fund receives a premium and sells credit protection. If a credit event occurs the Fund will, depending on the terms of the particular swap contract, either (i) pay to the buyer of protection an amount equal to the notional amount of the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the referenced obligation or underlying securities comprising the referenced index.

(1)

As of August 31, 2018, implied credit spreads in absolute terms, calculated using a model, and utilized in determining the market value of credit default swap contracts on the reference security, serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e., higher) credit spreads represent a deterioration of the referenced entity’s credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the contract.

(2)

The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap contract.

 

  See accompanying notes to the financial statements.   73


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Centrally Cleared Interest Rate Swaps

 

Fund Pays

   Fund Receives   Notional
Amount
     Expiration
Date
     Periodic
Payment
Frequency
     Premiums
Paid/
(Received)($)
     Value ($)      Net
Unrealized
Appreciation/
(Depreciation) ($)
 

2.37%

   3 Month NZD Bank
Bill Rate
  NZD     68,509,500        09/19/2023        Quarterly               (102,512      (102,512

2.41%

   3 Month NZD Bank
Bill Rate
  NZD     68,509,500        09/19/2023        Quarterly               (180,505      (180,505

3 Month NZD Bank Bill Rate

   2.37%   NZD     422,286,000        09/19/2023        Quarterly        4,881        618,703        613,822  

3 Month NZD Bank Bill Rate

   3.16%   NZD     28,006,000        09/19/2028        Quarterly               533,598        533,598  

3 Month NZD Bank Bill Rate

   3.02%   NZD     132,589,000        09/19/2028        Quarterly        (19,648      1,432,066        1,451,714  

3 Month NZD Bank Bill Rate

   2.91%   NZD     29,150,000        09/19/2028        Quarterly               128,500        128,500  

3 Month NZD Bank Bill Rate

   2.88%   NZD     29,150,000        09/19/2028        Quarterly               81,068        81,068  

3 Month NZD Bank Bill Rate

   2.93%   NZD     76,675,000        09/19/2028        Quarterly        126,397        427,120        300,723  

3 Month NZD Bank Bill Rate

   2.92%   NZD     36,927,000        09/19/2028        Quarterly        38,460        184,244        145,784  

2.92%

   3 Month USD LIBOR   USD     22,735,000        09/20/2028        Quarterly               7,395        7,395  

2.94%

   3 Month USD LIBOR   USD     21,219,000        09/20/2028        Quarterly               (29,375      (29,375

2.95%

   3 Month USD LIBOR   USD     23,578,000        09/20/2028        Quarterly               (40,909      (40,909

3 Month CAD LIBOR

   2.71%   CAD     105,101,000        09/20/2028        Semi-Annual        34,688        610,445        575,757  

3 Month CAD LIBOR

   2.74%   CAD     36,200,000        09/20/2028        Semi-Annual               274,825        274,825  

3 Month CAD LIBOR

   2.77%   CAD     26,400,000        09/20/2028        Semi-Annual               258,380        258,380  

3 Month CAD LIBOR

   2.76%   CAD     50,772,000        09/20/2028        Semi-Annual               460,340        460,340  

3 Month CAD LIBOR

   2.70%   CAD     17,694,000        09/20/2028        Semi-Annual               93,059        93,059  

3 Month CAD LIBOR

   2.61%   CAD     50,049,000        09/20/2028        Semi-Annual               (52,657      (52,657

3 Month USD LIBOR

   3.04%   USD     37,458,000        09/20/2028        Quarterly        (7,340      385,188        392,528  

3 Month USD LIBOR

   2.98%   USD     4,734,000        09/20/2028        Quarterly               20,665        20,665  

3 Month USD LIBOR

   2.99%   USD     56,848,000        09/20/2028        Quarterly               175,835        175,835  

3 Month USD LIBOR

   2.96%   USD     40,754,000        09/20/2028        Quarterly               127,879        127,879  

3 Month USD LIBOR

   3.00%   USD     25,386,000        09/20/2028        Quarterly               174,248        174,248  

3.02%

   3 Month USD LIBOR   USD     10,034,000        09/20/2028        Quarterly               (81,189      (81,189

1.23%

   3 Month SEK STIBOR   SEK     169,636,000        12/19/2028        Quarterly               (40,568      (40,568

3 Month SEK STIBOR

   1.20%   SEK     98,380,000        12/19/2028        Quarterly               (2,235      (2,235

1.72%

   6 Month GBP LIBOR   GBP     49,939,000        06/21/2028        Semi-Annual        4,591        59,425        54,834  

2.76%

   6 Month AUD BBSW   AUD     94,793,000        09/19/2028        Semi-Annual        (76,743      (418,642      (341,899

2.78%

   6 Month AUD BBSW   AUD     56,647,000        09/19/2028        Semi-Annual        (60,039      (323,856      (263,817

2.84%

   6 Month AUD BBSW   AUD     215,875,000        09/19/2028        Semi-Annual        13,244        (2,076,554      (2,089,798

2.85%

   6 Month AUD BBSW   AUD     26,122,000        09/19/2028        Semi-Annual               (266,564      (266,564

2.88%

   6 Month AUD BBSW   AUD     14,242,000        09/19/2028        Semi-Annual               (174,047      (174,047

2.88%

   6 Month AUD BBSW   AUD     36,556,000        09/19/2028        Semi-Annual               (444,362      (444,362

0.93%

   6 Month EURIBOR   EUR     11,804,000        09/20/2028        Semi-Annual               (66,236      (66,236

0.94%

   6 Month EURIBOR   EUR     11,803,000        09/20/2028        Semi-Annual               (73,623      (73,623

1.01%

   6 Month EURIBOR   EUR     12,497,000        09/20/2028        Semi-Annual               (176,149      (176,149

1.09%

   6 Month EURIBOR   EUR     16,246,000        09/20/2028        Semi-Annual               (393,650      (393,650

1.58%

   6 Month GBP LIBOR   GBP     81,459,000        09/20/2028        Semi-Annual               (322,674      (322,674

1.61%

   6 Month GBP LIBOR   GBP     151,620,000        09/20/2028        Semi-Annual               (1,057,627      (1,057,627

6 Month CHF LIBOR

   0.45%   CHF     37,710,000        09/20/2028        Semi-Annual               191,730        191,730  

6 Month CHF LIBOR

   0.44%   CHF     29,603,000        09/20/2028        Semi-Annual               116,703        116,703  

6 Month EURIBOR

   0.98%   EUR     25,356,000        09/20/2028        Semi-Annual               277,995        277,995  

6 Month EURIBOR

   1.00%   EUR     13,330,000        09/20/2028        Semi-Annual               186,373        186,373  

6 Month EURIBOR

   1.00%   EUR     29,782,000        09/20/2028        Semi-Annual        19,154        401,134        381,980  

6 Month EURIBOR

   0.96%   EUR     33,701,000        09/20/2028        Semi-Annual               296,568        296,568  

6 Month EURIBOR

   0.94   EUR     1,445,000        09/20/2028        Semi-Annual               9,178        9,178  

2.77%

   6 Month AUD BBSW   AUD     26,955,000        12/19/2028        Semi-Annual               (83,674      (83,674

2.83%

   6 Month AUD BBSW   AUD     27,973,000        12/19/2028        Semi-Annual               (192,676      (192,676

6 Month EURIBOR

   0.97%   EUR     16,098,000        12/20/2028        Semi-Annual               62,583        62,583  
               

 

 

    

 

 

    

 

 

 
   $ 77,645      $ 994,963      $ 917,318  
  

 

 

    

 

 

    

 

 

 

 

74   See accompanying notes to the financial statements.  


GMO Implementation Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

OTC Total Return Swaps

 

Fund Pays

 

Fund

Receives

 

Counterparty

  Notional
Amount
    Expiration
Date
    Periodic
Payment
Frequency
    Premiums
Paid/
(Received) ($)
    Value ($)     Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Total Return on Equity Basket(m)

  1 Month Federal Funds Rate minus 0.40%   MORD     USD       21,710,774       05/18/2020       Monthly             (125,547     (125,547

Total Return on Equity Basket(m)

  1 Month Federal Funds Rate minus 1.00%   MORD     USD       15,452,438       05/18/2020       Monthly             (1,170,848     (1,170,848

Total Return on Equity Basket(m)

  1 Month Federal Funds Rate minus 0.75%   MORD     USD       706,578       05/18/2020       Monthly             (76,915     (76,915

Total Return on Equity Basket(m)

  1 Month Federal Funds Rate minus 1.75%   MORD     USD       9,945,838       05/18/2020       Monthly             (268,259     (268,259

Total Return on Equity Basket(m)

  1 Month Federal Funds Rate minus 0.75%   MORD     USD       1,930,189       05/18/2020       Monthly             (149,891     (149,891

Total Return on Equity Basket(m)

  1 Month Federal Funds Rate minus 0.90%   MORD     USD       816,294       05/18/2020       Monthly             4,498       4,498  

Total Return on Equity Basket(m)

  1 Month Federal Funds Rate minus 0.40%   MORD     USD       713,683       05/18/2020       Monthly             (51,895     (51,895
             

 

 

   

 

 

   

 

 

 
  $     $ (1,838,857   $ (1,838,857
 

 

 

   

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

*

Non-income producing security.

 

(a)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on securities sold short, OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(b)

All or a portion of this security is out on loan (Note 2).

 

(c)

All or a portion of this investment is held in connection with one or more holdings within the Fund.

 

(d)

Security valued at the local price and adjusted by applying a premium or discount since holding exceeds foreign ownership limits.

 

(e)

Investment valued using significant unobservable inputs (Note 2).

 

(f)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(g)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

 

(h)

Security is in default.

 

(i)

Indexed security in which price and/or coupon is linked to the price of a specific instrument or financial statistic (Note 2).

 

(j)

All or a portion of this security or derivative is owned by GMO Implementation SPC Ltd., which is a 100% owned subsidiary of GMO Implementation Fund.

 

(k)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(l)

The rate shown represents yield-to-maturity.

 

(m)

Custom equity basket swap which has a notional amount of less than 1% of the Fund’s total net assets.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

 

  See accompanying notes to the financial statements.   75


GMO International Developed Equity Allocation Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    97.7

Preferred Stocks

    0.8  

Short-Term Investments

    1.0  

Investment Funds

    0.2  

Swap Contracts

    0.0

Futures Contracts

    (0.1

Other

    0.4  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary¤   % of Investments  

Japan

    25.1

United Kingdom

    14.1  

Germany

    11.1  

France

    7.1  

Sweden

    5.2  

Other Emerging

    5.1 † 

Switzerland

    4.7  

Australia

    4.5  

Italy

    4.2  

Norway

    3.4  

Hong Kong

    3.1  

Netherlands

    2.5  

Other Developed

    2.4 ‡ 

China

    2.3  

Taiwan

    2.2  

Denmark

    1.5  

Russia

    1.5  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments and includes exposure through the use of derivative financial instruments, if any. The table excludes exposure through forward currency contracts, if any.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

^

Rounds to 0.0%.

 

 

76


GMO International Developed Equity Allocation Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    MUTUAL FUNDS — 100.0%

 

    Affiliated Issuers — 100.0%

 

    1,994,003     GMO Emerging Markets Fund, Class VI     63,987,561  
    25,654,645     GMO International Equity Fund, Class IV     571,072,393  
     

 

 

 
    TOTAL MUTUAL FUNDS
(COST $648,982,688)
    635,059,954  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.0%

 

    Money Market Funds — 0.0%

 

    241,796     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (a)     241,796  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $241,796)     241,796  
     

 

 

 
    TOTAL INVESTMENTS — 100.0%
(Cost $649,224,484)
    635,301,750  
    Other Assets and Liabilities (net) — (0.0%)     (59,275
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $635,242,475  
     

 

 

 

Notes to Schedule of Investments:

 

(a)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

 

  See accompanying notes to the financial statements.   77


GMO International Equity Allocation Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    96.2

Short-Term Investments

    1.4  

Preferred Stocks

    1.3  

Investment Funds

    0.7  

Swap Contracts

    0.0

Futures Contracts

    (0.2

Other

    0.6  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary¤   % of Investments  

Japan

    18.0

United Kingdom

    10.3  

Germany

    8.0  

China

    7.7  

Taiwan

    7.5  

France

    5.1  

Russia

    4.9  

Other Emerging

    4.9 † 

Sweden

    3.8  

Switzerland

    3.4  

Australia

    3.2  

Italy

    3.0  

Korea

    2.9  

Norway

    2.4  

Hong Kong

    2.2  

Thailand

    2.1  

South Africa

    1.8  

Netherlands

    1.8  

Other Developed

    1.7 ‡ 

India

    1.6  

Turkey

    1.5  

Mexico

    1.1  

Denmark

    1.1  
 

 

 

 
    100.0 % 
 

 

 

 

 

&

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments and includes exposure through the use of derivative financial instruments, if any. The table excludes exposure through forward currency contracts, if any.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Investments.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Investments.

 

^

Rounds to 0.0%.

 

 

78


GMO International Equity Allocation Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares     Description   Value ($)  
    MUTUAL FUNDS — 100.0%

 

    Affiliated Issuers — 100.0%

 

    10,984,300     GMO Emerging Markets Fund, Class VI     352,486,183  
    29,993,948     GMO International Equity Fund, Class IV     667,665,290  
     

 

 

 
   

TOTAL MUTUAL FUNDS

(COST $1,028,871,672)

    1,020,151,473  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.0%

 

    Money Market Funds — 0.0%

 

    356,878     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (a)     356,878  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $356,878)     356,878  
     

 

 

 
    TOTAL INVESTMENTS — 100.0% (Cost $1,029,228,550)     1,020,508,351  
    Other Assets and Liabilities (net) — (0.0%)     (62,735
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $1,020,445,616  
     

 

 

 

Notes to Schedule of Investments:

 

(a)

The rate disclosed is the 7 day net yield as of August 31, 2018.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

 

  See accompanying notes to the financial statements.   79


GMO SGM Major Markets Fund

(A Series of GMO Trust)

Consolidated Investment Concentration Summary (a)

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Debt Obligations

    65.2

Short-Term Investments

    35.8  

Forward Currency Contracts

    (0.5

Futures Contracts

    (2.0 )# 

Other

    1.5  
 

 

 

 
    100.0 % 
 

 

 

 

 

(a)

GMO Alternative Asset SPC Ltd. is a 100% owned subsidiary of GMO SGM Major Markets Fund. As such, the holdings of GMO Alternative Asset SPC Ltd. have been included with GMO SGM Major Markets Fund.

 

&

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts. The exposure the Fund has to futures contracts based on notional amounts is 12.7% of net assets.

 

#

Some or all is comprised of commodity exposure. See Consolidated Schedule of Investments.

 

 

80


GMO SGM Major Markets Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Par Value†         
Description
  Value ($)  
    DEBT OBLIGATIONS — 65.2%

 

    United States — 65.2%

 

          U.S. Government — 44.8%  
    67,858,800     U.S. Treasury Note, 0.75%, due 10/31/18     67,723,085  
    38,862,300     U.S. Treasury Note, 1.25%, due 11/30/18     38,781,696  
    30,258,800     U.S. Treasury Note, 1.50%, due 12/31/18 (a)     30,192,716  
    33,100,000     U.S. Treasury Note, 1.25%, due 01/31/19     32,965,531  
    22,207,000     U.S. Treasury Note, 0.75%, due 02/15/19     22,058,664  
    41,500,000     U.S. Treasury Note, 1.13%, due 05/31/19 (a)     41,117,422  
    27,758,800     U.S. Treasury Note, Variable Rate, USBM + 0.05%, 2.14%, due 10/31/19     27,775,928  
    209,991,300     U.S. Treasury Note, Variable Rate, USBM + 0.00%, 2.09%, due 01/31/20 (b)     209,968,688  
    227,697,400     U.S. Treasury Note, Variable Rate, USBM + 0.03%, 2.12%, due 04/30/20 (b)     227,730,662  
    70,258,800     U.S. Treasury Note, Variable Rate, USBM + 0.04%, 2.13%, due 07/31/20 (a)     70,250,746  
     

 

 

 
    Total U.S. Government     768,565,138  
     

 

 

 
    U.S. Government Agency — 20.4%

 

    27,760,000     Federal Home Loan Banks, 0.88%, due 10/01/18     27,732,823  
    29,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR – 0.25%, 2.09%, due 10/18/18     29,000,817  
    13,880,000     Federal Home Loan Banks, Variable Rate, 1 mo. USD LIBOR – .09%, 1.98%, due 01/14/19     13,880,920  
    55,520,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR – .16%, 2.18%, due 01/28/19     55,548,963  
    9,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR – 0.23%, 2.11%, due 02/13/19     9,000,769  
    13,880,000     Federal Home Loan Banks, Variable Rate, 1 mo. USD LIBOR – .08%, 1.99%, due 04/26/19     13,880,723  
    19,500,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR – 0.19%, 2.16%, due 05/10/19     19,506,638  
    15,000,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR – 0.16%, 2.17%, due 06/12/19     15,008,036  
    75,000,000     Federal Home Loan Banks, Variable Rate, 1 mo. USD LIBOR – 0.09%, 1.98%, due 07/12/19     74,993,262  
    15,500,000     Federal Home Loan Banks, Variable Rate, 1 mo. USD LIBOR – 0.07%, 2.00%, due 01/23/20     15,494,024  
    30,530,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR – 0.16%, 2.18%, due 02/07/20     30,534,918  
     Par Value† /
Shares
    Description   Value ($)  
    United States — continued

 

          U.S. Government Agency — continued  
    44,410,000     Federal Home Loan Banks, Variable Rate, 3 mo. USD LIBOR – .23%, 2.11%, due 05/04/20     44,384,861  
     

 

 

 
    Total U.S. Government Agency     348,966,754  
     

 

 

 
    Total United States     1,117,531,892  
     

 

 

 
    TOTAL DEBT OBLIGATIONS
(COST $1,117,596,937)
    1,117,531,892  
     

 

 

 
    SHORT-TERM INVESTMENTS — 35.8%

 

    Foreign Government Obligation — 1.0%

 

JPY

    1,911,000,000     Japan Treasury Discount Bill, Zero Coupon, due 11/26/18     17,204,641  
     

 

 

 
   

Total Foreign Government Obligations

    17,204,641  
     

 

 

 
    Money Market Funds — 2.1%

 

    6,345,378     SSgA USD Liquidity Fund-Class S2 Shares (a)     6,345,378  
    29,610,205     State Street Institutional Treasury Plus Money Market Fund-Premier Class, 1.88% (c)     29,610,205  
     

 

 

 
    Total Money Market Funds     35,955,583  
     

 

 

 
    U.S. Government — 32.7%

 

    9,000,000     U.S. Treasury Bill, 1.84%, due 10/18/18 (a) (d)     8,978,220  
    57,000,000     U.S. Treasury Bill, 1.88%, due 10/25/18 (a) (d)     56,839,307  
    71,500,000     U.S. Treasury Bill, 1.96%, due 11/08/18 (a) (b) (d)     71,236,642  
    11,686,400     U.S. Treasury Bill, 0.64%, due 09/06/18 (d)     11,685,175  
    14,500,000     U.S. Treasury Bill, 1.34%, due 09/13/18 (a) (d)     14,493,085  
    11,000,000     U.S. Treasury Bill, 1.55%, due 09/20/18 (a) (d)     10,990,662  
    34,976,000     U.S. Treasury Bill, 1.65%, due 09/27/18 (d)     34,933,487  
    71,284,700     U.S. Treasury Bill, 1.73%, due 10/04/18 (a) (d)     71,169,753  
    136,573,100     U.S. Treasury Bill, 1.80%, due 10/11/18 (d)     136,297,631  
    56,000,000     U.S. Treasury Bill, 2.10%, due 01/03/19 (a) (d)     55,600,498  
    9,438,000     U.S. Treasury Bill, 2.18%, due 01/31/19 (d)     9,352,648  
    23,872,500     U.S. Treasury Bill, 2.18%, due 02/07/19 (d)     23,646,338  
 

 

  See accompanying notes to the financial statements.   81


GMO SGM Major Markets Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Par Value†         
Description
  Value ($)  
    U.S. Government — continued

 

    55,517,500     U.S. Treasury Note, 1.00%, due 11/30/18     55,369,707  
     

 

 

 
    Total U.S. Government     560,593,153  
     

 

 

 
   

TOTAL SHORT-TERM INVESTMENTS

(COST $613,677,979)

    613,753,377  
     

 

 

 
    TOTAL INVESTMENTS — 101.0%
(Cost $1,731,274,916)
    1,731,285,269  
    Other Assets and Liabilities (net) — (1.0%)     (16,495,358
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $1,714,789,911  
     

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Forward Currency Contracts

 

Settlement
Date
 

Counter-
party

  Currency
Sold
    Currency
Purchased
    Net
Unrealized
Appreciation
(Depreciation) ($)
 
09/19/2018   SSB     AUD       102,750,000       USD       75,897,829       2,032,504  
10/16/2018   UBS     AUD       79,774,269       USD       58,004,270       653,543  
10/22/2018   UBS     AUD       157,162,355       USD       114,111,657       1,122,009  
11/16/2018   MSCI     AUD       70,000,000       USD       50,879,360       547,492  
09/24/2018   MSCI     CHF       85,373,867       USD       85,768,832       (2,455,763
09/25/2018   UBS     CHF       57,000,000       USD       57,618,127       (1,290,301
10/22/2018   UBS     CHF       99,690,828       USD       101,005,925       (2,270,735
10/29/2018   DB     CHF       44,882,135       USD       45,869,710       (656,201
10/22/2018   UBS     EUR       124,456,632       USD       142,237,129       (2,745,264
11/20/2018   MSCI     EUR       110,000,000       USD       125,944,500       (2,486,926
09/20/2018   SSB     GBP       95,120,889       USD       121,216,829       (2,175,386
09/18/2018   JPM     JPY       300,000,000       USD       2,729,889       27,512  
11/26/2018   BCLY     JPY       1,911,000,000       USD       17,315,760       16,126  
09/17/2018   SSB     NZD       109,830,399       USD       74,327,173       1,663,605  
09/11/2018   JPM     USD       1,745,917       CAD       2,275,578       (1,979
09/11/2018   MSCI     USD       27,486,095       CAD       35,952,915       67,200  
09/18/2018   DB     USD       16,079,651       JPY       1,803,847,369       169,267  
09/19/2018   JPM     USD       15,791,814       AUD       21,474,796       (353,928
09/19/2018   MSCI     USD       10,486,103       AUD       14,374,796       (152,293
09/24/2018   JPM     USD       2,069,799       CHF       2,000,000       (3,017
09/28/2018   UBS     USD       16,360,221       JPY       1,808,720,583       (55,553
10/09/2018   DB     USD       1,745,336       JPY       194,098,149       5,758  
10/22/2018   MSCI     USD       60,855,453       JPY       6,717,346,597       (196,122
10/22/2018   SSB     USD       60,882,755       JPY       6,717,346,597       (223,425
           

 

 

 
            $ (8,761,877
           

 

 

 

Futures Contracts

 

Number

of

Contracts +

 

Type

  Expiration
Date
  Notional
Amount ($)
    Value/Net
Unrealized
Appreciation
(Depreciation) ($)
 
Buys  
837   Australian Government Bond 10 Yr.   September 2018     79,049,942       1,799,492  
1,705   CAC40 10 Euro   September 2018     107,309,513       276,610  
1,222   Crude Oil (a)   September 2018     85,295,600       3,282,046  
17   DAX Index   September 2018     6,103,823       2,177  
3,653   FTSE 100 Index   September 2018     353,289,421       (8,683,011
871   Hang Seng Index   September 2018     154,162,449       (1,896,827
5,076   Mini MSCI Emerging Markets   September 2018     267,733,620       (16,923,878
246   MSCI Singapore   September 2018     6,521,395       (71,363
776   SPI 200   September 2018     88,629,193       2,776,238  
72   TOPIX   September 2018     11,246,641       (8,530
446   U.S. Treasury Note 10 Yr. (CBT)   December 2018     53,638,469       (45,975
     

 

 

   

 

 

 
      $ 1,212,980,066     $ (19,493,021
     

 

 

   

 

 

 
Sales        
1,309   Corn (a)   December 2018     23,889,250       2,222,803  
13   Euro Bund   September 2018     2,469,540       (9,777
915   FTSE/JSE TOP 40   September 2018     32,587,520       (838,567
251   Japanese Government Bond 10 Yr. (OSE)   September 2018     340,399,161       595,948  
2,955   S&P 500 E-Mini   September 2018     428,785,275       (17,462,549
70   Silver (a)   December 2018     5,094,950       78,056  
1,014   UK Gilt Long Bond   December 2018     161,224,395       (64,458
     

 

 

   

 

 

 
      $ 994,450,091     $ (15,478,544
     

 

 

   

 

 

 

 

+

Buys - Fund is long the futures contract.

 

 

Sales - Fund is short the futures contract.

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

82   See accompanying notes to the financial statements.  


GMO SGM Major Markets Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

(a)

All or a portion of this security or derivative is owned by GMO Alternative Asset SPC Ltd., which is a 100% owned subsidiary of GMO SGM Major Markets Fund.

 

(b)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(c)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(d)

The rate shown represents yield-to-maturity.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

  See accompanying notes to the financial statements.   83


GMO Special Opportunities Fund

(A Series of GMO Trust)

Consolidated Investment Concentration Summary (a)

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    73.6

Short-Term Investments

    26.3  

Written Options

    (0.1

Other

    0.2  
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary¤   Debt Obligations as a
% of Total Net Assets
 

United States

    1.2
 

 

 

 
    1.2 % 
 

 

 

 
 
Country/Region Summary¤   Equity Investments
% of Total Net Assets
 

United States

    57.6

United Kingdom

    7.2  

Netherlands

    4.8  

Germany

    4.0  

Other Developed

    0.0 ‡ 
 

 

 

 
    73.6 % 
 

 

 

 
 
Industry Group Summary   % of Equity Investments#  

Diversified Financials

    27.3

Retailing

    21.8  

Automobiles & Components

    10.0  

Banks

    9.8  

Commercial & Professional Services

    9.4  

Software & Services

    6.4  

Capital Goods

    5.5  

Real Estate

    5.2  

Consumer Services

    4.6  

Energy

    0.0
 

 

 

 
    100.0 % 
 

 

 

 
(a)

GMO Special Opportunities SPC Ltd. is a 100% owned subsidiary of GMO Special Opportunities Fund. As such, the holdings of GMO Special Opportunities SPC Ltd. have been included with GMO Special Opportunities Fund.

 

&

In the table above, derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table excludes short-term investments. The table includes exposure through the use of certain derivative financial instruments and excludes exposure through certain currency linked derivatives such as forward currency contracts and currency options. The table is based on duration adjusted net exposures (both investments and derivatives), taking into account the market value of securities and the notional amounts of swaps and other derivative financial instruments. For example, U.S. asset-backed securities may represent a relatively small percentage due to their short duration, even though they represent a large percentage of market value (direct and indirect). Duration is based on GMO’s models. The greater the duration of a bond, the greater its contribution to the concentration percentage. Credit default swap exposures are factored into the duration adjusted exposure using the reference security and applying the same methodology to that security. The tables are not normalized, thus, due to the exclusions listed above and negative exposures, which may be attributable to derivatives or short sales, if any, the tables may not total to 100%.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Total Net Assets.

 

#

Equity investments may consist of common stocks and other stock-related securities, such as preferred stocks, if any. This table excludes exposure to derivative contracts, short-term investments, mutual funds and investment funds, if any. For a summary of these exposures, if any, see the Schedule of Investments.

 

^

Rounds to 0.0%.

 

 

84


GMO Special Opportunities Fund

(A Series of GMO Trust)

Consolidated Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares         
Description
  Value ($)  
    COMMON STOCKS — 73.6%

 

    Canada — 0.0%

 

    6,000,000     Jagercor Energy Corp * (a) (b)     45,977  
     

 

 

 
    Germany — 4.0%

 

    302,500     Brenntag AG     18,234,282  
     

 

 

 
    Netherlands — 4.8%

 

    325,000     InterXion Holding NV *     21,427,250  
     

 

 

 
    United Kingdom — 7.2%

 

    905,000     Metro Bank Plc *     32,732,492  
     

 

 

 
    United States — 57.6%

 

    710,000     Ally Financial, Inc.     19,084,800  
    94,500     Berkshire Hathaway, Inc. – Class B *     19,724,040  
    223,800     Cimpress NV *     31,332,000  
    46,500     Credit Acceptance Corp. *     21,237,015  
    920,000     General Motors Co.     33,166,000  
    498,772     Interactive Brokers Group, Inc. – Class A     31,003,668  
    865,000     Redfin Corp. * (c)     17,135,650  
    255,000     Shake Shack, Inc. – Class A *     15,414,750  
    536,066     Wayfair, Inc. – Class A *     72,460,041  
     

 

 

 
    Total United States     260,557,964  
     

 

 

 
    TOTAL COMMON STOCKS
(COST $216,949,506)
    332,997,965  
     

 

 

 
     Shares /
Par Value†
    Description   Value ($)  
    SHORT-TERM INVESTMENTS — 26.3%

 

    Money Market Funds — 2.7%

 

    12,399,578     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (d) (e)     12,399,578  
     

 

 

 
    U.S. Government — 23.6%

 

    9,000,000     U.S. Treasury Bill, 1.84%, due 10/18/18 (f)     8,978,220  
    46,000,000     U.S. Treasury Bill, 1.96%, due 11/08/18 (f) (g)     45,830,567  
    52,000,000     U.S. Treasury Bill, 2.03%, due 12/13/18 (f)     51,700,277  
     

 

 

 
    Total U.S. Government     106,509,064  
     

 

 

 
    TOTAL SHORT-TERM INVESTMENTS (COST $118,902,976)     118,908,642  
     

 

 

 
    TOTAL INVESTMENTS — 99.9%
(Cost $335,852,482)
    451,906,607  
    Other Assets and Liabilities (net) — 0.1%     441,172  
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $452,347,779  
     

 

 

 

 

 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Written Options

Equity Options

 

Description      Exercise
Price
       Expiration
Date
       Number of
Contracts
       Notional
Amount
       Value ($)  

Equity Options — Puts

                          

Redfin Corp. (c)

       17.50          11/16/18          (2,300        USD       4,556,300          (184,000

Redfin Corp. (c)

       19.00          09/21/18          (1,000        USD       1,981,000          (45,000
                          

 

 

 
      
TOTAL WRITTEN EQUITY OPTIONS – PUTS
(Premiums $369,592)

 
     $ (229,000
                          

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

*

Non-income producing security.

 

(a)

Investment valued using significant unobservable inputs (Note 2).

 

(b)

Affiliated company (Note 10).

 

(c)

All or a portion of this investment is held in connection with one or more holdings within the Fund.

 

(d)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(e)

All or a portion of this security is owned by GMO Special Opportunities SPC Ltd., which is a 100% owned subsidiary of GMO Special Opportunities Fund.

(f)

The rate shown represents yield-to-maturity.

 

(g)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

 

  See accompanying notes to the financial statements.   85


GMO Strategic Opportunities Allocation Fund

(A Series of GMO Trust)

Investment Concentration Summary

August 31, 2018 (Unaudited)

 

Asset Class Summary&   % of Total Net Assets  

Common Stocks

    70.5

Debt Obligations

    20.6  

Short-Term Investments

    9.6  

Mutual Funds

    1.6  

Preferred Stocks

    0.7  

Investment Funds

    0.5  

Swap Contracts

    0.1  

Loan Participations

    0.0

Rights/Warrants

    0.0

Forward Currency Contracts

    0.0

Purchased Options

    0.0

Loan Assignments

    0.0

Written/Credit Linked Options

    0.0

Reverse Repurchase Agreements

    (0.0 )^ 

Futures Contracts

    (0.1

Securities Sold Short

    (2.2

Other

    (1.3
 

 

 

 
    100.0 % 
 

 

 

 
 
Country/Region Summary¤   Debt Obligations as a
% of Total Net Assets
 

United States

    14.3

Other Emerging

    2.4 † 

Euro Region

    0.0 ^# 

Other Developed

    (0.1 )‡ 
 

 

 

 
    16.6 % 
 

 

 

 
 
Country/Region Summary¤   Equity Investments as a
% of Total Net Assets
 

United States

    19.9

Japan

    7.5  

Other Emerging

    5.2 † 

United Kingdom

    5.0  

Taiwan

    4.8  

China

    4.6  

Germany

    3.4  

Russia

    3.1  

Other Developed

    2.9 ‡ 

France

    2  

Switzerland

    1.8  

South Korea

    1.7  

Sweden

    1.6  

Italy

    1.3  

Australia

    1.3  

Thailand

    1.3  

South Africa

    1.1  

Norway

    1.0  
 

 

 

 
    69.5 % 
 

 

 

 
&

The table above incorporates aggregate indirect asset class exposure associated with investments in other funds of GMO Trust (“underlying funds”). Derivative financial instruments, if any, are based on market values or unrealized appreciation/depreciation, in the case of forward currency contracts, rather than notional amounts.

 

¤

The table above incorporates aggregate indirect country exposure associated with investments in the underlying funds. The table excludes short-term investments. The table includes exposure through the use of certain derivative financial instruments and excludes exposure through certain currency linked derivatives such as forward currency contracts and currency options. The table is based on duration adjusted net exposures (both investments and derivatives), taking into account the market value of securities and the notional amounts of swaps and other derivative financial instruments. For example, U.S. asset-backed securities may represent a relatively small percentage due to their short duration, even though they represent a large percentage of market value (direct and indirect). Duration is based on GMO’s models. The greater the duration of a bond, the greater its contribution to the concentration percentage. Credit default swap exposures are factored into the duration-adjusted exposure using the reference security and applying the same methodology to that security. The tables are not normalized, thus, due to the exclusions listed above and negative exposures, which may be attributable to derivatives or short sales, if any, the tables may not total to 100%.

 

“Other Emerging” is comprised of emerging countries that each represent between (1.0)% and 1.0% of Total Net Assets.

 

#

“Euro Region” is comprised of derivative financial instruments attributed to the Eurozone and not a particular country.

 

“Other Developed” is comprised of developed countries that each represent between (1.0)% and 1.0% of Total Net Assets.

 

^

Rounds to 0.0%.

 

 

86


GMO Strategic Opportunities Allocation Fund

(A Series of GMO Trust)

Schedule of Investments

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares         
Description
  Value ($)  
    COMMON STOCKS — 9.8%

 

    Australia — 0.1%

 

    11,400     Caltex Australia Ltd     247,725  
    15,100     Costa Group Holdings Ltd     78,606  
    29,870     Downer EDI Ltd     166,175  
    2,400     Macquarie Group Ltd     224,480  
    9,804     Mineral Resources Ltd     106,794  
    65,069     Nine Entertainment Co Holdings Ltd     113,059  
    15,300     OZ Minerals Ltd     99,478  
    15,200     Sandfire Resources NL     77,507  
     

 

 

 
    Total Australia     1,113,824  
     

 

 

 
    Austria — 0.0%

 

    600     Oesterreichische Post AG     26,513  
    4,007     OMV AG     212,439  
     

 

 

 
    Total Austria     238,952  
     

 

 

 
    Belgium — 0.0%

 

    4,800     AGFA-Gevaert NV *     21,079  
    700     Orange Belgium SA     10,581  
     

 

 

 
    Total Belgium     31,660  
     

 

 

 
    Brazil — 0.2%

 

    132,900     Banco do Brasil SA     982,124  
    39,300     Banco Santander Brasil SA     333,844  
    72,100     Cia de Saneamento Basico do Estado de Sao Paulo     431,917  
    12,700     Estacio Participacoes SA     70,280  
    66,500     JBS SA     153,470  
    22,600     Localiza Rent a Car SA     119,461  
    16,700     Petrobras Distribuidora SA     81,100  
     

 

 

 
    Total Brazil     2,172,196  
     

 

 

 
    Canada — 0.3%

 

    9,400     Bank of Montreal     770,512  
    300     Bank of Nova Scotia (The)     17,363  
    1,900     BRP Inc Sub Voting     99,179  
    3,100     Canadian Imperial Bank of Commerce     290,521  
    800     Canfor Pulp Products Inc     16,779  
    300     Constellation Software Inc     228,756  
    4,800     Dollarama Inc     181,517  
    4,600     Magna International Inc     249,070  
    3,300     Royal Bank of Canada     262,129  
    1,700     Sun Life Financial Inc     67,558  
    9,900     Toronto-Dominion Bank (The)     596,655  
     

 

 

 
    Total Canada     2,780,039  
     

 

 

 
    China — 0.4%

 

    100,000     Agile Group Holdings Ltd     163,558  
    2,411,000     Agricultural Bank of China Ltd – Class H     1,168,313  
    85,500     BAIC Motor Corp Ltd – Class H     71,936  
    36,000     China Communications Services Corp Ltd – Class H     29,826  
    14,000     China Lilang Ltd     15,529  
     Shares         
Description
  Value ($)  
    China — continued  
    1,544,000     China Petroleum & Chemical Corp – Class H     1,553,552  
    71,000     China Resources Pharmaceutical Group Ltd     113,620  
    34,000     China Shineway Pharmaceutical Group Ltd     48,048  
    120,000     Chongqing Rural Commercial Bank Co Ltd – Class H     64,726  
    8,000     Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd – Class H     29,475  
    165,200     Guangzhou R&F Properties Co Ltd – Class H     333,849  
    26,000     Hua Hong Semiconductor Ltd     70,990  
    7,000     JNBY Design Ltd     11,928  
    23,000     Kingboard Holdings Ltd     81,878  
    24,000     Powerlong Real Estate Holdings Ltd     12,274  
    9,000     Shanghai Pharmaceuticals Holding Co Ltd – Class H     23,641  
    101,000     Shimao Property Holdings Ltd     301,623  
    44,000     SSY Group Ltd     40,939  
    50,000     Tianneng Power International Ltd     62,149  
    27,000     XTEP International Holdings Ltd     18,040  
    4,600     YiChang HEC ChangJiang Pharmaceutical Co Ltd – Class H     21,094  
    113,000     Yuzhou Properties Co Ltd     60,132  
     

 

 

 
    Total China     4,297,120  
     

 

 

 
    Denmark — 0.0%

 

    2,200     Novo Nordisk A/S Sponsored ADR     108,174  
    4,900     Novo Nordisk A/S – Class B     241,208  
     

 

 

 
    Total Denmark     349,382  
     

 

 

 
    France — 0.2%

 

    1,240     Christian Dior SE     535,004  
    5,500     CNP Assurances     127,120  
    1,868     Coface SA     17,526  
    200     L’Oreal SA     47,881  
    2,700     Metropole Television SA     53,457  
    1,200     Sanofi     103,048  
    2,000     Sanofi ADR(a)     85,700  
    17,200     STMicroelectronics NV – NY Shares (Registered)     355,868  
    19,000     STMicroelectronics NV     392,019  
     

 

 

 
    Total France     1,717,623  
     

 

 

 
    Germany — 0.3%

 

    5,481     Allianz SE (Registered)     1,168,230  
    1,100     BASF SE     101,646  
    6,490     Bayerische Motoren Werke AG     628,276  
    228     Bechtle AG     23,746  
    1,500     Covestro AG     127,712  
    4,975     Daimler AG (Registered Shares)     321,735  
    22,600     Deutsche Lufthansa AG (Registered)     590,483  
    500     Deutsche Pfandbriefbank AG     7,319  
    100     Henkel AG & Co KGaA     11,158  
    400     Jenoptik AG     15,737  
    1,600     RHOEN-KLINIKUM AG     42,016  
    900     Software AG     44,382  
 

 

  See accompanying notes to the financial statements.   87


GMO Strategic Opportunities Allocation Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares         
Description
  Value ($)  
    Germany — continued  
    1,100     Volkswagen AG     177,066  
     

 

 

 
    Total Germany     3,259,506  
     

 

 

 
    Hong Kong — 0.1%

 

    22,600     Champion (REIT)     16,623  
    1,900     CK Asset Holdings Ltd     13,550  
    18,500     Dah Sing Banking Group Ltd     38,158  
    3,600     Dah Sing Financial Holdings Ltd     22,391  
    19,400     Hysan Development Co Ltd     99,547  
    21,400     Kerry Properties Ltd     81,156  
    7,200     Luk Fook Holdings International Ltd     25,054  
    12,700     Pacific Textiles Holdings Ltd     9,630  
    111,400     SJM Holdings Ltd     126,128  
    348,600     WH Group Ltd     263,273  
    26,900     Wharf Holdings Ltd (The)     76,820  
    17,600     Wharf Real Estate Investment Co Ltd     116,773  
    13,400     Wheelock & Co Ltd     84,140  
    8,500     Yue Yuen Industrial Holdings Ltd     23,564  
     

 

 

 
    Total Hong Kong     996,807  
     

 

 

 
    India — 0.1%

 

    47,300     Infosys Ltd Sponsored ADR (a)     982,421  
     

 

 

 
    Ireland — 0.0%

 

    300     ICON Plc *     44,706  
     

 

 

 
    Italy — 0.2%

 

    53,300     Enel SPA     263,512  
    16,043     EXOR NV     1,043,904  
    39,800     Fiat Chrysler Automobiles NV * (b)     680,978  
    4,900     Hera SPA     15,372  
    31,625     Iren SPA     74,173  
    13,000     Societa Cattolica di Assicurazioni SC     105,505  
     

 

 

 
    Total Italy     2,183,444  
     

 

 

 
    Japan — 1.0%

 

    1,100     Alpine Electronics Inc     24,424  
    600     AOKI Holdings Inc     8,093  
    36,900     Asahi Kasei Corp     540,715  
    94,000     Astellas Pharma Inc     1,593,638  
    15,700     Brother Industries Ltd     322,075  
    4,400     Capcom Co Ltd     102,554  
    1,100     Central Japan Railway Co     220,855  
    1,600     CKD Corp     23,633  
    1,400     Cosmo Energy Holdings Co Ltd     51,584  
    900     Daiwabo Holdings Co Ltd     53,671  
    2,600     Denka Co Ltd     88,970  
    500     Denso Corp     24,091  
    1,200     Fancl Corp     61,643  
    14,000     Fuji Electric Co Ltd     112,776  
     Shares         
Description
  Value ($)  
    Japan — continued  
    2,900     Fuji Media Holdings Inc     49,818  
    200     Fuyo General Lease Co Ltd     12,005  
    1,300     Geo Holdings Corp     18,908  
    3,700     Hakuhodo DY Holdings Inc     62,425  
    2,100     Hanwa Co Ltd     70,791  
    100,300     Hitachi Ltd (b)     654,715  
    1,600     House Foods Group Inc     47,436  
    53,500     ITOCHU Corp     934,851  
    1,300     Kakaku.com Inc     24,005  
    1,400     Kanematsu Corp     20,763  
    800     Keihin Corp     16,812  
    400     Kohnan Shoji Co Ltd     9,224  
    1,700     Kose Corp     313,452  
    400     Mandom Corp     12,015  
    52,100     Marubeni Corp     426,879  
    83,900     Mitsubishi Chemical Holdings Corp     751,722  
    18,500     Mitsubishi Electric Corp     249,740  
    6,400     Mitsubishi Gas Chemical Co Inc     133,042  
    4,400     Mitsui Chemicals Inc     113,719  
    700     Modec Inc     21,185  
    3,300     NET One Systems Co Ltd     76,433  
    2,700     Nichias Corp     35,099  
    18,800     Nippon Telegraph & Telephone Corp (b)     836,430  
    2,300     Nippon Television Holdings Inc     38,049  
    900     Nishi-Nippon Financial Holdings Inc     10,468  
    225     Okinawa Electric Power Co (The)     4,522  
    1,900     Pola Orbis Holdings Inc     66,959  
    10,900     Prima Meat Packers Ltd     54,109  
    800     Rengo Co Ltd     6,864  
    3,300     Rohto Pharmaceutical Co Ltd     105,421  
    800     Seiko Holdings Corp     22,370  
    13,500     Sekisui Chemical Co Ltd     234,524  
    600     Showa Denko KK (b)     28,498  
    5,500     SKY Perfect JSAT Holdings Inc     26,032  
    106,000     Sojitz Corp     368,866  
    80,900     Sumitomo Chemical Co Ltd     459,173  
    1,100     Sumitomo Heavy Industries Ltd     35,791  
    400     Sushiro Global Holdings Ltd *     22,736  
    1,200     T-Gaia Corp     31,579  
    1,800     Tokyo Electron Ltd     306,450  
    1,800     Tosoh Corp     28,242  
    400     Towa Pharmaceutical Co Ltd     27,844  
    9,200     Toyota Tsusho Corp     313,423  
    2,000     TS Tech Co Ltd     75,462  
    3,700     Ube Industries Ltd     94,144  
    1,700     Valor Holdings Co Ltd     36,063  
    800     Yamaha Motor Co Ltd (b)     20,263  
    4,900     Zeon Corp     52,525  
     

 

 

 
    Total Japan     10,590,568  
     

 

 

 
 

 

88   See accompanying notes to the financial statements.  


GMO Strategic Opportunities Allocation Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares         
Description
  Value ($)  
    Malaysia — 0.0%

 

    56,100     Top Glove Corp Berhad     152,000  
     

 

 

 
    Malta — 0.0%

 

    125,500     BGP Holdings Plc * (c)      
     

 

 

 
    Mexico — 0.0%

 

    4,100     Megacable Holdings SAB de CV CPO     19,325  
     

 

 

 
    Netherlands — 0.0%

 

    1,300     Heineken Holding NV     124,038  
     

 

 

 
    New Zealand — 0.0%

 

    4,300     Air New Zealand Ltd     9,387  
     

 

 

 
    Norway — 0.1%

 

    533     Aker ASA – A Shares     41,760  
    2,513     Austevoll Seafood ASA     33,067  
    1,100     Bakkafrost P/F     62,755  
    18,500     DNB ASA     376,105  
    23,082     Equinor ASA     592,058  
    6,839     Storebrand ASA     60,545  
     

 

 

 
    Total Norway     1,166,290  
     

 

 

 
    Poland — 0.0%

 

    3,912     Cyfrowy Polsat SA *     23,724  
     

 

 

 
    Portugal — 0.0%

 

    1,100     Altri SGPS SA     10,144  
    1,400     Navigator Co SA (The)     6,995  
     

 

 

 
    Total Portugal     17,139  
     

 

 

 
    Singapore — 0.0%

 

    3,300     Venture Corp Ltd     43,567  
     

 

 

 
    South Africa — 0.1%

 

    49,002     Absa Group Ltd     541,969  
    5,509     Bidvest Group Ltd (The)     80,957  
    6,061     Foschini Group Ltd (The)     72,007  
    3,798     Liberty Holdings Ltd     30,049  
    9,418     Mr Price Group Ltd     144,378  
    2,740     Reunert Ltd     14,194  
    4,273     Standard Bank Group Ltd     54,158  
     

 

 

 
    Total South Africa     937,712  
     

 

 

 
    South Korea — 0.1%

 

    1,962     LG Corp     126,045  
    4,442     LG Electronics Inc     306,243  
    473     Samsung SDS Co Ltd     103,066  
    4,784     SK Hynix Inc     356,790  
    19,000     SK Telecom Co Ltd Sponsored ADR     494,190  
     

 

 

 
    Total South Korea     1,386,334  
     

 

 

 
     Shares         
Description
  Value ($)  
    Spain — 0.0%

 

    2,550     Ebro Foods SA     54,870  
    900     Ence Energia y Celulosa SA     8,441  
    8,800     International Consolidated Airlines Group SA     78,988  
     

 

 

 
    Total Spain     142,299  
     

 

 

 
    Sweden — 0.3%

 

    3,869     Granges AB     45,321  
    1,000     Kindred Group Plc SDR     12,298  
    427     Nolato AB – B Shares     30,166  
    22,366     Sandvik AB     391,509  
    98,646     Svenska Cellulosa AB SCA – Class B     1,148,359  
    5,623     Swedish Match AB     300,597  
    47,048     Volvo AB – B Shares     810,491  
    800     Wihlborgs Fastigheter AB     9,649  
     

 

 

 
    Total Sweden     2,748,390  
     

 

 

 
    Switzerland — 0.0%

 

    100     Autoneum Holding AG     23,763  
    270     BKW AG     19,152  
    100     Bucher Industries AG (Registered)     35,039  
    2,200     GAM Holding AG*     16,989  
    100     Georg Fischer AG (Registered)     130,890  
    255     Novartis AG (Registered)     21,155  
    396     Roche Holding AG     99,287  
    400     Vontobel Holding AG (Registered)     28,542  
     

 

 

 
    Total Switzerland     374,817  
     

 

 

 
    Taiwan — 0.2%

 

    57,000     Gigabyte Technology Co Ltd     97,258  
    184,000     Hon Hai Precision Industry Co Ltd     483,375  
    270,000     Inventec Corp     242,337  
    59,000     Micro-Star International Co Ltd     203,953  
    87,000     Novatek Microelectronics Corp     426,586  
    127,000     Pou Chen Corp     140,030  
    44,000     Synnex Technology International Corp     58,891  
     

 

 

 
    Total Taiwan     1,652,430  
     

 

 

 
    Thailand — 0.0%

 

    56,500     Home Product Center PCL NVDR     25,198  
     

 

 

 
    United Kingdom — 0.5%

 

    34,305     3i Group Plc     399,453  
    36     AstraZeneca Plc     2,717  
    1,417     Barratt Developments Plc     9,969  
    1,264     Bellway Plc     47,886  
    5,967     Berkeley Group Holdings Plc (The)     282,246  
    11,739     British American Tobacco Plc     567,666  
    8,108     Coca-Cola HBC AG *     277,619  
    2,891     Computacenter Plc     50,833  
    500     Diageo Plc Sponsored ADR(a)     69,705  
 

 

  See accompanying notes to the financial statements.   89


GMO Strategic Opportunities Allocation Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares         
Description
  Value ($)  
    United Kingdom — continued  
    9,245     Electrocomponents Plc     89,112  
    27,481     Ferrexpo Plc     55,473  
    35,096     Firstgroup Plc *     40,507  
    3,258     Galliford Try Plc     41,088  
    54,407     GlaxoSmithKline Plc     1,101,898  
    1,100     GlaxoSmithKline Plc Sponsored ADR     44,550  
    2,638     Hunting Plc *     28,575  
    28,954     IG Group Holdings Plc     339,996  
    8,176     Inchcape Plc     73,449  
    20,370     Indivior Plc *     71,616  
    3,195     National Express Group Plc     16,427  
    157     Next Plc     11,210  
    3,700     Nomad Foods Ltd *     77,145  
    35,248     Persimmon Plc     1,115,139  
    15,478     Plus500 Ltd     309,221  
    2,251     Royal Mail Plc     13,090  
    1,033     Spectris Plc     31,581  
    2,809     Vesuvius Plc     22,630  
    206     Victrex Plc     8,469  
     

 

 

 
    Total United Kingdom     5,199,270  
     

 

 

 
    United States — 5.6%

 

    3,100     AbbVie, Inc. (b)     297,538  
    25,700     ACCO Brands Corp. (b)     318,680  
    9,300     Activision Blizzard, Inc.     670,530  
    3,900     Acushnet Holdings Corp. (a)     105,495  
    7,600     Adobe Systems, Inc. * (b)     2,002,676  
    1,600     Adtalem Global Education, Inc. * (a)     76,560  
    200     Aflac, Inc.     9,248  
    1,600     Allstate Corp. (The)     160,912  
    500     Alphabet, Inc. – Class C *     609,095  
    3,200     American Eagle Outfitters, Inc.     83,072  
    400     American Express Co.     42,392  
    200     American National Insurance Co.     25,668  
    5,300     Ameriprise Financial, Inc. (a) (b)     752,388  
    1,100     Andeavor (a)     168,069  
    1,350     Apergy Corp. * (a)     61,047  
    4,000     Apple Hospitality REIT, Inc. (a)     70,600  
    600     Apple, Inc.     136,578  
    800     Applied Industrial Technologies, Inc.     61,640  
    2,000     Arrow Electronics, Inc. * (a)     155,060  
    6,000     Avery Dennison Corp. (b)     631,080  
    23,600     Baxter International, Inc.     1,755,132  
    4,000     BGC Partners, Inc. – Class A (a)     49,680  
    1,200     Boise Cascade Co. (a)     52,440  
    4,200     BorgWarner, Inc.     183,834  
    1,500     Brady Corp. – Class A     60,675  
    1,500     Briggs & Stratton Corp. (b)     30,240  
    7,600     Bristol-Myers Squibb Co.     460,180  
    2,300     Bruker Corp.     81,834  
    4,100     Brunswick Corp.     272,322  
    4,500     CA, Inc.     197,100  
     Shares         
Description
  Value ($)  
    United States — continued  
    200     Cabot Microelectronics Corp. (a)     22,546  
    6,300     Cadence Design Systems, Inc. *     296,352  
    3,700     Callaway Golf Co.     84,397  
    2,700     Caterpillar, Inc.     374,895  
    13,000     CBRE Group, Inc. – Class A *     634,530  
    300     Central Garden & Pet Co. *     11,910  
    6,000     Citizens Financial Group, Inc.     246,960  
    2,800     CNO Financial Group, Inc.     60,508  
    3,200     Columbia Sportswear Co.     290,240  
    1,000     Cooper-Standard Holding, Inc. *     138,430  
    9,800     CoreCivic, Inc. (REIT)     253,722  
    1,300     CSG Systems International, Inc. (a)     48,555  
    2,200     Cummins, Inc. (a)     311,960  
    2,700     Curo Group Holdings Corp. *     83,322  
    43,500     Dana, Inc. (a)     851,295  
    16,100     Danaher Corp. (b)     1,666,994  
    900     Deluxe Corp. (a)     53,298  
    1,900     E*TRADE Financial Corp. *     111,834  
    1,900     Eastman Chemical Co. (a)     184,357  
    2,600     eBay, Inc. *     89,986  
    22,300     Eli Lilly & Co. (a) (b)     2,355,995  
    400     EMCOR Group, Inc.     32,040  
    7,300     Enova International, Inc. *     242,360  
    12,700     Estee Lauder Cos, Inc. (The) – Class A     1,779,524  
    700     Exterran Corp. * (b)     19,173  
    300     Federal Agricultural Mortgage Corp. – Class C (a)     23,121  
    2,600     Federated Investors, Inc. – Class B (a)     60,216  
    7,200     Fidelity National Financial, Inc.     288,720  
    6,700     First American Financial Corp. (b)     380,962  
    10,300     Gannett Co., Inc. (a)     105,884  
    5,200     Gap Inc. (The) (a)     157,820  
    2,400     Garmin Ltd. (a)     163,536  
    14,300     General Motors Co. (a)     515,515  
    2,300     GEO Group, Inc. (The) (REIT)     58,351  
    200     Graham Holdings Co. – Class B     112,530  
    700     Grand Canyon Education, Inc. * (a)     83,398  
    600     Group 1 Automotive, Inc.     46,254  
    1,800     Heidrick & Struggles International, Inc.     79,560  
    5,000     Herman Miller, Inc. (a)     191,500  
    10,100     Hewlett Packard Enterprise Co.     166,953  
    12,800     Honeywell International, Inc.     2,035,968  
    10,300     Host Hotels & Resorts, Inc. (REIT) (a)     221,759  
    74,200     HP, Inc.     1,829,030  
    52,900     Huntsman Corp. (b)     1,612,921  
    1,700     IAC/InterActiveCorp * (b)     335,240  
    600     ICF International, Inc.     48,990  
    1,000     Insight Enterprises, Inc. *     55,140  
    600     Insperity, Inc.     71,910  
    15,400     Intel Corp. (a)     745,822  
    500     Inter Parfums, Inc.     32,650  
    18,300     Interpublic Group of Cos., Inc. (The) (a)     427,305  
 

 

90   See accompanying notes to the financial statements.  


GMO Strategic Opportunities Allocation Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares         
Description
  Value ($)  
    United States — continued  
    1,400     Intuit, Inc.     307,258  
    1,700     ITT, Inc. (a)     100,487  
    300     Johnson Outdoors, Inc. – Class A     30,384  
    13,400     Johnson & Johnson (b)     1,804,846  
    1,100     Jones Lang LaSalle, Inc.     167,772  
    1,900     KB Home (a)     47,215  
    1,800     KLA-Tencor Corp. (a)     209,178  
    22,600     Kohl’s Corp.     1,787,886  
    700     Koppers Holdings, Inc. *     24,815  
    1,100     Kulicke & Soffa Industries, Inc.     28,369  
    3,200     La-Z-Boy, Inc.     106,400  
    4,500     Lear Corp.     729,900  
    5,000     Legg Mason, Inc. (a)     156,000  
    1,600     Louisiana-Pacific Corp.     46,656  
    600     ManpowerGroup, Inc.     56,238  
    10,000     Marathon Oil Corp.     215,100  
    10,200     Mastercard, Inc. – Class A (b)     2,198,712  
    400     Materion Corp.     25,520  
    2,300     McKesson Corp. (a)     296,125  
    900     MDC Holdings, Inc. (a)     28,530  
    26,800     Merck & Co., Inc. (b)     1,838,212  
    3,000     Meritor, Inc. *     64,980  
    1,000     Michaels Cos , Inc. (The) * (b)     16,990  
    37,700     Micron Technology, Inc. * (b)     1,980,004  
    11,500     Modine Manufacturing Co. *     193,775  
    1,800     Moog, Inc. – Class A     142,038  
    6,500     Movado Group, Inc.     276,900  
    3,700     Murphy Oil Corp. (b)     114,071  
    3,800     NetApp, Inc. (a)     329,878  
    2,000     Netflix, Inc. * (a)     735,360  
    1,800     New York Times Co. (The) – Class A (a)     41,940  
    1,200     Newpark Resources, Inc. *     12,600  
    18,500     News Corp. – Class A (b)     241,795  
    4,200     News Corp. – Class B     57,120  
    5,600     Old Republic International Corp.     124,208  
    8,700     Omnicom Group, Inc. (a)     603,084  
    5,200     ON Semiconductor Corp. *     110,968  
    1,600     Oshkosh Corp.     112,416  
    900     Penn National Gaming, Inc. * (a)     31,014  
    17,100     PepsiCo, Inc. (a)     1,915,371  
    58,000     Pfizer, Inc. (a) (b)     2,408,160  
    6,200     Phillips 66 (a)     734,762  
    6,400     Piedmont Office Realty Trust, Inc. – Class A (REIT) (a)     126,976  
    2,500     Popular, Inc.     125,850  
    1,000     PotlatchDeltic Corp. (REIT) (a)     48,300  
    11,800     Procter & Gamble Co. (The) (a)     978,810  
    800     Progress Software Corp. (b)     32,744  
    10,500     Progressive Corp. (The)     709,065  
    10,900     PVH Corp. (b)     1,560,444  
    9,100     Qurate Retail, Inc. * (a)     189,189  
    2,300     Raymond James Financial, Inc. (a)     213,992  
     Shares         
Description
  Value ($)  
    United States — continued  
    800     Regional Management Corp. *     26,664  
    11,800     Regions Financial Corp. (a)     229,628  
    500     Reinsurance Group of America, Inc.(b)     71,425  
    1,100     Reliance Steel & Aluminum Co.     96,679  
    700     Ryman Hospitality Properties, Inc. (REIT)     62,111  
    1,500     Scholastic Corp.     63,060  
    400     SEACOR Holdings, Inc. * (a)     20,580  
    3,000     Seagate Technology Plc (a)     160,620  
    3,100     Service Corp. International (a)     130,076  
    6,800     Shutterfly, Inc. * (a)     528,224  
    1,100     SPX Corp. *     37,389  
    4,200     State Street Corp.     365,022  
    6,100     Stoneridge, Inc. *     182,573  
    900     Sykes Enterprises, Inc. *     27,216  
    3,700     Synopsys, Inc. * (a)     377,918  
    3,400     TCF Financial Corp.     86,190  
    4,900     TE Connectivity Ltd. (b)     449,232  
    700     Tech Data Corp. * (a)     50,925  
    600     Teledyne Technologies, Inc. * (a)     142,356  
    3,800     Telephone & Data Systems, Inc. (a)     114,152  
    900     Tenneco, Inc. – Class A     38,511  
    4,700     Timken Co. (The)     228,655  
    1,600     Tower International, Inc.     54,080  
    1,900     Trinseo SA     146,585  
    2,400     Triple-S Management Corp. – Class B * (b)     52,248  
    4,200     Twenty-First Century Fox, Inc.– Class A (a)     190,680  
    500     United States Cellular Corp. * (a)     21,380  
    1,200     Universal Corp. (a)     71,760  
    1,100     Universal Forest Products, Inc.     41,206  
    1,600     Urban Outfitters, Inc. *     74,368  
    3,100     US Foods Holding Corp. *     101,029  
    42,000     Verizon Communications, Inc. (b)     2,283,540  
    2,400     Vishay Intertechnology, Inc. (a)     57,120  
    600     Visteon Corp. * (a)     66,234  
    2,800     Wolverine World Wide, Inc. (b)     109,704  
    14,600     Xenia Hotels & Resorts, Inc. (REIT) (b)     354,196  
     

 

 

 
    Total United States     61,229,746  
     

 

 

 
   

TOTAL COMMON STOCKS

(COST $104,620,106)

    106,009,914  
     

 

 

 
    PREFERRED STOCKS (d) — 0.1%  
    Germany — 0.1%  
    4,264     Henkel AG & Co KGaA     544,241  
    1,000     Volkswagen AG     163,468  
     

 

 

 
    Total Germany     707,709  
     

 

 

 
   

TOTAL PREFERRED STOCKS

(COST $747,568)

    707,709  
     

 

 

 
 

 

  See accompanying notes to the financial statements.   91


GMO Strategic Opportunities Allocation Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Par Value† /
Shares
    Description   Value ($)  
    DEBT OBLIGATIONS — 7.9%  
    United States — 7.9%  
          U.S. Government — 7.9%      
    13,307,293     U.S. Treasury Inflation Indexed Bond, 0.63%, due 04/15/23 (e)     13,227,587  
    4,639,450     U.S. Treasury Inflation Indexed Bond, 0.25%, due 01/15/25 (e)     4,495,148  
    9,065,787     U.S. Treasury Inflation Indexed Bond, 0.63%, due 01/15/26 (e)     8,971,942  
    13,779,615     U.S. Treasury Inflation Indexed Bond, 0.38%, due 01/15/27 (e)     13,322,089  
    2,314,590     U.S. Treasury Inflation Indexed Bond, 0.38%, due 07/15/27 (e)     2,240,059  
    2,557,911     U.S. Treasury Inflation Indexed Bond, 0.50%, due 01/15/28 (b) (e)     2,486,636  
    14,806,099     U.S. Treasury Inflation Indexed Bond, 1.75%, due 01/15/28 (e)     16,054,014  
    21,714,317     U.S. Treasury Inflation Indexed Bond, 2.50%, due 01/15/29 (e)     25,297,462  
     

 

 

 
    Total U.S. Government     86,094,937  
     

 

 

 
    Total United States     86,094,937  
     

 

 

 
   

TOTAL DEBT OBLIGATIONS

(COST $86,602,731)

    86,094,937  
     

 

 

 
    MUTUAL FUNDS — 84.3%

 

    United States — 84.3%

 

          Affiliated Issuers — 84.3%      
    5,388,046     GMO Core Plus Bond Fund, Class IV     114,657,625  
    1,098,695     GMO Emerging Country Debt Fund, Class IV     29,499,968  
    7,358,839     GMO Emerging Markets Fund, Class VI     236,145,133  
    11,693,640     GMO International Equity Fund, Class IV     260,300,422  
    1,141,493     GMO Opportunistic Income Fund, Class VI     30,489,283  
    4,269,297     GMO Quality Fund, Class VI     113,136,378  
    5,065,238     GMO U.S. Equity Fund, Class VI     75,016,179  
    2,287,519     GMO U.S. Treasury Fund     57,142,212  
     

 

 

 
   

TOTAL MUTUAL FUNDS

(COST $855,373,960)

    916,387,200  
     

 

 

 
    SHORT-TERM INVESTMENTS — 0.1%

 

    Money Market Funds — 0.1%

 

    1,195,166     State Street Institutional Treasury Money Market Fund-Premier Class, 1.87% (f)     1,195,166  
     

 

 

 
   

TOTAL SHORT-TERM INVESTMENTS

(COST $1,195,166)

    1,195,166  
     

 

 

 
   

TOTAL INVESTMENTS — 102.2%

(Cost $1,048,539,531)

    1,110,394,926  
     

 

 

 
     Shares         
Description
  Value ($)  
    SECURITIES SOLD SHORT — (2.2)%  
    COMMON STOCKS — (2.2)%  
    Brazil — (0.0)%

 

    (9,300   Pagseguro Digital Ltd – Class A *     (268,677
     

 

 

 
    Canada — (0.1)%

 

    (7,500   Agnico Eagle Mines Ltd     (258,900
    (13,400   Cameco Corp     (139,494
    (26,600   Enbridge Inc     (908,922
     

 

 

 
    Total Canada     (1,307,316
     

 

 

 
    France — (0.0)%

 

    (7,029   DBV Technologies SA *     (312,010
    (526   Iliad SA     (67,904
    (524   Wendel SA     (77,583
     

 

 

 
    Total France     (457,497
     

 

 

 
    Germany — (0.2)%

 

    (145,479   Deutsche Bank AG (Registered)     (1,640,051
    (784   GEA Group AG     (29,780
     

 

 

 
    Total Germany     (1,669,831
     

 

 

 
    Italy — (0.0)%

 

    (22,754   Saipem SPA *     (121,685
     

 

 

 
    Japan — (0.1)%

 

    (171   AEON REIT Investment Corp     (183,877
    (29   Daiwa House Investment Corp (REIT)     (67,255
    (3,600   Kansai Paint Co Ltd     (71,150
    (12,700   Mitsui OSK Lines Ltd     (341,146
    (3,500   Murata Manufacturing Co Ltd     (603,524
    (1,900   Nippon Paint Holdings Co Ltd     (75,101
    (17,200   Orient Corp     (24,298
     

 

 

 
    Total Japan     (1,366,351
     

 

 

 
    Netherlands — (0.0)%

 

    (13,576   Altice NV – Class B *     (40,777
     

 

 

 
    Portugal — (0.0)%

 

    (30,526   CTT-Correios de Portugal SA     (118,680
     

 

 

 
    Spain — (0.1)%

 

    (203,674   Bankia SA     (762,980
    (3,581   Cellnex Telecom SA     (91,843
     

 

 

 
    Total Spain     (854,823
     

 

 

 
    Switzerland — (0.1)%

 

    (16,189   LafargeHolcim Ltd (Registered) *     (787,511
     

 

 

 
 

 

92   See accompanying notes to the financial statements.  


GMO Strategic Opportunities Allocation Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

(showing percentage of total net assets)

August 31, 2018 (Unaudited)

 

     Shares         
Description
  Value ($)  
    United Kingdom — (0.0)%

 

    (11,257   Hochschild Mining Plc     (25,216
    (148,909   Melrose Industries Plc     (430,971
     

 

 

 
    Total United Kingdom     (456,187
     

 

 

 
    United States — (1.5)%

 

    (8,500   Acacia Communications, Inc. *     (346,544
    (63,300   Advanced Micro Devices, Inc. *     (1,593,261
    (1,000   Aerie Pharmaceuticals, Inc. *     (61,350
    (20,551   Altice USA, Inc. – Class A     (368,274
    (9,500   BioMarin Pharmaceutical, Inc. *     (949,810
    (5,500   Carvana Co. *     (356,070
    (4,100   Charter Communications, Inc. – Class A *     (1,272,640
    (2,100   Chipotle Mexican Grill, Inc. *     (997,878
    (20,400   Clovis Oncology, Inc. *     (729,300
    (26,500   Envision Healthcare Corp. *     (1,202,040
     Shares         
Description
  Value ($)  
    United States — continued

 

    (26,600   Incyte Corp. *     (1,966,006
    (117,300   Pandora Media, Inc. *     (1,083,852
    (42,400   Roku, Inc. *     (2,522,376
    (4,600   Shake Shack, Inc. *     (278,070
    (16,300   TESARO, Inc. *     (528,935
    (2,700   Tesla, Inc. *     (814,482
    (45,300   Under Armour, Inc. – Class A *     (926,385
     

 

 

 
    Total United States     (15,997,273
     

 

 

 
   

TOTAL COMMON STOCKS

(PROCEEDS $20,888,520)

    (23,446,608
     

 

 

 
   

TOTAL SECURITIES SOLD SHORT

(PROCEEDS $20,888,520)

    (23,446,608
    Other Assets and Liabilities (net) — (0.0%)     (20,124
     

 

 

 
    TOTAL NET ASSETS — 100.0%     $1,086,928,194  
     

 

 

 
 

 

A summary of outstanding financial instruments at August 31, 2018 is as follows:

Swap Contracts

OTC Total Return Swaps

 

Fund Pays

   Fund Receives     

Counterparty

  Notional
Amount
    

Expiration
Date

   Periodic
Payment
Frequency
     Premiums
Paid/
(Received)
     Value
($)
    Net
Unrealized
Appreciation/
(Depreciation) ($)
 

Total Return on Equity Basket  (g)

    
1 Month Federal Funds
Rate minus 0.40%
 
 
   MORD     USD        1,643,400      05/18/2020      Monthly               (30,085     (30,085

Total Return on Equity Basket (g)

    
1 Month Federal Funds
Rate minus 2.38%
 
 
   MORD     USD        40,204      05/18/2020      Monthly               (4,198     (4,198

Total Return on Equity Basket (g)

    
1 Month Federal Funds
Rate minus 1.75%
 
 
   MORD     USD        362,270      05/18/2020      Monthly               (14,493     (14,493

Total Return on Equity Basket (g)

    
1 Month Federal Funds
Rate minus 1.00%
 
 
   MORD     USD        160,147      05/18/2020      Monthly               (26,363     (26,363
                   

 

 

    

 

 

   

 

 

 
                    $      $ (75,139   $ (75,139
  

 

 

    

 

 

   

 

 

 

As of August 31, 2018, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover commitments or collateral requirements, if any, of the relevant broker or exchange.

 

  See accompanying notes to the financial statements.   93


GMO Strategic Opportunities Allocation Fund

(A Series of GMO Trust)

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Notes to Schedule of Investments:

 

Denominated in U.S. Dollar, unless otherwise indicated.

 

*

Non-income producing security.

 

(a)

All or a portion of this security is out on loan (Note 2).

 

(b)

All or a portion of this security has been pledged to cover margin requirements on futures and/or cleared swap contracts, collateral on securities sold short, OTC swap contracts, forward currency contracts, and/or written options, if any (Note 4).

 

(c)

Investment valued at fair value using methods determined in good faith by the Trustees of GMO Trust or persons acting at their direction pursuant to procedures approved by the Trustees. Investment valued using significant unobservable inputs (Note 2).

(d)

Preferred dividend rates are disclosed to the extent that a stated rate exists.

 

(e)

Indexed security in which price and/or coupon is linked to the price of a specific instrument or financial statistic (Note 2).

 

(f)

The rate disclosed is the 7 day net yield as of August 31, 2018.

 

(g)

Periodic payments made/received are based on the total return of the referenced entity. Custom equity basket swap which has a notional amount of less than 1% of the Fund’s total net assets.

For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 95.

 

 

94   See accompanying notes to the financial statements.  


GMO Trust Funds

(A Series of GMO Trust)

 

Schedule of Investments — (Continued)

August 31, 2018 (Unaudited)

 

 

Portfolio Abbreviations:

144A - Securities exempt from registration under Rule 144A of the Securities Act

of 1933. These securities may be resold in transactions exempt from registration,

normally to qualified institutional investors.

ADR - American Depositary Receipt

AUD BBSW - Bank Bill Swap Reference Rate denominated in Australian Dollar.

CAD LIBOR - London Interbank Offered Rate denominated in Canadian Dollar.

CDO - Collateralized Debt Obligation

CHF LIBOR - London Interbank Offered Rate denominated in Swiss Franc.

CLO - Collateralized Loan Obligation

CMT - Constant Maturity Treasury

CPO - Ordinary Participation Certificate (Certificado de Participacion Ordinares),

representing a bundle of shares of the multiple series of one issuer that trade

together as a unit.

CVR - Contingent Value Right

ETF - Exchange-Traded Fund

EURIBOR - Euro Interbank Offered Rate

Foreign Registered - Shares issued to foreign investors in markets that have foreign ownership limits.

FSA - Insured as to the payment of principal and interest by Financial Security

Assurance.

GBP LIBOR - London Interbank Offered Rate denominated in British Pounds.

GDR - Global Depositary Receipt

LIBOR - London Interbank Offered Rate

NVDR - Non-Voting Depositary Receipt

NZD Bank Bill Rate - Bank Bill Rate denominated in New Zealand Dollar.

OJSC - Open Joint-Stock Company

OTC - Over-the-Counter

PJSC - Private Joint-Stock Company

QPSC - Qatar Private Stock Company

Reg S - Security exempt from registration under Regulation S of the Securities Act

of 1933, which exempts from registration securities offered and sold outside the

United States. Security may not be offered or sold in the United States except

pursuant to an exemption from, or in a transaction not subject to, the registration

requirements of the Securities Act of 1933.

REIT - Real Estate Investment Trust

SDR - Swedish Depository Receipt

SEK STIBOR - Stockholm Interbank Offered Rate denominated in Swedish Krona

USBM - U.S. Treasury 3 Month Bill Money Market Yield.

USD LIBOR - London Interbank Offered Rate denominated in United States

Dollars.

The rates shown on variable rate notes are the current interest rates at August 31,

2018, which are subject to change based on the terms of the security.

Counterparty Abbreviations:

 

BCLY - Barclays Bank plc

BOA - Bank of America, N.A.

DB - Deutsche Bank AG

GS - Goldman Sachs International

JPM - JPMorgan Chase Bank, N.A.

MORD - Morgan Stanley Capital Services LLC

MSCI - Morgan Stanley & Co.

International PLC

SSB - State Street Bank and Trust

Company

UBS - UBS Securities LLC

 

 

Currency Abbreviations:

 

AUD - Australian Dollar

BRL - Brazilian Real

CAD - Canadian Dollar

CHF - Swiss Franc

EUR - Euro

GBP - British Pound

JPY - Japanese Yen

NOK - Norwegian Krone

NZD - New Zealand Dollar

SEK - Swedish Krona

USD - United States Dollar

 
 

 

  See accompanying notes to the financial statements.   95


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited)

 

 

     Alpha Only
Fund
     Benchmark-Free
Allocation Fund
     Benchmark-
Free Fund
     Global Asset
Allocation Fund
 

Assets:

           

Investments in affiliated issuers, at value (Notes 2 and 10)(a)

   $ 7,476,175      $ 12,552,472,324      $ 1,113,718,893      $ 2,191,777,680  

Investments in unaffiliated issuers, at value (Note 2)(b)

     114,116,544        7,583,551        2,477,182,964        371,211  

Foreign currency, at value (Note 2)(c)

     86,807               692,699         

Cash

                   230,452        12  

Receivable for investments sold

     119,503        57,982,217        1,205,181        444,755  

Receivable for Fund shares sold

            7,520,063        16,049,266         

Dividend withholding tax receivable

     85,431               952,774         

Dividends and interest receivable

     212,330        6,754        3,914,956        267,451  

Unrealized appreciation on open forward currency contracts (Note 4)

     463,811               2,230,442         

Receivable for variation margin on open futures contracts (Note 4)

                   26,900         

Due from broker (Note 2)

                   35         

Receivable for open OTC swap contracts (Note 4)

                   37,304         

Receivable for expenses reimbursed and/or waived by GMO (Note 5)

     77,769        1,615,309        73,627        8,104  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

     122,638,370        12,627,180,218        3,616,315,493        2,192,869,213  
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

 

Investments sold short, at value (Note 2)(d)

                   46,887,107         

Payable for investments purchased

     17,663        59,989,325        1,260,022        266,976  

Payable for Fund shares repurchased

     2,826,884        5,517,628               446,895  

Accrued foreign capital gains tax payable (Note 2)

                   195,073         

Payable to affiliate for (Note 5):

 

Management fee

     52,494        7,001,321                

Supplemental support fee – Class MF

            438,448                

Shareholder service fee

     10,812        843,860                

Payable to agents unaffiliated with GMO

     40        2,385        765        428  

Payable for variation margin on open futures contracts (Note 4)

     3,675                       

Unrealized depreciation on open forward currency contracts (Note 4)

     77,608               353,507         

Interest and dividend payable for short sales

                   54,987         

Payable for open OTC swap contracts (Note 4)

                   665,959         

Payable to Trustees and related expenses

     782        39,224        13,927        6,721  

Accrued expenses

     150,750        228,628        560,115        96,815  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

     3,140,708        74,060,819        49,991,462        817,835  
  

 

 

    

 

 

    

 

 

    

 

 

 

Net assets

   $ 119,497,662      $ 12,553,119,399      $ 3,566,324,031      $ 2,192,051,378  
  

 

 

    

 

 

    

 

 

    

 

 

 

(a)  Cost of investments – affiliated issuers:

   $ 7,476,175      $ 12,214,810,128      $ 1,053,663,365      $ 2,165,505,034  

(b)  Cost of investments – unaffiliated issuers:

   $ 113,053,194      $ 7,583,551      $ 2,441,596,271      $ 365,188  

(c)  Cost of foreign currency:

   $ 87,838      $      $ 693,837      $  

(d)  Proceeds from securities sold short:

   $      $      $ 49,149,255      $  

 

96   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     Alpha Only
Fund
    Benchmark-Free
Allocation Fund
    Benchmark-
Free Fund
    Global Asset
Allocation Fund
 

Net assets consist of:

 

Paid-in capital

   $ 495,164,334     $ 12,373,892,179     $ 3,680,136,670     $ 2,410,680,951  

Accumulated undistributed (distributions in excess of) net investment income

     525,103       (10,650,835     49,327,308       6,853,906  

Accumulated net realized gain (loss)

     (373,326,529     (147,784,141     (249,551,027     (251,762,148

Net unrealized appreciation (depreciation)

     (2,865,246     337,662,196       86,411,080       26,278,669  
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 119,497,662     $ 12,553,119,399     $ 3,566,324,031     $ 2,192,051,378  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net assets attributable to:

 

Class III

   $ 7,237,380     $ 4,834,185,866     $ 3,566,324,031     $ 2,192,051,378  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class IV

   $ 112,260,282     $ 2,623,225,002     $     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class MF

   $     $ 5,095,708,531     $     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares outstanding:

 

Class III

     357,913       178,855,534       177,373,742       67,245,141  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class IV

     5,548,707       97,057,262              
  

 

 

   

 

 

   

 

 

   

 

 

 

Class MF

           188,397,011              
  

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value per share:

 

Class III

   $ 20.22     $ 27.03     $ 20.11     $ 32.60  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class IV

   $ 20.23     $ 27.03     $     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class MF

   $     $ 27.05     $     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   97


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     Global
Developed
Equity
Allocation Fund
     Global Equity
Allocation Fund
     Consolidated
Implementation
Fund
     International
Developed
Equity
Allocation Fund
 

Assets:

 

Investments in affiliated issuers, at value (Notes 2 and 10)(a)

   $ 460,355,817      $ 2,013,440,565      $      $ 635,059,954  

Investments in unaffiliated issuers, at value (Note 2)(b)

     121,679        656,642        10,494,690,927        241,796  

Foreign currency, at value (Note 2)(c)

                   3,230,624         

Cash

                   748,622         

Receivable for investments sold

                   7,619,974         

Receivable for Fund shares sold

                   62,596,322        32,286  

Dividend withholding tax receivable

                   2,919,301         

Dividends and interest receivable

     208        1,076        18,292,581        431  

Unrealized appreciation on open forward currency contracts (Note 4)

                   18,872,718         

Receivable for variation margin on open futures contracts (Note 4)

                   542,475         

Due from broker (Note 2)

                   219,272,794         

Receivable for open OTC swap contracts (Note 4)

                   1,559,929         

Receivable for expenses reimbursed and/or waived by GMO (Note 5)

     8,379        8,250        394,319        8,265  

Miscellaneous receivable

                   5,121         
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

     460,486,083        2,014,106,533        10,830,745,707        635,342,732  
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

 

Investments sold short, at value (Note 2)(d)

                   349,517,368         

Payable for investments purchased

                   12,436,264         

Payable for Fund shares repurchased

     2,342        76,381               44,866  

Accrued foreign capital gains tax payable (Note 2)

                   729,583         

Payable to agents unaffiliated with GMO

     81        407        2,026        118  

Payable for variation margin on open cleared swap contracts (Note 4)

                   2,080,895         

Unrealized depreciation on open forward currency contracts (Note 4)

                   8,697,555         

Interest payable for open OTC swap contracts (Note 4)

                   97,648         

Interest and dividend payable for short sales

                   487,970         

Payable for open OTC swap contracts (Note 4)

                   1,843,355         

Written options outstanding, at value (Note 4)(e)

                   1,560,905         

Payable to Trustees and related expenses

     1,350        6,965        33,851        1,918  

Accrued expenses

     54,558        93,216        1,341,978        53,355  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

     58,331        176,969        378,829,398        100,257  
  

 

 

    

 

 

    

 

 

    

 

 

 

Net assets

   $ 460,427,752      $ 2,013,929,564      $ 10,451,916,309      $ 635,242,475  
  

 

 

    

 

 

    

 

 

    

 

 

 

(a)  Cost of investments – affiliated issuers:

   $ 422,557,332      $ 1,952,524,582      $      $ 648,982,688  

(b)  Cost of investments – unaffiliated issuers:

   $ 121,679      $ 656,642      $ 10,493,419,330      $ 241,796  

(c)  Cost of foreign currency:

   $      $      $ 3,235,918      $  

(d)  Proceeds from securities sold short:

   $      $      $ 349,350,301      $  

(e)  Premiums on written options:

   $      $      $ 1,184,920      $  

 

98   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     Global
Developed
Equity
Allocation Fund
    Global Equity
Allocation Fund
    Consolidated
Implementation
Fund
    International
Developed
Equity
Allocation Fund
 

Net assets consist of:

 

Paid-in capital

   $ 508,054,410     $ 2,174,681,454     $ 10,853,230,679     $ 804,251,009  

Accumulated undistributed (distributions in excess of) net investment income

     1,193,129       5,615,286       179,152,954       871,516  

Accumulated net realized gain (loss)

     (86,618,272     (227,283,159     (527,364,699     (155,957,316

Net unrealized appreciation (depreciation)

     37,798,485       60,915,983       (53,102,625     (13,922,734
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 460,427,752     $ 2,013,929,564     $ 10,451,916,309     $ 635,242,475  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net assets attributable to:

 

Core Class

   $     $     $ 10,451,916,309     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class III

   $ 460,427,752     $ 2,013,929,564     $     $ 635,242,475  
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares outstanding:

 

Core Class

                 769,884,673        
  

 

 

   

 

 

   

 

 

   

 

 

 

Class III

     20,395,614       77,328,651             39,473,205  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value per share:

 

Core Class

   $     $     $ 13.58     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class III

   $ 22.57     $ 26.04     $     $ 16.09  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   99


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     International
Equity
Allocation Fund
     Consolidated
SGM Major
Markets Fund
     Consolidated
Special
Opportunities
Fund
     Strategic
Opportunities
Allocation Fund
 

Assets:

 

Investments in affiliated issuers, at value (Notes 2 and 10)(a)

   $ 1,020,151,473      $      $ 45,977      $ 916,387,200  

Investments in unaffiliated issuers, at value (Note 2)(b)

     356,878        1,731,285,269        451,860,630        194,007,726  

Foreign currency, at value (Note 2)(c)

            129,203               32,701  

Cash

            137        60,389        3  

Receivable for investments sold

                   2,243,907         

Receivable for Fund shares sold

            6,543                

Dividend withholding tax receivable

                   87,848        17,891  

Dividends and interest receivable

     440        2,227,287        68,435        433,049  

Unrealized appreciation on open forward currency contracts (Note 4)

            6,305,016                

Receivable for variation margin on open futures contracts (Note 4)

            1,579,358                

Due from broker (Note 2)

            1,004,721                

Receivable for expenses reimbursed and/or waived by GMO (Note 5)

     7,583        72,879               21,552  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets

     1,020,516,374        1,742,610,413        454,367,186        1,110,900,122  
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

 

Investments sold short, at value (Note 2)(d)

                          23,446,608  

Payable for investments purchased

            3,005,943        1,073,871        109,604  

Payable for Fund shares repurchased

     5,522        89,579               202,162  

Payable to affiliate for (Note 5):

 

Management fee

            1,252,507        417,433         

Shareholder service fee

            83,942        20,872         

Payable to agents unaffiliated with GMO

     191        337        174        217  

Payable for variation margin on open futures contracts (Note 4)

            8,134,948                

Unrealized depreciation on open forward currency contracts (Note 4)

            15,066,893                

Interest and dividend payable for short sales

                          21,771  

Payable for open OTC swap contracts (Note 4)

                          75,139  

Written options outstanding, at value (Note 4)(e)

                   229,000         

Payable to Trustees and related expenses

     3,327        4,205        3,749        3,542  

Accrued expenses

     61,718        182,148        274,308        112,885  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities

     70,758        27,820,502        2,019,407        23,971,928  
  

 

 

    

 

 

    

 

 

    

 

 

 

Net assets

   $ 1,020,445,616      $ 1,714,789,911      $ 452,347,779      $ 1,086,928,194  
  

 

 

    

 

 

    

 

 

    

 

 

 

(a)  Cost of investments – affiliated issuers:

   $ 1,028,871,672      $      $ 317,181      $ 855,373,960  

(b)  Cost of investments – unaffiliated issuers:

   $ 356,878      $ 1,731,274,916      $ 335,535,301      $ 193,165,571  

(c)  Cost of foreign currency:

   $      $ 40      $      $ 33,050  

(d)  Proceeds from securities sold short:

   $      $      $      $ 20,888,520  

(e)  Premiums on written options:

   $      $      $ 369,592      $  

 

100   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Assets and Liabilities — August 31, 2018 (Unaudited) — (Continued)

 

 

     International
Equity
Allocation Fund
    Consolidated
SGM Major
Markets Fund
    Consolidated
Special
Opportunities
Fund
    Strategic
Opportunities
Allocation Fund
 

Net assets consist of:

 

Paid-in capital

   $ 1,136,530,407     $ 1,735,371,796     $ 347,111,453     $ 1,028,909,160  

Accumulated undistributed (distributions in excess of) net investment income

     108,594       5,833,108       (2,536,523     5,208,206  

Accumulated net realized gain (loss)

     (107,473,186     17,178,933       (8,425,875     (6,410,681

Net unrealized appreciation (depreciation)

     (8,720,199     (43,593,926     116,198,724       59,221,509  
  

 

 

   

 

 

   

 

 

   

 

 

 
   $ 1,020,445,616     $ 1,714,789,911     $ 452,347,779     $ 1,086,928,194  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net assets attributable to:

 

Class III

   $ 1,020,445,616     $ 30,679,090     $     $ 1,086,928,194  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class IV

   $     $ 11,614,500     $     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class VI

   $     $ 1,672,496,321     $ 452,347,779     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Shares outstanding:

 

Class III

     34,180,682       955,703             52,861,698  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class IV

           362,932              
  

 

 

   

 

 

   

 

 

   

 

 

 

Class VI

           52,209,765       23,071,088        
  

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value per share:

 

Class III

   $ 29.85     $ 32.10     $     $ 20.56  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class IV

   $     $ 32.00     $     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

Class VI

   $     $ 32.03     $ 19.61     $  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   101


GMO Trust Funds

 

Statements of Operations — Six Months Ended August 31, 2018 (Unaudited)

 

 

     Alpha Only
Fund
    Benchmark-Free
Allocation Fund
    Benchmark-
Free Fund
    Global Asset
Allocation Fund
 

Investment Income:

        

Dividends from affiliated issuers (Note 10)

   $ 121,707     $ 49,444,208     $ 3,951,780     $ 11,907,454  

Dividends from unaffiliated issuers (Net of withholding tax) (Note 2)(a)

     2,984,458       53,442       36,994,712       2,603  

Interest

     87,549       3,178       18,567,889       4,864  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

     3,193,714       49,500,828       59,514,381       11,914,921  
  

 

 

   

 

 

   

 

 

   

 

 

 

Expenses:

        

Management fee (Note 5)

     455,817       43,017,304              

Shareholder service fee – Class III (Note 5)

     5,744       3,759,338              

Shareholder service fee – Class IV (Note 5)

     87,334       1,372,689              

Supplemental support fee – Class MF (Note 5)

           2,739,132              

Audit and tax fees

     67,546       14,511       61,562       12,833  

Custodian, fund accounting agent and transfer agent fees

     114,809       47,730       762,977       31,228  

Dividend expense on short sales

                 1,070,322        

Legal fees

     5,372       81,326       37,373       13,945  

Registration fees

     2,862       3,195             1,884  

Trustees’ fees and related expenses (Note 5)

     2,430       153,335       49,093       26,949  

Interest expense and borrowing costs for investments sold short (Note 2)

                 140,194        

Miscellaneous

     32,584       31,865       61,587       7,488  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     774,498       51,220,425       2,183,108       94,327  

Fees and expenses reimbursed and/or waived by GMO (Note 5)

     (195,048     (161,920     (395,881     (64,812

Indirectly incurred management fees waived or borne by GMO (Note 5)

           (9,244,999            

Indirectly incurred shareholder service fee waived or borne by GMO (Note 5)

           (789,174            
  

 

 

   

 

 

   

 

 

   

 

 

 

Net expenses

     579,450       41,024,332       1,787,227       29,515  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     2,614,264       8,476,496       57,727,154       11,885,406  
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized and unrealized gain (loss):

        

Net realized gain (loss) on:

        

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(b)

     26,417,976             83,843,849        

Investments in affiliated issuers

     10,202       86,863,740       46,076,031       (16,192,193

Realized gain distributions from affiliated issuers (Note 10)

           154,325,296       60,618,195       19,824,531  

Futures contracts

     (9,469,476           (6,163,056      

Swap contracts

                 1,276,686        

Forward currency contracts

     1,454,862             5,624,743        

Foreign currency and foreign currency related transactions

     (128,903           445,969        
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

     18,284,661       241,189,036       191,722,417       3,632,338  
  

 

 

   

 

 

   

 

 

   

 

 

 

Change in net unrealized appreciation (depreciation) on:

        

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(c)

     (34,722,064           (234,514,668     (1,873

Investments in affiliated issuers

     793       (585,423,031     (154,048,159     (60,696,773

Investments in securities sold short

                 2,262,148        

Futures contracts

     1,041,661             (15,841,225      

Swap contracts

                 (628,655      

Forward currency contracts

     248,399             5,163,444        

Foreign currency and foreign currency related transactions

     (28,468           (49,369      
  

 

 

   

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

     (33,459,679     (585,423,031     (397,656,484     (60,698,646
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

     (15,175,018     (344,233,995     (205,934,067     (57,066,308
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

   $ (12,560,754   $ (335,757,499   $ (148,206,913   $ (45,180,902
  

 

 

   

 

 

   

 

 

   

 

 

 

(a)  Withholding tax:

   $ 290,870     $     $ 4,606,209     $  

(b)  Foreign capital gains tax on net realized gain (loss):

   $ 1,968     $     $     $  

(c)  Foreign capital gains tax on change in net unrealized appreciation (depreciation):

   $ (2,118   $     $ 195,073     $  

 

102   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Operations — Six Months Ended August 31, 2018 (Unaudited) — (Continued)

 

 

     Global
Developed
Equity
Allocation Fund
    Global Equity
Allocation Fund
    Consolidated
Implementation
Fund
    International
Developed
Equity
Allocation Fund
 

Investment Income:

        

Dividends from unaffiliated issuers (Net of withholding tax) (Note 2)(a)

   $ 1,518     $ 6,974     $ 151,374,405     $ 2,401  

Interest

     3       15       73,419,892       202  

Dividends from affiliated issuers (Note 10)

     2,200,613       9,652,026             3,883,590  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

     2,202,134       9,659,015       224,794,297       3,886,193  
  

 

 

   

 

 

   

 

 

   

 

 

 

Expenses:

        

Audit and tax fees

     13,707       12,510       151,360       12,515  

Custodian, fund accounting agent and transfer agent fees

     26,938       30,563       2,000,127       27,858  

Dividend expense on short sales

                 6,816,959        

Legal fees

     2,546       11,953       128,162       3,366  

Registration fees

     1,560       1,655             1,571  

Trustees’ fees and related expenses (Note 5)

     5,428       25,786       129,901       7,554  

Interest expense and borrowing costs for investments sold short (Note 2)

                 471,189        

Miscellaneous

     4,564     8,642     121,904     4,324
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     54,743       91,109       9,819,602       57,188  

Fees and expenses reimbursed and/or waived by GMO (Note 5)

     (48,783     (62,925     (2,220,194     (48,908
  

 

 

   

 

 

   

 

 

   

 

 

 

Net expenses

     5,960       28,184       7,599,408       8,280  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     2,196,174       9,630,831       217,194,889       3,877,913  
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized and unrealized gain (loss):

        

Net realized gain (loss) on:

        

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(b)

                 34,227,748        

Investments in affiliated issuers

     1,519,207       (52,212           (448,843

Investments in securities sold short

                 170,715,452        

Realized gain distributions from affiliated issuers (Note 10)

     11,276,944       44,259,293              

Futures contracts

                 (25,585,308      

Written options

                 7,024,467        

Swap contracts

                 7,085,008        

Forward currency contracts

                 29,957,022        

Foreign currency and foreign currency related transactions

                 (867,846      
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

     12,796,151       44,207,081       222,556,543 **      (448,843
  

 

 

   

 

 

   

 

 

   

 

 

 

Change in net unrealized appreciation (depreciation) on:

        

Investments in unaffiliated issuers (net of foreign capital gains tax) (Note 2)(c)

                 (778,222,704      

Investments in affiliated issuers

     (18,854,719     (118,346,994           (48,177,236

Investments in securities sold short

                 8,700,464        

Futures contracts

                 (82,711,582      

Written options

                 (1,077,543      

Swap contracts

                 4,068,713        

Forward currency contracts

                 34,925,277        

Foreign currency and foreign currency related transactions

                 (204,472      
  

 

 

   

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

     (18,854,719     (118,346,994     (814,521,847     (48,177,236
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

     (6,058,568     (74,139,913     (591,965,304     (48,626,079
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

   $ (3,862,394   $ (64,509,082   $ (374,770,415   $ (44,748,166
  

 

 

   

 

 

   

 

 

   

 

 

 

(a)  Withholding tax:

   $     $     $ 18,774,721     $  

(b)  Foreign capital gains tax on net realized gain (loss):

   $     $     $ 335,884     $  

(c)  Foreign capital gains tax on change in net unrealized appreciation (depreciation):

   $     $     $ 82,910     $  

*   Includes printing expenses:

   $ 3,396     $ 4,903     $ 9,877     $ 3,126  

 

**

For the details related to in-kind redemption realized gain (loss) please refer to Note 6.

 

  See accompanying notes to the financial statements.   103


GMO Trust Funds

 

Statements of Operations — Six Months Ended August 31, 2018 (Unaudited) — (Continued)

 

 

     International
Equity
Allocation Fund
    Consolidated
SGM Major
Markets Fund
    Consolidated
Special
Opportunities
Fund
    Strategic
Opportunities
Allocation Fund
 

Investment Income:

        

Dividends from affiliated issuers (Note 10)

   $ 5,128,084     $ 9,352,205     $     $ 4,986,829  

Interest

     48       6,964,382       1,828,031       2,282,020  

Dividends from unaffiliated issuers (Net of withholding tax) (Note 2)(a)

     2,427       177,293       2,194,641       1,123,252  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

     5,130,559       16,493,880       4,022,672       8,392,101  
  

 

 

   

 

 

   

 

 

   

 

 

 

Expenses:

        

Management fee (Note 5)

           7,790,023       4,367,987        

Shareholder service fee – Class III (Note 5)

           22,126              

Shareholder service fee – Class IV (Note 5)

           6,021              

Shareholder service fee – Class VI (Note 5)

           492,636       218,399        

Audit and tax fees

     12,517       45,768       61,501       14,281  

Custodian, fund accounting agent and transfer agent fees

     27,264       153,304       68,767       52,072  

Dividend expense on short sales

                       178,403  

Legal fees

     5,896       24,861       15,626       6,566  

Registration fees

     2,319       34,972       1,882       1,465  

Trustees’ fees and related expenses (Note 5)

     12,730       20,811       11,268       14,298  

Interest expense and borrowing costs for investments sold short (Note 2)

                       85,149  

Miscellaneous

     5,079       32,523       18,607       11,824  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

     65,805       8,623,045       4,764,037       364,058  

Fees and expenses reimbursed and/or waived by GMO (Note 5)

     (51,829     (276,553           (84,565
  

 

 

   

 

 

   

 

 

   

 

 

 

Net expenses

     13,976       8,346,492       4,764,037       279,493  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

     5,116,583       8,147,388       (741,365     8,112,608  
  

 

 

   

 

 

   

 

 

   

 

 

 

Realized and unrealized gain (loss):

        

Net realized gain (loss) on:

        

Investments in unaffiliated issuers

           (254,004     184,213,297       (1,787,622

Investments in affiliated issuers

     64,743       (781,391           4,674,505  

Realized gain distributions from affiliated issuers (Note 10)

                       10,845,672  

Futures contracts

           (20,146,381     (1,169,451      

Written options

                 102,658        

Swap contracts

                       171,660  

Forward currency contracts

           53,008,241       (195,350      

Foreign currency and foreign currency related transactions

           1,868,707       (11,211     1,512  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gain (loss)

     64,743       33,695,172       182,939,943       13,905,727  
  

 

 

   

 

 

   

 

 

   

 

 

 

Change in net unrealized appreciation (depreciation) on:

        

Investments in unaffiliated issuers

           881,693       (126,538,231     1,859,787  

Investments in affiliated issuers

     (92,603,361     1,206,230       (24,160     (54,127,491

Investments in securities sold short

                       (2,558,088

Futures contracts

           (6,526,002     1,067,000        

Written options

                 140,592        

Swap contracts

                       (75,139

Forward currency contracts

           (20,389,403     (4,181      

Foreign currency and foreign currency related transactions

           (44,706     (3,699     (659
  

 

 

   

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation)

     (92,603,361     (24,872,188     (125,362,679     (54,901,590
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

     (92,538,618     8,822,984       57,577,264       (40,995,863
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

   $ (87,422,035   $ 16,970,372     $ 56,835,899     $ (32,883,255
  

 

 

   

 

 

   

 

 

   

 

 

 

(a)  Withholding tax:

   $     $     $ 57,933     $ 95,163  

 

104   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Changes in Net Assets

 

 

     Alpha Only Fund     Benchmark-Free Allocation Fund  
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
    Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 

Increase (decrease) in net assets:

        

Operations:

        

Net investment income (loss)

   $ 2,614,264     $ 4,191,623     $ 8,476,496     $ 276,830,059  

Net realized gain (loss)

     18,284,661       (6,145,710     241,189,036       249,711,675  

Change in net unrealized appreciation (depreciation)

     (33,459,679     13,893,648       (585,423,031     808,309,413  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     (12,560,754     11,939,561       (335,757,499     1,334,851,147  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

        

Net investment income

        

Class III

     (27,835     (104,020     (5,248,770     (113,187,765

Class IV

     (772,269     (2,679,412     (3,468,288     (73,419,032

Class MF

                 (6,832,480     (136,226,196
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (800,104     (2,783,432     (15,549,538     (322,832,993
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

        

Class III

     (24,308     (387,767     (194,794,071     (463,077,586

Class IV

     (97,448,569     (12,270,377     (60,854,172     (125,243,907

Class MF

                 (380,652,123     (658,879,382
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (97,472,877     (12,658,144     (636,300,366     (1,247,200,875
  

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

        

Class III

                 207,255       1,805,688  

Class IV

                 112,191       1,055,758  

Class MF

                 227,404       2,043,593  
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

                 546,850       4,905,039  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

     (97,472,877     (12,658,144     (635,753,516     (1,242,295,836
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (110,833,735     (3,502,015     (987,060,553     (230,277,682
Net assets:

 

   

Beginning of period

     230,331,397       233,833,412       13,540,179,952       13,770,457,634  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 119,497,662     $ 230,331,397     $ 12,553,119,399     $ 13,540,179,952  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 525,103     $ (1,289,057   $ (10,650,835   $ (3,577,793
  

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   105


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     Benchmark-Free Fund     Global Asset Allocation Fund  
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
    Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 

Increase (decrease) in net assets:

        

Operations:

        

Net investment income (loss)

   $ 57,727,154     $ 98,773,297     $ 11,885,406     $ 54,584,348  

Net realized gain (loss)

     191,722,417       172,217,499       3,632,338       35,891,926  

Change in net unrealized appreciation (depreciation)

     (397,656,484     278,770,548       (60,698,646     184,349,065  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     (148,206,913     549,761,344       (45,180,902     274,825,339  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

        

Net investment income

        

Class III

     (12,716,161     (126,068,577     (6,964,930     (61,208,240
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (12,716,161     (126,068,577     (6,964,930     (61,208,240
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

        

Class III

     (759,449,314     (332,857,369     (231,543,519     (162,848,213
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (759,449,314     (332,857,369     (231,543,519     (162,848,213
  

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

        

Class III

     207,484       1,394,003       136,172       890,639  
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

     207,484       1,394,003       136,172       890,639  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

     (759,241,830     (331,463,366     (231,407,347     (161,957,574
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (920,164,904     92,229,401       (283,553,179     51,659,525  

Net assets:

        

Beginning of period

     4,486,488,935       4,394,259,534       2,475,604,557       2,423,945,032  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 3,566,324,031     $ 4,486,488,935     $ 2,192,051,378     $ 2,475,604,557  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 49,327,308     $ 4,316,315     $ 6,853,906     $ 1,933,430  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

106   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     Global Developed Equity Allocation Fund     Global Equity Allocation Fund  
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
    Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 

Increase (decrease) in net assets:

        

Operations:

        

Net investment income (loss)

   $ 2,196,174     $ 13,476,279     $ 9,630,831     $ 62,996,031  

Net realized gain (loss)

     12,796,151       (12,629,429     44,207,081       61,488,425  

Change in net unrealized appreciation (depreciation)

     (18,854,719     128,701,084       (118,346,994     331,592,435  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     (3,862,394     129,547,934       (64,509,082     456,076,891  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

        

Net investment income

        

Class III

     (2,396,264     (18,007,301     (5,334,598     (70,822,350
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (2,396,264     (18,007,301     (5,334,598     (70,822,350
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

        

Class III

     (2,597,675     (635,039,526     (245,186,721     (264,039,968
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (2,597,675     (635,039,526     (245,186,721     (264,039,968
  

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

        

Class III

     1,263       522,102       39,335       887,839  
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

     1,263       522,102       39,335       887,839  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

     (2,596,412     (634,517,424     (245,147,386     (263,152,129
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (8,855,070     (522,976,791     (314,991,066     122,102,412  

Net assets:

        

Beginning of period

     469,282,822       992,259,613       2,328,920,630       2,206,818,218  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 460,427,752     $ 469,282,822     $ 2,013,929,564     $ 2,328,920,630  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 1,193,129     $ 1,393,219     $ 5,615,286     $ 1,319,053  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   107


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     Consolidated Implementation Fund     International Developed Equity
Allocation Fund
 
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28,
2018
    Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 

Increase (decrease) in net assets:

        

Operations:

        

Net investment income (loss)

   $ 217,194,889     $ 280,077,196     $ 3,877,913     $ 20,855,069  

Net realized gain (loss)

     222,556,543       600,813,750       (448,843     (4,311,611

Change in net unrealized appreciation (depreciation)

     (814,521,847     329,325,797       (48,177,236     108,212,184  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     (374,770,415     1,210,216,743       (44,748,166     124,755,642  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

        

Net investment income

        

Core Class

     (42,611,658     (335,144,868            

Class III

                 (3,108,368     (20,807,945
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (42,611,658     (335,144,868     (3,108,368     (20,807,945
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

        

Core Class

     (636,731,036     (600,296,581            

Class III

                 18,216,143       (40,941,783
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (636,731,036     (600,296,581     18,216,143       (40,941,783
  

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

        

Core Class

     330,066       4,240,205              

Class III

                 15,949       68,771  
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

     330,066       4,240,205       15,949       68,771  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

     (636,400,970     (596,056,376     18,232,092       (40,873,012
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (1,053,783,043     279,015,499       (29,624,442     63,074,685  
Net assets:

 

 

Beginning of period

     11,505,699,352       11,226,683,853       664,866,917       601,792,232  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 10,451,916,309     $ 11,505,699,352     $ 635,242,475     $ 664,866,917  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 179,152,954     $ 4,569,723     $ 871,516     $ 101,971  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

108   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     International Equity Allocation Fund     Consolidated SGM Major
Markets Fund
 
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
    Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 

Increase (decrease) in net assets:

        

Operations:

        

Net investment income (loss)

   $ 5,116,583     $ 32,701,985     $ 8,147,388     $ 2,462,962  

Net realized gain (loss)

     64,743       (2,354,468     33,695,172       60,070,603  

Change in net unrealized appreciation (depreciation)

     (92,603,361     185,788,303       (24,872,188     (46,769,175
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     (87,422,035     216,135,820       16,970,372       15,764,390  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

        

Net investment income

        

Class III

     (6,649,866     (33,024,114            
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

     (6,649,866     (33,024,114            
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gains

        

Class III

                       (180,594

Class IV

                       (953,492

Class VI

                       (56,853,796
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net realized gains

                       (57,987,882
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

        

Class III

     (36,924,479     (118,301,310     3,857,548       20,704,296  

Class IV

                 (385,307     (42,897,635

Class VI

                 (187,934,353     439,311,501  
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (36,924,479     (118,301,310     (184,462,112     417,118,162  
  

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

        

Class III

     114,511       713,905              
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

     114,511       713,905              
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

     (36,809,968     (117,587,405     (184,462,112     417,118,162  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (130,881,869     65,524,301       (167,491,740     374,894,670  
Net assets:

 

   

Beginning of period

     1,151,327,485       1,085,803,184       1,882,281,651       1,507,386,981  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 1,020,445,616     $ 1,151,327,485     $ 1,714,789,911     $ 1,882,281,651  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ 108,594     $ 1,641,877     $ 5,833,108     $ (2,314,280
  

 

 

   

 

 

   

 

 

   

 

 

 

 

  See accompanying notes to the financial statements.   109


GMO Trust Funds

 

Statements of Changes in Net Assets — (Continued)

 

 

     Consolidated Special
Opportunities Fund
    Strategic Opportunities
Allocation Fund
 
     Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
    Six Months Ended
August 31, 2018
(Unaudited)
    Year Ended
February 28, 2018
 

Increase (decrease) in net assets:

        

Operations:

        

Net investment income (loss)

   $ (741,365   $ (1,242,656   $ 8,112,608     $ 51,040,647  

Net realized gain (loss)

     182,939,943       94,297,391       13,905,727       66,838,550  

Change in net unrealized appreciation (depreciation)

     (125,362,679     192,334,667       (54,901,590     153,597,624  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

     56,835,899       285,389,402       (32,883,255     271,476,821  
  

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to shareholders from:

        

Net investment income

        

Class III

                 (3,227,397     (55,183,123

Class VI

           (680,089            
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net investment income

           (680,089     (3,227,397     (55,183,123
  

 

 

   

 

 

   

 

 

   

 

 

 

Net realized gains

        

Class III

                 (46,531,912     (1,947,705

Class VI

     (225,776,660     (67,496,961            
  

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions from net realized gains

     (225,776,660     (67,496,961     (46,531,912     (1,947,705
  

 

 

   

 

 

   

 

 

   

 

 

 

Net share transactions (Note 9):

        

Class III

                 (133,062,787     (930,852,849

Class VI

     (418,280,487     (175,366,785            
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in net assets resulting from net share transactions

     (418,280,487     (175,366,785     (133,062,787     (930,852,849
  

 

 

   

 

 

   

 

 

   

 

 

 

Purchase premiums and redemption fees (Notes 2 and 9):

        

Class III

                 192,588       1,948,317  

Class VI

     3,324,305       1,580,217              
  

 

 

   

 

 

   

 

 

   

 

 

 

Increase in net assets resulting from purchase premiums and redemption fees

     3,324,305       1,580,217       192,588       1,948,317  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets resulting from net share transactions, purchase premiums and redemption fees

     (414,956,182     (173,786,568     (132,870,199     (928,904,532
  

 

 

   

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

     (583,896,943     43,425,784       (215,512,763     (714,558,539
Net assets:

 

   

Beginning of period

     1,036,244,722       992,818,938       1,302,440,957       2,016,999,496  
  

 

 

   

 

 

   

 

 

   

 

 

 

End of period

   $ 452,347,779     $ 1,036,244,722     $ 1,086,928,194     $ 1,302,440,957  
  

 

 

   

 

 

   

 

 

   

 

 

 

Accumulated undistributed (distributions in excess of) net investment income

   $ (2,536,523   $ (1,795,158   $ 5,208,206     $ 322,995  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

110   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

ALPHA ONLY FUND

 

    Class III Shares   Class IV Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014   2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 21.80     $ 20.96     $ 22.04     $ 22.93     $ 23.98     $ 24.22     $ 21.81     $ 20.97     $ 22.05     $ 22.95     $ 23.99     $ 24.24
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(a)

      0.31       0.41       0.35       0.37       0.34       0.53       0.31       0.39       0.37       0.39       0.35       0.58

Net realized and unrealized gain (loss)

      (1.81 )       0.68       (0.80 )       (0.40 )       (0.96 )       (0.76 )       (1.81 )       0.71       (0.81 )       (0.41 )       (0.95 )       (0.80 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (1.50 )       1.09       (0.45 )       (0.03 )       (0.62 )       (0.23 )       (1.50 )       1.10       (0.44 )       (0.02 )       (0.60 )       (0.22 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.08 )       (0.25 )       (0.63 )       (0.86 )       (0.43 )       (0.01 )       (0.08 )       (0.26 )       (0.64 )       (0.88 )       (0.44 )       (0.03 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.08 )       (0.25 )       (0.63 )       (0.86 )       (0.43 )       (0.01 )       (0.08 )       (0.26 )       (0.64 )       (0.88 )       (0.44 )       (0.03 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 20.22     $ 21.80     $ 20.96     $ 22.04     $ 22.93     $ 23.98     $ 20.23     $ 21.81     $ 20.97     $ 22.05     $ 22.95     $ 23.99
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

      (6.90 )%**       5.22 %       (2.02 )%       (0.06 )%       (2.60 )%       (0.94 )%       (6.89 )%**       5.27 %       (1.98 )%       (0.03 )%       (2.51 )%       (0.93 )%

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 7,237     $ 7,829     $ 7,852     $ 7,712     $ 26,695     $ 35,392     $ 112,260     $ 222,503     $ 225,982     $ 286,305     $ 3,333,388     $ 3,523,518

Net expenses to average daily net assets

      0.69 %(c)*       0.67 %(c)       0.68 %(c)       0.66 %(c)       0.65 %       0.30 %(c)(d)       0.63 %(c)*       0.62 %(c)       0.62 %(c)       0.60 %(c)       0.60 %       0.26 %(c)(d)

Net investment income (loss) to average daily net assets(a)

      2.94 %*       1.91 %       1.62 %       1.66 %       1.44 %       2.19 %       2.86 %*       1.80 %       1.69 %       1.76 %       1.46 %       2.42 %

Portfolio turnover rate

      41 %(e)**       67 %(e)       22 %(e)       85 %       123 %       66 %       41 %(e)**       67 %(e)       22 %(e)       85 %       123 %       66 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.26 %*       0.22 %       0.20 %       0.06 %       0.04 %       0.37 %(f)       0.21 %*       0.23 %       0.20 %       0.05 %       0.04 %       0.36 %(f)

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(e) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 108%, 135% and 80%, respectively, of the average value of its portfolio.

(f) 

Ratios include indirect fees waived or borne by the Fund

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   111


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

BENCHMARK-FREE ALLOCATION FUND

 

    Class III Shares   Class IV Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016(a)   2015(b)   2014(b)   2018   2017   2016(a)   2015(b)   2014(b)

Net asset value, beginning of period

    $ 27.76     $ 25.78     $ 23.46     $ 27.04     $ 27.07     $ 25.77     $ 27.75     $ 25.78     $ 23.46     $ 27.03     $ 27.06     $ 25.75
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                               

Net investment income (loss)(c)

      0.01       0.52       0.37       0.19       0.38       0.48       0.02       0.58       0.40       0.20       0.36       0.46

Net realized and unrealized gain (loss)

      (0.71 )       2.12       2.35       (3.26 )       0.86       1.57       (0.71 )       2.06       2.33       (3.26 )       0.89       1.61
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (0.70 )       2.64       2.72       (3.07 )       1.24       2.05       (0.69 )       2.64       2.73       (3.06 )       1.25       2.07
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                               

From net investment income

      (0.03 )       (0.66 )       (0.40 )       (0.34 )       (0.52 )       (0.39 )       (0.03 )       (0.67 )       (0.41 )       (0.34 )       (0.53 )       (0.40 )

From net realized gains

                        (0.17 )       (0.75 )       (0.36 )                         (0.17 )       (0.75 )       (0.36 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.03 )       (0.66 )       (0.40 )       (0.51 )       (1.27 )       (0.75 )       (0.03 )       (0.67 )       (0.41 )       (0.51 )       (1.28 )       (0.76 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 27.03     $ 27.76     $ 25.78     $ 23.46     $ 27.04     $ 27.07     $ 27.03     $ 27.75     $ 25.78     $ 23.46     $ 27.03     $ 27.06
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

      (2.52 )%**       10.28 %       11.66 %       (11.51 )%       4.71 %       8.03 %       (2.47 )%**       10.30 %       11.71 %       (11.46 )%       4.75 %       8.12 %

Ratios/Supplemental Data:

                                               

Net assets, end of period (000’s)

    $ 4,834,186     $ 5,162,084     $ 5,248,863     $ 5,872,663     $ 6,040,891     $ 3,109,509     $ 2,623,225     $ 2,756,005     $ 2,663,418     $ 2,508,115     $ 3,363,711     $ 2,511,906

Net operating expenses to average daily net assets(e)

      0.65 %*       0.65 %       0.65 %       0.66 %       0.64 %       0.59 %(f)       0.60 %*       0.60 %       0.60 %       0.61 %       0.59 %       0.54 %(f)

Interest and/or dividend expenses to average daily net assets(g)

                        0.02 %       0.05 %                               0.02 %       0.05 %      

Total net expenses to average daily net assets(e)

      0.65 %*       0.65 %       0.65 %       0.68 %       0.69 %       0.59 %       0.60 %*       0.60 %       0.60 %       0.63 %       0.64 %       0.54 %

Net investment income (loss) to average daily net assets(c)

      0.09 %*       1.93 %       1.46 %       0.73 %       1.41 %       1.79 %       0.16 %*       2.13 %       1.61 %       0.80 %       1.32 %       1.73 %

Portfolio turnover rate

      8 %**       9 %       7 %       53 %(h)       84 %       52 %       8 %**       9 %       7 %       53 %(h)       84 %       52 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:(i)

      0.15 %*       0.16 %       0.15 %       0.16 %       0.20 %       0.27 %       0.15 %*       0.16 %       0.15 %       0.16 %       0.20 %       0.27 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.00 (j)      $ 0.01     $ 0.02     $ 0.01     $ 0.01     $ 0.03     $ 0.00 (j)      $ 0.01     $ 0.02     $ 0.01     $ 0.01     $ 0.03

 

(a) 

The amounts shown, where applicable, are consolidated through the period ended July 31, 2015 (Note 2 - Basis of presentation and principles of consolidation).

(b) 

Consolidated financial highlights (Note 2 - Basis of presentation and principles of consolidation).

(c) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(d) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(e) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(f) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(g) 

Interest and dividend expense incurred as a result of entering into reverse repurchase agreements, securities sold short and/or cleared swap contracts, if any, is included in the Fund’s net expenses.

(h) 

Had the Fund not been consolidated for the year ended February 29, 2016, the portfolio turnover would have been 23%.

(i) 

Ratios include indirect fees waived or borne by GMO.

(j) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

112   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

BENCHMARK-FREE ALLOCATION FUND (continued)

 

    Class MF Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016(a)   2015(b)   2014(b)

Net asset value, beginning of period

    $ 27.77     $ 25.80     $ 23.47     $ 27.04     $ 27.07     $ 25.76
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                       

Net investment income (loss)(c)

      0.02       0.56       0.35       0.19       0.37       0.49

Net realized and unrealized gain (loss)

      (0.71 )       2.08       2.39       (3.24 )       0.88       1.58
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (0.69 )       2.64       2.74       (3.05 )       1.25       2.07
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                       

From net investment income

      (0.03 )       (0.67 )       (0.41 )       (0.35 )       (0.53 )       (0.40 )

From net realized gains

                        (0.17 )       (0.75 )       (0.36 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.03 )       (0.67 )       (0.41 )       (0.52 )       (1.28 )       (0.76 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 27.05     $ 27.77     $ 25.80     $ 23.47     $ 27.04     $ 27.07
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

      (2.47 )%**       10.29 %       11.76 %       (11.45 )%       4.78 %       8.11 %

Ratios/Supplemental Data:

                       

Net assets, end of period (000’s)

    $ 5,095,709     $ 5,622,091     $ 5,858,177     $ 8,025,066     $ 12,255,179     $ 9,103,523

Net operating expenses to average daily net assets(e)

      0.60 %*       0.60 %       0.60 %(f)       0.58 %(f)       0.55 %(f)       0.53 %(g)

Interest and/or dividend expenses to average daily net assets(h)

                        0.02 %       0.05 %      

Total net expenses to average daily net assets(e)

      0.60 %*       0.60 %       0.60 %(f)       0.60 %(f)       0.60 %(f)       0.53 %

Net investment income (loss) to average daily net assets(c)

      0.15 %*       2.06 %       1.38 %       0.77 %       1.37 %       1.83 %

Portfolio turnover rate

      8 %**       9 %       7 %       53 %(i)       84 %       52 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:(j)

      0.15 %*       0.16 %       0.16 %       0.19 %       0.23 %       0.27 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.00 (k)      $ 0.01     $ 0.02     $ 0.01     $ 0.01     $ 0.03

 

(a) 

The amounts shown, where applicable, are consolidated through the period ended July 31, 2015 (Note 2 - Basis of presentation and principles of consolidation).

(b) 

Consolidated financial highlights (Note 2 - Basis of presentation and principles of consolidation).

(c) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(d) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(e) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(f) 

Class MF net expenses include a supplemental support fee reduction (Note 5).

(g) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(h) 

Interest and dividend expense incurred as a result of entering into reverse repurchase agreements, securities sold short and/or cleared swap contracts, if any, is included in the Fund’s net expenses.

(i) 

Had the Fund not been consolidated for the year ended February 29, 2016, the portfolio turnover would have been 23%.

(j) 

Ratios include indirect fees waived or borne by GMO.

(k) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   113


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

BENCHMARK-FREE FUND

 

    Class III Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 20.91     $ 18.95     $ 17.00     $ 20.30     $ 22.09     $ 21.33
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                       

Net investment income (loss)(a)

      0.29       0.46       0.43       0.58       0.61       0.59

Net realized and unrealized gain (loss)

      (1.02 )       2.10       2.01       (2.70 )       0.61       1.45
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (0.73 )       2.56       2.44       (2.12 )       1.22       2.04
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                       

From net investment income

      (0.07 )       (0.60 )       (0.49 )       (0.60 )       (0.79 )       (0.74 )

From net realized gains

                        (0.58 )       (2.22 )       (0.54 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.07 )       (0.60 )       (0.49 )       (1.18 )       (3.01 )       (1.28 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 20.11     $ 20.91     $ 18.95     $ 17.00     $ 20.30     $ 22.09
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

      (3.48 )%**       13.59 %       14.52 %       (10.82 )%       5.76 %       9.66 %

Ratios/Supplemental Data:

                       

Net assets, end of period (000’s)

    $ 3,566,324     $ 4,486,489     $ 4,394,260     $ 4,305,118     $ 5,052,362     $ 4,367,658

Net operating expenses to average daily net assets(c)

      0.03 %*       0.02 %       0.01 %       0.00 %(d)       0.00 %(d)       0.00 %(d)(e)

Interest and/or dividend expenses to average daily net assets(f)

      0.06 %*       0.00 %(g)       0.00 %(g)                  

Total net expenses to average daily net assets(c)

      0.09 %*       0.02 %       0.01 %       0.00 %(d)       0.00 %(d)       0.00 %(d)

Net investment income (loss) to average daily net assets(a)

      2.84 %*       2.29 %       2.37 %       3.09 %       2.90 %       2.67 %

Portfolio turnover rate

      34 %**       78 %(h)       83 %(h)       101 %       60 %       51 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.02 %*       0.03 %       0.04 %       0.01 %       0.00 %(i)       0.00 %(i)

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.00 (j)      $ 0.01     $ 0.00 (j)      $ 0.00 (j)      $ 0.00 (j)      $ 0.00 (j) 

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

Net expenses to average daily net assets were less than 0.01%.

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f) 

Interest expense incurred as a result of entering into reverse repurchase agreements and/or margin on cleared swap contracts, if any, is included in the Fund’s net expenses. Income earned on investing proceeds from reverse repurchase agreements, if any, is included in interest income.

(g) 

Ratio is less than 0.01%.

(h) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 81% and 86%, respectively, of the average value of its portfolio.

(i) 

Fees and expenses reimbursed by GMO were less than 0.01%.

(j) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

114   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

GLOBAL ASSET ALLOCATION FUND

 

    Class III Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017(a)   2016(a)   2015(a)   2014(a)

Net asset value, beginning of period

    $ 33.31     $ 30.48     $ 27.60     $ 33.81     $ 35.40     $ 32.70
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                       

Net investment income (loss)(b)

      0.17       0.73       0.61       1.02       0.96       0.81

Net realized and unrealized gain (loss)

      (0.78 )       2.93       3.00       (4.53 )       0.60       2.73
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      (0.61 )       3.66       3.61       (3.51 )       1.56       3.54
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                       

From net investment income

      (0.10 )       (0.83 )       (0.73 )       (1.14 )       (1.29 )       (0.84 )

From net realized gains

                        (1.56 )       (1.86 )      
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

      (0.10 )       (0.83 )       (0.73 )       (2.70 )       (3.15 )       (0.84 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 32.60     $ 33.31     $ 30.48     $ 27.60     $ 33.81     $ 35.40
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      (1.83 )%**       12.04 %       13.21 %       (10.98 )%       4.55 %       10.88 %

Ratios/Supplemental Data:

                       

Net assets, end of period (000’s)

    $ 2,192,051     $ 2,475,605     $ 2,423,945     $ 3,317,792     $ 4,868,922     $ 5,362,913

Net expenses to average daily net assets(d)(e)

      0.00 %*       0.00 %       0.00 %       0.00 %       0.00 %       0.00 %(f)

Net investment income (loss) to average daily net assets(b)

      1.00 %*       2.24 %       2.06 %       3.33 %       2.75 %       2.33 %

Portfolio turnover rate

      10 %(g)**       20 %(g)       19 %(g)       20 %       38 %       46 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.01 %*       0.01 %       0.01 %       0.01 %       0.01 %       0.01 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

    $ 0.00 (h)      $ 0.01     $ 0.02     $ 0.01     $ 0.01     $ 0.01

 

(a) 

Per share amounts were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

Net expenses to average daily net assets were less than 0.01%.

(f) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(g) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 11%, 22% and 18%, respectively, of the average value of its portfolio.

(h) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   115


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

GLOBAL DEVELOPED EQUITY ALLOCATION FUND

 

     Class III Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

     $ 22.88     $ 19.60     $ 17.40     $ 22.84     $ 25.00     $ 21.13
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(a)

       0.11       0.42       0.52       0.51       0.80       0.61

Net realized and unrealized gain (loss)

       (0.30 )       3.55       2.87       (3.64 )       0.02 (b)        3.96
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (0.19 )       3.97       3.39       (3.13 )       0.82       4.57
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.12 )       (0.69 )       (0.55 )       (0.52 )       (0.82 )       (0.70 )

From net realized gains

                   (0.64 )       (1.79 )       (2.16 )      
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.12 )       (0.69 )       (1.19 )       (2.31 )       (2.98 )       (0.70 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 22.57     $ 22.88     $ 19.60     $ 17.40     $ 22.84     $ 25.00
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

       (0.83 )%**       20.39 %       20.03 %       (14.81 )%       3.32 %       21.68 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 460,428     $ 469,283     $ 992,260     $ 1,432,776     $ 1,770,455     $ 1,591,060

Net expenses to average daily net assets(d)(e)

       0.00 %*       0.00 %       0.00 %       0.00 %       0.00 %       0.00 %(f)

Net investment income (loss) to average daily net assets(a)

       0.95 %*       1.99 %       2.78 %       2.49 %       3.34 %       2.62 %

Portfolio turnover rate

       3 %**       5 %       29 %       14 %       16 %       36 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.02 %*       0.01 %       0.01 %       0.01 %       0.01 %       0.01 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

     $ 0.00 (g)      $ 0.02     $ 0.01     $ 0.00 (g)      $ 0.00 (g)       

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The amount shown for a share outstanding does not correspond with the aggregate net realized and unrealized gain (loss) on investments due to the timing of purchases and redemptions of Fund shares in relation to fluctuating market values of the investments of the Fund.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

Net expenses to average daily net assets were less than 0.01%.

(f) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(g) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

116   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

GLOBAL EQUITY ALLOCATION FUND

 

     Class III Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017(a)   2016(a)   2015(a)   2014(a)

Net asset value, beginning of period

     $ 26.86     $ 22.84     $ 19.71     $ 26.22     $ 28.29     $ 25.80
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(b)

       0.11       0.68       0.57       0.60       0.96       0.84

Net realized and unrealized gain (loss)

       (0.87 )       4.11       3.67       (4.47 )       (0.03 )(c)       3.63
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (0.76 )       4.79       4.24       (3.87 )       0.93       4.47
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.06 )       (0.77 )       (0.70 )       (0.60 )       (0.90 )       (0.87 )

From net realized gains

                   (0.41 )       (2.04 )       (2.10 )       (1.11 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.06 )       (0.77 )       (1.11 )       (2.64 )       (3.00 )       (1.98 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 26.04     $ 26.86     $ 22.84     $ 19.71     $ 26.22     $ 28.29
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(d)

       (2.82 )%**       21.06 %       21.93 %       (15.96 )%       3.37 %       17.60 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 2,013,930     $ 2,328,921     $ 2,206,818     $ 2,879,168     $ 3,800,256     $ 2,948,319

Net expenses to average daily net assets(f)(g)

       0.00 %*       0.00 %       0.00 %       0.00 %       0.00 %       0.00 %(e)

Net investment income (loss) to average daily net assets(b)

       0.86 %*       2.67 %       2.63 %       2.58 %       3.54 %       3.02 %

Portfolio turnover rate

       4 %**       14 %       27 %       15 %       21 %       51 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.01 %*       0.01 %       0.01 %       0.01 %       0.01 %       0.01 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

     $ 0.00 (h)      $ 0.01     $ 0.02     $ 0.01     $ 0.01     $ 0.01

 

(a) 

Per share amounts were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

The amount shown for a share outstanding does not correspond with the aggregate net realized and unrealized gain (loss) on investments due to the timing of purchases and redemptions of Fund shares in relation to fluctuating market values of the investments of the Fund.

(d) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(g) 

Net expenses to average daily net assets were less than 0.01%.

(h) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   117


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

CONSOLIDATED IMPLEMENTATION FUND

 

     Core Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

     $ 14.09     $ 13.06     $ 11.80     $ 13.59     $ 12.71     $ 11.30
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)†

       0.27       0.33       0.27       0.21       0.25       0.32

Net realized and unrealized gain (loss)

       (0.73 )       1.11       1.24       (2.00 )       0.63       1.09
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (0.46 )       1.44       1.51       (1.79 )       0.88       1.41
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.05 )       (0.41 )       (0.25 )                  
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.05 )       (0.41 )       (0.25 )                  
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 13.58     $ 14.09     $ 13.06     $ 11.80     $ 13.59     $ 12.71
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(a)

       (3.23 )%**       11.12 %       12.88 %       (13.17 )%       6.92 %       12.48 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 10,451,916     $ 11,505,699     $ 11,226,684     $ 13,655,203     $ 15,915,866     $ 10,160,905

Net operating expenses to average daily net assets

       0.01 %*       0.00 %(b)       0.00 %(b)       0.00 %(b)       0.00 %(b)       0.00 %(b)(c)

Interest and/or dividend expenses to average daily net assets(d)

       0.13 %*       0.04 %       0.05 %       0.07 %       0.07 %      

Total net expenses to average daily net assets

       0.14 %*       0.04 %       0.05 %       0.07 %       0.07 %       0.00 %

Net investment income (loss) to average daily net assets

       3.89 %*       2.44 %       2.11 %       1.62 %       1.89 %       2.61 %

Portfolio turnover rate

       62 %**       146 %       142 %       127 %       115 %       65 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.04 %*       0.04 %       0.05 %       0.05 %       0.04 %       0.08 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

     $ 0.00 (e)      $ 0.01     $ 0.01     $ 0.01            

 

(a) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(b) 

Ratio is less than 0.01%.

(c) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(d) 

Interest expense and dividend expense incurred as a result of entering into repurchase agreements, securities sold short and/or margin on cleared swap contracts, if any, is included in the Fund’s net expenses. Income earned on investing proceeds from reverse repurchase agreements, if any, is included in interest income.

(e) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

118   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

INTERNATIONAL DEVELOPED EQUITY ALLOCATION FUND

 

     Class III Shares  
     Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended February 28/29,  
    2018     2017     2016     2015     2014  

Net asset value, beginning of period

   $ 17.32     $ 14.72     $ 13.05     $ 16.88     $ 17.99     $ 14.86  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from investment operations:

            

Net investment income (loss)(a)

     0.10       0.53       0.45       0.48       0.74       0.54  

Net realized and unrealized gain (loss)

     (1.25     2.61       1.79       (3.83     (1.11     3.16  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

     (1.15     3.14       2.24       (3.35     (0.37     3.70  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less distributions to shareholders:

            

From net investment income

     (0.08     (0.54     (0.57     (0.48     (0.74     (0.57
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

     (0.08     (0.54     (0.57     (0.48     (0.74     (0.57
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

   $ 16.09     $ 17.32     $ 14.72     $ 13.05     $ 16.88     $ 17.99  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(b)

     (6.64 )%*      21.41     17.37     (20.09 )%      (1.86 )%      25.02

Ratios/Supplemental Data:

            

Net assets, end of period (000’s)

   $ 635,242     $ 664,867     $ 601,792     $ 942,823     $ 1,180,493     $ 1,150,492  

Net expenses to average daily net assets(c)(d)

     0.00 %*      0.00     0.00     0.00     0.00     0.00 %(e) 

Net investment income (loss) to average daily net assets(a)

     1.17 %*      3.20     3.14     3.07     4.24     3.28

Portfolio turnover rate

     1 %**      5     10     14     7     52

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

     0.01 %*      0.01     0.01     0.01     0.01     0.01

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

   $ 0.00 (f)     $ 0.00 (f)     $ 0.01     $ 0.00 (f)     $ 0.00 (f)        

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

Net expenses to average daily net assets were less than 0.01%.

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   119


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

INTERNATIONAL EQUITY ALLOCATION FUND

 

     Class III Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017(a)   2016(a)   2015(a)   2014(a)

Net asset value, beginning of period

     $ 32.62     $ 27.49     $ 23.40     $ 31.71     $ 34.11     $ 31.29
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(b)

       0.15       0.93       0.84       0.84       1.32       1.05

Net realized and unrealized gain (loss)

       (2.72 )       5.19       4.15       (7.11 )       (1.83 )       3.96
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (2.57 )       6.12       4.99       (6.27 )       (0.51 )       5.01
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.20 )       (0.99 )       (0.90 )       (0.87 )       (1.35 )       (1.02 )

From net realized gains

                         (1.17 )       (0.54 )       (1.17 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.20 )       (0.99 )       (0.90 )       (2.04 )       (1.89 )       (2.19 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 29.85     $ 32.62     $ 27.49     $ 23.40     $ 31.71     $ 34.11
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

       (7.89 )%**       22.38 %       21.57 %       (20.70 )%       (1.30 )%       16.22 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 1,020,446     $ 1,151,327     $ 1,085,803     $ 1,134,800     $ 1,595,039     $ 1,790,318

Net expenses to average daily net assets(d)(e)

       0.00 %*       0.00 %       0.00 %       0.00 %       0.00 %       0.00 %(f)

Net investment income (loss) to average daily net assets(b)

       0.95 %*       3.00 %       3.20 %       2.92 %       3.94 %       3.15 %

Portfolio turnover rate

       1 %**       12 %       7 %       14 %       18 %       40 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.01 %*       0.01 %       0.01 %       0.01 %       0.01 %       0.01 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

     $ 0.00 (g)      $ 0.02     $ 0.02     $ 0.01     $ 0.01     $ 0.02

 

(a) 

Per share amounts were adjusted to reflect a 1:3 reverse stock split effective July 15, 2016.

(b) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

Net expenses to average daily net assets were less than 0.01%.

(f) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(g) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

120   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

CONSOLIDATED SGM MAJOR MARKETS FUND

 

    Class III Shares   Class IV Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,   Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended
February 28,

2018
  Period from
October 26,
2016
(commencement
of operations)
through
February 28,
2017
    2018   2017   2016   2015   2014

Net asset value, beginning of period

    $ 31.87     $ 32.68     $ 33.25     $ 33.80     $ 32.18     $ 30.47     $ 31.76     $ 32.56     $ 35.27
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                                   

Net investment income (loss)(a)

      0.13       0.24       (0.21 )       (0.26 )       (0.25 )       (0.22 )       0.14       (0.09 )       (0.05 )

Net realized and unrealized gain (loss)

      0.10       0.23       1.87       (0.29 )       1.87 (b)        1.93       0.10       0.57       (0.62 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      0.23       0.47       1.66       (0.55 )       1.62       1.71       0.24       0.48       (0.67 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                                   

From net investment income

                  (1.01 )                                     (0.82 )

From net realized gains

            (1.28 )       (1.22 )                               (1.28 )       (1.22 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

            (1.28 )       (2.23 )                               (1.28 )       (2.04 )
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 32.10     $ 31.87     $ 32.68     $ 33.25     $ 33.80     $ 32.18     $ 32.00     $ 31.76       32.56
   

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      0.72 %**       1.44 %       5.12 %       (1.63 )%       5.03 %       5.61 %       0.76 %**       1.47 %       (1.79 )%**

Ratios/Supplemental Data:

                                   

Net assets, end of period (000’s)

    $ 30,679     $ 26,630     $ 6,117     $ 24,020     $ 1,499,443     $ 1,662,189     $ 11,615     $ 11,903     $ 54,825

Net expenses to average daily net assets(d)

      1.00 %*       1.00 %       1.00 %       0.85 %       0.80 %       0.75 %       0.95 %*       0.95 %       0.95 %*

Net investment income (loss) to average daily net assets(a)

      0.80 %*       0.75 %       (0.61 )%       (0.79 )%       (0.76 )%       (0.70 )%       0.85 %*       (0.27 )%       (0.41 )%*

Portfolio turnover rate

      39 %(e)**       106 %(e)       15 %(e)       29 %       45 %       97 %       39 %(e)**       106 %(e)       15 %**(e)

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.03 %*       0.03 %       0.04 %       0.03 %       0.08 %       0.13 %       0.03 %*       0.03 %       0.05 %

 

    Class VI Shares
    Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28   Period from
December 1,
2015
(commencement
of operations)
through
February 29,
2016
    2018   2017

Net asset value, beginning of period

    $ 31.78     $ 32.57     $ 33.26     $ 33.07
   

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

               

Net investment income (loss)(a)

      0.14       0.05       (0.16 )       (0.05 )

Net realized and unrealized gain (loss)

      0.11       0.44       1.85       0.24
   

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

      0.25       0.49       1.69       0.19
   

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

               

From net investment income

                  (1.16 )      

From net realized gains

            (1.28 )       (1.22 )      
   

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

            (1.28 )       (2.38 )      
   

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

    $ 32.03     $ 31.78     $ 32.57     $ 33.26
   

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(c)

      0.79 %**       1.50 %       5.22 %       0.57 %**

Ratios/Supplemental Data:

               

Net assets, end of period (000’s)

    $ 1,672,496     $ 1,843,748     $ 1,446,445     $ 1,297,025

Net expenses to average daily net assets(d)

      0.91 %*       0.91 %       0.91 %       0.91 %*

Net investment income (loss) to average daily net assets(a)

      0.89 %*       0.16 %       (0.47 )%       (0.59 )%*

Portfolio turnover rate

      39 %(e)**       106 %(e)       15 %(e)       29 %**

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

      0.03 %*       0.03 %       0.04 %       0.13 %
(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The amount shown for a share outstanding does not correspond with the aggregate net realized and unrealized gain (loss) on investments due to the timing of purchases and redemptions of Fund shares in relation to fluctuating market values of the investments of the Fund.

(c) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(d) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(e) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 48%, 51% and 47%, respectively, of the average value of its portfolio.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

 

  See accompanying notes to the financial statements.   121


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

CONSOLIDATED SPECIAL OPPORTUNITIES FUND

 

     Class VI Shares  
     Six Months
Ended
August 31,
2018
(Unaudited)
    Year Ended February 28/29,     Period from
July 28, 2014
(commencement
of operations)
through
February 28,
2015
 
    2018     2017     2016  

Net asset value, beginning of period

   $ 25.27     $ 20.39     $ 18.65     $ 19.81     $ 20.00  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) from investment operations:

          

Net investment income (loss)†

     (0.02     (0.03     0.21       0.16       (0.03

Net realized and unrealized gain (loss)

     1.66       6.57       2.23       (0.85     (0.15 )(a) 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

     1.64       6.54       2.44       (0.69     (0.18
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Less distributions to shareholders:

          

From net investment income

           (0.02     (0.32     (0.21     (0.01

From net realized gains

     (7.30     (1.64     (0.38     (0.26      
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

     (7.30     (1.66     (0.70     (0.47     (0.01
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

   $ 19.61     $ 25.27     $ 20.39     $ 18.65     $ 19.81  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(b)

     6.81 %**      32.60     13.21     (3.64 )%      (0.89 )%** 

Ratios/Supplemental Data:

          

Net assets, end of period (000’s)

   $ 452,348     $ 1,036,245     $ 992,819     $ 1,138,735     $ 843,864  

Net expenses to average daily net assets

     1.20 %*      1.21     1.23     1.29     1.36 %* 

Net investment income (loss) to average daily net assets

     (0.19 )%*      (0.12 )%      1.05     0.80     (0.25 )%* 

Portfolio turnover rate

     6 %**      10     87     69     64 %** 

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

                             0.02 %* 

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

   $ 0.10     $ 0.04     $ 0.03     $ 0.07     $ 0.13  

 

(a) 

The amount shown for a share outstanding does not correspond with the aggregate net realized and unrealized gain (loss) on investments due to the timing of purchases and redemptions of Fund shares in relation to fluctuating market values of the investments of the Fund.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

122   See accompanying notes to the financial statements.  


GMO Trust Funds

 

Financial Highlights

(For a share outstanding throughout each period)

 

 

STRATEGIC OPPORTUNITIES ALLOCATION FUND

 

     Class III Shares
     Six Months
Ended
August 31,
2018
(Unaudited)
  Year Ended February 28/29,
    2018   2017   2016   2015   2014

Net asset value, beginning of period

     $ 22.08     $ 19.76     $ 17.43     $ 21.89     $ 23.43     $ 21.47
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Income (loss) from investment operations:

                        

Net investment income (loss)(a)

       0.15       0.58       0.51       0.75       0.76       0.68

Net realized and unrealized gain (loss)

       (0.75 )       2.39       2.36       (3.47 )       0.44       2.96
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total from investment operations

       (0.60 )       2.97       2.87       (2.72 )       1.20       3.64
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Less distributions to shareholders:

                        

From net investment income

       (0.06 )       (0.63 )       (0.53 )       (0.80 )       (0.87 )       (0.78 )

From net realized gains

       (0.86 )       (0.02 )       (0.01 )       (0.94 )       (1.87 )       (0.90 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total distributions

       (0.92 )       (0.65 )       (0.54 )       (1.74 )       (2.74 )       (1.68 )
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Net asset value, end of period

     $ 20.56     $ 22.08     $ 19.76     $ 17.43     $ 21.89     $ 23.43
    

 

 

     

 

 

     

 

 

     

 

 

     

 

 

     

 

 

 

Total Return(b)

       (2.69 )%**       15.10 %       16.60 %       (13.00 )%       5.36 %       17.24 %

Ratios/Supplemental Data:

                        

Net assets, end of period (000’s)

     $ 1,086,928     $ 1,302,441     $ 2,016,999     $ 1,967,916     $ 2,449,194     $ 2,455,863

Net operating expenses to average daily net assets(c)

       0.00 %(d)*       0.00 %(d)       0.00 %(d)       0.00 %(d)       0.00 %(d)       0.00 %(d)(e)

Interest and/or dividend expenses to average daily net assets(f)

       0.05 %*                              

Total net expenses to average daily net assets(c)

       0.05 %*                              

Net investment income (loss) to average daily net assets(a)

       1.36 %*       2.73 %       2.69 %       3.80 %       3.31 %       2.99 %

Portfolio turnover rate

       20 %(g)**       20 %(g)       28 %(g)       65 %       30 %       53 %

Fees and expenses reimbursed and/or waived by GMO to average daily net assets:

       0.01 %*       0.01 %       0.01 %       0.01 %       0.01 %       0.01 %

Purchase premiums and redemption fees consisted of the following per share amounts (Note 2):†

     $ 0.00 (h)      $ 0.02     $ 0.00 (h)      $ 0.00 (h)      $ 0.00 (h)      $ 0.00 (h) 

 

(a) 

Net investment income is affected by the timing of the declaration of dividends by the underlying funds in which the Fund invests, if any.

(b) 

The total returns would have been lower had certain expenses not been reimbursed and/or waived during the periods shown, if applicable, and assumes the effect of reinvested distributions, if any. Calculation excludes purchase premiums and redemption fees which are borne by the shareholder purchasing or redeeming Fund shares, if any.

(c) 

Net expenses exclude expenses incurred indirectly through investment in the underlying funds (Note 5).

(d) 

Net expenses to average daily net assets were less than 0.01%.

(e) 

The net expense ratio does not include the effect of expense reductions (Note 2).

(f) 

Interest and dividend expense incurred as a result of entering into reverse repurchase agreements, securities sold short and/or cleared swap contracts, if any, is included in the Fund’s net expenses.

(g) 

The portfolio turnover rate excludes investments in GMO U.S. Treasury Fund (“USTF”) which is used as a short-term investment vehicle for cash management. The Fund’s portfolio turnover rate during the period ended August 31, 2018 and the years ended February 28, 2018 and February 28, 2017, including transactions in USTF, was 20%, 25% and 39%, respectively, of the average value of its portfolio.

(h) 

Purchase premiums and redemption fees were less than $0.01 per share.

Calculated using average shares outstanding throughout the period.

*

Annualized.

**

Not annualized.

 

  See accompanying notes to the financial statements.   123


GMO Trust Funds

 

Notes to Financial Statements

August 31, 2018 (Unaudited)

 

 

1.

Organization

Each of Alpha Only Fund, Benchmark-Free Allocation Fund, Benchmark-Free Fund, Global Asset Allocation Fund, Global Developed Equity Allocation Fund, Global Equity Allocation Fund, Implementation Fund, International Developed Equity Allocation Fund, International Equity Allocation Fund, SGM Major Markets Fund, Special Opportunities Fund and Strategic Opportunities Allocation Fund, (each a “Fund” and collectively the “Funds”) is a series of GMO Trust (the “Trust”). The Trust is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust was established as a Massachusetts business trust under the laws of The Commonwealth of Massachusetts on June 24, 1985. The Declaration of Trust permits the Trustees of the Trust (“Trustees”) to create an unlimited number of series of shares (Funds) and to subdivide Funds into classes. The Funds are advised and managed by Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”).

The Funds may invest in GMO U.S. Treasury Fund and in money market funds unaffiliated with GMO.

Many of the Funds may invest primarily in other GMO Funds and Implementation Fund, Special Opportunities Fund, and SGM Major Markets Fund may also invest in their wholly-owned subsidiaries, GMO Implementation SPC Ltd., GMO Special Opportunities SPC Ltd. and GMO Alternative Asset SPC Ltd., respectively. These GMO Funds and wholly-owned subsidiaries are referenced herein as “underlying funds.” As a result, the Funds are exposed to all of the risks of the underlying funds in which they invest. Several of the underlying funds themselves invest a substantial portion of their assets in other GMO Funds. The financial statements of the underlying funds should be read in conjunction with the Funds’ financial statements. The financial statements are available without charge on the Securities and Exchange Commission’s (“SEC”) website at www.sec.gov or on GMO’s website at www.gmo.com.

The following table provides information about the Funds’ principal investment objectives and benchmarks (if any):

 

     
Fund Name   Benchmark   Investment Objective
Alpha Only Fund   FTSE 3-Month Treasury Bill Index   Total return greater than benchmark
Benchmark-Free Allocation Fund   Not Applicable   Positive total return, not relative return
Benchmark-Free Fund   Not Applicable   Positive total return
Global Asset Allocation Fund  

GMO Global Asset Allocation Index

(65% MSCI ACWI, 35% Bloomberg Barclays U.S. Aggregate Index)

  Total return greater than benchmark
Global Developed Equity Allocation Fund   MSCI World Index   Total return greater than benchmark
Global Equity Allocation Fund   MSCI ACWI   Total return greater than benchmark
Implementation Fund   Not Applicable   Positive total return, not relative return
International Developed Equity Allocation Fund   MSCI EAFE Index   Total return greater than benchmark
International Equity Allocation Fund   MSCI ACWI ex USA   Total return greater than benchmark
SGM Major Markets Fund  

Not Applicable

  Long-term total return
Special Opportunities Fund   Not Applicable   Positive total return
Strategic Opportunities Allocation Fund  

GMO Strategic Opportunities Allocation

Index (75% MSCI World Index (MSCI

Standard Index Series), 25% Bloomberg Barclays U.S. Aggregate Index)

  Total return greater than benchmark

Alpha Only Fund, Benchmark-Free Fund, Implementation Fund, Special Opportunities Fund and Strategic Opportunities Allocation Fund currently limit subscriptions.

Global Developed Equity Allocation Fund is currently distributed in Switzerland. The distribution of shares in Switzerland will be exclusively made to, and directed at, qualified investors as defined in the Swiss Collective Investment Schemes Act of 23 June 2006, as amended, and its implementing ordinance.

 

124


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

2.

Significant accounting policies

The following is a summary of significant accounting policies followed by each Fund in the preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and have been consistently followed by the Funds in preparing these financial statements. The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates. The accounting records of the Funds are maintained in U.S. dollars.

Basis of presentation and principles of consolidation: Benchmark-Free Allocation Fund, Implementation Fund, Special Opportunities Fund and SGM Major Markets Fund

Implementation Fund, Special Opportunities Fund and SGM Major Markets Fund include the accounts of their wholly-owned subsidiaries Implementation SPC Ltd., Special Opportunities SPC Ltd., and Alternative Asset SPC Ltd. (each a “wholly-owned subsidiary”), respectively, and the accompanying financial statements have been consolidated for those accounts. The consolidated financial statements include all of the assets and liabilities of each wholly-owned subsidiary. Prior to August 1, 2015, Benchmark-Free Allocation Fund (“BFAF”) included the accounts of its wholly-owned subsidiary, Implementation Fund. Effective August 1, 2015, BFAF was no longer the sole shareholder of Implementation Fund, thus consolidation was no longer required. The accompanying Financial Highlights for BFAF include the accounts of Implementation Fund through July 31, 2015. All interfund accounts and transactions have been eliminated in consolidation.

Portfolio valuation

Shares of the underlying funds and other open-end registered investment companies are valued at their most recent net asset value. Direct investments held by the Funds and underlying funds are valued as follows: Exchange-traded securities (other than exchange-traded options) for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price or (iii) most recent quoted price published by the exchange (if no reported last sale or official closing price) or (iv) the quoted price provided by a pricing source (in the event GMO deems the private market to be a more reliable indicator of market value than the exchange). Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within that range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions. Cleared derivatives are valued using the price quoted (which may be based on a model) by the relevant clearing house. If an updated quote for a cleared derivative is not available when a Fund calculates its net asset value, the derivative will generally be valued using an industry standard model, which may differ from the model used by the relevant clearing house. Over-the-counter (“OTC”) derivatives are generally valued at the price determined by an industry standard model. Unlisted securities for which market quotations are readily available are generally valued at the most recent quoted price. If quotations are not readily available or circumstances make an existing valuation methodology or procedure unreliable, derivatives and other securities are valued at fair value as determined in good faith by the Trustees or persons acting at their direction pursuant to procedures approved by the Trustees. Because of the uncertainty inherent in pricing, and in particular fair value pricing, the value determined for a particular security may be materially different from the value realized upon its sale. See the table below for information about securities and derivatives, if any, that were fair valued using methods determined in good faith by or at the direction of the Trustees. The Funds and/or the underlying funds classify such securities as Level 3 (levels defined below). For the period ended August 31, 2018, the Funds did not reduce the value of any of their OTC derivatives contracts, if any, based on the creditworthiness of their counterparties. See Note 4 “Derivative financial instruments” for a further discussion on valuation of derivatives.

The foregoing valuation methodologies are modified for equities that trade in non-U.S. securities markets that close before the close of the New York Stock Exchange (“NYSE”) due to time zone differences, including the value of equities that underlie futures, options and other derivatives (to the extent the market for those derivatives closes prior to the close of the NYSE). In those cases, the price will generally be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees that are intended to reflect valuation changes through the NYSE close. The table below shows the percentage of the net assets of the Funds, held either directly or through investments in the underlying funds, if any, that were valued using fair value inputs obtained from that independent pricing service as of August 31, 2018. These securities listed on foreign exchanges (including the value of equity securities that underlie futures, options and other derivatives (to the extent the market for such instruments closes prior to the close of the NYSE)) are classified as Level 2 (levels defined below) in the table below and are described in the disclosures of the underlying funds.

 

125


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Typically, the Funds and the underlying funds value fixed income securities at the most recent price supplied by a pricing source determined by GMO. GMO evaluates pricing sources on an ongoing basis and may change a pricing source at any time. GMO monitors erratic or unusual movements (including unusual inactivity) in the prices supplied for a security and has discretion to override a price supplied by a source (e.g., by taking a price supplied by another source) when it believes that the price supplied is not reliable. Alternative pricing sources are often but not always available for securities held by the Funds and the underlying funds. See the table below for information about securities for which no alternative pricing source was available.

“Quoted price” typically means the bid price for securities held long and the ask price for securities sold short. If a market quotation for a security does not involve a bid or an ask, the “quoted price” may be the price provided by a market participant or other third-party pricing source in accordance with the market practice for that security. If an updated quoted price for a security is not available when a Fund calculates its net asset value, the Fund will generally use the last quoted price so long as GMO believes that the last quoted price continues to represent that security’s fair value.

In the case of derivatives, prices determined by a model may reflect an estimate of the average of bid and ask prices, regardless of whether a Fund has a long position or a short position.

As discussed above, certain of the Funds and underlying funds invest in securities and/or derivatives which may have been fair valued using methods determined in good faith by or at the direction of the Trustees, fair valued using inputs obtained from an independent pricing service, or valued using prices for which no alternative pricing source was available. The table below presents securities and/or derivatives on a net basis, based on market values or unrealized appreciation/(depreciation), which will tend to understate the Funds’ exposure. The net aggregate direct and indirect exposure to these valuation methodologies (based on each Fund’s net assets) as of August 31, 2018 is as follows:

Securities and derivatives

 

       
Fund Name   Fair valued using
methods determined in
good faith by or at the
direction of the Trustees
    Fair valued using
inputs obtained
from an independent
pricing service (Net)
    Single source;
No alternative
pricing source
was available
 

Alpha Only Fund

          61%        

Benchmark-Free Allocation Fund

    < 1%       37%       2%  

Benchmark-Free Fund

    < 1%       44%       2%  

Global Asset Allocation Fund

    < 1%       39%       < 1%  

Global Developed Equity Allocation Fund

    < 1%       55%        

Global Equity Allocation Fund

    < 1%       62%        

Consolidated Implementation Fund

    < 1%       47%       1%  

International Developed Equity Allocation Fund

    < 1%       94%        

International Equity Allocation Fund

    < 1%       92%        

Consolidated SGM Major Markets Fund

          < 1%        

Consolidated Special Opportunities Fund

          11%        

Strategic Opportunities Allocation Fund

    < 1%       46%       1%  

U.S. GAAP requires the Funds to disclose the fair value of their investments in a three-level hierarchy (Levels 1, 2 and 3). The valuation hierarchy is based upon the relative observability of inputs to the valuation of the Funds’ investments. The inputs or methodologies used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers into or out of an investment’s assigned level within the fair value hierarchy. In addition, in periods of market dislocation, the observability of prices and inputs may be reduced for many instruments. This condition, as well as changes related to the liquidity of investments, could cause a security to be reclassified between levels.

 

126


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

U.S. GAAP requires additional disclosures about fair value measurements for material Level 3 securities and derivatives, if any (determined by each category of asset or liability as compared to a Fund’s total net assets separately identified in the table below). Other than Funds with investments valued using unadjusted prices supplied by a third-party pricing source (e.g., broker quotes) or as disclosed in the Asset and Liability Valuation Inputs table below, there were no other Funds with classes of investments or derivatives with direct material Level 3 holdings at August 31, 2018.

The three levels are defined as follows:

Level 1 – Valuations based on quoted prices for identical securities in active markets.

The types of assets and liabilities categorized in Level 1 generally include actively traded domestic and certain foreign equity securities; certain U.S. government obligations; derivatives actively traded on a national securities exchange (such as some futures and options); and shares of open-end mutual funds (even if their investments are valued using Level 2 or Level 3 inputs).

Level 2 – Valuations determined using other significant direct or indirect observable inputs.

The types of assets and liabilities categorized in Level 2 generally include certain U.S. government agency securities, mortgage-backed securities, asset-backed securities, certain sovereign debt obligations, and corporate bonds valued using vendor prices or broker quotes; cleared derivatives and certain OTC derivatives such as swaps, options, swaptions, and forward currency contracts valued using industry standard models; certain restricted securities valued at the most recent available market or quoted price; certain securities that are valued at the local price and adjusted by applying a premium or discount when the holdings exceed foreign ownership limitations; certain debt obligations, such as collateralized loan obligations, that have yet to begin trading that are valued at cost; and certain foreign equity securities that are adjusted based on inputs from an independent pricing service approved by the Trustees, including the value of equity securities that underlie futures, options and other derivatives (to the extent the market for such instruments closes prior to the close of the NYSE) to reflect estimated valuation changes through the NYSE close.

Level 3 – Valuations based primarily on inputs that are unobservable and significant.

The types of assets and liabilities categorized in Level 3 generally include, but are not limited to, certain debt securities (such as asset-backed, mortgage-backed, loans and sovereign debt) and derivatives even though they are valued using broker quotes; certain debt securities and derivatives adjusted by a specified discount for liquidity or other considerations; securities whose trading has been suspended or that have been de-listed from their current primary trading exchange valued at the most recent available market or quoted price; securities in default or bankruptcy proceedings for which there is no current market quotation valued at the most recent available market or quoted price; potential litigation recoveries and interests related to bankruptcy proceedings; third-party investment funds where valuations are provided by fund sponsors and which are adjusted for liquidity considerations as well as the timing of the receipt of information; certain equity securities valued based on the last traded exchange price adjusted for the movement in a relevant index; certain securities that are valued using a price from a comparable security related to the same issuer; and certain recently acquired equity securities that have yet to begin trading that are valued at cost.

The following is a summary of the respective levels assigned to the Funds’ direct securities and derivatives, if any, as of August 31, 2018:

 

         
Description   Level 1     Level 2     Level 3     Total  

Alpha Only Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Australia

  $     $ 1,106,315     $     $ 1,106,315  

Austria

          351,180             351,180  

Belgium

          87,891             87,891  

Brazil

    26,444       2,549,180             2,575,624  

Chile

          16,307             16,307  

China

    43,328       14,351,945             14,395,273  

Colombia

    11,352                   11,352  

Czech Republic

          15,540             15,540  
                                 

 

127


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Alpha Only Fund (continued)

         

Asset Valuation Inputs (continued)

         

Common Stocks (continued)

         

Denmark

  $     $ 7,432     $     $ 7,432  

Egypt

          10,410             10,410  

Finland

          471,231             471,231  

France

    21,425       1,804,482             1,825,907  

Germany

          3,780,354             3,780,354  

Greece

                36,561       36,561  

Hong Kong

          590,070             590,070  

Hungary

          49,758             49,758  

India

          3,746,677             3,746,677  

Indonesia

          199,360             199,360  

Ireland

          6,718             6,718  

Israel

          171,964             171,964  

Italy

    237,829       1,244,882             1,482,711  

Japan

          8,347,294             8,347,294  

Malaysia

          423,966       0 §      423,966  

Mexico

    1,133,671                   1,133,671  

Netherlands

          1,045,023             1,045,023  

New Zealand

          28,776             28,776  

Norway

          1,158,402             1,158,402  

Philippines

          63,855             63,855  

Poland

          153,714             153,714  

Portugal

          44,339             44,339  

Qatar

          11,213             11,213  

Russia

          534,145             534,145  

Singapore

          206,392             206,392  

South Africa

          3,432,075             3,432,075  

South Korea

    460,377       3,723,949             4,184,326  

Spain

          644,176             644,176  

Sweden

          1,441,335             1,441,335  

Switzerland

          3,741,934             3,741,934  

Taiwan

    877,712       6,107,072             6,984,784  

Thailand

          2,194,175             2,194,175  

Turkey

          788,774             788,774  

United Arab Emirates

          17,918             17,918  

United Kingdom

    1,285,900       6,555,223             7,841,123  

United States

    29,785,962                   29,785,962  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    33,884,000       71,225,446       36,561       105,146,007  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Brazil

    16,656       158,659             175,315  

Colombia

    14,927                   14,927  

Germany

          364,103             364,103  

Russia

          15,231             15,231  

South Korea

          582,948             582,948  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

    31,583       1,120,941             1,152,524  
   

 

 

   

 

 

   

 

 

   

 

 

 

Rights/Warrants

         

Thailand

                0 §      0 § 
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL RIGHTS/WARRANTS

                0 §      0 § 
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

128


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Alpha Only Fund (continued)

         

Asset Valuation Inputs (continued)

         

Mutual Funds

         

United States

  $ 7,476,175     $     $     $ 7,476,175  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    7,476,175                   7,476,175  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    7,818,013                   7,818,013  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    49,209,771       72,346,387       36,561       121,592,719  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          463,811             463,811  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 49,209,771     $ 72,810,198     $ 36,561     $ 122,056,530  
   

 

 

   

 

 

   

 

 

   

 

 

 
           

Liability Valuation Inputs

         

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

  $     $ (77,608   $     $ (77,608

Futures Contracts

         

Equity Risk

    (4,276,176                 (4,276,176
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (4,276,176   $ (77,608   $     $ (4,353,784
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Benchmark-Free Allocation Fund

         

Asset Valuation Inputs

         

Mutual Funds

  $ 12,552,472,324     $     $     $ 12,552,472,324  

Short-Term Investments

    7,583,551                   7,583,551  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    12,560,055,875                   12,560,055,875  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 12,560,055,875     $     $     $ 12,560,055,875  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Benchmark-Free Fund

 

Asset Valuation Inputs

         

Common Stocks

         

Australia

  $     $ 29,766,873     $     $ 29,766,873  

Austria

          6,982,677             6,982,677  

Belgium

          1,851,216             1,851,216  

Brazil

    1,737,121       37,211,648             38,948,769  

Canada

    57,794,676                   57,794,676  

Chile

          67,998             67,998  

China

    8,399,367       197,273,757             205,673,124  

Colombia

    2,463,871                   2,463,871  

Czech Republic

          221,434             221,434  

Denmark

    1,784,871       6,855,927             8,640,798  

Egypt

          9,052             9,052  

Finland

          8,920,493             8,920,493  

France

    8,257,681       37,713,979             45,971,660  

Germany

          73,743,520             73,743,520  

Greece

                67,166       67,166  

Hong Kong

          19,196,324             19,196,324  

Hungary

          1,215,368             1,215,368  

India

          55,453,565             55,453,565  

Indonesia

    52,074       5,514,637             5,566,711  

Ireland

    1,877,652                   1,877,652  
                                 

 

129


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Benchmark-Free Fund (continued)

 

Asset Valuation Inputs (continued)

         

Common Stocks (continued)

         

Israel

  $     $ 824,737     $     $ 824,737  

Italy

    10,676,640       19,863,277             30,539,917  

Japan

          173,075,765             173,075,765  

Malaysia

          5,229,385             5,229,385  

Mexico

    21,388,701                   21,388,701  

Netherlands

          12,634,564             12,634,564  

New Zealand

          1,476,693             1,476,693  

Norway

          24,437,103             24,437,103  

Pakistan

          137,840             137,840  

Peru

    109,010                   109,010  

Philippines

          1,053,266             1,053,266  

Poland

          5,066,103             5,066,103  

Portugal

          560,664             560,664  

Qatar

          1,227,584             1,227,584  

Russia

    1,245,550       23,482,770             24,728,320  

Singapore

          4,812,328             4,812,328  

South Africa

    39,260       50,908,012             50,947,272  

South Korea

    5,774,220       62,591,000             68,365,220  

Spain

          10,626,914             10,626,914  

Sweden

          36,373,607             36,373,607  

Switzerland

    130,480       40,205,460             40,335,940  

Taiwan

    5,669,145       89,654,896             95,324,041  

Thailand

          28,125,758             28,125,758  

Turkey

          13,710,089             13,710,089  

United Arab Emirates

          976,044             976,044  

United Kingdom

    11,327,592       96,479,158             107,806,750  

United States

    150,725,147                   150,725,147  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    289,453,058       1,185,531,485       67,166       1,475,051,709  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Brazil

          9,708,528             9,708,528  

Colombia

    26,944                   26,944  

Germany

          2,741,634             2,741,634  

Russia

          2,736,137             2,736,137  

South Korea

          13,367,627             13,367,627  

Sweden

          94,852             94,852  

Taiwan

          29,243             29,243  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

    26,944       28,678,021             28,704,965  
   

 

 

   

 

 

   

 

 

   

 

 

 

Rights/Warrants

         

Thailand

    74,814                   74,814  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL RIGHTS/WARRANTS

    74,814                   74,814  
   

 

 

   

 

 

   

 

 

   

 

 

 

Investment Funds

         

United States

    1,734,614                   1,734,614  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENT FUNDS

    1,734,614                   1,734,614  
   

 

 

   

 

 

   

 

 

   

 

 

 

Debt Obligations

         

United States

    161,862,888       592,084,194             753,947,082  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

    161,862,888       592,084,194             753,947,082  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

130


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Benchmark-Free Fund (continued)

 

Asset Valuation Inputs (continued)

         

Mutual Funds

         

United States

  $ 1,113,718,893     $     $     $ 1,113,718,893  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    1,113,718,893                   1,113,718,893  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    18,223,136       199,446,644             217,669,780  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    1,585,094,347       2,005,740,344       67,166       3,590,901,857  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          2,230,442             2,230,442  

Swap Contracts

         

Equity Risk

          37,304             37,304  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,585,094,347     $ 2,008,008,090     $ 67,166     $ 3,593,169,603  
   

 

 

   

 

 

   

 

 

   

 

 

 
           

Liability Valuation Inputs

         

Common Stocks

         

Brazil

  $ (2,643,435   $     $     $ (2,643,435

Canada

    (5,511,435                 (5,511,435

Denmark

          (1,168,643           (1,168,643

Finland

          (39,707           (39,707

France

          (2,094,194           (2,094,194

Germany

          (6,169,376           (6,169,376

Israel

    (1,188,536                 (1,188,536

Italy

          (5,477,322           (5,477,322

Japan

          (7,081,894           (7,081,894

Netherlands

          (618,318           (618,318

Singapore

          (73,496           (73,496

Spain

          (6,606,422           (6,606,422

Sweden

          (45,218           (45,218

Switzerland

          (2,838,305           (2,838,305

United Kingdom

          (3,922,527           (3,922,527

United States

    (1,408,279                 (1,408,279
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    (10,751,685     (36,135,422           (46,887,107
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          (353,507           (353,507

Futures Contracts

         

Equity Risk

    (12,540,909                 (12,540,909

Swap Contracts

         

Equity Risk

          (665,959           (665,959
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (23,292,594   $ (37,154,888   $     $ (60,447,482
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Global Asset Allocation Fund

         

Asset Valuation Inputs

         

Mutual Funds

  $ 2,191,777,680     $     $     $ 2,191,777,680  

Debt Obligations

         

Asset-Backed Securities

          55,973             55,973  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

          55,973             55,973  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

131


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Global Asset Allocation Fund (continued)

         

Asset Valuation Inputs (continued)

         

Short-Term Investments

  $ 315,238     $     $     $ 315,238  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    2,192,092,918       55,973             2,192,148,891  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 2,192,092,918     $ 55,973     $     $ 2,192,148,891  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Global Developed Equity Allocation Fund

         

Asset Valuation Inputs

         

Mutual Funds

  $ 460,355,817     $     $     $ 460,355,817  

Short-Term Investments

    121,679                   121,679  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    460,477,496                   460,477,496  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 460,477,496     $     $     $ 460,477,496  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Global Equity Allocation Fund

         

Asset Valuation Inputs

         

Mutual Funds

  $ 2,013,440,565     $     $     $ 2,013,440,565  

Short-Term Investments

    656,642                   656,642  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    2,014,097,207                   2,014,097,207  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 2,014,097,207     $     $     $ 2,014,097,207  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Consolidated Implementation Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Australia

  $     $ 102,646,178     $     $ 102,646,178  

Austria

          27,035,385             27,035,385  

Belgium

          8,657,425             8,657,425  

Brazil

    22,436,987       128,864,478             151,301,465  

Canada

    189,484,519                   189,484,519  

Chile

          1,183,490             1,183,490  

China

    31,436,425       812,673,509             844,109,934  

Colombia

    11,568,086                   11,568,086  

Czech Republic

          2,294,668             2,294,668  

Denmark

    5,236,605       19,745,778             24,982,383  

Egypt

          129,694             129,694  

Finland

          32,180,897             32,180,897  

France

    19,017,334       128,066,283             147,083,617  

Germany

          293,671,364             293,671,364  

Greece

          505,928             505,928  

Hong Kong

          56,945,469             56,945,469  

Hungary

          4,495,847             4,495,847  

India

          171,936,036             171,936,036  

Indonesia

    1,053,315       51,767,348             52,820,663  

Ireland

    4,664,326       52,683             4,717,009  

Israel

    23,474,902       15,912,085             39,386,987  

Italy

    31,075,593       74,450,340             105,525,933  

Japan

          578,352,108             578,352,108  

Malaysia

          16,912,282             16,912,282  

Mexico

    127,439,367                   127,439,367  

Netherlands

    32,906,362       49,105,836             82,012,198  

New Zealand

          2,844,871             2,844,871  

Norway

          72,212,945             72,212,945  
                                 

 

132


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Consolidated Implementation Fund (continued)

         

Asset Valuation Inputs (continued)

         

Common Stocks (continued)

         

Pakistan

  $     $ 1,633,976     $     $ 1,633,976  

Philippines

          12,863,795             12,863,795  

Poland

          69,985,792             69,985,792  

Portugal

          2,256,625             2,256,625  

Qatar

          25,704,874             25,704,874  

Russia

    15,984,601       259,665,427             275,650,028  

Singapore

          14,272,940             14,272,940  

South Africa

    541,788       259,531,776             260,073,564  

South Korea

    17,951,712       243,416,358             261,368,070  

Spain

    25,203,259       34,242,129             59,445,388  

Sweden

          116,063,344             116,063,344  

Switzerland

          155,141,883             155,141,883  

Taiwan

    40,745,212       521,705,781             562,450,993  

Thailand

          159,548,871             159,548,871  

Turkey

    316,646       98,682,877             98,999,523  

United Arab Emirates

          12,967,608             12,967,608  

United Kingdom

    101,612,975       306,941,451             408,554,426  

United States

    1,002,428,640       1,480,812       4,652,628       1,008,562,080  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    1,704,578,654       4,948,749,246       4,652,628       6,657,980,528  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Brazil

    8,841       32,689,585             32,698,426  

Germany

          14,748,228             14,748,228  

Russia

          13,806,431             13,806,431  

South Korea

          47,925,562             47,925,562  

Taiwan

          445,387             445,387  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

    8,841       109,615,193             109,624,034  
   

 

 

   

 

 

   

 

 

   

 

 

 

Rights/Warrants

         

Brazil

                436,824       436,824  

Canada

                137,808       137,808  

Thailand

    362,657                   362,657  

United States

                130,841       130,841  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL RIGHTS/WARRANTS

    362,657             705,473       1,068,130  
   

 

 

   

 

 

   

 

 

   

 

 

 

Investment Funds

         

United States

    35,554,467                   35,554,467  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENT FUNDS

    35,554,467                   35,554,467  
   

 

 

   

 

 

   

 

 

   

 

 

 

Debt Obligations

         

Italy

          4,112,828             4,112,828  

Jamaica

          6,305,356             6,305,356  

Japan

          365,016,854             365,016,854  

Luxembourg

                6,069,889       6,069,889  

Puerto Rico

    1,368,750       18,717,566             20,086,316  

Spain

                4,987,421       4,987,421  

United States

    951,482,870       1,825,597,967       43,408,370       2,820,489,207  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

    952,851,620       2,219,750,571       54,465,680       3,227,067,871  
   

 

 

   

 

 

   

 

 

   

 

 

 

Mutual Funds

         

United States

    43,733,040                   43,733,040  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    43,733,040                   43,733,040  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

133


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Consolidated Implementation Fund (continued)

         

Asset Valuation Inputs (continued)

         

Short-Term Investments

  $ 123,009,874     $ 293,477,628     $     $ 416,487,502  

Purchased Options

    2,375,845             799,510       3,175,355  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    2,862,474,998       7,571,592,638       60,623,291       10,494,690,927  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          18,872,718             18,872,718  

Swap Contracts

         

Credit Risk

          1,555,431             1,555,431  

Equity Risk

          4,498             4,498  

Interest Rate Risk

          7,595,247             7,595,247  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 2,862,474,998     $ 7,599,620,532     $ 60,623,291     $ 10,522,718,821  
   

 

 

   

 

 

   

 

 

   

 

 

 
           

Liability Valuation Inputs

         

Common Stocks

         

Brazil

  $ (9,681,039   $     $     $ (9,681,039

Canada

    (20,192,254                 (20,192,254

China

    (36,000,257                 (36,000,257

Denmark

          (2,951,578           (2,951,578

France

          (6,403,772           (6,403,772

Germany

          (22,072,712           (22,072,712

Israel

    (1,591,362                 (1,591,362

Italy

          (15,077,266           (15,077,266

Japan

          (56,677,611           (56,677,611

Netherlands

          (1,304,877           (1,304,877

Singapore

          (452,242           (452,242

Spain

          (13,457,532           (13,457,532

Switzerland

          (13,177,723           (13,177,723

United Kingdom

          (14,255,233           (14,255,233

United States

    (136,221,910                 (136,221,910
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    (203,686,822     (145,830,546           (349,517,368
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          (8,697,555           (8,697,555

Futures Contracts

         

Equity Risk

    (62,026,499                 (62,026,499

Written Options

         

Equity Risk

    (1,560,905                 (1,560,905

Swap Contracts

         

Equity Risk

          (1,843,355           (1,843,355

Interest Rate Risk

          (6,600,284           (6,600,284
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (267,274,226   $ (162,971,740   $     $ (430,245,966
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

International Developed Equity Allocation Fund

         

Asset Valuation Inputs

         

Mutual Funds

  $ 635,059,954     $     $     $ 635,059,954  

Short-Term Investments

    241,796                   241,796  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    635,301,750                   635,301,750  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 635,301,750     $     $     $ 635,301,750  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

134


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

International Equity Allocation Fund

         

Asset Valuation Inputs

         

Mutual Funds

  $ 1,020,151,473     $     $     $ 1,020,151,473  

Short-Term Investments

    356,878                   356,878  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    1,020,508,351                   1,020,508,351  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,020,508,351     $     $     $ 1,020,508,351  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Consolidated SGM Major Markets Fund

         

Asset Valuation Inputs

         

Debt Obligations

         

U.S. Government

  $ 768,565,138     $     $     $ 768,565,138  

U.S. Government Agency

    348,966,754                   348,966,754  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

    1,117,531,892                   1,117,531,892  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    596,548,736       17,204,641             613,753,377  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    1,714,080,628       17,204,641             1,731,285,269  
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Forward Currency Contracts

         

Foreign Currency Risk

          6,305,016             6,305,016  

Futures Contracts

         

Equity Risk

          3,055,025             3,055,025  

Interest Rate Risk

    2,395,440                   2,395,440  

Physical Commodity Contract Risk

    5,582,905                   5,582,905  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,722,058,973     $ 26,564,682     $     $ 1,748,623,655  
   

 

 

   

 

 

   

 

 

   

 

 

 
           

Liability Valuation Inputs

         

Forward Currency Contracts

         

Foreign Currency Risk

  $     $ (15,066,893   $     $ (15,066,893

Futures Contracts

         

Equity Risk

    (34,386,427     (11,498,298           (45,884,725

Interest Rate Risk

    (120,210                 (120,210
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (34,506,637   $ (26,565,191   $     $ (61,071,828
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Consolidated Special Opportunities Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Canada

  $     $     $ 45,977     $ 45,977  

Germany

          18,234,282             18,234,282  

Netherlands

    21,427,250                   21,427,250  

United Kingdom

          32,732,492             32,732,492  

United States

    260,557,964                   260,557,964  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    281,985,214       50,966,774       45,977       332,997,965  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    118,908,642                   118,908,642  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    400,893,856       50,966,774       45,977       451,906,607  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 400,893,856     $ 50,966,774     $ 45,977     $ 451,906,607  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

135


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Consolidated Special Opportunities Fund (continued)

         

Liability Valuation Inputs

         

Written Options

         

Equity Risk

  $ (229,000   $     $     $ (229,000
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (229,000   $     $     $ (229,000
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Strategic Opportunities Allocation Fund

         

Asset Valuation Inputs

         

Common Stocks

         

Australia

  $     $ 1,113,824     $     $ 1,113,824  

Austria

          238,952             238,952  

Belgium

          31,660             31,660  

Brazil

          2,172,196             2,172,196  

Canada

    2,780,039                   2,780,039  

China

          4,297,120             4,297,120  

Denmark

    108,174       241,208             349,382  

France

    441,568       1,276,055             1,717,623  

Germany

          3,259,506             3,259,506  

Hong Kong

          996,807             996,807  

India

    982,421                   982,421  

Ireland

    44,706                   44,706  

Italy

    680,978       1,502,466             2,183,444  

Japan

          10,590,568             10,590,568  

Malaysia

          152,000             152,000  

Malta

                0 §       

Mexico

    19,325                   19,325  

Netherlands

          124,038             124,038  

New Zealand

          9,387             9,387  

Norway

          1,166,290             1,166,290  

Poland

          23,724             23,724  

Portugal

          17,139             17,139  

Singapore

          43,567             43,567  

South Africa

          937,712             937,712  

South Korea

    494,190       892,144             1,386,334  

Spain

          142,299             142,299  

Sweden

          2,748,390             2,748,390  

Switzerland

          374,817             374,817  

Taiwan

          1,652,430             1,652,430  

Thailand

          25,198             25,198  

United Kingdom

    191,400       5,007,870             5,199,270  

United States

    61,229,746                   61,229,746  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    66,972,547       39,037,367       0 §      106,009,914  
   

 

 

   

 

 

   

 

 

   

 

 

 

Preferred Stocks

         

Germany

          707,709             707,709  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL PREFERRED STOCKS

          707,709             707,709  
   

 

 

   

 

 

   

 

 

   

 

 

 

Debt Obligations

         

United States

          86,094,937             86,094,937  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL DEBT OBLIGATIONS

          86,094,937             86,094,937  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

136


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

         
Description   Level 1     Level 2     Level 3     Total  

Strategic Opportunities Allocation Fund (continued)

         

Asset Valuation Inputs (continued)

         

Mutual Funds

         

United States

  $ 916,387,200     $     $     $ 916,387,200  
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL MUTUAL FUNDS

    916,387,200                   916,387,200  
   

 

 

   

 

 

   

 

 

   

 

 

 

Short-Term Investments

    1,195,166                   1,195,166  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

    984,554,913       125,840,013             1,110,394,926  
   

 

 

   

 

 

   

 

 

   

 

 

 
           

Liability Valuation Inputs

         

Common Stocks

         

Brazil

  $ (268,677   $     $     $ (268,677

Canada

    (1,307,316                 (1,307,316

France

          (457,497           (457,497

Germany

          (1,669,831           (1,669,831

Italy

          (121,685           (121,685

Japan

          (1,366,351           (1,366,351

Netherlands

          (40,777           (40,777

Portugal

          (118,680           (118,680

Spain

          (854,823           (854,823

Switzerland

          (787,511           (787,511

United Kingdom

          (456,187           (456,187

United States

    (15,997,273                 (15,997,273
   

 

 

   

 

 

   

 

 

   

 

 

 

TOTAL COMMON STOCKS

    (17,573,266     (5,873,342           (23,446,608
   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives^

         

Swap Contracts

         

Equity Risk

          (75,139           (75,139
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (17,573,266   $ (5,948,481   $     $ (23,521,747
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

The risks referenced in the tables above are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Derivative financial instruments” sections below for a further discussion of risks.

 

  ^

The tables above are based on market values or unrealized appreciation/(depreciation), in the case of forward currency contracts, rather than the notional amounts of derivatives. The uncertainties surrounding the valuation inputs for a derivative are likely to be more significant to the Funds’ net asset values than the uncertainties surrounding inputs for a non-derivative security with the same market value.

 

  §

Represents the interest in securities that were determined to have a value of zero at August 31, 2018.

The underlying funds held at period end are classified above as Level 1. For the summary of valuation inputs of the underlying funds, please refer to the underlying funds’ Notes to Financial Statements.

For all Funds for the period ended August 31, 2018, there were no significant transfers between Level 1 and Level 2.

 

137


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The following is a reconciliation of securities and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:

 

                     
     Balances
as of
February 28,
2018
    Purchases     Sales     Accrued
Discounts/
Premiums
   

Total
Realized
Gain/

(Loss)

   

Change in
Unrealized
Appreciation

(Depreciation)

    Transfer
into
Level 3†
    Transfer
out of
Level 3†
    Balances
as of
August 31,
2018
   

Net Change in
Unrealized
Appreciation
(Depreciation)
from
Investments
Still Held as
of August 31,

2018

 

Alpha Only Fund

                     

Common Stocks

                     

Greece

  $     $     $     $     $     $     $ 36,561 ‡    $     $ 36,561     $  

Rights/Warrants

                     

Brazil

    5,671             0             0       (5,671                        
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

  $ 5,671     $     $ 0     $     $ 0     $ (5,671   $ 36,561     $     $ 36,561     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 

Benchmark-Free Fund

 

                 

Common Stocks

                     

Greece

  $     $     $     $     $     $     $ 67,166 ‡    $     $ 67,166     $  

Rights/Warrants

                     

Brazil

    113,625             0             0       (113,625                        
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

  $ 113,625     $     $ 0     $     $ 0     $ (113,625   $ 67,166     $     $ 67,166     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 

Consolidated Implementation Fund

 

                 

Common Stocks

                     

United Kingdom

  $     $     $     $     $ (235,198   $ 235,198     $     $     $     $  

United States

          4,733,782                     (81,154                 4,652,628       (81,154

Rights/Warrants

                     

Brazil

    203,741       519,966       0                   (286,883                 436,824       (83,142

Canada

    217,232                               (79,424                 137,808       (71,715

United States

    48,966             (6,110           (105,144     193,129                   130,841       104,672  

Debt Obligations

                     

Bank Loans

                     

Luxembourg

          6,038,500       (16,213     16,769       475       30,358                   6,069,889       30,358  

Spain

    6,460,857       954,915       (3,785,043     (8,996     (119,455     (6,765                 3,495,513       (6,765

United States

    24,534,800       19,554,057       (10,508,389     199,562       159,475       (684,730                 33,254,775       (684,730

Corporate Debt

                       

Brazil

    30,260,306             (27,088,798     5,152,097       (17,181,152     8,857,547                          

Spain

    2,788,545       72,974       (1,292,834     (3,959     (24,692     (48,126                 1,491,908       (48,126

United States

    1,269,450       1,694,560       (350,075     27,516       17,666       93,378       7,401,100             10,153,595       93,378  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

  $ 65,783,897     $ 33,568,754     $ (43,047,462   $ 5,382,989     $ (17,488,025   $ 8,222,528     $ 7,401,100     $     $ 59,823,781     $ (747,224
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                       

Purchased Options

                     

United States

  $     $ 849,684     $     $     $     $ (50,174   $     $     $ 799,510     $ (50,174
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

  $ 65,783,897     $ 34,418,438     $ (43,047,462   $ 5,382,989     $ (17,488,025   $ 8,172,354     $ 7,401,100     $     $ 60,623,291     $ (797,398
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 

Consolidated Special Opportunities Fund

 

                 

Common Stocks

                     

Canada

  $ 70,137     $     $     $     $     $ (24,160   $     $     $ 45,977     $ (24,160
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments

  $ 70,137     $     $     $     $     $ (24,160   $     $     $ 45,977     $ (24,160
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                                 

 

 

The Funds account for securities and derivatives, if any, transferred into and out of Level 3 at the value at the end of the period.

 

Financial assets transferred between levels were due to a change in observable and/or unobservable inputs.

 

138


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The net aggregate direct and indirect exposure to investments in securities and/or derivatives using Level 3 inputs and presented on a net basis, which will tend to understate the Funds’ exposure, (based on each Fund’s net assets) as of August 31, 2018 were as follows:

 

   
Fund Name   Level 3 securities
and derivatives
 

Alpha Only Fund

    < 1%  

Benchmark-Free Allocation Fund

    1%  

Benchmark-Free Fund

    < 1%  

Global Asset Allocation Fund

    < 1%  

Global Developed Equity Allocation Fund

    < 1%  

Global Equity Allocation Fund

    < 1%  

Consolidated Implementation Fund

    1%  

International Developed Equity Allocation Fund

    < 1%  

International Equity Allocation Fund

    < 1%  

Consolidated SGM Major Markets Fund

     

Consolidated Special Opportunities Fund

    < 1%  

Strategic Opportunities Allocation Fund

    1%  

Cash

Cash and foreign currency, if any, in the Statements of Assets and Liabilities consist of cash balances held with the custodian.

Due to/from broker

Due to/from broker in the Statements of Assets and Liabilities includes collateral on swap contracts, futures contracts, option contracts and forward currency contracts, if any, and may include marked-to-market amounts related to foreign currency or cash owed.

Foreign currency translation

The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm Eastern time. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated in the Statements of Operations from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.

Loan assignments and participations

Certain Funds may invest in direct debt instruments, which are interests in amounts owed to lenders or lending syndicates, to suppliers of goods or services, or to other parties by corporate, governmental or other borrower. Such “loans” may include bank loans, promissory notes, and loan participations, or in the case of suppliers of goods or services, trade claims or other receivables. A loan is often administered by a bank or other financial institution that acts as agent for all holders. The agent administers the terms of the loan, as specified in the loan agreement. Unless, under the terms of the loan or other indebtedness a Fund has direct recourse against the borrower, it may have to rely on the agent to enforce its rights against the borrower. When investing in a loan participation, (i) a Fund has the right to receive payments of principal, interest and any fees to which it is entitled only from the party from whom the Fund has purchased the participation and only upon receipt by that party of payments from the borrower and (ii) a Fund generally has no right to enforce compliance by the borrower with the terms of the loan agreement or to vote on matters arising under the loan agreement. Thus, a Fund may be subject to credit risk both of the party from whom it purchased the loan participation and the borrower and that Fund may have minimal control over the terms of any loan modification. Loan assignments and participations outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

 

139


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Repurchase agreements

The Funds may enter into repurchase agreements with banks and brokers. Under a repurchase agreement a Fund acquires a security for a relatively short period for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired may be less than the amount owed to the Fund by the seller. If the seller in a repurchase agreement transaction defaults or enters into insolvency proceedings and the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and, even if the Fund is able to dispose of the securities, the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities. As of August 31, 2018, the Funds listed below had entered into repurchase agreements. The value of related collateral for each broker listed below exceeds the value of the repurchase agreements at period end. Repurchase agreements outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

 

       
Fund Name   Counterparty   Gross Value    

Weighted Average

Maturity (days)

 

Benchmark-Free Fund

  Daiwa Capital
Markets
    $115,734,491       4  

Consolidated Implementation Fund

  Nomura Securities
International, Inc.
    149,999,882       4  

Reverse repurchase agreements

The Funds may enter into reverse repurchase agreements with banks and brokers to enhance return. Under a reverse repurchase agreement a Fund sells portfolio assets subject to an agreement by that Fund to repurchase the same assets at an agreed upon price and date. A Fund can use the proceeds received from entering into a reverse repurchase agreement to make additional investments, which generally causes the Fund’s portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and as a result may realize a loss on the transaction if the securities it sold are worth more than the purchase price it originally received from the buyer. Reverse repurchase agreements outstanding at the end of the year, if any, are listed in each applicable Fund’s Schedule of Investments.

Inflation-indexed bonds

Certain Funds may invest in inflation-indexed bonds. Inflation-indexed bonds are fixed income securities whose principal value is adjusted periodically according to the rate of inflation/deflation. Two structures are common. The U.S. Treasury and some other issuers use a structure that accrues inflation/deflation into the principal value of the bond. Many other issuers adjust the coupon accruals for inflation related changes. Most other issuers pay out any inflation related accruals as part of a semiannual coupon.

The market price of inflation-indexed bonds normally changes when real interest rates change. Real interest rates, in turn, are tied to the relationship between nominal interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e., nominal interest rate minus inflation) might decline, leading to an increase in value of inflation-indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation, real interest rates might rise, leading to a decrease in value of inflation-indexed bonds. Coupon payments received by a Fund from inflation-indexed bonds are generally included in the Fund’s gross income for the period in which they accrue. In addition, any increase/decrease in the principal amount of an inflation-indexed bond is generally included in the Fund’s gross income even though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Short sales

Certain Funds may enter into short sales transactions. A short sale is a transaction in which a Fund sells securities it may not own in anticipation of a decline in the fair market value of the securities. Securities sold in short sale transactions and the interest payable on such securities, if any, are reflected as a liability in the Statements of Assets and Liabilities. A Fund is obligated to deliver securities at the trade price at the time the short position is closed. Possible losses from short sales may be unlimited, whereas losses from purchases cannot exceed the total amount invested. Short sales outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

 

140


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Some Funds may loan their portfolio securities through an “enhanced custody” program offered by the Funds’ custodian to facilitate the borrowing of securities for the Funds’ short sales. Under the program, a Fund borrows securities from the custodian and sells short those borrowed securities. The Fund may utilize various ways of collateralizing its obligation to return the borrowed securities, including by pledging securities held in the Fund’s custodial account to the custodian, or by lending securities held in the Fund’s custodial account to the custodian. The loans will be secured by collateral from the custodian equal at all times to at least 100% of the market value of the loaned securities. For its participation in the enhanced custody program, the Fund will pay the custodian a securities borrow fee and a financing charge. The following table provides the value of securities on loan under this program as of August 31, 2018:

 

   
Fund Name  

Value of securities

on loan ($)

 

Benchmark-Free Fund

    25,760,595  

Implementation Fund

    118,828,587  

Strategic Opportunities Allocation Fund

    11,363,020  

Municipal obligations

Municipal obligations are issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies and instrumentalities and the District of Columbia to obtain funds for various public purposes. Municipal notes are generally used to provide for short-term capital needs, such as to finance working capital needs of municipalities or to provide various interim or construction financing, and generally have maturities of one year or less. Municipal bonds, which meet longer-term capital needs and generally have maturities of more than one year when issued, have two principal classifications: “general obligation” bonds and “revenue” bonds. Issuers of general obligation bonds include states, counties, cities, towns and regional districts. The basic security behind general obligation bonds is the issuer’s pledge of its full faith, credit, and taxing power for the payment of principal and interest. Revenue bonds have been issued to fund a wide variety of capital projects. The principal security for a revenue bond is generally the net revenues derived from a particular facility or group of facilities or, in some cases, from the proceeds of a special excise or other specific revenue source. Although the principal security behind these bonds varies widely, many provide additional security in the form of a debt service reserve fund whose monies also may be used to make principal and interest payments on the issuer’s obligations. Municipal obligations at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Trade claims

Certain Funds may purchase trade claims against companies, including companies in bankruptcy or reorganization proceedings. Trade claims generally include claims of suppliers for goods delivered and not paid, claims for unpaid services rendered, claims for contract rejection damages and claims related to litigation. Trade claims are illiquid instruments which generally do not pay interest and there can be no guarantee that the debtor will ever be able to satisfy the obligation on the trade claim. Such claims are typically unsecured and may be subordinated to other unsecured obligations of a debtor, and generally are subject to defenses of the debtor with respect to the underlying transaction giving rise to the trade claim. Trade claims outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Taxes and distributions

Each Fund has elected to be treated or intends to elect to be treated and intends to qualify each tax year as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). Each Fund intends to distribute its net investment income, if any, and its net realized short-term and long-term capital gains, if any, after giving effect to any available capital loss carryforwards for U.S. federal income tax purposes. Therefore, each Fund makes no provision for U.S. federal income or excise taxes.

Alternative Asset SPC Ltd., Implementation SPC Ltd. and Special Opportunities SPC Ltd. are wholly-owned subsidiaries of SGM Major Markets Fund, Implementation Fund and Special Opportunities Fund, respectively, and each has elected to be treated as a (non-U.S.) corporation for U.S. federal income tax purposes.

 

141


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The policy of each Fund is to declare and pay dividends of its net investment income, if any, at least annually, although the Funds are permitted to, and will from time to time, declare and pay dividends of net investment income, if any, more frequently. Each Fund also intends to distribute net realized short-term and long-term capital gains, if any, at least annually. In addition, each Fund may, from time to time at their discretion, make unscheduled distributions in advance of large redemptions by shareholders or as otherwise deemed appropriate by a Fund. Typically, all distributions are reinvested in additional shares of each Fund, at net asset value, unless GMO or its agents receive and process a shareholder election to receive cash distributions. Distributions to shareholders are recorded by each Fund on the ex-dividend date.

Taxes on foreign interest and dividend income are generally withheld in accordance with the applicable country’s tax treaty with the United States. The foreign withholding rates applicable to a Fund’s investments in certain jurisdictions may be higher if a significant portion of the Fund is held by non-U.S. shareholders and/or if certain investments are made by a Fund’s wholly-owned subsidiary. Each Fund may be subject to taxation on realized capital gains, repatriation proceeds and other transaction-based charges imposed by certain countries in which it invests. Transaction-based charges are generally calculated as a percentage of the transaction amount. Taxes related to capital gains realized during the period ended August 31, 2018, if any, are reflected as part of Net realized gain (loss) in the Statements of Operations. Changes in tax liabilities related to capital gain taxes on unrealized investment gains, if any, are reflected as part of Change in net unrealized appreciation (depreciation) in the Statements of Operations.

Certain Funds have previously filed for and/or may file for additional tax refunds with respect to certain taxes withheld by certain countries. Generally, the amount of such refunds that a Fund reasonably determines are collectible and free from significant contingencies are reflected in a Fund’s net asset value and are reflected as Dividends from unaffiliated issuers in the Statements of Operations. In certain circumstances, a Fund’s receipt of such refunds may cause the Fund and/or its shareholders to be liable for U.S. federal income taxes, interest charges and related fees.

Foreign taxes paid by each Fund may be treated, to the extent permissible by the Code (and other applicable U.S. federal tax guidance) and if that Fund so elects, as if paid by U.S. shareholders of that Fund.

Income and capital gain distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP. Certain capital accounts in the financial statements are periodically adjusted for permanent differences in order to reflect their tax character. These adjustments have no impact on net assets or net asset value per share. Temporary differences that arise from recognizing certain items of income, expense, gain or loss in different periods for financial statement and tax purposes will likely reverse at some time in the future. Distributions in excess of net investment income or net realized gains are temporary over-distributions for financial statement purposes resulting from differences in the recognition or classification of income or distributions for financial statement and tax purposes.

Distributions in excess of a Fund’s tax basis earnings and profits, if significant, are reported in the Funds’ financial statements as a return of capital.

 

142


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

As of February 28, 2018, certain Funds elected to defer to March 1, 2018 late-year ordinary losses and post-October capital losses. The Funds’ loss deferrals are as follows:

 

     
Fund Name   Late-Year
Ordinary Loss
Deferral ($)
    Post-October
Capital Losses ($)
 

Alpha Only Fund

    (498,528)       (432,765)  

Benchmark-Free Allocation Fund

    (14,099,472)        

Benchmark-Free Fund

           

Global Asset Allocation Fund

           

Global Developed Equity Allocation Fund

    (1,264)        

Global Equity Allocation Fund

    (12,338)        

Consolidated Implementation Fund

           

International Developed Equity Allocation Fund

    (3,056)        

International Equity Allocation Fund

    (5,092)        

Consolidated SGM Major Markets Fund

    (2,314,280)       (21,486,920)  

Consolidated Special Opportunities Fund

    (1,795,158)       (4,297)  

Strategic Opportunities Allocation Fund

           

As of February 28, 2018, certain Funds had capital loss carryforwards available to offset future realized gains, if any, to the extent permitted by the Code. Net capital losses recognized in taxable years beginning on or after March 1, 2011 are carried forward without expiration and generally retain their short-term and/or long-term tax character, as applicable. In addition, such losses should be utilized prior to losses scheduled to expire on or before February 28, 2019. As a result of this ordering rule, losses that are subject to expiration may expire unused. Utilization of the capital loss carryforwards, post-October capital losses, late-year ordinary losses, and losses realized subsequent to February 28, 2018, if any, could be subject to further limitations imposed by the Code related to share ownership activity. The Funds’ capital loss carryforwards are as follows:

 

       
     Short-Term ($)    

Total

Short-Term
($)

    Long-Term ($)  
Fund Name   Expiration
Date
2/28/2019
   

No

Expiration
Date

   

No

Expiration
Date

 
Alpha Only Fund           (222,208,680)       (222,208,680)       (172,307,094)  
Benchmark-Free Allocation Fund     (10,499,416)       (20,273,725)       (30,773,141)       (208,740,084)  
Benchmark-Free Fund           (27,643,271)       (27,643,271)       (388,241,964)  
Global Asset Allocation Fund                       (189,439,171)  
Global Developed Equity Allocation Fund                       (79,826,540)  
Global Equity Allocation Fund                       (191,565,767)  
Consolidated Implementation Fund           (704,778,936)       (704,778,936)        
International Developed Equity Allocation Fund     (22,515,333)             (22,515,333)       (66,355,364)  
International Equity Allocation Fund                       (54,500,044)  
Consolidated SGM Major Markets Fund                        
Consolidated Special Opportunities Fund                        
Strategic Opportunities Allocation Fund                        

 

143


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

As of August 31, 2018, the approximate total cost, aggregate investment-level gross/net unrealized appreciation (depreciation) in the value of total investments (including total securities sold short, if any), and the net unrealized appreciation (depreciation) of outstanding financial instruments for U.S. federal income tax purposes were as follows:

 

     
     Total Investments     Outstanding
Financial
Instruments
 
         
Fund Name   Aggregate
Cost ($)
    Gross Unrealized
Appreciation ($)
    Gross Unrealized
(Depreciation) ($)
    Net Unrealized
Appreciation
(Depreciation) ($)
    Net Unrealized
Appreciation
(Depreciation) ($)
 

Alpha Only Fund

    121,025,665       7,841,047       (7,273,993)       567,054       (3,889,973)  

Benchmark-Free Allocation Fund

    12,349,630,410       294,808,863       (84,383,398)       210,425,465        

Benchmark-Free Fund

    3,470,903,588       185,860,385       (112,749,223)       73,111,162       (11,292,629)  

Global Asset Allocation Fund

    2,235,693,744             (43,544,853)       (43,544,853)        

Global Developed Equity Allocation Fund

    442,266,892       18,210,604             18,210,604        

Global Equity Allocation Fund

    2,038,541,684       21,260,463       (45,704,940)       (24,444,477)        

Consolidated Implementation Fund

    10,188,477,795       445,365,264       (488,669,500)       (43,304,236)       (53,480,343)  

International Developed Equity Allocation Fund

    716,229,582       6,780,646       (87,708,478)       (80,927,832)        

International Equity Allocation Fund

    1,082,125,719       27,352,286       (88,969,654)       (61,617,368)        

Consolidated SGM Major Markets Fund

    1,718,587,661       73,742,524       (61,044,916)       12,697,608       (49,316,346)  

Consolidated Special Opportunities Fund

    341,409,249       126,411,048       (15,913,690)       110,497,358       140,592  

Strategic Opportunities Allocation Fund

    1,047,871,890       49,631,392       (10,554,964)       39,076,428       (75,139)  

The Funds are subject to authoritative guidance related to the accounting and disclosure of uncertain tax positions under U.S. GAAP. This guidance sets forth a minimum threshold for the financial statement recognition of tax positions taken based on the technical merits of such positions. United States and non-U.S. tax rules (including the interpretation and application of tax laws) are subject to change. The Funds file tax returns and/or adopt certain tax positions in various jurisdictions. Non-U.S. taxes are provided for based on the Funds’ understanding of the prevailing tax rules of the non-U.S. markets in which they invest. Recently enacted tax rules, including interpretations of tax laws and tax legislation/initiatives currently under consideration in various jurisdictions, including the U.S., might affect the way the Funds and their investors are taxed prospectively and/or retroactively. Prior to the expiration of the relevant statutes of limitations, if any, the Funds are subject to examination by U.S. federal, state, local and non-U.S. jurisdictions with respect to the tax returns they have filed and the tax positions they have adopted. The Funds’ U.S. federal income tax returns are generally subject to examination by the Internal Revenue Service for a period of three years after they are filed. State, local and/or non-U.S. tax returns and/or other filings may be subject to examination for different periods, depending upon the tax rules of each applicable jurisdiction.

Security transactions and related investment income

Security transactions are accounted for in the financial statements on trade date. For purposes of daily net asset value calculations, the Funds’ policy is that security transactions are generally accounted for on the following business day. GMO may override that policy and a Fund may account for security transactions on trade date if it experiences significant purchases or redemptions or engages in significant portfolio transactions. Dividend income, net of applicable foreign withholding taxes, if any, is recorded on the ex-dividend date or, if later, when a Fund is informed of the ex-dividend date. Income dividends and capital gain distributions from the underlying funds are recorded on the ex-dividend date. Interest income is recorded on the accrual basis and is adjusted for the amortization of premiums and accretion of discounts. Principal on inflation-indexed securities is adjusted for inflation and any increase or decrease is recorded as interest income or investment loss. Coupon income is not recognized on securities for which collection is not expected. Paydown gains and losses on mortgage-related and other asset-backed securities, if any, are recorded as components of interest income in the Statements of Operations. Non-cash dividends, if any, are recorded at the fair market value of the asset received. In determining the net gain or loss on securities sold, the Funds use the identified cost basis.

 

144


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Expenses and class allocations

Most of the expenses of the Trust are directly attributable to an individual Fund. Generally, common expenses are allocated among the Funds based on, among other things, the nature and type of expense and the relative size of the Funds. Investment income, common expenses, purchase premiums and redemption fees, if any, and realized and unrealized gains and losses are allocated among the classes of shares of the Funds, if applicable, based on the relative net assets of each class. Shareholder service fees and supplemental support fees, if any, which are directly attributable to a class of shares, are charged to that class’s operations. In addition, the Funds may incur fees and expenses indirectly as a shareholder in the underlying funds. Because the underlying funds have different expense and fee levels and the Funds may own different proportions of the underlying funds at different times, the amount of fees and expenses indirectly incurred by a Fund will vary (see Note 5).

State Street Bank and Trust Company (“State Street”) serves as the Funds’ custodian, fund accounting agent and transfer agent. Prior to November 3, 2017, Brown Brothers Harriman (“BBH”) served as Alpha Only Fund’s custodian and fund accounting agent. Prior to December 31, 2013, State Street’s transfer agent fees may have been reduced by an earnings allowance calculated on the average daily cash balances each Fund maintained in a State Street transfer agent account. Earnings allowances were reported as a reduction of expenses in the Statements of Operations. Effective January 1, 2014, any cash balances maintained at the transfer agent are held in a Demand Deposit Account and interest income earned, if any, is shown as interest income in the Statements of Operations. Any cash balances maintained at the custodian are held in a Demand Deposit Account and interest income earned, if any, is shown as interest income in the Statements of Operations.

Purchases and redemptions of Fund shares

Purchase premiums and redemption fees (if applicable) are paid to and retained by a Fund to help offset estimated portfolio transaction costs and other related costs (e.g., bid to ask spreads, stamp duties, and transfer fees) incurred by the Fund (directly or indirectly through investments in underlying funds or a wholly-owned subsidiary) as a result of an investor’s purchase or redemption by allocating estimated transaction costs to the purchasing or redeeming shareholder. Such fees are recorded as a component of the Funds’ net share transactions. A Fund may impose a new purchase premium and redemption fee or modify an existing fee at any time.

Purchase premiums are not charged on reinvestments of dividends or other distributions. Redemption fees apply to all shares of a Fund regardless of how the shares were acquired (e.g., by direct purchase or by reinvestment of dividends or other distributions).

If GMO determines that any portion of a cash purchase or redemption, as applicable, is offset by a corresponding cash redemption or purchase occurring on the same day, it ordinarily will waive or reduce the purchase premium or redemption fee with respect to that portion.

GMO also may waive or reduce the purchase premium or redemption fee for a cash purchase or redemption of a Fund’s shares if the Fund will not incur transaction costs or will incur reduced transaction costs.

GMO also may reduce the purchase premium to the extent that securities are used to purchase a Fund’s shares (taking into account transaction costs, stamp duties or transfer fees). GMO may reduce redemption fees to the extent a Fund uses portfolio securities to redeem its shares (taking into account transaction costs, stamp duties or transfer fees).

GMO may consider known cash flows out of or into underlying funds when placing orders for the cash purchases or redemptions of underlying fund shares by accounts over which it has investment discretion, including the Funds and other pooled investment vehicles. Consequently, participants in those vehicles will tend to benefit more than other Fund shareholders from the waivers of purchase premiums and redemption fees that may occur when purchases and redemptions occur on the same day.

 

145


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

As of August 31, 2018, the premium on cash purchases and the fee on cash redemptions were as follows:

 

                         
     Alpha Only Fund   Benchmark-Free Allocation Fund(a)   Benchmark-Free
Fund(b)
  Global Asset Allocation Fund(c)   Global Developed Equity Allocation Fund(d)   Global Equity Allocation Fund(e)   Implementation Fund(f)   International Developed Equity Allocation Fund(g)   International Equity Allocation Fund(h)   SGM Major Markets Fund   Special Opportunities Fund   Strategic Opportunities Allocation Fund(i)
Purchase Premium                       0.50%  
Redemption Fee                       0.50%  

 

  (a)

For the periods from June 30, 2016 to June 30, 2018, June 30, 2015 to June 30, 2016, June 30, 2014 to June 30, 2015 and June 30, 2013 to June 30, 2014, the premium on cash purchases and the fee on cash redemptions were each 0.20%, 0.18%, 0.13% and 0.11%, respectively, of the amount invested or redeemed. Prior to June 30, 2013, these same fees were each 0.12% of the amount invested or redeemed.

  (b)

For the periods from June 30, 2016 to June 30, 2018, June 30, 2015 to June 30, 2016, June 30, 2014 to June 30, 2015 and June 30, 2013 to June 30, 2014, the premium on cash purchases and the fee on cash redemptions were each 0.25%, 0.18%, 0.13% and 0.14%, respectively, of the amount invested or redeemed. Prior to June 30, 2013, these same fees were each 0.13% of the amount invested or redeemed.

  (c)

For the period from June 30, 2016 to June 30, 2018, June 30, 2015 to June 30, 2016 and June 30, 2013 to June 30, 2015, the premium on cash purchases and the fee on cash redemptions were each 0.15%, 0.14% and 0.11%, respectively, of the amount invested or redeemed. Prior to June 30, 2013, these same fees were each 0.10% of the amount invested or redeemed.

  (d)

For the period from March 10, 2014 to June 30, 2018, the premium on cash purchases and the fee on cash redemptions were each 0.08% of the amount invested or redeemed. Prior to March 10, 2014, there was no premium on cash purchases or fee on cash redemptions.

  (e)

For the period from June 30, 2016 to June 30, 2018, June 30, 2015 to June 30, 2016, and June 30, 2013 to June 30, 2015, the premium on cash purchases and the fee on cash redemptions were each 0.18%, 0.19% and 0.11%, respectively, of the amount invested or redeemed. Prior to June 30, 2013, these same fees were each 0.12% of the amount invested or redeemed.

  (f)

For the period from June 30, 2015 to June 30, 2018, the premium on cash purchases and the fee on cash redemptions were each 0.20% of the amount invested or redeemed. Prior to June 30, 2015, there was no premium on cash purchases or fee on cash redemptions.

  (g)

For the period from March 10, 2014 to June 30, 2018, the premium on cash purchases and the fee on cash redemptions were each 0.08% of the amount invested or redeemed. Prior to March 10, 2014, there was no premium on cash purchases or fees on cash redemptions.

  (h)

For the period from June 30, 2016 to June 30, 2018, June 30, 2015 to June 30, 2016 and June 30, 2013 to June 30, 2015, the premium on cash purchases and the fee on cash redemptions were each 0.25%, 0.27% and 0.20%, respectively, of the amount invested or redeemed. Prior to June 20, 2013, the same fees were each 0.21% of the amount invested or redeemed.

  (i)

For the period from June 30, 2016 to June 30, 2018, June 30, 2015 to June 30, 2016 and June 30, 2013 to June 30, 2015, the premium on cash purchases and the fee on cash redemptions were each 0.20%, 0.14% and 0.06% of the amount invested or redeemed. Prior to June 30, 2013, these same fees were each 0.07% of the amount invested or redeemed.

Recently-issued accounting guidance

In March 2017, the Financial Accounting Standards Board (“FASB”) issued an amendment to U.S. GAAP, which amends the required amortization period for purchased callable debt securities that have been purchased at a premium. The scope of the amendment is limited to debt securities that have an explicit non-contingent call feature at a fixed price on a preset date or dates. The amendment requires that the aforementioned premium on such debt securities shall be amortized through the next call date, whereas current U.S. GAAP requires amortization through the maturity date of the security. This amendment does not apply to debt securities purchased at a discount and is effective for fiscal years beginning after December 15, 2018. GMO is currently evaluating the impact, if any, of this guidance on the Fund’s financial statements and disclosures.

 

146


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

3.

Investment and other risks

The following chart identifies selected risks associated with each Fund. Risks not marked for a particular Fund may, however, still apply to some extent to that Fund at various times.

 

                         
     Alpha Only Fund   Benchmark-Free Allocation Fund   Benchmark-Free Fund   Global Asset Allocation Fund   Global Developed Equity Allocation Fund   Global Equity Allocation Fund   Implementation Fund   International Developed Equity Allocation Fund   International Equity Allocation Fund   SGM Major Markets Fund   Special Opportunities Fund   Strategic Opportunities Allocation Fund
Commodities Risk       X   X   X           X           X   X   X
Counterparty Risk   X   X   X   X   X   X   X   X   X   X   X   X
Credit Risk   X   X   X   X   X   X   X   X   X   X   X   X
Currency Risk   X   X   X   X   X   X   X   X   X   X   X   X
Derivatives and Short Sales Risk   X   X   X   X   X   X   X   X   X   X   X   X
Focused Investment Risk   X   X   X   X   X   X   X   X   X   X   X   X
Fund of Funds Risk   X   X   X   X   X   X   X   X   X   X   X   X
Futures Contracts Risk       X   X   X                       X       X
Illiquidity Risk   X   X   X   X   X   X   X   X   X   X   X   X
Large Shareholder Risk   X   X   X   X   X   X   X   X   X   X   X   X
Leveraging Risk   X   X   X   X   X   X   X   X   X   X   X   X
Management and Operational Risk   X   X   X   X   X   X   X   X   X   X   X   X
Market Disruption and Geopolitical Risk   X   X   X   X   X   X   X   X   X   X   X   X
Market Risk – Asset-Backed Securities       X   X   X           X           X   X   X
Market Risk – Equities   X   X   X   X   X   X   X   X   X   X   X   X
Market Risk – Fixed Income   X   X   X   X   X   X   X   X   X   X   X   X
Merger Arbitrage Risk       X                   X               X   X
Non-Diversified Funds   X   X   X   X   X   X   X   X   X   X   X   X
Non-U.S. Investment Risk   X   X   X   X   X   X   X   X   X   X   X   X
Small Company Risk   X   X   X   X   X   X   X   X   X       X   X

Investing in mutual funds involves many risks. The risks of investing in a particular Fund depend on the types of investments in its portfolio and the investment strategies GMO employs on its behalf. This section does not describe every potential risk of investing in the Funds. Funds could be subject to additional risks because of the types of investments they make and market conditions, which may change over time.

Each Fund that invests in other GMO Funds, other investment companies or in a wholly-owned subsidiary (collectively, “Underlying Funds”) is exposed to the risks to which the Underlying Funds in which it invests are exposed, as well as the risk that the Underlying

 

147


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Funds will not perform as expected. Therefore, unless otherwise noted, the selected risks summarized below include both direct and indirect risks, and references in this section to investments made by a Fund include those made both directly by the Fund and indirectly by the Fund through Underlying Funds.

An investment in a Fund is not a bank deposit and, therefore, is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.

 COMMODITIES RISK. Commodity prices can be extremely volatile and are affected by many factors. Exposure to commodities can cause the value of a Fund’s shares to decline or fluctuate in a rapid and unpredictable manner. The value of commodity-related derivatives or indirect investments in commodities may fluctuate more than the commodity, commodities or commodity index to which they relate. See “Derivatives and Short Sales Risk” for a discussion of specific risks of a Fund’s derivatives investments, including commodity-related derivatives.

 COUNTERPARTY RISK. Funds that enter into contracts with counterparties, such as repurchase or reverse repurchase agreements or OTC derivatives contracts, or that lend their securities run the risk that the counterparty will be unable or unwilling to make timely settlement payments or otherwise honor its obligations. If a counterparty fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, the Fund could miss investment opportunities or otherwise be forced to hold investments it would prefer to sell, resulting in losses for the Fund. In addition, a Fund may suffer losses if a counterparty fails to comply with applicable laws, regulations or other requirements. The Funds are not subject to any limit on their exposure to any one counterparty nor to a requirement that counterparties with whom they enter into contracts maintain a specific rating by a nationally recognized rating organization. Counterparty risk is pronounced during unusually adverse market conditions and is particularly acute in environments in which financial services firms are exposed (as they were in 2008) to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions.

Participants in OTC derivatives markets typically are not subject to the same level of credit evaluation and regulatory oversight as are members of exchange-based markets, and, therefore, OTC derivatives generally expose a Fund to greater counterparty risk than exchange-traded derivatives. A Fund is subject to the risk that a counterparty will not settle a derivative in accordance with its terms because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem. If a counterparty’s obligation to a Fund is not collateralized, then the Fund is essentially an unsecured creditor of the counterparty. If a counterparty defaults, the Fund will have contractual remedies (whether or not the obligation is collateralized), but the Fund may be unable to enforce them, thus causing the Fund to suffer a loss. Counterparty risk is greater for derivatives with longer maturities because of the longer time during which events may occur that prevent settlement. Counterparty risk also is greater when a Fund has entered into derivatives contracts with a single or small group of counterparties as it sometimes does as a result of its use of swaps and other OTC derivatives. Funds that use swap contracts are subject, in particular, to the creditworthiness of the counterparties because some types of swap contracts have terms longer than six months (and, in some cases, decades). The creditworthiness of a counterparty may be adversely affected by greater than average volatility in the markets, even if the counterparty’s net market exposure is small relative to its capital. Counterparty risk still exists even if a counterparty’s obligations are secured by collateral because the Fund’s interest in the collateral may not be perfected or additional collateral may not be posted promptly as required. GMO’s view with respect to a particular counterparty is subject to change. The fact, however, that it changes adversely (whether due to external events or otherwise) does not mean that a Fund’s existing transactions with that counterparty will necessarily be terminated or modified. In addition, a Fund may enter into new transactions with a counterparty that GMO no longer considers a desirable counterparty (for example, re-establishing the transaction with a lower notional amount or entering into a countervailing trade with the same counterparty). Counterparty risk also will be greater if a counterparty’s obligations exceed the value of the collateral held by the Fund (if any).

The Funds also are subject to counterparty risk because they execute their securities transactions through brokers and dealers. If a broker or dealer fails to meet its contractual obligations, goes bankrupt, or otherwise experiences a business interruption, the Funds could miss investment opportunities or be unable to dispose of investments they would prefer to sell, resulting in losses for the Funds. Counterparty risk with respect to derivatives has been and will continue to be affected by new rules and regulations relating to the derivatives market. As described under “Derivatives and Short Sales Risk,” some derivatives transactions are required to be centrally cleared, and a party to a cleared derivatives transaction is subject to the credit risk of the clearing house and the clearing member through which it holds its cleared position. Credit risk of market participants with respect to derivatives that are centrally cleared is concentrated in a few clearing houses, and it is not clear how an insolvency proceeding of a clearing house would be conducted and

 

148


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

what impact an insolvency of a clearing house would have on the financial system. Also, in the event of a counterparty’s (or its affiliate’s) insolvency, the possibility exists that the Funds’ ability to exercise remedies, such as the termination of transactions, netting of obligations or realization on collateral, could be stayed or eliminated under new special resolution regimes adopted in the United States, the European Union and various other jurisdictions. Such regimes provide governmental authorities with broad authority to intervene when a financial institution is experiencing financial difficulty. In particular, in the European Union, governmental authorities could reduce, eliminate, or convert to equity the liabilities to the Funds of a counterparty experiencing financial difficulties (sometimes referred to as a “bail in”).

 CREDIT RISK. This is the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner. The market price of a fixed income investment will normally decline as a result (and/or in anticipation) of the issuer’s, guarantor’s, or obligor’s failure to meet its payment obligations, or a downgrading of the credit rating of the investment. This risk is particularly acute in environments in which financial services firms are exposed (as they were in 2008) to systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions. Fixed income investments also are subject to illiquidity risk. See “Illiquidity Risk.”

All fixed income investments are subject to credit risk. Financial strength and solvency of an issuer are the primary factors influencing credit risk. The risk varies depending upon whether the issuer is a corporation, a government or government entity, whether the particular security has a priority over other obligations of the issuer in payment of principal and interest and whether it has any collateral backing or credit enhancement. Credit risk may change over the term of a fixed income investment. U.S. government securities are subject to varying degrees of credit risk depending upon whether the securities are supported by the full faith and credit of the United States, supported by the ability to borrow from the U.S. Treasury, supported only by the credit of the issuing U.S. government agency, instrumentality, or corporation, or otherwise supported by the United States. For example, issuers of many types of U.S. government securities (e.g., the Federal Home Loan Mortgage Corporation (“Freddie Mac”), Federal National Mortgage Association (“Fannie Mae”), and Federal Home Loan Banks), although chartered or sponsored by Congress, are not funded by Congressional appropriations and their fixed income securities, including mortgage-backed and other asset-backed securities, are neither guaranteed nor insured by the U.S. government. These securities are subject to more credit risk than U.S. government securities that are supported by the full faith and credit of the United States (e.g., U.S. Treasury bonds). Investments in sovereign or quasi-sovereign debt involve the risk that the governmental entities responsible for repayment may be unable or unwilling to pay interest and repay principal when due. A governmental entity’s ability and willingness to pay interest and repay principal in a timely manner may be affected by a variety of factors, including its cash flow, the size of its reserves, its access to foreign exchange, the relative size of its debt service burden to its economy as a whole, and political constraints. Investments in quasi-sovereign issuers are subject to the additional risk that the issuer may default independently of its sovereign. Sovereign debt risk is greater for fixed income securities issued or guaranteed by emerging countries.

In many cases, the credit risk and market price of a fixed income investment are reflected in its credit ratings, and a Fund holding a rated investment is subject to the risk that the investment’s rating will be downgraded, resulting in a decrease in the market price of the fixed income investment.

Securities issued by the U.S. government historically have presented minimal credit risk. However, events in 2011 led several major rating agencies to downgrade the long-term credit rating of U.S. bonds and introduced greater uncertainty about the repayment by the United States of its obligations. A further credit rating downgrade could decrease, and a default in the payment of principal or interest on U.S. government securities would decrease, the market price of a Fund’s investments and increase the volatility of a Fund’s portfolio.

As described under “Market Risk — Asset-Backed Securities,” asset-backed securities may be backed by many types of assets and their payment of interest and repayment of principal largely depend on the cash flows generated by the assets backing them. The credit risk of a particular asset-backed security depends on many factors, as described under “Market Risk — Asset-Backed Securities.” The obligations of issuers also may be subject to bankruptcy, insolvency and other laws affecting the rights and remedies of creditors.

A Fund also is exposed to credit risk on a reference security to the extent it writes protection under credit default swaps. See “Derivatives and Short Sales Risk” for more information regarding risks associated with the use of credit default swaps.

 

149


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The extent to which the market price of a fixed income investment changes in response to a credit event depends on many factors and can be difficult to predict. For example, even though the effective duration of a long-term floating rate security is very short, an adverse credit event or change in the perceived creditworthiness of its issuer could cause its market price to decline much more than its effective duration would suggest.

Credit risk is particularly pronounced for below investment grade investments (commonly referred to as “junk bonds”). The sovereign debt of many non-U.S. governments, including their sub-divisions and instrumentalities, is below investment grade. Many asset-backed securities also are below investment grade. Below investment grade investments have speculative characteristics, often are less liquid than higher quality investments, present a greater risk of default and are more susceptible to real or perceived adverse industry conditions. Investments in distressed or defaulted or other low quality debt investments generally are considered speculative and may involve substantial risks not normally associated with investments in higher quality investments, including adverse business, financial or economic conditions that lead to payment defaults and insolvency proceedings on the part of their issuers. In particular, distressed or defaulted obligations might be repaid, if at all, only after lengthy workout or bankruptcy proceedings, during which the issuer does not make any interest or other payments and a Fund incurs additional expenses in seeking recovery. If GMO’s assessment of the eventual recovery value of a distressed or defaulted debt investment proves incorrect, a Fund may lose a substantial portion or all of its investment or may be required to accept cash or instruments worth less than its original investment. In the event of a default of sovereign debt, the Funds may be unable to pursue legal action against the issuer.

 CURRENCY RISK. Currency risk is the risk that fluctuations in exchange rates will adversely affect the market value of a Fund’s investments. Currency risk includes the risk that the currencies in which a Fund’s investments are traded, in which a Fund receives income, or in which a Fund has taken a position will decline in value. Currency risk also includes the risk that the currency to which the Fund has obtained exposure through hedging declines in value relative to the currency being hedged, in which event the Fund may realize a loss on both the hedging instrument and the currency being hedged. Currency exchange rates can fluctuate significantly for many reasons. See “Market Disruption and Geopolitical Risk.”

Many of the Funds use derivatives to take currency positions that are under- or over-weighted (in some cases significantly) relative to the currency exposure of their portfolios and their benchmarks. If the exchange rates of the currencies involved do not move as expected, a Fund could lose money on both its holdings of a particular currency and the derivative. See also “Non-U.S. Investment Risk.”

Some currencies are illiquid (e.g., some emerging country currencies), and a Fund may not be able to convert them into U.S. dollars or may only be able to do so at an unfavorable exchange rate. Exchange rates for many currencies are affected by exchange control regulations.

Derivative transactions in foreign currencies (such as futures, forwards, options and swaps) may involve leveraging risk in addition to currency risk, as described under “Leveraging Risk.” In addition, the obligations of counterparties in currency derivative transactions are often not secured by collateral, which increases counterparty risk (see “Counterparty Risk”).

 DERIVATIVES AND SHORT SALES RISK. All of the Funds may invest in derivatives, which are financial contracts whose value depends on, or is derived from, the value of underlying assets, such as securities, commodities or currencies, reference rates, such as interest rates, currency exchange rates, inflation rates, or indices. Derivatives involve the risk that their value may not change as expected relative to changes in the value of the assets, rates, or indices they are designed to track. Derivatives include, but are not limited to, futures contracts, forward contracts, foreign currency contracts, swap contracts, contracts for differences, options on securities and indices, options on futures contracts, options on swap contracts, interest rate caps, floors and collars, reverse repurchase agreements, and other OTC contracts.

The use of derivatives involves risks that are potentially greater than, the risks of investing directly in securities. In particular, a Fund’s use of OTC derivatives exposes it to the risk that the counterparties will be unable or unwilling to make timely settlement payments or otherwise honor their obligations. An OTC derivatives contract typically can be closed, or the position transferred, only with the consent of the other party to the contract. If the counterparty defaults, the Fund will still have contractual remedies but may not be able to enforce them. Because the contract for each OTC derivative is individually negotiated, the counterparty may interpret contractual terms (e.g., the definition of default) differently than the Fund, and if it does, the Fund may decide not to pursue its claims against the counterparty to avoid the cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain payments GMO believes are owed to the Fund under an OTC derivatives contract, or those payments may be delayed or made only after the Fund has incurred the cost of litigation.

 

150


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

A Fund may invest in derivatives that (i) do not require the counterparty to post collateral (e.g., foreign currency forwards), (ii) require collateral but that do not provide for the Fund’s security interest in it to be perfected, (iii) require a significant upfront deposit by the Fund unrelated to the derivative’s fundamental fair (or intrinsic) value, or (iv) do not require that collateral be regularly marked-to-market. When a counterparty’s obligations are not fully secured by collateral, a Fund runs a greater risk of not being able to recover what it is owed if the counterparty defaults. Derivatives also present other risks described in this section, including market risk, illiquidity risk, currency risk, credit risk, and counterparty risk.

Many derivatives, in particular OTC derivatives, are complex and their valuation often requires modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing models used may not produce valuations that are consistent with the values a Fund realizes when it closes or sells an OTC derivative. Valuation risk is more pronounced when a Fund enters into OTC derivatives with specialized terms because the value of those derivatives in some cases is determined only by reference to similar derivatives with more standardized terms. As a result, inaccurate valuations may result in increased cash payments to counterparties, under-collateralization and/or errors in the calculation of a Fund’s net asset value.

A Fund’s use of derivatives may not be effective or have the desired results. Moreover, suitable derivatives will not be available in all circumstances. For example, the cost of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate is deemed to be an affiliate of a Fund, the Funds will not be permitted to trade with that counterparty.

Swap contracts and other OTC derivatives are highly susceptible to illiquidity risk (see “Illiquidity Risk”) and counterparty risk (see “Counterparty Risk”). These derivatives also are subject to documentation risk, which is the risk that ambiguities, inconsistencies or errors in the documentation relating to a derivative transaction may lead to a dispute with the counterparty or unintended investment results. In addition, see “Commodities Risk” for a discussion of risks specific to commodity-related derivatives. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish and/or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. See “Leveraging Risk.”

A Fund’s use of derivatives may be subject to special tax rules and could generate additional taxable income for shareholders. In addition, the tax treatment of a Fund’s use of derivatives will sometimes be unclear.

The SEC has proposed a rule under the 1940 Act, regulating the use by registered investment companies of derivatives and many related instruments. That rule, if adopted as proposed, would, among other things, restrict a Fund’s ability to engage in derivatives transactions or so increase the cost of derivatives transactions that a Fund would be unable to implement its investment strategy.

Derivatives Regulation. The U.S. government has enacted legislation that provides for new regulation of the derivatives market, including clearing, margin, reporting, and registration requirements. The European Union (and some other countries) have adopted similar requirements, which affect a Fund when it enters into a derivatives transaction with a counterparty subject to those requirements. Because these U.S. and European Union requirements are new and evolving (and some of the rules are not yet final), their impact on the Funds remains unclear.

Transactions in some types of swaps (including interest rate swaps and credit default swaps on North American and European indices) are required to be centrally cleared. In a transaction involving those swaps (“cleared derivatives”), a Fund’s counterparty is a clearing house rather than a bank or broker. Since the Funds are not members of clearing houses and only members of a clearing house (“clearing members”) can participate directly in the clearing house, the Funds hold cleared derivatives through accounts at clearing members. In cleared derivatives positions, the Funds make payments (including margin payments) to and receive payments from a clearing house through their accounts at clearing members. Clearing members guarantee performance of their clients’ obligations to the clearing house.

In some ways, cleared derivative arrangements are less favorable to mutual funds than bilateral arrangements, for example, by requiring that funds provide more margin for their cleared derivatives positions. Also, as a general matter, in contrast to a bilateral derivatives position, following a period of notice to a Fund, a clearing member at any time can require termination of an existing cleared derivatives position or an increase in the margin required at the outset of a transaction. Clearing houses also have broad rights to increase the margin required for existing positions or to terminate those positions at any time. Any increase in margin requirements or termination of existing cleared derivatives positions by the clearing member or the clearing house could interfere with the ability of a Fund to pursue its investment strategy. Further, any increase in margin requirements by a clearing member could expose a Fund to

 

151


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

greater credit risk to its clearing member because margin for cleared derivatives positions in excess of a clearing house’s margin requirements typically is held by the clearing member (see “Counterparty Risk”). Also, a Fund is subject to risk if it enters into a derivatives transaction that is required to be cleared (or that GMO expects to be cleared), and no clearing member is willing or able to clear the transaction on the Fund’s behalf. While the documentation in place between the Funds and their clearing members generally provides that the clearing members will accept for clearing all cleared derivatives transactions that are within credit limits (specified in advance) for each Fund, the Funds are still subject to the risk that no clearing member will be willing or able to clear a transaction. In those cases, the position might have to be terminated, and the Fund could lose some or all of the benefit of the position, including loss of an increase in the value of the position and loss of hedging protection. In addition, the documentation governing the relationship between the Funds and clearing members is drafted by the clearing members and generally is less favorable to the Funds than the documentation for typical bilateral derivatives. For example, documentation relating to cleared derivatives generally includes a one-way indemnity by the Funds in favor of the clearing member for losses the clearing member incurs as the Funds’ clearing member. Also, such documentation typically does not provide the Funds any remedies if the clearing member defaults or becomes insolvent. While futures contracts entail similar risks, the risks may be more pronounced for cleared derivatives due to their more limited liquidity and market history.

Some types of cleared derivatives are required to be executed on an exchange or on a swap execution facility. A swap execution facility is a trading platform where multiple market participants can execute derivatives by accepting bids and offers made by multiple other participants in the platform. While this execution requirement is designed to increase transparency and liquidity in the cleared derivatives market, trading on a swap execution facility can create additional costs and risks for the Funds. For example, swap execution facilities typically charge fees, and if a Fund executes derivatives on a swap execution facility through a broker intermediary, the intermediary may impose fees as well. Also, a Fund may be required to indemnify a swap execution facility, or a broker intermediary who executes cleared derivatives on a swap execution facility on the Fund’s behalf, against any losses or costs that may be incurred as a result of the Fund’s transactions on the swap execution facility.

If a Fund wishes to execute a package of transactions that include a swap that is required to be executed on a swap execution facility as well as other transactions (for example, a transaction that includes both a security and an interest rate swap that hedges interest rate exposure with respect to such security), the Fund may be unable to execute all components of the package on the swap execution facility. In that case, the Fund would need to trade some components of the package on the swap execution facility and other components in another manner, which could subject the Fund to the risk that some components would be executed successfully and others would not, or that the components would be executed at different times, leaving the Fund with an unhedged position for a period of time.

The U.S. government and the European Union have adopted mandatory minimum margin requirements for bilateral derivatives. New variation margin requirements became effective in March 2017 and new initial margin requirements will become effective in 2020. Such requirements could increase the amount of margin a Fund needs to provide in connection with its derivatives transactions and, therefore, make derivatives transactions more expensive.

These and other new rules and regulations could, among other things, further restrict a Fund’s ability to engage in, or increase the cost to the Fund of, derivatives transactions, for example, by making some types of derivatives no longer available to the Fund or otherwise limiting liquidity. The implementation of the clearing requirement has increased the cost of derivatives transactions for the Funds, since the Funds have to pay fees to their clearing members and are typically required to post more margin for cleared derivatives than they historically posted for bilateral derivatives. The cost of derivatives transactions is expected to increase further as clearing members raise their fees to cover the cost of additional capital requirements and other regulatory changes applicable to the clearing members. These rules and regulations are new and evolving, and, therefore, their potential impact on the Funds and the financial system are not yet known. While the new rules and regulations and central clearing of some derivatives transactions are designed to reduce systemic risk (i.e., the risk that the interdependence of large derivatives dealers could cause them to suffer liquidity, solvency or other challenges simultaneously), there is no assurance that they will achieve that result, and in the meantime, as noted above, central clearing and related requirements expose the Funds to new kinds of costs and risks.

Options. Some Funds are permitted to write options. The market price of an option is affected by many factors, including changes in the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant stock market and underlying securities. The market price of an option also may be adversely affected if the market for the option becomes less liquid. In addition, since an American-style option allows the holder to exercise its rights any time before the

 

152


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

option’s expiration, the writer of an American-style option has no control over when it will be required to fulfill its obligations as a writer of the option. (The writer of a European-style option is not subject to this risk because the holder may only exercise the option on its expiration date.) If a Fund writes a call option and does not hold the underlying security or instrument, the Fund’s potential loss is theoretically unlimited.

National securities exchanges generally have established limits on the maximum number of options an investor or group of investors acting in concert may write. A Fund, GMO, and other funds advised by GMO likely constitute such a group. When applicable, these limits restrict a Fund’s ability to purchase or write options on a particular security.

Unlike exchange-traded options, which are standardized with respect to the underlying instrument, expiration date, contract size, and strike price, the terms of OTC options (i.e., options not traded on exchanges) generally are established through negotiation with the other party to the option contract. While a Fund has greater flexibility to tailor an OTC option, OTC options generally expose a Fund to greater credit risk than exchange-traded options, which are guaranteed by the clearing organization of the exchanges where they are traded. Purchasing and writing put and call options are highly specialized activities and entail greater than ordinary market risks.

Special tax rules apply to a Fund’s transactions in options, which could increase the taxes payable by shareholders subject to U.S. income taxation. In particular, a Fund’s options transactions potentially could cause a substantial portion of the Fund’s distributions to be taxable at ordinary income tax rates. See the Funds’ Prospectus and Statement of Additional Information for more information.

Short Investment Exposure. Some Funds may sell securities or currencies short as part of their investment programs in an attempt to increase their returns or for hedging purposes. Short sales expose a Fund to the risk that it will be required to acquire, convert, or exchange a security or currency to replace the borrowed security or currency when the security or currency sold short has appreciated in value, thus resulting in a loss to the Fund. Purchasing a security or currency to close out a short position can itself cause the price of the security or currency to rise further, thereby exacerbating any losses. A Fund that sells short a security or currency it does not own typically pays borrowing fees to a broker and is required to pay the broker any dividends or interest it receives on a borrowed security.

A Fund also may create short investment exposure by taking a derivative position in which the value of the derivative moves in the opposite direction from the price of an underlying asset, pool of assets, rate, currency or index.

Short sales of securities or currencies a Fund does not own and “short” derivative positions involve forms of investment leverage, and the amount of the Fund’s potential loss is theoretically unlimited. A Fund is subject to increased leveraging risk and other investment risks described in this “Investment and other risks” section to the extent it sells short securities or currencies it does not own or takes “short” derivative positions.

 FOCUSED INVESTMENT RISK. Funds with investments that are focused in a limited number of asset classes, sectors, industries, issuers, currencies, countries, or regions (or in sectors within a country or region) that are subject to the same or similar risk factors and funds with investments whose prices are closely correlated are subject to greater overall risk than funds with investments that are more diversified or whose prices are not as closely correlated.

A Fund that invests in the securities of a small number of issuers has greater exposure to adverse developments affecting those issuers and to a decline in the market price of those issuers’ securities than Funds investing in the securities of a larger number of issuers. Securities, sectors, or companies that share common characteristics are often subject to similar business risks and regulatory burdens, and often react similarly to specific economic, market, political or other developments.

Similarly, Funds having a significant portion of their assets in investments tied economically (or related) to a particular geographic region, country or market (e.g., emerging markets), or to sectors within a region, country, or market (e.g., Russian oil) have more exposure to regional and country economic risks than funds making investments throughout the world. The political and economic prospects of one country or group of countries within the same geographic region may affect other countries in that region, and a recession, debt crisis or decline in the value of the currency of one country can spread to other countries. Furthermore, companies in a particular geographic region or country are vulnerable to events affecting other companies in that region or country because they often share common characteristics, are exposed to similar business risks and regulatory burdens, and react similarly to specific economic, market, political or other developments. See also “Non-U.S. Investment Risk.”

 

153


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 FUND OF FUNDS RISK. Funds that invest in Underlying Funds (including underlying GMO Funds) or in a wholly-owned subsidiary of a GMO Fund are exposed to the risk that the Underlying Funds or wholly-owned subsidiary will not perform as expected. The Funds also are indirectly exposed to all of the risks to which the Underlying Funds or a wholly-owned subsidiary are exposed.

Absent reimbursement, a Fund bears the fees and expenses of an Underlying Fund (including purchase premiums and redemption fees, if any) and the expenses of a wholly-owned subsidiary in which it invests, and may incur additional expenses when investing in an Underlying Fund or wholly-owned subsidiary. In addition, total Fund expenses will increase if a Fund makes a new or further investment in Underlying Funds with higher fees or expenses than the average fees and expenses of the Underlying Funds then in the Fund’s portfolio.

Because some underlying GMO Funds invest a substantial portion of their assets in other GMO Funds (pursuant to an exemptive order obtained from the SEC), the Asset Allocation Funds have more tiers of investments than funds in many other mutual fund groups and therefore may be subject to greater fund of funds risk. In addition, to the extent a Fund invests in shares of underlying GMO Funds, it is indirectly subject to Large Shareholder Risk when an underlying GMO Fund has large shareholders (e.g., other GMO Funds). See “Large Shareholder Risk.”

At any particular time, one Underlying Fund may be purchasing securities of an issuer whose securities are being sold by another Underlying Fund, resulting in a Fund that holds each Underlying Fund indirectly incurring the costs associated with the two transactions without changing its exposure to those securities.

Investments in exchange-traded funds (“ETFs”) involve the risk that an ETF’s performance may not track the performance of the index it is designed to track. In addition, ETFs often use derivatives to track the performance of an index, and, therefore, investments in those ETFs are subject to the same derivatives risks discussed in “Derivatives and Short Sales Risk.” ETFs are investment companies that typically hold a portfolio of securities designed to track the price, performance, and dividend yield of a particular securities market index (or sector of an index). As investment companies, ETFs incur their own management and other fees and expenses, such as trustee fees, operating expenses, registration fees, and marketing expenses, and a Fund that invests in ETFs will bear a proportionate share of such fees and expenses. As a result, an investment by a Fund in an ETF could lead to higher operating expenses and lower returns than if the Fund were to invest directly in the securities underlying the ETF.

A Fund’s investments in one or more Underlying Funds or a wholly-owned subsidiary could affect the amount, timing and character of its distributions and could cause the Fund to recognize taxable income in excess of the cash generated by such investments, requiring the Fund in turn to liquidate investments at disadvantageous times to generate cash needed to make required distributions.

 FUTURES CONTRACTS RISK. The risk of loss to a Fund resulting from its use of futures contracts (or “futures”) is potentially unlimited. Futures markets are highly volatile, and the use of futures contracts may increase the volatility of the Fund’s net asset value. A Fund’s ability to establish and close out positions in futures contracts is subject to the development and maintenance of a liquid secondary market. A liquid secondary market may not exist for any particular futures contract at any particular time, and a Fund might be unable to effect closing transactions to terminate its exposure to the contract. In using futures contracts, a Fund relies on GMO’s ability to predict market and price movements correctly. The skills needed to use futures contracts successfully are different from those needed for traditional portfolio management. If a Fund uses futures contracts for hedging purposes, it runs the risk that changes in the prices of the contracts will not correlate perfectly with changes in the securities, index, or other asset underlying the contracts or movements in the prices of the Fund’s investments that are the subject of the hedge.

A Fund typically will be required to post margin with its futures commission merchant in connection with its positions in futures contracts. If the Fund has insufficient cash to meet margin requirements, the Fund may have to sell other investments at disadvantageous times. A Fund may be unable to reenter or may be delayed in recovering margin or other amounts deposited with a futures commission merchant or futures clearinghouse. For example, should the futures commission merchant become insolvent, a Fund may be unable to recover all (or any) of the margin it has deposited or realize the value of any increase in the price of its positions.

The Commodity Futures Trading Commission (the “CFTC”) and the various exchanges have established limits (referred to as “speculative position limits”) on the maximum net long or net short positions that any person and certain of its affiliated entities may hold or control in a particular futures contract. In addition, an exchange may impose trading limits on the number of contracts a person

 

154


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

may trade on a particular day. An exchange may order the liquidation of positions found to be in violation of these limits, and it may impose sanctions or restrictions. In addition, the Dodd-Frank Wall Street Reform and Consumer Protection Act requires the CFTC to establish speculative position limits on listed futures and economically equivalent OTC derivatives, and those limits may adversely affect the market liquidity of those futures and derivatives. As a result of such limits, positions held by other GMO clients or by GMO or its affiliates may prevent GMO from taking positions on behalf of a Fund in a particular futures contract or OTC derivative.

Futures contracts traded on markets outside the United States generally are not subject to regulation by the CFTC or other U.S. regulators. U.S. regulators neither regulate the activities of a foreign exchange nor have the power to compel enforcement of the rules of a foreign exchange or the laws of the country where the exchange is located. Margin and other payments made by a Fund in foreign countries may not have the same protections as payments in the United States. In addition, foreign futures contracts may be less liquid and more volatile than U.S. contracts.

• ILLIQUIDITY RISK. Illiquidity risk is the risk that low trading volume, lack of a market maker, large position size, or legal restrictions (including daily price fluctuation limits or “circuit breakers”) limits, delays or prevents a Fund from selling particular securities or closing derivative positions at desirable prices. In addition to these risks, a Fund is exposed to illiquidity risk when it has an obligation to purchase particular securities (e.g., as a result of entering into reverse repurchase agreements, writing a put, or closing a short position). To the extent a Fund’s investments include asset-backed securities, distressed, defaulted or other low quality debt securities, emerging country debt or equity securities, securities of companies with smaller market capitalizations or smaller total float adjusted market capitalizations, or emerging market securities, it is subject to increased illiquidity risk. These types of investments can be difficult to value, exposing a Fund to the risk that the price at which it sells them will be less than the price at which they were valued when held by the Fund. Illiquidity risk also may be greater in times of financial stress. For example, Inflation-Protected Securities issued by the U.S. Treasury (“TIPS”) have experienced periods of greatly reduced liquidity during disruptions in fixed income markets, such as the events surrounding the bankruptcy of Lehman Brothers in 2008. Less liquid securities are more susceptible than other securities to price declines when market prices decline generally.

A Fund may buy securities or other investments that are less liquid than those in its benchmark. The more illiquid investments a Fund has, the greater the likelihood of its paying redemption proceeds in-kind.

Historically, the credit markets have experienced periods characterized by a significant lack of liquidity, and they may experience similar periods in the future. A lack of liquidity could require a Fund to sell securities to satisfy collateral posting requirements and meet redemptions, which could, in turn, create downward price pressure on the securities being sold.

A Fund’s, and particularly Risk Premium Fund’s, ability to use options as part of its investment program depends on the liquidity of the options market. That market may not be liquid when a Fund seeks to close out an option position, and the hours of trading for options on an exchange may not conform to the hours during which the underlying securities are traded. To the extent that the options markets close before the markets for the underlying securities, significant price and rate movements can take place in the markets for those securities that are not immediately reflected in the options markets. If a Fund receives a redemption request and is unable to close out an option it has sold, the Fund may temporarily be leveraged in relation to its assets.

 LARGE SHAREHOLDER RISK. To the extent a large number of shares of a Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy (e.g., GMO asset allocation accounts), the Fund is subject to the risk that a redemption by those shareholders of all or a large portion of their Fund shares will adversely affect the Fund’s performance by forcing the Fund to sell portfolio securities, potentially at disadvantageous prices, to raise the cash needed to satisfy the redemption request. In addition, the Funds and other accounts over which GMO has investment discretion that invest in the Funds are not limited in how often they may sell Fund shares. The Asset Allocation Funds and separate accounts managed by GMO for its clients hold substantial percentages of the outstanding shares of many Funds, and asset allocation decisions by GMO may result in substantial redemptions from (or investments in) those Funds. These transactions may adversely affect the Fund’s performance to the extent that the Fund is required to sell investments when it would not have otherwise done so. Redemptions of a large number of shares also may increase transaction costs or, by necessitating a sale of portfolio securities, have adverse tax consequences for Fund shareholders. Further, from time to time a Fund may trade in anticipation of a purchase or redemption order that ultimately is not received or differs in size from the actual order, leading to temporary underexposure or overexposure to the Fund’s intended investment program. In addition, redemptions and purchases of shares by a large shareholder or group of shareholders could limit the use of any capital loss carryforwards to offset future realized capital gains (if any) and other

 

155


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

losses that would otherwise reduce distributable net investment income. In addition, large shareholders may limit or prevent a Fund’s use of equalization for U.S. federal tax purposes.

To the extent a Fund invests in other GMO Funds subject to large shareholder risk, the Fund is indirectly subject to this risk.

 LEVERAGING RISK. The use of traditional borrowing (including to meet redemption requests), reverse repurchase agreements and other derivatives and securities lending creates leverage (i.e., a Fund’s investment exposures exceed its net asset value). Leverage increases a Fund’s losses when the value of its investments (including derivatives) declines. Because many derivatives have a leverage component (i.e., a notional value in excess of the assets needed to establish or maintain the derivative position), adverse changes in the value or level of the underlying asset, rate or index may result in a loss substantially greater than the amount invested in the derivative itself. In the case of swaps, the risk of loss generally is related to a notional principal amount, even if the parties have not made any initial investment. Some derivatives, similar to short sales, have the potential for unlimited loss, regardless of the size of the initial investment. Similarly, a Fund’s portfolio will be leveraged and can incur losses if the value of the Fund’s assets declines between the time a redemption request is received or deemed to be received by a Fund (which in some cases may be the business day prior to actual receipt of the transaction activity by the Fund) and the time at which the Fund liquidates assets to meet redemption requests. Such a decline in the value of a Fund’s assets is more likely in the case of Funds managed from GMO’s non-U.S. offices for which the time period between the NAV determination and corresponding liquidation of assets could be longer due to time zone differences and market schedules. In the case of redemptions representing a significant portion of a Fund’s portfolio, the leverage effects described above can be significant and could expose a Fund and non-redeeming shareholders to material losses.

A Fund may manage some of its derivative positions by offsetting derivative positions against one another or against other assets. To the extent offsetting positions do not behave in relation to one another as expected, a Fund may perform as if it were leveraged.

Some Funds are permitted to purchase securities on margin or to sell securities short, either of which creates leverage. To the extent the market prices of securities pledged to counterparties to secure a Fund’s margin account or short sale decline, the Fund may be required to deposit additional funds with the counterparty to avoid having the pledged securities liquidated to compensate for the decline.

 MANAGEMENT AND OPERATIONAL RISK. Each Fund is subject to management risk because it relies on GMO to achieve its investment objective. Each Fund runs the risk that GMO’s investment techniques will fail to produce desired results and may cause the Fund to incur significant losses. GMO also may fail to use derivatives effectively, choosing to hedge or not to hedge positions at disadvantageous times.

For many Funds, GMO uses quantitative models as part of its investment process. GMO’s models may not accurately predict future market movements, or characteristics. In addition, they are based on assumptions that can limit their effectiveness, and they rely on data that is subject to limitations (e.g., inaccuracies, staleness) that could adversely affect their predictive value. The Funds also run the risk that GMO’s assessment of an investment (including a security’s fundamental fair (or intrinsic) value) is wrong.

GMO relies heavily on quantitative models in making investment decisions for SGM Major Markets Fund. The usefulness of GMO’s models may be diminished by the faulty incorporation of mathematical models into computer code, by reliance on proprietary and third-party technology that includes errors, omissions, bugs, or viruses, and by the retrieval of limited or imperfect data for processing by the model. These risks are present in the ordinary course of business and are more likely to occur when GMO is making changes to its models. Any of these risks could adversely affect a Fund’s performance.

There can be no assurance that key GMO personnel will continue to be employed by GMO. The loss of their services could have an adverse impact on GMO’s ability to achieve the Funds’ investment objectives.

The Funds also are subject to a risk of loss resulting from other services provided by GMO and other service providers, including pricing, administrative, accounting, tax, legal, custody, transfer agency, and other services. Operational risk includes the possibility of loss caused by inadequate procedures and controls, human error, and system failures by a service provider. For example, trading delays or errors could prevent a Fund from benefiting from investment gains or avoiding losses. In addition, a service provider may be unable to provide a net asset value (“NAV”) for a Fund or share class on a timely basis. GMO is not contractually liable to the Funds for losses associated with operational risk absent its willful misfeasance, bad faith, gross negligence, or reckless disregard of its contractual obligations to provide services to the Funds. Other Fund service providers also have contractual limitations on their liability to the Funds for losses resulting from their errors.

 

156


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Funds and their service providers (including GMO) are susceptible to cyber-attacks and to technological malfunctions that may have effects similar to those of a cyber-attack. Cyber-attacks include, among others, stealing or corrupting data maintained online or digitally, preventing legitimate users from accessing information or services on a website, releasing confidential information without authorization, and disrupting operations. Successful cyber-attacks against, or security breakdowns of, a Fund, GMO, a sub-adviser, or a custodian, transfer agent, or other service provider may adversely affect the Fund or its shareholders. For instance, cyber-attacks may interfere with the processing of shareholder transactions, affect a Fund’s ability to calculate its net asset value, cause the release or misappropriation of private shareholder information or confidential Fund information, impede trading, cause reputational damage, and subject the Fund to regulatory fines, penalties or financial losses, and additional compliance costs. The Funds’ service providers regularly experience cyber-attacks and expect they will continue to do so. While GMO has established business continuity plans and systems designed to prevent, detect and respond to cyber-attacks, those plans and systems have inherent limitations. Similar types of cyber security risks also are present for issuers of securities in which the Funds invest, which could have material adverse consequences for those issuers and result in a decline in the market price of their securities. Furthermore, as a result of cyber-attacks, technological disruptions, malfunctions, or failures, an exchange or market may close or suspend trading in specific securities or the entire market, which could prevent the Funds from, among other things, buying or selling securities or accurately pricing their investments. The Funds cannot directly control cyber security plans and systems of their service providers, the Funds’ counterparties, issuers of securities in which the Funds invest, or securities markets and exchanges.

 MARKET DISRUPTION AND GEOPOLITICAL RISK. The Funds are subject to the risk that geopolitical and other events (e.g., wars and terrorism) will disrupt securities markets and adversely affect global economies and markets, thereby reducing the value of the Funds’ investments. Sudden or significant changes in the supply or prices of commodities or in other economic inputs (e.g., the marked decline in oil prices that began in late 2014) may have material and unexpected effects on both global securities markets and individual countries, regions, sectors, companies, or industries. Terrorism in the United States and around the world has increased geopolitical risk. The terrorist attacks on September 11, 2001 resulted in the closure of some U.S. securities markets for four days, and similar attacks are possible in the future. Securities markets may be susceptible to market manipulation or other fraudulent trading practices, which could disrupt their orderly functioning or reduce the prices of securities traded on them, including securities held by the Funds. Fraud and other deceptive practices committed by an issuer of securities held by a Fund undermine GMO’s due diligence efforts and, when discovered, will likely cause a steep decline in the market price of those securities and thus negatively affect the value of the Fund’s investments. In addition, when discovered, financial fraud may contribute to overall market volatility, which can negatively affect a Fund’s investment program as well as the rates or indices underlying a Fund’s investments.

While the U.S. government has always honored its credit obligations, a default by the U.S. government (as has been threatened in recent years) would be highly disruptive to the U.S. and global securities markets and could significantly reduce the value of the Funds’ investments. Similarly, political events within the United States have resulted, and may in the future result, in a shutdown of government services, which could adversely affect the U.S. economy, reduce the value of many Fund investments, and impair the operation of the U.S. or other securities markets. Uncertainty over the sovereign debt of several European Union countries, as well as uncertainty over the continued existence of the European Union itself, has disrupted and may continue to disrupt markets in the United States and around the world. If a country changes its currency or if the European Union dissolves, the world’s securities markets likely will be significantly disrupted. In June 2016, the United Kingdom approved a referendum to leave the European Union (commonly known as “Brexit”) and in March 2017, the United Kingdom commenced the formal process of withdrawing from the European Union. Brexit has resulted in volatility in European and global markets and could have negative long-term impacts on financial markets in the United Kingdom and throughout Europe. Considerable uncertainty exists over the potential consequences and precise timeframe for Brexit, how it will be conducted, how negotiations of trade agreements will proceed, and how the financial markets will react, and as this process unfolds markets may be further disrupted. The consequences of the United Kingdom’s or another country’s exit from the European Union also could threaten the stability of the euro for remaining countries and could negatively affect the financial markets of other countries in the European region and beyond. War, terrorism, economic uncertainty, and related geopolitical events, such as sanctions, tariffs, the imposition of exchange controls or other cross-border trade barriers, have led, and in the future may lead, to increased short-term market volatility and may have adverse long-term effects on U.S. and world economies and markets generally. Likewise, natural and environmental disasters, such as the earthquake and tsunami in Japan in early 2011, and systemic market dislocations of the kind surrounding the insolvency of Lehman Brothers in 2008, if repeated, would be highly disruptive to economies and markets, adversely affecting individual companies and industries, securities markets, interest rates, credit ratings, inflation, investor sentiment, and other factors affecting the market price of the Funds’ investments. During such market disruptions, the Funds’ exposure to the risks described elsewhere in this “Investment and other risks” section will likely increase. Market disruptions, including sudden government interventions, can also prevent the Funds from implementing their investment

 

157


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

programs and achieving their investment objectives. For example, a market disruption may adversely affect the orderly functioning of the securities markets and may cause the Funds’ derivatives counterparties to discontinue offering derivatives on some underlying commodities, securities, reference rates, or indices, or to offer them on a more limited basis. To the extent a Fund has focused its investments in the stock index of a particular region, adverse geopolitical and other events in that region could have a disproportionate impact on the Fund.

 MARKET RISK. All of the Funds are subject to market risk, which is the risk that the market price of their holdings will decline. Market risks include:

Asset-Backed Securities — Investments in asset-backed securities not only are subject to all of the market risks described under “Market Risk — Fixed Income,” but to other market risks as well.

Asset-backed securities are often exposed to greater risk of severe credit downgrades, illiquidity, and defaults than many other types of fixed income investments. These risks become particularly acute during periods of adverse market conditions, such as those that occurred in 2008.

As described under “Market Risk — Fixed Income” the market price of asset-backed securities, like that of other fixed income investments with complex structures, can decline for a variety of reasons, including market uncertainty about their credit quality and the reliability of their payment streams. Payment of interest on asset-backed securities and repayment of principal largely depend on the cash flow generated by the assets backing the securities, as well as the deal structure (e.g., the amount of underlying assets or other support available to produce the cash flows necessary to service interest and make principal payments), the quality of the underlying assets, the level of credit support and the credit quality of the credit-support provider, if any, and the performance of other service providers with access to the payment stream. A problem in any of these factors can lead to a reduction in the payment stream GMO expected a Fund to receive when the Fund purchased the asset-backed security. Principal repayments of asset-backed securities are at risk if obligors of the underlying obligations default and the value of the defaulted obligations exceeds whatever credit support the securities have. Asset-backed securities backed by sub-prime mortgage loans, in particular, expose a Fund to potentially greater declines in value due to defaults because sub-prime mortgage loans are typically made to less creditworthy borrowers and thus have a higher risk of default than conventional mortgage loans. The issuance of asset-backed securities also are subject to bankruptcy, insolvency and other laws affecting the rights and remedies of creditors. As of the date of this report, many asset-backed securities owned by the Funds that were once rated investment grade are now rated below investment grade. See “Credit Risk” for more information about credit risk.

When worldwide economic and liquidity conditions deteriorated in 2008, the markets for asset-backed securities became fractured, and uncertainty about the creditworthiness of those securities (and underlying assets) caused credit spreads (the difference between yields on asset-backed securities and U.S. Government securities) to widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions to make markets in many asset-backed (as well as others) fixed income securities. These events reduced liquidity and contributed to substantial declines in the market prices of asset-backed (and other) fixed income securities and may occur again. Also, government actions and proposals affecting the terms of underlying home and consumer loans, changes in demand for products (e.g., automobiles) financed by those loans, and the inability of borrowers to refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity effects on asset-backed securities.

The market price of an asset-backed security depends in part on the servicing of its underlying assets and is, therefore, subject to risks associated with the negligence or defalcation of its servicer. In some circumstances, the mishandling of documentation for underlying assets also can affect the rights of holders of those underlying assets. The insolvency of a servicer is likely to result in a decline in the market price of the securities it is servicing, as well as costs and delays. The obligations underlying asset-backed securities, in particular securities backed by pools of residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as was provided by the asset-backed security. When interest rates rise, the obligations underlying asset-backed securities may be repaid more slowly than anticipated, and the market price of those securities may decrease.

The existence of insurance on an asset-backed security does not guarantee that the principal and interest will be paid because the insurer could default on its obligations.

 

158


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The risk of investing in asset-backed securities has increased since 2008 because performance of the various sectors in which the assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more highly correlated. See “Focused Investment Risk” for more information about risks of investing in correlated sectors. A single financial institution may serve as a servicer for many asset-backed securities. As a result, a disruption in that institution’s business may have a material impact on the many asset-backed securities it services.

Equities — Funds that invest in equities run the risk that the market price of an equity will decline. That decline may be attributable to factors affecting the issuer, such as poor performance by the issuer’s management or reduced demand for its goods or services, or to factors affecting a particular industry, such as a decline in demand, labor or raw material shortages, or increased production costs. A decline also may result from general market conditions not specifically related to a company or industry, such as real or perceived adverse economic conditions, changes in the general outlook for corporate earnings, changes in interest or currency rates, or adverse investor sentiment generally. The market prices of equities are volatile and can decline in a rapid or unpredictable manner. If a Fund purchases an equity for what GMO believes is less than its fundamental fair (or intrinsic) value, the Fund runs the risk that the market price of the equity will not appreciate or will decline due to GMO’s incorrect assessment. The market prices of equities trading at high multiples of current earnings often are more sensitive to changes in future earnings expectations than the market prices of equities trading at lower multiples.

To the extent a Fund invests in GMO Risk Premium Fund (“Risk Premium Fund”), the Fund is exposed to Risk Premium Fund’s market risk with respect to equities. Because of Risk Premium Fund’s emphasis on writing put options on stock indices, GMO expects the Fund’s net asset value to decline when those indices decline in value. Also, Risk Premium Fund’s investment strategy of writing put options on stock indices can be expected to cause the Fund to underperform relative to those indices when the markets associated with those indices rise sharply because of the Fund’s lack of exposure to the upside of those markets.

Fixed Income — Funds that invest in fixed income investments (including bonds, notes, bills, synthetic debt instruments, and asset-backed securities) are subject to various market risks. The market price of a fixed income investment can decline due to market-related factors, including rising interest rates and widening credit spreads, or decreased liquidity due to market uncertainty about the value of a fixed income investment (or class of fixed income investments). In addition, the market price of fixed income investments with complex structures, such as asset-backed securities and sovereign and quasi-sovereign debt instruments, can decline due to uncertainty about their credit quality and the reliability of their payment streams. Some fixed income investments also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as high a yield as was provided by the fixed income investment. When interest rates rise, fixed income investments also may be repaid more slowly than anticipated, causing a decrease in their market price. During periods of economic uncertainty and change, the market price of a Fund’s investments in below investment grade investments (commonly referred to as “junk bonds”) may be particularly volatile. Often below investment grade investments are subject to greater sensitivity to interest rate and economic changes than higher rated investments and can be more difficult to value, exposing a Fund to the risk that the price at which it sells them will be less than the price at which they were valued when held by the Fund. See “Credit Risk” and “Illiquidity Risk” for more information about these risks.

A risk run by each Fund with significant investment in fixed income investments is that an increase in prevailing interest rates will cause the market price of those securities to decline. The risk associated with increases in interest rates (also called “interest rate risk”) is generally greater for Funds investing in fixed income investments with longer durations. In addition, in managing some Funds, GMO may seek to evaluate potential investments in part by considering the volatility of interest rates. The value of a Fund’s investments may be significantly reduced if GMO’s assessment proves incorrect.

The extent to which the market price of a fixed income investment changes with changes in interest rates is referred to as interest rate duration, which can be measured mathematically or empirically. A longer-maturity investment generally has longer interest rate duration because its fixed rate is locked in for a longer period of time. Floating-rate or adjustable-rate investments generally have shorter interest rate durations because their interest rates are not fixed but rather float up and down as interest rates change. Conversely, inverse floating-rate investments have durations that move in the opposite direction from short-term interest rates and thus tend to underperform fixed rate investments when interest rates rise but outperform them when interest rates decline. Fixed income investments paying no interest, such as zero coupon and principal-only securities, are subject to additional interest rate risk.

The market price of inflation-indexed bonds (including TIPS) typically declines during periods of rising real interest rates (i.e., nominal interest rate minus inflation) and increases during periods of declining real interest rates. In some interest rate environments,

 

159


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

such as when real interest rates are rising faster than nominal interest rates, the market price of inflation-indexed bonds may decline more than the price of non-inflation-indexed (or nominal) fixed income bonds with similar maturities.

Generally, when interest rates on short term U.S. Treasury obligations equal or approach zero, a Fund that invests a substantial portion of its assets in U.S. Treasury obligations, such as U.S. Treasury Fund, will have a negative return unless GMO waives or reduces its management fees.

Fixed income securities denominated in foreign currencies also are subject to currency risk. See “Currency Risk.”

In response to government intervention, economic or market developments, or other factors, markets for fixed income investments may experience periods of high volatility, reduced liquidity or both. During those periods, a Fund could have unusually high shareholder redemptions, requiring it to generate cash by selling portfolio assets when it would otherwise not do so, including at unfavorable prices. Fixed income investments may be difficult to value during such periods. In recent years, central banks and governmental financial regulators, including the U.S. Federal Reserve, have kept interest rates historically low by purchasing bonds. However, the U.S. Federal Reserve recently has increased interest rates and continued economic recovery, and the Federal Reserve’s conclusion of its quantitative easing program increase the likelihood that interest rates will increase in the United States and throughout the financial system. A substantial increase in interest rates could have an adverse effect on prices for fixed income investments and on the performance of the Funds. Other actions by central banks or regulators (such as intervention in foreign currency markets or currency controls) also could have a material adverse effect on the Funds.

 MERGER ARBITRAGE RISK. Some Funds engage in transactions in which the Fund purchases securities at prices below the value of the consideration GMO expects the Fund to receive upon consummation of a proposed merger, exchange offer, tender offer, or other similar transaction (“merger arbitrage transactions”). The purchase price paid by the Fund may substantially exceed the market price of the securities before the announcement of the transaction.

If a Fund engages in merger arbitrage and the merger later appears unlikely to be consummated or, in fact, is not consummated or is delayed, the market price of the securities purchased by the Fund is likely to decline sharply, resulting in losses to the Fund. The risk/reward payout of merger arbitrage strategies typically is asymmetric, with the losses in failed transactions often far exceeding the gains in successful transactions. A proposed merger can fail to be consummated for many reasons, including regulatory and antitrust restrictions, industry weakness, company specific events, failed financings, and general market declines.

Merger arbitrage strategies are subject to the risk of overall market movements, and a Fund may experience losses even if a transaction is consummated. A Fund’s investments in derivatives or short sales of securities to hedge or otherwise adjust long or short investment exposure in connection with a merger arbitrage may not perform as GMO expected or may otherwise reduce the Fund’s gains or increase its losses. Also, a Fund may be unable to hedge against market fluctuations or other risks. In addition, a Fund may sell securities short when GMO expects the Fund to receive the securities upon consummation of a transaction; if the Fund does not actually receive the securities, the Fund will have an unintended “naked” short position and may be required to cover its short position at a time when the securities sold short have appreciated in value, thus resulting in a loss. A Fund’s merger arbitrage transactions could result in tax inefficiencies, including larger distributions of net investment income and net realized capital gains than otherwise would be the case.

 NON-DIVERSIFIED FUNDS. Some of the Funds are not “diversified” investment companies within the meaning of the 1940 Act. This means they are allowed to invest in the securities of relatively few issuers. As a result, they may be subject to greater credit, market and other risks than if their investments were more diversified, and poor performance by a single investment may have a greater impact on their performance.

The following Funds are not diversified investment companies within the meaning of the 1940 Act:

 

   

Alpha Only Fund

   

Implementation Fund

   

SGM Major Markets Fund

   

Special Opportunities Fund

In addition, each of the Funds may invest a portion of its assets in shares of one or more other GMO Funds that are not diversified investment companies under the 1940 Act. Each of the Funds may invest without limitation in GMO Funds that are not diversified.

 

160


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 NON-U.S. INVESTMENT RISK. Funds that invest in non-U.S. securities are subject to more risks than Funds that invest only in U.S. securities. Many non-U.S. securities markets include securities of only a small number of companies in a small number of industries. As a result, the market prices of securities traded on those markets often fluctuate more than those of U.S. securities. In addition, issuers of non-U.S. securities often are not subject to as much regulation as U.S. issuers, and the reporting, accounting, custody, and auditing standards to which those issuers are subject often are not as rigorous as U.S. standards. Transactions in non-U.S. securities generally involve higher commission rates, transfer taxes, and custodial costs. In addition, some countries limit a Fund’s ability to profit from short-term trading (as defined in that country).

A Fund may be subject to non-U.S. taxation, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments; (ii) transactions in those investments; and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. A Fund may seek a refund of taxes paid, but its efforts may not be successful, in which case the Fund will have incurred additional expenses for no benefit. In addition, a Fund’s pursuit of a tax refund may subject it to administrative and judicial proceedings in the country where it is seeking the refund. A Fund’s decision to seek a refund is in its sole discretion, and, particularly in light of the cost involved, it may decide not to seek a refund, even if it is entitled to one. The outcome of a Fund’s efforts to obtain a refund is inherently unpredictable. Accordingly, a refund is not typically reflected in a Fund’s net asset value until it is received or until GMO is confident that it will be received. In some cases, the amount of a refund could be material to a Fund’s net asset value. Generally, absent a determination that a refund is collectible and free from significant contingencies, a refund is not reflected in a Fund’s net asset value. See “Taxes, Non-U.S. Taxes” in the GMO Trust Statement of Additional Information for additional information. For information on possible special Australian tax consequences of an investment in the Funds, see the Funds’ Prospectus and Statement of Additional Information.

Investing in non-U.S. securities also exposes a Fund to the risk of nationalization, expropriation, or confiscatory taxation of assets of their issuers, government involvement in every country, including the U.S., or in the affairs of specific companies or industries (including wholly or partially state-owned enterprises), adverse changes in investment regulations, capital requirements or exchange controls (which may include suspension of the ability to transfer currency from a country), and adverse political and diplomatic developments, including the imposition of economic sanctions.

In some non-U.S. securities markets, custody arrangements for securities provide significantly less protection than custody arrangements in U.S. securities markets, and prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose a Fund to credit and other risks it does not have in the United States. Fluctuations in currency exchange rates also affect the market prices of a Fund’s non-U.S. securities (see “Currency Risk”).

The Funds need a license to invest directly in securities traded in many non-U.S. securities markets. These licenses are often subject to limitations, including maximum investment amounts. Once a license is obtained, a Fund’s ability to continue to invest directly is subject to the risk that the license will be terminated or suspended. If a license to invest in a particular market is terminated or suspended, to obtain exposure to that market the Fund will be required to purchase American Depositary Receipts, Global Depositary Receipts, shares of other funds that are licensed to invest directly, or derivative instruments. The receipt of a non-U.S. license by one of GMO’s clients may preclude a Fund from obtaining a similar license. In addition, the activities of a GMO client could cause the suspension or revocation of a Fund’s license.

Funds that invest a significant portion of their assets in securities of issuers tied economically to emerging countries (or investments related to emerging markets) are subject to greater non-U.S. investment risk than Funds investing primarily in more developed non-U.S. countries (or markets). The risks of investing in those securities include: greater fluctuations in currency exchange rates; increased risk of default (by both government and private issuers); greater social, economic, and political uncertainty and instability (including the risk of war or natural disaster); increased risk of nationalization, expropriation, or other confiscation of issuer assets; greater governmental involvement in the economy or in the affairs of specific companies or industries (including wholly or partially state-owned enterprises); less governmental supervision and regulation of securities markets and participants in those markets; controls on investment, capital controls and limitations on repatriation of invested capital, dividends, interest and other income and on a Fund’s ability to exchange local currencies for U.S. dollars; inability to purchase and sell investments or otherwise settle security or derivative transactions (i.e., a market freeze); unavailability of currency hedging techniques; less rigorous auditing and financial reporting standards and resulting unavailability of material information about issuers; slower clearance and settlement; difficulties in obtaining and enforcing legal judgments; and significantly smaller market capitalizations of issuers. In addition, the economies of emerging countries may depend predominantly on only a few industries or revenues from particular commodities and often are more volatile than the economies of developed countries.

 

161


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 SMALL COMPANY RISK. Companies with smaller market capitalizations tend to have limited product lines, markets, or financial resources, lack the competitive strength of larger companies, have less experienced managers and depend on fewer key employees than larger companies. In addition, their securities often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations. Market risk and illiquidity risk are particularly pronounced for the securities of these companies.

Temporary Defensive Positions. Temporary defensive positions are positions that are inconsistent with a Fund’s principal investment strategies and are taken in response to adverse market, economic, political, or other conditions.

Benchmark-Free Allocation Fund, Benchmark-Free Fund and Implementation Fund may take temporary defensive positions if deemed prudent by GMO.

To the extent a Fund takes a temporary defensive position, or otherwise holds cash, cash equivalents, or high quality debt investments on a temporary basis, the Fund may not achieve its investment objective.

 

4.

Derivative financial instruments

At August 31, 2018, only Alpha Only Fund, Benchmark-Free Fund, Implementation Fund, SGM Major Markets Fund, Special Opportunities Fund and Strategic Opportunities Allocation Fund held derivative financial instruments directly. For a listing of derivative financial instruments, if any, held by the underlying funds, please refer to the underlying funds’ Schedule of Investments. The derivative information provided below only pertains to direct investments made by Alpha Only Fund, Benchmark-Free Fund, Implementation Fund, SGM Major Markets Fund, Special Opportunities Fund and Strategic Opportunities Allocation Fund (or their respective wholly-owned subsidiary, if any).

Derivatives are financial contracts whose value depends on, or is derived from, the value of underlying assets, reference rates, or indices, that are used to increase, decrease or adjust elements of the investment exposures of a Fund’s portfolio. Derivatives may relate to securities, interest rates, currencies, currency exchange rates, inflation rates, commodities and indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other exchange-traded and OTC contracts.

Use of Derivatives by Alpha Only Fund and Special Opportunities Fund

Alpha Only Fund’s investment program involves having both long and short investment exposures. Alpha Only Fund seeks to construct a portfolio in which it has long investment exposure to asset classes and sub-asset classes that GMO expects will outperform relative to the asset classes and sub-asset classes to which it has short investment exposure.

The Funds may use derivatives to gain long investment exposure to securities or other assets. For example, a Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Funds also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts, and options) to gain exposure to a given currency. In addition, Special Opportunities Fund may use derivatives to gain investment exposure to commodities, including the use of exchange-traded futures and foreign exchange contracts to gain exposure to a range of global equity, bond, currency, and commodity markets.

The Funds may use derivatives in an attempt to reduce their investment exposures (which may result in a reduction below zero). A Fund also may use currency derivatives in an attempt to reduce some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that GMO believes is highly correlated with the relevant currency.

The Funds may use derivatives in an attempt to adjust elements of their investment exposures to various securities, sectors, markets, indices, and currencies (and in the case of Special Opportunities Fund, commodities) without actually having to sell existing investments or make new direct investments. For example, if a Fund holds a large proportion of stocks of companies in a particular sector and GMO believes that stocks of companies in another sector will outperform those stocks, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). In adjusting its investment exposures, a Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currencies in which its equities are traded.

 

162


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Funds may use derivatives to effect transactions intended as substitutes for securities lending.

Special Opportunities Fund may have investment exposures in excess of its net assets (i.e., it may be leveraged). Alpha Only Fund is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, Alpha Only Fund will typically have gross investment exposures in excess of its net assets (i.e., the Fund will be leveraged) and therefore is subject to heightened risk of loss. Alpha Only Fund’s performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.

A Fund’s foreign currency exposure may differ significantly from the currencies in which its equities are traded.

Use of Derivatives by Benchmark-Free Fund, Implementation Fund and Strategic Opportunities Allocation Fund

The Funds may use derivatives to gain long investment exposure to securities, commodities or other assets. For example, a Fund may use derivatives instead of investing directly in equity securities, including using equity derivatives to maintain equity exposure when it holds cash by “equitizing” its cash balances using futures contracts or other types of derivatives. The Funds also may use exchange-traded futures and forward foreign exchange contracts to gain exposure to a range of global equity, bond, currency, and commodity markets and may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.

The Funds may use derivatives such as futures, options, and swap contracts, in an attempt to reduce their investment exposures (which may result in a reduction below zero). For example, a Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer or may use a bond futures contract to short the bond market of a particular country. A Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Funds may use an instrument denominated in a different currency that GMO believes is highly correlated with the relevant currency. Implementation Fund uses exchange-traded futures and forward contracts as an integral part of its investment program.

The Funds may use derivatives in an attempt to adjust elements of their investment exposures to individual commodities, various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if a Fund holds a large proportion of a certain type of security or commodity and GMO believes that another security or commodity will outperform such security or commodity, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of those stocks) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). Long and short swap contracts and contracts for differences also may be used for these purposes. Derivatives used to effect synthetic sales and purchases will generally be unwound as actual portfolio securities are sold and purchased. In adjusting investment exposures, each Fund also may use currency derivatives, seeking currency exposure that is different (in some cases, significantly different) from the currency exposure represented by its portfolio. Each Fund’s foreign currency exposure may differ significantly from the currency exposure represented by its investments.

The Funds may use derivatives to effect transactions intended as substitutes for securities lending.

Each of the Funds is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of their derivative positions, the Funds may have gross investment exposures in excess of their net assets (i.e., the Funds may be leveraged) and therefore are subject to heightened risk of loss. Each Fund’s performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.

Use of Derivatives by SGM Major Markets Fund

The Fund invests in a range of global equity, bond, currency, and commodity markets using exchange traded futures and forward non-U.S. exchange contracts as well as making other investments.

The Fund may use derivatives to gain long and/or short investment exposure to global equities, bonds, currencies, commodities, or other assets. In particular, the Fund may use exchange traded futures and forward foreign exchange contracts to gain exposure to a range of global equity, bond, currency, and commodity markets. The Fund also may use currency derivatives (including forward currency contracts, futures contracts, swap contracts and options) to gain exposure to a given currency.

 

163


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Fund may use derivatives in an attempt to adjust its investment exposures. For example, the Fund may use credit default swaps to take a short position with respect to the likelihood of default by an issuer. The Fund also may use currency derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a different currency that GMO believes is highly correlated with the relevant currency.

The Fund may use derivatives, such as futures, options, and swap contracts, in an attempt to adjust elements of its investment exposures to individual commodities, various securities, sectors, markets, indices and currencies without actually having to sell existing investments or make new direct investments. For example, if the Fund holds a large proportion of a certain type of security or commodity and GMO believes that another security or commodity will outperform such security or commodity, the Fund might use a short futures contract on an appropriate index (to synthetically “sell” a portion of the Fund’s portfolio) in combination with a long futures contract on another index (to synthetically “buy” exposure to that index). Long and short swap contracts and contracts for differences also may be used for these purposes. Derivatives used to effect synthetic sales and purchases will generally be unwound as actual portfolio securities are sold and purchased. In addition, the Fund may alter the interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is designed to maintain the Fund’s exposure to the credit of an issuer through the debt instrument but adjust the Fund’s interest rate exposure through the swap. With these swaps, the Fund and its counterparties exchange interest rate exposure, such as fixed versus variable rates and shorter duration versus longer duration exposure. In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is different (in some cases, significantly different) from the currencies in which its equities are traded.

The Fund is not limited in its use of derivatives or in the total notional value of its derivative positions. As a result of its derivative positions, the Fund will typically have gross investment exposures in excess of its net assets (i.e., the Fund will be leveraged) and therefore is subject to heightened risk of loss. The Fund’s performance can depend substantially, if not primarily, on the performance of assets or indices underlying its derivatives even though it does not own those assets or indices.

* * *

Certain derivatives transactions that may be used by the Funds, including certain interest rate swaps and certain credit default index swaps, are required to be transacted through a central clearing organization. The Funds hold cleared derivatives transactions, if any, through clearing members, who are members of derivatives clearing houses. Certain other derivatives, including futures and certain options, are transacted on exchanges. The Funds hold exchange-traded derivatives through clearing brokers that are typically members of the exchanges. In contrast to bilateral derivatives transactions, following a period of advance notice to the Fund, clearing brokers generally can require termination of existing cleared or exchange-traded derivatives transactions at any time and increases in margin above the margin that it required at the beginning of a transaction. Clearing houses and exchanges also have broad rights to increase margin requirements for existing transactions and to terminate transactions. Any such increase or termination could interfere with the ability of a Fund to pursue its investment strategy. Also, a Fund is subject to execution risk if it enters into a derivatives transaction that is required to be cleared (or that GMO expects to be cleared), and no clearing member is willing or able to clear the transaction on the Fund’s behalf. In that case, the transaction might have to be terminated, and the Fund could lose some or all of the benefit of any increase in the value of the transaction after the time of the transaction.

The use of derivatives involves risks that are in addition to, and potentially greater than, the risks associated with investing directly in securities and other more traditional assets. See “Investment and other risks” above for further information.

 

164


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

For Funds that held derivatives during the period ended August 31, 2018, the following table shows how the Fund used these derivatives (marked with an X):

 

             
Type of Derivative and Objective for Use   Alpha Only
Fund
    Benchmark-
Free Fund
    Consolidated
Implementation
Fund*
    Strategic
Opportunities
Allocation
Fund
    Consolidated
SGM Major
Markets
Fund*
    Consolidated
Special
Opportunities
Fund*
 
Forward currency contracts                                                

Adjust currency exchange rate risk

                                    X          

Adjust exposure to foreign currencies

    X       X       X               X       X  

Manage against anticipated currency exchange rate changes

                    X                          
Futures contracts                                                

Adjust exposure to certain securities markets

            X       X               X          

Substitute for direct investment

                                    X       X  

Adjust interest rate exposure

                    X               X          

Maintain the diversity and liquidity of the portfolio

            X       X               X          

Hedge some or all of the broad market exposure of the underlying funds and/or assets in which the Fund invests

    X                                          
Options (Purchased)                                                

Substitute for direct equity investment

                    X                          
Options (Written)                                                

Substitute for direct equity investment

                    X                       X  

Adjust currency exchange rate risk

                                               

Adjust exposure to foreign currencies

                                               

Adjust interest rate exposure

                    X                          
Swap contracts                                                

Adjust exposure to certain securities markets

                                               

Adjust interest rate exposure

                    X                          

Substitute for direct investment in securities

            X       X       X                  

Achieve exposure to a reference entity’s credit

                    X                          
Rights and/or warrants                                                

Received as a result of corporate actions

    X       X       X       X                  

 

  *

Certain derivatives may be held by the Fund’s wholly-owned subsidiary.

Forward currency contracts

The Funds may enter into forward currency contracts, including forward cross currency contracts. A forward currency contract is an agreement between two parties to buy and sell a currency at a set price on a future date (or to pay or receive the amount of the change in relative values of the two currencies). The market price of a forward currency contract fluctuates with changes in forward currency exchange rates. The value of each of the Fund’s forward currency contracts is marked-to-market daily using rates supplied by a quotation service and changes in value are recorded by each Fund as unrealized gains or losses. Realized gains or losses on the contracts are equal to the difference between the value of the contract at the time it was opened and the value at the time it was settled.

 

165


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

These contracts involve market risk in excess of the unrealized gain or loss. Forward currency contracts expose a Fund to the market risk of unfavorable movements in currency values and the risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most forward currency contracts are not collateralized. Forward currency contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Futures contracts

The Funds may purchase and sell futures contracts. A futures contract is a contract that obligates the holder to buy or sell an asset at a predetermined delivery price at a specified time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures contract, a Fund is required to deposit cash, U.S. government and agency obligations or other liquid assets with the futures clearing broker in accordance with the initial margin requirements of the broker or exchange. Futures contracts are generally valued at the settlement price established at the close of business each day by the board of trade or exchange on which they are traded (and if the futures are traded outside the U.S. and the market for such futures is closed prior to the close of the NYSE due to time zone differences, the values will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees to reflect estimated valuation changes through the NYSE close). The value of each of the Fund’s futures contracts is marked-to-market daily and an appropriate payable or receivable for the change in value (“variation margin”) is recorded by each Fund. The payable or receivable is settled on the following business day. Gains or losses are recognized but not accounted for as realized until the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin as recorded in the Statements of Assets and Liabilities. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures contracts expose the Funds to the risk that they may not be able to enter into a closing transaction due to an illiquid market. Futures contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Options

The Funds may purchase call and put options. A call option gives the holder the right to buy an asset; a put option gives the holder the right to sell an asset. “Quanto” options are cash-settled options in which the underlying asset (often an index) is denominated in a currency other than the currency in which the option is settled. By purchasing options a Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it to purchase the underlying asset at a set price from the writer of the option and, in the case of a put option, entitling it to sell the underlying asset at a set price to the writer of the option. A Fund pays a premium for a purchased option. That premium, if any, which is disclosed in the Schedule of Investments, is subsequently reflected in the marked-to-market value of the option. The potential loss associated with purchasing put and call options is limited to the premium paid. Purchased option contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

The Funds may write (i.e., sell) call and put options on futures, swaps (“swaptions”), securities or currencies they own or in which they may invest. Writing options alters a Fund’s exposure to the underlying asset by, in the case of a call option, obligating that Fund to sell the underlying asset at a set price to the option-holder and, in the case of a put option, obligating that Fund to purchase the underlying asset at a set price from the option-holder. In some cases (e.g., index options), settlement will be in cash, based on a formula price. When a Fund writes a call or put option, an amount equal to the premium received is recorded as a liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, a Fund has no control over whether it will be required to sell (call) or purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in the price of the asset underlying the option. In the event that a Fund writes call options without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price of the underlying asset increases during the term of

the option. OTC options expose a Fund to the risk the Fund may not be able to enter into a closing transaction because of an illiquid market. Written option contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

When an option contract is closed, that Fund records a realized gain or loss equal to the difference between the value of the contract at the time it was opened and the value at the time it was closed. Realized gains and losses on purchased options are included in realized gains and losses on investment securities. If a written call option is exercised, the premium originally received is recorded as an addition to sales proceeds. If a written put option is exercised, the premium originally received is recorded as a reduction in the cost of investments purchased. Gains and losses from the expiration or closing of written option contracts are separately disclosed in the Statements of Operations.

 

166


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

In a credit linked option contract, one party makes payments to another party in exchange for the option to exercise a contract where the buyer has the right to receive a specified return if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities and a specified decrease in the value of the related collateral occurs. A writer of a credit linked option receives periodic payments in return for its obligation to pay an agreed-upon value to the other party if they exercise their option in the case of a credit event. If no credit event occurs, the seller has no payment obligation and will keep the premiums received.

Exchange-traded options are valued at the last sale price, provided that price is between the closing bid and ask prices. If the last sale price is not within this range, then they will be valued at the closing bid price for long positions and the closing ask price for short positions (and if the market of the underlying reference security closes or the official closing time of the underlying index occurs prior to the close of the NYSE due to time zone differences, the values will be adjusted, to the extent practicable and available, based on inputs from an independent pricing service approved by the Trustees to reflect estimated valuation changes through the NYSE close). The Funds value OTC options using industry models and inputs provided by primary pricing sources.

Swap contracts

The Funds may directly or indirectly use various swap contracts, including, without limitation, swaps on securities and securities indices, total return swaps, interest rate swaps, basis swaps, currency swaps, credit default swaps, variance swaps, commodity swaps, inflation swaps, municipal swaps, dividend swaps, volatility swaps, correlation swaps and other types of available swaps. A swap contract is an agreement to exchange the return generated by one asset for the return generated by another asset. Some swap contracts are net settled. When entering into a swap contract and during the term of the transaction, a Fund and/or the swap counterparty may post or receive cash or securities as collateral.

Initial upfront payments received or made upon entering into a swap contract are included in the fair market value of the swap. The Funds do not amortize upfront payments. Net periodic payments made or received to compensate for differences between the stated terms of the swap contract and prevailing market conditions (credit spreads, currency exchange rates, interest rates, and other relevant factors) are recorded as realized gains or losses in the Statements of Operations. A liquidation payment received or made at the termination of the swap contract is recorded as realized gain or loss in the Statements of Operations. The periodic frequency of payments received may differ from periodic payment frequencies made and their frequencies could be monthly, quarterly, semiannually, annually or at maturity.

Interest rate swap contracts involve an exchange by the parties of their respective commitments to pay or rights to receive interest (e.g., an exchange of floating rate interest payments for fixed rate interest payments with respect to the notional amount of principal). Basis swaps are interest rate swaps that involve the exchange of two floating interest rate payments and may involve the exchange of two different currencies.

Inflation swaps involve the exchange of a floating rate linked to an index for a fixed rate interest payment with respect to a notional amount or principal.

Total return swap contracts involve a commitment by one party to pay interest to the other party in exchange for a payment to it from the other party based on the return of a reference asset (e.g., a security, basket of securities, or futures contract), both based on notional amounts. To the extent the return of the reference asset exceeds or falls short of the interest payments, one party is entitled to receive a payment from or obligated to make a payment to the other party.

In a credit default swap contract, one party makes payments to another party in exchange for the right to receive a specified return (or to put a security) if a credit event (e.g., default or similar event) occurs with respect to a reference entity or entities. A seller of credit default protection receives periodic payments in return for its obligation to pay the principal amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of a credit event. If no credit event occurs, the seller has no payment obligations so long as there is no early termination.

For credit default swap contracts on asset-backed securities, a credit event may be triggered by various occurrences, which may include an issuer’s failure to pay interest or principal on a reference security, a breach of a material representation or covenant, an agreement by the holders of an asset-backed security to a maturity extension, or a write-down on the collateral underlying the security. For credit default swap contracts on corporate or sovereign issuers, a credit event may be triggered by such occurrences as the issuer’s bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.

 

167


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Correlation swaps involve receiving a stream of payments based on the actual average correlation between or among the price movements of two or more underlying variables over a period of time, in exchange for making a regular stream of payments based on a fixed “strike” correlation level (or vice versa), where both payment streams are based on a notional amount. The underlying variables may include, without limitation, commodity prices, exchange rates, interest rates and stock indices.

Variance swap contracts involve an agreement by two parties to exchange cash flows based on the measured variance (or square of volatility) of a specified underlying asset. One party agrees to exchange a “fixed rate” or strike price payment for the “floating rate” or realized price variance on the underlying asset with respect to the notional amount. At inception, the strike price chosen is generally fixed at a level such that the fair value of the swap is zero. As a result, no money changes hands at the initiation of the contract. At the expiration date, the amount payable by one party to the other is the difference between the realized price variance of the underlying asset and the strike price multiplied by the notional amount. A receiver of the realized price variance would be entitled to receive a payment when the realized price variance of the underlying asset is greater than the strike price and would be obligated to make a payment when that variance is less than the strike price. A payer of the realized price variance would be obligated to make a payment when the realized price variance of the underlying asset is greater than the strike price and would be entitled to receive a payment when that variance is less than the strike price. This type of agreement is essentially a forward contract on the future realized price variance of the underlying asset.

Forward starting dividend swap contracts involve an exchange by the parties of their respective commitments to pay or rights to receive the changes in a dividend index point. A Fund gains exposure by either paying or receiving an amount in respect of an increase or decrease in the change of the relevant dividend index point based on a notional amount. For example, if a Fund took a long position on a dividend index swap, the Fund would receive payments if the relevant index point increased in value and would be obligated to pay if that index point decreased in value.

Future swap contracts involve an exchange by the parties of their respective commitments to pay or rights to receive the changes in an index. The Fund gains exposure by either paying or receiving an amount in respect of an increase or decrease in the change of the index based on a notional amount. For example, if the Fund took a long position on a future swap, the Fund would receive payments if the relevant index increased in value and would be obligated to pay if that index decreased in value.

Generally, the Funds price their OTC swap contracts daily using industry standard models that may incorporate quotations from market makers or pricing vendors and record the change in value, if any, as unrealized gain or loss in the Statements of Operations. Gains or losses are realized upon the termination of the swap contracts or reset dates, as appropriate. Cleared swap contracts are valued using the quote (which may be based on a model) published by the relevant clearing house. If an updated quote for a cleared swap contract is not available by the time that a Fund calculates its net asset value on any business day, then that swap contract will generally be valued using an industry standard model, which may differ from the model used by the relevant clearing house.

The values assigned to swap contracts may differ significantly from the values realized upon termination, and the differences could be material. Entering into swap contracts involves counterparty credit, legal, and documentation risk that is generally not reflected in the value assigned to the swap contract. Such risks include the possibility that the counterparty defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that a Fund has amounts on deposit in excess of amounts owed by that Fund, or that any collateral the other party posts is insufficient or not timely received by a Fund. Credit risk is particularly acute in economic environments in which financial services firms are exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. Swap contracts outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

Rights and warrants

The Funds may purchase or otherwise receive warrants or rights. Warrants and rights generally give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds typically use warrants and rights in a manner similar to their use of purchased options on securities, as described in the section entitled “Options” above. Risks associated with the use of warrants and rights are generally similar to risks associated with the use of purchased options. However, warrants and rights often do not have standardized terms, and may have longer maturities and may be less liquid than exchange-traded options. In addition, the terms of warrants or rights may limit a Fund’s ability to exercise the warrants or rights at such times and in such quantities as the Fund would otherwise wish. Rights and/or warrants outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.

 

168


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

As provided by U.S. GAAP, the table below is based on market values or unrealized appreciation/(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Funds (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.

The following is a summary of the valuations of derivative instruments categorized by risk exposure.

The Effect of Derivative Instruments on the Statements of Assets and Liabilities as of August 31, 2018 and the Statements of Operations for the period ended August 31, 2018^:

The risks referenced in the tables below are not intended to be inclusive of all risks. Please see the “Investment and other risks” and “Portfolio valuation” sections for a further discussion of risks.

 

               
     Credit
Contracts
    Commodity
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Alpha Only Fund

               

Asset Derivatives

               

Investments, at value (rights and/or warrants)

  $     $     $ 0     $     $     $     $ 0  

Unrealized Appreciation on Forward Currency Contracts

                      463,811                   463,811  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 0     $ 463,811     $     $     $ 463,811  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $ 0     $     $     $       0  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $     $ 463,811     $     $     $ 463,811  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Derivatives

               

Unrealized Depreciation on Forward Currency Contracts

  $     $     $     $ (77,608   $     $     $ (77,608

Unrealized Depreciation on Futures Contracts¤

                (4,276,176                       (4,276,176
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (4,276,176   $ (77,608   $     $     $ (4,353,784
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ (4,276,176   $ (77,608   $     $     $ (4,353,784
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

               

Investments (rights and/or warrants)

  $     $     $ 1,286     $     $     $     $ 1,286  

Forward Currency Contracts

                      1,454,862                   1,454,862  

Futures Contracts

                (9,469,476                       (9,469,476
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (9,468,190   $ 1,454,862     $     $     $ (8,013,328
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

               

Investments (rights and/or warrants)

  $     $     $ (5,671   $     $     $     $ (5,671

Forward Currency Contracts

                      248,399                   248,399  

Futures Contracts

                1,041,661                         1,041,661  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 1,035,990     $ 248,399     $     $     $ 1,284,389  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

 

169


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

               
     Credit
Contracts
    Commodity
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Benchmark-Free Fund

               

Asset Derivatives

               

Investments, at value (rights and/or warrants)

  $     $             —     $ 74,814     $     $     $             —     $ 74,814  

Unrealized Appreciation on Forward Currency Contracts

                      2,230,442                   2,230,442  

Swap Contracts, at value¤

                37,304                         37,304  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 112,118     $ 2,230,442     $     $     $ 2,342,560  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $ 74,814     $     $     $     $ 74,814  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ 37,304     $ 2,230,442     $     $     $ 2,267,746  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Derivatives

               

Unrealized Depreciation on Forward Currency Contracts

  $     $     $     $ (353,507   $     $     $ (353,507

Unrealized Depreciation on Futures Contracts¤

                (12,540,909                       (12,540,909

Swap Contracts, at value¤

                (665,959                       (665,959
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (13,206,868   $ (353,507   $     $     $ (13,560,375
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ (13,206,868   $ (353,507   $     $     $ (13,560,375
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

               

Investments (rights and/or warrants)

  $     $     $ (101,748   $     $     $     $ (101,748

Forward Currency Contracts

                      5,624,743                   5,624,743  

Futures Contracts

                (6,163,056                       (6,163,056

Swap Contracts

                1,276,686                         1,276,686  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (4,988,118   $ 5,624,743     $     $     $ 636,625  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

               

Investments (rights and/or warrants)

  $     $     $ (114,332   $     $     $     $ (114,332

Forward Currency Contracts

                      5,163,444                   5,163,444  

Futures Contracts

                (15,841,225                       (15,841,225

Swap Contracts

                (628,655                       (628,655
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (16,584,212   $ 5,163,444     $     $     $ (11,420,768
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Consolidated Implementation Fund

               

Asset Derivatives

               

Investments, at value (rights and/or warrants)

  $     $     $ 1,068,130     $     $     $     $ 1,068,130  

Investments, at value (purchased options)

                3,175,355                         3,175,355  

Unrealized Appreciation on Forward Currency Contracts

                      18,872,718                   18,872,718  

Swap Contracts, at value¤

    1,555,431             4,498             7,595,247             9,155,176  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,555,431     $     $ 4,247,983     $ 18,872,718     $ 7,595,247     $     $ 32,271,379  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $ 1,068,130     $     $     $     $ 1,068,130  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $ 1,555,431     $     $ 3,179,853     $ 18,872,718     $ 7,595,247     $     $ 31,203,249  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

 

170


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

               
     Credit
Contracts
    Commodity
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Consolidated Implementation Fund (continued)

 

           

Liability Derivatives

               

Unrealized Depreciation on Forward Currency Contracts

  $     $     $     $ (8,697,555   $     $             —     $ (8,697,555

Unrealized Depreciation on Futures Contracts¤

                (62,026,499                       (62,026,499

Written Options, at value

                (1,560,905                       (1,560,905

Swap Contracts, at value¤

                (1,843,355           (6,600,284           (8,443,639
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (65,430,759   $ (8,697,555   $ (6,600,284   $     $ (80,728,598
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ (65,430,759   $ (8,697,555   $ (6,600,284   $     $ (80,728,598
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

               

Investments (purchased options)

  $     $     $ (1,249,469   $     $     $     $ (1,249,469

Investments (rights and/or warrants)

                (57,400                       (57,400

Forward Currency Contracts

                      29,957,022                   29,957,022  

Futures Contracts

                (25,407,108           (178,200           (25,585,308

Written Options

    585,000             6,439,467                         7,024,467  

Swap Contracts

    (886,967           4,765,198             3,206,777             7,085,008  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ (301,967   $     $ (15,509,312   $ 29,957,022     $ 3,028,577     $     $ 17,174,320  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

               

Investments (purchased options)

  $     $     $ (2,393,667   $     $     $     $ (2,393,667

Investments (rights and/or warrants)

                (228,332                       (228,332

Forward Currency Contracts

                      34,925,277                   34,925,277  

Futures Contracts

                (82,781,778           70,196             (82,711,582

Written Options

    (14,062           (1,063,481                       (1,077,543

Swap Contracts

    773,222             (1,799,053           5,094,544             4,068,713  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 759,160     $     $ (88,266,311   $ 34,925,277     $ 5,164,740     $     $ (47,417,134
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Consolidated SGM Major Markets Fund

               

Asset Derivatives

               

Unrealized Appreciation on Forward Currency Contracts

  $     $     $     $ 6,305,016     $     $     $ 6,305,016  

Unrealized Appreciation on Futures Contracts¤

          5,582,905       3,055,025             2,395,440             11,033,370  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 5,582,905     $ 3,055,025     $ 6,305,016     $ 2,395,440     $     $ 17,338,386  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $ 5,582,905     $ 3,055,025     $ 6,305,016     $ 2,395,440     $     $ 17,338,386  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liability Derivatives

               

Unrealized Depreciation on Forward Currency Contracts

  $     $     $     $ (15,066,893   $     $     $ (15,066,893

Unrealized Depreciation on Futures Contracts¤

                (45,884,725           (120,210           (46,004,935
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (45,884,725   $ (15,066,893   $ (120,210   $     $ (61,071,828
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ (45,884,725   $ (15,066,893   $ (120,210   $     $ (61,071,828
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

               

Forward Currency Contracts

  $     $     $     $ 53,008,241     $     $     $ 53,008,241  

Futures Contracts

          7,191,700       (11,370,636           (15,967,445           (20,146,381
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 7,191,700     $ (11,370,636   $ 53,008,241     $ (15,967,445   $     $ 32,861,860  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

 

171


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

               
     Credit
Contracts
    Commodity
Contracts
    Equity
Contracts
    Foreign
Currency
Contracts
    Interest
Rate
Contracts
    Other
Contracts
    Total  

Consolidated SGM Major Markets Fund (continued)

               

Change in Net Appreciation (Depreciation) on

               

Forward Currency Contracts

  $             —     $     $     $ (20,389,403   $     $             —     $ (20,389,403

Futures Contracts

          6,965,192       (21,971,327           8,480,133             (6,526,002
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 6,965,192     $ (21,971,327   $ (20,389,403   $ 8,480,133     $     $ (26,915,405
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Consolidated Special Opportunities Fund

               

Liability Derivatives

               

Written Options, at value

  $     $     $ (229,000   $     $     $     $ (229,000
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (229,000   $     $     $     $ (229,000
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ (229,000   $     $     $     $ (229,000
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

               

Forward Currency Contracts

  $     $     $     $ (195,350   $     $     $ (195,350

Futures Contracts

          (1,169,451                             (1,169,451

Written Options

                102,658                         102,658  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ (1,169,451   $ 102,658     $ (195,350   $     $     $ (1,262,143
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

               

Forward Currency Contracts

  $     $     $     $ (4,181   $     $     $ (4,181

Futures Contracts

          1,067,000                               1,067,000  

Written Options

                140,592                         140,592  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $ 1,067,000     $ 140,592     $ (4,181   $     $     $ 1,203,411  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

Strategic Opportunities Allocation Fund

               

Liability Derivatives

               

Swap Contracts, at value¤

  $     $     $ (75,139   $     $     $     $ (75,139
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (75,139   $     $     $     $ (75,139
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives not subject to Master Agreements

  $     $     $     $     $     $     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total subject to Master Agreements

  $     $     $ (75,139   $     $     $     $ (75,139
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Realized Gain (Loss) on

               

Investments (rights and/or warrants)

  $     $     $ (35   $     $     $     $ (35

Swap Contracts

                171,660                         171,660  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ 171,625     $     $     $     $ 171,625  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Change in Net Appreciation (Depreciation) on

               

Swap Contracts

  $     $     $ (75,139   $     $     $     $ (75,139
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $     $     $ (75,139   $     $     $     $ (75,139
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                         

 

  ^

Because the Funds recognize changes in value through the Statements of Operations, they do not qualify for hedge accounting under authoritative guidance for derivative instruments. The Funds’ investments in derivatives may represent an economic hedge; however, they are considered to be non-hedge transactions for the purpose of these tables.

  ¤

The table includes cumulative unrealized appreciation/depreciation of futures and value of cleared swap contracts, if any, as reported in the Schedule of Investments. Period end variation margin on open futures and cleared swap contracts, if any, is reported within the Statements of Assets and Liabilities.

 

172


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Certain Funds are party to International Swaps and Derivatives Association, Inc. Master Agreements, Global Master Repurchase Agreements or other similar types of agreements (collectively, “Master Agreements”) that generally govern the terms of OTC derivative transactions, repurchase agreements and reverse repurchase agreements. The Master Agreements may include collateral posting terms and set-off provisions that apply in the event of a default and/or termination event. Upon the occurrence of such an event, including the bankruptcy or insolvency of the counterparty, the Master Agreements may permit the non-defaulting party to calculate a single net payment to close out applicable transactions. However, there is no guarantee that the terms of a Master Agreement will be enforceable; for example, when bankruptcy or insolvency laws impose restrictions on or prohibitions against the right of offset. Additionally, the set-off and netting provisions of a Master Agreement may not extend to the obligations of the counterparty’s affiliates or across varying types of transactions. Because no such event has occurred, the Funds do not presently have a legally enforceable right of set-off and these amounts have not been offset in the Statements of Assets and Liabilities, but have been presented separately in the table below. Termination events may also include a decline in the net assets of a Fund below a certain level over a specified period of time and may entitle a counterparty to elect an early termination of all the transactions under the Master Agreement with that counterparty. Such an election by one or more of the counterparties could have a material adverse impact on a Fund’s operations. An estimate of the aggregate net payment, if any, that may need to be paid by a Fund (or may be received by a Fund) in such an event is represented by the Net Amounts in the tables below. For more information about other uncertainties and risks, see “Investments and other risks” above.

For financial reporting purposes, in the Statements of Assets and Liabilities any cash collateral that has been pledged to cover obligations of the Funds is reported as Due from Broker and any cash collateral received from the counterparty is reported as Due to Broker. Any non-cash collateral pledged by the Funds is noted in the Schedules of Investments. The tables below show the potential effect of netting arrangements made available by the Master Agreements on the financial position of the Funds. For financial reporting purposes, the Funds’ Statements of Assets and Liabilities generally show derivative assets and derivative liabilities (regardless of whether they are subject to netting arrangements) on a gross basis, which reflects the full risks and exposures of the Fund prior to netting. See Note 2 for information on repurchase agreements and reverse repurchase agreements held by the Funds at August 31, 2018, if any.

The tables above present the Funds’ derivative assets and liabilities by type of financial instrument. The following tables present the Funds’ OTC and/or exchange-traded derivative assets and liabilities by counterparty net of amounts that may be available for offset under the Master Agreements by the terms of the agreement and net of the related collateral received or pledged by the Funds as of August 31, 2018:

Alpha Only Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Bank of America, N.A.

  $ 41,717     $     $ (6,308   $ 35,409  

Barclays Bank plc

    54,141                   54,141  

Goldman Sachs International

    9,863       (6,768     (3,095    

JPMorgan Chase Bank, N.A.

    253,078             (52,089     200,989  

Morgan Stanley & Co. International PLC

    86,883       (60,000     (15,896     10,987  

State Street Bank and Trust Company

    18,129             (220     17,909  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 463,811     $ (66,768   $ (77,608   $ 319,435  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Bank of America, N.A.

  $ 6,308     $         —     $ 6,308     $         —  

Goldman Sachs International

    3,095             3,095        

JPMorgan Chase Bank, N.A.

    52,089             52,089        

Morgan Stanley & Co. International PLC

    15,896             15,896        

State Street Bank and Trust Company

    220             220        
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 77,608     $     $ 77,608     $  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

173


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Benchmark-Free Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Bank of America, N.A.

  $ 184,372     $ (6,748   $ (20,214   $ 157,410  

Barclays Bank plc

    248,764       (210,000     (16,811     21,953  

Goldman Sachs International

    111,506             (110,564     942  

JPMorgan Chase Bank, N.A.

    838,467       (729,596     (108,871    

Morgan Stanley & Co. International PLC

    719,884       (477,000     (96,261     146,623  

Morgan Stanley Capital Services LLC

    37,304             37,304        

State Street Bank and Trust Company

    127,449             (786     126,663  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 2,267,746     $ (1,423,344   $ (316,203   $ 453,591  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Bank of America, N.A.

  $ 20,214     $     $ 20,214     $         —  

Barclays Bank plc

    16,811             16,811        

Goldman Sachs International

    110,564             110,564        

JPMorgan Chase Bank, N.A.

    108,871             108,871        

Morgan Stanley & Co. International PLC

    96,261             96,261        

Morgan Stanley Capital Services LLC

    665,959       (628,655     (37,304    

State Street Bank and Trust Company

    786             786        
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 1,019,466     $ (628,655   $ 316,203     $  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Consolidated Implementation Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Bank of America, N.A.

  $ 777,947     $ (666,988   $ (110,959   $

Barclays Bank plc

    3,157,972       (751,381     (2,406,591    

Goldman Sachs International

    2,180,307       (1,671,779     (259,079     249,449  

JPMorgan Chase Bank, N.A.

    6,129,650       (3,712,104     (2,417,546    

Morgan Stanley Capital Services LLC.

    4,498             4,498        

Morgan Stanley & Co. International PLC

    7,704,589       (3,240,000     (3,499,087     965,502  

Morgan Stanley & Co. LLC

    3,175,355             (1,560,905     1,614,450  

State Street Bank and Trust Company

    477,684             (4,293     473,391  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 23,608,002     $ (10,042,252   $ (10,253,962   $ 3,302,792  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Bank of America, N.A.

  $ 110,959     $     $ 110,959     $  

Barclays Bank plc

    2,406,591             2,406,591        

Goldman Sachs International

    259,079             259,079        

JPMorgan Chase Bank, N.A.

    2,417,546             2,417,546        

Morgan Stanley Capital Services LLC

    1,843,355       (1,838,857     (4,498    

Morgan Stanley & Co. International PLC

    3,499,087             3,499,087        

Morgan Stanley & Co. LLC

    1,560,905             1,560,905        

State Street Bank and Trust Company

    4,293             4,293        
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 12,101,815     $ (1,838,857   $ 10,253,962        
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

174


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

Consolidated SGM Major Markets Fund

 

         
Counterparty   Gross Derivative
Assets Subject to
Master Agreements
    Collateral
Received
    Derivative
Assets/(Liabilities)
Available for Offset
    Net Amount
of Derivative
Assets
 

Barclays Bank plc

  $ 16,126     $     $     $ 16,126  

Deutsche Bank AG

    175,025             175,025        

JPMorgan Chase Bank, N.A.

    27,512             27,512        

Morgan Stanley & Co. International PLC

    614,692             614,692        

State Street Bank and Trust Company

    3,696,109             (2,398,811     1,297,298  

UBS AG

    1,775,552             1,775,552        
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 6,305,016     $     $ 193,970     $ 1,313,424  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 
   
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Deutsche Bank AG

  $ 656,201     $     $ (175,025   $ 481,176  

JPMorgan Chase Bank, N.A.

    358,924             (27,512     331,412  

Morgan Stanley & Co. International PLC

    5,291,104       (4,676,412     (614,692    

State Street Bank and Trust Company

    2,398,811             2,398,811        

UBS AG

    6,361,853       (4,586,301     (1,775,552      
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 15,066,893     $ (9,262,713   $ (193,970   $ 812,588  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Consolidated Special Opportunities Fund

 

         
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Morgan Stanley & Co. LLC

  $ 229,000     $ (229,000   $         —     $         —
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 229,000     $ (229,000   $     $  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Strategic Opportunities Allocation Fund

 

         
Counterparty   Gross Derivative
Liabilities Subject to
Master Agreements
    Collateral
Pledged
    Derivative
(Assets)/Liabilities
Available for Offset
    Net Amount
of Derivative
Liabilities
 

Morgan Stanley Capital Services LLC

  $ 75,139     $         —     $         —     $ 75,139  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 75,139     $     $     $ 75,139  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

  *

The actual collateral received and/or pledged is more than the amount shown.

The average derivative activity of notional amounts (forward currency contracts, futures contracts and swap contracts), market values (rights and/or warrants), and principal amounts or number of contracts (options) outstanding, based on absolute values, at each month-end, was as follows for the period ended August 31, 2018:

 

             
Fund Name   Forward
Currency
Contracts ($)
    Futures
Contracts ($)
    Swap
Contracts ($)
    Options
(Principal)
    Options
(Contracts)
    Rights and/or
Warrants ($)
 

Alpha Only Fund

    31,658,051       149,486,403                         1,095  

Benchmark-Free Fund

    166,493,762       304,627,911       11,919,790                   239,401  

Consolidated Implementation Fund

    1,648,201,785       1,419,369,445       2,084,642,947       16,666,667       48,805       1,411,160  

Consolidated SGM Major Markets Fund

    1,134,983,294       2,468,090,083                          

Consolidated Special Opportunities Fund

    3,899,977       1,357,365                   550        

Strategic Opportunities Allocation Fund

                1,243,078                   16,508  

 

175


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

5.

Fees and other transactions with affiliates

GMO receives a management fee for the services it provides to certain Funds. Management fees are paid monthly at the annual rate equal to the percentage of each Fund’s average daily net assets set forth in the table below:

 

                         
     Alpha Only Fund     Benchmark-Free Allocation Fund     Benchmark-Free Fund     Global Asset Allocation Fund     Global Developed Equity Allocation Fund     Global Equity Allocation Fund     Implementation Fund     International Developed Equity Allocation Fund     International Equity Allocation Fund     SGM Major Markets Fund     Special Opportunities Fund     Strategic Opportunities Allocation Fund  

Management Fee

    0.50%       0.65%                                                 0.85%       1.10%        

For certain Funds above, GMO does not charge the Fund a management fee or shareholder service fee, but it receives management and/or shareholder service fees from the underlying funds in which the Fund invests. Because those fees vary from fund to fund, the levels of indirect net expenses set forth below are affected by GMO’s asset allocation decisions.

In addition, each class of shares of certain Funds pays GMO directly or indirectly a shareholder service or supplemental support fee. Shareholder service fees are paid to GMO for providing client services and reporting, such as performance information, client account information, personal and electronic access to Fund information, access to analysis and explanations of Fund reports, and assistance in maintaining and correcting client-related information. Class MF shares of Benchmark-Free Allocation Fund are subject to a supplemental support fee payable to GMO for providing supplemental support services to Class MF shareholders and their investment advisers. Those supplemental support services include, without limitation, (i) providing and presenting (a) educational and explanatory information about the Fund and its asset allocation strategy as requested or directed by an investor or its investment adviser; (b) similar educational and explanatory information about the strategies of the GMO Funds in which the Fund invests; (c) information for inclusion in the quarterly or other periodic reports of the investor; (ii) responding to information requests relating to oversight functions of the investor’s board of directors in areas including pricing, compliance, and taxation; (iii) providing access to and setting up meetings with GMO’s Chief Investment Strategist and Head of GMO’s Asset Allocation Team and other investment professionals of GMO; (iv) assisting with inquiries from an investor’s investment adviser; and (v) providing such other assistance as may be requested from time to time by an investor or its agent, so long as that assistance is not primarily intended to result in the sale of Fund shares.

Shareholder service and/or supplemental support fees are paid monthly at the annual rate equal to the percentage of each applicable Class’s average daily net assets set forth in the table below:

 

           
Fund Name   Class III     Class IV     Class V     Class VI     Class MF  

Alpha Only Fund

    0.15%       0.10%                          

Benchmark-Free Allocation Fund

    0.15%       0.10%                       0.10%  

SGM Major Markets Fund

    0.15%       0.10%               0.055%          

Special Opportunities Fund

    0.15%*       0.10%*       0.085%*       0.055%          

 

  *

Class is offered but has no shareholders as of August 31, 2018.

 

176


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

For each Fund, other than Special Opportunities Fund, GMO has contractually agreed to reimburse the Fund for its “Specified Operating Expenses” (as defined below). For Special Opportunities Fund, GMO has contractually agreed to reimburse the Fund for the portion of its “Specified Operating Expenses” (as defined below) that exceeds 0.10% of the Fund’s average daily net assets (“Expense Threshold Amount”). Any such reimbursements are paid to a Fund concurrently with the Fund’s payment of management fees to GMO.

Subject to the exclusions noted below, “Specified Operating Expenses” means: audit expenses, fund accounting expenses, pricing service expenses, expenses of non-investment related tax services, transfer agency expenses, expenses of non-investment related legal services provided to the Funds by or at the direction of GMO, organizational and start-up expenses, federal securities law filing expenses, printing expenses, state and federal registration fees and custody expenses. In the case of Benchmark-Free Fund, “Specified Operating Expenses” does not include the Fund’s direct custody expenses attributable to its holdings of emerging market securities.

For Special Opportunities Fund, GMO is permitted to recover from the Fund, on a class-by-class basis, as applicable, the “Specified Operating Expenses” GMO has borne or reimbursed (whether through reduction of its fees or otherwise) to the extent that the Fund’s “Specified Operating Expenses” later fall below the Expense Threshold Amount or the lower expense limit in effect when GMO seeks to recover the expenses. The Fund, however, is not obligated to pay any such amount more than three years after GMO bore or reimbursed an expense. The amount GMO is entitled to recover may not cause a Fund to exceed the Expense Threshold Amount or the lower expense limit in effect when GMO seeks recovery.

For the period ended August 31, 2018, GMO did not recoup any previously recorded waivers and/or reimbursements.

On August 31, 2018, the waivers and/or reimbursements subject to possible future recoupment are as follows:

 

       
     Expiring
during year ending
February 28, 2019
    Expiring
during year ending
February 29, 2020
    Expiring
during year ending
February 28, 2021
 

Consolidated Special Opportunities Fund, Class VI

    $—       $—       $—  

For each Fund, other than Benchmark-Free Allocation Fund, that pays GMO a management fee, GMO has contractually agreed to waive or reduce that fee, but not below zero, to the extent necessary to offset the management fees paid to GMO that are directly or indirectly borne by the Fund as a result of the Fund’s direct or indirect investments in other GMO Funds.

For each Fund, other than Benchmark-Free Allocation Fund, that charges a shareholder service fee, GMO has contractually agreed to waive or reduce the shareholder service fee charged to holders of each class of shares of the Fund, but not below zero, to the extent necessary to offset the shareholder service fees directly or indirectly borne by the class of shares of the Fund as a result of the Fund’s direct or indirect investments in other GMO Funds.

These contractual waivers and reimbursements will continue through at least June 30, 2019 for each Fund unless the Funds’ Board of Trustees authorizes their modification or termination or reduces the fee rates paid to GMO under the Fund’s management contract or servicing and supplemental support agreement.

For Benchmark-Free Allocation Fund only, the fees payable to GMO under its management contract and servicing and supplemental support agreement are reduced by amounts equal to the management fees and shareholder service fees, respectively, that GMO receives as a result of the Fund’s investment in underlying GMO Funds. In addition, effective March 1, 2014, GMO has contractually agreed to reduce the rate of the supplemental support fees charged to the Fund’s Class MF shares to a rate to be charged in any month (starting on the first business day of the month) based on the net assets attributable to Class MF shares as of the last business day of the preceding month based on the following schedule: 0.10% on the first $6 billion of net assets, 0.05% on the next $2 billion, 0.03% on the next $2 billion, and 0.01% thereafter; provided, however, that the effective rate charged at any time will not be reduced to less than 0.06% of Class MF’s average daily net assets. The rate will be calculated before giving effect to any reduction or waiver described above, and any applicable reduction or waiver will serve to further reduce the supplemental support fee paid to GMO. This reduction will continue through at least June 30, 2019, and may not be terminated prior to this date

without the action or consent of the Fund’s Board of Trustees.

 

177


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Funds’ portion of the gross fees paid by the Trust to the Trust’s independent Trustees and their legal counsel and any agents unaffiliated with GMO during the period ended August 31, 2018 is shown in the table below and is included in the Statements of Operations.

 

     
Fund Name   Independent Trustees and
their legal counsel ($)
    Agent unaffiliated
with GMO ($)
 

Alpha Only Fund

    2,430       198  

Benchmark-Free Allocation Fund

    153,335       13,897  

Benchmark-Free Fund

    49,093       4,584  

Global Asset Allocation Fund

    26,949       2,566  

Global Developed Equity Allocation Fund

    5,428       533  

Global Equity Allocation Fund

    25,786       2,399  

Consolidated Implementation Fund

    129,901       11,845  

International Developed Equity Allocation Fund

    7,554       726  

International Equity Allocation Fund

    12,730       1,246  

Consolidated SGM Major Markets Fund

    20,811       1,884  

Consolidated Special Opportunities Fund

    11,268       1,084  

Strategic Opportunities Allocation Fund

    14,298       1,288  

Certain Funds incur fees and expenses indirectly as a shareholder in the underlying funds. For the period ended August 31, 2018 these indirect fees and expenses expressed as an annualized percentage of each Fund’s average daily net assets were as follows:

 

         
Fund Name   Indirect Net Expenses
(excluding shareholder
service fees)
    Indirect Shareholder
Service Fees
    Indirect Interest
Expense
    Total Indirect
Expenses
 

Alpha Only Fund

    < 0.001%       0.000%       0.000%       < 0.001%  

Benchmark-Free Allocation Fund

    0.148%       0.012%       0.105%     0.265%  

Benchmark-Free Fund

    0.223%       0.019%       < 0.001%       0.242%  

Global Asset Allocation Fund

    0.420%       0.067%       < 0.001%       0.487%  

Global Developed Equity Allocation Fund

    0.443%       0.071%       0.000%       0.514%  

Global Equity Allocation Fund

    0.489%       0.068%       0.000%       0.557%  

Consolidated Implementation Fund

    0.000%       0.000%       0.000%       0.000%  

International Developed Equity Allocation Fund

    0.523%       0.087%       0.000%       0.610%  

International Equity Allocation Fund

    0.570%       0.078%       0.000%       0.648%  

Consolidated SGM Major Markets Fund

    0.002%       0.000%       0.000%       0.002%  

Consolidated Special Opportunities Fund

    0.000%       0.000%       0.000%       0.000%  

Strategic Opportunities Allocation Fund

    0.389%       0.059%       0.001%       0.449%  

 

  *

Includes indirect dividend expenses.

The Funds are permitted to purchase or sell securities from or to certain other GMO funds under specified conditions outlined in procedures adopted by the Trustees. The procedures have been designed to ensure that any purchase or sale of securities by a Fund from another fund or portfolio that is or could be considered an affiliate by virtue of having a common investment adviser (or affiliated investment advisers), common Trustees and/or common officers complies with Rule 17a-7 of the 1940 Act. Further, as defined under the procedures, each transaction is effectuated at the current market price. During the period ended August 31, 2018, the Funds did not engage in these transactions.

 

178


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

6.

Purchases and sales of securities

Cost of purchases and proceeds from sales of securities, excluding short-term investments and including GMO U.S. Treasury Fund, if applicable, for the period ended August 31, 2018 are noted in the table below:

 

         
     Purchases ($)     Purchases ($)     Sales ($)     Sales ($)  
         
Fund Name   U.S. Government
Securities
    Investments (Non-U.S.
Government Securities)
    U.S. Government
Securities
    Investments (Non-U.S.
Government Securities)
 

Alpha Only Fund

          182,658,727             273,968,717  

Benchmark-Free Allocation Fund

          1,089,875,688             1,577,623,067  

Benchmark-Free Fund

    388,379,130       879,235,876       720,723,756       1,255,279,338  

Global Asset Allocation Fund

          258,188,985             464,757,924  

Global Developed Equity Allocation Fund

          20,985,456             12,436,257  

Global Equity Allocation Fund

          95,146,368             291,512,461  

Consolidated Implementation Fund

    1,458,144,327       4,421,860,555       1,765,152,428       4,124,210,924  

International Developed Equity Allocation Fund

          25,576,996             6,442,044  

International Equity Allocation Fund

          12,101,633             50,392,894  

Consolidated SGM Major Markets Fund

    610,623,161       57,075,865       194,085,047       1,129,705,815  

Consolidated Special Opportunities Fund

          32,463,144             551,207,360  

Strategic Opportunities Allocation Fund

    33,093,500       198,520,661       55,043,101       342,616,271  

Included in the table above are cost of purchases and proceeds from sales of securities for in-kind transactions, excluding short-term investments, in accordance with U.S. GAAP for the period ended August 31, 2018. In-kind transactions are noted in the table below.

 

     
Fund Name   Purchases ($)     Sales ($)  

Consolidated Implementation Fund

            210,796,589*  

Consolidated SGM Major Markets Fund

    1,017,970,052          

Strategic Opportunities Allocation Fund

    76,103,884          

For the period ended August 31, 2018, the Funds had the following net realized gains/(losses) attributed to redemption in-kind transactions:

 

   
Fund Name   Net realized gains/(losses)
attributed to redemption in-kind
transactions ($)
 

Consolidated Implementation Fund

    (1,571,191)*  

 

*

Amount represents contribution of assets to wholly owned subsidiary.

 

7.

Guarantees

In the normal course of business the Funds enter into contracts with third-party service providers that contain a variety of representations and warranties and that provide general indemnifications. The Funds’ maximum exposure under these arrangements is unknown, as it involves possible future claims that may or may not be made against the Funds. Based on experience, GMO is of the view that the risk of loss to the Funds in connection with the Funds’ indemnification obligations is remote; however, there can be no assurance that such obligations will not result in material liabilities that adversely affect the Funds.

 

179


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

8.

Principal shareholders and related parties as of August 31, 2018

 

         
Fund Name   Number of
shareholders that held
more than 10% of the
outstanding shares of
the Fund
    Percentage of
outstanding shares of
the Fund held by those
shareholders owning
greater than 10% of the
outstanding shares of
the Fund
    Percentage of the
shares of the Fund held
by senior management
of GMO and
GMO Trust officers
    Percentage of the
Fund’s shares held by
accounts for which
GMO has
investment discretion
 

Alpha Only Fund

    3 ‡      93.58%       0.09%       98.98%  

Benchmark-Free Allocation Fund

    1       40.59%       0.88%       3.47%  

Benchmark-Free Fund

                      100.00%  

Global Asset Allocation Fund

                0.21%       8.48%  

Global Developed Equity Allocation Fund

    2       63.51%       < 0.01%        

Global Equity Allocation Fund

    1       20.28%       0.01%       0.28%  

Implementation Fund

    1 ‡      95.13%             100.00%  

International Developed Equity Allocation Fund

    5       77.36%       < 0.01%       1.89%  

International Equity Allocation Fund

    4 †      69.25%       0.01%       26.40%  

SGM Major Markets Fund±

    2 ‡      77.83%       0.10%       72.08%  

Special Opportunities Fund

    2     94.68%       0.07%       98.72%  

Strategic Opportunities Allocation Fund

    1       12.22%             99.92%  

 

 

One of the shareholders is another fund managed by GMO.

 

One of the shareholders is another fund of the Trust.

  #

Two of the shareholders are other funds of the Trust.

 

9.

Share transactions

The Declaration of Trust permits each Fund to issue an unlimited number of shares of beneficial interest (without par value). Transactions in the Funds’ shares were as follows:

 

     Six Months Ended
August 31, 2018 (Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Alpha Only Fund

 

Class III:

 

Shares sold

        $       207,676     $ 4,479,301  

Shares issued to shareholders in reinvestment of distributions

    1,332       27,835       4,822       104,020  

Shares repurchased

    (2,516     (52,143     (228,094     (4,971,088
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (1,184   $ (24,308     (15,596   $ (387,767
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

 

Shares sold

    169,174     $ 3,654,268       693,110     $ 15,100,002  

Shares issued to shareholders in reinvestment of distributions

    33,909       709,028       114,030       2,454,724  

Shares repurchased

    (4,856,026     (101,811,865     (1,383,604     (29,825,103
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (4,652,943   $ (97,448,569     (576,464   $ (12,270,377
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

180


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     Six Months Ended
August 31, 2018 (Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Benchmark-Free Allocation Fund

 

Class III:

 

Shares sold

    8,210,472     $ 223,539,705       28,656,547     $ 784,060,061  

Shares issued to shareholders in reinvestment of distributions

    178,085       4,817,211       3,792,767       103,472,036  

Shares repurchased

    (15,516,656     (423,150,987     (50,073,202     (1,350,609,683

Purchase premiums

          39,640             325,703  

Redemption fees

          167,615             1,479,985  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (7,128,099   $ (194,586,816     (17,623,888   $ (461,271,898
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

 

Shares sold

    1,602,934     $ 43,874,202       33,152,599     $ 884,564,391  

Shares issued to shareholders in reinvestment of distributions

    103,829       2,808,587       2,584,989       70,493,151  

Shares repurchased

    (3,954,256     (107,536,961     (39,749,823     (1,080,301,449

Purchase premiums

          21,378             191,609  

Redemption fees

          90,813             864,149  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (2,247,493   $ (60,741,981     (4,012,235   $ (124,188,149
   

 

 

   

 

 

   

 

 

   

 

 

 

Class MF:

 

Shares sold

    2,797,372     $ 77,123,961       3,559,155     $ 97,318,372  

Shares issued to shareholders in reinvestment of distributions

    252,400       6,832,480       4,991,594       136,226,196  

Shares repurchased

    (17,077,155     (464,608,564     (33,216,277     (892,423,950

Purchase premiums

          43,344             368,062  

Redemption fees

          184,060             1,675,531  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (14,027,383   $ (380,424,719     (24,665,528   $ (656,835,789
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Benchmark-Free Fund

 

Class III:

 

Shares sold

    938,921     $ 18,908,028       8,166,414     $ 167,857,391  

Shares issued to shareholders in reinvestment of distributions

    622,665       12,521,790       6,085,559       124,326,073  

Shares repurchased

    (38,745,706     (790,879,132     (31,557,062     (625,040,833

Purchase premiums

          336             125,696  

Redemption fees

          207,148             1,268,307  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (37,184,120   $ (759,241,830     (17,305,089   $ (331,463,366
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Global Asset Allocation Fund

 

Class III:

 

Shares sold

    2,597,535     $ 85,114,944       7,497,173     $ 245,763,796  

Shares issued to shareholders in reinvestment of distributions

    180,902       5,863,029       1,625,800       53,486,252  

Shares repurchased

    (9,842,503     (322,521,492     (14,335,654     (462,098,261

Purchase premiums

          27,802             283,262  

Redemption fees

          108,370             607,377  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (7,064,066   $ (231,407,347     (5,212,681   $ (161,957,574
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Global Developed Equity Allocation Fund

 

Class III:

 

Shares sold

    14,420     $ 322,581           $  

Shares issued to shareholders in reinvestment of distributions

    105,589       2,337,736       803,500       17,587,926  

Shares repurchased

    (236,397     (5,257,992     (30,910,313     (652,627,452

Purchase premiums

          258              

Redemption fees

          1,005             522,102  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (116,388   $ (2,596,412     (30,106,813   $ (634,517,424
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

181


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     Six Months Ended
August 31, 2018 (Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Global Equity Allocation Fund

 

Class III:

 

Shares sold

    32,132     $ 849,543       5,343,410     $ 133,870,494  

Shares issued to shareholders in reinvestment of distributions

    198,103       5,089,261       2,660,619       69,685,837  

Shares repurchased

    (9,591,360     (251,125,525     (17,925,341     (467,596,299

Purchase premiums

          1,206             47,316  

Redemption fees

          38,129             840,523  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (9,361,125   $ (245,147,386     (9,921,312   $ (263,152,129
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Consolidated Implementation Fund

 

Core Class:

 

Shares sold

    20,605,855     $ 282,827,287       50,778,902     $ 682,972,263  

Shares issued to shareholders in reinvestment of distributions

    3,137,825       42,611,658       24,407,827       335,144,868  

Shares repurchased

    (70,479,660     (962,169,981     (118,308,728     (1,618,413,712

Purchase premiums

          64,769             1,185,847  

Redemption fees

          265,297             3,054,358  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (46,735,980   $ (636,400,970     (43,121,999   $ (596,056,376
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

International Developed Equity Allocation Fund

 

Class III:

 

Shares sold

    1,441,372     $ 24,249,170       953,876     $ 16,192,699  

Shares issued to shareholders in reinvestment of distributions

    163,778       2,631,907       1,042,628       17,857,292  

Shares repurchased

    (519,148     (8,664,934     (4,482,823     (74,991,774

Purchase premiums

          13,253             10,870  

Redemption fees

          2,696             57,901  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    1,086,002     $ 18,232,092       (2,486,319   $ (40,873,012
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

International Equity Allocation Fund

         

Class III:

         

Shares sold

    245,551     $ 7,597,500       2,158,679     $ 70,077,115  

Shares issued to shareholders in reinvestment of distributions

    221,416       6,620,339       1,031,273       32,737,392  

Shares repurchased

    (1,586,042     (51,142,318     (7,389,534     (221,115,817

Purchase premiums

          2,500             175,411  

Redemption fees

          112,011             538,494  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (1,119,075   $ (36,809,968     (4,199,582   $ (117,587,405
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

182


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

     Six Months Ended
August 31, 2018 (Unaudited)
    Year Ended
February 28, 2018
 
   
     Shares     Amount     Shares     Amount  

Consolidated SGM Major Markets Fund

         

Class III:

         

Shares sold

    158,131     $ 5,087,676       706,650     $ 22,622,929  

Shares issued to shareholders in reinvestment of distributions

                5,601       180,593  

Shares repurchased

    (38,101     (1,230,128     (63,722     (2,099,226
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    120,030     $ 3,857,548       648,529     $ 20,704,296  
   

 

 

   

 

 

   

 

 

   

 

 

 

Class IV:

         

Shares sold

        $       486,556     $ 16,036,518  

Shares issued to shareholders in reinvestment of distributions

                18,456       591,952  

Shares repurchased

    (11,889     (385,307     (1,814,180     (59,526,105
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (11,889   $ (385,307     (1,309,168   $ (42,897,635
   

 

 

   

 

 

   

 

 

   

 

 

 

Class VI:

         

Shares sold

    2,576,662     $ 83,047,846       15,616,936     $ 506,604,097  

Shares issued to shareholders in reinvestment of distributions

                1,716,945       55,073,241  

Shares repurchased

    (8,376,310     (270,982,199     (3,731,302     (122,365,837
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (5,799,648   $ (187,934,353     13,602,579     $ 439,311,501  
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Consolidated Special Opportunities Fund

         

Class VI:

         

Shares sold

    470,274     $ 10,375,802       2,130,296     $ 47,393,583  

Shares issued to shareholders in reinvestment of distributions

    11,125,095       225,776,659       2,841,238       68,177,050  

Shares repurchased

    (29,533,321     (654,432,948     (12,646,455     (290,937,418

Purchase premiums

          52,140             181,760  

Redemption fees

          3,272,165             1,398,457  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (17,937,952   $ (414,956,182     (7,674,921   $ (173,786,568
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

Strategic Opportunities Allocation Fund

         

Class III:

         

Shares sold

    77,861     $ 1,614,847       831,215     $ 17,129,720  

Shares issued to shareholders in reinvestment of distributions

    2,266,680       46,285,603       2,497,054       54,242,468  

Shares repurchased

    (8,467,559     (180,963,237     (46,410,191     (1,002,225,037

Purchase premiums

                       

Redemption fees

          192,588             1,948,317  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease)

    (6,123,018   $ (132,870,199     (43,081,922   $ (928,904,532
   

 

 

   

 

 

   

 

 

   

 

 

 
                                 

 

 
 

 

183


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

 

10.

Investments in affiliated companies and other Funds of the Trust

An affiliated company for the purposes of this disclosure is a company in which a Fund has or had direct ownership of at least 5% of the issuer’s voting securities or an investment in other funds of GMO Trust. A summary of the Funds’ transactions involving companies that are or were affiliates during the period ended August 31, 2018 is set forth below:

 

                 
Affiliate   Value,
beginning of
period
    Purchases     Sales
Proceeds
    Dividend
Income*
    Distributions
of Realized
Gains*
    Net Realized
Gain (Loss)
    Net Increase/
Decrease in
Unrealized
Appreciation/
Depreciation
    Value, end of
period
 

Alpha Only Fund

                 

GMO U.S. Treasury Fund

  $ 13,848,473     $ 118,586,707     $ 124,970,000     $ 121,707     $     $ 10,202     $ 793     $ 7,476,175  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

Benchmark-Free Allocation Fund

                 

GMO Emerging Country Debt Fund, Class IV

  $ 338,343,014     $ 12,250,752     $ 17,784,551     $ 4,487,712     $     $ (129,488   $ (20,116,261   $ 312,563,466  

GMO High Yield Fund, Class VI

          204,419,676       57,982,217                   1,136,906       2,951,487       150,525,852  

GMO Implementation Fund

    10,973,015,970       312,247,731       943,553,294       40,589,176             22,684,984       (418,063,250     9,946,332,141  

GMO Opportunistic Income Fund, Class VI

    542,342,069       55,188,343       38,075,503       4,367,320             3,422,105       2,516,064       565,393,078  

GMO Risk Premium Fund, Class VI

          322,967,912       16,082,874                   370,567       11,962,897       319,218,502  

GMO SGM Major Markets Fund, Class VI

    1,015,978,511       18,048,037       101,253,207                   4,361,524       4,487,752       941,622,617  

GMO Special Opportunities Fund, Class VI

    669,099,430       164,753,237       402,891,421             154,325,296       55,017,142       (169,161,720     316,816,668  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 13,538,778,994     $ 1,089,875,688     $ 1,577,623,067     $   49,444,208     $ 154,325,296     $ 86,863,740     $ (585,423,031   $ 12,552,472,324  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

Benchmark-Free Fund

                 

GMO Emerging Country Debt Fund, Class IV

  $ 133,185,460     $ 1,541,536     $ 17,100,000     $ 1,541,536     $     $ (187,932   $ (7,662,058   $ 109,777,006  

GMO Emerging Markets Fund, Class VI

    569,680,947       883,352       80,000,000       883,352             7,337,354       (69,483,357     428,418,296  

GMO Opportunistic Income Fund, Class VI

    217,604,583       16,962,594       41,000,000       1,526,892             4,452,023       (2,170,969     195,848,231  

GMO Risk Premium Fund, Class VI

          111,397,624                               4,325,767       115,723,391  

GMO SGM Major Markets Fund, Class VI

    184,449,116             34,000,000                   2,440,994       (450,452     152,439,658  

GMO Special Opportunities Fund, Class VI

    323,594,896       60,618,195       226,127,282             60,618,195       32,033,592       (78,607,090     111,512,311  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 1,428,515,002     $ 191,403,301     $ 398,227,282     $ 3,951,780     $ 60,618,195     $ 46,076,031     $ (154,048,159   $ 1,113,718,893  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

 

184


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

                 
Affiliate   Value,
beginning of
period
    Purchases     Sales
Proceeds
    Dividend
Income*
    Distributions
of Realized
Gains*
    Net Realized
Gain (Loss)
    Net Increase/
Decrease in
Unrealized
Appreciation/
Depreciation
    Value, end of
period
 

Global Asset Allocation Fund

 

GMO Alpha Only Fund, Class IV

  $ 74,946,917     $ 1,544,636     $ 5,492,471     $ 268,305     $     $ (689,761   $ (4,556,966   $ 65,752,355  

GMO Asset Allocation Bond Fund, Class VI

    399,177,319       6,691,525       144,798,220       2,325,988             (22,620,979     27,242,856       265,692,501  

GMO Core Plus Bond Fund, Class IV

    249,614,612       122,706,592       45,518,979       1,391,054             174,878       4,815,707       331,792,810  

GMO Emerging Country Debt Fund, Class IV

    55,530,671       652,209       8,867,467       652,209             (34,496     (3,071,420     44,209,497  

GMO Emerging Markets Fund, Class VI

    467,717,958       23,761,009       26,843,372       886,476             3,191,696       (55,912,650     411,914,641  

GMO International Equity Fund, Class IV

    519,183,914       22,106,819       50,121,602       3,150,332             (3,888,207     (29,511,502     457,769,422  

GMO Opportunistic Income Fund, Class VI

    48,813,182       8,331,545       26,470,854       202,791             1,719,370       (1,405,839     30,987,404  

GMO Quality Fund, Class VI

    178,367,480       13,719,325       37,328,567       573,594       6,815,283       6,622,001       2,239,196       163,619,435  

GMO Risk Premium Fund, Class VI

    62,350,340       226,286       9,423,853       226,286             (285,437     3,391,828       56,259,164  

GMO SGM Major Markets Fund, Class VI

    73,567,091       1,550,500       9,695,498                   670,239       15,342       66,107,674  

GMO U.S. Equity Fund, Class VI

    178,908,774       20,944,457       32,846,117       722,735       13,009,248       (976,288     (4,084,750     161,946,076  

GMO U.S. Treasury Fund

    167,046,625       35,954,082       67,340,222       1,507,684             (75,209     141,425       135,726,701  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 2,475,224,883     $ 258,188,985     $ 464,747,222     $ 11,907,454     $ 19,824,531     $ (16,192,193   $ (60,696,773   $ 2,191,777,680  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

Global Developed Equity Allocation Fund

 

GMO Emerging Markets Fund, Class VI

  $ 46,991,022     $ 3,161,628     $ 290,682     $ 91,897     $     $ 43,933     $ (5,336,693   $ 44,569,208  

GMO International Equity Fund, Class IV

    217,379,783       5,811,172       395,355       1,373,005             36,911       (14,689,746     208,142,765  

GMO Quality Fund, Class VI

    102,786,624       4,139,003       6,348,045       321,308       3,817,694       1,063,866       4,484,856       106,126,304  

GMO U.S. Equity Fund, Class VI

    101,984,701       7,873,653       5,402,175       414,403       7,459,250       374,497       (3,313,136     101,517,540  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 469,142,130     $ 20,985,456     $ 12,436,257     $ 2,200,613     $ 11,276,944     $ 1,519,207     $ (18,854,719   $ 460,355,817  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

Global Equity Allocation Fund

 

GMO Emerging Markets Fund, Class VI

  $ 608,573,770     $ 26,450,482     $ 50,741,911     $ 1,166,884     $     $ 4,635,701     $ (72,269,138   $ 516,648,904  

GMO International Equity Fund, Class IV

    896,831,372       19,869,939       79,722,386       5,598,487             (18,252,191     (40,459,854     778,266,880  

GMO Quality Fund, Class VI

    412,807,154       17,892,984       89,700,051       1,258,604       14,954,380       16,392,209       3,799,979       361,192,275  

GMO U.S. Equity Fund, Class VI

    409,993,568       30,932,963       71,348,113       1,628,051       29,304,913       (2,827,931     (9,417,981     357,332,506  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 2,328,205,864     $ 95,146,368     $ 291,512,461     $ 9,652,026     $ 44,259,293     $ (52,212   $ (118,346,994   $ 2,013,440,565  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

International Developed Equity Allocation Fund

 

GMO Emerging Markets Fund, Class VI

  $ 67,378,736     $ 5,265,463     $ 820,700     $ 129,974     $     $ 83,306     $ (7,919,244   $ 63,987,561  

GMO International Equity Fund, Class IV

    597,172,345       20,311,533       5,621,344       3,753,616             (532,149     (40,257,992     571,072,393  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 664,551,081     $ 25,576,996     $ 6,442,044     $ 3,883,590     $     $ (448,843   $ (48,177,236   $ 635,059,954  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

 

185


GMO Trust Funds

 

Notes to Financial Statements — (Continued)

August 31, 2018 (Unaudited)

 

 

                 
Affiliate   Value,
beginning of
period
    Purchases     Sales
Proceeds
    Dividend
Income*
    Distributions
of Realized
Gains*
    Net Realized
Gain (Loss)
    Net Increase/
Decrease in
Unrealized
Appreciation/
Depreciation
    Value, end of
period
 

International Equity Allocation Fund

 

GMO Emerging Markets Fund, Class VI

  $ 402,051,540     $ 6,834,639     $ 12,237,134     $ 723,858     $     $ 1,320,081     $ (45,482,943   $ 352,486,183  

GMO International Equity Fund, Class IV

    748,929,812       5,266,994       38,155,760       4,404,226             (1,255,338     (47,120,418     667,665,290  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 1,150,981,352     $ 12,101,633     $ 50,392,894     $ 5,128,084     $     $ 64,743     $ (92,603,361   $ 1,020,151,473  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

Consolidated SGM Major Markets Fund

 

GMO U.S. Treasury Fund

  $ 1,072,205,111     $ 57,075,865     $ 1,129,705,815 (a)     $ 9,352,205     $     $ (781,391   $ 1,206,230     $  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

Consolidated Special Opportunities Fund

 

Jagercor Energy Corp

  $ 70,137     $     $     $     $     $     $ (24,160   $ 45,977  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

Strategic Opportunities Allocation Fund

 

GMO Core Plus Bond Fund, Class IV

  $ 99,134,920     $ 30,487,118     $ 16,720,688     $ 487,118     $     $ (122,663   $ 1,878,938     $ 114,657,625  

GMO Emerging Country Debt Fund, Class IV

    39,992,630       456,549       8,854,634       456,549             (462,812     (1,631,765     29,499,968  

GMO Emerging Markets Fund, Class VI

    305,084,580       510,832       37,941,204       510,832             5,562,340       (37,071,415     236,145,133  

GMO International Equity Fund, Class IV

    349,818,348       1,794,004       71,474,090 (b)       1,794,004             (6,120,583     (13,717,257     260,300,422  

GMO Opportunistic Income Fund, Class VI

    45,985,113       283,091       16,149,547       283,091             1,338,394       (967,768     30,489,283  

GMO Quality Fund, Class VI

    131,528,842       5,046,728       29,205,083       391,774       4,654,954       4,810,140       955,751       113,136,378  

GMO U.S. Equity Fund, Class VI

    130,082,686       6,534,647       57,667,845 (c)       343,929       6,190,718       (319,675     (3,613,634     75,016,179  

GMO U.S. Treasury Fund

    93,901,813       9,720,338       46,508,962       719,532             (10,636     39,659       57,142,212  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Totals

  $ 1,195,528,932     $ 54,833,307     $ 284,522,053     $ 4,986,829     $ 10,845,672     $ 4,674,505     $ (54,127,491   $ 916,387,200  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
                                                                 

 

  *

The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2018 through August 31, 2018. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 28, 2019.

  (a) 

$1,017,970,052 was redeemed in-kind.

  (b) 

$37,086,238 was redeemed in-kind.

  (c) 

$39,017,646 was redeemed in-kind.

 

186


GMO Trust Funds

 

Board Review of Investment Management Agreements

August 31, 2018 (Unaudited)

 

 

GMO Alpha Only Fund

Approval of renewal of management agreement for GMO Alpha Only Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. The Trustees noted that the Fund is not currently offered as a standalone investment and the investment strategies it pursues are intended to complement the strategies used by the Manager in managing other GMO funds or accounts. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds. The Trustees noted in particular that, while the Fund may invest in other GMO funds (“underlying GMO funds”) that charge advisory fees, the Manager offsets against the fees the Fund pays to the Manager the management fees, shareholder servicing fees and most other expenses of those underlying GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

 

187


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Benchmark-Free Allocation Fund

Approval of renewal of management agreement for GMO Benchmark-Free Allocation Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing and supplemental support fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

 

188


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds. The Trustees noted in particular that some GMO funds in which the Fund may invest (“underlying GMO funds”) do not charge any advisory fees. The Trustees also noted that, with respect to all other underlying GMO funds, the Manager offsets against the fees the Fund pays the Manager the management fees, shareholder servicing fees and most other expenses of those other underlying GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Benchmark-Free Fund

Approval of renewal of management agreement for GMO Benchmark-Free Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. The Trustees noted that the Fund is not currently offered as a standalone investment and the investment strategies it pursues are intended to complement the strategies used by the Manager in managing other GMO funds or accounts. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

 

189


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees noted that the Fund does not pay a fee to the Manager under the Fund’s management or shareholder servicing and supplemental support agreement but that the Fund instead indirectly bears the management and shareholder servicing fees paid to the Manager by the other GMO funds in which the Fund invests. The Trustees noted that they had approved the Manager’s management and shareholder servicing and supplemental support agreements with the other GMO funds in which the Fund may invest and had concluded that the fees payable by those funds to the Manager under those agreements were reasonable.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the nature, extent and quality of services to be provided supported the approval of the agreement.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Global Asset Allocation Fund

Approval of renewal of management agreement for GMO Global Asset Allocation Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

 

190


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees noted that the Fund does not pay a fee to the Manager under the Fund’s management or shareholder servicing and supplemental support agreement but that the Fund instead indirectly bears the management and shareholder servicing fees paid to the Manager by the other GMO funds in which the Fund invests. The Trustees noted that they had approved the Manager’s management and shareholder servicing and supplemental support agreements with the other GMO funds in which the Fund may invest and had concluded that the fees payable by those funds to the Manager under those agreements were reasonable.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the nature, extent and quality of services to be provided supported the approval of the agreement.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Global Developed Equity Allocation Fund

Approval of renewal of management agreement for GMO Global Developed Equity Allocation Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

 

191


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and] of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees noted that the Fund does not pay a fee to the Manager under the Fund’s management or shareholder servicing and supplemental support agreement but that the Fund instead indirectly bears the management and shareholder servicing fees paid to the Manager by the other GMO funds in which the Fund invests. The Trustees reviewed information comparing the management fees indirectly borne by the Fund as a result of its investing in other GMO funds to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees noted that they had approved the Manager’s management and shareholder servicing and supplemental support agreements with the other GMO funds in which the Fund may invest and had concluded that the fees payable by those funds to the Manager under those agreements were reasonable.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the nature, extent and quality of services to be provided supported the approval of the agreement.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

 

192


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

GMO Global Equity Allocation Fund

Approval of renewal of management agreement for GMO Global Equity Allocation Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and] of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees noted that the Fund does not pay a fee to the Manager under the Fund’s management or shareholder servicing and supplemental support agreement but that the Fund instead indirectly bears the management and shareholder servicing fees paid to the Manager by the other GMO funds in which the Fund invests. The Trustees reviewed information comparing the management fees indirectly borne by the Fund as a result of its investing in other GMO funds to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees noted that they had approved the Manager’s management and shareholder servicing and supplemental support agreements with the other GMO funds in which the Fund may invest and had concluded that the fees payable by those funds to the Manager under those agreements were reasonable.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s

 

193


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the nature, extent and quality of services to be provided supported the approval of the agreement.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Implementation Fund

Approval of renewal of management agreement for GMO Implementation Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. The Trustees noted that the Fund is not currently offered as a standalone investment and the investment strategies it pursues are intended to complement the strategies used by the Manager in managing other GMO funds or accounts. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees considered the fact that the Fund does not pay a fee to the Manager under the Fund’s management agreement or any shareholder servicing and supplemental support agreement.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds. The Trustees also considered possible alternative fee arrangements.

 

194


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the nature, extent and quality of services to be provided supported the approval of the agreement.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO International Developed Equity Allocation Fund

Approval of renewal of management agreement for GMO International Developed Equity Allocation Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees noted that the Fund does not pay a fee to the Manager under the Fund’s management or shareholder servicing and supplemental support agreement but that the Fund instead indirectly bears the management and shareholder servicing fees paid to the Manager by the other GMO funds in which the Fund invests. The Trustees reviewed information comparing the management fees indirectly borne by the Fund as a result of its investing in other GMO funds to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees noted that they had approved the Manager’s management and shareholder servicing and supplemental support agreements with the other GMO funds in which the Fund may invest and had concluded that the fees payable by those funds to the Manager under those agreements were reasonable.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

 

195


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds. 

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the nature, extent and quality of services to be provided supported the approval of the agreement.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

International Equity Allocation Fund

Approval of renewal of management agreement for GMO International Equity Allocation Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees noted that the Fund does not pay a fee to the Manager under the Fund’s management or shareholder servicing and supplemental support agreement but that the Fund instead indirectly bears the management and shareholder servicing fees paid to the

 

196


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

Manager by the other GMO funds in which the Fund invests. The Trustees reviewed information comparing the management fees indirectly borne by the Fund as a result of its investing in other GMO funds to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to those other vehicles and accounts. The Trustees noted that they had approved the Manager’s management and shareholder servicing and supplemental support agreements with the other GMO funds in which the Fund may invest and had concluded that the fees payable by those funds to the Manager under those agreements were reasonable.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the nature, extent and quality of services to be provided supported the approval of the agreement.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO SGM Major Markets Fund

Approval of renewal of management agreement for GMO SGM Major Markets Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. In addition, the Trustees considered the Fund’s

 

197


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

performance in light of various risk and performance measures and as compared to the performance both of a composite of accounts with similar objectives managed by the Manager and of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics and to fees received by the Manager for providing sub-advisory services to a fund managed by a third-party and to the fees shown on the Manager’s fee schedule for its other pooled investment vehicles and separately managed accounts. The Trustees noted the differences in the services provided by the Manager to the Fund and to the third-party fund and to those other vehicles and accounts. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

GMO Special Opportunities Fund

Approval of renewal of management agreement for GMO Special Opportunities Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

 

198


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. The Trustees noted that the Fund is not currently offered as a standalone investment and the investment strategies it pursues are intended to complement the strategies used by the Manager in managing other GMO funds or accounts. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees also considered the fees payable to the Manager under the Fund’s management and shareholder servicing and supplemental support agreements. The Trustees reviewed information comparing the management fee payable by the Fund to the management fees of funds managed by other managers that were determined by a third-party data service to have similar investment characteristics. The Trustees also considered the shareholder servicing fees charged by the Manager to different share classes of the Fund in light of the services provided by the Manager.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees observed that the Fund’s management fee did not have any breakpoints and considered the extent to which breakpoints were embedded in the Fund’s fee. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

After reviewing these and other factors, the Trustees concluded that the fees charged to the Fund under the Fund’s management agreement were reasonable.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

 

199


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

GMO Strategic Opportunities Allocation Fund

Approval of renewal of management agreement for GMO Strategic Opportunities Allocation Fund (the “Fund”). At a meeting on June 7, 2018, the Trustees of GMO Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2018 of the management agreements between Grantham, Mayo, Van Otterloo & Co. LLC (the “Manager”) and the Trust, on behalf of the Fund and the other series of the Trust (collectively, the “GMO funds”).

Throughout the year the Trustees considered information relevant to the renewal of the Fund’s management agreement and met both privately and with representatives of the Manager. In deciding whether to approve the management agreement of the Fund, the Trustees also considered information the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) requested specifically for that purpose.

At a meeting on May 17, 2018, the Trustees discussed in great detail with representatives of the Manager the investment performance of the Fund and the other GMO funds. Following that meeting the Independent Trustees, their independent legal counsel and their independent compliance consultant met privately to discuss the extensive materials the Manager had provided them at their request. At that meeting, the Independent Trustees instructed their independent legal counsel to request additional information from the Manager, which they received before and at a meeting of the Trustees on June 7, 2018. At the June meeting, representatives of the Manager answered the Trustees’ questions, and the Independent Trustees then met privately once again with their independent legal counsel.

Using various metrics, the Trustees considered the Fund’s investment performance, as well as the performance of the other GMO funds managed by the investment division that manages the Fund. The Trustees discussed how a fund investing in the types of securities used by the Manager in managing the Fund should be expected to perform in different market conditions and considered whether the Fund had performed in accordance with those expectations. The Trustees noted that the Fund is not currently offered as a standalone investment and the investment strategies it pursues are intended to complement the strategies used by the Manager in managing other GMO funds or accounts. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of funds and accounts managed by other managers that were determined by a third-party data service to have similar investment classification or objective.

The Trustees considered the Fund’s expense ratio (i.e., annual operating expenses per share as a percentage of net asset value per share) as compared to the expense ratios of funds managed by other managers in a peer group determined by a third-party data service to have similar investment characteristics. In considering the Fund’s expense ratio, the Trustees took into account the Manager’s undertaking to reimburse a portion of the Fund’s operating expenses.

The Trustees noted that the Fund does not pay a fee to the Manager under the Fund’s management or shareholder servicing and supplemental support agreement but that the Fund instead indirectly bears the management and shareholder servicing fees paid to the Manager by the other GMO funds in which the Fund invests. The Trustees noted that they had approved the Manager’s management and shareholder servicing and supplemental support agreements with the other GMO funds in which the Fund may invest and had concluded that the fees payable by those funds to the Manager under those agreements were reasonable.

The Trustees also considered the non-investment management services the Manager provides to the Fund, including but not limited to valuation, legal and compliance, accounting and operational services.

The Trustees also reviewed information provided to them by the Manager regarding its profits from managing the Fund and the Trust overall. The Trustees reviewed the Manager’s methodology in preparing that information, including its allocation of expenses among the GMO funds, and considered the effect of different approaches to calculating profitability. The Trustees took note of various “fallout benefits” to the Manager resulting from its management of the Fund and the other GMO funds.

The Trustees considered possible economies of scale to the Manager at the Fund’s recent asset levels and whether the fees payable by the Fund to the Manager reflected these economies of scale. The Trustees also considered possible alternative fee arrangements.

The Trustees also considered the experience and sophistication of the Manager and its personnel (including, among others, management and investment management personnel and legal and compliance personnel). The Trustees considered recent personnel changes at the Manager. The Trustees also considered the resources the Manager employed in managing the Fund, the Manager’s organization, its reputation and relationship with Fund investors, and other matters concerning the business and organization of the Manager and the nature and quality of its services to the Fund.

 

200


GMO Trust Funds

 

Board Review of Investment Management Agreements — (Continued)

August 31, 2018 (Unaudited)

 

 

After reviewing these and other factors, the Trustees concluded that the nature, extent and quality of services to be provided supported the approval of the agreement.

In their deliberations, the Trustees considered the factors they individually deemed relevant in light of the legal advice furnished to them, with each Trustee weighting specific factors as he thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s management agreement for another year.

 

201


GMO Trust Funds

(A Series of GMO Trust)

 

Fund Expenses

August 31, 2018 (Unaudited)

 

 

Expense Examples: The following information is in relation to expenses for the six month period ended August 31, 2018.

As a shareholder of the Funds, you may incur two types of costs: (1) transaction costs, including purchase premium and redemption fees, if applicable; and (2) ongoing costs, including direct and /or indirect management fees, direct and/or indirect shareholder services fees, and distribution (12b-1) and/or administration fees for Funds with Class M shares, if applicable, and other Fund expenses. This example is intended to help you understand your ongoing costs (in dollars) of investing in the Funds and to compare these costs with the ongoing costs of investing in other mutual funds.

These examples are based on an investment of $1,000 invested at the beginning of the period and held for the entire period, March 1, 2018 through August 31, 2018.

Actual Expenses

This section of the table for each class below provides information about actual account values and actual expenses. You may use the information in this section, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, a $10,000,000 account value divided by $1,000 = 10,000), then multiply the result by the number under the heading entitled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes

This section of the table for each class below provides information about hypothetical account values and hypothetical expenses based on the Funds’ actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Funds’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Funds with other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as purchase premium and redemption fees. Therefore, this section of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.

 

    Actual     Hypothetical    

 

 
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Annualized
Expense Ratio
 

Alpha Only Fund

 

       

Class III

    $1,000.00       $931.00       $3.36       $1,000.00       $1,021.73       $3.52       0.69%  

Class IV

    $1,000.00       $931.10       $3.07       $1,000.00       $1,022.03       $3.21       0.63%  

Benchmark-Free Allocation Fund

 

       

Class III

    $1,000.00       $974.80       $4.58       $1,000.00       $1,020.57       $4.69       0.92%  

Class IV

    $1,000.00       $975.30       $4.33       $1,000.00       $1,020.82       $4.43       0.87%  

Class MF

    $1,000.00       $975.30       $4.33       $1,000.00       $1,020.82       $4.43       0.87%  

Benchmark-Free Fund

 

       

Class III

    $1,000.00       $965.20       $1.63       $1,000.00       $1,023.54       $1.68       0.33%  

Global Asset Allocation Fund

 

       

Class III

    $1,000.00       $981.70       $2.45       $1,000.00       $1,022.74       $2.50       0.49%  

Global Developed Equity Allocation Fund

 

       

Class III

    $1,000.00       $991.70       $2.56       $1,000.00       $1,022.63       $2.60       0.51%  

Global Equity Allocation Fund

 

       

Class III

    $1,000.00       $971.80       $2.78       $1,000.00       $1,022.38       $2.85       0.56%  

Implementation Fund

 

       

Core Class

    $1,000.00       $967.70       $0.69       $1,000.00       $1,024.50       $0.71       0.14%  

International Developed Equity Allocation Fund

 

       

Class III

    $1,000.00       $933.60       $2.97       $1,000.00       $1,022.13       $3.11       0.61%  

 

202


GMO Trust Funds

(A Series of GMO Trust)

 

Fund Expenses — (Continued)

August 31, 2018 (Unaudited)

 

 

    Actual     Hypothetical    

 

 
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Beginning
Account Value
March 1, 2018
    Ending
Account Value
August 31, 2018
    Expenses Paid
During the Period*
    Annualized
Expense Ratio
 

International Equity Allocation Fund

 

       

Class III

    $1,000.00       $921.10       $3.15       $1,000.00       $1,021.93       $3.31       0.65%  

SGM Major Markets Fund

 

       

Class III

    $1,000.00       $1,007.20       $5.06       $1,000.00       $1,020.16       $5.09       1.00%  

Class IV

    $1,000.00       $1,007.60       $4.81       $1,000.00       $1,020.42       $4.84       0.95%  

Class VI

    $1,000.00       $1,007.90       $4.61       $1,000.00       $1,020.62       $4.63       0.91%  

Special Opportunities Fund

 

       

Class VI

    $1,000.00       $1,068.10       $6.26       $1,000.00       $1,019.16       $6.11       1.20%  

Strategic Opportunities Allocation Fund

 

       

Class III

    $1,000.00       $973.10       $2.49       $1,000.00       $1,022.68       $2.55       0.50%  

 

  *

Expenses are calculated using each class’s annualized net expense ratio (including indirect expenses incurred) for the six months ended August 31, 2018, multiplied by the average account value over the period, multiplied by 184 days in the period, divided by 365 days in the year.

 

203


Item 2. Code of Ethics.

Not applicable to this filing.

Item 3. Audit Committee Financial Expert.

Not applicable to this filing.

Item 4. Principal Accountant Fees and Services.

Not applicable to this filing.

Item 5. Audit Committee of Listed Registrants.

Not applicable to this registrant.

Item 6. Schedule of Investments.

The complete schedule of investments for each series of the registrant is included as part of the semi-annual reports to shareholders filed under Item 1 of this Form N-CSR.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable to this registrant.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable to this registrant.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable to this registrant.

Item 10. Submission of Matters to a Vote of Security Holders.

There were no material changes to the procedures by which shareholders may recommend nominees to the registrant’s Board of Trustees.

Item 11. Controls and Procedures.

 

  (a)

The registrant’s Principal Executive Officer and Principal Financial Officer have concluded as of a date within 90 days of the filing of this report, based on their evaluation of the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) that the design and operation of such procedures are effective to provide reasonable assurance that information required to be disclosed by the registrant on Form N-CSR is recorded, processed, summarized, and reported within the time periods specified in the Commission’s rules and forms.

 

  (b)

There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.


Item 12. Exhibits.

(a)(1) Not applicable to this filing.

(a)(2) Certifications by the Principal Executive Officer and Principal Financial Officer of the registrant as required by Rule 30a-2(a) under the Investment Company Act of 1940 are attached hereto as EX-99.CERT.

(a)(3) Not applicable to this registrant.

 

  (b)

Certifications by the Principal Executive Officer and Principal Financial Officer of the registrant pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940 are attached hereto as EX-99.906CERT.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant)   GMO Trust
By (Signature and Title):  

/s/ Sheppard N. Burnett

  Sheppard N. Burnett, Chief Executive Officer
  Date: October 31, 2018

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

(Registrant)   GMO Trust
By (Signature and Title):  

/s/ Sheppard N. Burnett

  Sheppard N. Burnett, Chief Executive Officer
  Date: October 31, 2018

 

By (Signature and Title):  

/s/ Betty Maganzini

  Betty Maganzini, Principal Financial Officer
  Date: October 31, 2018